Citrus Sinensis ID: 039371
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 346 | 2.2.26 [Sep-21-2011] | |||||||
| Q6Z8C8 | 459 | Cyclin-dependent kinase F | yes | no | 0.838 | 0.631 | 0.608 | 1e-110 | |
| Q84SN3 | 433 | Cyclin-dependent kinase F | no | no | 0.838 | 0.669 | 0.518 | 1e-90 | |
| Q04859 | 622 | Serine/threonine-protein | yes | no | 0.820 | 0.456 | 0.517 | 5e-88 | |
| P20793 | 622 | Serine/threonine-protein | yes | no | 0.820 | 0.456 | 0.510 | 2e-87 | |
| P20794 | 623 | Serine/threonine-protein | yes | no | 0.820 | 0.455 | 0.503 | 1e-86 | |
| Q9JKV2 | 629 | Serine/threonine-protein | no | no | 0.861 | 0.473 | 0.496 | 2e-85 | |
| Q62726 | 629 | Serine/threonine-protein | no | no | 0.820 | 0.451 | 0.506 | 5e-85 | |
| Q9UPZ9 | 632 | Serine/threonine-protein | no | no | 0.820 | 0.449 | 0.496 | 6e-85 | |
| Q55FJ6 | 507 | Probable serine/threonine | yes | no | 0.835 | 0.570 | 0.481 | 2e-83 | |
| P43294 | 443 | Serine/threonine-protein | no | no | 0.924 | 0.722 | 0.466 | 3e-82 |
| >sp|Q6Z8C8|CDKF4_ORYSJ Cyclin-dependent kinase F-4 OS=Oryza sativa subsp. japonica GN=CDKF-4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 398 bits (1022), Expect = e-110, Method: Compositional matrix adjust.
Identities = 177/291 (60%), Positives = 231/291 (79%), Gaps = 1/291 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M+++ ++K++G+G+FG VW+AI KQ+GE VA+K +K++ YS+EEC++L+EVK LR++N H
Sbjct: 1 MDRFKMIKEVGDGTFGSVWRAINKQNGEVVAVKKMKRKYYSFEECMSLREVKSLRRMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ EN LYF+ EYM+CNL+QLM +R + FSEAEV+NWCFQI Q L YMH++
Sbjct: 60 PNIVKLKEVIRENDILYFIMEYMECNLYQLMKDRVKPFSEAEVRNWCFQIFQALAYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLVS D IK+ADFGLA EV S PPYTEY++T YRAPE+LL S Y+S
Sbjct: 120 GYFHRDLKPENLLVSKDVIKLADFGLAREVTSVPPYTEYVSTRWYRAPEVLLQSSIYDSA 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL+T HPLFPGT E D++ KICN IGSP E+SW +GL LA+ ++FP+
Sbjct: 180 VDMWAMGAIMAELLTLHPLFPGTSEADEILKICNVIGSPDEQSWPQGLSLAETMKFQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291
+ GN L+ ++ S + + + LI LCSWDPCKRP AAE LQH FQGC VP
Sbjct: 240 VSGNQLAEVMTSVSSEAVDLISSLCSWDPCKRPKAAEVLQHTFFQGCTFVP 290
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|Q84SN3|CDKF3_ORYSJ Cyclin-dependent kinase F-3 OS=Oryza sativa subsp. japonica GN=CDKF-3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 333 bits (854), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 151/291 (51%), Positives = 211/291 (72%), Gaps = 1/291 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
ME+Y ++++IG+G+ G V++A ++ E VA+K +K++ + WEEC++L+EVK L+K+N H
Sbjct: 1 MERYKVIREIGDGTCGNVFRAYNTETNEIVAVKKMKRKFFQWEECISLREVKALQKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ EN+ L+F+FE M+CNL+ ++ R+ FSE E++N+ QILQGL YMH
Sbjct: 60 PNIVKLKEVTMENHELFFIFENMECNLYDVIRERQAAFSEEEIRNFMVQILQGLAYMHNN 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLV++ T+KIADFGLA EV S PPYT+Y++T YRAPE+LL S Y
Sbjct: 120 GYFHRDLKPENLLVTDGTVKIADFGLAREVSSSPPYTDYVSTRWYRAPEVLLQSSAYTPA 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
+DMWA+G I+AEL T PLFPG E DQLYKIC +G+P W EG+ L ++ + F +
Sbjct: 180 IDMWAVGAILAELFTLSPLFPGGSETDQLYKICAVLGTPDHTVWPEGMNLPRSSSFNFFQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291
+ NL LIP+A + + LI+ LCSWDP +RPTA ++LQHP F VP
Sbjct: 240 IPPRNLWELIPNATLEAIDLIQQLCSWDPRRRPTAEQSLQHPFFNVGNWVP 290
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q04859|MAK_MOUSE Serine/threonine-protein kinase MAK OS=Mus musculus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 5e-88, Method: Compositional matrix adjust.
Identities = 148/286 (51%), Positives = 212/286 (74%), Gaps = 2/286 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT MKQ+G+G++G V +SGE VAIK +K++ YSW+EC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N++KL+E+ EN LYFVFEYM NL+QLM +R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL TF PLFPGT E D+++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ NL LIP+A+ + + L+ + +WDP KRPTA++AL+HP FQ
Sbjct: 240 QCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors. Could have an important function in sensory cells and in spermatogenesis. May participate in signaling pathways used in visual and olfactory sensory transduction. Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20793|MAK_RAT Serine/threonine-protein kinase MAK OS=Rattus norvegicus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 322 bits (826), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 146/286 (51%), Positives = 212/286 (74%), Gaps = 2/286 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT M+Q+G+G++G V +SGE VAIK +K++ YSW+EC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N++KL+E+ EN LYF+FEYM NL+QLM +R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL TF PLFPGT E D+++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ NL LIP+A+ + + L+ + +WDP KRPTA++AL+HP FQ
Sbjct: 240 QCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Could play an important function in spermatogenesis. Phosphorylates FZR1 in a cell cycle-dependent manner (By similarity). Plays a role in the transcriptional coactivation of AR. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 320 bits (820), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 144/286 (50%), Positives = 211/286 (73%), Gaps = 2/286 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT M+Q+G+G++G V +SGE VAIK +K++ YSW+EC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N++KL+E+ EN LYF+FEYM NL+QLM +R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL PLFPGT E D+++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDVWAVGSIMAELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ NL LIP+A+++ + L+ + +WDP KRPTA++AL+HP FQ
Sbjct: 240 QCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9JKV2|ICK_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus GN=Ick PE=2 SV=2 | Back alignment and function description |
|---|
Score = 315 bits (808), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 149/300 (49%), Positives = 213/300 (71%), Gaps = 2/300 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT +KQ+G+G++G V +SGE +AIK +K++ YSWEEC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTIKQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIVKL+E+ EN LYF+FEYM NL+QL+ R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANIVKLKEVIRENDHLYFIFEYMKENLYQLIKERNKLFPESAIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRDL +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAE+ T PLFPG E D ++KIC +G+P + W EG +L+ A + +P
Sbjct: 180 PIDIWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFLWP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCK 299
+ NNL LIP+A+ + + L+ L WDP KRPTA++AL++P FQ + +S DS K
Sbjct: 240 QCIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQIGHPLGIISKDSGK 299
|
May play a role in cardiac development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q62726|ICK_RAT Serine/threonine-protein kinase ICK OS=Rattus norvegicus GN=Ick PE=1 SV=1 | Back alignment and function description |
|---|
Score = 314 bits (805), Expect = 5e-85, Method: Compositional matrix adjust.
Identities = 145/286 (50%), Positives = 207/286 (72%), Gaps = 2/286 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT +KQ+G+G++G V +SGE +AIK +K++ YSWEEC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTIKQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIVKL+E+ EN LYF+FEYM NL+QL+ R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANIVKLKEVIRENDHLYFIFEYMKENLYQLIKERNKLFPESAIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRDL +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDLKPENLLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAE+ T PLFPG E D ++KIC +G+P + W EG +L+ A + +P
Sbjct: 180 PIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFIWP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ NNL LIP+A+ + + L+ L WDP KRPTA++AL++P FQ
Sbjct: 240 QCIPNNLKTLIPNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQ 285
|
May play a role in cardiac development. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9UPZ9|ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 6e-85, Method: Compositional matrix adjust.
Identities = 142/286 (49%), Positives = 208/286 (72%), Gaps = 2/286 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT ++Q+G+G++G V +SGE +AIK +K++ YSWEEC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTIRQLGDGTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N+VKL+E+ EN LYF+FEYM NL+QL+ R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVVKLKEVIRENDHLYFIFEYMKENLYQLIKERNKLFPESAIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRDL +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDLKPENLLCMGPELVKIADFGLAREIRSKPPYTDYVSTRWYRAPEVLLRSTNYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAE+ T PLFPG E D ++KIC +G+P + W EG +L+ A +++P
Sbjct: 180 PIDVWAVGCIMAEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFRWP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ NNL LIP+A+ + + L+ + WDP KRPTA++AL++P FQ
Sbjct: 240 QCVPNNLKTLIPNASSEAVQLLRDMLQWDPKKRPTASQALRYPYFQ 285
|
May play a key role in the development of multiple organ systems and particularly in cardiac development. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q55FJ6|Y8078_DICDI Probable serine/threonine-protein kinase DDB_G0268078 OS=Dictyostelium discoideum GN=DDB_G0268078 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 142/295 (48%), Positives = 210/295 (71%), Gaps = 6/295 (2%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
MEKY +KQ+G+G++G V +AI ++GE VAIK +K++ W+EC+ L+E+K L+K+ H
Sbjct: 1 MEKYQFIKQVGDGAYGDVIKAIDVKTGEIVAIKRMKKKFSDWKECIQLREIKALKKLK-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL E+ E L+FVFEY++ NL++ + +R + E ++N +QILQ L++MH
Sbjct: 60 PNIVKLLEIILERDELFFVFEYLENNLYESIKDRTKLLPETTIRNIIYQILQALHFMHTN 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
G+FHRDL +N+++ + +KIADFGLA E++S PP+T+YI+T YRAPE+LL YN+
Sbjct: 120 GFFHRDLKPENIMLVGERLKIADFGLAREIESKPPFTDYISTRWYRAPEVLLRCTYYNAP 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
+D+WA+G IMAEL + P+FPG+ E DQL+KIC +GSPT +W +G++LA + G+ FP
Sbjct: 180 IDIWAVGAIMAELYSLKPMFPGSSEIDQLFKICTIMGSPTSATWIDGIKLANSMGFTFPN 239
Query: 241 LQG---NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPS 292
+Q N LS L+P+AN D + LI L +DP KRPT +ALQH F+ + +PS
Sbjct: 240 VQPPSINPLSTLLPNANQDAIELITDLLQYDPLKRPTPLQALQHRYFK--VSIPS 292
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P43294|MHK_ARATH Serine/threonine-protein kinase MHK OS=Arabidopsis thaliana GN=MHK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 305 bits (782), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 151/324 (46%), Positives = 214/324 (66%), Gaps = 4/324 (1%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +Y +++++G+G+ G V++A+ ++ E VA+K +K++ Y WEEC+NL+EVK LRK+N H
Sbjct: 9 MCRYKILEELGDGTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLN-H 67
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
P+I+KL+E+ E+ L+F+FE MD NL+ +M R++ FSE E++++ Q+LQGL +MH+
Sbjct: 68 PHIIKLKEIVREHNELFFIFECMDHNLYHIMKERERPFSEGEIRSFMSQMLQGLAHMHKN 127
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLV+N+ +KIADFGLA EV S PPYTEY++T YRAPE+LL S Y
Sbjct: 128 GYFHRDLKPENLLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPA 187
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G I+AEL PLFPG E DQLYKIC +G P ++ E +++ +
Sbjct: 188 VDMWAVGAILAELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTE 247
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCKM 300
++ L+P+A + + LI LCSWDP KRPTA EAL HP F Q S I ++
Sbjct: 248 FPQTRIADLLPNAAPEAIDLINRLCSWDPLKRPTADEALNHPFFSMATQA-SYPIHDLEL 306
Query: 301 RLTPSAKKSGWKAKLIVWFLRWEP 324
RL A + L W EP
Sbjct: 307 RLDNMAALPNLELNL--WDFNREP 328
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 346 | ||||||
| 359474639 | 452 | PREDICTED: cyclin-dependent kinase F-4-l | 0.893 | 0.683 | 0.636 | 1e-117 | |
| 356531493 | 455 | PREDICTED: cyclin-dependent kinase F-4-l | 0.893 | 0.679 | 0.635 | 1e-116 | |
| 357484657 | 449 | Serine/threonine protein kinase ICK [Med | 0.893 | 0.688 | 0.619 | 1e-116 | |
| 356496445 | 450 | PREDICTED: cyclin-dependent kinase F-4-l | 0.893 | 0.686 | 0.629 | 1e-115 | |
| 224074450 | 453 | predicted protein [Populus trichocarpa] | 0.901 | 0.688 | 0.622 | 1e-115 | |
| 255557681 | 455 | mak, putative [Ricinus communis] gi|2235 | 0.881 | 0.670 | 0.631 | 1e-115 | |
| 297800140 | 460 | hypothetical protein ARALYDRAFT_492943 [ | 0.881 | 0.663 | 0.617 | 1e-114 | |
| 18415242 | 461 | putative serine/threonine protein kinase | 0.893 | 0.670 | 0.607 | 1e-113 | |
| 356558874 | 450 | PREDICTED: cyclin-dependent kinase F-4-l | 0.893 | 0.686 | 0.622 | 1e-113 | |
| 30684655 | 464 | putative serine/threonine protein kinase | 0.893 | 0.665 | 0.607 | 1e-113 |
| >gi|359474639|ref|XP_002265359.2| PREDICTED: cyclin-dependent kinase F-4-like [Vitis vinifera] gi|296088459|emb|CBI37450.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1097), Expect = e-117, Method: Compositional matrix adjust.
Identities = 198/311 (63%), Positives = 245/311 (78%), Gaps = 2/311 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M+KYT++K++G+G+FG VW+AI KQ+GE VAIK +K++ YSWEECLNL+EVK LRK+N H
Sbjct: 1 MDKYTIIKEVGDGTFGSVWRAINKQTGEVVAIKKMKRKYYSWEECLNLREVKSLRKMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ EN LYFVFEYM+CNL+QLM +R + FSE EV+NWCFQ+ QGL YMHR+
Sbjct: 60 PNIVKLREVFRENDILYFVFEYMECNLYQLMKDRLKLFSETEVRNWCFQVFQGLAYMHRR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLV+ D IKIADFGLA E++S PPYTEY++T YRAPE+LL S Y S
Sbjct: 120 GYFHRDLKPENLLVTKDVIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSSTYGSA 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL T PLFPG+ E D++YKIC+ +GSPT SWAEGL+LA A Y+FP+
Sbjct: 180 VDMWAMGAIMAELFTLRPLFPGSSEADEIYKICSVMGSPTWNSWAEGLKLANAINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV-PSMSIDSCK 299
+LS+LIPSA++D +SLI LCSWDPCKRPTA EALQHP FQ C V PS+ +
Sbjct: 240 FSSIHLSVLIPSASEDAISLITSLCSWDPCKRPTALEALQHPFFQSCFYVPPSLRPRTAV 299
Query: 300 MRLTPSAKKSG 310
R PS + G
Sbjct: 300 TRTPPSGETKG 310
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531493|ref|XP_003534312.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 425 bits (1093), Expect = e-116, Method: Compositional matrix adjust.
Identities = 197/310 (63%), Positives = 244/310 (78%), Gaps = 1/310 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
ME+Y L+K+IG+G+FG VW+AI KQ+GE VAIK +K++ YSWEEC+NL+EVK LRK+N H
Sbjct: 1 MERYKLIKEIGDGTFGTVWRAINKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ E+ LYFVFEYM+CNL+QLM +R++ FSEAEV+NWCFQ+ QGL YMH++
Sbjct: 60 PNIVKLKEVIRESDILYFVFEYMECNLYQLMKDREKLFSEAEVRNWCFQVFQGLAYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLV+ D IKIADFGLA E+ S PPYTEY++T YRAPE+LL S Y SK
Sbjct: 120 GYFHRDLKPENLLVTKDFIKIADFGLAREISSQPPYTEYVSTRWYRAPEVLLQSYMYTSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL + PLFPG E D++YKIC IG+PT ESWA+GL+LA+ Y+FP+
Sbjct: 180 VDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTFESWADGLKLARDINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCKM 300
L G +LS LIPSA+DD +SLI LCSWDPCKRPTA+EALQHP FQ C +P +
Sbjct: 240 LAGVHLSALIPSASDDAISLITSLCSWDPCKRPTASEALQHPFFQSCFYIPPSLRNRAVA 299
Query: 301 RLTPSAKKSG 310
R P A G
Sbjct: 300 RTPPPAGTRG 309
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357484657|ref|XP_003612616.1| Serine/threonine protein kinase ICK [Medicago truncatula] gi|355513951|gb|AES95574.1| Serine/threonine protein kinase ICK [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1086), Expect = e-116, Method: Compositional matrix adjust.
Identities = 192/310 (61%), Positives = 244/310 (78%), Gaps = 1/310 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
ME+Y ++K++G+G+FG VW+AI KQ+GE VAIK +K++ YSWEEC+NL+EVK LRK+N H
Sbjct: 1 MERYKIIKEVGDGTFGSVWRAISKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ E+ LYFVFEYM+CNL+QLM +R++ FSE E++NWCFQ+ QGL YMH++
Sbjct: 60 PNIVKLKEVIRESDILYFVFEYMECNLYQLMKDREKLFSEGEIRNWCFQVFQGLAYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLV+ D IKIADFGLA E++S PPYTEY++T YRAPE+LL S Y+SK
Sbjct: 120 GYFHRDLKPENLLVTKDVIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSYIYSSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL + PLFPG E D++YKIC IG+PT +SWA+GL+LA+ Y+FP+
Sbjct: 180 VDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTTDSWADGLKLARDINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCKM 300
L G NLS LIPSA+D +SLI+ LCSWDPCKRPTA+EALQHP FQ C +P
Sbjct: 240 LAGVNLSALIPSASDHAISLIQSLCSWDPCKRPTASEALQHPFFQSCFYIPPSLRSRAVA 299
Query: 301 RLTPSAKKSG 310
R P A G
Sbjct: 300 RTPPPAGTRG 309
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496445|ref|XP_003517078.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1085), Expect = e-115, Method: Compositional matrix adjust.
Identities = 195/310 (62%), Positives = 243/310 (78%), Gaps = 1/310 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
ME+Y L+K++G+G+FG VW+AI KQ+GE VAIK +K++ YSWEEC+NL+EVK LRK+N H
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ E+ LYFVFEYM+CNL+QLM +R++ FSE EV+NWCFQ+ QGL YMH++
Sbjct: 60 PNIVKLKEVIRESDILYFVFEYMECNLYQLMKDREKLFSEGEVRNWCFQVFQGLAYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLV+ D IKIADFGLA E+ S PPYTEY++T YRAPE+LL S Y SK
Sbjct: 120 GYFHRDLKPENLLVTKDFIKIADFGLAREISSQPPYTEYVSTRWYRAPEVLLQSYLYTSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL + PLFPG E D++YKIC IG+PT ESWA+GL+LA+ Y+FP+
Sbjct: 180 VDMWAMGAIMAELFSLRPLFPGASEADEIYKICGVIGNPTFESWADGLKLARDINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCKM 300
L G +LS LIPSA+DD +SLI LCSWDPCKRPTA+EALQHP FQ C +P +
Sbjct: 240 LAGVHLSALIPSASDDAISLITSLCSWDPCKRPTASEALQHPFFQSCFYIPPSLRNRAVA 299
Query: 301 RLTPSAKKSG 310
R P A G
Sbjct: 300 RTPPPAGTRG 309
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074450|ref|XP_002304373.1| predicted protein [Populus trichocarpa] gi|222841805|gb|EEE79352.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1082), Expect = e-115, Method: Compositional matrix adjust.
Identities = 196/315 (62%), Positives = 248/315 (78%), Gaps = 3/315 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
ME+Y L+K++G+G+FG VW+AI KQSGE VAIK +K++ YSWEEC+NL+EVK LRK+N H
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ EN LYFVFEYM+CNL+QL +R++ FSEAEV+NWCFQ+ QGL YMH++
Sbjct: 60 PNIVKLREVIRENDILYFVFEYMECNLYQLTKDREKLFSEAEVRNWCFQVFQGLAYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLVS IKIADFGLA EV+S PPYTEY++T YRAPE+LL S Y+SK
Sbjct: 120 GYFHRDLKPENLLVSKSIIKIADFGLAREVNSQPPYTEYVSTRWYRAPEVLLQSYLYSSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL T PLFPGT E D++YKIC+ IGSPT ++WA+GL LA+A Y+FP+
Sbjct: 180 VDMWAMGAIMAELFTLRPLFPGTSEADEIYKICSVIGSPTTDTWADGLNLARAINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCKM 300
G +L LIPSA++D ++LI+ LCSWDPC RP+AA+ALQHP FQ C VP +
Sbjct: 240 FAGVHLPTLIPSASEDAINLIKSLCSWDPCTRPSAADALQHPFFQSCFYVPPSLRPRAAI 299
Query: 301 RLTPSAKKSGWKAKL 315
TP++ +G K L
Sbjct: 300 TRTPAS--AGTKGGL 312
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557681|ref|XP_002519870.1| mak, putative [Ricinus communis] gi|223540916|gb|EEF42474.1| mak, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 419 bits (1078), Expect = e-115, Method: Compositional matrix adjust.
Identities = 194/307 (63%), Positives = 245/307 (79%), Gaps = 2/307 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
ME+Y L+K++G+G+FG VW+AI KQSGE VAIK +K++ Y+WEEC+NL+EVK LR++N H
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYTWEECVNLREVKSLRRMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ EN LYFVFEYMDCNL+QL+ +R + F EAEV+NWCFQ+ QGL YMH++
Sbjct: 60 PNIVKLKEVIRENDILYFVFEYMDCNLYQLIKDRVKLFPEAEVRNWCFQVFQGLAYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLV+ IKIADFGLA E++S PPYTEY++T YRAPE+LL S Y+SK
Sbjct: 120 GYFHRDLKPENLLVTKGIIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSYLYSSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL T PLFPGT E D++YKICN IGSPT++SWA+GL LA+A Y+FP+
Sbjct: 180 VDMWAMGAIMAELFTLRPLFPGTSEADEIYKICNIIGSPTKDSWADGLNLARAINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV-PSMSIDSCK 299
G LS LIPSA++D ++LI+ LCSWDP KRP+A EALQHP FQ C V P++ +
Sbjct: 240 FGGVQLSALIPSASEDAVNLIKSLCSWDPSKRPSAGEALQHPFFQSCFYVPPTLRSRAPV 299
Query: 300 MRLTPSA 306
R PSA
Sbjct: 300 TRTPPSA 306
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297800140|ref|XP_002867954.1| hypothetical protein ARALYDRAFT_492943 [Arabidopsis lyrata subsp. lyrata] gi|297313790|gb|EFH44213.1| hypothetical protein ARALYDRAFT_492943 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1075), Expect = e-114, Method: Compositional matrix adjust.
Identities = 189/306 (61%), Positives = 243/306 (79%), Gaps = 1/306 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M++Y L+K++G+G+FG VW+AI KQ+GE VAIK +K++ YSW+EC+NL+EVK LR++N H
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ EN LYFVFEYM+CNL+QLM +R++ F+EA++KNWCFQ+ QGL+YMH++
Sbjct: 60 PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLSYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLVS D IKIADFGLA EV+S PP+TEY++T YRAPE+LL S Y SK
Sbjct: 120 GYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL++ P+FPG E D++YKIC+ IG+PTEE+W EGL LA Y+FP+
Sbjct: 180 VDMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCKM 300
L G LS L+PSA++D ++LIE LCSWDPC RPTAAE LQHP FQ C VP +
Sbjct: 240 LPGVPLSSLMPSASEDAINLIERLCSWDPCSRPTAAEVLQHPFFQSCFYVPPSLRPKPSV 299
Query: 301 RLTPSA 306
TP A
Sbjct: 300 ARTPPA 305
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18415242|ref|NP_567574.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|13430556|gb|AAK25900.1|AF360190_1 putative kinase [Arabidopsis thaliana] gi|14532760|gb|AAK64081.1| putative kinase [Arabidopsis thaliana] gi|332658741|gb|AEE84141.1| putative serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1067), Expect = e-113, Method: Compositional matrix adjust.
Identities = 189/311 (60%), Positives = 243/311 (78%), Gaps = 2/311 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M++Y L+K++G+G+FG VW+AI KQ+GE VAIK +K++ YSW+EC+NL+EVK LR++N H
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ EN LYFVFEYM+CNL+QLM +R++ F+EA++KNWCFQ+ QGL+YMH++
Sbjct: 60 PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLSYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLVS D IKIADFGLA EV+S PP+TEY++T YRAPE+LL S Y SK
Sbjct: 120 GYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL++ P+FPG E D++YKIC+ IG+PTEE+W EGL LA Y+FP+
Sbjct: 180 VDMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV-PSMSIDSCK 299
L G LS L+PSA++D ++LIE LCSWDP RPTAAE LQHP FQ C V PS+
Sbjct: 240 LPGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPSLRPKPSV 299
Query: 300 MRLTPSAKKSG 310
R P G
Sbjct: 300 ARTPPPVGPRG 310
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558874|ref|XP_003547727.1| PREDICTED: cyclin-dependent kinase F-4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1067), Expect = e-113, Method: Compositional matrix adjust.
Identities = 193/310 (62%), Positives = 239/310 (77%), Gaps = 1/310 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
ME+Y L+K++G+G+FG VW+AI KQSGE VAIK +K++ YSWEEC+NL+EVK LRK+N H
Sbjct: 1 MERYKLIKEVGDGTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIVKL+E+ E L VFEYM+ NL+QLM NR++ FSE EV+NWCFQ+ QGL YMH++
Sbjct: 60 ANIVKLKEVIRECDTLCLVFEYMEYNLYQLMKNREKLFSENEVRNWCFQVFQGLAYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLV+ D IKIADFGLA E+ S PPYTEY++T YRAPE+LL S Y+SK
Sbjct: 120 GYFHRDLKPENLLVTKDVIKIADFGLAREISSLPPYTEYVSTRWYRAPEVLLQSHLYSSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL T PLFPG+ E D++YKIC+ +GSPT ESWA+GL+LA+ Y+FP+
Sbjct: 180 VDMWAMGAIMAELFTLRPLFPGSSEADEIYKICSVLGSPTTESWADGLKLARDINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCKM 300
L G +LS LIPS +DD +SL+ LCSWDPCKRPTAAE LQHP FQ C +P
Sbjct: 240 LAGVHLSTLIPSRSDDAISLVTSLCSWDPCKRPTAAEVLQHPFFQSCFYIPPSLRTRAVT 299
Query: 301 RLTPSAKKSG 310
R PSA G
Sbjct: 300 RTPPSAGTRG 309
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30684655|ref|NP_849407.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|332658742|gb|AEE84142.1| putative serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1066), Expect = e-113, Method: Compositional matrix adjust.
Identities = 189/311 (60%), Positives = 243/311 (78%), Gaps = 2/311 (0%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M++Y L+K++G+G+FG VW+AI KQ+GE VAIK +K++ YSW+EC+NL+EVK LR++N H
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ EN LYFVFEYM+CNL+QLM +R++ F+EA++KNWCFQ+ QGL+YMH++
Sbjct: 60 PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLSYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLVS D IKIADFGLA EV+S PP+TEY++T YRAPE+LL S Y SK
Sbjct: 120 GYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL++ P+FPG E D++YKIC+ IG+PTEE+W EGL LA Y+FP+
Sbjct: 180 VDMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV-PSMSIDSCK 299
L G LS L+PSA++D ++LIE LCSWDP RPTAAE LQHP FQ C V PS+
Sbjct: 240 LPGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPSLRPKPSV 299
Query: 300 MRLTPSAKKSG 310
R P G
Sbjct: 300 ARTPPPVGPRG 310
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 346 | ||||||
| TAIR|locus:2134746 | 464 | AT4G19110 [Arabidopsis thalian | 0.838 | 0.625 | 0.635 | 2.1e-107 | |
| TAIR|locus:2163583 | 499 | AT5G45430 [Arabidopsis thalian | 0.838 | 0.581 | 0.621 | 1.1e-103 | |
| MGI|MGI:96913 | 622 | Mak "male germ cell-associated | 0.820 | 0.456 | 0.517 | 9.4e-82 | |
| UNIPROTKB|F1RV90 | 624 | MAK "Uncharacterized protein" | 0.841 | 0.466 | 0.506 | 2e-81 | |
| UNIPROTKB|Q6DCJ4 | 648 | mak "Mak-prov protein" [Xenopu | 0.820 | 0.438 | 0.524 | 2e-81 | |
| RGD|3036 | 622 | Mak "male germ cell-associated | 0.841 | 0.467 | 0.506 | 2e-81 | |
| UNIPROTKB|P20793 | 622 | Mak "Serine/threonine-protein | 0.841 | 0.467 | 0.506 | 2e-81 | |
| UNIPROTKB|E1BDG4 | 623 | MAK "Uncharacterized protein" | 0.841 | 0.467 | 0.503 | 4.1e-81 | |
| UNIPROTKB|Q2YDJ7 | 382 | MAK "Uncharacterized protein" | 0.841 | 0.761 | 0.503 | 4.1e-81 | |
| UNIPROTKB|E2RE89 | 589 | MAK "Uncharacterized protein" | 0.910 | 0.534 | 0.474 | 1.4e-80 |
| TAIR|locus:2134746 AT4G19110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1040 (371.2 bits), Expect = 2.1e-107, Sum P(2) = 2.1e-107
Identities = 185/291 (63%), Positives = 238/291 (81%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M++Y L+K++G+G+FG VW+AI KQ+GE VAIK +K++ YSW+EC+NL+EVK LR++N H
Sbjct: 1 MDRYKLIKEVGDGTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ EN LYFVFEYM+CNL+QLM +R++ F+EA++KNWCFQ+ QGL+YMH++
Sbjct: 60 PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRQKLFAEADIKNWCFQVFQGLSYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLVS D IKIADFGLA EV+S PP+TEY++T YRAPE+LL S Y SK
Sbjct: 120 GYFHRDLKPENLLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL++ P+FPG E D++YKIC+ IG+PTEE+W EGL LA Y+FP+
Sbjct: 180 VDMWAMGAIMAELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291
L G LS L+PSA++D ++LIE LCSWDP RPTAAE LQHP FQ C VP
Sbjct: 240 LPGVPLSSLMPSASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVP 290
|
|
| TAIR|locus:2163583 AT5G45430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1027 (366.6 bits), Expect = 1.1e-103, P = 1.1e-103
Identities = 181/291 (62%), Positives = 234/291 (80%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
ME+YTL+K++G+G+FG VW+A+ KQ+ E VAIK +K++ +SWEEC+NL+EVK L ++N H
Sbjct: 1 MERYTLLKEVGDGTFGNVWRAVNKQTNEVVAIKRMKKKYFSWEECVNLREVKSLSRMN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL+E+ EN LYFVFEYM+CNL+QLM +R + F+E++++NWCFQ+ QGL+YMH++
Sbjct: 60 PNIVKLKEVIRENDILYFVFEYMECNLYQLMKDRPKHFAESDIRNWCFQVFQGLSYMHQR 119
Query: 121 GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
GYFHRDL +NLLVS D IKIAD GLA E+DS PPYTEY++T YRAPE+LL S Y SK
Sbjct: 120 GYFHRDLKPENLLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVYTSK 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VDMWA+G IMAEL++ PLFPG E D++YKIC+ IGSPTEE+W EGL LA Y+FP+
Sbjct: 180 VDMWAMGAIMAELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQFPQ 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291
G +LS ++P A+ D ++LIE LCSWDPC RPT AEALQHP FQ C +P
Sbjct: 240 FPGVHLSSVMPYASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIP 290
|
|
| MGI|MGI:96913 Mak "male germ cell-associated kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
Identities = 148/286 (51%), Positives = 212/286 (74%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT MKQ+G+G++G V +SGE VAIK +K++ YSW+EC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMKQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N++KL+E+ EN LYFVFEYM NL+QLM +R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVIKLKEVIRENDHLYFVFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL TF PLFPGT E D+++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ NL LIP+A+ + + L+ + +WDP KRPTA++AL+HP FQ
Sbjct: 240 QCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|F1RV90 MAK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 2.0e-81, P = 2.0e-81
Identities = 149/294 (50%), Positives = 216/294 (73%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT M+Q+G+G++G V +SGE VAIK +K++ YSW+EC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N++KL+E+ EN LYF+FEYM NL+QLM +R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL T PLFPGT E D+++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ-GCLQVPS 292
+ NL LIP+A+++ + L+ + SWDP KRPTA++AL+HP FQ G + PS
Sbjct: 240 QCAPINLKTLIPNASNEAIQLMTEMLSWDPKKRPTASQALKHPYFQVGQVLGPS 293
|
|
| UNIPROTKB|Q6DCJ4 mak "Mak-prov protein" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 2.0e-81, P = 2.0e-81
Identities = 150/286 (52%), Positives = 209/286 (73%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT MKQ+G+G++G V +SGE VAIK +K++ YSWEEC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMKQLGDGTYGSVIMGRSNESGELVAIKRMKRKFYSWEECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N+VKL+E+ EN LYFVFEYM NL+QLM +R + E+ ++N +QILQGL ++H+
Sbjct: 60 ANVVKLKEVIRENDHLYFVFEYMKENLYQLMKDRNKLLPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + IKIADFGL E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELIKIADFGLVRELRSQPPYTDYVSTRWYRAPEVLLRSSSYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL T PLFPGT E DQ++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDLWAVGSIMAELYTLRPLFPGTSEVDQIFKICQVLGTPKKNDWPEGYQLAASMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ NL LIP+A++D ++L+ WDP KRPTA++AL+HP FQ
Sbjct: 240 QCIPINLKTLIPNASEDALNLMRDTMQWDPKKRPTASQALRHPYFQ 285
|
|
| RGD|3036 Mak "male germ cell-associated kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 2.0e-81, P = 2.0e-81
Identities = 149/294 (50%), Positives = 216/294 (73%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT M+Q+G+G++G V +SGE VAIK +K++ YSW+EC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N++KL+E+ EN LYF+FEYM NL+QLM +R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL TF PLFPGT E D+++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ-GCLQVPS 292
+ NL LIP+A+ + + L+ + +WDP KRPTA++AL+HP FQ G + PS
Sbjct: 240 QCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPS 293
|
|
| UNIPROTKB|P20793 Mak "Serine/threonine-protein kinase MAK" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 2.0e-81, P = 2.0e-81
Identities = 149/294 (50%), Positives = 216/294 (73%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT M+Q+G+G++G V +SGE VAIK +K++ YSW+EC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N++KL+E+ EN LYF+FEYM NL+QLM +R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL TF PLFPGT E D+++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDVWAVGSIMAELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ-GCLQVPS 292
+ NL LIP+A+ + + L+ + +WDP KRPTA++AL+HP FQ G + PS
Sbjct: 240 QCIPINLKTLIPNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPS 293
|
|
| UNIPROTKB|E1BDG4 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 814 (291.6 bits), Expect = 4.1e-81, P = 4.1e-81
Identities = 148/294 (50%), Positives = 216/294 (73%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT M+Q+G+G++G V +SGE VAIK +K++ YSW+EC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N++KL+E+ EN LYF+FEYM NL+QLM +R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL T PLFPGT E D+++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ-GCLQVPS 292
+ NL LIP+A+++ + L+ + +WDP KRPTA++AL+HP FQ G + PS
Sbjct: 240 QCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPS 293
|
|
| UNIPROTKB|Q2YDJ7 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 814 (291.6 bits), Expect = 4.1e-81, P = 4.1e-81
Identities = 148/294 (50%), Positives = 216/294 (73%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT M+Q+G+G++G V +SGE VAIK +K++ YSW+EC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N++KL+E+ EN LYF+FEYM NL+QLM +R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL T PLFPGT E D+++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ-GCLQVPS 292
+ NL LIP+A+++ + L+ + +WDP KRPTA++AL+HP FQ G + PS
Sbjct: 240 QCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQVGQVLGPS 293
|
|
| UNIPROTKB|E2RE89 MAK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 809 (289.8 bits), Expect = 1.4e-80, P = 1.4e-80
Identities = 151/318 (47%), Positives = 221/318 (69%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M +YT M+Q+G+G++G V +SGE VAIK +K++ YSW+EC+NL+EVK L+K+N H
Sbjct: 1 MNRYTTMRQLGDGTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N++KL+E+ EN LYF+FEYM NL+QLM +R + F E+ ++N +QILQGL ++H+
Sbjct: 60 ANVIKLKEVIRENDHLYFIFEYMKENLYQLMKDRNKLFPESVIRNIMYQILQGLAFIHKH 119
Query: 121 GYFHRDLISKNLL-VSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G+FHRD+ +NLL + + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S
Sbjct: 120 GFFHRDMKPENLLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSS 179
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
+D+WA+G IMAEL T PLFPGT E D+++KIC +G+P + W EG +LA + ++FP
Sbjct: 180 PIDVWAVGSIMAELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ-GCLQVPSMSIDSC 298
+ NL LIP+A+++ + L+ + +WDP KRPTA++AL+H FQ G + PS
Sbjct: 240 QCVPINLKTLIPNASNEAIQLMTEMLNWDPKKRPTASQALKHQYFQVGQVLGPSSHHPEL 299
Query: 299 KMRLTPSAKKSGWKAKLI 316
K L + K L+
Sbjct: 300 KQSLNKQVQPLESKPSLV 317
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6Z8C8 | CDKF4_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.6082 | 0.8381 | 0.6318 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00003204001 | SubName- Full=Chromosome chr2 scaffold_140, whole genome shotgun sequence; (458 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 346 | |||
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-155 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-105 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-103 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-100 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-84 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-83 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-81 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-79 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-77 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-76 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-74 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-74 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-73 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-72 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-71 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-69 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-68 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-67 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-67 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-64 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-64 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-63 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-61 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-59 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-58 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-58 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-58 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-58 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-58 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-57 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-56 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-56 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-56 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-56 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-55 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-54 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-53 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-52 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-51 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-51 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-50 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-49 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-49 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-49 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-48 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-45 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-44 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-44 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-42 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-41 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-40 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-40 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-39 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-38 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-34 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-34 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-33 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-33 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-33 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-32 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-32 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-30 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-28 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-27 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-27 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-26 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-26 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-25 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-24 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-24 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-23 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-23 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-23 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-21 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-20 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-19 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-19 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-19 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-17 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-17 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-10 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.003 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 435 bits (1121), Expect = e-155
Identities = 161/283 (56%), Positives = 218/283 (77%), Gaps = 2/283 (0%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
Y ++KQ+G+G+FG V+ A K++GE VAIK +K++ YSWEEC+NL+EVK LRK+N HPNI
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 64 VKLQELASENYRLYFVFEYMDCNLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQGY 122
VKL+E+ EN LYFVFEYM+ NL+QLM +RK FSE+ +++ +QILQGL ++H+ G+
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 123 FHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKV 181
FHRDL +NLLVS + +KIADFGLA E+ S PPYT+Y++T YRAPE+LL S Y+S V
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPV 180
Query: 182 DMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241
D+WALG IMAEL T PLFPG+ E DQLYKIC+ +G+PT++ W EG +LA G++FP+
Sbjct: 181 DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF 240
Query: 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
+L LIP+A+ + + LI+ + WDP KRPTA++ALQHP F
Sbjct: 241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = e-105
Identities = 116/288 (40%), Positives = 176/288 (61%), Gaps = 13/288 (4%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE---CLNLKEVKCLRKINNH 60
Y ++++GEG++G V++A K++GE VA+K K R+ + EE L+E+ L+++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK--KIRLDNEEEGIPSTALREISLLKELK-H 57
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
PNIVKL ++ +LY VFEY D +L + + R S +K+ +Q+L+GL Y H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQ 176
HRDL +N+L++ D +K+ADFGLA P YT + TL YRAPE+LL S
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
Y++ VD+W++G I AE+IT PLFPG E DQL+KI +G+PTEESW G+ +
Sbjct: 176 YSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW-PGVTKLPDYKP 234
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
FPK +L ++P + + + L+ + ++P KR +A EAL+HP F
Sbjct: 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 303 bits (779), Expect = e-103
Identities = 121/284 (42%), Positives = 180/284 (63%), Gaps = 4/284 (1%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPN 62
Y + +IGEG++G V++A K +GE VAIK +K R S L+E+K L+++N HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPN 59
Query: 63 IVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
I+KL ++ LY VFE+MD +L++L+ +R++ E+ +K++ +Q+LQGL + H G
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 123 FHRDLISKNLLV-SNDTIKIADFGLAWEVDSCP-PYTEYITTLQYRAPEMLLMSGQYNSK 180
HRDL +NLL+ + +K+ADFGLA S PYT Y+ T YRAPE+LL Y++
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VD+W++G I AEL++ PLFPG E DQL+KI +G+P E W + LA+ + + FPK
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
G L L P+A+ + L+ + +DP KR TA +AL HP F
Sbjct: 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 295 bits (758), Expect = e-100
Identities = 119/283 (42%), Positives = 188/283 (66%), Gaps = 3/283 (1%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
Y ++ +IGEG+F +V +A +++G+Y AIK +K+ S E+ NL+E++ LR+++ HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 64 VKLQE--LASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
++L E + RL VFE MD NL++L+ RK+ E VK++ +Q+L+ L++MHR G
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 122 YFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKV 181
FHRD+ +N+L+ +D +K+ADFG + S PPYTEYI+T YRAPE LL G Y K+
Sbjct: 121 IFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKM 180
Query: 182 DMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241
D+WA+G + E+++ PLFPGT E DQ+ KI + +G+P E + + + Y FP
Sbjct: 181 DIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN-YNFPSK 239
Query: 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
+G L L+P+A+ + + L++ L ++DP +R TA +AL+HP F
Sbjct: 240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 255 bits (654), Expect = 8e-84
Identities = 106/290 (36%), Positives = 169/290 (58%), Gaps = 13/290 (4%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLN---LKEVKCLRKIN 58
+Y K++GEG++ V++A K++G VAIK +K ++ +N L+E+K L+++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
HPNI+ L ++ + VFE+M+ +L +++ ++ + A++K++ L+GL Y+H
Sbjct: 61 -HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPP--YTEYITTLQYRAPEMLLMSG 175
HRDL NLL+++D +K+ADFGLA S P T + T YRAPE+L +
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVVTRWYRAPELLFGAR 178
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
Y VDMW++G I AEL+ P PG + DQL KI A+G+PTEE+W L
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL---PD 235
Query: 236 Y-KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
Y +F L + P+A+DD + L++ L + +P KR TA +AL+HP F
Sbjct: 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 2e-83
Identities = 115/296 (38%), Positives = 177/296 (59%), Gaps = 24/296 (8%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-----CLNLKEVKCLRKIN 58
Y + QIGEG++G+V++A K++GE VA+K +I E ++E+K L+K+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK----KIRMENEKEGFPITAIREIKLLQKLR 56
Query: 59 NHPNIVKLQELASENYR--LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
HPNIV+L+E+ + + +Y VFEYMD +L L+ + + F+E+++K + Q+L+GL Y
Sbjct: 57 -HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 117 MHRQGYFHRDLISKNLLVSND-TIKIADFGLA--WEVDSCPPYTEYITTLQYRAPEMLLM 173
+H G HRD+ N+L++ND +K+ADFGLA + + YT + TL YR PE+LL
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
+ +Y +VDMW++G I+AEL P+F G+ E +QL KI GSPT+E+W +L
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235
Query: 234 HGYKFPKLQGNNL-----SLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
K K L L+ PSA + L++ L + DP KR +A +ALQH F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSA----LDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 7e-81
Identities = 105/283 (37%), Positives = 155/283 (54%), Gaps = 31/283 (10%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
Y +++++GEGSFGKV+ A K++G+ VAIK +K++ + L+E+K L+K+ HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59
Query: 64 VKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
V+L ++ + +LY V EY + +L L+ R SE E + + QIL L Y+H +G
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKGI 118
Query: 123 FHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKV 181
HRDL +N+L+ D +K+ADFGLA ++D T ++ T +Y APE +L+ Y V
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE-VLLGKGYGKAV 177
Query: 182 DMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241
D+W+LG+I+ EL+T P FPG DDQL ++ IG P
Sbjct: 178 DIWSLGVILYELLTGKPPFPG---DDQLLELFKKIGKPKPPFPPP--------------- 219
Query: 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
+ + LI L DP KR TA EALQHP F
Sbjct: 220 --------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 244 bits (626), Expect = 1e-79
Identities = 120/297 (40%), Positives = 174/297 (58%), Gaps = 22/297 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQR-------IYSWEECLNLKEVKCL 54
++Y + +I EG++G V++A K++GE VA+K LK I S L+E+ L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS------LREINIL 58
Query: 55 RKINNHPNIVKLQELA--SENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQ 112
K+ HPNIV ++E+ S ++Y V EY++ +L LM KQ F ++EVK Q+L
Sbjct: 59 LKLQ-HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEM 170
G+ ++H HRDL + NLL++N +KI DFGLA E S PYT+ + TL YRAPE+
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL 177
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
LL + +Y++ +DMW++G I AEL+T PLFPG E DQL KI +G+PTE+ W EL
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCS---WDPCKRPTAAEALQHPLF 284
A F K N L P+ + + +LL +DP KR +A +AL+HP F
Sbjct: 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGF-DLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 9e-77
Identities = 116/304 (38%), Positives = 170/304 (55%), Gaps = 32/304 (10%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK---------QRIYSWEECLNLKEVKC 53
+Y L+K IG G++G V A+ K++G VAIK + +RI L+E+K
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI--------LREIKL 52
Query: 54 LRKINNHPNIVKLQEL----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCF 108
LR + H NI+ L ++ + E++ +Y V E M+ +LH+++ + Q ++ ++ + +
Sbjct: 53 LRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS-PQPLTDDHIQYFLY 110
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPY----TEYITTL 163
QIL+GL Y+H HRDL N+LV SN +KI DFGLA VD TEY+ T
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES 223
YRAPE+LL S +Y +D+W++G I AEL+T PLFPG DQL I +G+P+EE
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230
Query: 224 WAEGLELAKAHGY--KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
+ + KA Y PK LS L P A+ + + L+E + +DP KR TA EAL H
Sbjct: 231 -LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289
Query: 282 PLFQ 285
P
Sbjct: 290 PYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 2e-76
Identities = 107/286 (37%), Positives = 150/286 (52%), Gaps = 31/286 (10%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINNHPN 62
Y L++++G GSFG V++A K +G+ VA+K L K+ S ++ +E++ LR+++ HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-HPN 59
Query: 63 IVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
IV+L + + LY V EY + +L +S SE E K QIL+GL Y+H G
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSNG 118
Query: 122 YFHRDLISKNLLVSND-TIKIADFGLA--WEVDSCPPYTEYITTLQYRAPEMLLMSGQYN 178
HRDL +N+L+ + +KIADFGLA S T ++ T Y APE+LL Y
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
KVD+W+LG+I+ EL+T P F G DQL I +G P E +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK------------ 225
Query: 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
S A D LI+ + DP KRPTA E LQHP F
Sbjct: 226 -------WSSGSEEAKD----LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 1e-74
Identities = 109/304 (35%), Positives = 170/304 (55%), Gaps = 29/304 (9%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL---------KQRIYSWEECLNLKEV 51
+ KY +++++G+G++G VW+AI +++ E VA+K + QR + +E+
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--------REI 57
Query: 52 KCLRKINNHPNIVKLQE-LASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQ 109
L+++ +HPNIVKL + +EN + +Y VFEYM+ +LH ++ R + + +Q
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI--RANILEDVHKRYIMYQ 115
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA------WEVDSCPPYTEYITT 162
+L+ L Y+H HRDL N+L+++D +K+ADFGLA E P T+Y+ T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE 222
YRAPE+LL S +Y VDMW++G I+ E++ PLFPGT +QL KI IG P+ E
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235
Query: 223 SWAE-GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
A P L L+P A+DD + L++ L ++P KR TA EAL+H
Sbjct: 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 282 PLFQ 285
P
Sbjct: 296 PYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 2e-74
Identities = 114/290 (39%), Positives = 177/290 (61%), Gaps = 16/290 (5%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKINNH 60
Y +++IGEG++G V++A K +GE VA+K K R+ + +E + ++E+ L+++N H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALK--KIRLETEDEGVPSTAIREISLLKELN-H 57
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQILQGLNYMHR 119
PNIV+L ++ +LY VFE++D +L + M S+ +K++ +Q+LQG+ Y H
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 120 QGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCP--PYTEYITTLQYRAPEMLLMSGQ 176
HRDL +NLL+ +K+ADFGLA P YT + TL YRAPE+LL S Q
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
Y++ VD+W++G I AE++ PLFPG E DQL++I +G+P E+ W L Y
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD---Y 233
Query: 237 K--FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
K FPK +LS ++P+ ++D + L+ + +DP KR +A ALQHP F
Sbjct: 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 1e-73
Identities = 106/288 (36%), Positives = 169/288 (58%), Gaps = 9/288 (3%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRKINN 59
+Y ++ +IGEG+ G V++A +++GE VA+K + R E + L+E+K L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQ- 57
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
HP +VKL ++ V EYM +L +++ + ++ EA+VK++ +L+G+ YMH
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLA--WEVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
G HRDL NLL+S D +KIADFGLA + + Y+ + T YRAPE+L + +
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
Y+ VD+WA+G I AEL+ PLFPG + +QL + +G+P EE+W L +
Sbjct: 178 YDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
FP+ + L + P A+ + + L++ L +DP KR +AAEAL+HP F
Sbjct: 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 2e-72
Identities = 103/290 (35%), Positives = 149/290 (51%), Gaps = 9/290 (3%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINN 59
KY ++ +GEG++G V + K +GE VAIK K+ E+ L+EVK LR++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKE-SEDDEDVKKTALREVKVLRQLR- 58
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
H NIV L+E RLY VFEY++ L +L+ V+++ +Q+LQ + Y H
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 120 QGYFHRDLISKNLLVS-NDTIKIADFGLAWEV--DSCPPYTEYITTLQYRAPEMLLMSGQ 176
HRD+ +N+LVS + +K+ DFG A + P T+Y+ T YRAPE+L+
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
Y VD+WA+G IMAEL+ PLFPG + DQLY I +G + G
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 237 KFPKL-QGNNLSLLIPSANDD-EMSLIELLCSWDPCKRPTAAEALQHPLF 284
FP+ Q +L P + ++ DP +R T E LQHP F
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 6e-71
Identities = 109/293 (37%), Positives = 166/293 (56%), Gaps = 18/293 (6%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKIN-- 58
Y + +IGEG++G V++A +G +VA+K K R+ EE + L+E+ L+++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK--KVRVPLSEEGIPLSTLREIALLKQLESF 58
Query: 59 NHPNIVKLQE--LASENYR---LYFVFEYMDCNLHQLMSN-RKQCFSEAEVKNWCFQILQ 112
HPNIV+L + R L VFE++D +L +S K +K+ Q+L+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEML 171
G++++H HRDL +N+LV++D +KIADFGLA T + TL YRAPE+L
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
L S Y + VDMW++G I AEL PLF GT E DQL KI + IG P+EE W + L
Sbjct: 179 LQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
++ FP + +P ++ + L++ + +++P KR +A EALQHP F
Sbjct: 238 RSS---FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 4e-69
Identities = 114/290 (39%), Positives = 182/290 (62%), Gaps = 13/290 (4%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKINN 59
YT +++IGEG++G V++ K++G+ VA+K K R+ S EE + ++E+ L+++
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK--KIRLESEEEGVPSTAIREISLLKELQ- 57
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLM-SNRKQCFSEAE-VKNWCFQILQGLNYM 117
HPNIV LQ++ + RLY +FE++ +L + + S K + +AE VK++ +QILQG+ +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCP--PYTEYITTLQYRAPEMLLMS 174
H + HRDL +NLL+ + IK+ADFGLA P YT + TL YRAPE+LL S
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
+Y++ VD+W++G I AE+ T PLF G E DQL++I +G+PTE+ W G+ +
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW-PGVTSLPDY 235
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
FPK + +L + + ++D + L+E + +DP KR +A +AL HP F
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 3e-68
Identities = 103/305 (33%), Positives = 165/305 (54%), Gaps = 27/305 (8%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKINNH 60
Y ++ ++GEG+FG+V++A + ++G VA+K K +++ ++ L+E+K L+K+ H
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALK--KILMHNEKDGFPITALREIKILKKLK-H 66
Query: 61 PNIVKLQELA---SENYR-----LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQ 112
PN+V L ++A + + +Y V YMD +L L+ N +E+++K + Q+L+
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPP------------YTEY 159
G+NY+H HRD+ + N+L+ N +KIADFGLA D PP YT
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP 219
+ T YR PE+LL +Y + VD+W +G + AE+ T P+ G + DQL+ I G+P
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246
Query: 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL 279
TEE+W L G L + + L+ L S DP KR TA++AL
Sbjct: 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306
Query: 280 QHPLF 284
+HP F
Sbjct: 307 EHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 2e-67
Identities = 110/284 (38%), Positives = 158/284 (55%), Gaps = 12/284 (4%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKINNHPNIVKL 66
IGEG++G V++A SGE VA+K K R+ + + + +L+E+ L + HPNIV+L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALK--KVRMDNERDGIPISSLREITLLLNLR-HPNIVEL 71
Query: 67 QELASENY--RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
+E+ + ++ V EY + +L L+ N FSE++VK Q+L+GL Y+H H
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIH 131
Query: 125 RDLISKNLLVSNDT--IKIADFGLAWEV-DSCPPYTEYITTLQYRAPEMLLMSGQYNSKV 181
RDL NLL+ D +KIADFGLA P T + TL YRAPE+LL Y + +
Sbjct: 132 RDLKVSNLLL-TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAI 190
Query: 182 DMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241
DMWA+G I+AEL+ PL PG E +QL I +G+P E W +L + PK
Sbjct: 191 DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQ 250
Query: 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
NNL P ++ + L+ L +DP KR TA EAL+ F+
Sbjct: 251 PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-67
Identities = 112/301 (37%), Positives = 171/301 (56%), Gaps = 25/301 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKIN 58
+ Y +++IGEG++GKV++A K +G+ VA+K K R+ EE + L+E+ L+ ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLS 58
Query: 59 NHPNIVKLQELASENYR-------LYFVFEYMDCNLHQLM-SNRKQC---FSEAEVKNWC 107
IV+L L E+ LY VFEY+D +L + M SN + +K++
Sbjct: 59 ESIYIVRL--LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLVSND--TIKIADFGLAWEVDSCP--PYTEYITTL 163
+Q+L+G+ + H+ G HRDL +NLLV +KIAD GL S P YT I TL
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG-RAFSIPVKSYTHEIVTL 175
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES 223
YRAPE+LL S Y++ VD+W++G I AE+ PLFPG E QL I +G+PTE+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235
Query: 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283
W +L H +FP+ + +LS +P + + + L++ + +DP KR +A AL HP
Sbjct: 236 WPGVSKLRDWH--EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
Query: 284 F 284
F
Sbjct: 294 F 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 1e-64
Identities = 100/305 (32%), Positives = 162/305 (53%), Gaps = 30/305 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK---------ALKQRIYSWEECLNLKEVK 52
+Y ++ IG G++G V AI +SG+ VAIK L +R L+E+K
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKR--------TLRELK 56
Query: 53 CLRKINNHPNIVKLQEL----ASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCF 108
LR H NI+ ++++ ++ +Y V + M+ +LH ++ + Q +E ++ + +
Sbjct: 57 ILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLY 114
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPP-----YTEYITT 162
Q+L+GL Y+H HRDL NLLV+ D ++I DFG+A + S P TEY+ T
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE 222
YRAPE+LL +Y + +DMW++G I AE++ LFPG QL I + +GSP+EE
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234
Query: 223 SWAE-GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
G + + + P+ Q S + P A+ + + L+ + +DP +R T +ALQH
Sbjct: 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 282 PLFQG 286
P
Sbjct: 295 PFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 7e-64
Identities = 107/294 (36%), Positives = 175/294 (59%), Gaps = 15/294 (5%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKI 57
M++Y +++IGEG++G V++A + + E +A+K K R+ +E + ++E+ L+++
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALK--KIRLEQEDEGVPSTAIREISLLKEM 58
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAE--VKNWCFQILQGLN 115
H NIV+LQ++ RLY VFEY+D +L + M + F++ +K + +QIL+G+
Sbjct: 59 Q-HGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIA 116
Query: 116 YMHRQGYFHRDLISKNLLV--SNDTIKIADFGLAWEVDSCP--PYTEYITTLQYRAPEML 171
Y H HRDL +NLL+ + +K+ADFGLA P +T + TL YRAPE+L
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA-RAFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
L S Y++ VD+W++G I AE++ PLFPG E D+L+KI +G+P EE+W G+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP-GVTSL 234
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ FPK +L+ ++P+ + L+ + DP KR TA AL+H F+
Sbjct: 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 2e-63
Identities = 109/285 (38%), Positives = 169/285 (59%), Gaps = 12/285 (4%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKINNHPNI 63
+++IGEG++G V++A K +GE VA+K K R+ + E + ++E+ L+++N HPNI
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALK--KIRLDTETEGVPSTAIREISLLKELN-HPNI 61
Query: 64 VKLQELASENYRLYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
VKL ++ +LY VFE++ +L + M ++ +K++ FQ+LQGL + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 123 FHRDLISKNLLVSND-TIKIADFGLAWEVDSCP--PYTEYITTLQYRAPEMLLMSGQYNS 179
HRDL +NLL++ + IK+ADFGLA P YT + TL YRAPE+LL Y++
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
VD+W+LG I AE++T LFPG E DQL++I +G+P E W G+ + FP
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSLPDYKPSFP 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
K + S ++P ++D L+ + +DP KR +A AL HP F
Sbjct: 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 2e-61
Identities = 102/301 (33%), Positives = 161/301 (53%), Gaps = 32/301 (10%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQ---------RIYSWEECLNLKEVK 52
++Y + +G G++G+V A ++G VAIK L + R Y +E++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--------RELR 66
Query: 53 CLRKINNHPNIVKLQEL-----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNW 106
L+ ++ H N++ L ++ + E+++ +Y V M +L+ ++ + Q S+ ++
Sbjct: 67 LLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIV--KCQKLSDDHIQFL 123
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQY 165
+QIL+GL Y+H G HRDL N+ V+ D +KI DFGLA D T Y+ T Y
Sbjct: 124 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD--EMTGYVATRWY 181
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
RAPE++L YN VD+W++G IMAEL+T LFPG+ DQL +I N +G+P EE
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE-LL 240
Query: 226 EGLELAKAHGY--KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283
+ + A Y P++ + + AN + L+E + DP KR TAAEAL HP
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 284 F 284
Sbjct: 301 L 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 3e-59
Identities = 109/315 (34%), Positives = 172/315 (54%), Gaps = 36/315 (11%)
Query: 2 EKYT-LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---------EC----LN 47
E+Y +GEG++GKV +A +G+ VAIK +K S + C
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 48 LKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWC 107
L+E+K + +I H NI+ L ++ E + V + M +L +++ +RK +E++VK
Sbjct: 68 LRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASDLKKVV-DRKIRLTESQVKCIL 125
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPY---------- 156
QIL GLN +H+ + HRDL N+ +++ I KIADFGLA PPY
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY-GYPPYSDTLSKDETM 184
Query: 157 ------TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY 210
T + TL YRAPE+L+ + +Y+ VDMW++G I AEL+T PLFPG E DQL
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244
Query: 211 KICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPC 270
+I +G+P E++W + +L +F + +L + P+A+DD + L++ L +P
Sbjct: 245 RIFELLGTPNEDNWPQAKKLPLY--TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302
Query: 271 KRPTAAEALQHPLFQ 285
+R +A EAL+H F+
Sbjct: 303 ERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-58
Identities = 98/286 (34%), Positives = 163/286 (56%), Gaps = 8/286 (2%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
+ ++++GEG++ V++ + +GE VA+K + ++E+ ++++ H NI
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENI 60
Query: 64 VKLQELASENYRLYFVFEYMDCNLHQLMSNR--KQCFSEAEVKNWCFQILQGLNYMHRQG 121
V+L ++ +L VFEYMD +L + M + VK++ +Q+L+G+ + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 122 YFHRDLISKNLLVSND-TIKIADFGLAWEVDSCP--PYTEYITTLQYRAPEMLLMSGQYN 178
HRDL +NLL++ +K+ADFGLA P ++ + TL YRAP++LL S Y+
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAF-GIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
+ +D+W++G IMAE+IT PLFPGT +DQL KI +G+PTE +W G+ + F
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP-GISQLPEYKPTF 238
Query: 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
P+ +L L P A+ + L+ L +P R +A +ALQHP F
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 2e-58
Identities = 101/297 (34%), Positives = 161/297 (54%), Gaps = 24/297 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE---CL-NLKEVKCLRKI 57
+Y + IGEG++G V A K +G VAIK +I +E C L+E+K LR+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK----KISPFEHQTFCQRTLREIKILRRF 60
Query: 58 NNHPNIVKLQE-LASENYR----LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQ 112
H NI+ + + + ++ +Y V E M+ +L++L+ + Q S ++ + +QIL+
Sbjct: 61 K-HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLI--KTQHLSNDHIQYFLYQILR 117
Query: 113 GLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPY----TEYITTLQYRA 167
GL Y+H HRDL NLL+ +N +KI DFGLA D + TEY+ T YRA
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE++L S Y +D+W++G I+AE+++ PLFPG QL I +G+P++E
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL-NC 236
Query: 228 LELAKAHGY--KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
+ +A Y P + L P+A+ + L++ + +++P KR T EAL HP
Sbjct: 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-58
Identities = 111/303 (36%), Positives = 170/303 (56%), Gaps = 29/303 (9%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKI 57
++K+ ++ QIGEG++G+V++A K +GE VA+K K R+ + +E ++E+K LR++
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALK--KVRLDNEKEGFPITAIREIKILRQL 63
Query: 58 NNHPNIVKLQELASENYR----------LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWC 107
N H NIV L+E+ ++ Y VFEYMD +L L+ + FSE +K++
Sbjct: 64 N-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA--WEVDSCPPYTEYITTLQ 164
Q+L+GLNY H++ + HRD+ N+L++N IK+ADFGLA + + PYT + TL
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224
YR PE+LL +Y +D+W+ G I+ EL T P+F E QL I GSP W
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 225 AEGLELAKAHGYKFPKLQGN-----NLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL 279
+ ++L + K PK Q S + A D L++ + + DP KR TA EAL
Sbjct: 243 PDVIKLPYFNTMK-PKKQYRRRLREEFSFIPTPALD----LLDHMLTLDPSKRCTAEEAL 297
Query: 280 QHP 282
P
Sbjct: 298 NSP 300
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 3e-58
Identities = 109/297 (36%), Positives = 161/297 (54%), Gaps = 21/297 (7%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK----ALKQRIYSWEECLNLKEVKCLRKIN 58
KY +K IG G++G V A ++ E VAIK A RI + L+E+K LR ++
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI---DAKRTLREIKLLRHLD 62
Query: 59 NHPNIVKLQELASENYR-----LYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQILQ 112
H N++ ++++ +R +Y V+E MD +LHQ++ S+ Q S+ + + +Q+L+
Sbjct: 63 -HENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLR 119
Query: 113 GLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPY-TEYITTLQYRAPEM 170
GL Y+H HRDL NLL+ +N +KI DFGLA + TEY+ T YRAPE+
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
LL +Y + +D+W++G I AEL+ PLFPG QL I +GSP+EE +
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED-LGFIRN 238
Query: 231 AKAHGY--KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
KA Y P + + L P AN + L+E + +DP KR T EAL HP
Sbjct: 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 5e-58
Identities = 108/303 (35%), Positives = 157/303 (51%), Gaps = 26/303 (8%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKINN 59
KY + +IG+G+FG+V++A K++ + VA+K K + + +E L+E+K L+ +
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLK- 69
Query: 60 HPNIVKLQEL------ASENYR--LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQIL 111
H N+V L E+ Y+ Y VFE+ + +L L+SN+ F+ +E+K +L
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAW-----EVDSCPPYTEYITTLQY 165
GL Y+HR HRD+ + N+L++ D I K+ADFGLA + YT + TL Y
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW- 224
R PE+LL Y +DMW G IMAE+ T P+ G E QL I GS T E W
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249
Query: 225 -AEGLELAKAHGYKFPKLQGNNLSL-LIPSANDDE-MSLIELLCSWDPCKRPTAAEALQH 281
+ LEL K + P+ Q + L P D + LI+ L DP KR A AL H
Sbjct: 250 GVDKLELFKK--MELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307
Query: 282 PLF 284
F
Sbjct: 308 DFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 4e-57
Identities = 108/293 (36%), Positives = 164/293 (55%), Gaps = 20/293 (6%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL---NLKEVKCLRKINN 59
KY +++IGEG++G V++A +++ E VA+K + R+ +E + L+E+ CL K
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK--RVRLDDDDEGVPSSALREI-CLLKELK 57
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
H NIV+L ++ + +L VFEY D +L + + VK++ FQ+L+GL + H
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 120 QGYFHRDLISKNLLVS-NDTIKIADFGLAWE----VDSCPPYTEYITTLQYRAPEMLLMS 174
HRDL +NLL++ N +K+ADFGLA V Y+ + TL YR P++L +
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFGA 174
Query: 175 GQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
Y++ +DMW+ G I AEL PLFPG DDQL +I +G+PTEESW +L
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD- 233
Query: 234 HGYKFPKLQGNNLSL--LIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
YK + SL ++P N L++ L +P +R +A EALQHP F
Sbjct: 234 --YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 4e-57
Identities = 76/188 (40%), Positives = 111/188 (59%), Gaps = 5/188 (2%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQEL 69
+GEG FG V+ A K++G+ VAIK +K+ S L+E++ L+K+N HPNIVKL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGV 59
Query: 70 ASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLI 128
+ LY V EY + +L L+ + SE E+ QIL+GL Y+H G HRDL
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 129 SKNLLVS--NDTIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWA 185
+N+L+ N +K+ADFGL+ + S + T Y APE+LL G Y+ K D+W+
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 186 LGLIMAEL 193
LG+I+ EL
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 4e-56
Identities = 102/288 (35%), Positives = 162/288 (56%), Gaps = 5/288 (1%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+E Y + ++GEG++ V++ K + VA+K ++ C ++EV L+ + H
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-H 63
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV L ++ L VFEY+D +L Q + + + VK + FQ+L+GLNY HR+
Sbjct: 64 ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPP--YTEYITTLQYRAPEMLLMSGQY 177
HRDL +NLL++ +K+ADFGLA S P Y+ + TL YR P++LL S Y
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
++++DMW +G I E+ T PLFPG+ ++QL+ I +G+PTEE+W L + Y
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+PK + + L P + D L+ L ++ KR +A EA++HP F
Sbjct: 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 4e-56
Identities = 104/290 (35%), Positives = 156/290 (53%), Gaps = 8/290 (2%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+E Y + ++GEGS+ V++ K +G+ VA+K ++ ++E L+ + H
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-H 62
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV L ++ L VFEY+D +L Q M + S V+ + FQ+L+GL Y H++
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 121 GYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP--YTEYITTLQYRAPEMLLMSGQY 177
HRDL +NLL+S +K+ADFGLA S P Y+ + TL YR P++LL S +Y
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLA-RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 178 NSKVDMWALGLIMAELITFHPLFPG-TCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
++ +DMW +G I E+ T PLFPG T +DQL+KI +G+PTEE+W + Y
Sbjct: 182 STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241
Query: 237 KFPKLQGNNLSLLIP--SANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
FP L P L ++P KR +AAEA++HP F
Sbjct: 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 7e-56
Identities = 100/319 (31%), Positives = 155/319 (48%), Gaps = 40/319 (12%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKIN 58
KY + IG G++G+V++A +K + G+ AIK K + +E+ LR++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 59 NHPNIVKLQE--LASENYRLYFVFEYMDCNLHQLM----SNRKQCFSEAEVKNWCFQILQ 112
H N+V L E L + +Y +F+Y + +L Q++ ++ + VK+ +QIL
Sbjct: 61 -HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND-----TIKIADFGLAWEVDSC--PPYTE--YITTL 163
G++Y+H HRDL N+LV + +KI D GLA ++ P + T+
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED---------DQLYKICN 214
YRAPE+LL + Y +D+WA+G I AEL+T P+F G DQL +I
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239
Query: 215 AIGSPTEESWA------EGLELAKAHGYKFPKLQGNNLSL---LIPSANDDEMSLIELLC 265
+G+PTE+ W E L K K N+L+ + L+ L
Sbjct: 240 VLGTPTEKDWPDIKKMPEYDTLMKDF--KTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297
Query: 266 SWDPCKRPTAAEALQHPLF 284
+DP KR TA EAL+HP F
Sbjct: 298 EYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 9e-56
Identities = 97/287 (33%), Positives = 158/287 (55%), Gaps = 5/287 (1%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+E Y + ++GEG++ V++ K + VA+K ++ C ++EV L+ + H
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-H 62
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV L ++ L VFEY+D +L Q + N S VK + FQ+L+GL+Y H++
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPP--YTEYITTLQYRAPEMLLMSGQY 177
HRDL +NLL++ +K+ADFGLA S P Y+ + TL YR P++LL S +Y
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
++ +DMW +G I+ E+ T P+FPG+ ++L+ I +G+PTEE+W + Y
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
FP+ + L P + D + L+ L ++ R +A AL+H F
Sbjct: 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 5e-55
Identities = 103/294 (35%), Positives = 162/294 (55%), Gaps = 17/294 (5%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQS--GEYVAIKALKQRIYSWEECLN--LKEVKCLRKINN 59
Y L+K++G+G++G V A ++ E VAIK + ++S + L+E+K LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKIT-NVFSKKILAKRALRELKLLRHFRG 60
Query: 60 HPNIVKLQEL---ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
H NI L ++ N+ LY E M+ +LHQ++ + Q ++A +++ +QIL GL
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLK 119
Query: 116 YMHRQGYFHRDLISKNLLVSND-TIKIADFGLAW-----EVDSCPPYTEYITTLQYRAPE 169
Y+H HRDL NLLV+ D +KI DFGLA ++ TEY+ T YRAPE
Sbjct: 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE-GL 228
++L Y +D+W++G I+AEL+ P+F G DQL +I +G+P EE+ + G
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
A+ + P + + P+AN + L+E L ++DP KR + EAL+HP
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 5e-54
Identities = 100/288 (34%), Positives = 162/288 (56%), Gaps = 5/288 (1%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
ME Y ++++GEG++ V++ K + VA+K ++ C ++EV L+ + H
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-H 63
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV L ++ + L VFEY+D +L Q M + S VK + +QIL+GL Y HR+
Sbjct: 64 ANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPP--YTEYITTLQYRAPEMLLMSGQY 177
HRDL +NLL++ +K+ADFGLA S P Y+ + TL YR P++LL S +Y
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
++++DMW +G I E+ + PLFPG+ +D+L+ I +G+PTEE+W + Y
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
FPK + L P + + + L+ ++ KR +A EA++H F+
Sbjct: 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 8e-53
Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 40/290 (13%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNHP 61
KY ++KQIG+GSFGKV+ +K G+ +K + S +E + L EVK L+K+ NHP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQC---FSEAEVKNWCFQILQGLNYM 117
NI+K E E +L V EY D +L Q + +K+ F E ++ +W Q+ L Y+
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 118 HRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTE-YITTLQYRAPEMLLMSG 175
H + HRD+ +N L SN +K+ DFG++ + S + + T Y +PE L +
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE-LCQNK 178
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
YN K D+W+LG ++ EL T F G + KI
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG-------------------- 218
Query: 236 YKFPKLQGNNLSLLIPSANDDEMS-LIELLCSWDPCKRPTAAEALQHPLF 284
++P IPS E+ L+ L DP +RP+ A+ LQ P
Sbjct: 219 -QYPP---------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 1e-52
Identities = 112/300 (37%), Positives = 153/300 (51%), Gaps = 29/300 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-------WEECLNLKEVKCL 54
E+YT +KQ+G G++G V AI K++GE VAIK L + S + E LK +
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM--- 71
Query: 55 RKINNHPNIVKL------QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCF 108
H N++ L E Y V YM +L ++M + SE +V+ +
Sbjct: 72 ----QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVY 124
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRA 167
Q+L GL Y+H G HRDL NL V+ D +KI DFGLA D+ T Y+ T YRA
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--EMTGYVVTRWYRA 182
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE++L YN VD+W++G IMAE++T LF G DQL +I G P E + +
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE-FVQK 241
Query: 228 LELAKAHGY--KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
LE A Y PK + S L P A+ + L+E + D KR TA EAL+HP F
Sbjct: 242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 1e-51
Identities = 107/305 (35%), Positives = 163/305 (53%), Gaps = 31/305 (10%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQ---------RIYSWEECLNLKEVKC 53
+Y + + IG+GS+G V AI +GE VAIK + RI L+E+K
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRI--------LREIKL 52
Query: 54 LRKINNHPNIVKLQELA-----SENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCF 108
LR + HP+IV+++ + E +Y VFE M+ +LHQ++ E + + +
Sbjct: 53 LRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH-QFFLY 110
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPP----YTEYITTL 163
Q+L+ L Y+H FHRDL KN+L + D +KI DFGLA + P +T+Y+ T
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 164 QYRAPEML-LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE 222
YRAPE+ +Y +D+W++G I AE++T PLFPG QL I + +G+P+ E
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230
Query: 223 SWAE-GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
+ + E A+ + K Q S P+A+ + L+E L ++DP RPTA EAL
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290
Query: 282 PLFQG 286
P F+G
Sbjct: 291 PYFKG 295
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-51
Identities = 98/294 (33%), Positives = 157/294 (53%), Gaps = 19/294 (6%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-----EVKCLRK 56
EKY + +IGEGS+G V++ +++G+ VAIK + E+ +K E++ L++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK----KFVESEDDPVIKKIALREIRMLKQ 56
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
+ HPN+V L E+ +L+ VFEY D L++L N + E +K +Q LQ +N
Sbjct: 57 LK-HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVN 114
Query: 116 YMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLM 173
+ H+ HRD+ +N+L++ IK+ DFG A + YT+Y+ T YRAPE+L+
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGS--PTEESWAEGLELA 231
QY VD+WA+G + AEL+T PL+PG + DQLY I +G P + +
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234
Query: 232 KAHGYKFPKLQGNN-LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
K G P+ + L P+ + +S ++ DP +R + E L+HP F
Sbjct: 235 K--GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 2e-50
Identities = 107/295 (36%), Positives = 165/295 (55%), Gaps = 18/295 (6%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLR--KINN 59
++Y +KQ+G G++G V A+ +++G VAIK L + S E + + LR K
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMK 72
Query: 60 HPNIVKLQELASENYRL------YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQG 113
H N++ L ++ + + L Y V +M +L +LM + K SE ++ +Q+L+G
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK--LSEDRIQFLVYQMLKG 130
Query: 114 LNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLL 172
L Y+H G HRDL NL V+ D +KI DFGLA + DS T Y+ T YRAPE++L
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEVIL 188
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
Y VD+W++G IMAE++T PLF G DQL +I G+P++E + + L+
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE-FVQKLQSED 247
Query: 233 AHGY--KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
A Y K P+ + + L+P+AN ++++E + D R TAAEAL HP F+
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 1e-49
Identities = 95/304 (31%), Positives = 153/304 (50%), Gaps = 39/304 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEEC-----LNLKEVKCLRK 56
EKY + +GEGS+G V + K++G+ VAIK + E+ + ++E++ L++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIK----KFLESEDDKMVKKIAMREIRMLKQ 56
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
+ H N+V L E+ RLY VFE++D + + E+ V+ + FQIL+G+ +
Sbjct: 57 LR-HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 117 MHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLL 172
H HRD+ +N+LVS + +K+ DFG A + + P YT+Y+ T YRAPE+L+
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PGEVYTDYVATRWYRAPELLV 173
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
+Y VD+WA+G ++ E++T PLFPG + DQLY I +G+ L
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN-----------LIP 222
Query: 233 AHG---YKFPKLQG---------NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280
H K P G L P + + L + DP RP++++ L
Sbjct: 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
Query: 281 HPLF 284
H F
Sbjct: 283 HEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-49
Identities = 99/297 (33%), Positives = 160/297 (53%), Gaps = 33/297 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK---------ALKQRIYSWEECLNLKEVK 52
+Y ++ +G G+FG V A + +G+ VAIK L +R Y +E+K
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--------RELK 61
Query: 53 CLRKINNHPNIVKLQEL-ASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQIL 111
L+ + H NI+ L ++ S +YFV E + +LH+L+++R + ++ + +QIL
Sbjct: 62 LLKHLR-HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP--LEKQFIQYFLYQIL 118
Query: 112 QGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170
+GL Y+H G HRDL N+L++ N +KI DFGLA D P T Y++T YRAPE+
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD--PQMTGYVSTRYYRAPEI 176
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE-----SWA 225
+L +Y+ +VD+W+ G I AE++ PLFPG +Q I + +G+P ++
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
L ++ PK + S +A+ + L+E + +DP KR +AAEAL HP
Sbjct: 237 NTLRFVQS----LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-49
Identities = 104/295 (35%), Positives = 164/295 (55%), Gaps = 20/295 (6%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL---KEVKCLRKIN- 58
+Y + +IG G++G V++A SG +VA+K++ R+ + E+ L L +EV L+++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV--RVQTNEDGLPLSTVREVALLKRLEA 58
Query: 59 -NHPNIVKLQELAS-----ENYRLYFVFEYMDCNLHQLMSNRKQCFSEAE-VKNWCFQIL 111
+HPNIV+L ++ + ++ VFE++D +L + AE +K+ Q L
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 112 QGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCP-PYTEYITTLQYRAPE 169
+GL+++H HRDL +N+LV S +K+ADFGLA + SC T + TL YRAPE
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA-RIYSCQMALTPVVVTLWYRAPE 177
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
+LL S Y + VDMW++G I AE+ PLF G E DQL KI + IG P E+ W +
Sbjct: 178 VLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
L + F + ++P + L+ + +++P KR +A ALQHP F
Sbjct: 237 LPRG---AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 2e-48
Identities = 103/296 (34%), Positives = 162/296 (54%), Gaps = 19/296 (6%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIK-KQSGEYVAIKALKQRIYSWEECLNL---KEVKCLRKI 57
++Y + +IGEG++GKV++A K G +VA+K + R+ + EE + L +EV LR +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK--RVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 58 NN--HPNIVKLQELAS-----ENYRLYFVFEYMDCNLHQLMSNRKQCFSEAE-VKNWCFQ 109
HPN+V+L ++ + +L VFE++D +L + + E +K+ FQ
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAP 168
+L+GL+++H HRDL +N+LV S+ IK+ADFGLA T + TL YRAP
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
E+LL S Y + VD+W++G I AE+ PLF G+ + DQL KI + IG P EE W +
Sbjct: 179 EVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
L + F + + ++ L+ +++P KR +A AL HP F
Sbjct: 238 ALPRQ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 6e-47
Identities = 102/291 (35%), Positives = 149/291 (51%), Gaps = 15/291 (5%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNHPNIVK- 65
+ IG G+FG VW + G+ VA+K + + C +E+K L H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSA 64
Query: 66 ---LQELASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
LQ + + +Y V E M +LH+++ Q S VK + +QIL+GL Y+H G
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAG 123
Query: 122 YFHRDLISKNLLV-SNDTIKIADFGLA--WEVDSCPPYTEYITTLQYRAPEMLLMSGQYN 178
HRD+ NLLV SN +KI DFGLA E D T+ + T YRAPE+L+ S Y
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
S VD+W++G I AEL+ LF QL I + +G+P+ E+ E A+AH +
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243
Query: 239 PKLQGNNLSLLIPSANDDEMSLIELLCS---WDPCKRPTAAEALQHPLFQG 286
P +L +L ++ + LLC +DP KR +AA+AL HP
Sbjct: 244 PHKP-PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 159 bits (402), Expect = 2e-45
Identities = 88/323 (27%), Positives = 140/323 (43%), Gaps = 36/323 (11%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQR--IYSWEECLNLKEVKCLRKINNH 60
Y +++++GEGSFG+V+ A ++ VA+K L ++ S E L+E++ L +N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQ--CFSEAEVKNWCFQILQGLNYM 117
PNIVKL + + LY V EY+D +L L+ + SE+E QIL L Y+
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 118 HRQGYFHRDLISKNLLVSNDT--IKIADFGLAWEVDSC-------PPYTEYITTLQYRAP 168
H +G HRD+ +N+L+ D +K+ DFGLA + + + T Y AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 169 EMLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226
E+LL +S D+W+LG+ + EL+T P F G +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-------------- 223
Query: 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
L P L + L++ L + DP R +++ L H L
Sbjct: 224 ---LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280
Query: 287 CLQVPSMSIDSCKMRLTPSAKKS 309
S D K + + S
Sbjct: 281 LKLKESDLSDLLKPDDSAPLRLS 303
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-45
Identities = 86/292 (29%), Positives = 130/292 (44%), Gaps = 42/292 (14%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK--ALKQRIYSWEECLNLKEVKCLRKINNH 60
++T + +G GSFG V+ A+ K +GE +A+K L E L +E++ L + H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEAL-EREIRILSSLQ-H 58
Query: 61 PNIVKL--QELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
PNIV+ E E L EY+ +L L+ + E ++ + QIL+GL Y+
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 118 HRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQ----YRAPEMLL 172
H G HRD+ N+LV +D +K+ADFG A + E +++ + APE ++
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD-IETGEGTGSVRGTPYWMAPE-VI 175
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
+Y D+W+LG + E+ T P + E IGS E
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWS---ELGNPMAALYKIGSSGEPPE-------- 224
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
P+ +LS A D + DP KRPTA E LQHP
Sbjct: 225 -----IPE----HLS---EEAKD----FLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 1e-44
Identities = 97/292 (33%), Positives = 155/292 (53%), Gaps = 16/292 (5%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHP 61
K+ ++ +GEG++G V + K++ E VAIK K + E + L+E+K LR +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE- 60
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
NIV+L+E +LY VFEY++ N+ +L+ +V+++ +Q+++ +++ H+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND 120
Query: 122 YFHRDLISKNLLVS-NDTIKIADFGLAWEVD--SCPPYTEYITTLQYRAPEMLLMSGQYN 178
HRD+ +NLL+S ND +K+ DFG A + S YTEY+ T YR+PE LL+ Y
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE-LLLGAPYG 179
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
VDMW++G I+ EL PLFPG E DQL+ I +G E + HG +F
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239
Query: 239 PK------LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
P L+ L +L + + L++ L +P R + L HP F
Sbjct: 240 PAVNHPQSLERRYLGIL----SGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-44
Identities = 95/290 (32%), Positives = 146/290 (50%), Gaps = 14/290 (4%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
Y ++++GEGS+ V++ I + +G+ VA+K + + ++E L+ + H NI
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANI 65
Query: 64 VKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYF 123
V L ++ L FVFEYM +L Q M V+ + FQ+L+GL Y+H Q
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 124 HRDLISKNLLVSN-DTIKIADFGLAWEVD-SCPPYTEYITTLQYRAPEMLLMSGQYNSKV 181
HRDL +NLL+S +K+ADFGLA Y+ + TL YR P++LL + Y+S +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL 185
Query: 182 DMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
D+W G I E++ P FPG + +QL KI +G PTE++W +L F
Sbjct: 186 DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLP 245
Query: 241 LQGNNLSLL------IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
+ L ++ P A D L + P R +A +AL HP F
Sbjct: 246 CKPQQLRVVWKRLSRPPKAED----LASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 4e-44
Identities = 81/288 (28%), Positives = 141/288 (48%), Gaps = 44/288 (15%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINNHP 61
+ ++++IG+G FG+V++A K++G+ VAIK +K + E+ + E++ L+K HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEK--IINEIQILKKCK-HP 57
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIVK + L+ V E+ +L L+ + Q +E+++ C ++L+GL Y+H
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G HRD+ + N+L+++D +K+ DFGL+ ++ + T + APE+ + Y+
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEV-INGKPYDY 176
Query: 180 KVDMWALGLIMAELIT----FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
K D+W+LG+ EL + L P L+KI T
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPP----MKALFKI------ATNG------------- 213
Query: 236 YKFPKLQGNNLSLLIPSANDDE-MSLIELLCSWDPCKRPTAAEALQHP 282
P L+ P DE ++ +P KRPTA + L+HP
Sbjct: 214 --PPGLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-44
Identities = 96/316 (30%), Positives = 150/316 (47%), Gaps = 50/316 (15%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK----EVKCLRKIN 58
+Y ++ +G GS G V+ A+ + VA+K + + ++K E+K +R+++
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI-----VLTDPQSVKHALREIKIIRRLD 60
Query: 59 NHPNIVKLQE-LASENYRL-------------YFVFEYMDCNLHQLMSNRKQCFSEAEVK 104
H NIVK+ E L L Y V EYM+ +L ++ + SE +
Sbjct: 61 -HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHAR 117
Query: 105 NWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDT--IKIADFGLAWEVDSCPPY------ 156
+ +Q+L+GL Y+H HRDL N+ ++ + +KI DFGLA VD P Y
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD--PHYSHKGYL 175
Query: 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216
+E + T YR+P +LL Y +DMWA G I AE++T PLF G E +Q+ I ++
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235
Query: 217 GSPTEESWAEGLELAKAHGYKFPKLQGNN-------LSLLIPSANDDEMSLIELLCSWDP 269
EE E L P N+ L L+P N + + +E + +++P
Sbjct: 236 PVVREEDRNELLN-------VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288
Query: 270 CKRPTAAEALQHPLFQ 285
R TA EAL HP
Sbjct: 289 MDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 8e-42
Identities = 69/202 (34%), Positives = 114/202 (56%), Gaps = 13/202 (6%)
Query: 5 TLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINN 59
TL K++GEG+FG+V++ VA+K LK+ S ++ L+E + +RK++
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE-DASEQQIEEFLREARIMRKLD- 59
Query: 60 HPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HPNIVKL + +E L V EYM +L L NR + S +++ ++ QI +G+ Y+
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 118 HRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYR--APEMLLMS 174
+ + HRDL ++N LV + +KI+DFGL+ ++ Y L R APE L
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES-LKE 178
Query: 175 GQYNSKVDMWALGLIMAELITF 196
G++ SK D+W+ G+++ E+ T
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 3e-41
Identities = 98/292 (33%), Positives = 151/292 (51%), Gaps = 14/292 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEEC-LNLKEVKCLRKINNH 60
E+Y + +G G++G V A ++G VA+K L + S +E++ L+ + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-H 75
Query: 61 PNIVKLQELAS------ENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
N++ L ++ + E +Y V M +L+ ++ +K ++ V+ +QIL+GL
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGL 133
Query: 115 NYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
Y+H HRDL NL V+ D +KI DFGLA D T Y+ T YRAPE++L
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLN 191
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE-GLELAK 232
YN VD+W++G IMAEL+T LFPGT DQL I +G+P E + E A+
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
+ ++ N + + AN + L+E + D KR TAA+AL H F
Sbjct: 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 6e-41
Identities = 66/201 (32%), Positives = 116/201 (57%), Gaps = 12/201 (5%)
Query: 5 TLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINN 59
TL K++GEG+FG+V++ + VA+K LK+ S ++ L+E + +RK++
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE-DASEQQIEEFLREARIMRKLD- 59
Query: 60 HPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
HPN+VKL + +E LY V EYM+ +L + + S +++ ++ QI +G+ Y+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYR--APEMLLMSG 175
+ + HRDL ++N LV + +KI+DFGL+ ++ Y + L R APE L G
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES-LKEG 178
Query: 176 QYNSKVDMWALGLIMAELITF 196
++ SK D+W+ G+++ E+ T
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTL 199
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 96/292 (32%), Positives = 155/292 (53%), Gaps = 14/292 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL-NLKEVKCLRKINNH 60
E+Y + +G G++G V A + + VA+K L + S +E++ L+ + H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-H 73
Query: 61 PNIVKLQEL-----ASENY-RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
N++ L ++ + EN+ +Y V M +L+ ++ + Q S+ V+ +Q+L+GL
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV--KCQKLSDEHVQFLIYQLLRGL 131
Query: 115 NYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
Y+H G HRDL N+ V+ D ++I DFGLA + D T Y+ T YRAPE++L
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLN 189
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE-GLELAK 232
YN VD+W++G IMAEL+ LFPG DQL +I +G+P+ E + E A+
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
+ P + +L + AN + L+E + D KR +A+EAL HP F
Sbjct: 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 105/351 (29%), Positives = 166/351 (47%), Gaps = 47/351 (13%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIK-ALKQRIYSWEECLNLKEVKCLRKINNHPN 62
Y L IG GSFG V++AI + E VAIK L+ Y E L +K + NH N
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNL-------NHIN 120
Query: 63 IVKLQEL--------ASENYRLYFVFEYMDCNLHQLM---SNRKQCFSEAEVKNWCFQIL 111
I+ L++ +N L V E++ +H+ M + VK + +Q+
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180
Query: 112 QGLNYMHRQGYFHRDLISKNLLV--SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
+ L Y+H + HRDL +NLL+ + T+K+ DFG A + + YI + YRAPE
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPE 240
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
++L + Y + +D+W+LG I+AE+I +P+F G DQL +I +G+PTE+ E
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE--M 298
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSAN-DDEMSLIELLCSWDPCKRPTAAEALQHPLFQG-- 286
KFP ++ +L + P DD ++ I ++P KR EAL P F
Sbjct: 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358
Query: 287 --CLQVP------------------SMSIDSCKMRLTPSAKKSGWKAKLIV 317
C+++P MS D+C+ ++ P +K L+
Sbjct: 359 DPCIKLPKYIDKLPDLFNFCDAEIKEMS-DACRRKIIPKCTYEAYKEFLMS 408
|
Length = 440 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 88/314 (28%), Positives = 120/314 (38%), Gaps = 77/314 (24%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVK---------CLRKI 57
K IGEGSF V A +K++ + AIK L K+++ +KE K L ++
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--------IKEKKVKYVKIEKEVLTRL 58
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
N HP I+KL + LYFV EY L Q + + E + + +IL L Y
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEY 117
Query: 117 MHRQGYFHRDLISKNLLVSND-TIKIADFGLA---------------WEVDSCPPYTEYI 160
+H +G HRDL +N+L+ D IKI DFG A
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 161 T------TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICN 214
T +Y +PE+L D+WALG I+ +++T P F G+ E Y
Sbjct: 178 RFASFVGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTFQ 232
Query: 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT 274
I Y FP P+ D LIE L DP R
Sbjct: 233 KI---------------LKLEYSFP-----------PNFPPDAKDLIEKLLVLDPQDRLG 266
Query: 275 A----AEALQHPLF 284
E HP F
Sbjct: 267 VNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-39
Identities = 67/200 (33%), Positives = 114/200 (57%), Gaps = 7/200 (3%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINNHP 61
Y L IG G+FG V++ + ++G++VAIK + E ++ E+ L+ + HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HP 59
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIVK + LY + EY + +L Q++ + F E+ V + +Q+LQGL Y+H Q
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSC-PPYTEYITTLQYRAPEMLLMSGQYN 178
G HRD+ + N+L + D +K+ADFG+A +++ + T + APE++ MSG +
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG-AS 177
Query: 179 SKVDMWALGLIMAELITFHP 198
+ D+W+LG + EL+T +P
Sbjct: 178 TASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 1e-38
Identities = 94/291 (32%), Positives = 152/291 (52%), Gaps = 12/291 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ Y ++++GEGS+ V++ K +G+ VA+K ++ + ++E L+ + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HA 63
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
NIV L ++ L VFEY+ +L Q M VK + FQ+L+GL+Y+H++
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 122 YFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPP--YTEYITTLQYRAPEMLLMSGQYN 178
HRDL +NLL+S+ +K+ADFGLA S P Y+ + TL YR P++LL S +Y+
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLA-RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCE-DDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
+ +DMW +G I E+I FPG + DQL +I +G+P E++W L +
Sbjct: 183 TCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242
Query: 238 FPKLQGNNL----SLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
F NL + L + ++++ L C P R +A AL H F
Sbjct: 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCF--PKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 21/206 (10%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEY----VAIKALKQRIYSWEECLN-LKEVKCLRKINN 59
L K++GEG+FG+V++ K GE VA+K LK+ S EE L+E ++K++
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKE-GASEEEREEFLEEASIMKKLS- 59
Query: 60 HPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
HPNIV+L + ++ LY V EYM +L + + + ++ QI +G+ Y+
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQ-------YRAPEM 170
+ + HRDL ++N LV+ + +KI+DFGL+ ++ +Y + APE
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE----DDYYRKRGGGKLPIKWMAPE- 174
Query: 171 LLMSGQYNSKVDMWALGLIMAELITF 196
L G++ SK D+W+ G+++ E+ T
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 93/287 (32%), Positives = 129/287 (44%), Gaps = 49/287 (17%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKINNHPNIVKL- 66
+G+GSFGKV KK +G+ A+K L K++I +E + E L +IN HP IVKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59
Query: 67 ---QELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
Q +LY V EY L +S FSE + + +I+ L Y+H G
Sbjct: 60 YAFQT----EEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGI 114
Query: 123 FHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYT-EYITTLQYRAPEMLLMSGQYNSK 180
+RDL +N+L+ D IK+ DFGLA E+ S T + T +Y APE+LL Y
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL-GKGYGKA 173
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
VD W+LG+++ E++T P F E E E +FP+
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYA-------------------EDRKEIYEKILKDPLRFPE 214
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEA---LQHPLF 284
LS + LI L DP KR + A HP F
Sbjct: 215 ----FLSP-------EARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 9e-38
Identities = 107/314 (34%), Positives = 154/314 (49%), Gaps = 52/314 (16%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQ---------RIYSWEECLNLKEVKC 53
+Y +K IG G+ G V A +G+ VAIK L + R Y +E+
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--------RELV- 67
Query: 54 LRKINNHPNIVKL------QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNW- 106
L K+ NH NI+ L Q+ E +Y V E MD NL Q++ Q + E ++
Sbjct: 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI----QMDLDHERMSYL 123
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQY 165
+Q+L G+ ++H G HRDL N++V +D T+KI DFGLA + T Y+ T Y
Sbjct: 124 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
RAPE++L G Y VD+W++G IM E+I LFPGT DQ KI +G+P++E +
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE-FM 241
Query: 226 EGLE---------LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLI-----ELLCSW---D 268
L+ K GY F +L + L P ++ L +LL D
Sbjct: 242 SRLQPTVRNYVENRPKYAGYSFEELFPDV---LFPPDSESHNKLKASQARDLLSKMLVID 298
Query: 269 PCKRPTAAEALQHP 282
P KR + +ALQHP
Sbjct: 299 PEKRISVDDALQHP 312
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 89/306 (29%), Positives = 140/306 (45%), Gaps = 72/306 (23%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E Y +++IGEG+ G+V++A + +G+ VAIK K R+ + L + E+ + K HP
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIK--KMRLRKQNKELIINEIL-IMKDCKHP 75
Query: 62 NIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV + L+ V EYMD L +++ +E ++ C ++LQGL Y+H Q
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYR-----------AP 168
HRD+ S N+L+S D ++K+ADFG A + +T + + AP
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQ----------LTKEKSKRNSVVGTPYWMAP 185
Query: 169 EMLLMSGQ-YNSKVDMWALGLI---MAE----LITFHPLFPGTCEDDQLYKICNAIGSPT 220
E ++ + Y KVD+W+LG++ MAE + PL L+ I
Sbjct: 186 E--VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLITT------ 230
Query: 221 EESWAEGLELAKAHGYKFPKLQ-GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL 279
+G+ P L+ S P D + DP KRP+A E L
Sbjct: 231 -----KGI----------PPLKNPEKWS---PEFKD----FLNKCLVKDPEKRPSAEELL 268
Query: 280 QHPLFQ 285
QHP +
Sbjct: 269 QHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEY---VAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64
K++GEG+FG+V++ K VA+K LK+ E LKE + ++K+ HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVV 59
Query: 65 KLQELASENYRLYFVFEYMDC-NL--------HQLMSNRKQCFSEAEVKNWCFQILQGLN 115
+L + +E LY V EYM+ +L S K S ++ ++ QI +G+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 116 YMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYR------AP 168
Y+ + + HRDL ++N LV D +KI+DFGL+ +V Y + AP
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD---DDYYRKKTGGKLPIRWMAP 176
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITF 196
E L G + SK D+W+ G+++ E+ T
Sbjct: 177 ESLK-DGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 81/281 (28%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIK--ALKQRIYSWEECLNL--KEVKCLRKINNHPNIVK 65
+G GSFG V++ + G++ A+K +L + +E + +E+ L K+ HPNIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQ 66
Query: 66 LQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
E LY E + +L +L+ + F E ++ + QIL GL Y+H + H
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLK-KYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 125 RDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
RD+ N+LV +N +K+ADFG+A +V + + + APE++ G Y D+
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 184 WALGLIMAELITFHPLFPGTCEDDQ-LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242
W+LG + E+ T P + E ++KI + P
Sbjct: 186 WSLGCTVLEMATGKPPW-SQLEGVAAVFKIGRSKELP----------------------- 221
Query: 243 GNNLSLLIPSANDDEMSLIELLC-SWDPCKRPTAAEALQHP 282
IP DE L C DP RPTAAE L+HP
Sbjct: 222 ------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 9e-34
Identities = 93/301 (30%), Positives = 140/301 (46%), Gaps = 23/301 (7%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+++Y +K IG G+ G V A G VA+K L + + L K NH
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 61 PNIVKL------QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
NI+ L Q+ E +Y V E MD NL Q++ + +Q+L G+
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQMLCGI 136
Query: 115 NYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
++H G HRDL N++V +D T+KI DFGLA + T Y+ T YRAPE++L
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG 196
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
G Y VD+W++G IM EL+ +F GT DQ K+ +G+P+ E +
Sbjct: 197 MG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255
Query: 234 HGYKFPKLQGNNLSLLIP------SANDDEMS------LIELLCSWDPCKRPTAAEALQH 281
+ P+ G + L P + D++ L+ + DP KR + EAL+H
Sbjct: 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315
Query: 282 P 282
P
Sbjct: 316 P 316
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 96/301 (31%), Positives = 138/301 (45%), Gaps = 23/301 (7%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+++Y +K IG G+ G V A VAIK L + + L K NH
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 61 PNIVKL------QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
NI+ L Q+ E +Y V E MD NL Q++ + +Q+L G+
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 132
Query: 115 NYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
++H G HRDL N++V +D T+KI DFGLA + T Y+ T YRAPE++L
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
G Y VD+W++G IM E++ LFPG DQ K+ +G+P E + +
Sbjct: 193 MG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 234 HGYKFPKLQGNNLSLLIPSA---NDDEMS---------LIELLCSWDPCKRPTAAEALQH 281
+ PK G L P + D E + L+ + DP KR + EALQH
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311
Query: 282 P 282
P
Sbjct: 312 P 312
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 94/315 (29%), Positives = 158/315 (50%), Gaps = 44/315 (13%)
Query: 9 QIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKL 66
++G G++G V++A +K + A+K ++ S C +E+ LR++ HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC---REIALLRELK-HPNVISL 63
Query: 67 QE--LASENYRLYFVFEYMDCNLHQLM-------SNRKQC-FSEAEVKNWCFQILQGLNY 116
Q+ L+ + +++ +F+Y + +L ++ +N+K VK+ +QIL G++Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 117 MHRQGYFHRDLISKNLLVSND-----TIKIADFGLAWEVDS-CPPYTEY---ITTLQYRA 167
+H HRDL N+LV + +KIAD G A +S P + + T YRA
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED---------DQLYKICNAIGS 218
PE+LL + Y +D+WA+G I AEL+T P+F ED DQL +I N +G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 219 PTEESWAEGLELAKAHGYKFPKLQGN---NLSLL------IPSANDDEMSLIELLCSWDP 269
P ++ W E ++ H + N N SL+ + L++ L + DP
Sbjct: 244 PADKDW-EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 302
Query: 270 CKRPTAAEALQHPLF 284
KR T+ +A+Q P F
Sbjct: 303 IKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-33
Identities = 97/301 (32%), Positives = 138/301 (45%), Gaps = 23/301 (7%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+++Y +K IG G+ G V A VAIK L + + L K NH
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 61 PNIVKL------QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
NI+ L Q+ E +Y V E MD NL Q++ + +Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 115 NYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
++H G HRDL N++V +D T+KI DFGLA + T Y+ T YRAPE++L
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
G Y VD+W++G IM E+I LFPGT DQ K+ +G+P E + +
Sbjct: 200 MG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258
Query: 234 HGYKFPKLQGNNLSLLIPSA---NDDEMS---------LIELLCSWDPCKRPTAAEALQH 281
+ PK G + L P D E + L+ + D KR + EALQH
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 282 P 282
P
Sbjct: 319 P 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 96/320 (30%), Positives = 163/320 (50%), Gaps = 54/320 (16%)
Query: 9 QIGEGSFGKVWQAIKKQ---SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVK 65
++G G++G V++A +K EY A+K ++ S C +E+ LR++ HPN++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEY-ALKQIEGTGISMSAC---REIALLRELK-HPNVIA 62
Query: 66 LQE--LASENYRLYFVFEYMDCNLHQLM-------SNRKQC-FSEAEVKNWCFQILQGLN 115
LQ+ L+ + +++ +F+Y + +L ++ +N+K + VK+ +QIL G++
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 116 YMHRQGYFHRDLISKNLLVSND-----TIKIADFGLAWEVDS-CPPYTEY---ITTLQYR 166
Y+H HRDL N+LV + +KIAD G A +S P + + T YR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 167 APEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED---------DQLYKICNAIG 217
APE+LL + Y +D+WA+G I AEL+T P+F ED DQL +I + +G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 218 SPTEESWAEGLELAKAHGYKFPKLQGN-------NLSLL------IPSANDDEMSLIELL 264
P ++ W + ++ ++P LQ + N SL+ + L++ L
Sbjct: 243 FPADKDWEDIRKMP-----EYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKL 297
Query: 265 CSWDPCKRPTAAEALQHPLF 284
+ DP KR T+ +ALQ P F
Sbjct: 298 LTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 83/291 (28%), Positives = 133/291 (45%), Gaps = 41/291 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL----KQRIYSWEECLNLKEVKCLRKI 57
+ +T +++IG GSFG V+ A ++ E VAIK + KQ W++ + KEV+ L+++
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQQL 72
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HPN ++ + + + V EY + ++ K+ E E+ C LQGL Y+
Sbjct: 73 R-HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYL 131
Query: 118 HRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM--S 174
H HRD+ + N+L++ T+K+ADFG A V P ++ T + APE++L
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS---PANSFVGTPYWMAPEVILAMDE 188
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
GQY+ KVD+W+LG+ EL P LY I A
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNDS--------------- 231
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
P L N+ S D + ++ P RP++ E L+H
Sbjct: 232 ----PTLSSNDWS-------DYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 85/303 (28%), Positives = 124/303 (40%), Gaps = 66/303 (21%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEV-------KCLRK 56
+ +K +G GSFG+V K SG+Y A+K L + + + LK+V + L+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-----AKIVKLKQVEHVLNEKRILQS 57
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQGL 114
I HP +V L ++ LY V EY +L S + F E + + Q++ L
Sbjct: 58 I-RHPFLVNLYGSFQDDSNLYLVMEY--VPGGELFSHLRKSGRFPEPVARFYAAQVVLAL 114
Query: 115 NYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTL----QYRAPE 169
Y+H +RDL +NLL+ S+ IKI DFG A V TL +Y APE
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK------GRTYTLCGTPEYLAPE 168
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY-KICNAIGSPTEESWAEGL 228
++L G Y VD WALG+++ E++ +P F Q+Y KI
Sbjct: 169 IILSKG-YGKAVDWWALGILIYEMLAGYPPF-FDDNPIQIYEKILEGK------------ 214
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR-----PTAAEALQHPL 283
+FP + LI L D KR + HP
Sbjct: 215 -------VRFPSFFSPDAK-----------DLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256
Query: 284 FQG 286
F G
Sbjct: 257 FAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 81/288 (28%), Positives = 133/288 (46%), Gaps = 42/288 (14%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNHPN 62
+ ++K++G+GS+G V++ + ++ A+K + S +E + + E++ L +N HPN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPN 60
Query: 63 IVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQC---FSEAEVKNWCFQILQGLNYMH 118
I+ +E + +L V EY +L + +S RK+ E E+ Q+L+GL +H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 119 RQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQ- 176
Q HRDL S N LLV+ND +KI D G++ + T+ I T Y APE + G+
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPE--VWKGRP 177
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
Y+ K D+W+LG ++ E+ TF P F D YK+
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--------------------- 216
Query: 237 KFPKLQGNNLSLLIPSANDDEMS-LIELLCSWDPCKRPTAAEALQHPL 283
K+P IP ++ I + P RP + L P
Sbjct: 217 KYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA 255
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-32
Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 57/298 (19%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNHPNIVKLQ 67
I +G++G+V+ A KK +G+ AIK +K+ + ++ L E L + + P +VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLY 59
Query: 68 E-LASENYRLYFVFEYM---DCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+ LY V EY+ D L + E + + +I+ L Y+H G
Sbjct: 60 YSFQGKKN-LYLVMEYLPGGDLASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 122 YFHRDLISKNLLVSND-TIKIADFGLA---------WEVDSCPPYTEYITTLQYRAPEML 171
HRDL N+L+ ++ +K+ DFGL+ D + T Y APE++
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
L G ++ VD W+LG I+ E + P F G ++ I N
Sbjct: 174 LGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN----------------- 215
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA---EALQHPLFQG 286
K + +S D+ + LI L DP KR A E HP F+G
Sbjct: 216 ----GKIEWPEDVEVS-------DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 86/298 (28%), Positives = 135/298 (45%), Gaps = 46/298 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKA--LKQRIYSWEECLNLKEVKCLRKINN 59
+ Y L++ IG G+ V+ AI + E VAIK L++ S +E KEV+ + + N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR--KEVQAMSQCN- 57
Query: 60 HPNIVKLQELASENYRLYFVFEYMDC-NLHQLM--SNRKQCFSEAEVKNWCFQILQGLNY 116
HPN+VK L+ V Y+ +L +M S + EA + ++L+GL Y
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 117 MHRQGYFHRDLISKNLLVSND-TIKIADFGL-AWEVD----SCPPYTEYITTLQYRAPEM 170
+H G HRD+ + N+L+ D ++KIADFG+ A D + ++ T + APE+
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 171 LLMSGQYNSKVDMWALGLIMAELIT----FHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226
+ Y+ K D+W+ G+ EL T + P + + N P+ E+ A+
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV---LMLTLQND--PPSLETGAD 232
Query: 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
K + F K +I L DP KRPTA E L+H F
Sbjct: 233 ----YKKYSKSFRK-------------------MISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 40/288 (13%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQ 67
K +G+GS G V++ K +G+ A+K + L+E+K LR P +VK
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESPYVVKCY 65
Query: 68 ELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY-FHR 125
+ + V EYMD +L L+ + E + QIL+GL+Y+H + + HR
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLADLLK-KVGKIPEPVLAYIARQILKGLDYLHTKRHIIHR 124
Query: 126 DLISKNLLVSND-TIKIADFGLAWEVD-SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
D+ NLL+++ +KIADFG++ ++ + ++ T+ Y +PE + Y+ D+
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ-GESYSYAADI 183
Query: 184 WALGLIMAELIT-FHPLFPGTCED--DQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
W+LGL + E P P + + IC+ P
Sbjct: 184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAICD------GPP---------------PS 222
Query: 241 LQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQHPLFQGC 287
L S E I DP KRP+AAE LQHP +
Sbjct: 223 LPAEEFS--------PEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 84/296 (28%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL-KEVKCLRKINNHP 61
Y +++ IG+GSFG V + +K G+ + K + + +E L EV LR++ HP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HP 59
Query: 62 NIVKL--QELASENYRLYFVFEYMDC-NLHQLMSNRKQCFS---EAEVKNWCFQILQGLN 115
NIV+ + + N LY V EY + +L QL+ K+ E + Q+L L
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 116 YMHRQGY-----FHRDLISKNL-LVSNDTIKIADFGLAWEVDSCPPYTE-YITTLQYRAP 168
H + HRDL N+ L +N+ +K+ DFGLA + + + Y+ T Y +P
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
E L Y+ K D+W+LG ++ EL P F + KI
Sbjct: 180 E-QLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG------------- 225
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQHPL 283
KF + IP E+ +I+ + + DP KRP+ E LQ PL
Sbjct: 226 --------KFRR---------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 71/203 (34%), Positives = 113/203 (55%), Gaps = 7/203 (3%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINNHP 61
KY +K+IGEGSFGK K+ G+ IK + ++ E + KEV L + HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HP 59
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQC-FSEAEVKNWCFQILQGLNYMHR 119
NIV+ QE EN LY V +Y + +L++ ++ ++ F E ++ +W QI L ++H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEY-ITTLQYRAPEMLLMSGQY 177
+ HRD+ S+N+ ++ D TIK+ DFG+A ++S I T Y +PE+ + Y
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI-CENRPY 178
Query: 178 NSKVDMWALGLIMAELITFHPLF 200
N+K D+WALG ++ E+ T F
Sbjct: 179 NNKSDIWALGCVLYEMCTLKHAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 82/298 (27%), Positives = 140/298 (46%), Gaps = 59/298 (19%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL-KEVKCLRKINNH 60
E + +++++GEGS+G V++AI K++G+ VAIK + E+ + KE+ L++ ++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDS- 57
Query: 61 PNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
P IVK +N L+ V EY + +M + +E E+ +Q L+GL Y+H
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQY 177
HRD+ + N+L++ + K+ADFG++ + D+ I T + APE++ G Y
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-Y 176
Query: 178 NSKVDMWALGLI---MAE----LITFHPLFPGTCEDDQLYKICN----AIGSPTEESWAE 226
N+K D+W+LG+ MAE HP+ ++ I N + P + S
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPM-------RAIFMIPNKPPPTLSDPEKWS--- 226
Query: 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
P ND ++ DP +RP+A + LQHP
Sbjct: 227 ------------------------PEFND----FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 86/306 (28%), Positives = 131/306 (42%), Gaps = 72/306 (23%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-----------QRIYSWEECLNLKE 50
E Y L+++IG G++G V++A +GE VAIK +K Q I +EC
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC----- 57
Query: 51 VKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC---NLHQLMSNRKQCFSEAEVKNWC 107
HPNIV +L+ V EY C +L + + SE ++ C
Sbjct: 58 --------RHPNIVAYFGSYLRRDKLWIVMEY--CGGGSLQDIYQVTRGPLSELQIAYVC 107
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVD-SCPPYTEYITTLQY 165
+ L+GL Y+H G HRD+ N+L++ D +K+ADFG++ ++ + +I T +
Sbjct: 108 RETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYW 167
Query: 166 RAPEMLL--MSGQYNSKVDMWALGLI---MAEL----ITFHPLFPGTCEDDQLYKICNAI 216
APE+ G Y+ K D+WALG+ +AEL HP+
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM----------------- 210
Query: 217 GSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA 276
L L + PKL+ + I+ + DP KRPTA
Sbjct: 211 ---------RALFLISKSNFPPPKLKDKEK------WSPVFHDFIKKCLTKDPKKRPTAT 255
Query: 277 EALQHP 282
+ LQHP
Sbjct: 256 KLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 78/233 (33%), Positives = 125/233 (53%), Gaps = 8/233 (3%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINNHP 61
+Y ++K+IGEGSFGK++ A K E+ IK + ++ E+ + KEV L K+ HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HP 59
Query: 62 NIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
NIV EN RL+ V EY D + ++ R FSE ++ +W QI GL ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 120 QGYFHRDLISKNLLVSNDTI--KIADFGLAWEV-DSCPPYTEYITTLQYRAPEMLLMSGQ 176
+ HRD+ S+N+ +S + + K+ DFG+A ++ DS + T Y +PE + +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPE-ICQNRP 178
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
YN+K D+W+LG ++ EL T F G + KIC +P +++ L
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLR 231
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 79/314 (25%), Positives = 133/314 (42%), Gaps = 95/314 (30%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL-----------KE 50
E +TL++ IG+GSFG+V++AI K++ + VAIK ++L +E
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIK-----------VIDLEEAEDEIEDIQQE 49
Query: 51 VKCLRKINNHPNIVKLQELASENYRLYFVFEYMD---CNLHQLMSNRKQCFSEAEVKNWC 107
++ L + + P I K + +L+ + EY C L L + E +
Sbjct: 50 IQFLSQCRS-PYITKYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGK---LDETYIAFIL 104
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSC---------PPYT 157
++L GL Y+H +G HRD+ + N+L+S + +K+ADFG++ ++ S P+
Sbjct: 105 REVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF- 163
Query: 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG 217
+ APE ++ Y+ K D+W+LG+ EL G
Sbjct: 164 -------WMAPE-VIKQSGYDEKADIWSLGITAIELAK---------------------G 194
Query: 218 SPTEESWAEGLELAKAHGYKF---------PKLQGNNLSLLIPSANDDEMSLIELLCSWD 268
P L+ H + P L+GN S D + L + D
Sbjct: 195 EPP---------LSDLHPMRVLFLIPKNNPPSLEGNKFS---KPFKD----FVSLCLNKD 238
Query: 269 PCKRPTAAEALQHP 282
P +RP+A E L+H
Sbjct: 239 PKERPSAKELLKHK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 42/290 (14%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQ----RIYSWEECLNLKEVKCLRKIN 58
+Y L +++G+GSFG V+ K++ +K LK+ + E +E + L K++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 59 NHPNIVKLQELASENYRLYFVFEY-----MDCNLHQLMSNRKQCFSEAEVKNWCFQILQG 113
HP IVK E + EY +DC L +L K SE +V W Q+L G
Sbjct: 61 -HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEWFIQLLLG 118
Query: 114 LNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLA-WEVDSCPPYTEYITTLQYRAPEMLL 172
++YMH++ HRDL +KN+ + N+ +KI DFG++ + SC T + T Y +PE L
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
G Y+SK D+W+LG I+ E+ F G + L + + PT
Sbjct: 179 HQG-YDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPTPS---------- 224
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
P+ L+ ++ S + + DP RP+AAE L++P
Sbjct: 225 -----LPETYSRQLNSIMQS-----------MLNKDPSLRPSAAEILRNP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 90/292 (30%), Positives = 140/292 (47%), Gaps = 53/292 (18%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL---------KQRIYSWEECLNLKEVKCLRKINNH 60
IG GSFG V+ + SGE +A+K + K R S + L +E+ L+++ H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA-REIALLKELQ-H 65
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV+ + + L EY+ + N F E V+N+ QIL+GLNY+H +
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT---TLQ----YRAPEMLL 172
G HRD+ N+LV N IKI+DFG++ ++++ T+ +LQ + APE++
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 173 MSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
+ Y K D+W+LG ++ E++T HP FP + ++KI
Sbjct: 186 QT-SYTRKADIWSLGCLVVEMLTGKHP-FPDCTQLQAIFKI------------------- 224
Query: 232 KAHGYKFPKLQGNNLSLLIPS-ANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
G N S IPS + + + +E D KRPTAAE L+HP
Sbjct: 225 -----------GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHP 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 83/292 (28%), Positives = 132/292 (45%), Gaps = 50/292 (17%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---ECLNLKEVKCLRKINNHPNIV 64
K +G+GSFGKV A K + E A+K LK+ + + EC + E + L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECT-MTEKRVLALAGKHPFLT 59
Query: 65 KLQELASENYRLYFVFEYMDCNLHQLMSNRKQC--FSEAEVKNWCFQILQGLNYMHRQGY 122
+L RL+FV EY N LM + ++ F E + + +I+ GL ++H +G
Sbjct: 60 QLHSCFQTKDRLFFVMEY--VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI 117
Query: 123 FHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYT--EYITTLQYRAPEMLLMSGQ-YN 178
+RDL N+L+ ++ IKIADFG+ E T + T Y APE+L S Q Y
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVTTSTFCGTPDYIAPEIL--SYQPYG 174
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
VD WALG+++ E++ F G ED+ I ++
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------DEVRY 215
Query: 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR----PTAAEAL-QHPLFQ 285
P+ + + S+++ + +P KR PT + + HP F+
Sbjct: 216 PR-----------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 15/214 (7%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQR-IYSWEECLNLKE-VKCLRKI---NNHPNIV 64
+G G FG+V K A+K +K+R I +E + ++I NHP IV
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET----GQQEHIFSEKEILEECNHPFIV 56
Query: 65 KLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYF 123
KL + +Y + EY L ++ +R F E + + ++ Y+H +G
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRGII 115
Query: 124 HRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVD 182
+RDL +NLL+ SN +K+ DFG A ++ S + T +Y APE++L G Y+ VD
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVD 174
Query: 183 MWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216
W+LG+++ EL+T P F ED +I N I
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDP--MEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 80/290 (27%), Positives = 132/290 (45%), Gaps = 48/290 (16%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLK----EVKCLRKINNHPN 62
+IG G+FGKV+ A+ +GE +A+K ++ Q + +K E+K L + HPN
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD----NDPKTIKEIADEMKVLELLK-HPN 60
Query: 63 IVKLQELASENYRLYFVFEYMDCNLHQL--MSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
+VK + ++Y EY C+ L + + E ++ + Q+L+GL Y+H
Sbjct: 61 LVKYYGVEVHREKVYIFMEY--CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 121 GYFHRDLISKN-LLVSNDTIKIADFGLAWEV-DSCPPYTEYITTL----QYRAPEMLLMS 174
G HRD+ N L N IK+ DFG A ++ ++ E + +L Y APE++
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 175 GQ--YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
+ D+W+LG ++ E+ T + E D ++I +G+
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWS---ELDNEFQIMFHVGA-------------- 221
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
G+K P LS + ++ DP KRPTA+E LQHP
Sbjct: 222 --GHKPPIPDSLQLS-------PEGKDFLDRCLESDPKKRPTASELLQHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 81/287 (28%), Positives = 126/287 (43%), Gaps = 40/287 (13%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINNHPN 62
Y ++ +G+G+FG+ + + V K + R+ E L E+ L + HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPN 60
Query: 63 IVKLQELASENYRLYFVFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQ 120
I+ ++ L EY + L+ + +K Q F E V + FQI+ ++Y+H+
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 121 GYFHRDLISKNL-LVSNDTIKIADFGLAWEVDSCPPYTEYIT-TLQYRAPEMLLMSG-QY 177
G HRD+ + N+ L IK+ DFG++ + S E + T Y +PE+ G +Y
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC--QGVKY 178
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
N K D+WALG ++ EL+T F T + I
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDAT----NPLNLVVKI--------------------- 213
Query: 238 FPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQHPL 283
+QGN + S E+ SL+ L DP KRPTA E L PL
Sbjct: 214 ---VQGNY--TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-27
Identities = 70/237 (29%), Positives = 119/237 (50%), Gaps = 21/237 (8%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGE-YVAIKAL-----------KQRIYSWEECLNLKEV 51
Y +++ +G G+FG V++ KK +G+ +A+K + ++R S + ++ EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVS--EV 59
Query: 52 KCLRKINNHPNIVKLQELASENYRLYFVFEYMD-CNLHQL---MSNRKQCFSEAEVKNWC 107
+++ HPNIV+ + EN RLY V + ++ L + + +KQ F+E + N
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 108 FQILQGLNYMHRQGYF-HRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQY 165
Q++ L Y+H++ HRDL N +L +D + I DFGLA + T + T+ Y
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE 222
PE ++ + Y K D+WA G I+ ++ T P F T KI A+ P E
Sbjct: 180 SCPE-IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE 235
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLN-LKEVKCLRKINNHP 61
+ L++ IG+G+FGKV K+ + + A+K + KQ+ N L E + L+++N HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HP 60
Query: 62 NIVKLQELASENYRLYFVFEYM---DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
+V L + +Y V + + D H +K FSE +VK W +I+ L Y+H
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS---QKVKFSEEQVKFWICEIVLALEYLH 117
Query: 119 RQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
+G HRD+ N+L+ + I DF +A +V T T Y APE+ L Y
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEV-LCRQGY 176
Query: 178 NSKVDMWALGLIMAELIT 195
+ VD W+LG+ E +
Sbjct: 177 SVAVDWWSLGVTAYECLR 194
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 72/286 (25%), Positives = 128/286 (44%), Gaps = 40/286 (13%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS---WEECLNLKEVKCLRKINNH 60
+ ++ +IG+GSFG V++ ++K A+K + + EE ++ E + L K++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID--EARVLAKLD-S 58
Query: 61 PNIVKLQELASENYRLYFVFEYM-DCNLHQLM-SNRKQCFSEAEVKNWCFQILQGLNYMH 118
I++ E + +L V EY + +LH+L+ R + E +V + QIL GL ++H
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 119 RQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYIT-TLQYRAPEMLLMSGQ 176
+ HRD+ S NL + D +KI D G+A + + I T Y +PE+
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL-CEDKP 177
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
YN K D+WALG+++ E T F + + KI + P + +++ L
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQL-------- 229
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
LI+ + D +RP + L++P
Sbjct: 230 ---------------------AQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 76/232 (32%), Positives = 118/232 (50%), Gaps = 16/232 (6%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL----KQRIYSWEECLNLKEVKCLRKINN 59
+T +++IG GSFG V+ A ++ E VAIK + KQ W++ + KEVK L++I
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII--KEVKFLQRIK- 83
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
HPN ++ + + + V EY + L+ K+ E E+ LQGL Y+H
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 120 QGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM--SGQ 176
HRD+ + N+L++ +K+ADFG A P ++ T + APE++L GQ
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWMAPEVILAMDEGQ 200
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES--WAE 226
Y+ KVD+W+LG+ EL P LY I SPT +S W++
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQSNEWSD 251
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 58/203 (28%), Positives = 110/203 (54%), Gaps = 25/203 (12%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEY-----VAIKALKQRIYSWEECLNLKEVKCLRKINN 59
T +K++G G FG V G++ VAIK +++ S ++ + +E K + K++
Sbjct: 7 TFLKELGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFI--EEAKVMMKLS- 57
Query: 60 HPNIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HPN+V+L + ++ ++ V EYM C L + RK + + C + + + Y+
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGC-LLNYLRERKGKLGTEWLLDMCSDVCEAMEYL 116
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLA-WEVDSCPPYTEYITT---LQYRAPEMLL 172
G+ HRDL ++N LV ++ +K++DFGLA + +D YT T +++ PE +
Sbjct: 117 ESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD--QYTSSQGTKFPVKWAPPE-VF 173
Query: 173 MSGQYNSKVDMWALGLIMAELIT 195
+++SK D+W+ G++M E+ +
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 6/221 (2%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
+Y +++ +GEGSFG+ S + A+K ++ S + KE L K+ HPN
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPN 59
Query: 63 IVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
IV +E + LY V EY D + ++ R + F E + W Q+ G+ ++H +
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 121 GYFHRDLISKNL-LVSNDTIKIADFGLAWEVDSCPPYT-EYITTLQYRAPEMLLMSGQYN 178
HRD+ SKN+ L N +K+ DFG A + S Y Y+ T Y PE + + YN
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE-IWENMPYN 178
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP 219
+K D+W+LG I+ EL T F + + K+C P
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 33/221 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQ--SGEY---VAIKALKQRIYSWEECLNLKEVKCLR 55
EK TL++++G+GSFG V++ + K GE VAIK + + E L E ++
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64
Query: 56 KINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVK----------- 104
+ N H ++V+L + S V E M L S + EAE
Sbjct: 65 EFNCH-HVVRLLGVVSTGQPTLVVMELMA--KGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 105 -NWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEY--- 159
+I G+ Y+ + + HRDL ++N +V+ D T+KI DFG+ ++ T+Y
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY----ETDYYRK 177
Query: 160 ----ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ +++ APE L G + +K D+W+ G+++ E+ T
Sbjct: 178 GGKGLLPVRWMAPES-LKDGVFTTKSDVWSFGVVLWEMATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 82/287 (28%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL----KQRIYSWEECLNLKEVKCLRKI 57
E + + +IG GSFG V+ A + E VA+K + KQ W++ + KEVK L+++
Sbjct: 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDII--KEVKFLQQL 78
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HPN ++ + + + + V EY + L+ K+ E E+ LQGL Y+
Sbjct: 79 K-HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 118 HRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM--S 174
H HRD+ + N+L++ +K+ADFG A + P ++ T + APE++L
Sbjct: 138 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDE 194
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
GQY+ KVD+W+LG+ EL P LY I +S
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------NDS----------- 237
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
P LQ N + D ++ P +RP +AE L+H
Sbjct: 238 ----PTLQSNEWT-------DSFRGFVDYCLQKIPQERPASAELLRH 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 75/303 (24%), Positives = 139/303 (45%), Gaps = 38/303 (12%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
YT++K + GS G+V+ A K + V +K + Q+ + E + L+ V NHP++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK-IGQKGTTLIEAMLLQNV-------NHPSV 119
Query: 64 VKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYF 123
+++++ V + +L+ ++ R + + QIL+GL Y+H Q
Sbjct: 120 IRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRII 179
Query: 124 HRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVD 182
HRD+ ++N+ + D + I D G A P + T++ APE +L +YNSK D
Sbjct: 180 HRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKAD 238
Query: 183 MWALGLIMAELITF-HPLF--PGTCEDD-------QLYKICNAIG--------SPTEESW 224
+W+ G+++ E++ + +F P + ++ L KI + + P
Sbjct: 239 IWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLV 298
Query: 225 AEGLELAKAHGY---KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
+E A ++P Q NL + D E L+ + ++D RP+A E L +
Sbjct: 299 RGFIEYASLERQPYTRYPCFQRVNLPI------DGEF-LVHKMLTFDAAMRPSAEEILNY 351
Query: 282 PLF 284
P+F
Sbjct: 352 PMF 354
|
Length = 357 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 81/291 (27%), Positives = 127/291 (43%), Gaps = 48/291 (16%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQR-IYSWEECLNLKEVKCLRKINNH-PNIV 64
+K I +G+FG V+ A K+ +G+Y AIK LK+ + + + N+K + + I P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 65 KL-QELASENYRLYFVFEYM---DC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
KL S++Y LY V EY+ DC +L + + E K + +++ G+ +H+
Sbjct: 61 KLYYSFQSKDY-LYLVMEYLNGGDCASLIKTLGG----LPEDWAKQYIAEVVLGVEDLHQ 115
Query: 120 QGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYN 178
+G HRD+ +NLL+ +K+ DFGL+ +++ T Y APE +L G +
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLS-RNGLENK--KFVGTPDYLAPETILGVGD-D 171
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKI-CNAIGSPTEESWAEGLELAKAHGYK 237
D W+LG ++ E + +P F D I I P E
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCS---------- 221
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA---AEALQHPLFQ 285
P A D LI L DP KR A E HP F+
Sbjct: 222 -------------PEAVD----LINRLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 36/286 (12%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINNHP 61
KY ++ +G G+FG V +K + V IK + +++ E E + L+ ++ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HP 59
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHR 119
NI++ E E+ L V EY L + + R E + ++ QIL L+++H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 120 QGYFHRDLISKNLLVS--NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
+ HRDL ++N+L+ +KI DFG++ + S + T Y +PE L Y
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEGKPY 178
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
N K D+WALG ++ EL + F + KI + +P + ++ L
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQ------- 231
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283
LI + + DP KRP ++ + P+
Sbjct: 232 ----------------------LILSMLNLDPSKRPQLSQIMAQPI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---ECLNLKEVKCLRKINNHPNIV 64
K +G+GSFGKV A K + E AIK LK+ + + +C + E + L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDC-TMTEKRILALAAKHPFLT 59
Query: 65 KLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
L RL+FV EY++ + Q+ +RK F E + + ++ L ++HR G
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGV 117
Query: 123 FHRDLISKNLLVSNDT-IKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
+RDL N+L+ + K+ADFG+ E + + T + T Y APE +L +Y
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-ILQELEYGPS 176
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDD 207
VD WALG++M E++ P F EDD
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 74/229 (32%), Positives = 115/229 (50%), Gaps = 16/229 (6%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKAL----KQRIYSWEECLNLKEVKCLRKINNHPN 62
+++IG GSFG V+ A ++ E VAIK + KQ W++ + KEV+ L+K+ HPN
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII--KEVRFLQKLR-HPN 76
Query: 63 IVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
++ + + + V EY + L+ K+ E E+ LQGL Y+H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 123 FHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM--SGQYNS 179
HRD+ + N+L+S +K+ DFG A + P ++ T + APE++L GQY+
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYDG 193
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES--WAE 226
KVD+W+LG+ EL P LY I SP +S W+E
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPALQSGHWSE 241
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-24
Identities = 83/292 (28%), Positives = 133/292 (45%), Gaps = 49/292 (16%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL----------KQRIYSWEECLNLKEVKCLRKINN 59
IG+G++G+V+ A+ +GE +A+K + R + L E++ L+ ++
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALR-SEIETLKDLD- 66
Query: 60 HPNIVKLQELASENYRLYF--VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
H NIV Q L E Y EY+ F E V+ + Q+L+GL Y+
Sbjct: 67 HLNIV--QYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 118 HRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT---TLQYRAPEMLLM 173
H +G HRDL + NLLV D KI+DFG++ + D + ++ ++ + APE++
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 174 SGQ-YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP--TEESWAEGLEL 230
Q Y++KVD+W+LG ++ E +F G P EE+ A +L
Sbjct: 185 YSQGYSAKVDIWSLGCVVLE------MFAGR--------------RPWSDEEAIAAMFKL 224
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
P + + L P A D + + +P RPTA E LQHP
Sbjct: 225 GNKR--SAPPIPPDVSMNLSPVALD----FLNACFTINPDNRPTARELLQHP 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-24
Identities = 71/293 (24%), Positives = 131/293 (44%), Gaps = 47/293 (16%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL-----KEVKCLRKINNHPN 62
+Q+G G+F +QA ++G +A+K + + E + KE++ + ++N HP+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPH 64
Query: 63 IVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
I+++ E+ E+M + ++ F EA + N+ Q+L+GL+Y+H
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 123 FHRDLISKNLLV--SNDTIKIADFGLAWEVDSCPPYT-----EYITTLQYRAPEMLLMSG 175
HRD+ NLL+ + ++IADFG A + + + + T+ + APE +L
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLRGE 183
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQL---YKICNAIGSPTEESWAEGLELAK 232
QY D+W++G ++ E+ T P + + L +KI +A +P+
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS------------ 231
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC-SWDPCKRPTAAEALQHPLF 284
IP + + L C P RP + E L+HP+F
Sbjct: 232 -----------------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 15/211 (7%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKI---NN 59
+ ++ Q+G+G +G+V+ A KK +GE VA+K +K+ + LN ++ V R I
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK---LNEVRHVLTERDILTTTK 59
Query: 60 HPNIVKLQELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
+VKL ++ LY EY+ + L++N SE + + ++ + ++ +H
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALH 118
Query: 119 RQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYIT-TLQYRAPEMLLMSGQ 176
GY HRDL +N L+ IK+ DFGL+ + + Y + + Y APE+ L
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEV-LRGKG 174
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDD 207
Y+ VD W+LG ++ E + P F G+ ++
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 7e-24
Identities = 75/215 (34%), Positives = 113/215 (52%), Gaps = 13/215 (6%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---ECLNLKEVKCLRKINNHPNIV 64
K +G+GSFGKV A K + E+ AIKALK+ + + EC + E + L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVEC-TMVERRVLALAWEHPFLT 59
Query: 65 KLQELASENYRLYFVFEYMDCNLHQLMSNRKQC--FSEAEVKNWCFQILQGLNYMHRQGY 122
L L+FV EY+ N LM + + F EA + + +I+ GL ++H++G
Sbjct: 60 HLFCTFQTKEHLFFVMEYL--NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117
Query: 123 FHRDLISKNLLVSND-TIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQ-YNS 179
+RDL N+L+ D IKIADFG+ E ++ + + T Y APE+L GQ YN
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK--GQKYNE 175
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICN 214
VD W+ G+++ E++ F G ED+ I N
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-24
Identities = 85/291 (29%), Positives = 136/291 (46%), Gaps = 47/291 (16%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L +++G G FG+VW + + VA+K LK S E L +E + ++K+ H
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFL--QEAQIMKKLR-HD 61
Query: 62 NIVKLQELASENYRLYFVFEYMDCN---LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
+V+L + SE +Y V EYM L L S + ++ + QI +G+ Y+
Sbjct: 62 KLVQLYAVCSEEEPIYIVTEYM-SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 119 RQGYFHRDLISKNLLVSNDTI-KIADFGLA--WEVDSCPPYTEYITTLQYRAPEMLLMSG 175
+ Y HRDL ++N+LV + + KIADFGLA E D +++ APE G
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-G 179
Query: 176 QYNSKVDMWALGLIMAELITFHPL-FPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
++ K D+W+ G+++ E++T+ + +PG + E LE
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGM-------------------TNREVLE-QVER 219
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSW--DPCKRPTAAEALQHPL 283
GY+ P+ P +E+ + L C W DP +RPT E LQ L
Sbjct: 220 GYRMPR----------PPNCPEELYDLMLQC-WDKDPEERPT-FEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 86/325 (26%), Positives = 134/325 (41%), Gaps = 75/325 (23%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQR-IYSWEECLNLKEVKCLRKINNH 60
+ + ++K IG G+FG+VW K +G+ A+K L++ + + +++ + + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 61 PNIVKLQELASENYRLYFVFEYM---DCNLHQLMS--NRKQCFSEAEVKNWCFQILQGLN 115
P IVKL + LY V EYM D LM+ RK F E + + +++ L+
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGD-----LMNLLIRKDVFPEETARFYIAELVLALD 115
Query: 116 YMHRQGYFHRDLISKNLLVSNDT-IKIADFGLA----------------WEVDSCPPYTE 158
+H+ G+ HRD+ N+L+ D IK+ADFGL +
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 159 YIT--------------TLQYRAPEMLLMSGQYNSKVDMWALGLIMAE-LITFHPLFPGT 203
T Y APE +L Y + D W+LG+I+ E L F P + T
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 204 CEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIE- 262
++ KI N W E L FP P + + + LI
Sbjct: 235 LQETYN-KIIN---------WKESLR--------FPP---------DPPVSPEAIDLICR 267
Query: 263 LLCSWDPCKRPTAAE-ALQHPLFQG 286
LLC DP R + E HP F+G
Sbjct: 268 LLC--DPEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 84/289 (29%), Positives = 132/289 (45%), Gaps = 43/289 (14%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQR-IYSWEECLN-LKEVKCLRKINNHPNIVK 65
K +G+G+FGKV +K +G+Y A+K LK+ I + +E + L E + L+ HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTA 59
Query: 66 LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
L+ + RL FV EY + +R++ FSE + + +I+ L Y+H +R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 126 DLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTE-YITTLQYRAPEMLLMSGQYNSKVDM 183
DL +NL++ D IKI DFGL E S + + T +Y APE +L Y VD
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 184 WALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242
W LG++M E++ P +D ++L+ EL +FP+
Sbjct: 179 WGLGVVMYEMMCGR--LPFYNQDHEKLF------------------ELILMEEIRFPR-- 216
Query: 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKR-----PTAAEALQHPLFQG 286
LS + SL+ L DP +R A E ++H F
Sbjct: 217 --TLS-------PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-23
Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 10 IGEGSFGKVWQAIKKQ-----SGEY-VAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
+G G+FG+V++ SG VA+K L++ E+ LKE + N HPNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNI 61
Query: 64 VKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEA-----EVKNWCFQILQGLNY 116
VKL + N Y + E M+ L L R + F E+ + C + +G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 117 MHRQGYFHRDLISKNLLVSND------TIKIADFGLAWEVDSCPPYT---EYITTLQYRA 167
+ + + HRDL ++N LVS +KI DFGLA ++ Y E + +++ A
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPG 202
PE L+ G++ ++ D+W+ G++M E++T +P
Sbjct: 182 PES-LLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-23
Identities = 65/204 (31%), Positives = 114/204 (55%), Gaps = 27/204 (13%)
Query: 5 TLMKQIGEGSFGKV----WQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
T MK++G G FG V W+A K VAIKA+ + S E+ + +E K + K++ H
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQIK-----VAIKAINEGAMSEEDFI--EEAKVMMKLS-H 58
Query: 61 PNIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
P +V+L + ++ LY V E+M+ C L+ L + + S+ + + C + +G+ Y+
Sbjct: 59 PKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLE 117
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITT------LQYRAPEML 171
R + HRDL ++N LVS+ +K++DFG+ V EY ++ +++ PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD----DEYTSSSGAKFPVKWSPPEVF 173
Query: 172 LMSGQYNSKVDMWALGLIMAELIT 195
S +Y+SK D+W+ G++M E+ T
Sbjct: 174 NFS-KYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 3e-23
Identities = 82/292 (28%), Positives = 126/292 (43%), Gaps = 57/292 (19%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-------CLNLKEVKCLRKINN 59
+ +IG G+ G V++ I + +G A+K IY E C +E++ LR +N
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKV----IYGNHEDTVRRQIC---REIEILRDVN- 130
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
HPN+VK ++ N + + E+MD L E + + QIL G+ Y+HR
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGG--SLEGTH--IADEQFLADVARQILSGIAYLHR 186
Query: 120 QGYFHRDLISKNLLV-SNDTIKIADFG----LAWEVDSCPPYTEYITTLQYRAPEML--- 171
+ HRD+ NLL+ S +KIADFG LA +D C + T+ Y +PE +
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC---NSSVGTIAYMSPERINTD 243
Query: 172 LMSGQYNSKV-DMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
L G Y+ D+W+LG+ + E + FP G + WA L
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEF--YLGRFP--------------FGVGRQGDWA---SL 284
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
A P +A+ + I +P KR +A + LQHP
Sbjct: 285 MCAICMSQPPEAP-------ATASREFRHFISCCLQREPAKRWSAMQLLQHP 329
|
Length = 353 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-23
Identities = 64/202 (31%), Positives = 116/202 (57%), Gaps = 15/202 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEY-VAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+ T +K++G G FG V K G+Y VAIK +K+ S +E + +E K + K++ H
Sbjct: 4 KDLTFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEFI--EEAKVMMKLS-H 58
Query: 61 PNIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
+V+L + ++ +Y V EYM C L+ L + K+ F +++ C + +G+ Y+
Sbjct: 59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR-FQPSQLLEMCKDVCEGMAYLE 117
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITT---LQYRAPEMLLMS 174
+ + HRDL ++N LV + +K++DFGL+ V YT + + +++ PE+LL S
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLLYS 176
Query: 175 GQYNSKVDMWALGLIMAELITF 196
+++SK D+WA G++M E+ +
Sbjct: 177 -KFSSKSDVWAFGVLMWEVYSL 197
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 71/226 (31%), Positives = 105/226 (46%), Gaps = 26/226 (11%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINN--- 59
+ + +G G FGKV A K++GE AIKAL K I + +E +L K + + N
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 60 HPNIVKLQELASENYRLYFVFEYM---DCNLH---QLMSNRKQCFSEAEVKNWCFQILQG 113
HP +V L + FV EY D +H + S + F A V + G
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACV-------VLG 113
Query: 114 LNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLA----WEVDSCPPYTEYITTLQYRAP 168
L Y+H +RDL NLL+ + +KIADFGL D + + T ++ AP
Sbjct: 114 LQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT---STFCGTPEFLAP 170
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICN 214
E+L + Y VD W LG+++ E++ FPG E++ I N
Sbjct: 171 EVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN 215
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-23
Identities = 78/297 (26%), Positives = 126/297 (42%), Gaps = 51/297 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+IGEGS G V A K +G VA+K + R E L EV +R HP
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL-FNEVVIMRDYQ-HP 76
Query: 62 NIVKLQELASENYRLYFVFEYM------DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
NIV++ L+ V E++ D H M+ E ++ C +L+ L+
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMN-------EEQIATVCLAVLKALS 129
Query: 116 YMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEV-DSCPPYTEYITTLQYRAPEMLLM 173
++H QG HRD+ S + LL S+ +K++DFG +V P + T + APE++
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI---GSPTEESWAEGLEL 230
Y ++VD+W+LG+++ E++ P + ++ + I P
Sbjct: 190 L-PYGTEVDIWSLGIMVIEMVDGEPPY----FNEPPLQAMKRIRDNLPPK---------- 234
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287
K P+L+ S ++ + DP +R TAAE L HP
Sbjct: 235 LKNLHKVSPRLR----------------SFLDRMLVRDPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-23
Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 32/213 (15%)
Query: 5 TLMKQIGEGSFGKV----WQAIKKQSGEYVAIKALK-----QRIYSWEECLNLKEVKCLR 55
+KQ+GEG FGKV + + +GE VA+K+L Q +E +E++ LR
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE-----REIEILR 61
Query: 56 KINNHPNIVKLQELASENYR--LYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQIL 111
++ H NIVK + + + L + EY+ L +R Q + + + QI
Sbjct: 62 TLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQIC 119
Query: 112 QGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITT-------L 163
+G++Y+ Q Y HRDL ++N+LV S D +KI+DFGLA + P +Y +
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL---PEDKDYYYVKEPGESPI 176
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ APE L + +++S D+W+ G+ + EL T+
Sbjct: 177 FWYAPEC-LRTSKFSSASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 5e-23
Identities = 70/213 (32%), Positives = 109/213 (51%), Gaps = 13/213 (6%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---ECLNLKEVKCLRKINNHPNIVKL 66
+G+GSFGKV A K+SG A+K LK+ + + EC + E + L NHP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVEC-TMTEKRILSLARNHPFLTQL 61
Query: 67 QELASENYRLYFVFEYMDCNLHQLMSNRKQC--FSEAEVKNWCFQILQGLNYMHRQGYFH 124
RL+FV E++ N LM + ++ F EA + + +I L ++H +G +
Sbjct: 62 YCCFQTPDRLFFVMEFV--NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 125 RDLISKNLLVSNDT-IKIADFGLAWE--VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKV 181
RDL N+L+ ++ K+ADFG+ E + T + T Y APE +L Y V
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPE-ILQEMLYGPSV 177
Query: 182 DMWALGLIMAELITFHPLFPGTCEDDQLYKICN 214
D WA+G+++ E++ H F EDD I N
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-23
Identities = 75/290 (25%), Positives = 131/290 (45%), Gaps = 39/290 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E + L+++IG G++G V++A +GE AIK +K + E+ +++ + K H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
NIV +L+ E+ Q + + SE+++ + LQGL Y+H +G
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 122 YFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTEYITTLQYRAPEMLLMS--GQY 177
HRD+ N+L++ N +K+ADFG++ ++ + +I T + APE+ + G Y
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 178 NSKVDMWALGLIMAELITFHP----LFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
N D+WA+G+ EL P L P L L
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHP-----------------------MRALFLMTK 223
Query: 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283
++ PKL+ ++ +++ + +P KRPTA + LQHP
Sbjct: 224 SNFQPPKLKDK------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-23
Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 18/204 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL----KEVKCLRKI 57
E++TL +++G G FG+VW+ + K VAIK LK ++ L KEV+ L+++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKS-----DDLLKQQDFQKEVQALKRL 59
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
H +++ L + S +Y + E M+ L L S Q A + + Q+ +G+
Sbjct: 60 R-HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 116 YMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYITTLQYR--APEMLL 172
Y+ Q HRDL ++N+LV D + K+ADFGLA + Y + Y+ APE
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLA-RLIKEDVYLSSDKKIPYKWTAPEA-A 176
Query: 173 MSGQYNSKVDMWALGLIMAELITF 196
G +++K D+W+ G+++ E+ T+
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTY 200
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 7e-23
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 29/205 (14%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVK-------CLRKINNHPN 62
+G GSFG+V A K +GEY AIK LK+R E L +K+V+ L ++ +HP
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKR-----EILKMKQVQHVAQEKSILMEL-SHPF 79
Query: 63 IVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQC--FSEAEVKNWCFQILQGLNYMHRQ 120
IV + + R+YF+ E++ +L ++ ++ F K + +++ Y+H +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGG--ELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTL----QYRAPEMLLMSG 175
+RDL +NLL+ N +K+ DFG A +V + TL +Y APE++ G
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV------PDRTFTLCGTPEYLAPEVIQSKG 191
Query: 176 QYNSKVDMWALGLIMAELITFHPLF 200
+ VD W +G+++ E I +P F
Sbjct: 192 -HGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-23
Identities = 56/223 (25%), Positives = 109/223 (48%), Gaps = 32/223 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQA----IKKQSGEY-VAIKALKQRIYSWEECLNLKEVKCLRK 56
++ TL K +GEG+FG+V +A + + VA+K LK + + E++ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 57 INNHPNIVKLQELASENYRLYFVFEY-----------------MDCNLHQLMSNRKQCFS 99
I H NI+ L + ++ LY V EY + + +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET-LT 130
Query: 100 EAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158
+ ++ ++ +Q+ +G+ ++ + HRDL ++N+LV+ + +KIADFGLA ++ Y +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 159 YITT-----LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
TT +++ APE L Y + D+W+ G+++ E+ T
Sbjct: 191 --TTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTL 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 8e-23
Identities = 85/288 (29%), Positives = 127/288 (44%), Gaps = 41/288 (14%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQR--IYSWEECLNLKEVKCLRKINNHPNIVK 65
K +G+G+FGKV +K SG+Y A+K LK+ I E L E + L+ HP +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTS 59
Query: 66 LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
L+ RL FV EY++ +R++ FSE + + +I+ L+Y+H +R
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 126 DLISKNLLVSNDT-IKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
DL +NL++ D IKI DFGL E + + T +Y APE +L Y VD
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 184 WALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQG 243
W LG++M E++ C Y + + EL KFP+
Sbjct: 179 WGLGVVMYEMM---------CGRLPFYN----------QDHEKLFELILMEDIKFPR--- 216
Query: 244 NNLSLLIPSANDDEMSLIELLCSWDPCKR-----PTAAEALQHPLFQG 286
+ + D SL+ L DP KR A E ++H F G
Sbjct: 217 --------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 69/212 (32%), Positives = 106/212 (50%), Gaps = 13/212 (6%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---ECLNLKEVKCLRKINNH 60
+ + +G+GSFGKV A +K + E AIK LK+ + + EC + E + L
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVEC-TMVEKRVLALPGKP 60
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQC--FSEAEVKNWCFQILQGLNYMH 118
P + +L RLYFV EY+ N LM + +Q F E + +I GL ++H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYV--NGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 119 RQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYT--EYITTLQYRAPEMLLMSG 175
+G +RDL N+++ + IKIADFG+ E + T + T Y APE++
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFCGTPDYIAPEIIAYQ- 176
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDD 207
Y VD WA G+++ E++ P F G ED+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 35/282 (12%)
Query: 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQE 68
+IGEGS G V A +K SG VA+K + R E L EV +R H N+V++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL-FNEVVIMRDYQ-HQNVVEMYK 85
Query: 69 LASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDL 127
L+ + E++ L ++S + +E ++ C +LQ L Y+H QG HRD+
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 128 ISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWA 185
S ++L++ D +K++DFG ++ P + T + APE++ + Y ++VD+W+
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWS 202
Query: 186 LGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNN 245
LG+++ E++ P + D + + SP PKL+ N
Sbjct: 203 LGIMVIEMVDGEPPY---FSDSPVQAMKRLRDSPP------------------PKLK--N 239
Query: 246 LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287
+ P D +E + + +P +R TA E L HP
Sbjct: 240 AHKISPVLRD----FLERMLTREPQERATAQELLDHPFLLQT 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 77/291 (26%), Positives = 126/291 (43%), Gaps = 45/291 (15%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKL 66
+ ++G G+ G V + + + +G+ +A+K ++ I + L+E+ L K N P IV
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGF 64
Query: 67 QELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFH 124
N + EYMD +L +++ + E + +L+GL Y+H + H
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 125 RDLISKNLLV-SNDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVD 182
RD+ N+LV S IK+ DFG++ + V+S ++ T Y APE + Y+ K D
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPER-IQGNDYSVKSD 181
Query: 183 MWALGLIMAELITFHPLFPGTCED-------DQLYKICNAIGSPTEESWAEGLELAKAHG 235
+W+LGL + EL T FP E+ + L I N E
Sbjct: 182 IWSLGLSLIELATGR--FPYPPENDPPDGIFELLQYIVN------EPP------------ 221
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
P+L S D + L DP +RP+ E L+HP +
Sbjct: 222 ---PRLPSGKFSP-------DFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 81/285 (28%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNHPNIVKLQ 67
++G+G+FGKV++A K++G + A K ++ I S EE + + E+ L + HPNIV L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECK-HPNIVGLY 68
Query: 68 ELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRD 126
E +L+ + E+ D L +M ++ +E +++ C Q+L+ LN++H HRD
Sbjct: 69 EAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 127 LISKNLLVSND-TIKIADFGL-AWEVDSCPPYTEYITTLQYRAPEMLLM----SGQYNSK 180
L + N+L++ D +K+ADFG+ A + +I T + APE++ Y+ K
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYK 188
Query: 181 VDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240
D+W+LG+ + EL P L KI + PT + P
Sbjct: 189 ADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS-EPPTLDQ---------------PS 232
Query: 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
++ + + S DP RPTAAE L+HP
Sbjct: 233 KWSSSFNDFLKSCLVK-----------DPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-22
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 5 TLMKQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINN 59
L +++GEG+FGKV+ + E VA+K LK+ + +E + L
Sbjct: 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ- 66
Query: 60 HPNIVKLQELASENYRLYFVFEYM--------------DCNLHQLMSNRKQCFSEAEVKN 105
H NIVK + +E VFEYM D + + + +++
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 106 WCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYITTL- 163
QI G+ Y+ Q + HRDL ++N LV D + KI DFG++ +V + Y T+
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 164 --QYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
++ PE +M ++ ++ D+W+ G+++ E+ T+
Sbjct: 187 PIRWMPPES-IMYRKFTTESDVWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
++ L IG+G FG V + G+ VA+K LK + + L E + + H
Sbjct: 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLA--EASVMTTLR-H 59
Query: 61 PNIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
PN+V+L + + LY V EYM + L S + + A+ + + +G+ Y+
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 119 RQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
+ + HRDL ++N+LVS D + K++DFGLA ++ +++ APE L ++
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLA--KEASQGQDSGKLPVKWTAPEA-LREKKF 176
Query: 178 NSKVDMWALGLIMAELITF 196
++K D+W+ G+++ E+ +F
Sbjct: 177 STKSDVWSFGILLWEIYSF 195
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-22
Identities = 68/234 (29%), Positives = 115/234 (49%), Gaps = 32/234 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL--------KQRIYSWEECLNLKEVK 52
+ + + K+IG+G F V++AI G VA+K + K R ++C LKE+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR----QDC--LKEID 54
Query: 53 CLRKINNHPNIVKLQELAS--ENYRLYFVFEYMDC-NLHQLMSN---RKQCFSEAEVKNW 106
L+++ +HPN++K LAS EN L V E D +L +++ + +K+ E + +
Sbjct: 55 LLKQL-DHPNVIKY--LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE---YITT 162
Q+ L +MH + HRD+ N+ ++ +K+ D GL S T + T
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 169
Query: 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216
Y +PE + +G YN K D+W+LG ++ E+ F G + LY +C I
Sbjct: 170 PYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-22
Identities = 59/196 (30%), Positives = 109/196 (55%), Gaps = 11/196 (5%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64
TL+++IG G FG VW + + VAIK +++ S E+ + +E + + K++ HP +V
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI--EEAQVMMKLS-HPKLV 62
Query: 65 KLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
+L + +E + VFE+M+ C L + ++ FS+ + C + +G+ Y+
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGC-LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121
Query: 123 FHRDLISKNLLVS-NDTIKIADFGLAWEV--DSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
HRDL ++N LV N +K++DFG+ V D T +++ +PE+ S +Y+S
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS-KYSS 180
Query: 180 KVDMWALGLIMAELIT 195
K D+W+ G++M E+ +
Sbjct: 181 KSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-22
Identities = 63/202 (31%), Positives = 110/202 (54%), Gaps = 12/202 (5%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+KYT ++IG+G+ G V+ AI +G+ VAIK + + +E L + E+ +R+ N HP
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE-LIINEILVMRE-NKHP 76
Query: 62 NIVKLQELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV + L+ V EY+ +L +++ + C E ++ C + LQ L ++H
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT---TLQYRAPEMLLMSGQ 176
HRD+ S N+L+ D ++K+ DFG ++ P ++ T T + APE++
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPEVVTRK-A 191
Query: 177 YNSKVDMWALGLIMAELITFHP 198
Y KVD+W+LG++ E++ P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-22
Identities = 72/213 (33%), Positives = 110/213 (51%), Gaps = 13/213 (6%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---ECLNLKEVKCLRKINNHPNIV 64
K +G+GSFGKV+ A K + ++ AIKALK+ + + EC + E + L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVEC-TMVEKRVLSLAWEHPFLT 59
Query: 65 KLQELASENYRLYFVFEYMDCNLHQLMSNRKQC--FSEAEVKNWCFQILQGLNYMHRQGY 122
L L+FV EY+ N LM + + C F + +I+ GL ++H +G
Sbjct: 60 HLYCTFQTKENLFFVMEYL--NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 123 FHRDLISKNLLVSNDT-IKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQ-YNS 179
+RDL N+L+ D IKIADFG+ E + + T Y APE+LL GQ YN+
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL--GQKYNT 175
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKI 212
VD W+ G+++ E++ F G E++ I
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 9e-22
Identities = 73/280 (26%), Positives = 137/280 (48%), Gaps = 35/280 (12%)
Query: 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQE 68
+IGEGS G V A +K +G+ VA+K + R E L EV +R + H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL-FNEVVIMRDYH-HENVVDMYN 86
Query: 69 LASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDL 127
L+ V E+++ L ++++ + +E ++ C +L+ L+Y+H QG HRD+
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLHNQGVIHRDI 144
Query: 128 ISKNLLVSND-TIKIADFGLAWEVD-SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWA 185
S ++L+++D IK++DFG +V P + T + APE ++ Y ++VD+W+
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE-VISRLPYGTEVDIWS 203
Query: 186 LGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNN 245
LG+++ E+I P + + +I + + ++S +
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS--------------------HK 243
Query: 246 LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+S ++ ++L+ +P +R TA E LQHP +
Sbjct: 244 VSSVL-------RGFLDLMLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 32/215 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINNH 60
+ L++ IGEG++GKV++A K++G+ VAIK + +E +K E LRK +NH
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILRKYSNH 62
Query: 61 PNIVK------LQELASENYRLYFVFEYMDC------NLHQLMSNRKQCFSEAEVKNWCF 108
PNI + + +L+ V E C +L + + + + E +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMEL--CGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 109 QILQGLNYMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTE-----YITT 162
+ L+GL Y+H HRD+ +N LL N +K+ DFG++ ++DS T +I T
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS----TLGRRNTFIGT 176
Query: 163 LQYRAPEMLLMSGQ----YNSKVDMWALGLIMAEL 193
+ APE++ Q Y+++ D+W+LG+ EL
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 78/291 (26%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQ 67
+G+G FG+V K +G+ A K L K+R+ + E + L E K L K+++ IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLA 59
Query: 68 ELASENYRLYFVFEYMDC-NLHQLMSNRKQC-FSEAEVKNWCFQILQGLNYMHRQGYFHR 125
L V M+ +L + N + F EA + QI+ GL ++H++ +R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 126 DLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMW 184
DL +N+L+ + ++I+D GLA E+ T Y APE +L Y+ VD +
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPE-VLQGEVYDFSVDWF 178
Query: 185 ALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGN 244
ALG + E+I F + K K +
Sbjct: 179 ALGCTLYEMIAGRSPF-------------------------------RQRKEKVEKEELK 207
Query: 245 NLSLLIPSANDDEMS-----LIELLCSWDPCKR-----PTAAEALQHPLFQ 285
+L + D+ S L E L DP KR +A E +HPLF+
Sbjct: 208 RRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 74/211 (35%), Positives = 109/211 (51%), Gaps = 13/211 (6%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---ECLNLKEVKCLRKINNHPNIVKL 66
+G+GSFGKV A +K + E AIK LK+ + + EC + E + L + P + +L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC-TMVEKRVLALQDKPPFLTQL 66
Query: 67 QELASENYRLYFVFEYMDCNLHQLMSNRKQC--FSEAEVKNWCFQILQGLNYMHRQGYFH 124
RLYFV EY+ N LM + +Q F E + + +I GL ++HR+G +
Sbjct: 67 HSCFQTVDRLYFVMEYV--NGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY 124
Query: 125 RDLISKNLLV-SNDTIKIADFGLAWE--VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKV 181
RDL N+++ S IKIADFG+ E VD T + T Y APE++ Y V
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPDYIAPEIIAYQ-PYGKSV 182
Query: 182 DMWALGLIMAELITFHPLFPGTCEDDQLYKI 212
D WA G+++ E++ P F G ED+ I
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 4e-21
Identities = 59/202 (29%), Positives = 109/202 (53%), Gaps = 8/202 (3%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+KYT ++IG+G+ G V+ A+ +G+ VAI+ + + +E L + E+ +R+ N +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRE-NKNP 77
Query: 62 NIVKLQELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV + L+ V EY+ +L +++ + C E ++ C + LQ L ++H
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVD-SCPPYTEYITTLQYRAPEMLLMSGQYN 178
HRD+ S N+L+ D ++K+ DFG ++ + + T + APE++ Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YG 194
Query: 179 SKVDMWALGLIMAELITFHPLF 200
KVD+W+LG++ E+I P +
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVK-------CLRKINNH 60
K IG+GSFGKV A K G++ A+K L+++ L KE K L K H
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA-----ILKKKEQKHIMAERNVLLKNVKH 55
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSN--RKQCFSEAEVKNWCFQILQGLNYMH 118
P +V L +LYFV +Y+ N +L + R++ F E + + +I L Y+H
Sbjct: 56 PFLVGLHYSFQTADKLYFVLDYV--NGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 119 RQGYFHRDLISKNLLVSNDT-IKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQ 176
+RDL +N+L+ + + + DFGL E ++ + + T +Y APE+L
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ-P 172
Query: 177 YNSKVDMWALGLIMAELITFHPLF 200
Y+ VD W LG ++ E++ P F
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-21
Identities = 60/191 (31%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQR--IYSWEECLNLKEVKCLRKINNHPNIVK 65
K +G+G+FGKV +K +G Y A+K L++ I E + E + L+ HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59
Query: 66 LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
L+ + RL FV EY + +R++ F+E + + +I+ L Y+H + +R
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 126 DLISKNLLVSNDT-IKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
D+ +NL++ D IKI DFGL E + + T +Y APE +L Y VD
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 184 WALGLIMAELI 194
W LG++M E++
Sbjct: 179 WGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-21
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 6/214 (2%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
Y ++ +G+GS+G+V + G+ IK L R S E ++ L HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 64 VKLQE-LASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
V +E E+ LY V + + H+L + + E +V W QI L Y+H +
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 121 GYFHRDLISKNL-LVSNDTIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSGQYN 178
HRDL ++N+ L + IK+ D G+A +++ C + I T Y +PE L + YN
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPYN 180
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKI 212
K D+WALG + E+ T F + +Y+I
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 9e-21
Identities = 55/202 (27%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
T+ K IG G FG+V + K G+ VAIK LK + L E + + + HP
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HP 65
Query: 62 NIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NI++L+ + +++ + + EYM+ +L + + F+ ++ I G+ Y+
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 121 GYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYITT-----LQYRAPEMLLMS 174
Y HRDL ++N+LV+++ + K++DFGL+ ++ Y T +++ APE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA--TYTTKGGKIPIRWTAPEA-IAY 182
Query: 175 GQYNSKVDMWALGLIMAELITF 196
++ S D+W+ G++M E++++
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSY 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 9e-21
Identities = 60/202 (29%), Positives = 110/202 (54%), Gaps = 8/202 (3%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+KYT ++IG+G+ G V+ AI +G+ VAIK + + +E L + E+ +R+ N +P
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE-LIINEILVMRE-NKNP 76
Query: 62 NIVKLQELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV + L+ V EY+ +L +++ + C E ++ C + LQ L+++H
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVD-SCPPYTEYITTLQYRAPEMLLMSGQYN 178
HRD+ S N+L+ D ++K+ DFG ++ + + T + APE++ Y
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YG 193
Query: 179 SKVDMWALGLIMAELITFHPLF 200
KVD+W+LG++ E++ P +
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 70/237 (29%), Positives = 117/237 (49%), Gaps = 19/237 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L+K++G G FG+VW S + VA+K LK S + L E L K H
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFL---EEANLMKTLQHD 61
Query: 62 NIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+V+L + ++ +Y + EYM L L S+ ++ ++ QI +G+ Y+ R
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 120 QGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYIT------TLQYRAPEMLL 172
+ Y HRDL + N+LVS + KIADFGLA ++ EY +++ APE +
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAIN 177
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPL-FPGTCEDDQLYKICNAIGSPTEESWAEGL 228
G + K D+W+ G+++ E++T+ + +PG D + + P E+ + L
Sbjct: 178 F-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL 233
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 82/282 (29%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQEL 69
+G+G++G V+ A + +AIK + +R S L E L H NIV+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPER-DS-RYVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 70 ASEN-YRLYFVFEYMDCNLHQLMSNR--KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRD 126
SEN + F+ + +L L+ ++ +E + + QIL+GL Y+H HRD
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133
Query: 127 LISKNLLVS--NDTIKIADFGLAWEVDSCPPYTEYIT-TLQYRAPEMLLMSGQ--YNSKV 181
+ N+LV+ + +KI+DFG + + P TE T TLQY APE ++ G Y +
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE-VIDKGPRGYGAPA 192
Query: 182 DMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241
D+W+LG + E+ T P F +G P + G + K H P+
Sbjct: 193 DIWSLGCTIVEMATGKPPF-------------IELGEPQAAMFKVG--MFKIH----PE- 232
Query: 242 QGNNLSLLIPSANDDEMSLIELLC-SWDPCKRPTAAEALQHP 282
IP + E L C DP KR +A + LQ P
Sbjct: 233 --------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-----------QRIYSWEECLNLKEVK 52
Y L++++G G++G V++A +GE A+K +K Q I+ +EC
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC------- 63
Query: 53 CLRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQ 112
H NIV +L+ EY Q + + SE ++ C + LQ
Sbjct: 64 ------KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117
Query: 113 GLNYMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSC-PPYTEYITTLQYRAPEM 170
GL Y+H +G HRD+ N LL N +K+ADFG+A ++ + +I T + APE+
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 171 LLM--SGQYNSKVDMWALGLIMAELITFHP 198
+ +G YN D+WA+G+ EL P
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 78/279 (27%), Positives = 136/279 (48%), Gaps = 35/279 (12%)
Query: 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQE 68
+IGEGS G V A K SG+ VA+K + R E L EV +R H N+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQ-HENVVEMYN 84
Query: 69 LASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDL 127
L+ V E+++ L ++++ + +E ++ C +L+ L+ +H QG HRD+
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 128 ISKNLLVSND-TIKIADFGLAWEVD-SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWA 185
S ++L+++D +K++DFG +V P + T + APE L+ Y +VD+W+
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEVDIWS 201
Query: 186 LGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNN 245
LG+++ E++ P + E + +++ + + PKL+ N
Sbjct: 202 LGIMVIEMVDGEPPY-------------------FNEPPLKAMKMIRDN--LPPKLK--N 238
Query: 246 LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
L + PS ++ L DP +R TAAE L+HP
Sbjct: 239 LHKVSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-20
Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 17/221 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQ----RIYSWEECLNLKEVKCLRKI 57
+ +K +G G+FG+V + S Y A+K + R+ + N K V L+++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRV--LKEV 58
Query: 58 NNHPNIVKLQELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
+HP I++L + LY + EY+ L + N + FS + + +I+ L Y
Sbjct: 59 -SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCALEY 116
Query: 117 MHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSG 175
+H + +RDL +N+L+ + IK+ DFG A ++ +T T +Y APE++ G
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWT-LCGTPEYLAPEVIQSKG 174
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216
+N VD WALG+++ E++ +P F DD + I I
Sbjct: 175 -HNKAVDWWALGILIYEMLVGYPPF----FDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 58/199 (29%), Positives = 106/199 (53%), Gaps = 13/199 (6%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64
T+ ++G G +G+V++ + K+ VA+K LK+ EE L KE +++I HPN+V
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL--KEAAVMKEIK-HPNLV 65
Query: 65 KLQELASENYRLYFVFEYMDCN---LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+L + + Y + E+M L L +Q + + QI + Y+ ++
Sbjct: 66 QLLGVCTREPPFYIITEFM-TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 124
Query: 122 YFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITT---LQYRAPEMLLMSGQY 177
+ HRDL ++N LV N +K+ADFGL+ + YT + +++ APE L + ++
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KF 182
Query: 178 NSKVDMWALGLIMAELITF 196
+ K D+WA G+++ E+ T+
Sbjct: 183 SIKSDVWAFGVLLWEIATY 201
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 86/324 (26%), Positives = 146/324 (45%), Gaps = 52/324 (16%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E +T +++IG+GSFG+V++ I ++ + VAIK + E +E+ L + ++ P
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-P 62
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+ K + +L+ + EY+ L R F E ++ +IL+GL+Y+H +
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGG-SALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 122 YFHRDLISKNLLVSND-TIKIADFGLAWEV-DSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
HRD+ + N+L+S +K+ADFG+A ++ D+ ++ T + APE++ S Y+S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA-YDS 180
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
K D+W+LG+ EL A G P L + P
Sbjct: 181 KADIWSLGITAIEL---------------------AKGEPPNSDMHPMRVL-----FLIP 214
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCK 299
K NN L + I+ + DP RPTA E L+H
Sbjct: 215 K---NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF---------------- 255
Query: 300 MRLTPSAKKSGWKAKLIVWFLRWE 323
+ +AKK+ + +LI F RW+
Sbjct: 256 --IVKNAKKTSYLTELIDRFKRWK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-20
Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQR--IYSWEECLNLKEVKCLRKINNHPNIVK 65
K IG+GSFGKV A +K G + A+K L+++ + E+ + E L K HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 66 LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
L +LYFV +Y++ R++CF E + + ++ + Y+H +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 126 DLISKNLLV-SNDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
DL +N+L+ S + + DFGL E V+ + + T +Y APE +L Y+ VD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VLRKEPYDRTVDW 179
Query: 184 WALGLIMAELITFHPLF 200
W LG ++ E++ P F
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-20
Identities = 76/287 (26%), Positives = 132/287 (45%), Gaps = 45/287 (15%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64
L++++G G FG+VW+ + + VA+K LK ++ L E + ++K+ HP ++
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFL--AEAQIMKKLR-HPKLI 64
Query: 65 KLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
+L + + +Y V E M L L + ++ + Q+ G+ Y+ Q Y
Sbjct: 65 QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124
Query: 123 FHRDLISKNLLVSNDTI-KIADFGLA--WEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
HRDL ++N+LV + I K+ADFGLA + D +++ APE L + +++
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN-RFSI 183
Query: 180 KVDMWALGLIMAELITFHPL-FPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
K D+W+ G+++ E++T+ + +PG + L ++ GY+
Sbjct: 184 KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV--------------------DQGYRM 223
Query: 239 PKLQGNNLSLLIPSANDDEMSLIELLCSW--DPCKRPTAAEALQHPL 283
P P E+ I L C W DP RPT E LQ L
Sbjct: 224 PC----------PPGCPKELYDIMLDC-WKEDPDDRPT-FETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-20
Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQ 67
++IG+G+FG V++ + K + E VA+K + + + L+E + L++ + HPNIVKL
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLI 58
Query: 68 ELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRD 126
+ + +Y V E + +L + +K + ++ G+ Y+ + HRD
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 127 LISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITT-------LQYRAPEMLLMSGQYN 178
L ++N LV N+ +KI+DFG++ E + Y + +++ APE L G+Y
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEG----GIYTVSDGLKQIPIKWTAPEA-LNYGRYT 173
Query: 179 SKVDMWALGLIMAELITF 196
S+ D+W+ G+++ E +
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 13/217 (5%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---ECLNLKEVKCLRKINNH 60
+ + +G+GSFGKV A +K + E AIK LK+ + + EC + E + L
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC-TMVEKRVLALSGKP 60
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQC--FSEAEVKNWCFQILQGLNYMH 118
P + +L RLYFV EY+ N LM +Q F E + +I GL ++H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYV--NGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 119 RQGYFHRDLISKNLLV-SNDTIKIADFGLAWE--VDSCPPYTEYITTLQYRAPEMLLMSG 175
+G +RDL N+++ S IKIADFG+ E D T + T Y APE++
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPEIIAYQ- 176
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKI 212
Y VD WA G+++ E++ F G ED+ I
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-20
Identities = 81/287 (28%), Positives = 138/287 (48%), Gaps = 35/287 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+KYT ++IG+G+ G V+ AI +G+ VAIK + + +E L + E+ ++++ N P
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE-LIINEILVMKELKN-P 76
Query: 62 NIVKLQELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV + L+ V EY+ +L +++ + C EA++ C + LQ L ++H
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHAN 134
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVD-SCPPYTEYITTLQYRAPEMLLMSGQYN 178
HRD+ S N+L+ D ++K+ DFG ++ + + T + APE++ Y
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YG 193
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
KVD+W+LG++ E++ P + E+ L L +G
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPY-------------------LNENPLRALYLIATNGT-- 232
Query: 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
P+LQ N L P D +E+ D KR +A E LQHP +
Sbjct: 233 PELQ--NPEKLSPIFRDFLNRCLEM----DVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-20
Identities = 62/205 (30%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNH 60
E + ++ ++G+G+FGKV++A K++G A K ++ + S EE + + E++ L N H
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCN-H 68
Query: 61 PNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
P IVKL + +L+ + E+ + +M + +E +++ C Q+L+ L Y+H
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGL-AWEVDSCPPYTEYITTLQYRAPEMLLMS--- 174
HRDL + N+L++ D IK+ADFG+ A V + +I T + APE+++
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 175 -GQYNSKVDMWALGLIMAELITFHP 198
Y+ K D+W+LG+ + E+ P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-20
Identities = 64/211 (30%), Positives = 112/211 (53%), Gaps = 20/211 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L+K++G G FG+VW + VAIK+LKQ S E L E ++++ HP
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFL--AEANLMKQLQ-HP 61
Query: 62 NIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+V+L + ++ +Y + EYM+ + L + + ++ + QI +G+ ++ R
Sbjct: 62 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITT------LQYRAPEMLL 172
+ Y HRDL + N+LVS KIADFGLA ++ EY +++ APE +
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIED----NEYTAREGAKFPIKWTAPEA-I 175
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPL-FPG 202
G + K D+W+ G+++ E++T+ + +PG
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-20
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L+K++G G FG+VW + + VA+K LK S E L +E + ++K+ H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFL--EEAQIMKKLR-HD 61
Query: 62 NIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+V+L + SE +Y V EYM L L + + + Q+ G+ Y+ R
Sbjct: 62 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 120 QGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYIT------TLQYRAPEMLL 172
Y HRDL S N+LV + + KIADFGLA ++ EY +++ APE L
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIED----NEYTARQGAKFPIKWTAPEAAL 176
Query: 173 MSGQYNSKVDMWALGLIMAELIT 195
G++ K D+W+ G+++ EL+T
Sbjct: 177 Y-GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 68/227 (29%), Positives = 117/227 (51%), Gaps = 23/227 (10%)
Query: 7 MKQIGEGSFGKVW---QAIKKQSGEYVAIKALKQ-------RIYSWEECLNLKEVKCLRK 56
+K +G+GSFGKV+ + +G+ A+K LK+ R+ + E L EV
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV----- 55
Query: 57 INNHPNIVKLQELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
NHP IVKL +LY + +++ +L +S ++ F+E +VK + ++ L+
Sbjct: 56 --NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLAELALALD 112
Query: 116 YMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLM 173
++H G +RDL +N+L+ + IK+ DFGL+ E +D + T++Y APE++
Sbjct: 113 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNA-IGSP 219
G S D W+ G++M E++T F G + + I A +G P
Sbjct: 173 RGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVK-------CLRKINNH 60
K IG+GSFGKV A +K G+ A+K L+++I LN KE K L K H
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI-----VLNRKEQKHIMAERNVLLKNVKH 55
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
P +V L +LYFV ++++ R++ F E + + +I L Y+H
Sbjct: 56 PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 121 GYFHRDLISKNLLV-SNDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYN 178
+RDL +N+L+ S + + DFGL E + T + T +Y APE ++ Y+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPE-VIRKQPYD 174
Query: 179 SKVDMWALGLIMAELITFHPLF 200
+ VD W LG ++ E++ P F
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 7/192 (3%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVK 65
K +G+G+FGKV +K +G Y A+K LK+ + E L E + L+ + HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 59
Query: 66 LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH-RQGYFH 124
L+ + RL FV EY + +R++ FSE + + +I+ L+Y+H + +
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 125 RDLISKNLLVSNDT-IKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVD 182
RDL +NL++ D IKI DFGL E + + T +Y APE +L Y VD
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 178
Query: 183 MWALGLIMAELI 194
W LG++M E++
Sbjct: 179 WWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 62/205 (30%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNH 60
E + ++ ++G+G+FGKV++A K++G A K + + S EE + + E+ L + H
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCD-H 61
Query: 61 PNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
PNIVKL + L+ + E+ + +M ++ +E +++ C Q L+ LNY+H
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGL-AWEVDSCPPYTEYITTLQYRAPEMLLMSGQ- 176
HRDL + N+L + D IK+ADFG+ A + +I T + APE+++
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 177 ---YNSKVDMWALGLIMAELITFHP 198
Y+ K D+W+LG+ + E+ P
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 5/197 (2%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQR--IYSWEECLNLKEVKCLRKINNHPNIVK 65
K IG+GSFGKV A K ++ A+K L+++ + EE + E L K HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 66 LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
L +LYFV +Y++ R++CF E + + +I L Y+H +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 126 DLISKNLLV-SNDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
DL +N+L+ S I + DFGL E ++ + + T +Y APE +L Y+ VD
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE-VLHKQPYDRTVDW 179
Query: 184 WALGLIMAELITFHPLF 200
W LG ++ E++ P F
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 18/199 (9%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNHPNIVKLQE 68
+G G FG+V +K +G+ A+K +K+ + +E ++ +E + + I+N P I +LQ
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 69 LASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDL 127
+ LY V EY +L L++ + F E + + +++ ++ +H+ GY HRD+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDI 128
Query: 128 ISKNLLVSN-DTIKIADFGLAWE------VDSCPPYTEYITTLQYRAPEML-LMSG---- 175
+N+L+ IK+ADFG A V+S P + T Y APE+L M+G
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP----VGTPDYIAPEVLTTMNGDGKG 184
Query: 176 QYNSKVDMWALGLIMAELI 194
Y + D W+LG+I E+I
Sbjct: 185 TYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 54/200 (27%), Positives = 103/200 (51%), Gaps = 7/200 (3%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH--P 61
Y ++ IG G++G V++ +G VA+K + + +EV L ++ P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NI K + RL+ + EY + ++ LM + +E + ++L L Y+H+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCP-PYTEYITTLQYRAPEMLLMSGQYN 178
G HRD+ + N+LV+N +K+ DFG+A ++ + ++ T + APE++ Y+
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180
Query: 179 SKVDMWALGLIMAELITFHP 198
+K D+W+LG+ + E+ T +P
Sbjct: 181 TKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-19
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 7/205 (3%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---ECLNLKEVKCLRKINNHPNIV 64
K +G+GSFGKV A K GEY A+KALK+ + + EC + E + L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVEC-TMVEKRVLALAWENPFLT 59
Query: 65 KLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
L L+FV E+++ K F + +I+ GL ++H +G +
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 125 RDLISKNLLVSND-TIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVD 182
RDL N+++ D IKIADFG+ E V + + T Y APE+L +Y VD
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ-GLKYTFSVD 178
Query: 183 MWALGLIMAELITFHPLFPGTCEDD 207
W+ G+++ E++ F G ED+
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-19
Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 16/203 (7%)
Query: 7 MKQIGEGSFGKV----WQAIKKQSGEYVAIKALKQRIYSWEECLNL-KEVKCLRKINNHP 61
++ +GEG FGKV + +GE VA+K+LK +L KE++ LR + H
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLY-HE 66
Query: 62 NIVKLQELASENY--RLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
NIVK + + +E+ + + E++ +L + + K + + + QI +G++Y+
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQ----YRAPEMLLM 173
+ Y HRDL ++N+LV ++ +KI DFGL +++ Y L + APE L+
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 174 SGQYNSKVDMWALGLIMAELITF 196
S Y + D+W+ G+ + EL+T+
Sbjct: 187 SKFYIAS-DVWSFGVTLYELLTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-19
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEY---VAIKALKQRIYSWEECLN--LKEVKCLRKINNHPN 62
K++G+GSFG V + SG VA+K LK S + ++ LKE + ++ H N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLD-HEN 57
Query: 63 IVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
+++L + + L V E L +L + F + + ++ QI G+ Y+ +
Sbjct: 58 LIRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 121 GYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEMLLM 173
+ HRDL ++N+L+ S+D +KI DFGL + + Y+ + APE L
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAWCAPES-LR 173
Query: 174 SGQYNSKVDMWALGLIMAELITF 196
+ ++ D+W G+ + E+ T+
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTY 196
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 80/300 (26%), Positives = 142/300 (47%), Gaps = 47/300 (15%)
Query: 4 YTLMKQIGEGSFGKVWQAIK---KQSGEYVAIKALK-----QRIYSWEECLNLKEVKCLR 55
+ L+K +G G++GKV+ K SG+ A+K LK Q+ + E ++V L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV--LE 59
Query: 56 KINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
I P +V L + +L+ + +Y++ L +S R++ F E EV+ + +I+ L
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLAL 118
Query: 115 NYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWE--VDSCPPYTEYITTLQYRAPEML 171
++H+ G +RD+ +N+L+ SN + + DFGL+ E D + T++Y AP+++
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 172 L-MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
G ++ VD W++G++M EL+T P T + + + S AE
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGAS--PFTVDGE-------------KNSQAEISRR 223
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR----PTAAEAL-QHPLFQ 285
+P+ A D +I+ L DP KR P+ A+ + +HP FQ
Sbjct: 224 ILKSEPPYPQEMS-------ALAKD----IIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-18
Identities = 82/324 (25%), Positives = 144/324 (44%), Gaps = 52/324 (16%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E +T +++IG+GSFG+V++ I ++ + VAIK + E +E+ L + ++ P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-P 62
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+ K ++ +L+ + EY+ L E ++ +IL+GL+Y+H +
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGG-SALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 122 YFHRDLISKNLLVS-NDTIKIADFGLAWEV-DSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
HRD+ + N+L+S + +K+ADFG+A ++ D+ ++ T + APE++ S Y+S
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDS 180
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
K D+W+LG+ EL A G P L P
Sbjct: 181 KADIWSLGITAIEL---------------------AKGEPPHSELHPMKVLFLIPKNNPP 219
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCK 299
L+GN L +E + +P RPTA E L+H
Sbjct: 220 TLEGNYSKPL--------KEFVEACLNKEPSFRPTAKELLKHKF---------------- 255
Query: 300 MRLTPSAKKSGWKAKLIVWFLRWE 323
+ AKK+ + +LI + RW+
Sbjct: 256 --IVRFAKKTSYLTELIDRYKRWK 277
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 63/222 (28%), Positives = 111/222 (50%), Gaps = 28/222 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQA-------IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCL 54
+K TL K +GEG FG+V A K + VA+K LK + + E++ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRK---------------QCF 98
+ I H NI+ L +++ LY + EY NL + + R+ +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 99 SEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157
+ ++ + +Q+ +G+ Y+ Q HRDL ++N+LV+ N+ +KIADFGLA +V++ Y
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYK 194
Query: 158 EYIT---TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ +++ APE L Y + D+W+ G++M E+ T
Sbjct: 195 KTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 8/203 (3%)
Query: 7 MKQIGEGSFGKVWQAIK---KQSGEYVAIKALKQR--IYSWEECLNLKEVKCLRKINNHP 61
+K +G+G +GKV+Q K +G+ A+K LK+ + + ++ + K + + + HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
IV L +LY + EY+ + R+ F E + +I L ++H+QG
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 122 YFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTE-YITTLQYRAPEMLLMSGQYNS 179
+RDL +N LL + +K+ DFGL E T + T++Y APE+L+ SG +
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG-HGK 179
Query: 180 KVDMWALGLIMAELITFHPLFPG 202
VD W+LG +M +++T P F
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 57/189 (30%), Positives = 95/189 (50%), Gaps = 5/189 (2%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL--KEVKCLRKINNHPNIVKLQ 67
IG GS+ KV K++ A+K +K+ + + +E ++ E + +NHP +V L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 68 ELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDL 127
RL+FV EY++ R++ E + + +I LNY+H +G +RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 128 ISKNLLV-SNDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWA 185
N+L+ S IK+ D+G+ E + + + T Y APE +L Y VD WA
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWA 181
Query: 186 LGLIMAELI 194
LG++M E++
Sbjct: 182 LGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 61/219 (27%), Positives = 113/219 (51%), Gaps = 19/219 (8%)
Query: 8 KQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
K +G G+FGKV +A K + VA+K LK +S E + E+K + + NH N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 63 IVKLQELASENYRLYFVFEYMDCN----LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
IV L + + + EY C L+ L R+ + ++ ++ +Q+ +G+ ++
Sbjct: 101 IVNLLGACTIGGPILVITEY--CCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 119 RQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYITT---LQYRAPEMLLMS 174
+ HRDL ++N+L+++ I KI DFGLA ++ + Y +++ APE + +
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF-N 217
Query: 175 GQYNSKVDMWALGLIMAELITF--HPLFPGTCEDDQLYK 211
Y + D+W+ G+++ E+ + +P +PG D + YK
Sbjct: 218 CVYTFESDVWSYGILLWEIFSLGSNP-YPGMPVDSKFYK 255
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-18
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L ++G+G FG+VW + VAIK LK S E L +E + ++K+ H
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL--QEAQVMKKLR-HE 61
Query: 62 NIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+V+L + SE +Y V EYM L L + ++ + QI G+ Y+ R
Sbjct: 62 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 120 QGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYIT------TLQYRAPEMLL 172
Y HRDL + N+LV + + K+ADFGLA ++ EY +++ APE L
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIED----NEYTARQGAKFPIKWTAPEAAL 176
Query: 173 MSGQYNSKVDMWALGLIMAELIT 195
G++ K D+W+ G+++ EL T
Sbjct: 177 Y-GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 59/202 (29%), Positives = 107/202 (52%), Gaps = 13/202 (6%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEY---VAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
T K IG G FG+V++ I K G VAIK LK + L E + + ++H
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH- 66
Query: 62 NIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NI++L+ + ++ + EYM+ L + + + FS ++ I G+ Y+
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 121 GYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYITT-----LQYRAPEMLLMS 174
Y HRDL ++N+LV+++ K++DFGL+ ++ P T Y T+ +++ APE +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT-YTTSGGKIPIRWTAPEAIAYR 185
Query: 175 GQYNSKVDMWALGLIMAELITF 196
++ S D+W+ G++M E+++F
Sbjct: 186 -KFTSASDVWSFGIVMWEVMSF 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 73/295 (24%), Positives = 124/295 (42%), Gaps = 73/295 (24%)
Query: 8 KQIGEGSFGKVWQAI---KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64
K++G G+FG V + + K VA+K LKQ + + L+E + +++ HP IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIV 59
Query: 65 KL------------QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQ 112
+L ELA L + + R + +++K Q+
Sbjct: 60 RLIGVCKGEPLMLVMELAPLG------------PLLKYLKKR-REIPVSDLKELAHQVAM 106
Query: 113 GLNYMHRQGYFHRDLISKN-LLVSNDTIKIADFGL--AWEVDSCPPYTEYITT------L 163
G+ Y+ + + HRDL ++N LLV+ KI+DFG+ A S Y T L
Sbjct: 107 GMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS----DYYRATTAGRWPL 162
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES 223
++ APE + G+++SK D+W+ G+ + E ++ + Y E
Sbjct: 163 KWYAPECINY-GKFSSKSDVWSYGVTLWEAFSY---------GAKPYG---------EMK 203
Query: 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC-SWDPCKRPTAAE 277
AE + + + G + P+ P E+ I L C + P RPT +E
Sbjct: 204 GAEVIAMLE-SGERLPR----------PEECPQEIYSIMLSCWKYRPEDRPTFSE 247
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 3e-18
Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQ-RIYSWEECLN-LKEVKCLRKINNHPNIVKLQ 67
IG+GSFGKV Q K+ + A+K +++ I S E + L E L ++N P IV L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC-PFIVPLK 59
Query: 68 ELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
+LY V +++ H L R+ F + + + ++L L +H+ +R
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 126 DLISKNLLVS-NDTIKIADFGLA-WEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
DL +N+L+ I + DFGL + + T +Y APE+LL G Y VD
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDW 176
Query: 184 WALGLIMAELITFHPLF 200
W LG+++ E++T P F
Sbjct: 177 WTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-18
Identities = 62/199 (31%), Positives = 110/199 (55%), Gaps = 13/199 (6%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
++K TL + IGEG FG V Q + +G+ VA+K +K + + L+E + K++ H
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQA---FLEETAVMTKLH-H 58
Query: 61 PNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMH 118
N+V+L + N LY V E M NL + R + S ++ + + +G+ Y+
Sbjct: 59 KNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 119 RQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
+ HRDL ++N+LVS D + K++DFGLA V S + +++ APE L ++
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLA-RVGSMGVDNSKL-PVKWTAPEA-LKHKKF 174
Query: 178 NSKVDMWALGLIMAELITF 196
+SK D+W+ G+++ E+ ++
Sbjct: 175 SSKSDVWSYGVLLWEVFSY 193
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 80/322 (24%), Positives = 128/322 (39%), Gaps = 73/322 (22%)
Query: 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKI---NNHPN 62
+K +G+G G+V+ K +G+ A+K L ++ + +K V ++I +HP
Sbjct: 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKK--EMIKRNKVKRVLTEQEILATLDHPF 62
Query: 63 IVKL-QELASENYRLYFVFEY-MDCNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHR 119
+ L +E Y L V +Y L +L+ + +C SE + + ++L L Y+H
Sbjct: 63 LPTLYASFQTETY-LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 120 QGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYIT----------------- 161
G +RDL +N+L+ I ++DF L+ + D PP
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 162 -------------TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ 208
T +Y APE++ G + S VD W LG+++ E++ F G+ D+
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240
Query: 209 LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWD 268
I L K FP + S LI L D
Sbjct: 241 FSNI-----------------LKKE--VTFPGSPPVSSSA---------RDLIRKLLVKD 272
Query: 269 PCKR----PTAAEALQHPLFQG 286
P KR AAE QHP F+G
Sbjct: 273 PSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEY----VAIKALKQRI--YSWEECLNLKEVKCLRKINNHP 61
K +G G+FG V++ + GE VAIK L++ + +E L+ E + ++ HP
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD--EAYVMASVD-HP 69
Query: 62 NIVKLQELA-SENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
++V+L + S +L + C L + +++ S+ + NWC QI +G++Y+ +
Sbjct: 70 HVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY-LLNWCVQIAKGMSYLEEK 128
Query: 121 GYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITT-----LQYRAPEMLLMS 174
HRDL ++N+LV + +KI DFGLA +D EY +++ A E +L
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALESILH- 185
Query: 175 GQYNSKVDMWALGLIMAELITF 196
Y K D+W+ G+ + EL+TF
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 44/287 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-----LKEVKCLRK 56
E +T +++IG+GSFG+V++ I ++ E VAIK I EE + +E+ L +
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIK-----IIDLEEAEDEIEDIQQEITVLSQ 58
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
++ P I + + +L+ + EY+ L + E + +IL+GL+Y
Sbjct: 59 CDS-PYITRYYGSYLKGTKLWIIMEYLGGG-SALDLLKPGPLEETYIATILREILKGLDY 116
Query: 117 MHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEV-DSCPPYTEYITTLQYRAPEMLLMS 174
+H + HRD+ + N+L+S +K+ADFG+A ++ D+ ++ T + APE++ S
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
Y+ K D+W+LG+ EL P L+ I SP
Sbjct: 177 A-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--NSP--------------- 218
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
P L+G + +E + DP RPTA E L+H
Sbjct: 219 ----PTLEGQY--------SKPFKEFVEACLNKDPRFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 93/331 (28%), Positives = 140/331 (42%), Gaps = 86/331 (25%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKI---NNHPNI 63
+K IG G+FG+V KK +G A+K L++ +E + V+ R I ++P +
Sbjct: 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKE--QVAHVRAERDILAEADNPWV 63
Query: 64 VKLQELASENYRLYFVFEYM---DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
VKL + LY + EY+ D + LM +K F+E E + + + + ++ +H+
Sbjct: 64 VKLYYSFQDENYLYLIMEYLPGGDM-MTLLM--KKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 121 GYFHRDLISKNLLVSNDT-IKIADFGL----------------------AWEVDSCPPYT 157
GY HRD+ NLL+ IK++DFGL + P +
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 158 E---------------YIT--TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLF 200
Y T T Y APE+ L +G YN + D W+LG+IM E++ +P F
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPPF 239
Query: 201 PGTCEDD--QLY-KICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDE 257
C D+ + Y KI N W E L +FP LS P A D
Sbjct: 240 ---CSDNPQETYRKIIN---------WKETL--------QFP--DEVPLS---PEAKD-- 272
Query: 258 MSLIE-LLCSWDP-CKRPTAAEALQHPLFQG 286
LI+ L C + E HP F+G
Sbjct: 273 --LIKRLCCEAERRLGNNGVNEIKSHPFFKG 301
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 67/236 (28%), Positives = 109/236 (46%), Gaps = 42/236 (17%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQR-IYSWEECLNLKEVKCLRKINN 59
+ +Y ++K+IG G FG+V+ K++ E+ KA+ R + E+ + EV +R++
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-K 70
Query: 60 HPNIVKLQE--LASENYRLYFVFEYMDCNLHQLMSNRKQCF------SEAEVKNWCFQIL 111
H NIV+ + L N +LY + E+ C+ L N ++C+ E + + Q+L
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEF--CDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 112 QGLNYMHR-------QGYFHRDLISKNLLVSND------------------TIKIADFGL 146
L Y H + HRDL +N+ +S KI DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 147 AWEVDSCPPYTEYITTLQYRAPEMLLM-SGQYNSKVDMWALGLIMAELIT----FH 197
+ + + T Y +PE+LL + Y+ K DMWALG I+ EL + FH
Sbjct: 189 SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
|
Length = 1021 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 54/223 (24%), Positives = 109/223 (48%), Gaps = 31/223 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQA-IKKQSGEY----VAIKALKQR--IYSWEECLNLKEVKC 53
+ ++++GEG+FGKV++ + + VAIK LK+ +E ++
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE---FRQEAE 60
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNR---------------KQC 97
L HPNIV L + ++ +FEY+ +LH+ + K
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 98 FSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPY 156
++ + QI G+ Y+ + HRDL ++N LV T+KI+DFGL+ ++ S Y
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 157 ---TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
++ + +++ PE ++ G++ ++ D+W+ G+++ E+ ++
Sbjct: 181 RVQSKSLLPVRWMPPEA-ILYGKFTTESDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 33/220 (15%)
Query: 8 KQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
+ IG+G+FG+V+QA + + VA+K LK+ S + + + L +HPN
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPN 69
Query: 63 IVKLQELASENYRLYFVFEYM---DCN----------LHQLMSNRKQC---------FSE 100
IVKL + + + +FEYM D N L + S
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 101 AEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA---WEVDSCPPY 156
E Q+ G+ Y+ + + HRDL ++N LV + +KIADFGL+ + D
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+++ PE + + +Y ++ D+WA G+++ E+ ++
Sbjct: 190 ENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSY 228
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 62/227 (27%), Positives = 112/227 (49%), Gaps = 35/227 (15%)
Query: 3 KYTLMKQIGEGSFGKVWQA----IKKQSG-EYVAIKALKQRIYSWEECLNLKEVKCLRKI 57
L K +GEG FGKV +A +K ++G VA+K LK+ S E L E L+++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 58 NNHPNIVKLQELASENYRLYFVFEYM------------------------DCNLHQLMSN 93
N HP+++KL S++ L + EY + N L +
Sbjct: 61 N-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 94 RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLA---WE 149
++ + ++ ++ +QI +G+ Y+ HRDL ++N+LV+ KI+DFGL+ +E
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 150 VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
DS ++ +++ A E L Y ++ D+W+ G+++ E++T
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTL 225
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 10 IGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKL 66
IG G FG+V + K G+ +VAIK LK + L E + + + HPNI+ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHL 70
Query: 67 QELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
+ + +++ + + E+M+ L + F+ ++ I G+ Y+ Y HR
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHR 130
Query: 126 DLISKNLLV-SNDTIKIADFGLA---WEVDSCPPYTEYI---TTLQYRAPEMLLMSGQYN 178
DL ++N+LV SN K++DFGL+ + S P YT + +++ APE + ++
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFT 189
Query: 179 SKVDMWALGLIMAELITF 196
S D+W+ G++M E++++
Sbjct: 190 SASDVWSYGIVMWEVMSY 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 64/228 (28%), Positives = 111/228 (48%), Gaps = 29/228 (12%)
Query: 3 KYTLMKQIGEGSFGKVWQA----IKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLR 55
+ TL K +GEG FG+V A I K VA+K LK + + E++ ++
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72
Query: 56 KINNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRK---------------QCFS 99
I H NI+ L +++ LY + EY NL + + R+ + +
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 100 EAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTE 158
++ + +Q+ +G+ Y+ Q HRDL ++N+LV+ D + KIADFGLA +V + Y +
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 159 YIT---TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPL-FPG 202
+++ APE L Y + D+W+ G+++ E+ T +PG
Sbjct: 193 TTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 70/237 (29%), Positives = 115/237 (48%), Gaps = 20/237 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L ++G+G FG+VW + + VAIK LK E L +E + ++K+ H
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFL--QEAQIMKKLR-HD 61
Query: 62 NIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+V L + SE +Y V E+M L L + ++ + QI G+ Y+ R
Sbjct: 62 KLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 120 QGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYIT------TLQYRAPEMLL 172
Y HRDL + N+LV ++ + KIADFGLA ++ EY +++ APE L
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIED----NEYTARQGAKFPIKWTAPEAAL 176
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPL-FPGTCEDDQLYKICNAIGSPTEESWAEGL 228
G++ K D+W+ G+++ EL+T + +PG + L ++ P + E L
Sbjct: 177 Y-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESL 232
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 66/237 (27%), Positives = 116/237 (48%), Gaps = 20/237 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L K++G G FG+VW A + + VA+K +K S E L + K H
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFL---AEANVMKTLQHD 61
Query: 62 NIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+VKL + ++ +Y + E+M L L S+ ++ ++ QI +G+ ++ +
Sbjct: 62 KLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 120 QGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYIT------TLQYRAPEMLL 172
+ Y HRDL + N+LVS + KIADFGLA ++ EY +++ APE +
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEA-I 175
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPL-FPGTCEDDQLYKICNAIGSPTEESWAEGL 228
G + K D+W+ G+++ E++T+ + +PG + + + P E+ E L
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 80/306 (26%), Positives = 138/306 (45%), Gaps = 58/306 (18%)
Query: 4 YTLMKQIGEGSFGKVW---QAIKKQSGEYVAIKALK-----QRIYSWEECLNLKEVKCLR 55
+ L+K +G G++GKV+ + +G+ A+K L+ Q+ + E + V L
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV--LE 59
Query: 56 KINNHPNIVKLQELASENYRLYFVFEY-----MDCNLHQLMSNRKQCFSEAEVKNWCFQI 110
+ P +V L +L+ + +Y M +L+Q + FSE EV+ + +I
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEI 114
Query: 111 LQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEY--ITTLQYRA 167
+ L ++H+ G +RD+ +N+L+ ++ + + DFGL+ E S Y T++Y A
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI--GSPTEESWA 225
PE++ G + VD W+LG+++ EL+T F E + ++ I P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP----- 229
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR----PTAAEALQ- 280
FP S + P A D L +LL DP KR P A ++
Sbjct: 230 ------------FP-------SFIGPEAQD---LLHKLLRK-DPKKRLGAGPQGASEIKE 266
Query: 281 HPLFQG 286
HP F+G
Sbjct: 267 HPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 54/189 (28%), Positives = 93/189 (49%), Gaps = 5/189 (2%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL--KEVKCLRKINNHPNIVKLQ 67
IG GS+ KV K++ A+K +K+ + + +E ++ E +NHP +V L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 68 ELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDL 127
RL+FV E++ R++ E + + +I LN++H +G +RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 128 ISKNLLVSNDT-IKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWA 185
N+L+ + IK+ D+G+ E + + + T Y APE +L Y VD WA
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWA 181
Query: 186 LGLIMAELI 194
LG++M E++
Sbjct: 182 LGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 60/227 (26%), Positives = 109/227 (48%), Gaps = 26/227 (11%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGE-----YVAIKALKQRIYSWEECLNL---KEVKCLRKIN 58
+ +G G FG+V+ A K E V +KAL++ +E L +E+ RK++
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLS 66
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLM--------SNRKQCFSEAEVKNWCFQ 109
H N+V+L L E Y + EY D +L Q + + S + C Q
Sbjct: 67 -HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEV--DSCPPYTEYITTLQYR 166
I G++++ + HRDL ++N LVS+ +K++ L+ +V + L++
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185
Query: 167 APEMLLMSGQYNSKVDMWALGLIMAELITFHPL-FPGTCEDDQLYKI 212
APE + +++K D+W+ G++M E+ T L F G +++ L ++
Sbjct: 186 APEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-17
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 28/207 (13%)
Query: 7 MKQIGEGSFGKV----WQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
++ +GEG FGKV + +GE VA+K LK+ KE+ L+ + H N
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HEN 67
Query: 63 IVKLQELASE--NYRLYFVFEYMDCNLHQLMSNR----KQCFSEAEVKNWCFQILQGLNY 116
IVK + SE L + EY+ L S R K + A++ + QI +G+ Y
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYV-----PLGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 117 MHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQ-------YRAP 168
+H Q Y HRDL ++N+L+ ND +KI DFGLA V P EY + + A
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFWYAV 179
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELIT 195
E L +++ D+W+ G+ + EL+T
Sbjct: 180 E-CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 9e-17
Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 8/206 (3%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWE-ECLNLKEVKCLRKINNH--PNIVK 65
IG G FG+V+ K +G+ A+K L K+RI + E L L E L ++ P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 66 LQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
+ +L F+ + M+ +LH +S + FSEAE++ + +I+ GL +MH + +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 125 RDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
RDL N+L+ + ++I+D GLA + P+ + T Y APE+L Y+S D
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADW 179
Query: 184 WALGLIMAELITFHPLFPGTCEDDQL 209
++LG ++ +L+ H F D+
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQA----IKKQSGEY---VAIKALKQRIYSWEECLNLKEVKCL 54
++ L K +GEG FG+V +A I K + VA+K LK + + E++ +
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYM-DCNLHQLMSNRK---------------QCF 98
+ I H NI+ L + ++ LY + EY NL + + R+ +
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 99 SEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYT 157
S ++ + +Q+ +G+ Y+ + HRDL ++N+LV+ D + KIADFGLA V Y
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 158 EYIT---TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ +++ APE L Y + D+W+ G++M E+ T
Sbjct: 192 KTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 61/226 (26%), Positives = 109/226 (48%), Gaps = 16/226 (7%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK----QRIYSWEECLNLKEVKCLRK 56
+ + + K+IG G F +V++A G VA+K ++ + +C+ KE+ L++
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQ 58
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSN---RKQCFSEAEVKNWCFQILQ 112
+N HPN++K E+ L V E D +L +++ + +K+ E V + Q+
Sbjct: 59 LN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 113 GLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEM 170
L +MH + HRD+ N+ ++ +K+ D GL S + T Y +PE
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216
+ +G YN K D+W+LG ++ E+ F G + LY +C I
Sbjct: 178 IHENG-YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-16
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 8 KQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64
K IG G FG+V K G+ VAIK LK + L E + + + HPNI+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNII 68
Query: 65 KLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYF 123
L+ + +++ + V EYM+ +L + F+ ++ I G+ Y+ GY
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128
Query: 124 HRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITT-----LQYRAPEMLLMSGQY 177
HRDL ++N+LV SN K++DFGL+ V P Y T +++ APE + ++
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLS-RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KF 186
Query: 178 NSKVDMWALGLIMAELITF 196
S D+W+ G++M E++++
Sbjct: 187 TSASDVWSYGIVMWEVMSY 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M++ L++ IG+G FG V + G VA+K +K + + LR H
Sbjct: 5 MKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLR----H 58
Query: 61 PNIVKL-QELASENYRLYFVFEYM--DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
N+V+L + E LY V EYM + L S + + + + + + Y+
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 118 HRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
+ HRDL ++N+LVS D + K++DFGL E S + +++ APE L +
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEA-LREKK 175
Query: 177 YNSKVDMWALGLIMAELITF 196
+++K D+W+ G+++ E+ +F
Sbjct: 176 FSTKSDVWSFGILLWEIYSF 195
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 62/221 (28%), Positives = 111/221 (50%), Gaps = 32/221 (14%)
Query: 6 LMKQIGEGSFGKV--------WQAIKKQSGEY------VAIKALKQRIYSWEECLNLKEV 51
L +++GEG FG+V + + + + E+ VA+K L+ + LKE+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 52 KCLRKINNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRK-----------QCFS 99
K + ++ +PNI++L + + L + EYM+ +L+Q +S R+ S
Sbjct: 69 KIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 100 EAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT- 157
A + QI G+ Y+ + HRDL ++N LV N TIKIADFG++ + S Y
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187
Query: 158 --EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ +++ A E +L+ G++ + D+WA G+ + E+ T
Sbjct: 188 QGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTL 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 58/217 (26%), Positives = 108/217 (49%), Gaps = 23/217 (10%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
+ L++ +G G++G+V++ ++G+ AIK + + EE E+ L+K ++H NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKKYSHHRNI 75
Query: 64 VKL------QELASENYRLYFVFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLN 115
+ + +L+ V E+ ++ L+ N K E + C +IL+GL
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 116 YMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVD-SCPPYTEYITTLQYRAPEMLLM 173
++H HRD+ +N LL N +K+ DFG++ ++D + +I T + APE++
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 174 S----GQYNSKVDMWALGLI---MAE----LITFHPL 199
Y+ + D+W+LG+ MAE L HP+
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 10/202 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-KKQSGEY--VAIKALKQRIYSWEECLNLKEVKCLRKIN 58
E TL + IGEG FG V+Q + E VA+K K L+E +R+ +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 59 NHPNIVKLQELASENYRLYFVFE-YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HP+IVKL + +EN ++ V E L + K A + + +Q+ L Y+
Sbjct: 66 -HPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTL--QYRAPEMLLMS 174
+ + HRD+ ++N+LV S D +K+ DFGL+ ++ Y L ++ APE +
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 175 GQYNSKVDMWALGLIMAELITF 196
++ S D+W G+ M E++
Sbjct: 184 -RFTSASDVWMFGVCMWEILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 58/208 (27%), Positives = 113/208 (54%), Gaps = 22/208 (10%)
Query: 4 YTLMKQIGEGSFGKVWQAIK---KQSGEYVAIKALK-----QRIYSWEECLNLKEVKCLR 55
+ L++ +G G++GKV+ K +G+ A+K LK Q+ + E ++V L
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV--LE 59
Query: 56 KINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSN--RKQCFSEAEVKNWCFQILQG 113
+ P +V L + +L+ + +Y+ N +L ++ +++ F+E+EV+ + +I+
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYV--NGGELFTHLYQREHFTESEVRVYIAEIVLA 117
Query: 114 LNYMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTE----YITTLQYRAP 168
L+++H+ G +RD+ +N LL S + + DFGL+ E E + T++Y AP
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF--LAEEEERAYSFCGTIEYMAP 175
Query: 169 EMLLM-SGQYNSKVDMWALGLIMAELIT 195
E++ SG ++ VD W+LG++ EL+T
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 69/285 (24%), Positives = 115/285 (40%), Gaps = 37/285 (12%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC---LRKINNHPNIV 64
K +G+G+FG+V+ +G +A+K + S E + ++C L K H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 65 KLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
+ ++ L EYM + +E + + QIL+G+ Y+H H
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 125 RDLISKNLLV-SNDTIKIADFGLAWEVDS-CPPYT---EYITTLQYRAPEMLLMSGQYNS 179
RD+ N+L S +K+ DFG + + + C T T + +PE++ G Y
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGR 186
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
K D+W++G + E++T P WAE E A A +K
Sbjct: 187 KADVWSVGCTVVEMLTEKP------------------------PWAE-FE-AMAAIFKIA 220
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
N L + D + + + KRP+A E L+H
Sbjct: 221 TQPTN--PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 59/222 (26%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQA-------IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCL 54
++ L K +GEG FG+V A K VA+K LK + + E++ +
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRK---------------QCF 98
+ I H NI+ L +++ LY + EY NL + + R+ +
Sbjct: 78 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 99 SEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYT 157
S ++ + +Q+ +G+ Y+ + HRDL ++N+LV+ D + KIADFGLA ++ Y
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 158 EYIT---TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ +++ APE L Y + D+W+ G+++ E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 82/339 (24%), Positives = 125/339 (36%), Gaps = 91/339 (26%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKE---VKCLRKI--- 57
+ +K IG G+FG+V K + A+K L++ + L + VK R I
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA-----DVLMRNQAAHVKAERDILAE 57
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQGLN 115
++ +VKL + LYFV +Y+ +MS R F E + + ++ +
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGG--DMMSLLIRLGIFEEDLARFYIAELTCAIE 115
Query: 116 YMHRQGYFHRDLISKNLLVSNDT-IKIADFGL---------------------------- 146
+H+ G+ HRD+ N+L+ D IK+ DFGL
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 147 -AWEVDSCPPYT---------------EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIM 190
E+D C + T Y APE+LL +G Y D W++G+I+
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL 234
Query: 191 AELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLI 250
E++ P F + K+ N W L P Q L
Sbjct: 235 YEMLVGQPPFLADTPAETQLKVIN---------WETTLH--------IPS-QAK----LS 272
Query: 251 PSANDDEMSLIELLCSWDPCKR---PTAAEALQHPLFQG 286
A+D LI LC R A E HP F+G
Sbjct: 273 REASD----LILRLCC-GAEDRLGKNGADEIKAHPFFKG 306
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 7 MKQIGEGSFGKV----WQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNH 60
++Q+G+G+FG V + ++ +GE VA+K L+ S E L +E++ L+ + H
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH---STAEHLRDFEREIEILKSLQ-H 64
Query: 61 PNIVKLQELASENYR--LYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
NIVK + + R L V EY+ +L + ++ ++ + QI +G+ Y+
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 118 HRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQ-------YRAPE 169
+ Y HRDL ++N+LV ++ +KI DFGL P EY + + APE
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLT---KVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITF 196
L S +++ D+W+ G+++ EL T+
Sbjct: 182 SLTES-KFSVASDVWSFGVVLYELFTY 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 40/287 (13%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQ 67
+G+G FG+V + +G+ A K L K+RI + E + L E + L K+N+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLA 66
Query: 68 ELASENYRLYFVFEYM---DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
L V M D H + + F E + +IL GL +HR+ +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFH-IYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 125 RDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
RDL +N+L+ + I+I+D GLA ++ + T+ Y APE +L + +Y D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPE-VLNNQRYTLSPDY 184
Query: 184 WALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQG 243
W LG ++ E+I F G E + EE LE + + KF
Sbjct: 185 WGLGCLIYEMIEGQSPFRGRKEKVK-----------REEVDRRVLETEEVYSAKF----- 228
Query: 244 NNLSLLIPSANDDEMSLIELLCSWDP-----CKRPTAAEALQHPLFQ 285
+++ S+ ++L + DP C+ A E +HP F+
Sbjct: 229 ----------SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 5e-16
Identities = 59/217 (27%), Positives = 111/217 (51%), Gaps = 23/217 (10%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
+ L++ +G G++G+V++ ++G+ AIK + + EE +E+ L+K ++H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQEINMLKKYSHHRNI 65
Query: 64 VKL------QELASENYRLYFVFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLN 115
+ + +L+ V E+ ++ L+ N K E + C +IL+GL+
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 116 YMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVD-SCPPYTEYITTLQYRAPEMLLM 173
++H+ HRD+ +N LL N +K+ DFG++ ++D + +I T + APE++
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 174 ----SGQYNSKVDMWALGLI---MAE----LITFHPL 199
Y+ K D+W+LG+ MAE L HP+
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-16
Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 8/197 (4%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWE-ECLNLKE--VKCLRKINNHPNIVK 65
IG G FG+V+ K +G+ A+K L K+RI + E L L E + L + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 66 LQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
+ +L F+ + M+ +LH +S + FSE E++ + +I+ GL +MH + +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 125 RDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
RDL N+L+ + ++I+D GLA + P+ + T Y APE+L Y+S D
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADW 179
Query: 184 WALGLIMAELITFHPLF 200
++LG ++ +L+ H F
Sbjct: 180 FSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 53/189 (28%), Positives = 95/189 (50%), Gaps = 5/189 (2%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL--KEVKCLRKINNHPNIVKLQ 67
IG GS+ KV K++ + A+K +K+ + +E ++ E + +++P +V L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 68 ELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDL 127
RL+ V EY++ R++ E + + +I LN++H +G +RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 128 ISKNLLVSNDT-IKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWA 185
N+L+ D IK+ D+G+ E + + + T Y APE +L +Y VD WA
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE-ILRGEEYGFSVDWWA 181
Query: 186 LGLIMAELI 194
LG++M E++
Sbjct: 182 LGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 20/228 (8%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY------SWEECLNLKEVKCL 54
+ + + K+IG G F +V++A + VA+K K +I+ + ++C+ KE+ L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALK--KVQIFEMMDAKARQDCV--KEIDLL 56
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLM---SNRKQCFSEAEVKNWCFQI 110
+++N HPN++K + E+ L V E D +L Q++ +K+ E V + Q+
Sbjct: 57 KQLN-HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 111 LQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITTLQYRAP 168
+ +MH + HRD+ N+ ++ +K+ D GL S + T Y +P
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216
E + +G YN K D+W+LG ++ E+ F G + L+ +C I
Sbjct: 176 ERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 40/287 (13%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQ 67
+G+G FG+V + +G+ A K L K+RI + E + L E + L K+N+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLA 66
Query: 68 ELASENYRLYFVFEYM---DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
L V M D H + + F E + +I GL +HR+ +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFH-IYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 125 RDLISKNLLVSN-DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
RDL +N+L+ + I+I+D GLA E+ + T+ Y APE ++ + +Y D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE-VVKNERYTFSPDW 184
Query: 184 WALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQG 243
W LG ++ E+I F E K+ EE E + + KF
Sbjct: 185 WGLGCLIYEMIEGKSPFRQRKE-----KV------KREEVERRVKEDQEEYSEKF----- 228
Query: 244 NNLSLLIPSANDDEMSLIELLCSWDP-----CKRPTAAEALQHPLFQ 285
++ S+ L + DP C+ A E HP F+
Sbjct: 229 ----------SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 65/262 (24%), Positives = 116/262 (44%), Gaps = 38/262 (14%)
Query: 50 EVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQ 109
E + LR+++ HP ++ L ++ V +L+ + R + A+V Q
Sbjct: 210 EARLLRRLS-HPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQ 268
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSC---PPYTEYITTLQY 165
+L ++Y+H +G HRD+ ++N+LV+ + I + DFG A P + T+
Sbjct: 269 LLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFH--PLFPGTCEDDQLYKICNAIGSPTEES 223
APE +L Y VD+W+ GL++ E H LF + D++ P +
Sbjct: 329 NAPE-VLAGDPYTPSVDIWSAGLVIFE-AAVHTASLFSASRGDER---------RPYDAQ 377
Query: 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPS--ANDD---------------EMSLIELLC- 265
+ A+ H +FP+ G+ L A + ++ + L+C
Sbjct: 378 ILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCR 437
Query: 266 --SWDPCKRPTAAEALQHPLFQ 285
++D +RP+AAE L+ PLFQ
Sbjct: 438 ALTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 57/190 (30%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLN-LKEVKCLRK--INNHPNIVK 65
IG+G+FG+V+Q KK + A+K L K+ I + +E + + E L + ++ P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 66 LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
L+ + LY V +YM ++ FSE K + +++ L ++H+ +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 126 DLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTE-YITTLQYRAPEMLLMSGQYNSKVDM 183
DL +N+L+ + I + DFGL+ + T + T +Y APE+LL Y VD
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180
Query: 184 WALGLIMAEL 193
W+LG+++ E+
Sbjct: 181 WSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 55/216 (25%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 6 LMKQIGEGSFGKVWQAIKKQSG----EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
M+++GE +FGK+++ G + VAIK LK I + ++ ++ L +HP
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD-INNPQQWGEFQQEASLMAELHHP 67
Query: 62 NIVKLQELASENYRLYFVFEYMD-CNLHQLMSNR----------------KQCFSEAEVK 104
NIV L + ++ + +FEY++ +LH+ + R K +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 105 NWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPY---TEYI 160
+ QI G+ Y+ + H+DL ++N+L+ +KI+D GL+ E+ S Y + +
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+++ PE + M G+++S D+W+ G+++ E+ +F
Sbjct: 188 LPIRWMPPEAI-MYGKFSSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-15
Identities = 64/245 (26%), Positives = 112/245 (45%), Gaps = 25/245 (10%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
+ +++ IG+G++GKV++ K+ G A+K L I +E + E L+ + NHPN+
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIE-AEYNILQSLPNHPNV 81
Query: 64 VKLQEL--ASENY---RLYFVFEYMDCN------LHQLMSNRKQCFSEAEVKNWCFQILQ 112
VK + ++ +L+ V E CN L + + Q EA + + L
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLEL--CNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCP-PYTEYITTLQYRAPEM 170
GL ++H HRD+ N+L++ + +K+ DFG++ ++ S + T + APE+
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199
Query: 171 LLMSGQYNS----KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPT---EES 223
+ QY+ + D+W+LG+ EL P L+KI PT E
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN-PPPTLLHPEK 258
Query: 224 WAEGL 228
W
Sbjct: 259 WCRSF 263
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
EK T+ +++G+GSFG V++ I K + VAIK + + E L E +++
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65
Query: 57 INNHPNIVKLQELASENYRLYFVFEYM-----DCNLHQLMSNRKQCFSEA-----EVKNW 106
N H ++V+L + S+ + E M L L + +A ++
Sbjct: 66 FNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA---WEVDSCPPYTEYITT 162
+I G+ Y++ + HRDL ++N +V+ D T+KI DFG+ +E D + +
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+++ +PE L G + + D+W+ G+++ E+ T
Sbjct: 185 VRWMSPES-LKDGVFTTYSDVWSFGVVLWEIATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVK-CLRKIN--NHPNI 63
+K +G G FG V + I G+ + I + I +E+ + + +H I
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 64 VKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
V+L + L V + +L + + + NWC QI +G+ Y+
Sbjct: 72 VRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 123 FHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPP------YTEYITTLQYRAPEMLLMSG 175
HR+L ++N+L+ +D+I +IADFG+A D P Y+E+ T +++ A E +L G
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVA---DLLYPDDKKYFYSEHKTPIKWMALESILF-G 186
Query: 176 QYNSKVDMWALGLIMAELITF 196
+Y + D+W+ G+ + E++++
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSY 207
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 82/320 (25%), Positives = 149/320 (46%), Gaps = 45/320 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQ-AIKKQSGEYVAIKALKQRIYSWEECLNL--KEVKCLRKI 57
+ + ++ + G+FGK++ A++ + E A + + +C L K VK +
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 58 N-------------NHPNIVKLQE-LASENYRLYFVFEYMDCNLHQLMSNRKQCFSEA-- 101
NH NI+K++E L SE Y + + D +L+ M + + +
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANT-YMITQKYDFDLYSFMYDEAFDWKDRPL 265
Query: 102 --EVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA--WEVDSCPPY 156
+ + Q+L + Y+H + HRD+ +N+ ++ D I + DFG A +E +
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFD 325
Query: 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT--FHPLFPGTCE-DDQLYKIC 213
++ T+ +PE+L G Y D+W+ GLI+ ++++ F P+ G + QL KI
Sbjct: 326 YGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384
Query: 214 NAIGSPTEE---------SWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELL 264
+++ EE + + E+ A G+ P L N L +P+ D E L+++L
Sbjct: 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHA-GHSVPPLIRN---LGLPA--DFEYPLVKML 438
Query: 265 CSWDPCKRPTAAEALQHPLF 284
++D RP AAE L PLF
Sbjct: 439 -TFDWHLRPGAAELLALPLF 457
|
Length = 501 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 36/220 (16%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQ--------RIYSWEECLNLKEVKC 53
E + ++K IG G+FG+V K S + A+K L + + WEE
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE--------- 93
Query: 54 LRKINNHPN---IVKLQELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQ 109
R I H N IV+L ++ LY V EYM +L LMSN E + + +
Sbjct: 94 -RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAE 150
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDS-----CPPYTEYITTL 163
++ L+ +H G+ HRD+ N+L+ + +K+ADFG ++D+ C + T
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC---DTAVGTP 207
Query: 164 QYRAPEMLL---MSGQYNSKVDMWALGLIMAELITFHPLF 200
Y +PE+L G Y + D W++G+ + E++ F
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 61/213 (28%), Positives = 111/213 (52%), Gaps = 25/213 (11%)
Query: 6 LMKQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
L +++GEG+FGKV+ A +Q VA+K LK + + + +E + L + H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-REAELLTNLQ-H 66
Query: 61 PNIVKLQELASENYRLYFVFEYMD-CNLHQLM------------SNRKQCFSEAEVKNWC 107
+IVK + E L VFEYM +L++ + NR +++++ +
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYT---EYITTL 163
QI G+ Y+ Q + HRDL ++N LV N +KI DFG++ +V S Y + +
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
++ PE +M ++ ++ D+W+LG+++ E+ T+
Sbjct: 187 RWMPPES-IMYRKFTTESDVWSLGVVLWEIFTY 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 5 TLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINN 59
TL++ +G G+FG+V++ + VA+K L + +E L E + K N
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN- 67
Query: 60 HPNIVKLQELASENYRLYFVFEYM----------DCNLHQLMSNRKQCFSEAEVKNWCFQ 109
H NIV+L ++ E + + E M + R + ++
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRP---ERPSSLTMKDLLFCARD 124
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCPPYTE---YITT 162
+ +G Y+ + HRD+ ++N L++ KIADFG+A ++ Y + +
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+++ PE L G + SK D+W+ G+++ E+ +
Sbjct: 185 IKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSL 217
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 51/187 (27%), Positives = 100/187 (53%), Gaps = 7/187 (3%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQEL 69
+G+G+FG+V++ K VA+K K+ + + L E + L++ + HPNIVKL +
Sbjct: 3 LGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIGV 60
Query: 70 ASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLI 128
++ +Y V E + + + +K ++ + G+ Y+ + HRDL
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA 120
Query: 129 SKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITT--LQYRAPEMLLMSGQYNSKVDMWA 185
++N LV N+ +KI+DFG++ + D + + +++ APE L G+Y+S+ D+W+
Sbjct: 121 ARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEA-LNYGRYSSESDVWS 179
Query: 186 LGLIMAE 192
G+++ E
Sbjct: 180 YGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 66/231 (28%), Positives = 95/231 (41%), Gaps = 36/231 (15%)
Query: 25 QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN------NHPNIVKL-QELASENYRLY 77
+G VAIK L R + EE + R+ HPNIV L + L+
Sbjct: 1 MTGHEVAIKLL--RTDAPEE---EHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLF 55
Query: 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN 136
VFEY+ L ++++ E Q+L L H QG HRDL +N++VS
Sbjct: 56 AVFEYVPGRTLREVLAA-DGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQ 114
Query: 137 DTI----KIADFGL--------AWEVDSCPPYTEYITTLQYRAPEMLLMSGQ-YNSKVDM 183
+ K+ DFG+ +V + TE + T Y APE L G+ D+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL--RGEPVTPNSDL 172
Query: 184 WALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES---WAEGLELA 231
+A GLI E +T + G + LY+ SP + S W G L
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAEILYQQL----SPVDVSLPPWIAGHPLG 219
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 54/209 (25%), Positives = 107/209 (51%), Gaps = 21/209 (10%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + +++ IG+G++GKV++ + K++G A+K L I+ +E + E L+ +++HP
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIE-AEYNILKALSDHP 75
Query: 62 NIVKL-----QELASENYRLYFVFEYMDCN------LHQLMSNRKQCFSEAEVKNWCFQI 110
N+VK ++ +L+ V E CN L + R + E + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLEL--CNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 111 LQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCP-PYTEYITTLQYRAP 168
L GL ++H HRD+ N+L++ + +K+ DFG++ ++ S + T + AP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 169 EMLLMSGQ----YNSKVDMWALGLIMAEL 193
E++ Q Y+++ D+W+LG+ EL
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 50/190 (26%), Positives = 99/190 (52%), Gaps = 7/190 (3%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQ 67
++IG G+FG+V+ + VA+K+ ++ + + L+E + L++ + HPNIV+L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLI 59
Query: 68 ELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRD 126
+ ++ +Y V E + + + E+ G+ Y+ + HRD
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119
Query: 127 LISKNLLVS-NDTIKIADFGLA-WEVDSCPPYTEYITTL--QYRAPEMLLMSGQYNSKVD 182
L ++N LV+ + +KI+DFG++ E D T + + ++ APE L G+Y+S+ D
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA-LNYGRYSSESD 178
Query: 183 MWALGLIMAE 192
+W+ G+++ E
Sbjct: 179 VWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 8e-14
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 32/212 (15%)
Query: 8 KQIGEGSFGKVWQ--AIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVK 65
+IG G FGKV A + S V +K L+ E+ L L+EV+ R++N HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQ 59
Query: 66 LQELASENYRLYFVFEYMDCNL----HQLMSNRKQCFSEAE---VKNWCFQILQGLNYMH 118
E+ V E+ C L + L SNR A+ ++ ++ GL ++H
Sbjct: 60 CLGQCIESIPYLLVLEF--CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTE-YITT-------LQYRAPE 169
+ + H DL +N ++ D ++KI D+GLA E Y E Y T L++ APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALE-----QYPEDYYITKDCHAVPLRWLAPE 172
Query: 170 ML------LMSGQYNSKVDMWALGLIMAELIT 195
++ L+ K ++W+LG+ M EL T
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-14
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYV--AIKALKQRIYSWEECLNLKEVKCLRKINN 59
E IGEG+FG+V +A+ K+ G + AIK LK+ + E++ L K+ +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 60 HPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRK---------------QCFSEAEV 103
HPNI+ L LY EY NL + + + ++
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 104 KNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYITT 162
+ + G+ Y+ + + HRDL ++N+LV + KIADFGL+ + T
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181
Query: 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+++ A E L S Y +K D+W+ G+++ E+++
Sbjct: 182 VRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSL 214
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 52/301 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRK---- 56
+KY + + +G G+ G V A + GE A+K + S + + EV CL
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFF 91
Query: 57 --INNHPNIVKLQELASENYRLY-FVFEYMDC-NLHQLMSNRKQC---FSEAEVKNWCFQ 109
+ H + K EN + V +Y + +L Q + +R + F E E Q
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 110 ILQGLNYMHRQGYFHRDLISKN-LLVSNDTIKIADFGL----AWEVDSCPPYTEYITTLQ 164
+L ++++H + HRD+ S N LL SN +K+ DFG A V T + T
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPY 210
Query: 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224
Y APE + Y+ K DM++LG+++ EL+T F G ++ ++K P
Sbjct: 211 YVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP----- 264
Query: 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLI--ELLCSWDPCKRPTAAEALQHP 282
+P + EM I LL S DP +RP++++ L P
Sbjct: 265 -------------------------LPPSISPEMQEIVTALLSS-DPKRRPSSSKLLNMP 298
Query: 283 L 283
+
Sbjct: 299 I 299
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQ--------RIYSWEECLNLKEVKC 53
E Y ++K IG G+FG+V K S + A+K L + + WEE +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE-------RD 95
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQ 112
+ N P +V+L ++ LY V EYM +L LMSN E K + +++
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVL 153
Query: 113 GLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPY--TEYITTLQYRAPE 169
L+ +H G HRD+ N+L+ +K+ADFG ++D + T Y +PE
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPE 213
Query: 170 MLLMS---GQYNSKVDMWALGLIMAELI 194
+L G Y + D W++G+ + E++
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQ--SGE---YVAIKALKQRIYSWEECLNLKEVKCLRK 56
EK TL++++G+GSFG V++ + GE VA+K + + E L E ++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAE------------VK 104
H ++V+L + S+ V E M L S + EAE +
Sbjct: 66 FTCH-HVVRLLGVVSKGQPTLVVMELMAHG--DLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 105 NWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA---WEVDSCPPYTEYI 160
+I G+ Y++ + + HRDL ++N +V++D T+KI DFG+ +E D + +
Sbjct: 123 QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+++ APE L G + + DMW+ G+++ E+ +
Sbjct: 183 LPVRWMAPES-LKDGVFTTSSDMWSFGVVLWEITSL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 5 TLMKQIGEGSFGKVW----------------QAIKKQSGEYVAIKALKQRIYSWEECLNL 48
T +++GEG FG+V + VA+K L++ L
Sbjct: 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 49 KEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNR----------KQC 97
KE+K + ++ + PNI++L + + L + EYM+ +L+Q +S
Sbjct: 68 KEIKIMSRLKD-PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126
Query: 98 FSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156
S + + QI G+ Y+ + HRDL ++N LV N TIKIADFG++ + S Y
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 157 T---EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ +++ + E +L+ G++ + D+WA G+ + E++T
Sbjct: 187 RIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTL 228
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 61/222 (27%), Positives = 110/222 (49%), Gaps = 30/222 (13%)
Query: 6 LMKQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
L +++GEG+FGKV+ A + VA+KALK + + +E + L + H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-REAELLTNLQ-H 66
Query: 61 PNIVKLQELASENYRLYFVFEYMD-CNLHQLM------------SNRKQCFSE---AEVK 104
+IVK + + L VFEYM +L++ + +Q E +++
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 105 NWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT---EYI 160
+ QI G+ Y+ Q + HRDL ++N LV + +KI DFG++ +V S Y +
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF--HPLF 200
+++ PE +M ++ ++ D+W+ G+I+ E+ T+ P F
Sbjct: 187 LPIRWMPPES-IMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 68/306 (22%), Positives = 125/306 (40%), Gaps = 28/306 (9%)
Query: 5 TLMKQIGEGSFGK--VWQAIKKQSGEYVAIKALKQRIYSWEECLNL-KEVKCLRKINNHP 61
L+ IG+ V A K + VA+K + S E+ L +E+ R++ HP
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HP 59
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHR 119
NI+ + LY V M + L+ + E + +L L+Y+H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS---------CPPYTEYITTLQYRAPE 169
+G+ HR + + ++L+S D + ++ + + P + L + +PE
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP-KSSVKNLPWLSPE 178
Query: 170 MLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY--KICNAIGSPTEESWA 225
+L + G YN K D++++G+ EL H F Q+ K+ + ++S
Sbjct: 179 VLQQNLQG-YNEKSDIYSVGITACELANGHVPFKDM-PATQMLLEKVRGTVPCLLDKSTY 236
Query: 226 EGLELAKAHGYKFPKLQGNNL-SLLIPSA---NDDEMSLIELLCSWDPCKRPTAAEALQH 281
E + + + NN S+ P ++ +EL DP RP+A++ L H
Sbjct: 237 PLYEDSMSQS-RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295
Query: 282 PLFQGC 287
F+ C
Sbjct: 296 SFFKQC 301
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEY----VAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
+K +G G+FG V++ I GE VAIK L++ L E + + + P
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PY 70
Query: 63 IVKLQELA-SENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+ +L + + +L C L + N+ + S+ ++ NWC QI +G++Y+
Sbjct: 71 VCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQ-DLLNWCVQIAKGMSYLEEVR 129
Query: 122 YFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEY-----ITTLQYRAPEMLLMSG 175
HRDL ++N+LV + +KI DFGLA +D TEY +++ A E +L
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILHR- 186
Query: 176 QYNSKVDMWALGLIMAELITF 196
++ + D+W+ G+ + EL+TF
Sbjct: 187 RFTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 59/253 (23%), Positives = 108/253 (42%), Gaps = 43/253 (16%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E + +K IG G+FG+V KK +G A+K L++ +E + ++ R I
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE--QVGHIRAERDILVEA 58
Query: 62 N---IVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
+ +VK+ + LY + E++ + +K +E E + + + + ++ +H
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH 118
Query: 119 RQGYFHRDLISKNLLV-SNDTIKIADFGL------------------------------- 146
+ G+ HRD+ NLL+ S +K++DFGL
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 147 -----AWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFP 201
W+ + + T Y APE+ + +G YN D W+LG+IM E++ +P F
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 202 GTCEDDQLYKICN 214
+ K+ N
Sbjct: 238 SETPQETYKKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 28/215 (13%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQ---SGEYVAIKALKQRIYS---WEECLNLKEVKCLRKI 57
+TL + +G+G FG V +A K S + VA+K LK I+S EE L +E C+++
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFL--REAACMKEF 58
Query: 58 NNHPNIVKL----------QELASENYRLYFVFEYMDCNLHQLMSNRKQ---CFSEAEVK 104
+ HPN++KL L L F+ ++ D + LMS + +
Sbjct: 59 D-HPNVIKLIGVSLRSRAKGRLPIPMVILPFM-KHGDLHTFLLMSRIGEEPFTLPLQTLV 116
Query: 105 NWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITT- 162
+ I G+ Y+ + + HRDL ++N +++ + T+ +ADFGL+ ++ S Y + +
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 163 --LQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT 195
+++ A E L Y + D+WA G+ M E++T
Sbjct: 177 LPVKWLALES-LADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-13
Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 10 IGEGSFGKVWQAIKKQSGEYV--AIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQ 67
IGEG+FG+V +A K+ G + AIK +K+ + E++ L K+ +HPNI+ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 68 ELASENYRLYFVFEYMDC-NLHQLMSNRK---------------QCFSEAEVKNWCFQIL 111
LY EY NL + + S ++ ++ +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 112 QGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170
+G++Y+ ++ + HRDL ++N+LV N KIADFGL+ + T +++ A E
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 182
Query: 171 LLMSGQYNSKVDMWALGLIMAELITF 196
L S Y + D+W+ G+++ E+++
Sbjct: 183 LNYS-VYTTNSDVWSYGVLLWEIVSL 207
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 56/246 (22%), Positives = 105/246 (42%), Gaps = 39/246 (15%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINNHPNIVK 65
+K IG G+FG+V KK +G A+K L K + E+ +++ + + + +VK
Sbjct: 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVK 65
Query: 66 LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
+ + LY + E++ + +K SE + + + + ++ +H+ G+ HR
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125
Query: 126 DLISKNLLV-SNDTIKIADFGL------------------------------------AW 148
D+ NLL+ + +K++DFGL W
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW 185
Query: 149 EVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ 208
+ + + T Y APE+ + +G YN D W+LG+IM E++ +P F +
Sbjct: 186 KKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 209 LYKICN 214
K+ N
Sbjct: 245 YRKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK----- 56
+ + ++K IG G+FG+V K +G+ A+K L + W E L E C R+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK----W-EMLKRAETACFREERDVL 55
Query: 57 INNHPN-IVKLQELASENYRLYFVFE-YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
+N I L + LY V + Y+ +L L+S + E + + +++ +
Sbjct: 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115
Query: 115 NYMHRQGYFHRDLISKNLLVS-NDTIKIADFG--LAWEVDSCPPYTEYITTLQYRAPEML 171
+ +H+ GY HRD+ N+L+ N I++ADFG L D + T Y +PE+L
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 172 LM----SGQYNSKVDMWALGLIMAELI 194
G+Y + D W+LG+ M E++
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 9 QIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
++GEG+FGKV+ A + +Q VA+KALK+ S + + L + H +I
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR--QDFQREAELLTVLQHQHI 69
Query: 64 VKLQELASENYRLYFVFEYM---DCN---------LHQLMSNRKQCFSE---AEVKNWCF 108
V+ + +E L VFEYM D N L + ++
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT---EYITTLQ 164
QI G+ Y+ + HRDL ++N LV +KI DFG++ ++ S Y + ++
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ PE +L ++ ++ D+W+ G+++ E+ T+
Sbjct: 190 WMPPESILYR-KFTTESDIWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 73/294 (24%), Positives = 126/294 (42%), Gaps = 51/294 (17%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKL 66
+ +IG G+ G+V++ K++G +A+K +++ E L ++ + K ++ P IVK
Sbjct: 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 67 QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM-HRQGYFHR 125
+ ++ E M L +L+ + E + I++ L+Y+ + G HR
Sbjct: 80 YGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHR 139
Query: 126 DLISKNLLV-SNDTIKIADFGLAWE-VDS--------CPPYTEYITTLQYRAPEML---L 172
D+ N+L+ ++ +K+ DFG++ VDS C Y APE +
Sbjct: 140 DVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM---------APERIDPPD 190
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
+ +Y+ + D+W+LG+ + EL T FP YK C E L K
Sbjct: 191 PNPKYDIRADVWSLGISLVELAT--GQFP--------YKNCK----------TEFEVLTK 230
Query: 233 AHGYKFPKLQGN-NLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ P L N S S ++L + D KRP E LQHP +
Sbjct: 231 ILQEEPPSLPPNEGFSPDF-------CSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 43/246 (17%)
Query: 50 EVKCLRKINNHPNIVK-LQELASENYRLYFVFEY-----MDCNLHQLMSNRKQCFSEAEV 103
E+ CL + H IVK + S++ +L + EY ++ + Q + F E EV
Sbjct: 115 ELHCLAACD-HFGIVKHFDDFKSDD-KLLLIMEYGSGGDLNKQIKQRLKEHLP-FQEYEV 171
Query: 104 KNWCFQILQGLNYMHRQGYFHRDLISKNL-LVSNDTIKIADFGLAWEVD---SCPPYTEY 159
+QI+ L+ +H + HRDL S N+ L+ IK+ DFG + + S + +
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231
Query: 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP 219
T Y APE L +Y+ K DMW+LG+I+ EL+T H F G + + + ++
Sbjct: 232 CGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV------- 283
Query: 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL 279
L G P + +L++ L S +P RPT + L
Sbjct: 284 ---------------------LYGKYDPFPCP-VSSGMKALLDPLLSKNPALRPTTQQLL 321
Query: 280 QHPLFQ 285
+
Sbjct: 322 HTEFLK 327
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 7e-13
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK----I 57
E + ++K IG G+FG+V K + + A+K L + W E L E C R+ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK----W-EMLKRAETACFREERDVL 55
Query: 58 NNHPN--IVKLQELASENYRLYFVFE-YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
N N I L + LY V + Y+ +L L+S + E + + +++ +
Sbjct: 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115
Query: 115 NYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV--DSCPPYTEYITTLQYRAPEML 171
+ +H+ Y HRD+ N+L+ N I++ADFG ++ D + + T Y +PE+L
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 172 LM----SGQYNSKVDMWALGLIMAELI 194
G+Y + D W+LG+ M E++
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 41/226 (18%)
Query: 8 KQIGEGSFGKVWQA----------------IKKQSGEYVAIKALKQRIYSWEECLNLKEV 51
+++GEG FG+V ++K VA+K L+ LKEV
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 52 KCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAE-------- 102
K L ++ + PNI++L + + L + EYM+ +L+Q +S+ E
Sbjct: 71 KILSRLKD-PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129
Query: 103 ----------VKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVD 151
+ + QI G+ Y+ + HRDL ++N LV N TIKIADFG++ +
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 152 SCPPYT---EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELI 194
+ Y + +++ A E +LM G++ + D+WA G+ + E++
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 53/196 (27%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 9 QIGEGSFGKVWQAIKKQSGEY--VAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKL 66
++G G+FG V + + K + VAIK LK ++E + + +++N P IV++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN-PYIVRM 60
Query: 67 QELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
+ E L V E L++ +S +K + + V Q+ G+ Y+ + + HR
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 126 DLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYITT----LQYRAPEMLLMSGQYNSK 180
DL ++N LLV+ KI+DFGL+ + + Y + + L++ APE + +++S+
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR-KFSSR 178
Query: 181 VDMWALGLIMAELITF 196
D+W+ G+ M E ++
Sbjct: 179 SDVWSYGITMWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK----- 56
+ + ++K IG G+FG+V K + A+K L + WE L E C R+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK----WE-MLKRAETACFREERNVL 55
Query: 57 INNHPNIVKLQELA--SENYRLYFVFEY-MDCNLHQLMSNRKQCFSEAEVKNWCFQILQG 113
+N + A ENY LY V +Y + +L L+S + E + + +++
Sbjct: 56 VNGDCQWITTLHYAFQDENY-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 114 LNYMHRQGYFHRDLISKNLLVS-NDTIKIADFG--LAWEVDSCPPYTEYITTLQYRAPEM 170
++ +H+ Y HRD+ N+L+ N I++ADFG L D + + T Y +PE+
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 171 LLM----SGQYNSKVDMWALGLIMAELI 194
L G+Y + D W+LG+ M E++
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQ--------RIYSWEECLNLKEVKC 53
E Y ++K IG G+FG+V K + + A+K L + + WEE +
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE-------RD 95
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQ 112
+ N P +V+L ++ LY V EYM +L LMSN E + + +++
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVL 153
Query: 113 GLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEV--DSCPPYTEYITTLQYRAPE 169
L+ +H G+ HRD+ N+L+ +K+ADFG ++ + + T Y +PE
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 213
Query: 170 MLLMS---GQYNSKVDMWALGLIMAELI 194
+L G Y + D W++G+ + E++
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 6 LMKQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRI-YSWEECLNLKEVKCLRKINN 59
M+++GE FGKV++ + + VAIK LK + E K +R
Sbjct: 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE--EFKHEAMMRSRLQ 66
Query: 60 HPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNR---------------KQCFSEAEV 103
HPNIV L + ++ L +F Y +LH+ + R K A+
Sbjct: 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 104 KNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT---EY 159
+ QI G+ ++ H+DL ++N+LV + +KI+D GL EV + Y
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ +++ +PE +M G+++ D+W+ G+++ E+ ++
Sbjct: 187 LLPIRWMSPEA-IMYGKFSIDSDIWSYGVVLWEVFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRK- 56
+E++ ++K I G+FGKV+ KK + + A+K +K+ + +N + +V+ R
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK-----ADMINKNMVHQVQAERDA 57
Query: 57 --INNHPNIVKL-QELASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQ 112
++ P IV L L S N +Y V EY+ ++ L+ F E + ++
Sbjct: 58 LALSKSPFIVHLYYSLQSANN-VYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVAL 115
Query: 113 GLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLA 147
L+Y+HR G HRDL N+L+SN+ IK+ DFGL+
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 40/213 (18%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKL 66
+ +IG G+FG V + + K SG +A+K ++ + E+ L ++ + + ++ P IVK
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 67 QELASENYRLYF-------VFEYMDCNLHQLM----SNRKQCFSEAEVKNWCFQILQGLN 115
Y F E MD +L + K E + ++ LN
Sbjct: 69 -------YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 116 YMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWE-VDS--------CPPYTEYITTLQ 164
Y+ + HRD+ N+L+ N IK+ DFG++ + VDS C PY
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM------- 174
Query: 165 YRAPEMLLMSGQ--YNSKVDMWALGLIMAELIT 195
APE + S + Y+ + D+W+LG+ + E+ T
Sbjct: 175 --APERIDPSARDGYDVRSDVWSLGITLYEVAT 205
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEY----VAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
+K +G G+FG V++ + GE VAIK L++ L E + ++ +P+
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPH 70
Query: 63 IVKLQELA-SENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+ +L + + +L C L + ++ S+ + NWC QI +G+NY+ +
Sbjct: 71 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ-YLLNWCVQIAKGMNYLEERR 129
Query: 122 YFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPYTEY-----ITTLQYRAPEMLLMSG 175
HRDL ++N+LV +KI DFGLA + + EY +++ A E +L
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESILHR- 186
Query: 176 QYNSKVDMWALGLIMAELITF 196
Y + D+W+ G+ + EL+TF
Sbjct: 187 IYTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 69/211 (32%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEY--VAIKAL-KQRIYSWEECLNL-KEVKCLRKI 57
E + ++ +G GSFG+V A K + ++ VAIK K +I ++ ++ E K L I
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYK-NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMD-------CNLHQLMSNRKQCFSEAEVKNWCFQI 110
NHP V L + LY V E++ ++ N CF A++ F+
Sbjct: 89 -NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV-LIFEY 146
Query: 111 LQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
LQ LN + +RDL +NLL+ D IK+ DFG A VD+ YT T +Y APE
Sbjct: 147 LQSLNIV------YRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYT-LCGTPEYIAPE 198
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLF 200
+LL G + D W LG+ + E++ P F
Sbjct: 199 ILLNVG-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 43/231 (18%)
Query: 2 EKYTLMKQIGEGSFGKVW-------QAIKKQSGEY---------VAIKALKQRIYSWEEC 45
+ ++++GEG FG+V Q +++ VA+K L+
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 46 LNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNR---------- 94
LKEVK L +++ PNI +L + + + L + EYM+ +L+Q +
Sbjct: 65 DFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 95 KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSC 153
+ S + + QI G+ Y+ + HRDL ++N LV N TIKIADFG++ + S
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 154 PPYTEYITTLQYRAP--------EMLLMSGQYNSKVDMWALGLIMAELITF 196
Y +Q RAP E +L+ G++ +K D+WA G+ + E++T
Sbjct: 184 DYY-----RVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTL 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQ---SGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNH 60
L K +GEG FG V + Q S VA+K +K I+++ E L E C++ + H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-H 60
Query: 61 PNIVKLQELASENYRL------YFVFEYM-DCNLHQ-LMSNR----KQCFSEAEVKNWCF 108
PN++KL + E L + +M +LH L+ +R + + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRA 167
I G+ Y+ + + HRDL ++N ++ D T+ +ADFGL+ ++ S Y Q R
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR------QGRI 174
Query: 168 PEM--------LLMSGQYNSKVDMWALGLIMAELIT 195
+M L Y SK D+WA G+ M E+ T
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-12
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL----KQRIYSWEECLNLKEVKCLRKINNHPNIVK 65
+G+G++G V+ + Q G+ +A+K + + + +E L+E L K H NIV+
Sbjct: 8 LGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 66 LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHR 125
++ + E++ + NR E + QIL G+ Y+H HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 126 DLISKN-LLVSNDTIKIADFG----LAWEVDSCPPYTEYITTLQ----YRAPEMLLMSGQ 176
D+ N +L+ N IK+ DFG LAW V ++ + ++ + APE++ SG
Sbjct: 127 DIKGNNVMLMPNGIIKLIDFGCARRLAW-VGLHGTHSNMLKSMHGTPYWMAPEVINESG- 184
Query: 177 YNSKVDMWALGLIMAELITFHP 198
Y K D+W++G + E+ T P
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 8e-12
Identities = 77/287 (26%), Positives = 123/287 (42%), Gaps = 40/287 (13%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQ 67
+G+G FG+V + +G+ A K L K+RI + E + L E + L K+N+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSLA 66
Query: 68 ELASENYRLYFVFEYM---DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
L V M D H + + F E + +I GL +H++ +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFH-IYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 125 RDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
RDL +N+L+ + I+I+D GLA V + T+ Y APE ++ + +Y D
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE-VVKNERYTFSPDW 184
Query: 184 WALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQG 243
WALG ++ E+I F + KI EE E+ + + KF
Sbjct: 185 WALGCLLYEMIAGQSPF-----QQRKKKI------KREEVERLVKEVQEEYSEKF----- 228
Query: 244 NNLSLLIPSANDDEMSLIELLCSWDP-----CKRPTAAEALQHPLFQ 285
+ D SL ++L DP C+ A E +HPLF+
Sbjct: 229 ----------SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-12
Identities = 54/200 (27%), Positives = 104/200 (52%), Gaps = 17/200 (8%)
Query: 8 KQIGEGSFGKVWQAI--KKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRKINNHPN 62
++G G+FG V + + K+S + VA+K LK + + L L+E +++++N P
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELLREANVMQQLDN-PY 57
Query: 63 IVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
IV++ + E V E + L++ + K +E + Q+ G+ Y+
Sbjct: 58 IVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKH-VTEKNITELVHQVSMGMKYLEETN 115
Query: 122 YFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYITT----LQYRAPEMLLMSGQ 176
+ HRDL ++N LLV+ KI+DFGL+ + + Y + T +++ APE + +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY-K 174
Query: 177 YNSKVDMWALGLIMAELITF 196
++SK D+W+ G++M E ++
Sbjct: 175 FSSKSDVWSFGVLMWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 48/291 (16%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNHPNIV 64
+ ++G+G++G V++ + + +G +A+K + R+ E N + E+ L K + P IV
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEI--RLELDESKFNQIIMELDILHKAVS-PYIV 62
Query: 65 KLQELASENYRLYFVFEYMDC-NLHQLM--SNRKQCFSEAEVKNWCFQILQGLNYMHRQ- 120
+Y EYMD +L +L + E ++ + +++GL ++ +
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 121 GYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSG---- 175
HRD+ N+LV N +K+ DFG++ + + T I Y APE + G
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSYMAPERIKSGGPNQN 181
Query: 176 -QYNSKVDMWALGLIMAEL-ITFHPLFPGTCED--DQLYKICNAIGSPTEESWAEGLELA 231
Y + D+W+LGL + E+ + +P P T + QL I + G P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDP------------ 227
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
P L +DD + + P +RPT A+ L+HP
Sbjct: 228 -------PTLP--------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 70/287 (24%), Positives = 122/287 (42%), Gaps = 40/287 (13%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQ 67
+G+G FG+V + +G+ A K L K+RI + E + L E + L K+N+ +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVSLA 66
Query: 68 ELASENYRLYFVFEYM---DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
L V M D H + + F E + ++ GL + R+ +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFH-IYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 125 RDLISKNLLVSN-DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
RDL +N+L+ + I+I+D GLA ++ + T+ Y APE ++ + +Y D
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPE-VINNEKYTFSPDW 184
Query: 184 WALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQG 243
W LG ++ E+I F E + ++ + EE + KF
Sbjct: 185 WGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE-----------YSEKF----- 228
Query: 244 NNLSLLIPSANDDEMSLIELLCSWDP-----CKRPTAAEALQHPLFQ 285
++D S+ +L + +P C+ AA QHP+F+
Sbjct: 229 ----------SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYV----AIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
+K +G G+FG V++ I GE V AIK L + + E + ++ HP+
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD-HPH 70
Query: 63 IVKLQELA-SENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+V+L + S +L C L + ++ S+ + NWC QI +G+ Y+ +
Sbjct: 71 LVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQL-LLNWCVQIAKGMMYLEERR 129
Query: 122 YFHRDLISKNLLV-SNDTIKIADFGLA---------WEVD--SCPPYTEYITTLQYRAPE 169
HRDL ++N+LV S + +KI DFGLA + D P + + YR
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR--- 186
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITF 196
++ + D+W+ G+ + EL+TF
Sbjct: 187 ------KFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 41/288 (14%)
Query: 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQE 68
++G G++G V + +G +A+K ++ + S E+ L ++ + + P V
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 69 LASENYRLYFVFEYMDCNLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFH 124
++ E MD +L + + E + I++ L Y+H + H
Sbjct: 68 ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIH 127
Query: 125 RDLISKNLLVS-NDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEML---LMSGQYNS 179
RD+ N+L++ N +K+ DFG++ VDS T Y APE + L Y+
Sbjct: 128 RDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK-TIDAGCKPYMAPERINPELNQKGYDV 186
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK--AHGYK 237
K D+W+LG+ M EL A G +SW + K
Sbjct: 187 KSDVWSLGITMIEL---------------------ATGRFPYDSWKTPFQQLKQVVEEPS 225
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
P+L S + + + +RP E LQHP F+
Sbjct: 226 -PQLPAEKFSP-------EFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 10 IGEGSFGKVWQAIKKQSGEYV--AIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQ 67
IGEG+FG+V +A K+ G + AIK +K+ + E++ L K+ +HPNI+ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 68 ELASENYRLYFVFEYM-DCNLHQLMSNRK---------------QCFSEAEVKNWCFQIL 111
LY EY NL + + S ++ ++ +
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170
+G++Y+ ++ + HRDL ++N+LV + + KIADFGL+ + T +++ A E
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 194
Query: 171 LLMSGQYNSKVDMWALGLIMAELITF 196
L S Y + D+W+ G+++ E+++
Sbjct: 195 LNYS-VYTTNSDVWSYGVLLWEIVSL 219
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 9/191 (4%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQ 67
+G+G FG+V K +G+ A K L K+R+ E + L E + L K+N+ P IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59
Query: 68 ELASENYRLYFVFEYM---DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
L V M D H + + ++ V ++ QI G+ ++H +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYH-IYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 125 RDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDM 183
RD+ +N+L+ +++D GLA E+ T+ T Y APE +L Y+ VD
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKEEPYSYPVDW 177
Query: 184 WALGLIMAELI 194
+A+G + E++
Sbjct: 178 FAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK--------ALKQRIYSWEECLNLKEVKC 53
EK + ++GEG+ G V + K +G A+K L+++I L+E++
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQI--------LRELEI 52
Query: 54 LRKINNHPNIVK-----LQELASENYRLYFVFEYMDC----NLHQLMSNRKQCFSEAEVK 104
+ P IVK L E +S + EY + ++++ + R E +
Sbjct: 53 NKSCK-SPYIVKYYGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 105 NWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTL 163
+L+GL+Y+H + HRD+ N+L++ +K+ DFG++ E+ + T + T
Sbjct: 109 KIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTS 167
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAEL 193
Y APE + Y+ D+W+LGL + E+
Sbjct: 168 FYMAPER-IQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 10 IGEGSFGKVWQAI---KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKL 66
IG+G FG V+ + A+K+L RI EE + + K +HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 67 QE--LASENYRLYFVFEYM-DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYF 123
L SE L V YM +L + + + ++ + Q+ +G+ Y+ + +
Sbjct: 62 LGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 124 HRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPE-----MLLMSGQ- 176
HRDL ++N +L + T+K+ADFGLA ++ EY + + + M L S Q
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDIYD----KEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 177 --YNSKVDMWALGLIMAELIT 195
+ +K D+W+ G+++ EL+T
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 55/218 (25%), Positives = 107/218 (49%), Gaps = 19/218 (8%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
+++++ G+ G + I ++ E+V IKA QR + E LR IN HP+I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA-GQRGGT------ATEAHILRAIN-HPSI 145
Query: 64 VKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYF 123
++L+ + N + +L+ ++ ++ + ++ +L+ + Y+H
Sbjct: 146 IQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN-IAICDILAIERSVLRAIQYLHENRII 204
Query: 124 HRDLISKNLLVSN-DTIKIADFGLA-WEVD-SCPPYTEYITTLQYRAPEMLLMSGQYNSK 180
HRD+ ++N+ +++ + + DFG A + VD + Y + T+ APE LL Y
Sbjct: 205 HRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPE-LLARDPYGPA 263
Query: 181 VDMWALGLIMAELITFH-PLFP-----GTCEDDQLYKI 212
VD+W+ G+++ E+ T H LF G C+ D+ K+
Sbjct: 264 VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301
|
Length = 391 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRI---YSWEECLNLKEVKCLRKINNHPNIVK 65
+G+G FG+V + +G+ A K L K+R+ +E + E + L K+++ IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM--VEKRILAKVHSR-FIVS 57
Query: 66 LQELASENYRLYFVFEYM---DCNLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQG 121
L L V M D H + + F E + QI+ GL ++H++
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 122 YFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTE-YITTLQYRAPEMLLMSGQYNS 179
+RDL +N+L+ ND ++I+D GLA E+ T+ Y T + APE LL +Y+
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE-LLQGEEYDF 176
Query: 180 KVDMWALGLIMAELI 194
VD +ALG+ + E+I
Sbjct: 177 SVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 8 KQIGEGSFGKVW--QAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVK 65
++IG G FGKV + V +K LK S E+ L++ R I HPNI++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYR-ILQHPNILQ 59
Query: 66 LQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAE---VKNWCFQILQGLNYMHRQG 121
E VFEY + +L +S + ++ ++ +I G+ +MH+
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119
Query: 122 YFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTE-YITT-------LQYRAPEML- 171
+ H DL +N +++D T+K+ D+G+ Y E YI T L++ APE++
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPS-----RYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 172 -----LMSGQYNSKVDMWALGLIMAEL 193
L++ + ++WALG+ + EL
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC---LRKINNHPNIV 64
K +G+G+FG+V+ +G +A K ++ S E + ++C L K H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 65 K----LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
+ L++ A + ++ EYM + +E+ + + QIL+G++Y+H
Sbjct: 68 QYYGCLRDRAEKTLTIFM--EYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 121 GYFHRDLISKNLLV-SNDTIKIADFGLAWEVDS-CPPYT---EYITTLQYRAPEMLLMSG 175
HRD+ N+L S +K+ DFG + + + C T T + +PE++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 176 QYNSKVDMWALGLIMAELITFHP 198
Y K D+W+LG + E++T P
Sbjct: 186 -YGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKI--- 57
E + +K IG+G+FG+V KK +G+ A+K L K ++ ++ L VK R +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQ---LAHVKAERDVLAE 57
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
++ P +V L + LY + E++ M + FSE + + + + + +
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117
Query: 118 HRQGYFHRDLISKNLLVSNDT-IKIADFGLA 147
H+ G+ HRD+ N+L+ IK++DFGL+
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 33/231 (14%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEY--VAIKALKQRIYSWEECLN-LKEVKCLRKINNHP 61
L K +GEG FG V + Q VA+K +K I + E + L E C+++ + HP
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HP 60
Query: 62 NIVKL-----QELASENY-RLYFVFEYMD-CNLHQLM-----SNRKQCFSEAEVKNWCFQ 109
N+++L Q + SE Y + +M +LH + + Q + +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 110 ILQGLNYMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAP 168
I G+ Y+ + + HRDL ++N +L N + +ADFGL+ ++ + Y Q R
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR------QGRIA 174
Query: 169 EM--------LLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLY 210
+M L Y +K D+W+ G+ M E+ T +PG E+ ++Y
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-ENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC---LRKIN 58
+ L K +G G+FG+V+ +G +A+K + S E + ++C L K
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 59 NHPNIVK----LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
H IV+ L++ E +L EYM + +E + + QILQG+
Sbjct: 62 RHDRIVQYYGCLRD--PEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV 119
Query: 115 NYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDS-CPPYT--EYITTLQY-RAPE 169
+Y+H HRD+ N+L S +K+ DFG + + + C T + +T Y +PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHP 198
++ G Y K D+W++ + E++T P
Sbjct: 180 VISGEG-YGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 64/266 (24%), Positives = 107/266 (40%), Gaps = 61/266 (22%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRKI--- 57
+ +K +G G+FG+V A K + A+K L+++ + LN + VK R I
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK-----DVLNRNQVAHVKAERDILAE 57
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
++ +VKL + LYFV +Y+ + R + F E + + ++ + +
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117
Query: 118 HRQGYFHRDLISKNLLVSNDT-IKIADFGLA----W-------------EVDSCPPYTEY 159
H+ G+ HRD+ N+L+ D IK+ DFGL W DS P +
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 160 -------------------------------ITTLQYRAPEMLLMSGQYNSKVDMWALGL 188
+ T Y APE+LL G Y D W++G+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGV 236
Query: 189 IMAELITFHPLFPGTCEDDQLYKICN 214
I+ E++ P F + K+ N
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 85/344 (24%), Positives = 155/344 (45%), Gaps = 48/344 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQ-RIYSWEECLNLKEVKCLRKIN-- 58
+++ ++ +GEG+FGKV +A ++ EY A+K ++ Y+ + + ++ ++ +R+ +
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188
Query: 59 NHPNIVKLQE-LASENYRLYFVF-EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
+ ++K+Q +E + V +Y C L +M + FS + FQ L+Y
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDY 246
Query: 117 MHRQGYF-HRDLISKNLLV-SNDT----------------IKIADFGLAWEVDSCPPYTE 158
H + + H DL +N+L+ ++DT ++I D G D T
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTA 304
Query: 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGS 218
++T YR+PE++L G S DMW++G I+ EL T L+ + L+ + +G
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363
Query: 219 -PTEESWA------EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCS----- 266
P+E WA E L + G P +L+ + + E+ +LLC
Sbjct: 364 LPSE--WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL 421
Query: 267 --WDPCKRPTAAEALQHP----LFQGCLQVPSMSIDSCKMRLTP 304
+D KR A + HP + C Q P+ + +R TP
Sbjct: 422 LHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRPTP 465
|
Length = 467 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 10/205 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + + ++G G+ G V + K SG +A K + I ++E++ L + N+ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-P 63
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM-HR 119
IV + + E+MD +L Q++ K+ E + +L+GL Y+ +
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLREK 122
Query: 120 QGYFHRDLISKNLLV-SNDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQY 177
HRD+ N+LV S IK+ DFG++ + +DS ++ T Y +PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-QGTHY 179
Query: 178 NSKVDMWALGLIMAEL-ITFHPLFP 201
+ + D+W++GL + EL I +P+ P
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 50/184 (27%), Positives = 88/184 (47%), Gaps = 40/184 (21%)
Query: 106 WCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT---EYIT 161
+ FQ+ +G+ ++ + HRDL ++N+L+S N+ +KI DFGLA ++ P Y +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF--HPLFPGTCEDDQLYKICNAIGSP 219
L++ APE + Y + D+W+ G+++ E+ + P +PG D++ C +
Sbjct: 244 PLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEF---CRRL--- 295
Query: 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSW--DPCKRPTAAE 277
EG + +A Y P EM L C W +P +RPT +E
Sbjct: 296 -----KEGTRM-RAPDYTTP-----------------EMYQTMLDC-WHGEPSQRPTFSE 331
Query: 278 ALQH 281
++H
Sbjct: 332 LVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 58/225 (25%), Positives = 109/225 (48%), Gaps = 10/225 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + + ++G G+ G V++ K SG +A K + I ++E++ L + N+ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-P 63
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM-HR 119
IV + + E+MD +L Q++ + E + +++GL Y+ +
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREK 122
Query: 120 QGYFHRDLISKNLLV-SNDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQY 177
HRD+ N+LV S IK+ DFG++ + +DS ++ T Y +PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERL-QGTHY 179
Query: 178 NSKVDMWALGLIMAEL-ITFHPLFPGTCEDDQLYKICNAIGSPTE 221
+ + D+W++GL + E+ I +P+ P ++ +L C G P E
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 55/212 (25%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKI 57
++ TL + EG+FG+++ I K E V +K +K + L L+E L +
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 58 NNHPNIVKLQELASENYRLYFV-FEYMDC-NLHQLMSNRK-------QCFSEAEVKNWCF 108
+ H NI+ + + E+ FV + YM+ NL + + Q S ++ +
Sbjct: 66 S-HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEV---D-SCPPYTEYITTL 163
QI G++Y+H++G H+D+ ++N ++ + +KI D L+ ++ D C E +
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN-RPV 183
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELIT 195
++ A E L+ +Y+S D+W+ G+++ EL+T
Sbjct: 184 KWMALESLVNK-EYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC-LRKINN--H 60
+ L K +G+G+FG+V+ +G +A+K ++ S E + ++C ++ + N H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 61 PNIVKLQE-LASENYRLYFVF-EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
IV+ L R +F E+M + +E + + QIL+G++Y+H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 119 RQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDS-CPPYTEYIT---TLQYRAPEMLLM 173
HRD+ N+L S +K+ DFG + + + C T + T + +PE++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 174 SGQYNSKVDMWALGLIMAELITFHP 198
G Y K D+W++G + E++T P
Sbjct: 184 EG-YGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 29/95 (30%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 106 WCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITT-- 162
+ FQ+ +G+ ++ + HRDL ++N+L+S N+ +KI DFGLA ++ P Y +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 163 -LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
L++ APE + Y ++ D+W+ G+++ E+ +
Sbjct: 239 PLKWMAPESIF-DKVYTTQSDVWSFGVLLWEIFSL 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 61/261 (23%), Positives = 104/261 (39%), Gaps = 57/261 (21%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKI---NNHPNI 63
+K +G G+FG+V A K + A+K L+++ + VK R I ++ +
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRN--QVAHVKAERDILAEADNEWV 63
Query: 64 VKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYF 123
V+L + LYFV +Y+ + R F E + + ++ + +H+ G+
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123
Query: 124 HRDLISKNLLVSNDT-IKIADFGLA----WEVDS-------------------------- 152
HRD+ N+L+ D IK+ DFGL W DS
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 153 -------------------CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAEL 193
C ++ + T Y APE+LL +G Y D W++G+I+ E+
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHS-LVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEM 241
Query: 194 ITFHPLFPGTCEDDQLYKICN 214
+ P F + K+ N
Sbjct: 242 LVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 8 KQIGEGSFGKVW--QAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVK 65
K+IG G FGKV + + V +K L+ E+ L+E + R + H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQ 59
Query: 66 LQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAE--------VKNWCFQILQGLNYM 117
+E V E+ C L L + C +AE ++ +I GL ++
Sbjct: 60 CLGQCTEVTPYLLVMEF--CPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 118 HRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYITT-------LQYRAPE 169
H+ + H DL +N LL ++ T+KI D+GL+ +Y T L++ APE
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLS----HNKYKEDYYVTPDQLWVPLRWIAPE 172
Query: 170 ML------LMSGQYNSKVDMWALGLIMAELITF 196
++ L+ + ++W+LG+ + EL
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 82/334 (24%), Positives = 136/334 (40%), Gaps = 42/334 (12%)
Query: 6 LMKQIGEG--SFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
L +IG G + V+ A +G V ++ + E L+ L HPNI
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 64 VKLQELASENYRLYFVFEYM--DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+ + + L+ + +M L + + SEA + N F L+GLNY+H+ G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 122 YFHRDLISKNLLVSNDTIKIADFGL------------AWEVDSCPPYTEYITTLQYRAPE 169
Y HR++ + ++L+S D + ++ GL A V P ++ + L + +PE
Sbjct: 122 YIHRNIKASHILISGDGL-VSLSGLSHLYSLVRNGQKAKVVYDFPQFS--TSVLPWLSPE 178
Query: 170 MLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQL--------YKICNAIGSP 219
+L + G YN K D++++G+ EL T F L Y + P
Sbjct: 179 LLRQDLYG-YNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237
Query: 220 TEESWAEGLELAKAHGYKFPKLQG------NNLSLLIPSA---NDDEMSLIELLCSWDPC 270
EES + + G + + L PS+ + +L+EL DP
Sbjct: 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE 297
Query: 271 KRPTAAEALQHPLFQGCLQVPSMSIDSCKMRLTP 304
KRP+A+ L H F+ QV + S L P
Sbjct: 298 KRPSASSLLSHAFFK---QVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 46/199 (23%), Positives = 90/199 (45%), Gaps = 9/199 (4%)
Query: 5 TLMKQIGEGSFGKV---WQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + +G G FG++ + + VAI L+ + L E L + + H
Sbjct: 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HS 66
Query: 62 NIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV+L+ + + + V EYM L + + ++ + G+ Y+
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 121 GYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYTEY--ITTLQYRAPEMLLMSGQY 177
GY H+ L + +LV++D + KI+ F E S YT + + + APE + +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA-IQYHHF 185
Query: 178 NSKVDMWALGLIMAELITF 196
+S D+W+ G++M E++++
Sbjct: 186 SSASDVWSFGIVMWEVMSY 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 59/198 (29%), Positives = 78/198 (39%), Gaps = 58/198 (29%)
Query: 114 LNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLA---------------WEVDSCPPYT 157
L Y+H G HRDL NLL+ S IK+ DFGL+ E D+
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT----R 169
Query: 158 EYIT-----TLQYRAPEMLLMSGQYNSKVDMWALGLIMAE-LITFHPLFPGTCEDDQLYK 211
E++ T +Y APE++L G Y VD WA+G+I+ E L+ P F T E+
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228
Query: 212 ICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK 271
I + I W EG E + D LI L +P +
Sbjct: 229 ISDDI------EWPEGDE----------------------ALPADAQDLISRLLRQNPLE 260
Query: 272 R---PTAAEALQHPLFQG 286
R A E QH F G
Sbjct: 261 RLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 7e-09
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
++PN +KL + + +Y+ +L L+ + SEAEVK Q+++ LN +
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDL 125
Query: 118 HRQGYFHRDLISKNLL--VSNDTIKIADFGLAWEVD--SCPPYTEYITTLQYRAPEMLLM 173
H+ H D+ +N+L + D I + D+GL + SC Y TL Y +PE +
Sbjct: 126 HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC-----YDGTLDYFSPEKIKG 180
Query: 174 SGQYNSKVDMWALGLIMAELITF-HP 198
Y+ D WA+G++ EL+T HP
Sbjct: 181 H-NYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 37/254 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKIN 58
M++Y +++ IG+G G+V+ A VA+K +++ + L+E K +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL- 59
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFS-------EAEVKNWC--- 107
HP IV + + S+ +Y+ Y++ L L+ + Q S + V +
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAW--------EVDSCPPYTE 158
+I + Y+H +G HRDL N+L+ + I D+G A +D
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 159 Y-----------ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD 207
+ T Y APE LL + D++ALG+I+ +++T FP +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLS--FPYRRKKG 236
Query: 208 QLYKICNAIGSPTE 221
+ + I SP E
Sbjct: 237 RKISYRDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 71/300 (23%), Positives = 122/300 (40%), Gaps = 48/300 (16%)
Query: 24 KQSGEYVAIKALKQRIYSWEECLN-----LKEVKCLRKINNHPNIVKLQELASENYRLYF 78
K +GEYV ++ RI + E C N L+ + K+ NHPNIV + + L+
Sbjct: 22 KPTGEYVTVR----RI-NLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 76
Query: 79 VFEYMDCNLHQ--LMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN 136
V +M + + ++ SE + +L+ L+Y+H GY HR + + ++L+S
Sbjct: 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV 136
Query: 137 DTIKIADFGL------------AWEVDSCPPYTEYITTLQYRAPEMLLMSGQ-YNSKVDM 183
D K+ GL V P Y+ + L + +PE+L + Q Y++K D+
Sbjct: 137 DG-KVYLSGLRSNLSMINHGQRLRVVHDFPKYS--VKVLPWLSPEVLQQNLQGYDAKSDI 193
Query: 184 WALGLIMAELITFHPLF---PGTCEDDQLYKICNAIGSPTEESWAEGLELA---KAHGYK 237
+++G+ EL H F P T L K+ + + + EL G
Sbjct: 194 YSVGITACELANGHVPFKDMPAT--QMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGAN 251
Query: 238 FPKLQGNNLSLLIPSANDDEM------------SLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ +S PS + +E +P RP+A+ L H F+
Sbjct: 252 SGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 33/205 (16%)
Query: 7 MKQIGEGSFGKVWQAIKKQSGEYVAIK--------ALKQRIYS----WEECLNLKEVKCL 54
+ +G G+ G V + +G +A K +++++I EC + V
Sbjct: 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
N NI E+MDC + + + +++GL
Sbjct: 70 GAFLNENNIC-------------MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGL 116
Query: 115 NYM---HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170
Y+ HR HRD+ N+LV S IK+ DFG++ E+ + T ++ T Y +PE
Sbjct: 117 TYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-FVGTSTYMSPER 173
Query: 171 LLMSGQYNSKVDMWALGLIMAELIT 195
+ G+Y K D+W+LG+ + EL
Sbjct: 174 I-QGGKYTVKSDVWSLGISIIELAL 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 29/94 (30%), Positives = 57/94 (60%), Gaps = 5/94 (5%)
Query: 106 WCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT---EYIT 161
+ FQ+ +G+ ++ + HRDL ++N+L+S N+ +KI DFGLA ++ P Y +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT 195
L++ APE + Y ++ D+W+ G+++ E+ +
Sbjct: 238 PLKWMAPESIF-DKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 60/256 (23%), Positives = 106/256 (41%), Gaps = 32/256 (12%)
Query: 49 KEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCF 108
+E+ L+ I+ H I+ L + V C+L + +R +
Sbjct: 135 REIDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV-DRSGPLPLEQAITIQR 192
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPYTE----YITTL 163
++L+ L Y+H +G HRD+ ++N+ + + + DFG A ++D+ P T + TL
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH-PDTPQCYGWSGTL 251
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAE-LITFHPLF----PGTCEDDQLYKICNAIG- 217
+ +PE+L + Y +K D+W+ GL++ E + LF + QL I +
Sbjct: 252 ETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS--SSQLRSIIRCMQV 308
Query: 218 SPTEESWAEGLELAKAHG---------YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWD 268
P E L K Y P + D E + ++L ++D
Sbjct: 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKY----GMHM-DVEYLIAKML-TFD 362
Query: 269 PCKRPTAAEALQHPLF 284
RP+A + L PLF
Sbjct: 363 QEFRPSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 50/278 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK--------ALKQRIYSWEECLNLKEVKC 53
+ + + ++G G+ G V + + + SG +A K A++ +I ++E+K
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI--------IRELKV 52
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQ 112
L + N+ P IV + + E+MD +L Q++ + E + +L+
Sbjct: 53 LHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLR 110
Query: 113 GLNYMH-RQGYFHRDLISKNLLV-SNDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPE 169
GL Y+ + HRD+ N+LV S IK+ DFG++ + +DS ++ T Y +PE
Sbjct: 111 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE 168
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
L + Y + D+W+LGL + E+ +P I P E
Sbjct: 169 RLQGT-HYTVQSDIWSLGLSLVEMAI--GRYP--------------IPPPDA------KE 205
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDE---MSLIELL 264
L G + + + D M++ ELL
Sbjct: 206 LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELL 243
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 33/133 (24%), Positives = 70/133 (52%), Gaps = 7/133 (5%)
Query: 84 DCNLHQLMS-NRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTI-KI 141
D + L+S + + + ++ ++ +Q+ +G+ ++ + HRDL ++N+L++ I KI
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278
Query: 142 ADFGLAWEVDSCPPYTEYITT---LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-H 197
DFGLA ++ Y +T +++ APE + Y + D+W+ G+++ E+ +
Sbjct: 279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGG 337
Query: 198 PLFPGTCEDDQLY 210
+PG D Y
Sbjct: 338 TPYPGMIVDSTFY 350
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 50/187 (26%), Positives = 86/187 (45%), Gaps = 10/187 (5%)
Query: 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQE 68
+G G+ G V++A + +A+K + I + + E++ L K ++ P I+
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFYG 66
Query: 69 LASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLI 128
R+ E+MD L RK E + +++GL Y+ HRD+
Sbjct: 67 AFFVENRISICTEFMDGG--SLDVYRK--IPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122
Query: 129 SKNLLV-SNDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWAL 186
N+LV + +K+ DFG++ + V+S Y+ T Y APE + QY D+W+L
Sbjct: 123 PSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYMAPERIS-GEQYGIHSDVWSL 179
Query: 187 GLIMAEL 193
G+ EL
Sbjct: 180 GISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 30/171 (17%), Positives = 52/171 (30%), Gaps = 51/171 (29%)
Query: 86 NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-------- 137
+L ++ R + +E E+ C Q L L +HRQ L++ + L+ D
Sbjct: 2 SLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKTP 61
Query: 138 -TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ + +A EV YTE K D+++LG+ + E + +
Sbjct: 62 EQSRPDPYFMAPEVIQGQSYTE---------------------KADIYSLGITLYEALDY 100
Query: 197 HP--------------LFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
L G DD E +
Sbjct: 101 ELPYNEERELSAILEILLNGMPADDPR-------DRSNLEGVSAARSFEDF 144
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 46/183 (25%), Positives = 85/183 (46%), Gaps = 38/183 (20%)
Query: 105 NWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEVDSCPPYT---EYI 160
++ +Q+ +G++++ + HRDL ++N+L+++ I KI DFGLA ++ + Y
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277
Query: 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSP 219
+++ APE + + Y + D+W+ G+++ E+ + +PG D + YK+
Sbjct: 278 LPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----- 331
Query: 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSW--DPCKRPTAAE 277
GY+ +L P EM I C W DP KRPT +
Sbjct: 332 --------------EGYR----------MLSPECAPSEMYDIMKSC-WDADPLKRPTFKQ 366
Query: 278 ALQ 280
+Q
Sbjct: 367 IVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 39/125 (31%), Positives = 52/125 (41%), Gaps = 28/125 (22%)
Query: 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTE 221
T Y APE+LL + VD WALG+ + E +T P F D+ ++ I +
Sbjct: 543 TPDYLAPELLLGKP-HGPAVDWWALGVCLFEFLTGIPPF----NDETPQQVFQNILNRDI 597
Query: 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
W EG E LS + + IE+L + DP KR E QH
Sbjct: 598 P-WPEGEE---------------KLS-------VNAQNAIEILLTMDPTKRAGLKELKQH 634
Query: 282 PLFQG 286
PLF G
Sbjct: 635 PLFHG 639
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 29/111 (26%), Positives = 58/111 (52%), Gaps = 5/111 (4%)
Query: 90 LMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAW 148
+ N S ++ + +Q+ G+ ++ + HRDL ++N+L+ +KI DFGLA
Sbjct: 228 TLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 149 EVDSCPPYTEYITT---LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196
++ Y +T L++ APE + + Y + D+W+ G+++ E+ T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTL 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 31/116 (26%), Positives = 64/116 (55%), Gaps = 18/116 (15%)
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLVSNDTI-KIADFGLAWEV--DSCPPYTEYITT-- 162
Q+ QG++++ + HRD+ ++N+L+++ + KI DFGLA ++ DS Y+
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-----NYVVKGN 273
Query: 163 ----LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF--HPLFPGTCEDDQLYKI 212
+++ APE + Y + D+W+ G+++ E+ + P +PG + + YK+
Sbjct: 274 ARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSP-YPGILVNSKFYKM 327
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 31/72 (43%), Positives = 40/72 (55%), Gaps = 11/72 (15%)
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSC------PPYTEYIT 161
Q+L GL +HR G HRD+ +NLLV+ D +KI DFG A VD C P Y +
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA--VDMCTGINFNPLYG--ML 372
Query: 162 TLQYRAPEMLLM 173
+Y PE L+M
Sbjct: 373 DPRYSPPEELVM 384
|
Length = 507 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 52/193 (26%), Positives = 80/193 (41%), Gaps = 47/193 (24%)
Query: 100 EAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEV-DSCPPYT 157
E VK W +++ L+ +HR+G RDL N+L+ + I++ F EV DSC
Sbjct: 84 EECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD--G 141
Query: 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG 217
E + + Y APE+ +S + D W+LG I+ EL+T
Sbjct: 142 EAVENM-YCAPEVGGIS-EETEACDWWSLGAILFELLT---------------------- 177
Query: 218 SPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAA 276
G L + H P + +L IP +E SL++ L ++P +R A
Sbjct: 178 ---------GKTLVECH----PSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224
Query: 277 EA-----LQHPLF 284
A HP F
Sbjct: 225 VAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
++ L K +G G+FGKV +A KK S VA+K LK+ + E + E+K L
Sbjct: 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIH 66
Query: 57 INNHPNIVKLQELASE-NYRLYFVFEYMDC---NLHQLMSNRKQCFS 99
I NH N+V L ++ N L + E+ C NL + +++ FS
Sbjct: 67 IGNHLNVVNLLGACTKPNGPLMVIVEF--CKYGNLSNFLRAKREFFS 111
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 12/31 (38%), Positives = 18/31 (58%)
Query: 117 MHRQGYFHRDLISKNLLVSNDTIKIADFGLA 147
+H+ G H DL + N+++S I DFGL
Sbjct: 108 LHKAGIVHGDLTTSNIILSGGRIYFIDFGLG 138
|
Length = 204 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 5/64 (7%)
Query: 8 KQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
K +G G+FGKV +A K + VA+K LK + E + E+K L + NH N
Sbjct: 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHIN 100
Query: 63 IVKL 66
IV L
Sbjct: 101 IVNL 104
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 5/70 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
+ K +G G+FGKV +A K+ + VA+K LK ++ E + E+K L
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 57 INNHPNIVKL 66
+ H NIV L
Sbjct: 98 LGQHKNIVNL 107
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 50/217 (23%), Positives = 79/217 (36%), Gaps = 63/217 (29%)
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND--TIKIADFGLAWEVDSCPPYT--EYITTLQ 164
QIL L+ +H G HRD+ +N++ S + KI D G A ++ Y E++ +
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPR 322
Query: 165 YRAPEMLLMSGQYNS---------------------KVDMWALGLIMAELITFHPLFPGT 203
Y APE +MS Q S + D+++ GLI ++ FP
Sbjct: 323 YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA-----FPNL 377
Query: 204 CEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIEL 263
D L + + K + Y + L+ P A+ D E+
Sbjct: 378 RSDSNLIQFNRQL---------------KRNDYDLVAWR----KLVEPRASPDLRRGFEV 418
Query: 264 L-----CSWDPC---------KRPTAAEALQHPLFQG 286
L W+ +R +A AL HP F
Sbjct: 419 LDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455
|
Length = 566 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 9e-04
Identities = 38/155 (24%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 49 KEVKCLRKINNHPNIVKLQ----ELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEV 103
E+K LR+I+++ NI+K+ ++ + RL + EY L +++ K S
Sbjct: 67 NEIKNLRRIDSN-NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD-LSFKTK 124
Query: 104 KNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT 161
+ +GL +++ +++L S + LV+ + +KI GL ++ S PP+ +
Sbjct: 125 LDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL-EKILSSPPFKN-VN 182
Query: 162 TLQYRAPEMLL-MSGQYNSKVDMWALGLIMAELIT 195
+ Y + +ML + +Y K D+++LG+++ E+ T
Sbjct: 183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT 217
|
Length = 283 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 13/31 (41%), Positives = 19/31 (61%)
Query: 117 MHRQGYFHRDLISKNLLVSNDTIKIADFGLA 147
+H G H DL + N+++S I + DFGLA
Sbjct: 111 LHSAGIIHGDLTTSNMILSGGKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 26/86 (30%), Positives = 42/86 (48%), Gaps = 5/86 (5%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
+ L + +G G+FG+V +A QS VA+K LK S E+ + E+K +
Sbjct: 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSH 96
Query: 57 INNHPNIVKLQELASENYRLYFVFEY 82
+ H NIV L ++ +Y + EY
Sbjct: 97 LGPHLNIVNLLGACTKGGPIYIITEY 122
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 22/165 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE------ECLNLKEVKCLR 55
+++ + K IG G FG V++ + + ++ +I + E E L + +
Sbjct: 12 KEWKIDKLIGCGGFGCVYET--QCASDHCINNQAVAKIENLENETIVMETLVYNNIYDID 69
Query: 56 KINNHPNIVKLQELASENY---------RLYFVF---EYMDCNLHQLMSNRKQCFSEAEV 103
KI NI + L Y R+Y+ F E + N ++ R +C ++ +
Sbjct: 70 KIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFK-RIKCKNKKLI 128
Query: 104 KNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLA 147
KN +L L Y+H G H D+ +N++V N+ I D+G+A
Sbjct: 129 KNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.003
Identities = 12/31 (38%), Positives = 20/31 (64%)
Query: 117 MHRQGYFHRDLISKNLLVSNDTIKIADFGLA 147
+H+ G H DL + N++V +D + + DFGL
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDDKLYLIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 346 | |||
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.6 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.43 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.37 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.3 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.23 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.94 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.94 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.9 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.44 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.44 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.42 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.4 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.18 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.16 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.12 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.07 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.06 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.98 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.93 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.72 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.67 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.64 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.48 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.45 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.44 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.42 | |
| PLN02236 | 344 | choline kinase | 97.36 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.35 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 97.1 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.09 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.09 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.61 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.58 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.5 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.44 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.39 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.69 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.48 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.42 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.4 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.88 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 94.45 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.44 |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-67 Score=460.93 Aligned_cols=291 Identities=57% Similarity=1.021 Sum_probs=282.6
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-EEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY-RLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~-~~~iv 79 (346)
|+||.++++||.|+||.||+|+.+.+|+.||||.+++.....++...++|++.|+++..||||+++.+++.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 68999999999999999999999999999999999999999999999999999999966999999999998887 99999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
||||+.+|.+.+..++..|+|.+++.|+.||++||+|+|++|+.|||+||+|||+. +..+||+|||+|+.+...++++.
T Consensus 89 fE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTe 168 (538)
T KOG0661|consen 89 FEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTE 168 (538)
T ss_pred HHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcch
Confidence 99999999999999999999999999999999999999999999999999999997 77999999999999999999999
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
++.|..|+|||++...+.|+.+.|+|++|||++|+.+.++.|++.++.|++.+|++.+|.|..+.|.++.+.+...++++
T Consensus 169 YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~ 248 (538)
T KOG0661|consen 169 YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRF 248 (538)
T ss_pred hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~ 291 (346)
|...+..+..+.+..+.++.++|.+||++||.+||||+|+|+||||+......
T Consensus 249 P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~ 301 (538)
T KOG0661|consen 249 PQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASG 301 (538)
T ss_pred CcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccccc
Confidence 99999999999999999999999999999999999999999999999876543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-63 Score=424.72 Aligned_cols=262 Identities=32% Similarity=0.502 Sum_probs=227.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH------HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW------EECLNLKEVKCLRKINNHPNIVKLQELASENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~ 75 (346)
+-|.+.+.||+|+||.|-+|..+.||+.||||++++..... ......+|+++|+++ +|||||+++++|+.++.
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPDS 250 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCCc
Confidence 46899999999999999999999999999999997665433 223346899999999 89999999999999999
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC----cEEEeeccccccc
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEV 150 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~----~vkl~Dfg~a~~~ 150 (346)
.|+||||++| +|.+.+... +.+.|..-+.++.|++.|+.|||++||+||||||+|||++++ .+||+|||+|...
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred eEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 9999999985 666666554 459999999999999999999999999999999999999544 7999999999999
Q ss_pred CCCCCCccccccCcccCcccccccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSG--QYNSKVDMWALGLIMAELITFHPLFPGTCEDD-QLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~ 227 (346)
+....+.+.+|||.|.|||++...+ .+..+.||||+||++|-+++|.+||.+..... ...+|.++.-..-+..|.
T Consensus 330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~-- 407 (475)
T KOG0615|consen 330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD-- 407 (475)
T ss_pred ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh--
Confidence 9888899999999999999997543 24558999999999999999999998887766 666676665555555554
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~ 291 (346)
++|+++++||.+||..||++|||++|+|+||||+.....+
T Consensus 408 ------------------------~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 408 ------------------------RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred ------------------------hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 6899999999999999999999999999999999766443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-61 Score=397.47 Aligned_cols=286 Identities=32% Similarity=0.567 Sum_probs=256.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
|++|+.+.++|+|+||+||+|+++.||+.||||.+..+..+.. ..-.++|+++++++ +|||+|.+.++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEE
Confidence 8999999999999999999999999999999999977766544 34457999999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~ 157 (346)
+|||+.+.++.+......+++..++.++.|++.|+.|||+++++||||||+|||++ +|.+||||||+|+... +...++
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 99999999999988877799999999999999999999999999999999999995 6799999999999877 666788
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
.++.|..|+|||.+.+..+|+.+.||||+||++.||++|.+.|++.++.+++..|...+|...+.-..-.....-..+..
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~ 239 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR 239 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence 89999999999999988999999999999999999999999999999999999999999988876544333334445566
Q ss_pred CCCcCCCC-cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 238 FPKLQGNN-LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+|.+...+ +....++++.-+.+|+.+||..||.+|++.+|+|.||||.+.
T Consensus 240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 67665543 444567888899999999999999999999999999999653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-59 Score=383.67 Aligned_cols=286 Identities=37% Similarity=0.631 Sum_probs=255.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++||...+.+|+|.||.||+|++..||+.||||.++...... -....++|++.|+.+ +||||+.+.++|...+.+.||
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEE
Confidence 579999999999999999999999999999999997765442 345568999999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCCCC-Cc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPP-YT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~~~-~~ 157 (346)
+||++.+|...+..+...++..+++.++.++++||+|||++.|.||||||+|+|+ ++|.+||+|||+|+..++... ..
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 9999999999999998889999999999999999999999999999999999999 578999999999998876543 33
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..+.|..|+|||.+.+...|+...|+||+|||+.||+.|.+.|++.++-+++..|.+.+|+|.++.|.+....-....+.
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 34789999999999999999999999999999999999999999999999999999999999999998765544433333
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.........+++..++++.+|+.+|+..||.+|+|+.|+|+|+||++.+.
T Consensus 240 --~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 240 --QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred --cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 22333444578899999999999999999999999999999999998543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-58 Score=415.55 Aligned_cols=253 Identities=30% Similarity=0.535 Sum_probs=223.5
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+|...+.||+|+|+.||.+++..+|+.||+|++.+...- .......+|+++.+++ +|||||+++++|++.+++|||+
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEEE
Confidence 599999999999999999999999999999999764432 2334457899999999 7999999999999999999999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeecccccccCCC-CCCc
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSC-PPYT 157 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~~-~~~~ 157 (346)
|+|. |++.+.+. +.+.++|.+++.+++||+.||.|||+++|+|||||..|++++++ +|||+|||+|+..... ....
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence 9998 55555555 66679999999999999999999999999999999999999877 9999999999987744 5677
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
+.+|||.|.|||++. ....+..+||||+||++|.|+.|++||+..+-.+.+.+|... .+.
T Consensus 177 TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------------~Y~ 236 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------------EYS 236 (592)
T ss_pred eecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------------------Ccc
Confidence 899999999999998 556899999999999999999999999999888888887554 333
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+|. ..|.++++||++||+.||.+|||++++|.|+||+.-.
T Consensus 237 ~P~-----------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 237 MPS-----------HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred ccc-----------ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 332 5789999999999999999999999999999996544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-59 Score=396.61 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=222.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-EEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY-RLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~-~~~iv~ 80 (346)
++.+.++.||+|..|+||+++|+.|++.+|+|++.............+|+++++.. +||+||.+|+.|..++ .++|+|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEeeh
Confidence 36678899999999999999999999999999997777677777889999999999 8999999999999998 599999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEE-eCCcEEEeecccccccCCCCCCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|||+|+.++.+....+.++|..+..++.++++||.|||+ ++|+||||||+|||+ ++|.|||+|||.+...... ..++
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~t 236 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANT 236 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hccc
Confidence 999977666666666779999999999999999999995 899999999999999 6789999999999887765 7788
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGT-----CEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
++||..|||||.+. +..|+.++||||||.+++|+++|+.||... ...+.+..|+.. |++.
T Consensus 237 fvGT~~YMsPERi~-g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---ppP~----------- 301 (364)
T KOG0581|consen 237 FVGTSAYMSPERIS-GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---PPPR----------- 301 (364)
T ss_pred ccccccccChhhhc-CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---CCCC-----------
Confidence 99999999999998 567999999999999999999999999875 334444444332 1110
Q ss_pred cCCCCCCcCCCCcccccC-CCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIP-SANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
... .+|+++++|+..||++||.+|||+.|+++|||++....
T Consensus 302 ---------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 302 ---------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred ---------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 112 37999999999999999999999999999999997543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-57 Score=381.91 Aligned_cols=288 Identities=40% Similarity=0.630 Sum_probs=254.6
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN--YRLY 77 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 77 (346)
++.|+.++.|++|+||.||+|+++.|++.||+|.++.+.... -....++|+.++.+. +|||||.+.++.... +.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence 467999999999999999999999999999999997654211 123447999999999 699999999987643 6799
Q ss_pred EEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCC-CC
Q 039371 78 FVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSC-PP 155 (346)
Q Consensus 78 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~-~~ 155 (346)
||||||+.+|...+...+.++.+.+++-++.|++.|++|||.+.|+||||||+|+|+ +.|.+|++|||+|+..+.. .+
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 999999999999999888889999999999999999999999999999999999999 5679999999999988765 46
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
++..+.|..|+|||.+.+...|+.+.|+||+|||+.||+++.+.|++....+++.+|++.+|.|.+..|......-....
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 77889999999999999999999999999999999999999999999999999999999999999999986555444445
Q ss_pred CCCCCcCCCCcccccCCCC--chHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSAN--DDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~--~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..++......+...++..+ +...+|++.+|..||.+|.||+|.|+|+||.+.+.
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 6677666666666666554 99999999999999999999999999999998543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-57 Score=400.88 Aligned_cols=283 Identities=38% Similarity=0.631 Sum_probs=249.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN--YRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~~i 78 (346)
+.|+.+++||+|+||.||+|++..||+.||+|.+..+..+. -.....+|+.+|+++ +||||+++.+...+. ..+|+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEEE
Confidence 56899999999999999999999999999999997766433 334557999999999 899999999998766 78999
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC--CC
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC--PP 155 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~--~~ 155 (346)
|+|||+.+|.-.+....-.|++.+++.++.||++||+|||++||.|||||.+|||+| +|.+||+|||+|+..... .+
T Consensus 196 VFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 196 VFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred EEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 999999999999988877899999999999999999999999999999999999996 569999999999855443 36
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
++..+.|..|+|||.+.+...|+.+.|+||+|||+.||+.|++.|++.++.+++..|.+..|.|.++.|. ....--...
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~ 354 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATI 354 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccc
Confidence 7888999999999999999999999999999999999999999999999999999999999999999998 222222223
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
+.........+.+.....+..+.+|+..||..||.+|.||.++|+|+||+.
T Consensus 355 ~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 355 FKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 333333455566667889999999999999999999999999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-56 Score=382.06 Aligned_cols=256 Identities=32% Similarity=0.495 Sum_probs=223.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||.++.+.|++.||+|++++...... ......|..++.++ +||.||+++..|++++.+|+|
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEEE
Confidence 689999999999999999999999999999999987765443 44557899999998 899999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccc-cCCCCCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWE-VDSCPPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~-~~~~~~~~ 157 (346)
+||+.|+-+....++.+.++|+.++.++..|+.||.|||++||+||||||+|||++ +|+++|+|||+|.. ........
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~ 183 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATR 183 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccc
Confidence 99999744444444455699999999999999999999999999999999999995 67999999999984 45555677
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
+++||+.|||||++. ...|+.++|+||||+++|+|++|.+||.+.+......+|.......+
T Consensus 184 tfcGT~eYmAPEil~-~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~----------------- 245 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILL-GKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP----------------- 245 (357)
T ss_pred cccCCccccChHHHh-cCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC-----------------
Confidence 789999999999998 56799999999999999999999999999999888888876541111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP----TAAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp----s~~ell~hp~~~~~~ 288 (346)
....+.+++++++++|+.||++|. .+.++-+||||+...
T Consensus 246 ------------p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 246 ------------PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred ------------CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 123789999999999999999995 699999999998754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-56 Score=379.29 Aligned_cols=287 Identities=37% Similarity=0.604 Sum_probs=250.9
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeec-----CCEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASE-----NYRL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-----~~~~ 76 (346)
+|..++.||+|+||.|+.|.++.+|+.||+|.+....... ...+.++|+++++.+ +|+||+.+.+++.. -+.+
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeeccccccccccee
Confidence 5666899999999999999999999999999997444433 345668999999999 69999999999865 3578
Q ss_pred EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC---
Q 039371 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS--- 152 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~--- 152 (346)
|+|+|+|+.+|...+..++. +++..++.++.|++.||.|+|+.+++|||+||+|++++ +..+||+|||+|+..+.
T Consensus 102 YiV~elMetDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~ 180 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE 180 (359)
T ss_pred EEehhHHhhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence 99999998888888876654 99999999999999999999999999999999999995 55999999999998764
Q ss_pred CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH-HH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE-LA 231 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~ 231 (346)
....+..+.|..|.|||++.....|+.+.||||+|||+.||++|++.|++.+...++..|...+|.|+++....... .+
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 34556788999999999999889999999999999999999999999999999999999999999998887765442 23
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~ 291 (346)
...-...+..........++..++.+.+|+.+||..||.+|+|++|+|+|||+.....+.
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 333345667777777888999999999999999999999999999999999999876543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=384.66 Aligned_cols=283 Identities=34% Similarity=0.618 Sum_probs=241.3
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
|++|++.+.||+|+||+||+|.++.+++.||+|+++............+|+.+++++ +||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEE
Confidence 689999999999999999999999999999999997554433344556899999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~ 158 (346)
|+++|++.+.+...+..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++...... .....
T Consensus 83 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 83 EYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred eCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 9999999988877666689999999999999999999999999999999999995 569999999998764432 23344
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+.|+.+.|.............+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 57899999999987667789999999999999999999999999999999999999999999888876544333333444
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+...........+..+.++++||++||+.||.+|||++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 4433333333456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-55 Score=389.42 Aligned_cols=255 Identities=32% Similarity=0.505 Sum_probs=225.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHh--hhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEEC--LNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|..++.||.|+|++|++|+++.+++.||||++.++..-.+.. -...|-.+|.++.+||.|++++-.|+++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 68999999999999999999999999999999997765543332 2346888899998999999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--- 154 (346)
+||++ |+|++++.+.+ .|+|.-++.++.||+.||+|||++||+||||||+|||++ ++++||+|||.|...++..
T Consensus 153 Le~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred EEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 99998 78999988874 499999999999999999999999999999999999996 5699999999997664321
Q ss_pred -----------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Q 039371 155 -----------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES 223 (346)
Q Consensus 155 -----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 223 (346)
...+++||..|.+||++. ....++.+|||+||||+|.|+.|.+||.+.++--.+++|+...-.
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~----- 305 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE----- 305 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc-----
Confidence 124589999999999887 777999999999999999999999999999999999999876332
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
|+ ++.++.+.+||+++|..||.+|+|++||.+||||.+..
T Consensus 306 --------------fp-----------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 306 --------------FP-----------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred --------------CC-----------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 22 36789999999999999999999999999999998754
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-55 Score=372.56 Aligned_cols=287 Identities=37% Similarity=0.691 Sum_probs=250.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCC-eeeeeeeeecCC----
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPN-IVKLQELASENY---- 74 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~-iv~~~~~~~~~~---- 74 (346)
|+.|+.+++||.|+||+||+|+.+.+|+.||+|.+.....+ .......+|+.+++.+ +|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence 45688999999999999999999999999999999766542 2334457999999999 7999 999999997766
Q ss_pred --EEEEEEEcCCCCHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccc
Q 039371 75 --RLYFVFEYMDCNLHQLMSNRK---QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAW 148 (346)
Q Consensus 75 --~~~iv~e~~~g~l~~~~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~ 148 (346)
.+++|+||++-++..++...+ ..++...++.+++||+.||+|||+++|+||||||+||+++ +|.+||+|||+|+
T Consensus 89 ~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred cceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999999999999887766 4588899999999999999999999999999999999995 6799999999998
Q ss_pred ccC-CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHH
Q 039371 149 EVD-SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 149 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
... +...+.+..+|..|+|||++.+...|+...||||+|||++||+++++.|++..+.+++..|.+.++.|....|...
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 776 4445788899999999999998889999999999999999999999999999999999999999999999999865
Q ss_pred HHHHHhcCCCCCCcC-CCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 228 LELAKAHGYKFPKLQ-GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
...... ...++... ...+....+..+++..+++.+||+.+|.+|.|++.+|+||||.....
T Consensus 249 ~~~~~~-k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDY-KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccc-cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 443333 22454444 44555566777789999999999999999999999999999997644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=372.21 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=226.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+.+|.+.++||+|+||+||+|+++.++..||||.+.......+ ......|+++|+.+ +|||||.++++.++++.+|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999987764433 34456899999999 799999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-------CcEEEeecccccccC
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-------DTIKIADFGLAWEVD 151 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-------~~vkl~Dfg~a~~~~ 151 (346)
||||+ |+|.+++...+ .++|..++.++.||+.||++||+++|+||||||+|||++. -.+||+|||+|+...
T Consensus 88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999 57777777665 4999999999999999999999999999999999999953 258999999999999
Q ss_pred CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
+.....+.+|++.|||||++. ..+|+.|+|+||+|+++|+|++|.+||...+..+.+..+..+....+
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~----------- 234 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP----------- 234 (429)
T ss_pred chhHHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC-----------
Confidence 888889999999999999997 67899999999999999999999999999999888876644322111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
......++...+++...++.+|..|.+..+-+.|+++....
T Consensus 235 ----------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 235 ----------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ----------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 11235677788999999999999999999999999998765
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-56 Score=360.53 Aligned_cols=258 Identities=32% Similarity=0.507 Sum_probs=227.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhh-HHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++.+.||+|.|+.|+++.+..+|+.+|+|+++........... -+|+.+-+.+ +||||+++.+.+.+.+..|+|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeEEEE
Confidence 5799999999999999999999999999999999766555443333 3567776666 8999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-e--CC-cEEEeecccccccCCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-S--ND-TIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~--~~-~vkl~Dfg~a~~~~~~~~ 155 (346)
|+|+| ++...+-.+ .-++|..+...++||+++|.|||.+||||||+||+|+++ + ++ .+||+|||+|...++...
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 99996 777777665 348999999999999999999999999999999999999 2 23 899999999999887777
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....|||.|||||++. ..+|+.++|||+.|+++|-|+.|.+||.+.+....+++|..+.-..+.+.|
T Consensus 169 ~~G~~GtP~fmaPEvvr-kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w----------- 236 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW----------- 236 (355)
T ss_pred cccccCCCcccCHHHhh-cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc-----------
Confidence 88899999999999997 678999999999999999999999999999999999999877554444444
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+.+++++++|+++||..||.+|+|+.|+|+|||+.+..
T Consensus 237 ---------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 237 ---------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred ---------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 47899999999999999999999999999999998754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=384.38 Aligned_cols=254 Identities=33% Similarity=0.517 Sum_probs=222.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC----HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS----WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
.+|++.+.||+|+||+|++|.+..+++.||+|+++..... .......+|+.+++++..||||+++++++.....+|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 5899999999999999999999999999999988764221 223334579999999966999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeeccccccc-CCC
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWEV-DSC 153 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~~-~~~ 153 (346)
+||||+.| +|++.+.. .+++.|.+++.+++|++.|++|||++||+||||||+||+++. +++||+|||++... ...
T Consensus 97 ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~ 175 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED 175 (370)
T ss_pred EEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence 99999985 89999988 667999999999999999999999999999999999999964 69999999999887 455
Q ss_pred CCCccccccCcccCcccccccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSG-QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
....+.+||+.|+|||++.+.. +-+.++||||+|++||.|++|..||...+.......|.++.
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~---------------- 239 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE---------------- 239 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC----------------
Confidence 6788899999999999998766 55789999999999999999999999988777777765432
Q ss_pred hcCCCCCCcCCCCcccccCCC-CchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSA-NDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
+.+| ..+ |.++++|+++||..||.+|+|+.++++||||+.
T Consensus 240 ---~~~p-----------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 ---FKIP-----------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---ccCC-----------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 2222 134 899999999999999999999999999999997
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=369.49 Aligned_cols=280 Identities=35% Similarity=0.601 Sum_probs=243.9
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--C---EEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN--Y---RLY 77 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~---~~~ 77 (346)
.|+-.+.+|+|+||.||.|....+++.||||.+-.+.. ..-+|+.+|+.+ +|||||++.-+|... + ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHH
Confidence 47888999999999999999999999999998854422 123699999988 899999999888532 2 346
Q ss_pred EEEEcCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe--CCcEEEeecccccccCC
Q 039371 78 FVFEYMDCNLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS--NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 78 iv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~--~~~vkl~Dfg~a~~~~~ 152 (346)
+||||++-+|...+.. .+..++.-.++-+++||+.||.|||+.|||||||||+|+|+| .|.+||||||+|.....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999999988874 355699999999999999999999999999999999999996 56999999999999988
Q ss_pred CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
..+..++..|..|+|||.+.+...|+.+.||||.||++.||+-|++.|++.+..+++..|++.+|.|+.+......-..
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y- 257 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY- 257 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc-
Confidence 8888999999999999999999999999999999999999999999999999999999999999999988765432222
Q ss_pred hcCCCCCCcCCCCccc-ccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSL-LIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
....+|++....+.. .....++++.+|+.++|+.+|++|.++.|++.||||.+....
T Consensus 258 -~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 258 -TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred -ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 245666666655544 667889999999999999999999999999999999987654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-54 Score=355.73 Aligned_cols=255 Identities=32% Similarity=0.461 Sum_probs=223.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|+.++.||.|+||.|.+++++.+|..||+|++++...-.. .....+|..+|+.+ .||.++++++.+.+.+++|+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEEE
Confidence 4789999999999999999999999999999999976654322 22335788899998 69999999999999999999
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||||++|+-+....++.++++|..++.++.||+.||+|||+++|++||+||+|||+| +|.+||+|||+|..+... ..
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~ 199 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TW 199 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EE
Confidence 999999755544444445699999999999999999999999999999999999996 679999999999988874 56
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
+.+|||.|+|||++. ...|+.++|.||||+++|||+.|.+||.+.+......+|+++.- .
T Consensus 200 TlCGTPeYLAPEii~-sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-------------------~ 259 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQ-SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-------------------K 259 (355)
T ss_pred EecCCccccChHHhh-cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-------------------c
Confidence 789999999999998 77799999999999999999999999999999999999987643 3
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCC-----CCHHHHhcCCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR-----PTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R-----ps~~ell~hp~~~~~~~ 289 (346)
|| +..+.++++||+++|+.|-.+| ....++.+||||++...
T Consensus 260 fP-----------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 260 FP-----------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred CC-----------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 33 2578999999999999999999 35789999999997643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=375.17 Aligned_cols=288 Identities=34% Similarity=0.618 Sum_probs=243.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
|++|++.++||+|+||+||+|+++.+++.||+|+++............+|+.+++++ +||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEE
Confidence 689999999999999999999999999999999997654443344456899999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
||+++++.+.+...+..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++....... ....
T Consensus 84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 9999999988877766789999999999999999999999999999999999995 5699999999987544322 2334
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+++.|+|||.+.+...++.++||||+||++|+|++|..||.+.+..+....+.+..+.+..+.|.............+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 56789999999987666789999999999999999999999999999999999999999998888876544333333334
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
+...........+.+++++++||++||+.||.+|||++|+++||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 433333333344578899999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=378.40 Aligned_cols=260 Identities=32% Similarity=0.481 Sum_probs=217.1
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH--hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE--CLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|+++..||+|+||.||+|+.+.||..||+|+++++..-... .....|..+|... ++|+||++|..|++..++|+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEE
Confidence 57999999999999999999999999999999999877654332 2335677888775 89999999999999999999
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-----
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS----- 152 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~----- 152 (346)
||||++|+-.-.+....+.++|..++.++.+++.|++.+|+.|++||||||+|+||| .|++||+|||+|.....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 999999754444444455699999999999999999999999999999999999996 67999999999842210
Q ss_pred -------------------CCC------------------------CccccccCcccCcccccccCCCCChhhHHHHHHH
Q 039371 153 -------------------CPP------------------------YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLI 189 (346)
Q Consensus 153 -------------------~~~------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 189 (346)
... ....+|||.|+|||++.+ ..|+..+|+||||||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHHH
Confidence 000 012579999999999985 449999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCC
Q 039371 190 MAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDP 269 (346)
Q Consensus 190 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 269 (346)
+|||+.|.+||.+.++.++..+|+.-.. .+.+|.. ...++++++||.+||. ||
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~-----------------~l~fP~~---------~~~s~eA~DLI~rll~-d~ 430 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRE-----------------TLKFPEE---------VDLSDEAKDLITRLLC-DP 430 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhh-----------------hccCCCc---------CcccHHHHHHHHHHhc-CH
Confidence 9999999999999999999999876421 1122221 2567999999999999 99
Q ss_pred CCCCC---HHHHhcCCCCCCCCC
Q 039371 270 CKRPT---AAEALQHPLFQGCLQ 289 (346)
Q Consensus 270 ~~Rps---~~ell~hp~~~~~~~ 289 (346)
.+|.. ++||.+||||++...
T Consensus 431 ~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 431 ENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHhcCcccHHHHhcCCccccCCc
Confidence 99985 999999999998653
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=373.62 Aligned_cols=285 Identities=32% Similarity=0.535 Sum_probs=227.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++.............+|+.+++.+ +||||+++++++.++...++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEEE
Confidence 68999999999999999999999999999999997654443344556899999999 79999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCccc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTEY 159 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~~ 159 (346)
|+++++.+.+....+.+++..++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||++...... ......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 163 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCC
Confidence 999999998887767799999999999999999999999999999999999995 579999999998754322 233445
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE-DDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
.+++.|+|||++.+...++.++||||+||++|+|++|..||.+..+ .+.+..+....+.+....|.............+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccc
Confidence 7899999999987666789999999999999999999999987544 455666666666666665543222111000011
Q ss_pred CCcCCCCccccc--CCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 239 PKLQGNNLSLLI--PSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 239 ~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
............ ...++++.+|+++||+.||++|||+.|+++||||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 111111111111 1346789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=386.59 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=227.7
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccc--cCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRI--YSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
=|++++.||+|+.|.|-+|++..||+.+|||++.+.. .+......-+|+.+|+-+ .|||++++|+++++..++|+|.
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEE
Confidence 3789999999999999999999999999999997652 222334445788888777 8999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
||++| .|.+++... ++++|.+++++++||+.|+.|||..+|+|||+||+|+|++ .+++||+|||.|..........+
T Consensus 92 Eyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred EecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence 99985 666666654 5599999999999999999999999999999999999995 45799999999999888889999
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
.||+|.|.|||++.+..+-+.++||||+|+|||.|++|+.||++++....+.++.++.. .+
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-------------------~M 231 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-------------------EM 231 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-------------------cC
Confidence 99999999999999888889999999999999999999999999888888888766532 22
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPS 292 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~~ 292 (346)
| ..++.++++||++||.+||.+|+|.+||++|||+++....+.
T Consensus 232 P-----------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 232 P-----------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred C-----------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 2 368999999999999999999999999999999998876553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-54 Score=354.31 Aligned_cols=244 Identities=29% Similarity=0.447 Sum_probs=209.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHh-hhHHHHHHHHhhcCCCCeeeeee-eeecCCE-EEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEEC-LNLKEVKCLRKINNHPNIVKLQE-LASENYR-LYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~l~~l~~hp~iv~~~~-~~~~~~~-~~i 78 (346)
.+|+++++||+|.||+||++.+..+|..+|.|.+.....+.++. ....|+.+|++| +|||||++++ .|.+++. ++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHH
Confidence 46999999999999999999999999999999998766665543 447899999999 8999999998 4555544 899
Q ss_pred EEEcCC-CCHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCCEEEe-CCcEEEeecccccc
Q 039371 79 VFEYMD-CNLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMHR--QG--YFHRDLISKNLLVS-NDTIKIADFGLAWE 149 (346)
Q Consensus 79 v~e~~~-g~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~--~~--ivH~dikp~NIli~-~~~vkl~Dfg~a~~ 149 (346)
+||+|+ |+|...+. +.+..++|..+++++.|++.||.+||+ .+ |.||||||.||+++ +|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999998 67776664 345569999999999999999999999 45 99999999999996 67999999999988
Q ss_pred cCCCC-CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 150 VDSCP-PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 150 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
..... ...+.+|||+||+||.+. ...|+++|||||+||++|||+..++||.+.+-.+...+|..+..+|.+.
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~-~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~------ 250 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIH-ESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD------ 250 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHh-cCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH------
Confidence 77654 345689999999999998 6679999999999999999999999999998888888887764433332
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA 275 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~ 275 (346)
..+|.++..+|..|+.+||+.||+.
T Consensus 251 ----------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ----------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ----------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2468899999999999999999985
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=379.29 Aligned_cols=281 Identities=35% Similarity=0.563 Sum_probs=233.4
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC-----CCeeeeeeeeecCCEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH-----PNIVKLQELASENYRLY 77 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h-----p~iv~~~~~~~~~~~~~ 77 (346)
||++++.||+|+||.|-+|.+..|++.||||+++....- ......|+.+|..+.+| -|+|+++++|...+++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f--~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF--LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH--HHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 799999999999999999999999999999999755332 23345789999988633 38999999999999999
Q ss_pred EEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe---CCcEEEeecccccccCCC
Q 039371 78 FVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS---NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 78 iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~---~~~vkl~Dfg~a~~~~~~ 153 (346)
||+|.++-+|.+.+...+ ..++...++.++.||+.||.+||+.||+|+||||+|||+. ...||++|||+|...+..
T Consensus 265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 999999999999997653 3599999999999999999999999999999999999993 349999999999887763
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.- ++..+..|+|||++. +.+|+.+.||||||||++||++|.+.|++.+..+++..|++.+|.|+..+...+....+.
T Consensus 345 vy--tYiQSRfYRAPEVIL-GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf 421 (586)
T KOG0667|consen 345 VY--TYIQSRFYRAPEVIL-GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF 421 (586)
T ss_pred ce--eeeeccccccchhhc-cCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence 32 788999999999998 678999999999999999999999999999999999999999999998877655443322
Q ss_pred cCC--CCCCc------------------------------CCCCcccccC-CCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 234 HGY--KFPKL------------------------------QGNNLSLLIP-SANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 234 ~~~--~~~~~------------------------------~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
... .++.. ....+....+ .....+.+||.+||.+||.+|+|+.++|+
T Consensus 422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 211 00000 0001111112 23345789999999999999999999999
Q ss_pred CCCCCCCC
Q 039371 281 HPLFQGCL 288 (346)
Q Consensus 281 hp~~~~~~ 288 (346)
|||+.+..
T Consensus 502 Hpfl~~~~ 509 (586)
T KOG0667|consen 502 HPFLTGTS 509 (586)
T ss_pred Cccccccc
Confidence 99999543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-53 Score=377.91 Aligned_cols=255 Identities=30% Similarity=0.494 Sum_probs=226.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH-hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-CLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
|++|-+.+.||+|.||.||+|+.+.+.+.||+|.+.+.....++ ....+|+.+++.+ +||||+.+++.|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEE
Confidence 89999999999999999999999999999999999776655543 4456899999999 899999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCC-CCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP-PYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~-~~~ 157 (346)
+||+.|+|...+... +.++|+.++.++.|++.||.|||+++|.|||+||.||+++. +.+|++|||+|+..+... ...
T Consensus 80 te~a~g~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred ehhhhhhHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 999999887777665 45999999999999999999999999999999999999965 599999999998877654 345
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...|||.|||||.+. ...|+..+|.||+||++||++.|++||...........|......++
T Consensus 159 sikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----------------- 220 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----------------- 220 (808)
T ss_pred eccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc-----------------
Confidence 568999999999887 78899999999999999999999999988877777777765443333
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+..+..+.+|+..+|..||.+|.|..+++.|||.++..
T Consensus 221 -------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 221 -------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred -------------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 25688999999999999999999999999999998754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-52 Score=360.79 Aligned_cols=267 Identities=27% Similarity=0.373 Sum_probs=221.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||.|..++||+|++..+++.||||+++.+.....-....+|+..++.+ +||||++++..|..+..+|+||+
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEeeh
Confidence 68999999999999999999999999999999999887776666677899988888 89999999999999999999999
Q ss_pred cCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCCC----
Q 039371 82 YMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCP---- 154 (346)
Q Consensus 82 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~~---- 154 (346)
+|. |++++.+... +..++|..|..|++++++||.|||++|.+|||||+.|||+ ++|.|||+|||.+.......
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 998 5666666433 4459999999999999999999999999999999999999 57899999999875432221
Q ss_pred -CCccccccCcccCccc-ccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 155 -PYTEYITTLQYRAPEM-LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 155 -~~~~~~~t~~y~aPE~-~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.+.+++||++|||||+ .....-|+.|+||||||+++.||.+|+.||....+...+...+++....+. ...
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~---t~~----- 256 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL---TSG----- 256 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc---ccc-----
Confidence 2266799999999999 444556999999999999999999999999998887766655443322111 000
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
....-....+..+++++..||+.||++|||++++|+|+||+....
T Consensus 257 ------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 257 ------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred ------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 000011356779999999999999999999999999999997653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-53 Score=377.58 Aligned_cols=254 Identities=29% Similarity=0.508 Sum_probs=221.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
..|....+||+|+.|.||.|....+++.||+|.++..... +....++|+.+|+.. +|+|||.+++.|...+.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEEEe
Confidence 4688899999999999999999999999999999877655 444567999999999 79999999999998899999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|++| +|.+.+... . ++|.+++.+++.++.||+|||.+||+|||||.+|||++ +|.+||+|||+|..+.... ...+
T Consensus 351 ym~ggsLTDvVt~~-~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-R-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred ecCCCchhhhhhcc-c-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 9996 544444433 2 99999999999999999999999999999999999994 6799999999997766544 6677
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
.+|||+|||||++. ...|+++.||||||++++||+.|++||-..+....++.|..... |...
T Consensus 429 mVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-P~lk---------------- 490 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PKLK---------------- 490 (550)
T ss_pred ccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-CCcC----------------
Confidence 89999999999997 67799999999999999999999999998888888888765432 2111
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
....+|+.+++|+.+||+.||.+|+++.|||+||||+..
T Consensus 491 ----------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 491 ----------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred ----------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 124789999999999999999999999999999999654
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=364.54 Aligned_cols=287 Identities=35% Similarity=0.631 Sum_probs=242.1
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+++|++.++||+|+||.||+|.++.+++.||+|.+.............+|+.+++++ +||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999987554443344556899999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
||+++++...+......+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++....... ....
T Consensus 84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 9999999988877666799999999999999999999999999999999999995 5699999999987544322 2334
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+++.|+|||++.+...++.++||||+||++|+|++|.+||...+..+....+....+.+....|..............
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 46788999999987666688999999999999999999999999988888888888888888888876544333333334
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+...........+.+++++++||.+||+.||.+|||++|+++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 44333333444567889999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=362.11 Aligned_cols=257 Identities=30% Similarity=0.457 Sum_probs=210.6
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC--EEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY--RLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~--~~~iv~ 80 (346)
++...+.||+|+||+||++.+.++|+..|+|.+....... .....+|+.+|.++ +|||||++++...... .++|+|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeee
Confidence 5788899999999999999999999999999997663332 33346899999999 4999999999854444 699999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeecccccccCC----C
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWEVDS----C 153 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~~~~----~ 153 (346)
||+. |++.+.+...++.++|+.++.+++|+++||+|||++||+|+||||+|||++. +.+||+|||++..... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9998 5777777776657999999999999999999999999999999999999976 6999999999987663 1
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGT-CEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.......||+.|||||++......+.++||||+||++.||+||.+||... ...+.+..+.....
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~--------------- 240 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS--------------- 240 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC---------------
Confidence 22445789999999999985333446999999999999999999999773 33333333322111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
...+.+.+|+++++||++|++.||++||||+++|+|||.+....
T Consensus 241 -------------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 241 -------------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred -------------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 11223468899999999999999999999999999999987654
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=346.83 Aligned_cols=259 Identities=30% Similarity=0.459 Sum_probs=229.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-----H--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-----W--EECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
+.|+-.+.||+|..++|-++.++.||..+|+|++...... . ......+|+.+++++.+||+|+++.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4678889999999999999999999999999998533221 1 12233679999999999999999999999999
Q ss_pred EEEEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeecccccccCC
Q 039371 75 RLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS 152 (346)
Q Consensus 75 ~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~ 152 (346)
.+++|+|.|+ |.|.+++...- .++|...++|++|+++|++|||.++||||||||+|||++++ +++|+|||+|+....
T Consensus 97 F~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 9999999998 78888777654 49999999999999999999999999999999999999665 999999999999999
Q ss_pred CCCCccccccCcccCcccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLM-----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
.......+|||+|+|||.+.. ...|+...|+|++|+|+|.|+.|.+||-.....-.+..|+++.-.+.++.|+
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa-- 253 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA-- 253 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh--
Confidence 888889999999999998863 3448889999999999999999999998877778888888888777777777
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
++|...++||++||+.||++|.|++|+|+||||...
T Consensus 254 ------------------------dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 254 ------------------------DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ------------------------hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 578999999999999999999999999999999643
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=369.70 Aligned_cols=260 Identities=33% Similarity=0.516 Sum_probs=232.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+.|++.+.||+|.||.||+|+++.||+.+|+|++++...... .....+|+.+|+++.+||||+.+++.|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 479999999999999999999999999999999977765433 245568999999997799999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe---C--CcEEEeecccccccCCC
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS---N--DTIKIADFGLAWEVDSC 153 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~---~--~~vkl~Dfg~a~~~~~~ 153 (346)
||++. |.|.+.+... .++|.++..+++|++.++.|||+.|++||||||+|+|+. + +.+|++|||++......
T Consensus 115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99998 4777877766 399999999999999999999999999999999999993 2 37999999999988876
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......+||+.|+|||++. ...|+.++||||+|+++|.|++|.+||.+.+.......+..+....+.+.|.
T Consensus 193 ~~~~~~~Gtp~y~APEvl~-~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~-------- 263 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLG-GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWD-------- 263 (382)
T ss_pred ceEeeecCCccccCchhhc-CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcc--------
Confidence 6788899999999999886 5779999999999999999999999999999998888887776555555544
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
.++..++++|+.||..||.+|+|+.++|+|||+++....
T Consensus 264 ------------------~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 264 ------------------DISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred ------------------ccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 679999999999999999999999999999999976443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=358.52 Aligned_cols=281 Identities=33% Similarity=0.585 Sum_probs=225.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++.+.||+|+||+||+|+++.+++.||+|++....... ......+|+.+++.+ +||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEE
Confidence 58999999999999999999999999999999997553322 233456799999998 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CCc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PYT 157 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~~ 157 (346)
||+++++++.+......+++..++.++.|++.||.|||+.|++|+||||+||+++ ++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9999988887776666799999999999999999999999999999999999995 5689999999997754322 233
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+++.|+|||++. ...++.++||||+||++|+|++|++||.+.+..+....+....+..+.+.+.............
T Consensus 160 ~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLL-GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 457899999999887 4568999999999999999999999999988888777777766666655443222211111111
Q ss_pred CCCcCCC--CcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 238 FPKLQGN--NLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 238 ~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.+..... .........+.++.+||++||+.||++|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1111110 0011123468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=377.11 Aligned_cols=280 Identities=33% Similarity=0.537 Sum_probs=228.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--------C
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--------N 73 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--------~ 73 (346)
++|++++.||+|+||+||+|.+..+++.||+|++..... ...+|+.+++.+ +||||+++++++.. .
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-----YKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCc
Confidence 479999999999999999999999999999998854322 123688999999 79999999887632 2
Q ss_pred CEEEEEEEcCCCCHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C-cEEEeeccccc
Q 039371 74 YRLYFVFEYMDCNLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D-TIKIADFGLAW 148 (346)
Q Consensus 74 ~~~~iv~e~~~g~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~-~vkl~Dfg~a~ 148 (346)
..+++||||+++++.+.+. ..+..+++..++.++.||+.||+|||++||+||||||+||+++. + .+||+|||+|.
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 3578999999998877664 23456999999999999999999999999999999999999963 3 69999999998
Q ss_pred ccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 149 EVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 149 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
............+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+....+.+..+....+.|+.+.+....
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 76554455556789999999998766679999999999999999999999999999999999999988888876655322
Q ss_pred HHHHhcCCCCCCcCCCCcccc-cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLL-IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.. .....++......+... ....++++++||.+||+.||.+|||+.|+++||||+....
T Consensus 300 ~~--~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 300 PN--YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hh--hhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 11 11223333332222222 2356789999999999999999999999999999987644
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-50 Score=364.82 Aligned_cols=284 Identities=31% Similarity=0.456 Sum_probs=228.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN------ 73 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------ 73 (346)
+++|++.+.||+|+||.||+|.+..+|+.||+|++....... ......+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCcccc
Confidence 478999999999999999999999999999999997554332 334456899999888 799999999998644
Q ss_pred CEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 74 YRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 74 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
..+|++|||+++++...+.. .+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++.....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 35799999999998877643 389999999999999999999999999999999999995 56999999999976555
Q ss_pred CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
........+|+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+.+..+.|....+........
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred CccCCCCcccCCCCCchhcc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 44455567899999999987 56689999999999999999999999999988888888888888887665544333222
Q ss_pred hcCCCCCCcCCCCc------------ccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNL------------SLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......+....... .......++++++||.+||+.||++|||++|+|+||||+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 11111111111111 1112234678999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=356.70 Aligned_cols=279 Identities=34% Similarity=0.613 Sum_probs=225.6
Q ss_pred CceeeeeeecccCceEEEEEEEcc-CCcEEEEEEccccccCH-HHhhhHHHHHHHHhhc--CCCCeeeeeeeee-----c
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-SGEYVAIKALKQRIYSW-EECLNLKEVKCLRKIN--NHPNIVKLQELAS-----E 72 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~--~hp~iv~~~~~~~-----~ 72 (346)
++|++++.||+|+||+||+|.+.. +++.||+|+++...... ......+|+.+++.+. +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 589999999999999999999854 57889999986543322 2223446776666653 6999999999874 3
Q ss_pred CCEEEEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc
Q 039371 73 NYRLYFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV 150 (346)
Q Consensus 73 ~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~ 150 (346)
...++++||++++++.+.+.... ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 45689999999999988886543 3589999999999999999999999999999999999995 569999999999776
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
..........+++.|+|||++. ...++.++||||+||++|+|++|.+||.+.+..+.+..+.+..+.|.+..|......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 161 SFQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred cCCcccccccccccccChHHHh-CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 6544455667899999999886 566899999999999999999999999999999999999988888777766543321
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.. ..+............+.+++.+++++.+||+.||++|||+.|+++||||
T Consensus 240 ~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cc---hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 11 1111222223334456788999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-50 Score=361.66 Aligned_cols=285 Identities=35% Similarity=0.572 Sum_probs=225.2
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-----CEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASEN-----YRL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-----~~~ 76 (346)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... .......+|+.+++.+ +||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 699999999999999999999999999999998643222 2233456899999999 799999999987533 358
Q ss_pred EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-
Q 039371 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~- 154 (346)
|+||||+++++.+.+.... .+++..+..++.||++||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 80 ~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCCCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999999999888776544 499999999999999999999999999999999999995 5699999999987543211
Q ss_pred ---CCccccccCcccCcccccc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 155 ---PYTEYITTLQYRAPEMLLM-SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 155 ---~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
......+|+.|+|||++.. ...++.++||||+||++|+|++|++||.+.+....+..+....+.++...+......
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1234578999999998763 256899999999999999999999999998888888888888887776655432211
Q ss_pred HHh-cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 231 AKA-HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
... .-...............+..++++.+++.+||+.||++|||++|+++||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 100 00001111111122234567889999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-51 Score=350.04 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=220.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+.|++++.||.|.-|+||+|..+.++..+|+|++++..... +..+...|..+|..+ +||.++++|..|+.++..|++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEE
Confidence 56889999999999999999999999999999998776543 334456788889888 899999999999999999999
Q ss_pred EEcCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCC----
Q 039371 80 FEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDS---- 152 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~---- 152 (346)
||||.| +|...+.+++ ..++++.++.++..++.||+|||-.|||+|||||+|||+ ++|++.|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999986 6666665553 469999999999999999999999999999999999999 678999999998742210
Q ss_pred -------------------------------C----------------------CCCccccccCcccCcccccccCCCCC
Q 039371 153 -------------------------------C----------------------PPYTEYITTLQYRAPEMLLMSGQYNS 179 (346)
Q Consensus 153 -------------------------------~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~ 179 (346)
. ...+.++||-.|.|||++.+.+ .+.
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-Hgs 314 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGS 314 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CCc
Confidence 0 0112367899999999998544 799
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHH
Q 039371 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMS 259 (346)
Q Consensus 180 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (346)
++|+|+||+++|||+.|..||.+.+..+++.+|+......+.. +.++..++|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~----------------------------~~vs~~akD 366 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE----------------------------PEVSSAAKD 366 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC----------------------------CcchhHHHH
Confidence 9999999999999999999999999999999997654333221 357899999
Q ss_pred HHHHhcccCCCCCCC----HHHHhcCCCCCCCCC
Q 039371 260 LIELLCSWDPCKRPT----AAEALQHPLFQGCLQ 289 (346)
Q Consensus 260 li~~~l~~dP~~Rps----~~ell~hp~~~~~~~ 289 (346)
||+++|.+||++|.. |.||.+||||++...
T Consensus 367 LIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 367 LIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred HHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 999999999999999 999999999998764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-51 Score=356.70 Aligned_cols=257 Identities=31% Similarity=0.443 Sum_probs=213.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-------------HHhhhHHHHHHHHhhcCCCCeeeee
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-------------EECLNLKEVKCLRKINNHPNIVKLQ 67 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~l~~l~~hp~iv~~~ 67 (346)
+++|++++.||+|.||.|-+|++..+++.||||++.+..... ......+|+.+++++ .|||||+++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li 174 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI 174 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence 589999999999999999999999999999999995443221 112446899999999 799999999
Q ss_pred eeeecC--CEEEEEEEcCCCCHHHHHhcccCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEee
Q 039371 68 ELASEN--YRLYFVFEYMDCNLHQLMSNRKQC-FSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIAD 143 (346)
Q Consensus 68 ~~~~~~--~~~~iv~e~~~g~l~~~~~~~~~~-l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~D 143 (346)
++..+. +.+|+|+|||..+-....-. .++ +++.+++.++++++.||+|||.+||+||||||+|+|+ ++|.+||+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 999765 68999999998433222222 223 8999999999999999999999999999999999999 568999999
Q ss_pred cccccccCCC------CCCccccccCcccCccccccc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 039371 144 FGLAWEVDSC------PPYTEYITTLQYRAPEMLLMS---GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 144 fg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 214 (346)
||.+...... ......+|||.|+|||..... ...+.+.||||+|++||.|+.|+.||.+....+...+|..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 9998765322 223446899999999988752 3457899999999999999999999999999888888876
Q ss_pred HhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
..-..+ .. +.+..++++||.+||++||++|+++.++..|||...-
T Consensus 334 ~pL~fP-------------------~~---------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DPLEFP-------------------EN---------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CcccCC-------------------Cc---------ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 533222 21 3568899999999999999999999999999999765
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=361.96 Aligned_cols=284 Identities=31% Similarity=0.452 Sum_probs=229.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASEN------ 73 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------ 73 (346)
+++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+|+.+++.+ +||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeeccccccccc
Confidence 47999999999999999999999999999999999765433 2334456888888888 799999999987543
Q ss_pred CEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 74 YRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 74 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
..+|+||||+++++...+.. .+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++...+.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 46799999999998887753 388999999999999999999999999999999999995 56999999999987665
Q ss_pred CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
........+|+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+..+....+....+.|.++.+........
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CCcccCCcccCCcCCHHHHh-CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 55555668899999999987 56689999999999999999999999999999999999998888887765554333222
Q ss_pred hcCCCCCCcCCCC------------cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNN------------LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......+...... ........+.++++||.+||+.||.+|||++|+|+||||..+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 1111111111110 01111234567899999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=368.14 Aligned_cols=256 Identities=30% Similarity=0.476 Sum_probs=222.3
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH--hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE--CLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|.+++.||+|.||+|++|..+.+++.||||++++...-.+. .....|-.++....+||.++.++..|++.+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 57899999999999999999999999999999999877654322 2235677788877789999999999999999999
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCC
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPY 156 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~ 156 (346)
||||+.|+....+ ...+.++|..++.++..|+.||.|||++||+|||||.+|||+| +|.+||+|||++...- .....
T Consensus 447 vmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~T 525 (694)
T KOG0694|consen 447 VMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRT 525 (694)
T ss_pred EEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCcc
Confidence 9999997663223 3335599999999999999999999999999999999999996 6799999999997643 55578
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
++++|||.|+|||++. ...|+.+.|+|||||++|||+.|++||++++.++.+..|+....
T Consensus 526 sTfCGTpey~aPEil~-e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~------------------- 585 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLT-EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV------------------- 585 (694)
T ss_pred ccccCChhhcChhhhc-cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-------------------
Confidence 8899999999999998 67799999999999999999999999999999999998865422
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCL 288 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~ 288 (346)
.+| ..+|.++.++++++|+.||++|.. +++|.+||||+++.
T Consensus 586 ~yP-----------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 586 RYP-----------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred CCC-----------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 121 256899999999999999999986 58999999999764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=351.32 Aligned_cols=278 Identities=34% Similarity=0.605 Sum_probs=224.7
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhc--CCCCeeeeeeeeec-----CC
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKIN--NHPNIVKLQELASE-----NY 74 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~--~hp~iv~~~~~~~~-----~~ 74 (346)
+|++.+.||+|+||+||+|.++.+++.||+|.++...... ......+|+.+++.+. +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 6999999999999999999999999999999987543221 1122345666666553 69999999998754 35
Q ss_pred EEEEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
.++++||++++++.+.+.... ..+++..++.++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 689999999999888776543 3489999999999999999999999999999999999995 56999999999987665
Q ss_pred CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
........++..|+|||++. ...++.++||||+||++|+|++|.+||.+....+.+.++....+.+....|.......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (288)
T cd07863 161 QMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP- 238 (288)
T ss_pred cccCCCccccccccCchHhh-CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc-
Confidence 44445567899999999887 5668999999999999999999999999998888888888887777666654322111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
...+............+.++..+.++|.+||+.||++|||+.|+++||||
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 239 --RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred --ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11122222233444556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=359.23 Aligned_cols=284 Identities=31% Similarity=0.471 Sum_probs=228.1
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN------ 73 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------ 73 (346)
+++|++.+.||+|+||.||+|.+..+++.||+|.+....... ......+|+.+++.+ +||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeecccccccc
Confidence 478999999999999999999999999999999997654333 334556888888888 799999999988543
Q ss_pred CEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 74 YRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 74 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
...|++|||+++++...+.. .+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++.....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 35799999999998877653 389999999999999999999999999999999999995 56999999999987766
Q ss_pred CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
........+|+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+....+.+.++.+........
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred ccccCCccccCCccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 55556678899999999886 55689999999999999999999999999988888888888888877765544322221
Q ss_pred hcCC--------CCCCcCCCC----cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGY--------KFPKLQGNN----LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~--------~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.... .++...... ........+.++++||.+||+.||++|||++|+++||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 1100 111100000 01112234567899999999999999999999999999986654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=347.57 Aligned_cols=280 Identities=43% Similarity=0.782 Sum_probs=234.8
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEEEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN--YRLYFVFE 81 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~~iv~e 81 (346)
|++++.||+|++|.||+|.+..+++.||+|+++............+|+..+.++.+|||++++++++.++ +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7899999999999999999999999999999876544444445568888899987799999999999887 88999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccccCCCCCCccccc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYIT 161 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~~~~~~~~ 161 (346)
|++|++.+.+......+++..+..++.|++.||+|||+.|++|+||+|+||+++++.+||+|||.+.............+
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~~ 160 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYIS 160 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCCCC
Confidence 99999999887766679999999999999999999999999999999999999889999999999987765555555678
Q ss_pred cCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCc
Q 039371 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241 (346)
Q Consensus 162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
+..|+|||.+.....++.++||||+||++|+|++|.+||.+.+..+....+....+.+.... .............++..
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 239 (282)
T cd07831 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRHMNYNFPSK 239 (282)
T ss_pred CcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcccccccccCccc
Confidence 89999999876566788999999999999999999999999988888888877777666544 22222222223334443
Q ss_pred CCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
....+....+.++..+.++|.+||+.||++|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 240 KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 3333444456778999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-52 Score=360.36 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=220.3
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
.|..++.||+|.||.||+|.+..+++.||+|+++............+|+.++.++ ++|||.++|+.+-.+..++|+|||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHHHH
Confidence 5888899999999999999999999999999999988888888888999999999 799999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcccc
Q 039371 83 MDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEYI 160 (346)
Q Consensus 83 ~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~~ 160 (346)
|+|+....+.+.+..+.|..+.-++++++.||.|||.++.+|||||+.||++. +|.+||+|||.+....... ...+++
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfv 172 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFV 172 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccccc
Confidence 99765555555555569999999999999999999999999999999999994 5799999999986655433 347899
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (346)
|||.|||||++. ...|+.++||||||++++||++|.+|+....+...+..|-+
T Consensus 173 GTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-------------------------- 225 (467)
T KOG0201|consen 173 GTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-------------------------- 225 (467)
T ss_pred ccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC--------------------------
Confidence 999999999998 66799999999999999999999999987766433333311
Q ss_pred cCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
..+..+....|+.+++|+..||+.||+.||||.++|+|+|++..
T Consensus 226 ---~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 226 ---SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred ---CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 11222224678999999999999999999999999999999974
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=361.28 Aligned_cols=283 Identities=34% Similarity=0.506 Sum_probs=229.7
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-----EE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENY-----RL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~-----~~ 76 (346)
+|++++.||+|+||+||+|.+..+++.||+|.+....... ......+|+.+++.+ +||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986543322 234557899999999 7999999999998776 78
Q ss_pred EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC--
Q 039371 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-- 153 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-- 153 (346)
|+||||+.+++.+.+... ..+++..++.++.||+.||.|||++|++||||||+||+++ ++.+||+|||++......
T Consensus 80 ~lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 999999999888877654 4599999999999999999999999999999999999995 459999999999765432
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.......+++.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.++.+.+.........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 22334567889999999886667899999999999999999999999999999999999999898887666543322221
Q ss_pred cCCCCCCcC--CCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 234 HGYKFPKLQ--GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 234 ~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.-...+... ...........++++.+||.+||+.||++|||++|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111111100 011112334568899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=352.75 Aligned_cols=252 Identities=27% Similarity=0.370 Sum_probs=211.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++...... .......+|+.+++++ +||||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEE
Confidence 5899999999999999999999999999999998654322 1233446789999999 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
|||+.| +|.+.+... +.+++..+..++.|++.||+|||++|++||||||+||+++ ++.+||+|||++...... ..
T Consensus 80 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~ 156 (291)
T cd05612 80 MEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TW 156 (291)
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cc
Confidence 999985 676666554 4599999999999999999999999999999999999995 569999999999765432 23
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...|++.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+..... .
T Consensus 157 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-------------------~ 216 (291)
T cd05612 157 TLCGTPEYLAPEVIQ-SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL-------------------E 216 (291)
T ss_pred cccCChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-------------------C
Confidence 457899999999886 55689999999999999999999999988877666655543211 1
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~ 288 (346)
+ ....+..++++|++||+.||.+||+ ++++++||||+...
T Consensus 217 ~-----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 217 F-----------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred C-----------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 1 1245788999999999999999995 99999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=357.19 Aligned_cols=252 Identities=29% Similarity=0.421 Sum_probs=211.1
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||+||+|+++.+++.||+|++...... .......+|+.+++++ +||||+++++.+.+++..|+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEE
Confidence 47899999999999999999999999999999999754322 1223456899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
+|||+.| +|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++...... .
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T 172 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence 9999985 66666654 44589999999999999999999999999999999999995 569999999999766442 2
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 173 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------------------- 232 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL------------------- 232 (329)
T ss_pred ceecCChhhcCHHHHc-CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc-------------------
Confidence 3457899999999887 55679999999999999999999999988776655555433210
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
.+ ...++..+++||++||+.||.+|++ ++++++||||++.
T Consensus 233 ~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 233 KF-----------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred CC-----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 11 1236788999999999999999997 7999999999874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=325.74 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=222.1
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|-||.||+|+.++++-.||+|++.++..... +....+|+.+...| +||||+++|++|-+...+|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccceeEE
Confidence 5789999999999999999999999999999999966543322 22335788888888 79999999999999999999
Q ss_pred EEEcCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCCCC
Q 039371 79 VFEYMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 79 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~~~ 155 (346)
++||.. |.+...+... ...++|.....++.|++.||.|||.++++||||||+|+|+ .+|.+|++|||.+...+ ...
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~k 178 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNK 178 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCC
Confidence 999997 7888887744 3459999999999999999999999999999999999999 57899999999997665 456
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
..+.+||..|.|||... +..++...|+|++|++.||++.|.+||.+....+...+|.+....
T Consensus 179 R~tlcgt~dyl~pEmv~-~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~----------------- 240 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVE-GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK----------------- 240 (281)
T ss_pred ceeeecccccCCHhhcC-CCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-----------------
Confidence 67789999999999887 666899999999999999999999999999988888888765322
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
+| +.++..+.++|.+||..+|.+|.+..|++.|||+..
T Consensus 241 --~p-----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 --FP-----------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred --CC-----------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 22 367899999999999999999999999999999864
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-50 Score=352.31 Aligned_cols=300 Identities=25% Similarity=0.375 Sum_probs=253.0
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
|.+.+.||+|.|+.|.+|++--||+.||+|++++...+.. ....++|+..++.+ +|||||++|++..+...+|+|+|+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEEEEEEe
Confidence 7888999999999999999999999999999987766543 34457899999888 899999999999999999999999
Q ss_pred CC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE--eCCcEEEeecccccccCCCCCCccc
Q 039371 83 MD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV--SNDTIKIADFGLAWEVDSCPPYTEY 159 (346)
Q Consensus 83 ~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli--~~~~vkl~Dfg~a~~~~~~~~~~~~ 159 (346)
-+ |++.+++.+....+.|+.+++++.||+.|+.|||+..+|||||||+||.+ .-|-|||.|||++..+.+....++.
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~Ts 178 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTS 178 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcc
Confidence 98 59999999888889999999999999999999999999999999999998 4579999999999999999999999
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (346)
+|+..|.|||++.+..+-.++.||||||+|+|.|++|++||...++.+.+..|+++.-.-+
T Consensus 179 CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP------------------- 239 (864)
T KOG4717|consen 179 CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP------------------- 239 (864)
T ss_pred cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc-------------------
Confidence 9999999999999888778899999999999999999999999999999999987643222
Q ss_pred CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCccccc-ccCCcccc---------cc
Q 039371 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCK-MRLTPSAK---------KS 309 (346)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~-~~~~~~~~---------~~ 309 (346)
..++.+.++||..||..||++|.|.+||..|+|++......+..++-.. ..+..... ..
T Consensus 240 -----------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvsr~~L~ee~Ha~IIq~Mv~G~ 308 (864)
T KOG4717|consen 240 -----------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVSRHHLPEEAHATIIQQMVAGA 308 (864)
T ss_pred -----------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCceeehhhCChHHHHHHHHHHhccc
Confidence 3678999999999999999999999999999999987665443322221 12221111 11
Q ss_pred CccchhhhhhcccCcchhHHHHHHH
Q 039371 310 GWKAKLIVWFLRWEPFSSLLLFVAC 334 (346)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (346)
--....+.+.+.+.-||...+-+.+
T Consensus 309 IAs~e~Il~aLe~n~YNhiTATYfL 333 (864)
T KOG4717|consen 309 IASEEDILRALENNEYNHITATYFL 333 (864)
T ss_pred ccCHHHHHHHHhccccchhhhHHHH
Confidence 1122455666777777776665544
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=345.48 Aligned_cols=283 Identities=36% Similarity=0.618 Sum_probs=230.4
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+++|++.+.||+|++|+||+|.++.+++.||+|.+.............+|+.+++++ +||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEEE
Confidence 589999999999999999999999999999999987654333333456799999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
||+++++.+.+......+++..++.++.|+++||.|||++|++|+||+|+||+++ ++.++|+|||++....... ....
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 9999999888877666789999999999999999999999999999999999995 5699999999986543221 2223
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTC-EDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..++..|+|||.+.+...++.++||||+||++|+|++|..||.+.. ..+.+..+.+..+.+.+..|.............
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS 242 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence 3467889999988755668899999999999999999999997766 556677777777877777776554433332333
Q ss_pred CCCcCCCCcccccCCCC--chHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 238 FPKLQGNNLSLLIPSAN--DDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~--~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.+...........+..+ .++.+++.+||+.||++|||++++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 243 FPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 32222222233333455 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=344.89 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=227.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH--hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE--CLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
.||++.+.||+|.||.|-+|++...|+.||||.++++....+. ..+.+|+.++..+ +||||+.+|++|++.+.+.||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEE
Confidence 4799999999999999999999999999999999877665443 3446899999999 899999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
|||.. |.|.+++..++. ++|.+++.+++||..|+.|||+++++|||||.+|||+| ++++||.|||++.........+
T Consensus 132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 99997 688898887765 99999999999999999999999999999999999996 5699999999999888888899
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
+++|+|.|.+||++.+..+-++..|.||||++||.|+.|..||++.+-.....+|.++- +
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga-------------------Y- 270 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA-------------------Y- 270 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc-------------------c-
Confidence 99999999999999887888999999999999999999999999998777777664431 1
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..|..+.++.-||++||..||++|.|++++-.|=|++=-+.
T Consensus 271 -----------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 271 -----------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred -----------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeecccc
Confidence 12445778889999999999999999999999988764443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=356.38 Aligned_cols=255 Identities=29% Similarity=0.517 Sum_probs=230.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE-EEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYR-LYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~-~~i 78 (346)
|++|+.++.+|+|+||.+++++++.+++.|++|.+........ ...+.+|..++.++ .|||||.+.+.|.+++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEE
Confidence 7899999999999999999999999999999999976665443 34667899999998 79999999999998887 999
Q ss_pred EEEcCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-
Q 039371 79 VFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~- 154 (346)
+|+||+| ++.+.+.+.+ ..++|+.+..|+.|++.|+.|||+++|.|||||+.||+++ ++.|+|+|||+|+..++..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 9999995 6667776665 6799999999999999999999999999999999999995 5588999999999988766
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
...+..||+.|++||.+. +.+|+.++|||||||++|||++.+++|.+.+......+|+.....|.+
T Consensus 162 ~a~tvvGTp~YmcPEil~-d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------- 227 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILS-DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------- 227 (426)
T ss_pred hhheecCCCcccCHHHhC-CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-------------
Confidence 677889999999999887 788999999999999999999999999999999999999887755544
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
..++.+++.+|+.||+.+|..||++.++|.+|.++.
T Consensus 228 ----------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 228 ----------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ----------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 357899999999999999999999999999999874
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=346.60 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=210.4
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.|++.+.||+|+||+||+|.+..+|+.||+|.+...... .......+|+.++.++ +||+|+++.+.+.+++..+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEE
Confidence 488999999999999999999999999999998654332 2223456899999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 81 EYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 81 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||+.| ++...+... ...+++..+..++.|++.||+|||++||+||||||+||+++ ++.++|+|||++..........
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence 99985 665555433 33589999999999999999999999999999999999995 5699999999998765444445
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...||..|+|||++. ...++.++||||+||++|+|++|..||.+.........+......+.
T Consensus 160 ~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 221 (285)
T cd05631 160 GRVGTVGYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ----------------- 221 (285)
T ss_pred CCCCCCCccCHhhhc-CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-----------------
Confidence 567899999999987 56789999999999999999999999987654333222221111000
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~ 288 (346)
.......+.++.+|+++||+.||++||+ ++++++||||++..
T Consensus 222 ---------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 222 ---------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ---------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 0112357889999999999999999997 89999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-50 Score=308.49 Aligned_cols=285 Identities=34% Similarity=0.593 Sum_probs=247.6
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
|.+|...++||+|.||+||+|+++.+++.||+|.+..+..++ .....++|+-+++.+ +|.|||++++....+..+.+|
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEe
Confidence 678999999999999999999999999999999997665543 234557999999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCCC-CCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCP-PYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~~-~~~ 157 (346)
+|+|+.++..++..-++.++.+.++.++.|++.||.|||++++.|||+||.|.++ .+|.+||.|||+++..+-.. -++
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 9999999999999888889999999999999999999999999999999999999 57899999999998877543 345
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
..+.|..|.+|.++.+..-|+.+.|+||-|||+.|+.. |.+.|++.+..+++.+|...++.|.++.|......-....+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 56789999999999988889999999999999999986 78999999999999999999999999999754322111111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.-......+..+.|+.+..-+++++++|.-+|.+|+++++.++||||...
T Consensus 240 -p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 240 -PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred -CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 01112234556678888899999999999999999999999999999853
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=354.07 Aligned_cols=283 Identities=32% Similarity=0.542 Sum_probs=227.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------C
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN------Y 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------~ 74 (346)
++|++++.||+|+||+||+|.+..+++.||+|++....... ......+|+.+++++ +||||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccccC
Confidence 68999999999999999999999999999999987543332 223456899999999 799999999987543 4
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
..|+++|++++++...+.. ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++.....
T Consensus 94 ~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~- 170 (343)
T cd07878 94 EVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD- 170 (343)
T ss_pred cEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC-
Confidence 5799999998888776643 3499999999999999999999999999999999999995 56999999999976554
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH-H
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA-K 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~ 232 (346)
......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....+.+..+.+....... .
T Consensus 171 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred -CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 23445789999999998765678999999999999999999999999988888888888887777665543322111 1
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......+..............++.+.+||.+||+.||.+|||++|+++||||.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 111112222222233334466788999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=357.42 Aligned_cols=276 Identities=22% Similarity=0.327 Sum_probs=215.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||.||+|.+..+++.||+|.... ....+|+.+++++ +||||+++++++..+...++++|
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEEEe
Confidence 579999999999999999999999999999997542 2245799999999 79999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC--CCCcc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC--PPYTE 158 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~--~~~~~ 158 (346)
++.+++...+.... .+++.++..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++...... .....
T Consensus 164 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 164 RYKTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 99999888776554 489999999999999999999999999999999999995 569999999998653321 22334
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCChhhHHHHH---
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGT-------CEDDQLYKICNAIGSPTEESWAEGL--- 228 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~--- 228 (346)
..||+.|+|||++. ...++.++||||+||++|+|++|..||... .....+..+....+.++.+...+..
T Consensus 243 ~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 243 WAGTIATNAPELLA-RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred ccCccCCCChhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 67999999999887 566899999999999999999999776432 2345666677666655433211110
Q ss_pred H----HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 229 E----LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 229 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
. .........+... ... ......+.++.+||++||+.||.+|||++|+|+||||++...
T Consensus 322 ~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSR-PLW-TNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred HHHHHHHHhccCCCCCCC-CCH-HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 0 0000001111000 000 011245678999999999999999999999999999987643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=354.06 Aligned_cols=247 Identities=31% Similarity=0.454 Sum_probs=205.2
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||.||+|.++.+|+.||+|+++..... .......+|+.++.++ +||||+++++.+.+++.+|+||||+.|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999754322 2233456789999998 799999999999999999999999986
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~~~~~t 162 (346)
+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++.... .........||
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 55555544 45699999999999999999999999999999999999995 5699999999986532 22234456799
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||.+.+.......+..... .+
T Consensus 159 ~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-------------------~~---- 214 (323)
T cd05571 159 PEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------------------RF---- 214 (323)
T ss_pred ccccChhhhc-CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-------------------CC----
Confidence 9999999886 56689999999999999999999999988766555544432110 11
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
...+++++.++|++||+.||++|| ++.++++||||++.
T Consensus 215 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 215 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 135788999999999999999999 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=346.96 Aligned_cols=287 Identities=37% Similarity=0.611 Sum_probs=232.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASEN--YRLY 77 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 77 (346)
+++|++.+.||+|++|.||+|.+..+|+.||+|++........ .....+|+.+++++ +||||+++++++.+. +.++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEE
Confidence 5789999999999999999999999999999999865433221 22345799999999 799999999998654 5789
Q ss_pred EEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CC
Q 039371 78 FVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PP 155 (346)
Q Consensus 78 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~ 155 (346)
+|||++++++.+.+......+++.++..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+...... ..
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 9999999998888877666799999999999999999999999999999999999995 569999999999766543 22
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+.+....|...........
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 33345578899999987666789999999999999999999999999999999999999888887776654322221112
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
...+..............++.+.++|++||+.||++|||++++++||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 22222222222223345688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=342.04 Aligned_cols=280 Identities=38% Similarity=0.676 Sum_probs=228.4
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++++.||+|++|+||+|++..++..||+|.+....... ......+|+.+++++ +||||+++++++.+++.+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999986543322 223456799999999 79999999999999999999999
Q ss_pred cCCCCHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCc
Q 039371 82 YMDCNLHQLMSNRK--QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYT 157 (346)
Q Consensus 82 ~~~g~l~~~~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~ 157 (346)
|+.+++.+.+.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++....... ...
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 99998888775432 5689999999999999999999999999999999999994 5699999999987654322 223
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+++.|+|||++.+...++.++||||+||++|+|++|++||.+....+....+....+.+....|....... .....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 238 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP-DYKNT 238 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH-HHHhh
Confidence 34568899999988766668899999999999999999999999988888888888877777777665432211 11122
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
++.............+++++.++|++||+.||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 22222223333345688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=341.90 Aligned_cols=282 Identities=37% Similarity=0.647 Sum_probs=237.0
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc-CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++.+.||.|++|.||+|.+..+|+.||+|++..... ........+|+.+++++ +||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEec
Confidence 69999999999999999999999999999999976543 22334566899999999 69999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CCcc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PYTE 158 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~~~ 158 (346)
++++++.+.+......+++.+++.++.|++.||+|||+.|++|+||+|+||+++ ++.++|+|||.+....... ....
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 997788888876666799999999999999999999999999999999999995 5689999999987665433 2445
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||.+.+...++.++||||+||++|+|++|.+||.+......+..+....+.+....|.+..+........+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 57889999999987666679999999999999999999999999888888888988888888877765443333333333
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
+......+....+..+..+.++|++||+.||++|||++++++||||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 33333333444567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=342.91 Aligned_cols=279 Identities=35% Similarity=0.606 Sum_probs=226.8
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++.+.||+|++|.||+|++..+|+.||+|.++...... ......+|+.+++++ +||||+++++++.+.+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEe
Confidence 6999999999999999999999999999999986543222 123345799999999 79999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCccc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEY 159 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~ 159 (346)
|+++++.+.+....+.+++..++.++.||++||.|||++|++|+||||+||+++ ++.++|+|||++....... .....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 999999988877666799999999999999999999999999999999999995 5699999999987654322 23345
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPL-FPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
.++..|+|||.+.+...++.++||||+||++|+|++|..| |.+.+..+.+..+.+..+.+....|....+..... ..
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 237 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK--PY 237 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc--cc
Confidence 6788999999987656689999999999999999998877 56666677788888888877777665433222211 11
Q ss_pred CCcC-CCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 239 PKLQ-GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 239 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+... ........+.+++++.++|++||+.||.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1111 111223446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=355.58 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=207.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|.+..+++.||+|++....... ......+|..++.++ +||||+++++.+.++..+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence 68999999999999999999999999999999997543221 223345688888888 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--- 154 (346)
|||++| +|.+.+.. .+.+++.+++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999985 66666654 44699999999999999999999999999999999999995 5699999999986543211
Q ss_pred ---------------------------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 039371 155 ---------------------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFP 201 (346)
Q Consensus 155 ---------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 201 (346)
.....+||+.|+|||++. ...++.++||||+||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-CCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 012357899999999987 5668999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCC---CCCCHHHH
Q 039371 202 GTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPC---KRPTAAEA 278 (346)
Q Consensus 202 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~---~Rps~~el 278 (346)
+.+..+....+....... .++. ...++++++++|.+|+. +|. .||+++|+
T Consensus 238 ~~~~~~~~~~i~~~~~~~-----------------~~p~---------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei 290 (363)
T cd05628 238 SETPQETYKKVMNWKETL-----------------IFPP---------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEI 290 (363)
T ss_pred CCCHHHHHHHHHcCcCcc-----------------cCCC---------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 888777666664321110 1111 02467899999999875 444 46899999
Q ss_pred hcCCCCCCC
Q 039371 279 LQHPLFQGC 287 (346)
Q Consensus 279 l~hp~~~~~ 287 (346)
++||||++.
T Consensus 291 ~~hp~f~~~ 299 (363)
T cd05628 291 KTNPFFEGV 299 (363)
T ss_pred hCCCCCCCC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=353.09 Aligned_cols=253 Identities=28% Similarity=0.362 Sum_probs=209.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCC-cEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSG-EYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
+++|++.+.||+|+||.||+|.++.++ ..||+|++...... .......+|+.++..+ +||||+++++++.+++.+|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEE
Confidence 368999999999999999999876654 68999998654321 2233456789999998 7999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
+||||+.| +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 99999975 666666544 4599999999999999999999999999999999999995 569999999999766532
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+.......+......
T Consensus 185 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~----------------- 246 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILL-NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY----------------- 246 (340)
T ss_pred cceecCChhhcCHHHHh-CCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence 23567899999999987 556899999999999999999999999887766655555432111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~~ 288 (346)
+ .+..++.+.++|++||+.||++|+ |++++++||||++..
T Consensus 247 --~-----------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 247 --F-----------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred --C-----------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 1 134678899999999999999995 899999999998753
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=350.10 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=213.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||.||+|++..+++.||+|+++..... .......+|+.++..+ +||||+++++++.+++..|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEE
Confidence 5899999999999999999999999999999999755332 1233456788999998 699999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
|||++| +|.+.+.. .+.+++..++.++.|++.||.|||++||+||||||+||+++ ++.+||+|||++..... ...
T Consensus 80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccC
Confidence 999985 66666554 44599999999999999999999999999999999999995 56999999999976544 334
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...||+.|+|||++. ...++.++||||+||++|+|++|..||...+..+....+....... .
T Consensus 157 ~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----------------~ 218 (333)
T cd05600 157 SVVGSPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL-----------------Q 218 (333)
T ss_pred CcccCccccChhHhc-CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc-----------------c
Confidence 567899999999987 4578999999999999999999999999887766655553321100 0
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.+. .......+++++.++|.+||+.+|.+|||++++++||||+..
T Consensus 219 ~~~-----~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 219 RPV-----YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred CCC-----CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 000 000013568899999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=341.80 Aligned_cols=283 Identities=41% Similarity=0.687 Sum_probs=233.2
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN--YRLY 77 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 77 (346)
+++|++.+.||.|++|.||+|.+..+++.+++|.++...... ......+|+.+++++ +||||+++++++..+ +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence 468999999999999999999999999999999997544332 122346799999999 699999999998777 8999
Q ss_pred EEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CC
Q 039371 78 FVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PP 155 (346)
Q Consensus 78 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~ 155 (346)
++|||+++++.+.+......+++..+..++.|++.||+|||++|++|+||+|+||+++ ++.++|+|||.+...... ..
T Consensus 83 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 83 MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 9999999998888876666699999999999999999999999999999999999995 569999999998776553 23
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+++.|+|||.+.+...++.++||||+|+++|+|++|.+||......+...++....+.|....|...........
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 34456788999999887556678999999999999999999999999998888999988888888888775443322222
Q ss_pred CCCCCcCCCCcccccCC--CCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 236 YKFPKLQGNNLSLLIPS--ANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
..........+....+. +++.+.++|++||+.||++|||++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 22222222222233333 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=347.38 Aligned_cols=277 Identities=21% Similarity=0.285 Sum_probs=212.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||.||+|++..++..+|+|++.............+|+.+++++ +||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEee
Confidence 78999999999999999999999999999999997654434445567899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|++| +|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++ ++.++|+|||++...... ....
T Consensus 84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 161 (331)
T cd06649 84 HMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 161 (331)
T ss_pred cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-cccc
Confidence 9986 66665554 34589999999999999999999986 699999999999995 569999999998765432 3344
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhH--------------
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW-------------- 224 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------------- 224 (346)
..+++.|+|||++. ...++.++||||+||++|+|++|..||...+..+....+...........+
T Consensus 162 ~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 162 FVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred CCCCcCcCCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence 57899999999887 556899999999999999999999999877655433222111000000000
Q ss_pred ----------HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 225 ----------AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 225 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
....+....... ..........+++++++||++||+.||++|||++++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVN------EPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccchhHHHHHHHHHh------CCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 000000000000 0000001124678999999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=355.81 Aligned_cols=256 Identities=29% Similarity=0.501 Sum_probs=208.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|++..+++.||+|++...... .......+|+.++..+ +||||+++++.+.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEE
Confidence 5899999999999999999999999999999999754322 2223345789999998 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--- 154 (346)
|||+.| +|.+.+.. .+.+++..++.++.|++.||+|||++||+||||||+||+++ ++.++|+|||++.......
T Consensus 80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999986 55555554 44599999999999999999999999999999999999995 5699999999986532211
Q ss_pred ------------------------------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCC
Q 039371 155 ------------------------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHP 198 (346)
Q Consensus 155 ------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 198 (346)
......||+.|+|||++. ...++.++|||||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-CCCCCCeeeeecchhHHHHhhcCCC
Confidence 011246899999999886 5668999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC---H
Q 039371 199 LFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT---A 275 (346)
Q Consensus 199 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~ 275 (346)
||.+.+..+....+...... ..++. ...++++++++|++|+. +|.+|++ +
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~-----------------~~~~~---------~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 238 PFCSDNPQETYRKIINWKET-----------------LQFPD---------EVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCc-----------------cCCCC---------CCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 99888776655555332110 01110 01468899999999997 9999998 9
Q ss_pred HHHhcCCCCCCC
Q 039371 276 AEALQHPLFQGC 287 (346)
Q Consensus 276 ~ell~hp~~~~~ 287 (346)
+++++||||+..
T Consensus 291 ~~ll~h~~~~~~ 302 (364)
T cd05599 291 NEIKSHPFFKGV 302 (364)
T ss_pred HHHhcCCCcCCC
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=359.48 Aligned_cols=281 Identities=23% Similarity=0.327 Sum_probs=212.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc-----CCCCeeeeeeeeecC-CE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN-----NHPNIVKLQELASEN-YR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----~hp~iv~~~~~~~~~-~~ 75 (346)
++|++++.||+|+||+||+|.+..+++.||+|+++.... .......|+.++..+. +|++++.+++++..+ .+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 579999999999999999999999999999999964321 1112234555555552 355689999988764 57
Q ss_pred EEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEeCC-----------------
Q 039371 76 LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVSND----------------- 137 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~~~----------------- 137 (346)
+|+|||++++++.+.+... +.+++..+..++.||+.||+|||+ .||+||||||+|||++.+
T Consensus 207 ~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 8999999999999887765 459999999999999999999998 599999999999999543
Q ss_pred cEEEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 039371 138 TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG 217 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 217 (346)
.+||+|||.+..... ......||+.|+|||++. ...++.++|||||||++|+|++|++||.+.+..+.+..+....+
T Consensus 286 ~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g 362 (467)
T PTZ00284 286 RVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362 (467)
T ss_pred eEEECCCCccccCcc--ccccccCCccccCcHHhh-cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence 499999998754332 334567999999999987 56689999999999999999999999999988888888888888
Q ss_pred CCChhhHHHH-----HHHHHhcCCCCCCcCCCCccc------c-cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 218 SPTEESWAEG-----LELAKAHGYKFPKLQGNNLSL------L-IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 218 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~------~-~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
.++....... .......+...+......+.. . ....++.+.+||++||++||++|||++|+|+||||+
T Consensus 363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL 442 (467)
T ss_pred CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence 7765432210 001111110000000000000 0 001245688999999999999999999999999998
Q ss_pred CCC
Q 039371 286 GCL 288 (346)
Q Consensus 286 ~~~ 288 (346)
...
T Consensus 443 ~~~ 445 (467)
T PTZ00284 443 KYY 445 (467)
T ss_pred ccC
Confidence 743
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=347.59 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=206.0
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|.++.+++.||+|++..... .........|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999975432 222334467888888777899999999999999999999999986
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~~~~~t 162 (346)
+|...+.. ...+++..+..++.|++.||+|||++|++||||||+||+++ ++.+||+|||++.... .........||
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 56555544 34599999999999999999999999999999999999995 5699999999986532 22233456789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+......
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------------------ 214 (320)
T cd05590 160 PDYIAPEILQ-EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV------------------------ 214 (320)
T ss_pred ccccCHHHHc-CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCC------------------------
Confidence 9999999886 566899999999999999999999999988877666655432111
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA------AEALQHPLFQGCL 288 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~------~ell~hp~~~~~~ 288 (346)
..+.++.++.++|++||+.||++||++ +++++||||+...
T Consensus 215 ------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 215 ------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred ------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 112467899999999999999999998 9999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=346.67 Aligned_cols=248 Identities=29% Similarity=0.446 Sum_probs=204.5
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||.||++.+..+|+.||+|++...... .......+|+.+++.+ +||||+++++.+..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 4699999999999999999999999999754322 2233445788999888 799999999999999999999999986
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~~~~~t 162 (346)
+|...+.. ...+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++.... .........||
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 55555443 44699999999999999999999999999999999999995 5699999999986532 22233446789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||...+.......+..... .+
T Consensus 159 ~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~-------------------~~---- 214 (323)
T cd05595 159 PEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-------------------RF---- 214 (323)
T ss_pred cCcCCccccc-CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------------------CC----
Confidence 9999999886 56689999999999999999999999988776655554432111 11
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGCL 288 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~~ 288 (346)
...+++++.++|++||+.||++|+ ++.++++||||.+..
T Consensus 215 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 215 -------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred -------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 135688999999999999999998 899999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-48 Score=346.13 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=208.9
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+|++++.||+|+||.||+|.+..+++.||+|++..... .........|..++..+.+|++|+.+++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 69999999999999999999999999999999975432 2233345678888888865667999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCc
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYT 157 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~ 157 (346)
||++| +|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++.... ......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 99985 66655554 44589999999999999999999999999999999999995 5699999999986432 222334
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+..... .
T Consensus 160 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~-------------------~ 219 (324)
T cd05587 160 TFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV-------------------S 219 (324)
T ss_pred eecCCccccChhhhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------------C
Confidence 457899999999987 56689999999999999999999999998877666665543211 1
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA-----AEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-----~ell~hp~~~~~ 287 (346)
....++.++.+++++||+.||.+|++. +++++||||+..
T Consensus 220 -----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 220 -----------YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred -----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 113567899999999999999999986 899999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=341.34 Aligned_cols=274 Identities=30% Similarity=0.553 Sum_probs=210.6
Q ss_pred eeeecccCceEEEEEEEc--cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCEEEEEEEc
Q 039371 7 MKQIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--NYRLYFVFEY 82 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~~~iv~e~ 82 (346)
.++||+|+||+||+|+++ .+++.||+|.+...... ....+|+.+++++ +||||+++++.+.. +..++++||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS---MSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc---HHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999866 46789999998654332 2345799999999 79999999998854 4678999999
Q ss_pred CCCCHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-----CCcEEEeecccccc
Q 039371 83 MDCNLHQLMSNR--------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-----NDTIKIADFGLAWE 149 (346)
Q Consensus 83 ~~g~l~~~~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-----~~~vkl~Dfg~a~~ 149 (346)
+++++.+.+... ...+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 999988776432 22489999999999999999999999999999999999993 34899999999976
Q ss_pred cCCCC----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 039371 150 VDSCP----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE---------DDQLYKICNAI 216 (346)
Q Consensus 150 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~~~~ 216 (346)
..... ......+|+.|+|||++.+...++.++||||+||++|+|++|.+||..... .+.+..+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 54322 234467899999999987666789999999999999999999999975442 35677788888
Q ss_pred CCCChhhHHHHHHHHHhcC----CCCCCcCCCC----cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 217 GSPTEESWAEGLELAKAHG----YKFPKLQGNN----LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+.|....|........... .......... ........+..+.+||++||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 8888777765432111000 0000000000 011112345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=327.56 Aligned_cols=266 Identities=27% Similarity=0.484 Sum_probs=222.2
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-C
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-N 86 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~ 86 (346)
+.||+|+++.|..+....+|..||+|++.+. ......+.++|+.++.+..+|+||++++++|+++...|+|||-|.| .
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 5799999999999999999999999999877 4556667789999999999999999999999999999999999985 7
Q ss_pred HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C---cEEEeecccccccCC--------CC
Q 039371 87 LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D---TIKIADFGLAWEVDS--------CP 154 (346)
Q Consensus 87 l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~---~vkl~Dfg~a~~~~~--------~~ 154 (346)
++..+.++.. ++|.++.+++++|+.||.|||.+||.|||+||+|||... + .+||+||.+..-+.. .+
T Consensus 163 lLshI~~~~~-F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 163 LLSHIQKRKH-FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred HHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 8888877654 999999999999999999999999999999999999943 2 799999988743321 22
Q ss_pred CCccccccCcccCccccc----ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------------HHHHHHHHHH
Q 039371 155 PYTEYITTLQYRAPEMLL----MSGQYNSKVDMWALGLIMAELITFHPLFPGTCE---------------DDQLYKICNA 215 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------------~~~~~~i~~~ 215 (346)
...+.+|+..|||||+.. ....|+.+.|.||||+|+|-|++|.+||.+... ...+..|.++
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 344568899999999864 234589999999999999999999999977543 2345555555
Q ss_pred hCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCc
Q 039371 216 IGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSI 295 (346)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~~~~~ 295 (346)
.-.+|+..|. .+|.+++++++.+|..||.+|.++.++++|||++.+........
T Consensus 322 kYeFPdkdWa--------------------------hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalpt 375 (463)
T KOG0607|consen 322 KYEFPDKDWA--------------------------HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPT 375 (463)
T ss_pred CCcCChhhhH--------------------------HhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCC
Confidence 5566666665 67899999999999999999999999999999999876644433
Q ss_pred cccccc
Q 039371 296 DSCKMR 301 (346)
Q Consensus 296 ~~~~~~ 301 (346)
.....+
T Consensus 376 p~v~~r 381 (463)
T KOG0607|consen 376 PQVLQR 381 (463)
T ss_pred Cccccc
Confidence 333333
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=335.72 Aligned_cols=280 Identities=34% Similarity=0.647 Sum_probs=232.5
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
+|++.++||.|++|+||+|++..+|+.||+|+++............+|+.+++++ +||||+++++.+.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEec
Confidence 6999999999999999999999999999999997665443444556899999999 799999999999999999999999
Q ss_pred CCCCHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 83 MDCNLHQLMSNRK--QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 83 ~~g~l~~~~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
++|++.+.+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++....... ....
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 9999888776543 4589999999999999999999999999999999999995 5699999999987554322 2233
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||.+.+...++.++||||+||++|+|++|..||.+.+..+....+.+....|....|..... .......+
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ-LPEYKPTF 238 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc-Cchhcccc
Confidence 45688999999887556678999999999999999999999999998888888888888888777754442 22222233
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+...........+..+..+.+++.+||+.||.+||+++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 3322223333445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=344.16 Aligned_cols=245 Identities=29% Similarity=0.425 Sum_probs=203.3
Q ss_pred ecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-C
Q 039371 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-N 86 (346)
Q Consensus 10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~ 86 (346)
||+|+||+||+|++..+++.||+|+++.... ........+|+.++.++ +||||+++++.+.+++..|+||||++| +
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 7999999999999999999999999865432 22334456788999998 799999999999999999999999985 6
Q ss_pred HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCccccccCc
Q 039371 87 LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITTLQ 164 (346)
Q Consensus 87 l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~ 164 (346)
|.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+||+++ ++.++|+|||++..... ........||+.
T Consensus 80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence 6666654 44599999999999999999999999999999999999995 56999999999875332 223344678999
Q ss_pred ccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCC
Q 039371 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGN 244 (346)
Q Consensus 165 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+..... .
T Consensus 159 y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~-------------------~------- 211 (312)
T cd05585 159 YLAPELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL-------------------R------- 211 (312)
T ss_pred cCCHHHHc-CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-------------------C-------
Confidence 99999887 56689999999999999999999999988776655554432110 1
Q ss_pred CcccccCCCCchHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCC
Q 039371 245 NLSLLIPSANDDEMSLIELLCSWDPCKRP---TAAEALQHPLFQGC 287 (346)
Q Consensus 245 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~ell~hp~~~~~ 287 (346)
....+++++.++|.+||+.||.+|| ++.|+++||||+..
T Consensus 212 ----~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 212 ----FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ----CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 1135688999999999999999997 58999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=354.46 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=207.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
.+|++++.||+|+||+||+|++..+++.||+|++...... .......+|+.+++++ +||||+++++.+.+++.+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEE
Confidence 4799999999999999999999999999999999754322 2233446788889888 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC----
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC---- 153 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~---- 153 (346)
|||++| +|.+.+... +.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 80 MDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999985 666666544 4589999999999999999999999999999999999995 569999999997432100
Q ss_pred --------------------------------------------CCCccccccCcccCcccccccCCCCChhhHHHHHHH
Q 039371 154 --------------------------------------------PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLI 189 (346)
Q Consensus 154 --------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 189 (346)
.......||+.|+|||++. ...++.++||||+||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-CCCCCCeeeEEechHH
Confidence 0012346899999999887 5568999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCC
Q 039371 190 MAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDP 269 (346)
Q Consensus 190 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 269 (346)
+|+|++|.+||.+.+..+....+....... ..+. ...+++++.++|.+|+. ||
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------~~p~---------~~~~s~~~~~li~~l~~-~p 290 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSL-----------------HIPP---------QAKLSPEASDLIIKLCR-GP 290 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCc-----------------CCCC---------cccCCHHHHHHHHHHcc-CH
Confidence 999999999998877666555543321110 0000 13568899999999874 99
Q ss_pred CCCCC---HHHHhcCCCCCCCC
Q 039371 270 CKRPT---AAEALQHPLFQGCL 288 (346)
Q Consensus 270 ~~Rps---~~ell~hp~~~~~~ 288 (346)
.+|++ ++++++||||+...
T Consensus 291 ~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 291 EDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred hHcCCCCCHHHHhcCCCcCCcC
Confidence 99997 99999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=352.49 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=206.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
..|++++.||+|+||+||+|++..+++.||+|++...... .......+|+.+++++ +||||+++++.+.+++.+|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEE
Confidence 3799999999999999999999999999999999764332 2233456788999888 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--- 154 (346)
|||++| +|.+.+.. .+.+++..++.++.||+.||+|||+.||+||||||+||+++ ++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 80 MDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999985 66666554 44599999999999999999999999999999999999995 5699999999875321000
Q ss_pred ---------------------------------------------CCccccccCcccCcccccccCCCCChhhHHHHHHH
Q 039371 155 ---------------------------------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLI 189 (346)
Q Consensus 155 ---------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 189 (346)
......||+.|+|||++. ...++.++||||+||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-CCCCCCccceeehhhH
Confidence 012346899999999887 4568999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcc--c
Q 039371 190 MAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCS--W 267 (346)
Q Consensus 190 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~--~ 267 (346)
+|+|++|..||...+..+....+....... ..+. ...+++++.+||.+|+. .
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------~~~~---------~~~~s~~~~dli~~ll~~~~ 291 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL-----------------HIPP---------QVKLSPEAVDLITKLCCSAE 291 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHcccccc-----------------CCCC---------CCCCCHHHHHHHHHHccCcc
Confidence 999999999998877665555443211100 0110 12468899999999664 4
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 039371 268 DPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 268 dP~~Rps~~ell~hp~~~~~~ 288 (346)
+|..|++++++++||||++..
T Consensus 292 ~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 292 ERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred cccCCCCHHHHhcCcccCCCC
Confidence 555699999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=351.53 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=211.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||+||+|++..+++.||+|+++..... .......+|+.+++.+ +||||+++++++.+++.+|+|
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEE
Confidence 5799999999999999999999999999999999653321 1223345788888888 899999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--C
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--P 155 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~ 155 (346)
|||++| +|.+.+... .+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++....... .
T Consensus 122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 999975 666655432 489999999999999999999999999999999999995 5699999999997654322 2
Q ss_pred CccccccCcccCccccccc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLMS---GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.....||+.|+|||++... ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 266 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL------------- 266 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC-------------
Confidence 3456799999999988643 347899999999999999999999999888776666664422111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK--RPTAAEALQHPLFQGC 287 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~--Rps~~ell~hp~~~~~ 287 (346)
.++. ...++.++++||++||+.+|.+ |+|++++++||||+..
T Consensus 267 ----~~~~---------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 267 ----TFPD---------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred ----CCCC---------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 1111 1246899999999999999988 9999999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=336.33 Aligned_cols=286 Identities=36% Similarity=0.654 Sum_probs=232.4
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
|++|++.+.||+|++|+||+|.++.+|+.||+|.+....... ......+|+.+++++ +||||+++++++.++...++|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEE
Confidence 689999999999999999999999999999999986543322 223456799999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeecccccccCCCC-C
Q 039371 80 FEYMDCNLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWEVDSCP-P 155 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~~~~~~-~ 155 (346)
|||+++++.+.+..... .+++..+..++.||+.||+|||++|++|+||+|+||++++ +.+||+|||++....... .
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 99999988887765443 3688999999999999999999999999999999999963 479999999997654322 2
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+++.|+|||.+.+...++.++||||+||++|+|++|.+||...+..+...++....+.+....|...... ....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 238 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL-PDYK 238 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc-hhhh
Confidence 334467889999998875566899999999999999999999999998888888888888888877776532221 1111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
..++...........+..++++.+++.+||+.||++||+++++++||||++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 11222222233334467889999999999999999999999999999998754
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=353.98 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=206.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|.+..+++.||+|++...... .......+|+.++.++ +||||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence 5899999999999999999999999999999998654321 1223345788889888 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--- 154 (346)
|||+.| +|.+.+.. .+.+++..++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999975 66666654 45599999999999999999999999999999999999995 5699999999985321100
Q ss_pred ---------------------------------------------CCccccccCcccCcccccccCCCCChhhHHHHHHH
Q 039371 155 ---------------------------------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLI 189 (346)
Q Consensus 155 ---------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 189 (346)
......||+.|+|||++. ...++.++||||+||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-cCCCCCceeeEecchh
Confidence 001246899999999886 5668999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCC
Q 039371 190 MAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDP 269 (346)
Q Consensus 190 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 269 (346)
+|+|++|.+||.+.+..+....+...... ..++. ...++.++.+||++||+ +|
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~p~---------~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRET-----------------LYFPD---------DIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCc-----------------cCCCC---------CCCCCHHHHHHHHHHhc-CH
Confidence 99999999999887776666555432110 01111 02467899999999998 77
Q ss_pred CCC---CCHHHHhcCCCCCCC
Q 039371 270 CKR---PTAAEALQHPLFQGC 287 (346)
Q Consensus 270 ~~R---ps~~ell~hp~~~~~ 287 (346)
.+| +|+.|+++||||++.
T Consensus 291 ~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 291 ENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhcCCCCCHHHHhcCCCcCCC
Confidence 765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=344.00 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=210.8
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+|++++.||+|+||+||+|.+..+++.||+|+++..... ........|..++..+.+||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999764322 122334567777777767999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCc
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYT 157 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~ 157 (346)
||++| +|...+... +.+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 99985 666666544 4599999999999999999999999999999999999995 56999999999875432 22334
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+......
T Consensus 160 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~------------------- 219 (323)
T cd05616 160 TFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA------------------- 219 (323)
T ss_pred cCCCChhhcCHHHhc-CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence 567899999999887 566899999999999999999999999988877766666443211
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~ 288 (346)
+ ....+.++.+++.+||+.||.+|++ ..++++||||+...
T Consensus 220 ~-----------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 220 Y-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred C-----------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 1 1246789999999999999999998 48999999998643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=345.96 Aligned_cols=247 Identities=32% Similarity=0.481 Sum_probs=203.7
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||.||+|.+..+++.||+|++...... .......+|+.+++.+ +||||+++++.+.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999754322 2334456788889888 799999999999999999999999986
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~~~~~t 162 (346)
++...+.. ...+++.++..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++..... ........||
T Consensus 80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 55555543 45699999999999999999999999999999999999995 56999999999865322 2233446789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||...+..+....+.... ..
T Consensus 159 ~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------------------~~----- 213 (328)
T cd05593 159 PEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-------------------IK----- 213 (328)
T ss_pred cCccChhhhc-CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-------------------cc-----
Confidence 9999999886 5568999999999999999999999998776655444432210 01
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
+...+++++.++|++||+.||++|+ ++.++++||||.+.
T Consensus 214 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 214 ------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 1135688999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=351.51 Aligned_cols=257 Identities=30% Similarity=0.515 Sum_probs=212.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|++..+++.||+|+++..... ........|..++..+ +||||+++++.+.+++..|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEE
Confidence 5899999999999999999999999999999999754322 2233445788888888 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--- 154 (346)
|||+.| +|.+.+... +.+++..++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999975 676666655 5699999999999999999999999999999999999995 5699999999997654432
Q ss_pred ---------------------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 039371 155 ---------------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD 207 (346)
Q Consensus 155 ---------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 207 (346)
......||+.|+|||++. ...++.++|||||||++|+|++|..||...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 233457899999999987 4578999999999999999999999998887666
Q ss_pred HHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q 039371 208 QLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-AAEALQHPLFQG 286 (346)
Q Consensus 208 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-~~ell~hp~~~~ 286 (346)
....+...... ..++. ...+++++.++|.+||+ ||.+||+ ++++++||||+.
T Consensus 238 ~~~~i~~~~~~-----------------~~~p~---------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 238 TYNKIINWKES-----------------LRFPP---------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHhccCCc-----------------ccCCC---------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 65555431110 01111 12368999999999998 9999999 999999999987
Q ss_pred CC
Q 039371 287 CL 288 (346)
Q Consensus 287 ~~ 288 (346)
..
T Consensus 291 ~~ 292 (350)
T cd05573 291 ID 292 (350)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=333.91 Aligned_cols=281 Identities=57% Similarity=1.024 Sum_probs=242.9
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
|++.+.||+|++|+||+|....+++.|++|.+.............+|+..+.++.+|||++++++++.+++..++|||++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 78999999999999999999989999999998766554444455678899999955999999999999999999999999
Q ss_pred CCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccccc
Q 039371 84 DCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYIT 161 (346)
Q Consensus 84 ~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~ 161 (346)
+|++.+.+.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++ ++.++|+|||.+.............+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS 160 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCC
Confidence 989988887654 4689999999999999999999999999999999999996 46999999999987766555556678
Q ss_pred cCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCc
Q 039371 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241 (346)
Q Consensus 162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
+..|+|||++.....++.++|+||+|+++++|++|++||......+....+....+.+....|.+........+...+..
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd07830 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF 240 (283)
T ss_pred cccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccc
Confidence 88999999887666689999999999999999999999999999999999999999998888887766665555555554
Q ss_pred CCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.........+..+.++.++|++||+.||++|||++|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 4444444445567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=332.79 Aligned_cols=282 Identities=33% Similarity=0.554 Sum_probs=221.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+|+..++.+ +|+||+++++++.+++..|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEEEe
Confidence 68999999999999999999999999999999987554433333456799999998 79999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCccc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEY 159 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~ 159 (346)
++++++.+.+......+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++....... .....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07870 84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163 (291)
T ss_pred cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence 999999888776656689999999999999999999999999999999999995 5699999999987543321 23344
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE-DDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
.+++.|+|||.+.+...++.++||||+||++|+|++|..||.+... .+.+..+....+.|.+..+.............+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 5788999999887555688899999999999999999999976553 455666666667666665543322111111111
Q ss_pred CCcCCCCcccccC--CCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 239 PKLQGNNLSLLIP--SANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 239 ~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+............ ..+..+.+++.+|++.||++|||++|++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 1111111111111 235688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=344.54 Aligned_cols=275 Identities=24% Similarity=0.380 Sum_probs=209.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
.+|++++.||+|+||.||+|.+..+++.||+|+..... ...|+.+++++ +||||+++++++..++..++|||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhC-CCCCCcChhheEEeCCeeEEEEE
Confidence 36999999999999999999999999999999854332 34688889998 79999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcccc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYI 160 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~ 160 (346)
++.|++...+......+++..+..++.||+.||.|||++||+||||||+||+++ ++.++|+|||++.............
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 999999998887777799999999999999999999999999999999999995 5689999999997554444444567
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHHhCCCChhhH----HH
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFH-PLFPGTCE---------DDQLYKICNAIGSPTEESW----AE 226 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~----~~ 226 (346)
||..|+|||++. ...++.++||||+||++|+|+++. ++|..... ...+..+....+..+.... ..
T Consensus 218 gt~~y~aPE~~~-~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 218 GTVETNAPEVLA-RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred ccccccCCeecC-CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 899999999987 456899999999999999999865 44443221 1233334443332221111 00
Q ss_pred H-HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 227 G-LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 227 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
. ........... .............++.++.+||++||+.||++|||+.|+|+||||+.
T Consensus 297 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 297 LVRGFIEYASLER-QPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHhhcccCC-CcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0 00000000000 00000000011256778889999999999999999999999999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=346.43 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=204.7
Q ss_pred ceeeeeeecccCceEEEEEEEc---cCCcEEEEEEccccccC---HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYS---WEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
+|++++.||+|+||+||++++. .+++.||+|++...... ........|+.++..+.+||+|+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5999999999999999999864 47899999998654322 12233457889999997899999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
++||||+.| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999985 666666544 4599999999999999999999999999999999999995 5699999999987543322
Q ss_pred --CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 155 --PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 155 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
......||+.|+|||++.+...++.++|||||||++|+|++|..||...........+.....
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------------- 224 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--------------- 224 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh---------------
Confidence 223457899999999987555688999999999999999999999975432211111111100
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
... ....+.+++.+.+++.+||+.||++|| +++++++||||+..
T Consensus 225 ~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 225 KCD-----------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred cCC-----------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 000 001135688999999999999999999 88999999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=343.98 Aligned_cols=248 Identities=30% Similarity=0.447 Sum_probs=205.6
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|+++.+++.||+|+++.... .........|..++..+.+||||+++++++.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999976432 222234457888888777899999999999999999999999985
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~~~~~t 162 (346)
+|...+... ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++..... ........||
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 565555543 4599999999999999999999999999999999999995 56999999999865332 2233445789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+...... +
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~-------------------~---- 215 (321)
T cd05591 160 PDYIAPEILQ-ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL-------------------Y---- 215 (321)
T ss_pred ccccCHHHHc-CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------------C----
Confidence 9999999886 566899999999999999999999999988877766665432110 1
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCC-------CHHHHhcCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRP-------TAAEALQHPLFQGC 287 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-------s~~ell~hp~~~~~ 287 (346)
...++.++.+++++||+.||++|| +++++++||||+..
T Consensus 216 -------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 216 -------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred -------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 124578899999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=348.40 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=204.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|+.++.||+|+||+||+|++..+++.||+|++.............+|+.+++.+ +||||+++++++.+++.+++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEEEEe
Confidence 57889999999999999999999999999999997654444445567899999999 79999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCccc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEY 159 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~ 159 (346)
|+.|+.+.. ....++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++....... .....
T Consensus 153 ~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 228 (353)
T PLN00034 153 FMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228 (353)
T ss_pred cCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccccc
Confidence 998654322 12367888999999999999999999999999999999995 4689999999997654322 23456
Q ss_pred cccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 160 ITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 160 ~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.||..|+|||++.. ....+.++|||||||++|+|++|..||......+....+......
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~----------------- 291 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS----------------- 291 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-----------------
Confidence 78999999998742 233457999999999999999999999743322211111110000
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
........++.++++||.+||+.||++|||++|+++||||......
T Consensus 292 ---------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 292 ---------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred ---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence 0011123568899999999999999999999999999999986543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=342.37 Aligned_cols=286 Identities=34% Similarity=0.555 Sum_probs=228.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-----CEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN-----YRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-----~~~ 76 (346)
++|++.+.||+|++|.||+|.+..+|+.||+|+++............+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccceE
Confidence 68999999999999999999999999999999986543333444556799999999 699999999886543 458
Q ss_pred EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
++++|++++++...+.. ..+++..+..++.|++.||.+||+.|++||||||+||+++ ++.++|+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 84 YIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 99999999988877754 3489999999999999999999999999999999999995 56999999999876543221
Q ss_pred ----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....+++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+....+.++.+.+.......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence 2234678899999987655678999999999999999999999999888888888888888877776664333211
Q ss_pred HhcCC-CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 232 KAHGY-KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 232 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
..... ..+...........+..+.++.+++++||+.||++|||+.|+++||||+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 11100 111111111222345678999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=353.71 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=206.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|++..+++.||+|++...... .......+|+.+++++ +||||+++++.+.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999998654321 1223345788999998 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC----
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC---- 153 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~---- 153 (346)
|||++| +|.+.+... +.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|......
T Consensus 80 ~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 80 MDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999985 666666554 4589999999999999999999999999999999999995 569999999997432100
Q ss_pred ----------------------------------------CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHH
Q 039371 154 ----------------------------------------PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAEL 193 (346)
Q Consensus 154 ----------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 193 (346)
.......||+.|+|||++. ...++.++||||+||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-CCCCCcceeeeeccceeeeh
Confidence 0011346899999999887 56689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC
Q 039371 194 ITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP 273 (346)
Q Consensus 194 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 273 (346)
++|..||.+....+....+...... ...+. ...++.++.++|.+|+ .+|.+|+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~-----------------~~~~~---------~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETT-----------------LHIPS---------QAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCcc-----------------ccCCC---------CCCCCHHHHHHHHHHh-cCHhhcC
Confidence 9999999888766555444321110 00000 1256889999999977 5999999
Q ss_pred ---CHHHHhcCCCCCCC
Q 039371 274 ---TAAEALQHPLFQGC 287 (346)
Q Consensus 274 ---s~~ell~hp~~~~~ 287 (346)
|+.++++||||+..
T Consensus 291 ~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 291 GKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCHHHHhCCCCcCCC
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=324.67 Aligned_cols=258 Identities=30% Similarity=0.433 Sum_probs=218.2
Q ss_pred Cceeee-eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec----CCEE
Q 039371 2 EKYTLM-KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE----NYRL 76 (346)
Q Consensus 2 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~----~~~~ 76 (346)
++|++- +.||-|-.|.|-.+.++.|++.+|+|++.... ...+|+...-....|||||.++++|++ ...+
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 566655 47999999999999999999999999985321 133688887788899999999999864 3567
Q ss_pred EEEEEcCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CCcEEEeeccccccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEV 150 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~~vkl~Dfg~a~~~ 150 (346)
.+|||.|+| .|...+..++ ..++|.++..|++||+.|+.|||+.+|.||||||+|+|+. +..+||+|||+|...
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 899999985 6777776553 4699999999999999999999999999999999999994 338999999999888
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChhhHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE----DDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~ 226 (346)
.......+.+-||+|.|||++. ...|+...|+||+|+++|-|++|.+||.+... .....+|..+--.++.+.|.
T Consensus 215 ~~~~~L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs- 292 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS- 292 (400)
T ss_pred CCCccccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh-
Confidence 7777788889999999999885 67799999999999999999999999977643 34555565555556666665
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPS 292 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~~ 292 (346)
.+|++++++|+++|..+|++|.|+.++++|||+.+....+.
T Consensus 293 -------------------------~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 293 -------------------------CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ 333 (400)
T ss_pred -------------------------HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence 57899999999999999999999999999999998766554
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=342.03 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=203.2
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||.||+|.++.+|+.||+|+++.... .........|..++....+||||+++++.+.+++.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999976432 222333456777777766899999999999999999999999985
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~~~~~t 162 (346)
+|...+.. ...+++..+..++.|++.||+|||++||+||||||+||+++ ++.++|+|||++..... ........||
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 66666554 44599999999999999999999999999999999999995 56999999999864322 2233456789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+..... .
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~-------------------~----- 214 (316)
T cd05620 160 PDYIAPEILQ-GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP-------------------H----- 214 (316)
T ss_pred cCccCHHHHc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------C-----
Confidence 9999999987 56689999999999999999999999988776655544422110 0
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCCH-HHHhcCCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA-AEALQHPLFQGCL 288 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-~ell~hp~~~~~~ 288 (346)
....++.+++++|++||+.||++||++ +++++||||+...
T Consensus 215 ------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 215 ------YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred ------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 112467889999999999999999997 5899999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=347.64 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=212.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||+||+|.++.+++.||+|+++...... ......+|+.++..+ +||||+++++.+.+++..|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence 58999999999999999999999999999999997654321 223344677777776 899999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
|||++ |+|.+.+......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 99997 577777776656799999999999999999999999999999999999995 56999999999976544322
Q ss_pred CccccccCcccCcccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLM-----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
.....+|+.|+|||++.. ...++.++||||+||++|+|++|..||...+......++......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~------------ 227 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF------------ 227 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc------------
Confidence 223468999999998863 345788999999999999999999999888776666655432110
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
..++. .+.++.++.+||++||+ ||.+|||++++++||||+...
T Consensus 228 -----~~~~~---------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 228 -----LKFPE---------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred -----cCCCC---------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 01111 13578899999999998 999999999999999998743
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=335.13 Aligned_cols=282 Identities=36% Similarity=0.658 Sum_probs=227.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE-----
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYR----- 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~----- 75 (346)
++|++.+.||+|+||+||+|.+..+++.||+|.+....... ......+|+.+++.+.+||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 58999999999999999999999999999999986543322 223456799999999778999999999876655
Q ss_pred EEEEEEcCCCCHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeecccccc
Q 039371 76 LYFVFEYMDCNLHQLMSNRK----QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWE 149 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~ 149 (346)
.|++|||+++++.+.+.... ..+++..+..++.||+.||.|||++|++|+||+|+||++++ +.++|+|||.+..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 89999999999888775432 35899999999999999999999999999999999999964 5899999999875
Q ss_pred cCCC-CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 150 VDSC-PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 150 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
.... .......+++.|+|||.+.+...++.++||||+|+++|+|++|..||.+.+..+....+....+.+....|....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 5332 222334568889999988755668999999999999999999999999988888888888877777776665333
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
...... .++......+....+..+..+.++|.+||+.||.+|||++|+++||||+
T Consensus 241 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWH--EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchh--hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 322111 1222222233334457889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=332.52 Aligned_cols=280 Identities=37% Similarity=0.668 Sum_probs=229.4
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++++.||+|++|.||+|.+..+++.||+|.+....... ......+|+.+++++ +||||+++++++.+++..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999986544322 223456899999999 79999999999999999999999
Q ss_pred cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDCNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|+.+++...+... +..+++..+..++.|++.||+|||+.|++|+||+|+||+++ ++.++|+|||++....... ....
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 9998888777553 34589999999999999999999999999999999999995 5699999999987654322 2333
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||.+.+...++.++|||||||++|+|++|..||...+..+...++.+..+.+....|..... .......+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-LPDYKPSF 238 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-HHHHHhhc
Confidence 45688899999887556678999999999999999999999999888888888888888887766553222 22222233
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+...........+.++.+++++|.+||+.||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 3333333333445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=340.87 Aligned_cols=248 Identities=31% Similarity=0.482 Sum_probs=202.2
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|.+..+++.||+|+++..... ........|..++....+||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999754321 22233356677777666899999999999999999999999985
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~~~~~t 162 (346)
+|...+.. ...+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++..... ........||
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 56555544 44699999999999999999999999999999999999995 56999999999875432 2334456789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~------------------------- 213 (316)
T cd05592 160 PDYIAPEILK-GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP------------------------- 213 (316)
T ss_pred ccccCHHHHc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence 9999999887 55689999999999999999999999998877665555432110
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCCH-HHHhcCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA-AEALQHPLFQGC 287 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-~ell~hp~~~~~ 287 (346)
.....++.++.+++.+||+.||++||++ .++++||||+..
T Consensus 214 -----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 214 -----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 0113467889999999999999999986 589999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=333.99 Aligned_cols=286 Identities=36% Similarity=0.622 Sum_probs=231.8
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC---H-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS---W-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... . .......|+.+++++ +||||+++++++.+++..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEE
Confidence 689999999999999999999999999999999765433 1 223345788999988 69999999999999999999
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CC
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PY 156 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~ 156 (346)
|||++.|+|.+.+......+++..+..++.||++||.|||++|++|+||+|+||+++ ++.++|+|||++....... ..
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 999997788888766554699999999999999999999999999999999999995 5699999999997665432 23
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+..+.+.++....+.+....|......... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 237 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY--V 237 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc--c
Confidence 33456788999998865567899999999999999999999999988888888888877777776665432221111 1
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~ 291 (346)
.................+..+.++|.+||+.||++|||+.|+++||||++...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 1111112222334456788999999999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=340.78 Aligned_cols=250 Identities=29% Similarity=0.442 Sum_probs=203.8
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHH---HhhcCCCCeeeeeeeeecCCEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCL---RKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l---~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
|++++.||+|+||+||+|.+..+++.||+|+++...... ......+|..++ +.+ +||||+++++++.+++..|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence 789999999999999999999999999999997543211 122334455444 344 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~ 155 (346)
||||+.| +|...+.. +.+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+|||++..... ...
T Consensus 80 v~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 80 VMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCc
Confidence 9999986 55444432 3599999999999999999999999999999999999995 56999999999865332 223
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....|++.|+|||.+. ...++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 158 ~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~------------------ 218 (324)
T cd05589 158 TSTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV------------------ 218 (324)
T ss_pred ccccccCccccCHhHhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 34567899999999887 56689999999999999999999999998877666655543211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
.+ ...++..+.++|++||+.||.+|| ++.++++||||+..
T Consensus 219 -~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 219 -RY-----------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -CC-----------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 11 124678899999999999999999 69999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=348.03 Aligned_cols=257 Identities=28% Similarity=0.405 Sum_probs=208.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||.||+|.++.+++.||+|++...... .......+|..+++.+ +||||+++++.+.+++.+|+|
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 5899999999999999999999999999999998653221 1223345677777777 899999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--C
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--P 155 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~ 155 (346)
|||++| +|.+.+... .+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|....... .
T Consensus 122 ~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 122 MEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 999985 676666443 489999999999999999999999999999999999995 5699999999997764322 2
Q ss_pred CccccccCcccCccccccc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLMS---GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.....||+.|+|||++... ..++.++||||+||++|+|++|..||.+.+.......+........
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------------ 267 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN------------ 267 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC------------
Confidence 3456799999999998643 2478999999999999999999999998877766666654321111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK--RPTAAEALQHPLFQGC 287 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~--Rps~~ell~hp~~~~~ 287 (346)
++. ...++..+++++.+||+.++.+ |+|++|+++||||+..
T Consensus 268 -----~p~---------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 268 -----FPE---------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred -----CCC---------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 110 0246889999999999865543 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=341.35 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=208.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEc-cccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
.|+++++||+||.+.||++..... ..||+|.+ ....+........+|+..|.++.+|.+|+++++|...++.+|+|||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 699999999999999999986544 45555555 4444445556678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccccCCCC---CCcc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCP---PYTE 158 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~---~~~~ 158 (346)
+-+.+|...+.+....++.-.++.+..|++.++.++|+.||||.||||.|+++-.|.+||+|||.|..+.... ...+
T Consensus 441 ~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kds 520 (677)
T KOG0596|consen 441 CGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKDS 520 (677)
T ss_pred cccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccceeecc
Confidence 9888999999888776776799999999999999999999999999999999999999999999998766533 3456
Q ss_pred ccccCcccCcccccccC----------CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 159 YITTLQYRAPEMLLMSG----------QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
.+||+.||+||.+.... ..+.++||||||||+|+|+.|++||...... .+++ ..+..|..
T Consensus 521 QvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--~aKl-~aI~~P~~------- 590 (677)
T KOG0596|consen 521 QVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--IAKL-HAITDPNH------- 590 (677)
T ss_pred ccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--HHHH-HhhcCCCc-------
Confidence 89999999999986321 2578999999999999999999999544311 1111 11111111
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
...||... -..++.++++.||++||++|||+.++|+|||++...
T Consensus 591 ------~Iefp~~~----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 591 ------EIEFPDIP----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred ------cccccCCC----------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 11222221 123489999999999999999999999999998743
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=340.34 Aligned_cols=248 Identities=29% Similarity=0.473 Sum_probs=203.8
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|.+..+++.||+|+++.... .........|..++..+.+||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999976532 122333457888888877899999999999999999999999986
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~~~~~t 162 (346)
+|...+.. .+.+++..+..++.|++.||.|||++|++||||||+||+++ ++.++|+|||++.... .........++
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 55555544 44699999999999999999999999999999999999995 5699999999986532 22233345789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||.+.+.......+.... ..+
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-------------------~~~---- 215 (318)
T cd05570 160 PDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-------------------VRY---- 215 (318)
T ss_pred ccccCHHHhc-CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------------------CCC----
Confidence 9999999987 5668999999999999999999999998877655554443211 011
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA-----AEALQHPLFQGC 287 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-----~ell~hp~~~~~ 287 (346)
...++..+.++|++||+.||.+|||+ .++++||||+..
T Consensus 216 -------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 216 -------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred -------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 12467899999999999999999999 999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=340.11 Aligned_cols=284 Identities=32% Similarity=0.484 Sum_probs=225.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------C
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN------Y 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------~ 74 (346)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+|+.+++++ +||||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccccC
Confidence 68999999999999999999999999999999986543332 233456799999988 799999999988543 3
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
..|+|||++++++.+.+... +++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 57999999999988877643 89999999999999999999999999999999999995 569999999999876654
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.......++..|+|||.+. ...++.++||||+||++|+|++|..||.+.+..+....+....+.|+.+...........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCcccccccCHHHHh-CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 4444567889999999887 566899999999999999999999999999888888888888888776544332211111
Q ss_pred cCCCCCCcCCCCccc-------------ccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSL-------------LIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
.....+......... .....++.++++|++||+.||++|||+.|+|+||||+.....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 100000000000000 012346678999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=337.38 Aligned_cols=246 Identities=29% Similarity=0.414 Sum_probs=206.9
Q ss_pred eeeeeeecccCceEEEEEEEccCCcE-EEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-EEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEY-VAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENY-RLYFVF 80 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~-~~~iv~ 80 (346)
..+.+.+|+|+||+||+|..+ |+. ||+|++.....+.. ...+.+|+.++.++ +|||||++++++.++. .++|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceEEEE
Confidence 355667999999999999877 555 99999987665544 45567899999999 8999999999999887 799999
Q ss_pred EcCC-CCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCCEEEeCC--cEEEeecccccccCCC-C
Q 039371 81 EYMD-CNLHQLMSN-RKQCFSEAEVKNWCFQILQGLNYMHRQG-YFHRDLISKNLLVSND--TIKIADFGLAWEVDSC-P 154 (346)
Q Consensus 81 e~~~-g~l~~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~-ivH~dikp~NIli~~~--~vkl~Dfg~a~~~~~~-~ 154 (346)
||+. |+|...+.. .+..++...+..++.||+.|++|||+++ |+||||||+|||++.+ ++||+|||+++..... .
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~ 199 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT 199 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence 9998 566666666 3677999999999999999999999999 9999999999999755 8999999999876654 3
Q ss_pred CCccccccCcccCcccccc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 155 PYTEYITTLQYRAPEMLLM-SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......||+.|||||++.+ ...|+.++||||+|+++|||+||..||.+.........+......|+.+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p----------- 268 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP----------- 268 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC-----------
Confidence 4444789999999999975 3679999999999999999999999999988866666665444333321
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+++.+..++..||..||.+||+..+++.
T Consensus 269 -----------------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 269 -----------------KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -----------------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 237788999999999999999999988865
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=343.98 Aligned_cols=248 Identities=32% Similarity=0.481 Sum_probs=203.1
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|.+..+|+.||+|+++..... .......+|..++..+ +||||+++++.+.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999765332 2233446788888888 799999999999999999999999986
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYTEYIT 161 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~~~~~ 161 (346)
+|...+. ....+++..+..++.||+.||.|||+ +||+||||||+||+++ ++.+||+|||++.... .........|
T Consensus 80 ~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 80 GELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred CcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 5554444 34469999999999999999999997 7999999999999995 5699999999986532 2223344579
Q ss_pred cCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCc
Q 039371 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241 (346)
Q Consensus 162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
|+.|+|||++. ...++.++||||+||++|+|++|..||.+.+.......+.... ..+
T Consensus 159 t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-------------------~~~--- 215 (325)
T cd05594 159 TPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------------IRF--- 215 (325)
T ss_pred CcccCCHHHHc-cCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-------------------CCC---
Confidence 99999999886 5668999999999999999999999998876655544442211 111
Q ss_pred CCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 039371 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGCL 288 (346)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~~ 288 (346)
...+++++.++|++||+.||++|+ ++.++++||||++..
T Consensus 216 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 216 --------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred --------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 135688999999999999999997 999999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=347.81 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=207.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|.++.+++.||+|+++..... ........|..++..+ +||+|+++++.+.+++.+|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 5899999999999999999999999999999999654321 1223345688888888 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--- 154 (346)
|||++| +|.+.+... +.+++..++.++.|++.||+|||++||+||||||+||+++ ++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 80 MEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999985 666666543 4599999999999999999999999999999999999995 5699999999986442210
Q ss_pred ---------------------------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCC
Q 039371 155 ---------------------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFP 201 (346)
Q Consensus 155 ---------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 201 (346)
......||+.|+|||++. ...++.++||||+||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-CCCCCCcceeccccceeeecccCCCCCC
Confidence 011346899999999987 5668999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC---HHHH
Q 039371 202 GTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT---AAEA 278 (346)
Q Consensus 202 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~el 278 (346)
+.+..+....+...... ..++. ....+++++++|.+|+. ||.+|++ ++++
T Consensus 238 ~~~~~~~~~~i~~~~~~-----------------~~~p~---------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei 290 (360)
T cd05627 238 SETPQETYRKVMNWKET-----------------LVFPP---------EVPISEKAKDLILRFCT-DSENRIGSNGVEEI 290 (360)
T ss_pred CCCHHHHHHHHHcCCCc-----------------eecCC---------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHH
Confidence 88776666555432110 01110 01367899999999875 9999984 8999
Q ss_pred hcCCCCCCC
Q 039371 279 LQHPLFQGC 287 (346)
Q Consensus 279 l~hp~~~~~ 287 (346)
++||||++.
T Consensus 291 ~~hp~f~~~ 299 (360)
T cd05627 291 KSHPFFEGV 299 (360)
T ss_pred hcCCCCCCC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=338.32 Aligned_cols=249 Identities=29% Similarity=0.444 Sum_probs=203.2
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|.+..+++.||+|+++.... .........|..++....+||||+++++++.+++.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976532 222333456777777766899999999999999999999999985
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~~~~~t 162 (346)
+|...+... ..+++.++..++.|++.||.|||++|++||||||+||+++ ++.+||+|||++..... ........||
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 666666543 4589999999999999999999999999999999999995 56999999999865322 2233456789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+..... .+
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-------------------~~---- 215 (316)
T cd05619 160 PDYIAPEILL-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP-------------------CY---- 215 (316)
T ss_pred ccccCHHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------------CC----
Confidence 9999999886 56689999999999999999999999988776655544422110 00
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA-EALQHPLFQGCL 288 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~-ell~hp~~~~~~ 288 (346)
...++.+++++|.+||+.||++||++. ++++||||+...
T Consensus 216 -------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 216 -------PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -------CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 124678899999999999999999996 999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=333.11 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=209.6
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+|++.+.||+|+||+||++.+..+++.||+|++....... ......+|+.+++++ +||||+++++.+.+++.+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence 5899999999999999999999999999999986543322 223446799999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 81 EYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 81 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||+.| +|.+.+... ...+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence 99985 666555443 34589999999999999999999999999999999999995 4689999999997765444444
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+++.|+|||++. ...++.++||||+||++|+|++|..||.+.........+........
T Consensus 160 ~~~~~~~y~aPE~~~-~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 221 (285)
T cd05605 160 GRVGTVGYMAPEVVK-NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----------------- 221 (285)
T ss_pred cccCCCCccCcHHhc-CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-----------------
Confidence 567899999999986 56689999999999999999999999987655433333322111000
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQG 286 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~ 286 (346)
....+.++..+.+++.+||+.||++|| +++++++||||+.
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 222 ---------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ---------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 011235788899999999999999999 9999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=329.21 Aligned_cols=282 Identities=33% Similarity=0.568 Sum_probs=220.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++.+.||+|++|.||+|.++.+++.||+|++....... ......+|+.+++++ +|||++++++++..+...+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEEE
Confidence 68999999999999999999999999999999986543221 223346799999998 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
||++++++..+......+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 9999988887766666799999999999999999999999999999999999995 5689999999997765433 2334
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||.+.+...++.++||||+|+++|+|++|..||.+.+..+....+....+..............-......
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 56788999999987556788999999999999999999999998887777766665544332211100000000000011
Q ss_pred CCcC-CCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 239 PKLQ-GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 239 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+... ........+.++..+.+|+.+||+.||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 1110 011112234678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=340.82 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=200.3
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|.++.+++.||+|+++...... .......|..++..+.+||||+++++++.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654322 2233457888888887899999999999999999999999986
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc-CCCCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV-DSCPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~-~~~~~~~~~~~t 162 (346)
+|...+.. .+.+++..+..++.|++.||.|||++|++||||||+||+++ ++.+||+|||++... ..........||
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 66555544 35699999999999999999999999999999999999995 569999999998642 222334456789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||......+ .+.........+.........
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~---- 224 (329)
T cd05588 160 PNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNTEDYLFQVILEKQIRI---- 224 (329)
T ss_pred ccccCHHHHc-CCCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccchHHHHHHHHcCCCCC----
Confidence 9999999887 5668999999999999999999999996422110 000000000001111111111
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPT------AAEALQHPLFQGC 287 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps------~~ell~hp~~~~~ 287 (346)
...++..+.++|++||+.||.+|+| ++++++||||+..
T Consensus 225 -------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 225 -------PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred -------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 1356788999999999999999987 7899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=322.34 Aligned_cols=288 Identities=31% Similarity=0.563 Sum_probs=230.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc----EEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeec-CCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASE-NYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-~~~ 75 (346)
..|++++.||+|+||.||+|..+.++. .+|+|.++.+... .-.....+|+..++.+ +|||++.+..+|-+ +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhccCce
Confidence 579999999999999999997665543 6899999766332 2233456899999999 79999999999876 789
Q ss_pred EEEEEEcCCCCHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-----CCcEEEeeccc
Q 039371 76 LYFVFEYMDCNLHQLMSNR----KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-----NDTIKIADFGL 146 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-----~~~vkl~Dfg~ 146 (346)
+++++||.+.+|+..+... ...++...++.|++||+.|+.|||++-|.||||||.|||+. .|.|||+|+|+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 9999999999999988533 23589999999999999999999999999999999999993 37999999999
Q ss_pred ccccCCCC----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHH
Q 039371 147 AWEVDSCP----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTC---------EDDQLYKIC 213 (346)
Q Consensus 147 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~~i~ 213 (346)
++.....- ..+..+.|..|+|||.+.+...|+.+.|+|++|||+.||++..+.|.+.. ..+++.+|+
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 98776532 34556789999999999999999999999999999999999999996532 358899999
Q ss_pred HHhCCCChhhHHHHHHHHHhcC--CCCC--CcCCCCcc---cccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 214 NAIGSPTEESWAEGLELAKAHG--YKFP--KLQGNNLS---LLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~---~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
+.+|.|+...|.+....-.... ..++ ......+. .....-++...+|+.+||+.||.+|+|++++|+|+||.+
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 9999999999986543221100 0111 10110011 112234566999999999999999999999999999998
Q ss_pred CCCC
Q 039371 287 CLQV 290 (346)
Q Consensus 287 ~~~~ 290 (346)
..-+
T Consensus 343 d~lp 346 (438)
T KOG0666|consen 343 DPLP 346 (438)
T ss_pred CCCC
Confidence 7543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=337.05 Aligned_cols=254 Identities=29% Similarity=0.445 Sum_probs=209.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+|+..+.||+|+||+||+|.++.+|+.||+|++..... .........|..++..+.+|++|+++++++.+++.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 58899999999999999999999999999999975432 2222344578888888867788999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCc
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYT 157 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~ 157 (346)
||++| +|...+.. .+.+++.++..++.|++.||.|||++|++||||||+||+++ ++.+||+|||++...... ....
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 99985 66555544 44599999999999999999999999999999999999995 569999999998754322 2233
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+.......+......
T Consensus 160 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~------------------- 219 (323)
T cd05615 160 TFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS------------------- 219 (323)
T ss_pred CccCCccccCHHHHc-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------------
Confidence 456899999999887 566899999999999999999999999988776666655432111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~ 288 (346)
+ ....+.++.+++.+||+.||.+|++ .+++++||||+...
T Consensus 220 ~-----------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 220 Y-----------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred C-----------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 1 1246788999999999999999997 57999999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=338.59 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=208.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||++++..+++.||+|++...... .......+|..++..+ +||||+++++.+.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence 6899999999999999999999999999999999643221 1222345677777777 899999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
|||+. |+|.+.+......+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 99997 577777766556699999999999999999999999999999999999994 56999999999876543322
Q ss_pred CccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....||+.|+|||++.. ...++.++||||+||++|+|++|..||.+.+..+....+.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 227 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF------------ 227 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc------------
Confidence 223468999999999863 3457889999999999999999999998877666655553321100
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK--RPTAAEALQHPLFQGC 287 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~--Rps~~ell~hp~~~~~ 287 (346)
.+ ....+.++.+++++|++||..++++ |++++++++||||++.
T Consensus 228 -----~~--------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 228 -----QF--------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred -----cC--------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 00 1111347889999999999764443 8899999999999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=339.85 Aligned_cols=249 Identities=30% Similarity=0.423 Sum_probs=201.1
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|.+..+|+.||+|++...... ........|...+.+..+||||+++++.+.+++..|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999999999999999999654322 12223345555443333899999999999999999999999986
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~~~~~t 162 (346)
+|...+.. ...+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++..... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 56555544 45699999999999999999999999999999999999995 56999999999865322 2233445789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------------- 213 (323)
T cd05575 160 PEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL------------------------- 213 (323)
T ss_pred hhhcChhhhc-CCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence 9999999887 56689999999999999999999999988776665555432210
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA----AEALQHPLFQGCL 288 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~----~ell~hp~~~~~~ 288 (346)
...+..+..+.++|++||+.||.+||++ .++++||||+...
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 214 -----RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 1124568899999999999999999997 6999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=337.52 Aligned_cols=248 Identities=29% Similarity=0.459 Sum_probs=202.6
Q ss_pred eeeecccCceEEEEEEEc---cCCcEEEEEEccccccC---HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYS---WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++.||+|+||.||++++. .+++.||+|+++..... .......+|+.+++.+ +||||+++++.+..++.+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEE
Confidence 468999999999999864 46889999999754321 1223345788999998 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCc
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYT 157 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~ 157 (346)
||+.| +|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++..... .....
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99986 55555544 45589999999999999999999999999999999999995 56999999999864322 22333
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 159 ~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~-------------------- 217 (323)
T cd05584 159 TFCGTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL-------------------- 217 (323)
T ss_pred ccCCCccccChhhcc-CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence 457899999999887 45678999999999999999999999988776665555533211
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
.+.+.+++++.++|++||+.||++|| +++++++||||+..
T Consensus 218 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 218 ----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 11235678999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=336.38 Aligned_cols=283 Identities=20% Similarity=0.327 Sum_probs=210.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.++||+|+||.||+|.+..++..+|+|++.............+|+.+++++ +||||+++++++.+++.+++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEEEEe
Confidence 68999999999999999999999999999999987654444445567899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|+.| +|.+.+... +.+++..+..++.|++.||.|||+. +++|+||||+||+++ ++.+||+|||++..... .....
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~ 161 (333)
T cd06650 84 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANS 161 (333)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-hcccc
Confidence 9985 666666543 4589999999999999999999985 799999999999995 56899999999865533 22334
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCChhhHHH-----HHHHHH
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI-GSPTEESWAE-----GLELAK 232 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~-----~~~~~~ 232 (346)
..++..|+|||++. ...++.++|+||+||++|+|++|..||......+....+.... +.+....... ......
T Consensus 162 ~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (333)
T cd06650 162 FVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS 240 (333)
T ss_pred CCCCccccCHHHhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence 56899999999886 5568999999999999999999999998765543322111000 0000000000 000000
Q ss_pred hcCCCCCC---------cCC-CCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 233 AHGYKFPK---------LQG-NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 233 ~~~~~~~~---------~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
......+. ... ..........+.++++|+.+||+.||++|||++|+++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000000 000 000000123567899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=329.94 Aligned_cols=280 Identities=43% Similarity=0.762 Sum_probs=240.2
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
|++.+.||+|++|.||+|.+..+++.+++|.++..... .......+|+..++++ +||||+++++++.+++..++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEec
Confidence 78899999999999999999999999999998765443 2334456789999999 699999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcccc
Q 039371 83 MDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEYI 160 (346)
Q Consensus 83 ~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~~ 160 (346)
+++++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+....... ......
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 99999888877666799999999999999999999999999999999999996 4699999999987665543 333456
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (346)
++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.+..+....+....+.+.+..|....+........++.
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 78889999998755478999999999999999999999999999888888888888888888777766655555555555
Q ss_pred cCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
..........+.++.++.++|.+||+.||.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 44444455556789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=331.99 Aligned_cols=274 Identities=30% Similarity=0.546 Sum_probs=208.6
Q ss_pred eeeecccCceEEEEEEEcc--CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee--cCCEEEEEEEc
Q 039371 7 MKQIGEGSFGKVWQAIKKQ--SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS--ENYRLYFVFEY 82 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~--~~~~~~iv~e~ 82 (346)
..+||+|+||+||+|+++. ++..||+|.+...... ....+|+.+++++ +||||+++++++. .+...+++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS---MSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc---HHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3689999999999998654 5678999998654322 2345799999998 7999999999884 45678999999
Q ss_pred CCCCHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-----CCcEEEeecccccc
Q 039371 83 MDCNLHQLMSNR--------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-----NDTIKIADFGLAWE 149 (346)
Q Consensus 83 ~~g~l~~~~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-----~~~vkl~Dfg~a~~ 149 (346)
+++++.+.+... ...+++..+..++.|++.||.|||++||+||||||+||++. ++.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 999988776421 22489999999999999999999999999999999999993 34899999999976
Q ss_pred cCCCC----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 039371 150 VDSCP----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE---------DDQLYKICNAI 216 (346)
Q Consensus 150 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~~~~ 216 (346)
..... ......+|+.|+|||++.+...++.++||||+||++|+|++|.+||..... ......+....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 54322 233457899999999987666789999999999999999999999975432 34566677777
Q ss_pred CCCChhhHHHHHHHHHhcC----CCCCCcCCC----CcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 217 GSPTEESWAEGLELAKAHG----YKFPKLQGN----NLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+.+....|.+......... ......... .........+..+.+|+.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 7777777765322211000 000000000 0111122345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=338.73 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=198.7
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|.++.+++.||+|+++..... ........|..++.++.+||||+++++++.+++.+++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999765332 22233457888888877899999999999999999999999985
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~~~~~t 162 (346)
+|...+.. ...+++..++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||++.... .........||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 55555544 44599999999999999999999999999999999999995 5699999999986532 22233456789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||........ +.........+........
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------~~~~~~~~~~~~i~~~~~~----- 223 (329)
T cd05618 160 PNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQNTEDYLFQVILEKQIR----- 223 (329)
T ss_pred ccccCHHHHc-CCCCCCccceecccHHHHHHhhCCCCCccCCCcCC----------cccccHHHHHHHHhcCCCC-----
Confidence 9999999887 56689999999999999999999999953211000 0000000000001111111
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPT------AAEALQHPLFQGC 287 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps------~~ell~hp~~~~~ 287 (346)
+....+..+.++|++||+.||++||| ++++++||||++.
T Consensus 224 ------~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 224 ------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred ------CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 12356788999999999999999998 5899999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=343.41 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=207.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||.||+|.++.+++.||+|++...... .......+|..+++.+ +||||+++++.+.+++.+|+|
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEE
Confidence 6899999999999999999999999999999998653221 1223345677777777 899999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--C
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--P 155 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~ 155 (346)
|||++| +|.+.+... .+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++....... .
T Consensus 122 ~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 122 MEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence 999985 666665433 489999999999999999999999999999999999995 5699999999997664322 2
Q ss_pred CccccccCcccCccccccc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLMS---GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.....||+.|+|||++... ..++.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------------- 266 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL------------- 266 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc-------------
Confidence 3356799999999998643 237899999999999999999999999887766666665432111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK--RPTAAEALQHPLFQGC 287 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~--Rps~~ell~hp~~~~~ 287 (346)
.++. .+.++..++++|.+||+.++.+ |++++++++||||++.
T Consensus 267 ----~~~~---------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 267 ----TFPD---------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred ----cCCC---------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 0110 1357889999999999844433 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=331.94 Aligned_cols=283 Identities=34% Similarity=0.551 Sum_probs=219.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN------ 73 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------ 73 (346)
+++|++.++||+|++|.||+|.+..+++.||+|.+....... ......+|+.+++++ +||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence 578999999999999999999999999999999986543222 222345789999999 799999999987654
Q ss_pred --CEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc
Q 039371 74 --YRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV 150 (346)
Q Consensus 74 --~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~ 150 (346)
...+++|||+++++.+.+......+++.++..++.|+++||.|||++|++|+||+|+||+++ ++.++|+|||++...
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 34699999999999888877666799999999999999999999999999999999999996 568999999999765
Q ss_pred CCCC-----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHH
Q 039371 151 DSCP-----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 151 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (346)
.... ......++..|+|||.+.+...++.++||||+|+++|+|++|.+||.+.+.......+....+..+++.+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 4322 12234567889999988755567899999999999999999999999888877777777666666555444
Q ss_pred HHHHHHHhcCCCCCCcCCCCccc--ccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSL--LIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
............++......... .....+..+.++|.+||+.||.+|||++++++||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 32211111111111111100000 011245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=328.08 Aligned_cols=256 Identities=35% Similarity=0.621 Sum_probs=210.4
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHh-hhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEEC-LNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
|++++.||+|+||+||+|.+..+++.||+|++.......... ...+|+..++++ +||||+++++++.+....+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccccccccccccc
Confidence 899999999999999999999999999999998775544433 235699999999 899999999999999999999999
Q ss_pred CCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc-CCCCCCccc
Q 039371 83 MDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV-DSCPPYTEY 159 (346)
Q Consensus 83 ~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~-~~~~~~~~~ 159 (346)
+++ ++.+.+. ....+++..+..++.|+++||.+||++|++|+||||+||+++ ++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 80 CPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp ETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSS
T ss_pred ccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 998 7777776 444589999999999999999999999999999999999997 669999999999763 333445566
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (346)
.++..|+|||++......+.++||||+|+++|+|++|..||......+....+...........+.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 224 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-------------- 224 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--------------
Confidence 789999999988646778999999999999999999999999875444444443322111111000
Q ss_pred CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.....+..+.++|.+||+.||++|||+.++++||||
T Consensus 225 ---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 001123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=341.78 Aligned_cols=249 Identities=28% Similarity=0.412 Sum_probs=201.6
Q ss_pred ecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhc--CCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKIN--NHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~--~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
||+|+||+||+|+++.+++.||+|++....... .......|..++.... +||||+++++.+.+++.+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999986543221 2223345666666654 799999999999999999999999985
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~~~~~t 162 (346)
+|...+.. .+.+++..+..++.||+.||+|||++||+||||||+||+++ ++.++|+|||++..... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 66655554 45699999999999999999999999999999999999995 56999999999865332 2234456799
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+..... .++.
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------~~~~-- 218 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-------------------RFPK-- 218 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-------------------CCCC--
Confidence 9999999987556689999999999999999999999988776655554432211 1111
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCC----CHHHHhcCCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRP----TAAEALQHPLFQGCL 288 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp----s~~ell~hp~~~~~~ 288 (346)
..+++++.++|++||+.||.+|| +++++++||||+...
T Consensus 219 --------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 219 --------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred --------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 23678899999999999999998 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=326.77 Aligned_cols=279 Identities=38% Similarity=0.718 Sum_probs=228.1
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
|++.+.||.|++|.||+|.+..+|+.||+|++....... ......+|+..++.+ +|||++++++++.+++..+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEec
Confidence 788999999999999999999999999999987554322 223456799999999 799999999999999999999999
Q ss_pred CCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCccc
Q 039371 83 MDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEY 159 (346)
Q Consensus 83 ~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~ 159 (346)
+++++.+.+.... ..+++..+..++.|+++||+|||+++++|+||+|+||+++ ++.++|+|||.+....... .....
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 9988888776554 3589999999999999999999999999999999999995 5699999999987654322 22334
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (346)
.++..|+|||++.+...++.++||||+|+++|+|++|.+||...+..+...++.+..+.+....|....... .....++
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 238 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP-DYKPTFP 238 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch-hhhhhcc
Confidence 568899999988755567899999999999999999999999988888888888888888777664332221 1111223
Q ss_pred CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
...........+.++.++.++|++||+.||++|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 222233334456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=335.94 Aligned_cols=315 Identities=33% Similarity=0.538 Sum_probs=237.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-----CE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASEN-----YR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-----~~ 75 (346)
++|++.+.||+|+||+||+|.+..+++.||+|.+...... .......+|+.+++.+ +||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccCc
Confidence 6899999999999999999999999999999998654322 2233456799999988 799999999987644 35
Q ss_pred EEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-
Q 039371 76 LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC- 153 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~- 153 (346)
.|+++||+++++.+.+... +.+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 8999999999988877654 4599999999999999999999999999999999999995 569999999999766543
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH-HH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL-AK 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~ 232 (346)
.......++..|+|||.+.....++.++||||+||++|+|++|.+||.+.+.......+....+.+.++.+...... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 22334567889999998875556899999999999999999999999998887778778877777766554211110 00
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCcccccccCCccccccCcc
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCKMRLTPSAKKSGWK 312 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (346)
......+...........+.+++++.++|++||+.||++|||++++++||||+........... ...+.......+|.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 320 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVC--QTPFSFDFEEDALT 320 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccC--CCccchhhhhhhcC
Confidence 0000111111122233345788999999999999999999999999999999876544332221 12233334444444
Q ss_pred chhhhhhc
Q 039371 313 AKLIVWFL 320 (346)
Q Consensus 313 ~~~~~~~~ 320 (346)
...+++.+
T Consensus 321 ~~~~~~~~ 328 (337)
T cd07858 321 EEDIKELI 328 (337)
T ss_pred HHHHHHHH
Confidence 44444443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=326.97 Aligned_cols=282 Identities=32% Similarity=0.587 Sum_probs=222.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++.+.||+|++|.||+|.+..+++.||+|++....... ......+|+.+++.+ +||||+++++++.+++..++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEE
Confidence 68999999999999999999999999999999986544332 233456789999998 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~ 158 (346)
||++++++..+......+++.++..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++...... .....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 9999877776665555699999999999999999999999999999999999995 568999999998765432 22334
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||.+.+...++.++||||+|+++|+|++|.+||......+....+....+.................+...
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 56788999999887556678999999999999999999999998887777777766555443221110000000111112
Q ss_pred CCcCC-CCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 239 PKLQG-NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 239 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+.... .......+.++..+.+++.+||+.||++||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 21111 11222345778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=331.50 Aligned_cols=283 Identities=36% Similarity=0.629 Sum_probs=223.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeec-------
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASE------- 72 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------- 72 (346)
+++|++.+.||+|++|.||+|.++.+++.+|+|++....... ......+|+.+++++ +||||+++++.+.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccc
Confidence 479999999999999999999999999999999986543322 123346799999999 79999999998743
Q ss_pred -CCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc
Q 039371 73 -NYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV 150 (346)
Q Consensus 73 -~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~ 150 (346)
...+++++||+.+++...+......+++..+..++.|+++||.|||++|++|+||||+||+++ ++.++|+|||++...
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 335799999999999888877666799999999999999999999999999999999999995 569999999998754
Q ss_pred CCCCC------------CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 039371 151 DSCPP------------YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGS 218 (346)
Q Consensus 151 ~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 218 (346)
..... .....+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+.......+....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 43221 122356788999998875566899999999999999999999999999888888888887777
Q ss_pred CChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 219 PTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+.+..|.............................+..+.++|++||+.||++|||+.++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 766655532221111110111111111222234566789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=328.47 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=199.7
Q ss_pred ecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-C
Q 039371 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-N 86 (346)
Q Consensus 10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~ 86 (346)
||+|+||+||++.+..+++.||+|.+........ ......|+.+++.+ +||||+++.+.+..++..++||||++| +
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 6999999999999999999999999875443322 23345788899988 899999999999999999999999985 6
Q ss_pred HHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCccccc
Q 039371 87 LHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEYIT 161 (346)
Q Consensus 87 l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~~~ 161 (346)
|...+.. .+..+++..+..++.|++.||.|||++||+||||||+||+++ ++.++|+|||++....... ......|
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 6555432 334689999999999999999999999999999999999995 5699999999987654332 2334578
Q ss_pred cCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCc
Q 039371 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241 (346)
Q Consensus 162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
|+.|+|||++. ...++.++||||+||++|+|++|..||...........+.......
T Consensus 160 ~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------------- 216 (280)
T cd05608 160 TPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND---------------------- 216 (280)
T ss_pred CcCccCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------------
Confidence 99999999987 5678999999999999999999999997654322221111111000
Q ss_pred CCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
.....+.++.++.+++.+||+.||++|| |++++++||||++.
T Consensus 217 ----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 217 ----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred ----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 0011235788999999999999999999 88999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=327.11 Aligned_cols=280 Identities=38% Similarity=0.654 Sum_probs=226.6
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASEN--YRLYFVF 80 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~~iv~ 80 (346)
|++.+.||+|++|.||+|.+..+++.+|+|++...... .......+|+.+++++ +|||++++++++.+. +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 78999999999999999999999999999999866422 2233456799999999 699999999999888 8999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CCc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PYT 157 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~~ 157 (346)
||+++++.+.+......+++..+..++.|++.||+|||+.|++|+||+|+||+++ ++.++|+|||.+....... ...
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9999998888877656799999999999999999999999999999999999995 5699999999997665433 233
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...++..|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+....+.+....|.............
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 34567889999988755668999999999999999999999999999888888888877777766665332211111111
Q ss_pred CCCcCCCCcccccCC-CCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 238 FPKLQGNNLSLLIPS-ANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
............... ++..+.+++++||+.||.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 111111111122233 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=326.17 Aligned_cols=259 Identities=22% Similarity=0.335 Sum_probs=209.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||.||+|.+..+|+.||+|+++.............|+....+..+||||+++++++..++..|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 58999999999999999999999999999999998765555555566777766666689999999999999999999999
Q ss_pred cCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 82 YMDCNLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 82 ~~~g~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|++|++.+.+.. .+..+++..+..++.|++.||+|||++ +++||||||+||+++ ++.+||+|||.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999988766543 334689999999999999999999997 999999999999995 569999999998765543333
Q ss_pred ccccccCcccCccccccc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 157 TEYITTLQYRAPEMLLMS---GQYNSKVDMWALGLIMAELITFHPLFPGTC-EDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
....++..|+|||.+.+. ..++.++|+||+||++|+|++|..||.... ..+....+.....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 225 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--------------- 225 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC---------------
Confidence 345678899999988532 346889999999999999999999996532 2222222221100
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
... ....++.++.++|.+||..+|.+|||++++++||||+...
T Consensus 226 ---~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 226 ---PQL----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ---CCC----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 000 0124678899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=332.82 Aligned_cols=282 Identities=32% Similarity=0.517 Sum_probs=219.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN-------- 73 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-------- 73 (346)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+...... ......+|+.+++++ +||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~-~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ-SVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc-hHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccc
Confidence 5899999999999999999999999999999998665442 233456799999999 899999999876543
Q ss_pred ------CEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe--CCcEEEeecc
Q 039371 74 ------YRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS--NDTIKIADFG 145 (346)
Q Consensus 74 ------~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~--~~~vkl~Dfg 145 (346)
...|++|||+++++.+.+.. ..+++..++.++.|+++||.|||+.|++|+||||+||+++ ++.++|+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35799999999888776653 3489999999999999999999999999999999999995 3478999999
Q ss_pred cccccCCCC----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 146 LAWEVDSCP----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 146 ~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
.+....... ......++..|+|||.+.....++.++|||||||++|+|++|..||.+.+..+....+......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 987653321 1223357889999998765566889999999999999999999999988888777777766555444
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.............................+..+.++.+|+++||+.||++|||++++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 333322221111110001111111223345688899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=328.48 Aligned_cols=283 Identities=37% Similarity=0.620 Sum_probs=224.4
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-----
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENY----- 74 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~----- 74 (346)
+++|++.+.||.|++|+||+|.++.+|+.||+|+++..... .......+|+.+++++ +||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhc
Confidence 46899999999999999999999999999999998654322 1223445789999999 7999999999886654
Q ss_pred -----EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccc
Q 039371 75 -----RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAW 148 (346)
Q Consensus 75 -----~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~ 148 (346)
.+++++||+++++...+......+++..+..++.|++.||+|||+.||+|+||+|+||+++ ++.+||+|||.+.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 7899999999998888876666799999999999999999999999999999999999995 4699999999987
Q ss_pred ccCCCC--CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHH
Q 039371 149 EVDSCP--PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 149 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (346)
...... ......++..|+|||.+.....++.++||||+||++|+|++|++||...+..+.+..+.+..+.+.+..|..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 654322 223345677899999887555678999999999999999999999998888888888888777777665543
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
..+.......................++..+.+++.+||+.||.+|||++++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 2221111000000000111122234568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=336.94 Aligned_cols=248 Identities=30% Similarity=0.450 Sum_probs=200.2
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|.+..+|+.||+|++...... ........|...+.+..+||||+++++.++.++..|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999999999999999999654322 22233345555544434899999999999999999999999986
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~~~~~t 162 (346)
++...+. ....+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++..... ........||
T Consensus 81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 5555554 445699999999999999999999999999999999999995 56999999999865322 2233456789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||...+..+....+....
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-------------------------- 212 (325)
T cd05604 160 PEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-------------------------- 212 (325)
T ss_pred hhhCCHHHHc-CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence 9999999886 5668999999999999999999999998877666555543211
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA----AEALQHPLFQGC 287 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~----~ell~hp~~~~~ 287 (346)
....+..+..+.++|++||+.||.+||++ .++++||||+..
T Consensus 213 ----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 213 ----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 01123567889999999999999999986 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=334.52 Aligned_cols=292 Identities=37% Similarity=0.602 Sum_probs=234.7
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc-CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-----EE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINNHPNIVKLQELASENY-----RL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~-----~~ 76 (346)
+|++.+.||.|++|.||+|.+..+++.||+|.+..... ........+|+..++.+ +||||+++.+++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 69999999999999999999999999999999876543 22334556899999999 7999999999987765 78
Q ss_pred EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-
Q 039371 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~- 154 (346)
|++|||+++++...+.... .+++..+..++.|++.||++||+.|++|+||||+||+++ ++.++|+|||.+.......
T Consensus 80 ~lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 9999999988877776544 699999999999999999999999999999999999995 5699999999998765542
Q ss_pred ---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH-H
Q 039371 155 ---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE-L 230 (346)
Q Consensus 155 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~ 230 (346)
......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+....+.++++.+..... .
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 234456788999999987554789999999999999999999999999999888999988888877665542110 0
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCcc
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSID 296 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~ 296 (346)
........+...........+..+.++.++|++||+.||.+|||++++++||||++....+....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~ 304 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVA 304 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCC
Confidence 000000111112222333345678999999999999999999999999999999987765444333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=335.71 Aligned_cols=248 Identities=31% Similarity=0.438 Sum_probs=200.4
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|++..+++.||+|++...... ........|...+.+..+||||+++++.+.+++..|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999754322 12223344554443333899999999999999999999999986
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~~~~~t 162 (346)
++.+.+.. ...+++..++.++.||++||.|||++||+||||||+||+++ ++.+||+|||++.... .........||
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 55555544 44589999999999999999999999999999999999995 5699999999986532 22234456799
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------------------- 213 (325)
T cd05602 160 PEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL------------------------- 213 (325)
T ss_pred ccccCHHHHc-CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-------------------------
Confidence 9999999887 56689999999999999999999999988777666555533210
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCCHH----HHhcCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA----EALQHPLFQGC 287 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~----ell~hp~~~~~ 287 (346)
...+.+++.+.++|++||+.||.+|+++. ++++|+||+..
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 214 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 11246788999999999999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=335.60 Aligned_cols=284 Identities=35% Similarity=0.567 Sum_probs=225.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE-----
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYR----- 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~----- 75 (346)
++|++.+.||+|++|.||+|.+..+++.||+|++....... ......+|+.+++++ +|||++++.+++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccccc
Confidence 58999999999999999999999999999999986543322 223446799999998 89999999998866554
Q ss_pred -EEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 -LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 -~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
.++++|++++++.+.+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 899999998888887765 3599999999999999999999999999999999999995 569999999999765432
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH-HH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL-AK 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~ 232 (346)
.....++..|+|||.+.+...++.++||||+||++|+|++|..||.+....+.+..+....+.+++..+...... ..
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred --ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 334567889999998865557889999999999999999999999998888888888887776665544322111 00
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
......+..............+..+.++|++||+.||++|||+.++++||||+.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0001111111122223334568899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=324.73 Aligned_cols=282 Identities=36% Similarity=0.598 Sum_probs=223.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++.+.||+|++|.||+|.+..+++.|++|+++...... ......+|+.+++++ +||||+++++.+.+++..+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEE
Confidence 58999999999999999999999999999999987554332 234456899999999 6999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CCc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PYT 157 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~~ 157 (346)
||++++++..+......+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9999988887776666799999999999999999999999999999999999995 5699999999987665433 344
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...++..|+|||++.....++.++||||+|+++|+|++|.+||.+....+.+..+....+..++................
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 56678899999998755478999999999999999999999999888777777766665554443322211111111111
Q ss_pred CCCcCCC-Ccc-cccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 238 FPKLQGN-NLS-LLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 238 ~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
++..... ... .....++.++.++|++||..||++|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 1111100 000 1122358899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=334.66 Aligned_cols=287 Identities=33% Similarity=0.573 Sum_probs=229.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeee----cCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELAS----ENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~----~~~~~ 76 (346)
++|++.+.||+|++|.||+|.++.+|+.||+|++...... .......+|+.+++++ +||||+++++++. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCceE
Confidence 5799999999999999999999999999999998754332 2233445789999999 6999999999875 34578
Q ss_pred EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-
Q 039371 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~- 154 (346)
++||||+.|++...+... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 999999998887777554 4499999999999999999999999999999999999995 5699999999986543321
Q ss_pred ----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 155 ----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 155 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
......++..|+|||.+.....++.++||||+||++|+|++|.+||.+.+.......+....+.|+...+......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1234568889999999875566899999999999999999999999999888888888888888877665432221
Q ss_pred HH-hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 231 AK-AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 231 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
.. .....++...........+..+.++.++|++||+.||++|||++++++||||++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 11 1111222222222333445678999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=334.93 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=209.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||+||++.++.+++.||+|++.+..... .......|..++..+ +||+|+++++.+.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence 68999999999999999999999999999999986432211 122234677777776 899999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--C
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--P 155 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~ 155 (346)
|||+. |+|.+.+......+++..++.++.|++.||.|||++||+||||||+||+++ ++.+||+|||++....... .
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 99997 577777776556799999999999999999999999999999999999995 5699999999986543322 2
Q ss_pred CccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....||+.|+|||++.. ...++.++||||+||++|+|++|+.||...+..+....+.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 227 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF------------ 227 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc------------
Confidence 233578999999998862 3458899999999999999999999998887766666654321100
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK--RPTAAEALQHPLFQGC 287 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~--Rps~~ell~hp~~~~~ 287 (346)
.++ .....+++++++|+++||..++.+ |++++++++||||++.
T Consensus 228 -----~~p--------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 228 -----QFP--------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred -----cCC--------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 011 111357899999999999765544 7899999999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=337.26 Aligned_cols=248 Identities=28% Similarity=0.455 Sum_probs=204.3
Q ss_pred eeeecccCceEEEEEEE---ccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 7 MKQIGEGSFGKVWQAIK---KQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
++.||+|+||+||++++ ..+|+.||+|++....... ......+|+.++.++ +||||+++++.+.+++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcC
Confidence 46899999999999976 3578999999997654332 223446788999999 799999999999999999999999
Q ss_pred CCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCccc
Q 039371 83 MDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTEY 159 (346)
Q Consensus 83 ~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~~ 159 (346)
+.| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...... ......
T Consensus 80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 985 66666644 44599999999999999999999999999999999999995 569999999998765443 233446
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (346)
.|++.|+|||.+. ...++.++||||+||++|+|++|..||...+..+....+..... .
T Consensus 159 ~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-------------------~-- 216 (318)
T cd05582 159 CGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-------------------G-- 216 (318)
T ss_pred cCChhhcCHHHHc-CCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC-------------------C--
Confidence 7899999999886 45678999999999999999999999988776666555533211 0
Q ss_pred CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
....+++++.++|++||+.||++||| ++++++||||+..
T Consensus 217 ---------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 217 ---------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ---------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 11346788999999999999999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=329.32 Aligned_cols=287 Identities=34% Similarity=0.556 Sum_probs=227.9
Q ss_pred ceeeeeeecccCceEEEEEEEccC--CcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeee----cCCE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQS--GEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELAS----ENYR 75 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~----~~~~ 75 (346)
+|++.+.||+|+||.||++.+..+ +..||+|.+....... ......+|+.+++++.+||||+++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 689999999999999999999988 8999999986543222 23345679999999977999999998743 2356
Q ss_pred EEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 76 LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
+++++|+++++|.+.+... ..+++..++.++.|++.||.|||++|++|+||||+||+++ ++.++|+|||.+.......
T Consensus 81 ~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 7999999999988877654 4599999999999999999999999999999999999995 5689999999997654321
Q ss_pred -----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 155 -----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 155 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
......++..|+|||.+.+...++.++||||+||++|+|++|.+||...+....+..+....+.++.+.+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 123346889999999887556689999999999999999999999999998889999999888887665443222
Q ss_pred HHH-hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 230 LAK-AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 230 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
... ..................+..+..+.+++.+||+.||++|||++++++|||++++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 110 0000111111122233345678899999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=332.65 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=200.3
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
+.||+|+||+||+|.+..+++.||+|++....... ......+|..++.++.+||+|+.+++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997654322 2233457888888887899999999999999999999999985
Q ss_pred -CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCcccccc
Q 039371 86 -NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYTEYITT 162 (346)
Q Consensus 86 -~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~~~~~t 162 (346)
+|...+.. ...+++..+..++.||+.||+|||++|++||||||+||+++ ++.+||+|||++.... .........||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 56555544 34599999999999999999999999999999999999995 5699999999987532 22334456789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE------DDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
+.|+|||++. ...++.++||||+||++|+|++|..||..... .+....... ....
T Consensus 160 ~~y~aPE~~~-~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------------~~~~ 220 (327)
T cd05617 160 PNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL------------------EKPI 220 (327)
T ss_pred cccCCHHHHC-CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH------------------hCCC
Confidence 9999999887 56789999999999999999999999964321 111111111 1011
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT------AAEALQHPLFQGCL 288 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps------~~ell~hp~~~~~~ 288 (346)
.. ....+..+.+++++||+.||++|++ .+++++||||+...
T Consensus 221 ~~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 221 RI-----------PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred CC-----------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 11 1346788999999999999999998 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=324.59 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=199.7
Q ss_pred ecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-C
Q 039371 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-N 86 (346)
Q Consensus 10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~ 86 (346)
||+|+||+||++.++.+|+.||+|++....... .......|..+++++ +||||+++++.++++...++||||+.| +
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999986543321 223345688999999 899999999999999999999999985 6
Q ss_pred HHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccccccCc
Q 039371 87 LHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQ 164 (346)
Q Consensus 87 l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~ 164 (346)
|.+.+... ...+++..+..++.|++.||+|||+.|++||||||+||+++ ++.++|+|||++.............++..
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 66655433 33589999999999999999999999999999999999995 56899999999877655444445578999
Q ss_pred ccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCC
Q 039371 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGN 244 (346)
Q Consensus 165 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
|+|||++. ...++.++||||+||++|+|++|..||...........+...... ..
T Consensus 160 y~aPE~~~-~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~--------- 214 (277)
T cd05607 160 YMAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE---------------DE--------- 214 (277)
T ss_pred ccCHHHHc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc---------------cc---------
Confidence 99999887 455899999999999999999999999765432221121111000 00
Q ss_pred CcccccCCCCchHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCC
Q 039371 245 NLSLLIPSANDDEMSLIELLCSWDPCKRPTA----AEALQHPLFQGC 287 (346)
Q Consensus 245 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~----~ell~hp~~~~~ 287 (346)
.......+++++++++++||+.||++||++ ++++.||||++.
T Consensus 215 -~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 215 -VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred -cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 000113568899999999999999999999 778899999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=332.09 Aligned_cols=283 Identities=36% Similarity=0.589 Sum_probs=227.6
Q ss_pred Cceee-eeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-------------HhhhHHHHHHHHhhcCCCCeeeee
Q 039371 2 EKYTL-MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-------------ECLNLKEVKCLRKINNHPNIVKLQ 67 (346)
Q Consensus 2 ~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------------~~~~~~e~~~l~~l~~hp~iv~~~ 67 (346)
+||.. .+.||+|+||+||+|.+..+++.||+|++........ .....+|+.+++++ +||||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeeee
Confidence 57765 4679999999999999999999999999865433221 11345789999999 799999999
Q ss_pred eeeecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccc
Q 039371 68 ELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGL 146 (346)
Q Consensus 68 ~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~ 146 (346)
+++..++..+++||+++|++.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 999999999999999999988887654 3489999999999999999999999999999999999995 56999999999
Q ss_pred ccccCC---------------CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 039371 147 AWEVDS---------------CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYK 211 (346)
Q Consensus 147 a~~~~~---------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 211 (346)
+..... ........++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 876541 11122335678899999987656679999999999999999999999999999999999
Q ss_pred HHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 212 ICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 212 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+....+.|....|........... +............+..+.++.++|++||+.||++|||++|++.||||+...
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTE--FTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccc--cCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 988888888776654322111111 111111222233456788999999999999999999999999999998764
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=334.23 Aligned_cols=247 Identities=28% Similarity=0.426 Sum_probs=198.6
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHH-HHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKC-LRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~-l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
+.||+|+||+||+|++..+++.||+|++...... ........|... ++.+ +||||+++++.+.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 4799999999999999999999999999654322 122333455544 4555 89999999999999999999999998
Q ss_pred C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCCCccccc
Q 039371 85 C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPPYTEYIT 161 (346)
Q Consensus 85 g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~~~~~~~ 161 (346)
| +|...+.. ...+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.... .........|
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 6 55555543 45589999999999999999999999999999999999995 5699999999987532 2223344578
Q ss_pred cCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCc
Q 039371 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241 (346)
Q Consensus 162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
|+.|+|||++. ...++.++||||+||++|+|++|..||.+.+.......+....
T Consensus 159 t~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------- 212 (321)
T cd05603 159 TPEYLAPEVLR-KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP------------------------- 212 (321)
T ss_pred CcccCCHHHhc-CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-------------------------
Confidence 99999999886 5668999999999999999999999998877655544443211
Q ss_pred CCCCcccccCCCCchHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCC
Q 039371 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA----AEALQHPLFQGC 287 (346)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~----~ell~hp~~~~~ 287 (346)
....+..+.++.++|.+||+.||.+|+++ .++++||||...
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 01123567889999999999999999975 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=324.47 Aligned_cols=279 Identities=39% Similarity=0.708 Sum_probs=236.0
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
|++.+.||+|++|.||+|++..+++.||+|++...... ........|+.+++++ +|||++++++++.+.+..++++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEecC
Confidence 67889999999999999999999999999999765422 1223445788999988 799999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcccc
Q 039371 83 MDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEYI 160 (346)
Q Consensus 83 ~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~~ 160 (346)
+++++.+.+......+++..+..++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||.+....... ......
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 99999888887655699999999999999999999999999999999999995 4699999999987654432 334455
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (346)
++..|+|||.+.....++.++|+||+||++|+|++|.+||.+.+..+.+..+.+..+.+.+..|....... .....++.
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKPTFPK 238 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-cccccccc
Confidence 67889999998755578999999999999999999999999999999999999988888888887554443 33344455
Q ss_pred cCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
..........+..+..+.++|++||+.||++||+++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 44444445556678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=340.15 Aligned_cols=274 Identities=24% Similarity=0.347 Sum_probs=207.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
..|.+.+.||+|+||.||+|.+..+++.||+|..... ...+|+.+++++ +||||+++++++..++..+++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~-------~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA-------SSVHEARLLRRL-SHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc-------CHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEE
Confidence 3699999999999999999999999999999964321 235799999999 79999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---CCc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP---PYT 157 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~---~~~ 157 (346)
++.|++...+......+++..+..++.|++.||.|||++||+||||||+||+++ ++.++|+|||++....... ...
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 999999998877666799999999999999999999999999999999999995 4699999999997654321 122
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCC-CCCC------hHHHHHHHHHHhCCCChh-------h
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLF-PGTC------EDDQLYKICNAIGSPTEE-------S 223 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~------~~~~~~~i~~~~~~~~~~-------~ 223 (346)
...||..|+|||++. ...++.++|||||||++|+|++|..|+ .... ....+.+++........+ .
T Consensus 321 ~~~GT~~Y~APE~~~-~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 321 GIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred ccCCCcCCcCHHHHc-CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 356899999999987 566899999999999999999987554 3221 123344444432221110 0
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
+.......... ...+......+.. ....+.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 400 l~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 400 LVSQYRHRAAR-NRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHhhhhc-ccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 11111100000 0111111111111 1245678999999999999999999999999999975
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=336.93 Aligned_cols=275 Identities=23% Similarity=0.343 Sum_probs=210.9
Q ss_pred CceeeeeeecccCceEEEEEEEc--cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
.+|++++.||+|+||.||+|... .+++.||+|.+.... ...+|+.+++++ +||||+++++.+......|++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTI-SHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhc-CCCCccceeeeEeeCCEEEEE
Confidence 36999999999999999999754 356789999886432 224789999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---C
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP---P 155 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~---~ 155 (346)
||++.+++.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++ ++.++|+|||++....... .
T Consensus 165 ~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 165 MPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred ehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 99999999988843 45599999999999999999999999999999999999995 5699999999987654332 2
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhhHH----HHH
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTC---EDDQLYKICNAIGSPTEESWA----EGL 228 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~----~~~ 228 (346)
.....||+.|+|||++. ...++.++||||+||++|+|++|..||.+.. ....+..+.+..+..+.+... ...
T Consensus 244 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 244 CYGWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred ccccccccCccCHhHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 23457899999999886 5668999999999999999999999997654 345566666655443322111 011
Q ss_pred HHHHhcCCCCCCcCCCCcccc--cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLL--IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
............ ....... ....+.+++++|++||+.||++|||+.|+|+||||+..
T Consensus 323 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 323 KHFKQYAIVLRP--PYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHhhcccccC--CccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 111111100000 0000000 12456789999999999999999999999999999864
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=333.47 Aligned_cols=260 Identities=24% Similarity=0.366 Sum_probs=208.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||+||++++..+++.||+|++...... .......+|..++..+ +||+|+++++++.+++..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 6899999999999999999999999999999998653221 1222234566777666 899999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
|||+. |+|.+.+......+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 99997 477777766556799999999999999999999999999999999999995 56999999999976544322
Q ss_pred CccccccCcccCccccccc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLMS----GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....||+.|+|||++... ..++.++||||+||++|+|++|..||...+..+....+......+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~------------ 227 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF------------ 227 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc------------
Confidence 2235689999999988632 457889999999999999999999998877666655554321110
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK--RPTAAEALQHPLFQGC 287 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~--Rps~~ell~hp~~~~~ 287 (346)
.+ ......+++++++++.+||..++++ |++++++++||||+..
T Consensus 228 -----~~--------p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 228 -----QF--------PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred -----cC--------CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 01 1112356889999999999876654 5789999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=325.33 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=206.3
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.|++.+.||+|+||+||+|.+..+++.||+|.+........ .....+|+.+++++ +|++++.+++.+.+++..+++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEE
Confidence 48899999999999999999999999999999865433322 23346799999998 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 81 EYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 81 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||+.| +|.+.+... ...+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++..........
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 99985 666665433 33589999999999999999999999999999999999995 5689999999987655444444
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...|+..|+|||++. ...++.++||||+||++|+|++|..||................. ...
T Consensus 160 ~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~---------------~~~-- 221 (285)
T cd05630 160 GRVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK---------------EVQ-- 221 (285)
T ss_pred CCCCCccccChHHHc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh---------------hhh--
Confidence 457899999999986 56689999999999999999999999976543211111100000 000
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
......+++++++|+++||+.||++||| ++|+++||||++.
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 222 ---------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ---------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 0011356788999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=345.57 Aligned_cols=255 Identities=28% Similarity=0.422 Sum_probs=209.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENY------ 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~------ 74 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++....... ......+|+..+..+ +|+||+++++.+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCccc
Confidence 68999999999999999999999999999999997655443 334456788888888 7999999988765322
Q ss_pred --EEEEEEEcCC-CCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccc
Q 039371 75 --RLYFVFEYMD-CNLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLA 147 (346)
Q Consensus 75 --~~~iv~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a 147 (346)
.+++||||+. |+|.+.+... ...+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 4689999998 5777766542 34689999999999999999999999999999999999995 569999999998
Q ss_pred cccCCC---CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhH
Q 039371 148 WEVDSC---PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 148 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (346)
...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~----- 264 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP----- 264 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC-----
Confidence 765432 1233467899999999887 5668999999999999999999999998877666555543321111
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
..+.+++++.+++.+||+.||.+|||+.++++|||++..
T Consensus 265 ------------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 265 ------------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 124578899999999999999999999999999998753
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=317.85 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=205.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH----HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW----EECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++.+.||+|++|.||.|.+..+++.||+|.+....... ......+|+.+++++ +||||+++++++.++...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence 57999999999999999999999999999999986543322 123446788899998 8999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCC
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~ 155 (346)
+++|+++| ++.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++ +.++|+|||.+........
T Consensus 81 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999986 566655543 45899999999999999999999999999999999999964 6999999999875543211
Q ss_pred C----ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 Y----TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
. ....++..|+|||.+. ...++.++||||+|+++|+|++|+.||...........+......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVIS-GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN------------- 225 (263)
T ss_pred ccccccCCCcCccccCcceec-cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC-------------
Confidence 1 2345778999999987 455899999999999999999999999776554443333211100
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
......++..+.++|++||..+|.+|||+.++++||||
T Consensus 226 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 226 ---------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ---------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 01123568899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=344.42 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=209.0
Q ss_pred ceeeeeeecccCceEEEEEEEccC-CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQS-GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
.|.+.+.||+|++|.||+|.+..+ ++.||+|.+.... ........+|+.++..+ +||||+++++.+..++.+|+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEEE
Confidence 499999999999999999998887 7889999775432 22333445799999988 79999999999999999999999
Q ss_pred cCCC-CHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--
Q 039371 82 YMDC-NLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-- 154 (346)
Q Consensus 82 ~~~g-~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-- 154 (346)
|++| +|.+.+.. ...++++.++..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9974 77665543 244689999999999999999999999999999999999995 5699999999997654432
Q ss_pred -CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 155 -PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 155 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.....+||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+.+..+......+.
T Consensus 226 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~------------- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWE-RKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF------------- 291 (478)
T ss_pred ccccccCCCccccCHhHhC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------
Confidence 233457899999999886 56689999999999999999999999988877666666544321111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
...++.++.++|.+||+.||++|||++++++|||++.
T Consensus 292 ----------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 292 ----------------PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ----------------CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 1246788999999999999999999999999999864
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=320.90 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=211.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||.|++|.||+|.+..+++.||+|++.............+|+.+++.+ +|||++++++.+.++..+++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEEEE
Confidence 58999999999999999999999999999999997665444444566899999999 69999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~ 158 (346)
++.| ++.+.+... .+++..+..++.|++.|+.|||+++++|+||+|+||+++ ++.++|+|||.+...... .....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 9986 666666543 589999999999999999999999999999999999995 569999999999776643 23344
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+++.|+|||.+. ...++.++|+||+||++|+|++|..||...+.......+.....
T Consensus 158 ~~~~~~y~~PE~~~-~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--------------------- 215 (274)
T cd06609 158 FVGTPFWMAPEVIK-QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP--------------------- 215 (274)
T ss_pred ccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC---------------------
Confidence 56788999999887 45589999999999999999999999987665443333322110
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+.. ....++.++.+++.+||..||++|||++++++||||+..
T Consensus 216 ~~~-------~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 216 PSL-------EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred CCC-------cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 000 001267889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=331.52 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=197.0
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-CE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN-YR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-~~ 75 (346)
++|++.+.||+|+||.||+|.+. .+++.||+|+++............+|+.++..+.+||||+++++++... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 68999999999999999999752 4457899999976544444556678999999998899999999987654 56
Q ss_pred EEEEEEcCC-CCHHHHHhccc-----------------------------------------------------------
Q 039371 76 LYFVFEYMD-CNLHQLMSNRK----------------------------------------------------------- 95 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~~----------------------------------------------------------- 95 (346)
++++|||++ |+|.+.+....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 899999998 57776665321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC---CccccccCcccCcc
Q 039371 96 --QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP---YTEYITTLQYRAPE 169 (346)
Q Consensus 96 --~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE 169 (346)
..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++........ .....++..|+|||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 2377889999999999999999999999999999999996 56999999999976533221 12234567899999
Q ss_pred cccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCccc
Q 039371 170 MLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSL 248 (346)
Q Consensus 170 ~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
++. ...++.++||||+||++|+|++ |..||.+....+...........+ .
T Consensus 247 ~~~-~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------------~ 297 (338)
T cd05102 247 SIF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM----------------------------R 297 (338)
T ss_pred Hhh-cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC----------------------------C
Confidence 886 5668999999999999999997 999998765443333222111000 0
Q ss_pred ccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 249 LIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 249 ~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+++++.+++.+||+.||++|||+.|+++
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=320.47 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=204.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|++|.||+|.+..++..||+|++.............+|+.++.++ +||||+++++.+...+..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999987654444445567899999888 79999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcccc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYI 160 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~ 160 (346)
|++|+.+.... .+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++...... ......
T Consensus 80 ~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~ 154 (279)
T cd06619 80 FMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYV 154 (279)
T ss_pred cCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCC
Confidence 99976554332 378999999999999999999999999999999999995 569999999999765432 334457
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ---LYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
++..|+|||.+. ...++.++|+||+||++|+|++|..||........ ........... .
T Consensus 155 ~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------~ 216 (279)
T cd06619 155 GTNAYMAPERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----------------D 216 (279)
T ss_pred CChhhcCceeec-CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----------------C
Confidence 899999999887 55689999999999999999999999965322110 00000000000 0
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.+. ......++++.+++.+||+.||++||+++++++||||+..
T Consensus 217 ~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 217 PPV-------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred CCC-------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 000 0113467889999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=340.05 Aligned_cols=252 Identities=31% Similarity=0.468 Sum_probs=222.2
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEcccc--ccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQR--IYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.|+-++.||+|+||.||-|++..+.+.||||.+..+ ....+...+++|+..|+++ +|||++.+.++|-.+...|+||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccchHHHHH
Confidence 366688999999999999999999999999998543 3345667789999999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCCCCCccc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEY 159 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~~~~~~~ 159 (346)
|||-|+-.+.+.-.+.++.|.+|..|+.+.+.||+|||+.+.+|||||.-|||+ +.|.|||+|||+|.... +.+++
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---PAnsF 182 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---PANSF 182 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---chhcc
Confidence 999998888887777789999999999999999999999999999999999999 56799999999997654 56778
Q ss_pred cccCcccCccccc--ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 160 ITTLQYRAPEMLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 160 ~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
+|||+|||||++. ..+.|+-++||||||+++.+|...++|+-..+....++.|..+-. |+
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-Pt----------------- 244 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PT----------------- 244 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-CC-----------------
Confidence 9999999999986 356799999999999999999999999988888888888865421 11
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.. .+..|+.+++|+..||+.-|.+|||.+++|.|+|+..
T Consensus 245 ---Lq-------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 245 ---LQ-------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ---CC-------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 11 2456789999999999999999999999999999874
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=355.32 Aligned_cols=259 Identities=29% Similarity=0.427 Sum_probs=210.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASE--NYRLY 77 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 77 (346)
+++|++++.||+|+||+||+|.+..++..||+|++....... .......|+.++.++ +||||++++++|.+ ...+|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEE
Confidence 478999999999999999999999999999999997654433 344557899999999 79999999998843 46789
Q ss_pred EEEEcCCC-CHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCCEEEeCC---------
Q 039371 78 FVFEYMDC-NLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQ-------GYFHRDLISKNLLVSND--------- 137 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~-------~ivH~dikp~NIli~~~--------- 137 (346)
|||||+++ +|.+.+... ...+++..++.|+.||+.||.|||+. +|+|+||||+|||++.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 99999984 777776542 34699999999999999999999985 49999999999999531
Q ss_pred ---------cEEEeecccccccCCCCCCccccccCcccCcccccc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 039371 138 ---------TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM-SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD 207 (346)
Q Consensus 138 ---------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 207 (346)
.+||+|||++.............+|+.|+|||++.. ...++.++|||||||++|+|++|..||.......
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 489999999987665444455679999999998863 3458899999999999999999999997665544
Q ss_pred HHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 208 QLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 208 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.+...+..... ...+..+.++.+||..||+.+|.+|||+.|+|+|||++..
T Consensus 251 qli~~lk~~p~-----------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 251 QLISELKRGPD-----------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHhcCCC-----------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 33332221100 0113467889999999999999999999999999999865
Q ss_pred CC
Q 039371 288 LQ 289 (346)
Q Consensus 288 ~~ 289 (346)
..
T Consensus 302 ~~ 303 (1021)
T PTZ00266 302 GP 303 (1021)
T ss_pred CC
Confidence 43
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=321.07 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=210.4
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.|+..+.||+|+||+||+|.+..+++.||+|.+........ .....+|+.+++.+ +|++|+.+.+.+.+++..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEE
Confidence 48899999999999999999999999999999865543222 23346799999998 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 81 EYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 81 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||+.| ++.+.+... ...+++..+..++.|++.||.|||+.||+||||||+||+++ ++.++|+|||++..........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 99986 565555433 33599999999999999999999999999999999999995 5689999999997665444444
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...++..|+|||.+. ...++.++|+||+||++|+|++|..||.+.........+.........
T Consensus 160 ~~~g~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~---------------- 222 (285)
T cd05632 160 GRVGTVGYMAPEVLN-NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE---------------- 222 (285)
T ss_pred CCCCCcCccChHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc----------------
Confidence 567899999999986 566899999999999999999999999877655444333222111100
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
...+..+.++.+|+.+||+.||++||| ++++++||||+..
T Consensus 223 ----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 223 ----------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ----------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 112356788999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=324.46 Aligned_cols=260 Identities=23% Similarity=0.423 Sum_probs=209.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+..+++.||+|.+.............+|+.++.++ +||||+++++.+..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEe
Confidence 58999999999999999999999999999999987654444445567899999998 89999999999999999999999
Q ss_pred cCCC-CHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 82 YMDC-NLHQLMSNR--KQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|++| ++...+... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++ ++.++|+|||.+...... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~ 158 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA 158 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence 9987 554444432 2368999999999999999999997 5999999999999995 568999999998765432 22
Q ss_pred ccccccCcccCcccccccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 157 TEYITTLQYRAPEMLLMSG-----QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
....+++.|+|||.+.... .++.++||||+||++|+|++|..||...........+......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 226 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD------------ 226 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC------------
Confidence 3346788999999875322 35789999999999999999999997655443333322211111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
...+.+.++.++.++|.+||+.+|++||+++++++||||.....
T Consensus 227 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 227 --------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred --------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 01122357889999999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.11 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=209.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+.|++++.||+|+||.||+|.+..+++.+++|++.... ........+|+..++.+ +||||+++++.+..++.+++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEEEEEe
Confidence 46999999999999999999999999999999986543 22334456788889888 79999999999999999999999
Q ss_pred cCCCC-HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCcc
Q 039371 82 YMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTE 158 (346)
Q Consensus 82 ~~~g~-l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~ 158 (346)
|++|+ +...+......+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||.+...... .....
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 169 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS 169 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence 99975 4445555455689999999999999999999999999999999999996 669999999988654332 22344
Q ss_pred ccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 159 YITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
..+++.|+|||.+.. ...++.++||||+||++|+|++|..||...+......++..... +.
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~-------------- 234 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PT-------------- 234 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCC-cc--------------
Confidence 567889999998852 34478899999999999999999999977665444333321110 00
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
......++.++.++|++||+.||++||+++++++||||+.....
T Consensus 235 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 235 ------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred ------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 00113467789999999999999999999999999999876543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=320.03 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=211.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||.|++|+||+|.+..+++.|++|.+...... ......+|+..++.+ +|||++++++.+..++.+++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEEE
Confidence 4799999999999999999999999999999998654433 234456788999888 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|+.| ++...+. .. .+++.++..++.|++.||+|||++|++|+||+|+||+++ ++.++|+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~-~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 97 YLAGGSLTDVVT-ET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred ecCCCcHHHHHH-hc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 9986 4544443 32 489999999999999999999999999999999999995 5699999999987654332 2233
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||.+. ...++.++||||+||++|+|++|..||...+.......+.... .+..
T Consensus 175 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~----------------- 235 (296)
T cd06655 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL----------------- 235 (296)
T ss_pred cCCCccccCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-Cccc-----------------
Confidence 56888999999886 5668899999999999999999999998877655444332211 0000
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPS 292 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~~ 292 (346)
.....+++.+.++|++||..||++|||+.++++||||+.+...+.
T Consensus 236 ---------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~ 280 (296)
T cd06655 236 ---------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSS 280 (296)
T ss_pred ---------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccccc
Confidence 011356788999999999999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=306.59 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=224.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++.+.++.||+|+.|+|++++.+.+|...|+|.+......++..+++..+.++....++|+||+++++|-.+..++|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 45567889999999999999999999999999998887777788888888888888679999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEY 159 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~ 159 (346)
.|.--....+..-.++++|..+.++...++.||.||..+ ||+|||+||+|||+| .|++||||||.+-...+....+..
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrs 251 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRS 251 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccc
Confidence 998655566666667799999999999999999999965 899999999999995 689999999999887777777788
Q ss_pred cccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 160 ITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTC-EDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 160 ~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
.|.+.|||||.+.- ...|+..+||||||++++||.||+.||.+.+ +-+.+.++++... |..+.
T Consensus 252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~------------- 317 (391)
T KOG0983|consen 252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPG------------- 317 (391)
T ss_pred cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCc-------------
Confidence 99999999998863 3458999999999999999999999998854 4577777766322 11110
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
..+.|+++++|+..||+.|+.+||...++|+|||++...
T Consensus 318 -------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 318 -------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred -------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 124799999999999999999999999999999998644
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=324.63 Aligned_cols=281 Identities=34% Similarity=0.600 Sum_probs=217.3
Q ss_pred ceeeeeeecccCceEEEEEEEcc--CCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQ--SGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASEN--YRL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~ 76 (346)
+|++.++||+|++|.||+|.+.. +++.||+|.+..... ........+|+.++..+ +||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 58999999999999999999988 899999999976431 11123346788999998 799999999999888 889
Q ss_pred EEEEEcCCCCHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-----CCcEEEeecccc
Q 039371 77 YFVFEYMDCNLHQLMSNR----KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-----NDTIKIADFGLA 147 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-----~~~vkl~Dfg~a 147 (346)
++|||++++++.+.+... ...+++..++.++.|++.||.|||+++++|+||||+||+++ ++.+||+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 999999999888766432 23589999999999999999999999999999999999995 468999999998
Q ss_pred cccCCCC----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHHH
Q 039371 148 WEVDSCP----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED---------DQLYKICN 214 (346)
Q Consensus 148 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~ 214 (346)
....... ......++..|+|||.+.+...++.++||||+||++|+|++|.+||.+.... ..+..++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 7654322 1234467889999998876667899999999999999999999999765533 35566666
Q ss_pred HhCCCChhhHHHHHHHHHhcC----CCCCCcCCCCcccc---cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 215 AIGSPTEESWAEGLELAKAHG----YKFPKLQGNNLSLL---IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
..+.+....|........... ..........+... ....+.++.+++.+||+.||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 677666665543222211111 00000000111111 12567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=326.78 Aligned_cols=283 Identities=36% Similarity=0.582 Sum_probs=224.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENY------ 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~------ 74 (346)
++|++++.||+|++|.||+|.+..+++.||+|++....... ......+|+.+++++ +||||+++++++..+.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccccc
Confidence 68999999999999999999999999999999986543332 233456899999999 7999999999987553
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
..++|||++++++...+.. ..+++..+..++.|++.||+|||+.||+|+||||+||+++ ++.++|+|||.+......
T Consensus 94 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 4689999997777766653 3589999999999999999999999999999999999995 569999999998765432
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH-HHH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE-LAK 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~ 232 (346)
.....+++.|+|||.+.+...++.++|+||+||++|++++|..||.+.+.......+....+.++...+..... ...
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 172 --MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred --ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 23346788999999887545688999999999999999999999998887777777777666555442221111 011
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......+......+....+.++.++.++|.+||+.||++|||+.++++||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 111122222223334445678889999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=326.47 Aligned_cols=287 Identities=35% Similarity=0.633 Sum_probs=229.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASE--NYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~~~i 78 (346)
++|++.+.||+|+||.||+|.+..+++.+|+|.+...... .......+|+.++.++.+||||+++++++.. +...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 6899999999999999999999999999999988543222 2233445799999998779999999998864 346899
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--- 154 (346)
|||++++++...+... .+++..+..++.|++.||.|||+.||+|+||+|+||+++ ++.++|+|||.+.......
T Consensus 87 v~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 87 VFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred EecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 9999999888877654 589999999999999999999999999999999999995 5699999999987553321
Q ss_pred ---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 155 ---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 155 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
......++..|+|||.+.+...++.++||||+||++|+|++|+.||.+....+....+....+.++...+.......
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence 22335678899999988766678899999999999999999999999988888888888888777766554332211
Q ss_pred HhcCC-CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 232 KAHGY-KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 232 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
...-. ..............+.++.++.++|.+||+.||++|||+.++++|||++...+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 11110 111122222333445678999999999999999999999999999999887553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=321.01 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=209.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||.|++|+||+|.+..++..+|+|++..... ........|+.+++++ +||||+++++.+.++...++|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEEee
Confidence 689999999999999999999998999999999865422 2334456799999999 69999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|++| ++.+.+......+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||.+....... ....
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 9986 66666666556799999999999999999999999999999999999995 5699999999886554322 2334
Q ss_pred ccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 159 YITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
..+++.|+|||.+.. ...++.++|+||+||++|+|++|..||...+.......+.....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 225 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP----------------- 225 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCC-----------------
Confidence 568889999998752 34477899999999999999999999987765554444322110
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+.. .....++.++.++|.+||+.||.+|||++++++||||+..
T Consensus 226 ----~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 226 ----PTL------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ----CCc------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000 0113467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=324.67 Aligned_cols=276 Identities=22% Similarity=0.315 Sum_probs=209.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||.||++.+..++..+|+|.+.............+|+.+++++ +||||+++++.+.+++.++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEee
Confidence 58999999999999999999999999999999987554333444567899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|++| +|.+.+... +.+++..+..++.|+++||.|||+ .+++|+||+|+||+++ ++.++|+|||++...... ....
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence 9986 666665544 558999999999999999999997 5999999999999995 558999999988654332 2344
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CCh--------------hh
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGS-PTE--------------ES 223 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~--------------~~ 223 (346)
..++..|+|||.+. ...++.++|+||+||++|+|++|..||...+..... ........ ... ..
T Consensus 158 ~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 158 FVGTRSYMSPERLQ-GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCCCcCccChhHhc-CCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCccc
Confidence 57889999999876 456889999999999999999999999776543322 22211100 000 00
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+....+..... ... .........++.++.+++.+||..||++|||+.++++||||....
T Consensus 236 ~~~~~~~~~~~---~~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 236 PMAIFELLDYI---VNE---PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred hhhHHHHHHHH---hcC---CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 00000000000 000 000111123677899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=318.79 Aligned_cols=252 Identities=31% Similarity=0.452 Sum_probs=211.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|++|.||++.+..+++.||+|++...... .......+|+.+++++ +||||+++++++.+++.++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEE
Confidence 5899999999999999999999999999999998654322 2234456799999999 699999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
|||++ |+|.+.+... +.+++..+..++.|+++||.|||++|++|+||+|+||+++ ++.++|+|||++...... ..
T Consensus 80 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 80 MEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TY 156 (290)
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CC
Confidence 99995 5777766554 4599999999999999999999999999999999999995 569999999998776543 33
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+++.|+|||.+. ....+.++||||||+++|+|++|..||...+..+....+..... .
T Consensus 157 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~ 216 (290)
T cd05580 157 TLCGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV-------------------R 216 (290)
T ss_pred CCCCCccccChhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-------------------c
Confidence 456889999999886 45678999999999999999999999987775554444432110 0
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~~ 288 (346)
.....+..++++|++||+.||.+|+ +++|+++||||+...
T Consensus 217 -----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 217 -----------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 1124578899999999999999999 999999999998765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=317.53 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=202.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||.||+|.+..+++.||+|+++..... ......+|+.+++.+ +||||+++++.+...+..+++||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEe
Confidence 5789999999999999999999999999999998654322 223345788888888 89999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|+++ +|.+.+.. .+.+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||.+....... ....
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 87 FCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 9986 66665544 44699999999999999999999999999999999999995 5699999999987554322 2334
Q ss_pred ccccCcccCccccc--ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 159 YITTLQYRAPEMLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 159 ~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
..++..|+|||++. ....++.++|+||+||++|+|++|..||..................++
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---------------- 229 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP---------------- 229 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC----------------
Confidence 57899999999874 234578899999999999999999999866554333222211110000
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~ 283 (346)
. .. ....++..+.+++++||+.||++|||++++++|||
T Consensus 230 ---~-----~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 230 ---K-----LK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ---c-----cc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 00 01246778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=317.15 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=208.2
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
-|++.+.||.|+||.||+|.+..++..+++|.+..... .......+|+.+++.+ +|||++++++.+..++..++++||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEe
Confidence 47889999999999999999999999999999865432 2334456789999998 799999999999999999999999
Q ss_pred CCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCccc
Q 039371 83 MDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTEY 159 (346)
Q Consensus 83 ~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~~ 159 (346)
++| ++...+.....++++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++...... ......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 986 44455555455699999999999999999999999999999999999995 569999999998654332 223445
Q ss_pred cccCcccCccccc----ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 160 ITTLQYRAPEMLL----MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 160 ~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.++..|+|||++. ....++.++||||+||++|+|++|.+||...+..+....+........
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 228 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL--------------- 228 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC---------------
Confidence 6889999999874 234577899999999999999999999988766555444432211000
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.....++.++.++|++||+.||.+|||++++++||||+...
T Consensus 229 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 229 ------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred ------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 00124678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=326.74 Aligned_cols=283 Identities=21% Similarity=0.312 Sum_probs=202.6
Q ss_pred eeeeeeccc--CceEEEEEEEccCCcEEEEEEccccccCHHH-hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 5 TLMKQIGEG--SFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-CLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 5 ~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+++++||+| ++++||++.++.+|+.||+|.++........ ....+|+.+++.+ +||||+++++++..++..++|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence 467899999 6889999999999999999999766544333 3344688888777 89999999999999999999999
Q ss_pred cCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC----
Q 039371 82 YMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP---- 154 (346)
Q Consensus 82 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~---- 154 (346)
|+++ ++.+.+... ...+++..+..++.|++.||+|||++||+||||||+||+++ ++.++++||+.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9985 666666443 34589999999999999999999999999999999999995 5689999998654322110
Q ss_pred ----CCccccccCcccCccccccc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-------Chh
Q 039371 155 ----PYTEYITTLQYRAPEMLLMS-GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP-------TEE 222 (346)
Q Consensus 155 ----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------~~~ 222 (346)
......++..|+|||++... ..++.++||||+||++|+|++|..||................... +.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 01123456789999998743 458999999999999999999999998765544333332211000 000
Q ss_pred hHH-HHHHHHHhcCC--------CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 223 SWA-EGLELAKAHGY--------KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 223 ~~~-~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
... ........... ..+.............+++++++|+++||+.||++|||++|+++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 000 00000000000 0000000001112234577899999999999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=314.54 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=210.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||.|++|+||+|.+..++..+++|++.............+|+..++.+ +|||++++++.+..++..+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEEe
Confidence 68999999999999999999999899999999997665554555667899988888 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 82 YMDC-NLHQLMSNR--KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 82 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
++.| ++.+.+... ...+++..+..++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 9986 666666543 24589999999999999999999999999999999999995 56999999999865543221
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.....++..|+|||.+.....++.++|+||+||++|+|++|..||...+......+........
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 226 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPS------------- 226 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCC-------------
Confidence 2334678899999998755478999999999999999999999998776654444433221000
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.+. ......++..+.+++.+||+.||++|||++++++||||
T Consensus 227 -----~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 227 -----LET------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----cCC------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 000 00013567889999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=320.24 Aligned_cols=285 Identities=32% Similarity=0.546 Sum_probs=224.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeec-CCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASE-NYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-~~~~~iv 79 (346)
++|++.+.||.|+||.||+|.+..+++.||+|++...... .......+|+.+++++ +||||+++++++.. ++..+++
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcEEEE
Confidence 5899999999999999999999999999999988654322 2233455799999999 79999999999865 5678999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
+|++++++...+.. ..+++..+..++.|+++||.|||++|++|+||+|+||+++ ++.++|+|||.+..... ....
T Consensus 89 ~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~ 164 (328)
T cd07856 89 TELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTG 164 (328)
T ss_pred eehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcCC
Confidence 99998888776653 3488999999999999999999999999999999999995 56899999999875543 2234
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH-hcCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK-AHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~ 237 (346)
..++..|+|||.+.....++.++||||+||++|+|++|.+||...........+.+..+.++.+.......... ..-..
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd07856 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS 244 (328)
T ss_pred CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence 56788999999886546789999999999999999999999998888777777777777776554432211100 00001
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~ 291 (346)
.+...........+.++..+.++|++||+.+|++|||+++++.||||+....+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 111111122233356788999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=317.65 Aligned_cols=281 Identities=25% Similarity=0.430 Sum_probs=223.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC-C----CeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH-P----NIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h-p----~iv~~~~~~~~~~~~ 76 (346)
+||+++..+|+|.||.|-.+.+..++..||+|+++.- ..-.....-|+.++.++..+ | -++++.++|+..++.
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 5899999999999999999999999999999999632 22233345688999998533 3 388899999999999
Q ss_pred EEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-------------------
Q 039371 77 YFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN------------------- 136 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~------------------- 136 (346)
|||+|.++.++.+.+..++ .+++...++.+.+|+++++++||+.+++|.||||+||++.+
T Consensus 167 CivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 167 CIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 9999999989999887754 46999999999999999999999999999999999999821
Q ss_pred --CcEEEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 039371 137 --DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 137 --~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 214 (346)
..++++|||.|+...... ++.+.|..|+|||++. +-.++.++||||+||||+|+.+|...|+..++.+.+..+..
T Consensus 247 ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViL-gLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMer 323 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVIL-GLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMER 323 (415)
T ss_pred CCcceEEEecCCcceeccCc--ceeeeccccCCchhee-ccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHH
Confidence 158999999998765533 5678899999999998 56699999999999999999999999999999999988888
Q ss_pred HhCCCChhhHHHH-HHHHHhcC-CCCCCcCCCC-cccc-------------cCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 039371 215 AIGSPTEESWAEG-LELAKAHG-YKFPKLQGNN-LSLL-------------IPSANDDEMSLIELLCSWDPCKRPTAAEA 278 (346)
Q Consensus 215 ~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~-~~~~-------------~~~~~~~~~~li~~~l~~dP~~Rps~~el 278 (346)
.+|++|..+.... .+.....+ ..-++..... ...+ ....-.++.+||++||..||.+|+|+.|+
T Consensus 324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA 403 (415)
T KOG0671|consen 324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA 403 (415)
T ss_pred hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence 8887776665544 22111111 1111110000 0000 01122357899999999999999999999
Q ss_pred hcCCCCCCC
Q 039371 279 LQHPLFQGC 287 (346)
Q Consensus 279 l~hp~~~~~ 287 (346)
|+||||+..
T Consensus 404 L~HpFF~~~ 412 (415)
T KOG0671|consen 404 LSHPFFARL 412 (415)
T ss_pred hcCHHhhcC
Confidence 999999864
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=324.77 Aligned_cols=283 Identities=37% Similarity=0.574 Sum_probs=222.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------C
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN------Y 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------~ 74 (346)
++|.+.+.||+|++|.||+|.+..+|+.||+|++....... ......+|+.+++++ +||||+++++++... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCCc
Confidence 68999999999999999999999999999999986543222 223356899999998 799999999988654 3
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
.+++++|++.+++..... ..+++..+..++.|++.||+|||++|++||||||+||+++ ++.++|+|||++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEecccccCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 569999999877665542 3489999999999999999999999999999999999995 56999999999876543
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+....+..+....+.+.+..+.........
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 2234567889999998875566899999999999999999999999998877888888777776665544322111100
Q ss_pred -cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 234 -HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
.....+...........+..++++.++|++||+.||++|||++++++||||+.....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000112222222333345678899999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=323.88 Aligned_cols=283 Identities=33% Similarity=0.511 Sum_probs=222.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------C
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN------Y 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------~ 74 (346)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+|+.+++++ +||||+++++++... .
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccccc
Confidence 68999999999999999999999999999999997643332 233456799999999 799999999987543 4
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
..|++++++++++.+.+... .+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++.....
T Consensus 96 ~~~lv~~~~~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~- 172 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 172 (345)
T ss_pred cEEEEehhcccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence 57899999988887666543 489999999999999999999999999999999999995 56999999999876543
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......++..|+|||.+.+...++.++||||+||++|+|++|..||.+.+.......+....+.+.+..+.........
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 173 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred -cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 2334567889999998875567889999999999999999999999988888888888777776665554322111100
Q ss_pred -cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 234 -HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.....+..............++++.++|.+||+.||.+|||+.++++||||++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 00011111111112222346788999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=313.31 Aligned_cols=255 Identities=31% Similarity=0.491 Sum_probs=221.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH--hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE--CLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
|++|..++.||+|.||+|-+++.+.+++.||+|++++...-.+. ...+.|-.+++.. +||.+..+-..|+..+.+|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEE
Confidence 78999999999999999999999999999999999877654333 3346788888888 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccc-cCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWE-VDSCPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~-~~~~~~ 155 (346)
||||.+| .|...+.... .++|...+.+-..|+.||.|||+++||+||+|.+|.++| +|++||.|||++.. +.....
T Consensus 246 VMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccce
Confidence 9999986 4555554444 499999999999999999999999999999999999996 56999999999965 445567
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
..+++|||.|+|||++. ...|+.+.|+|.+|+++|||++|+.||...+....+..|+-. .
T Consensus 325 ~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------------------d 384 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------------------D 384 (516)
T ss_pred eccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------------------h
Confidence 78899999999999997 677999999999999999999999999998888777777544 2
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~ 288 (346)
.+|| ...+++++.|+..+|..||.+|.. +.|+.+|+||.+..
T Consensus 385 ~kFP-----------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 385 LKFP-----------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred ccCC-----------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 2333 367899999999999999999975 89999999998754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=325.84 Aligned_cols=243 Identities=29% Similarity=0.520 Sum_probs=206.9
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
+.+++.||+|.||+||+|..+.+ ..||+|.++...... ..+.+|+++|++| +|++||++++++..++.+|||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~--~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSP--EAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccCh--hHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEEEEec
Confidence 45788999999999999987743 469999998764443 3356899999999 7999999999999988999999999
Q ss_pred C-CCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeecccccccCCCCC--Ccc
Q 039371 84 D-CNLHQLMSN-RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPP--YTE 158 (346)
Q Consensus 84 ~-g~l~~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~~~~--~~~ 158 (346)
. |+|++++.. .+..+...+...++.|||+|++||+++++|||||-..|||++++ .+||+|||+|+..++..- ...
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 8 899999987 55679999999999999999999999999999999999999655 899999999996554322 222
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..-...|.|||++. ...++.+|||||||++||||+| |+.||++.+..+.+..+.++ ++
T Consensus 364 ~kfPIkWtAPEa~~-~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G--------------------yR 422 (468)
T KOG0197|consen 364 GKFPIKWTAPEALN-YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG--------------------YR 422 (468)
T ss_pred CCCCceecCHHHHh-hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc--------------------Cc
Confidence 23356799999997 6679999999999999999998 88999999999998888654 34
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+|.+ +.+++.+.+++..|+..+|++|||++.+..
T Consensus 423 lp~P---------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 423 LPRP---------EGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred CCCC---------CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 4433 468999999999999999999999987643
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=316.36 Aligned_cols=277 Identities=36% Similarity=0.650 Sum_probs=220.4
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhc--CCCCeeeeeeeeecCCE-----
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKIN--NHPNIVKLQELASENYR----- 75 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~--~hp~iv~~~~~~~~~~~----- 75 (346)
|++.+.||+|++|.||+|.++.+++.||+|+++....... .....+|+.+++++. +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999998999999999975443322 223446777776664 59999999999987766
Q ss_pred EEEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
++++||++++++.+.+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999998888776543 3589999999999999999999999999999999999995 569999999999776654
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.......++..|+|||.+. ...++.++|+||+||++|+|++|.+||.+....+...++.+....+....|.......
T Consensus 161 ~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 237 (287)
T cd07838 161 MALTSVVVTLWYRAPEVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP-- 237 (287)
T ss_pred cccccccccccccChHHhc-cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc--
Confidence 4445556788999999887 4568899999999999999999999999998888888887766555443332211100
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
...++...........+.++..+.++|++||+.||.+||+++++++||||
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 -RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred -hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00112222222333445677889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=321.25 Aligned_cols=257 Identities=29% Similarity=0.480 Sum_probs=211.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|++|+||+|.+..+++.||+|.+....... .......|+.++..+ +||||+++++.+.++...|++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEE
Confidence 58999999999999999999999999999999997654442 334456788999888 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--
Q 039371 80 FEYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-- 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-- 154 (346)
||++.| +|.+.+... ...+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 999975 676666543 34689999999999999999999999999999999999995 5699999999986543211
Q ss_pred ----------------------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 039371 155 ----------------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED 206 (346)
Q Consensus 155 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 206 (346)
......|+..|+|||++. ...++.++||||||+++|+|++|..||.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-CCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 112346788999999887 556799999999999999999999999887766
Q ss_pred HHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC----HHHHhcCC
Q 039371 207 DQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT----AAEALQHP 282 (346)
Q Consensus 207 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps----~~ell~hp 282 (346)
..+..+..... .++. ....+..+.+++.+||+.||++||| ++++++||
T Consensus 239 ~~~~~~~~~~~-------------------~~~~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 239 ETFSNILKKEV-------------------TFPG---------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHhcCCc-------------------cCCC---------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 65555432111 0110 0126789999999999999999999 99999999
Q ss_pred CCCCCC
Q 039371 283 LFQGCL 288 (346)
Q Consensus 283 ~~~~~~ 288 (346)
||++..
T Consensus 291 ~~~~~~ 296 (316)
T cd05574 291 FFRGVN 296 (316)
T ss_pred hhhcCC
Confidence 999754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=315.98 Aligned_cols=254 Identities=28% Similarity=0.480 Sum_probs=201.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||.||+|++..+++.||+|++...... ......+|+.+++++ +||||+++++.+..++..++|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEEe
Confidence 5799999999999999999999999999999998654322 223345788888888 89999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|+++ +|.+.+.. .+.+++..+..++.|++.||.|||+.||+|+||+|+||+++ ++.++|+|||++....... ....
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 87 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence 9986 56555543 45689999999999999999999999999999999999995 5689999999997654322 2334
Q ss_pred ccccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 159 YITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
..++..|+|||.+.. ...++.++|+||+||++|+|++|+.||......+....+.... .
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------------~ 226 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN-------------------F 226 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC-------------------C
Confidence 568889999998742 3447789999999999999999999996544332221111110 0
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~ 283 (346)
..+. .. ....++..+.+++++||+.||++|||++++++|+|
T Consensus 227 ~~~~-----~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 227 QPPK-----LK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCC-----Cc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0000 00 01246789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=317.79 Aligned_cols=256 Identities=27% Similarity=0.467 Sum_probs=207.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
.+|++.+.||+|++|.||+|.+..+++.|++|.+....... .....+|+.+++.+ +|||++++++.+..+...|+|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEeec
Confidence 58999999999999999999999999999999987654432 34456788888887 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|+.| ++.+.+.. ..+++.++..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||.+....... ....
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9985 66666543 3489999999999999999999999999999999999995 5689999999987654322 2233
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+++.|+|||.+. ...++.++||||+||++|+|++|..||...........+... +.+.
T Consensus 176 ~~~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~------------------ 235 (296)
T cd06654 176 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE------------------ 235 (296)
T ss_pred ccCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC------------------
Confidence 56888999999886 556789999999999999999999999776654433322111 0000
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
....+.++..+.+++.+||..||++|||+.++++||||.....
T Consensus 236 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 236 --------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred --------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 0011356788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=308.50 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=205.0
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeec-CCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASE-NYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-~~~~~iv~ 80 (346)
+|++++.||+|++|.||++.++.+++.||+|.+....... ......+|+.+++++ +|||++++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEe
Confidence 5999999999999999999999999999999986554332 333456788889888 79999999998764 45789999
Q ss_pred EcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CC
Q 039371 81 EYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PY 156 (346)
Q Consensus 81 e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~ 156 (346)
|+++| ++.+.+... ...+++.++..++.|++.||++||+.|++|+||+|+||+++ ++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 99985 676666553 34589999999999999999999999999999999999996 4589999999987654322 23
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+++.|+|||++. ...++.++|+||+||++|+|++|+.||...+.......+......
T Consensus 160 ~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~------------------ 220 (257)
T cd08223 160 STLIGTPYYMSPELFS-NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP------------------ 220 (257)
T ss_pred ccccCCcCccChhHhc-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC------------------
Confidence 3456788999999886 566889999999999999999999999876655444443322110
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.....+++.+.+++.+|++.||++|||+.++++||||
T Consensus 221 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 221 -----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0113567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=319.25 Aligned_cols=258 Identities=27% Similarity=0.484 Sum_probs=208.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|++|.||+|.+..+++.||+|.+...... ......+|+.+++.+ +||||+++++.+..++..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEeec
Confidence 5899999999999999999999999999999998754433 234456788888888 89999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|++| ++.+.+.. ..+++.++..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||.+....... ....
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 9985 56665543 3489999999999999999999999999999999999995 5699999999987654332 2234
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+++.|+|||.+. ...++.++|+||+||++|+|++|..||...+.......+... +.+.
T Consensus 175 ~~~~~~y~aPE~~~-~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~------------------ 234 (297)
T cd06656 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE------------------ 234 (297)
T ss_pred ccCCccccCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCC------------------
Confidence 56888999999886 566889999999999999999999999766543322221110 0000
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~ 291 (346)
.......+..+.+++.+||+.||++|||++++++||||+.....+
T Consensus 235 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 235 --------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred --------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 001124677889999999999999999999999999999776544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=330.72 Aligned_cols=301 Identities=25% Similarity=0.347 Sum_probs=246.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH-hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-CLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
..|.+..+||+|.|++|.+|++..++..||||.+++...+... ....+|+++++.+ +|||||+++.+.+....+|+||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEEE
Confidence 4689999999999999999999999999999999888776543 3357899999999 8999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeecccccccCCCCCCcc
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
||+.| .+.+++.+. +.+.+..++.++.|+..|++|||+++|||||||++||+++.+ ++||+|||++..........+
T Consensus 135 eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt 213 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT 213 (596)
T ss_pred EeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccc
Confidence 99985 666666655 448889999999999999999999999999999999999877 599999999999998889999
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
++|++.|.|||++.+..+.++++|+||+|+++|.|+.|..||++.+-.+.....+.+ .++.
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g-------------------k~rI 274 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG-------------------KYRI 274 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee-------------------eecc
Confidence 999999999999998888899999999999999999999999987765544443322 2222
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCccccc---ccCC---ccccccCcc
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCK---MRLT---PSAKKSGWK 312 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~ 312 (346)
+. .++.+..++|+++|..+|.+|++.++++.|+|+............... ..+. ..+...++.
T Consensus 275 p~-----------~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~p~~e~~~~~~~~~r~~~m~~~G~~ 343 (596)
T KOG0586|consen 275 PF-----------YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLAPLIERSTPFILAKRILHMNSIGHR 343 (596)
T ss_pred cc-----------eeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhhcccccCccchhhHHHHHHHhhccc
Confidence 22 467889999999999999999999999999999876543111100000 0000 123355667
Q ss_pred chhhhhhcccCcchhHHHHHHH
Q 039371 313 AKLIVWFLRWEPFSSLLLFVAC 334 (346)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~ 334 (346)
...+...+....|....+++..
T Consensus 344 ~~~i~~sL~~~k~d~i~a~y~l 365 (596)
T KOG0586|consen 344 RLKIEESLAKQKFDDINATYLL 365 (596)
T ss_pred hhhHHHHHhhhhHHHHHHHHhh
Confidence 7777777888888877776654
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=336.83 Aligned_cols=258 Identities=26% Similarity=0.455 Sum_probs=217.7
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
-++|++.||.|+||.||+|.++.++-..|.|++.... ..+....+-|+.+|..+ +||+|+++++.|..++.++|+.||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEEEEee
Confidence 3678999999999999999999999889999986543 33445567899999999 799999999999999999999999
Q ss_pred CCCCHHH-HHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc-CCCCCCccc
Q 039371 83 MDCNLHQ-LMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV-DSCPPYTEY 159 (346)
Q Consensus 83 ~~g~l~~-~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~-~~~~~~~~~ 159 (346)
|+|+--+ .+..-+..++|+++..+++|++.||.|||+++|+|||||.-|||++ +|.++|.|||.+... .......++
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 9976554 4555566799999999999999999999999999999999999994 789999999987543 333456788
Q ss_pred cccCcccCccccc----ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 160 ITTLQYRAPEMLL----MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 160 ~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.|||+|||||++. ...+|+.++||||||++|.+|..+.+|-...+....+-+|.+.-++...
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl-------------- 256 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL-------------- 256 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc--------------
Confidence 9999999999874 3567999999999999999999999999888888877777543211100
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
-....+..+.+++.+||..||..||+++++|+||||++...
T Consensus 257 -------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 257 -------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred -------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 01356788999999999999999999999999999996543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=319.61 Aligned_cols=262 Identities=24% Similarity=0.373 Sum_probs=208.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|+..+.||+|+||.||++.+..+++.||+|.+.............+|+..+.++.+||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 57888999999999999999999999999999997665555555667899999999679999999999998899999999
Q ss_pred cCCCCHHHHHh----cccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 82 YMDCNLHQLMS----NRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 82 ~~~g~l~~~~~----~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
++.+++.+... .....+++..+..++.|++.||+|||+. +++||||||+||+++ ++.++|+|||++........
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 99876654332 2235699999999999999999999975 999999999999995 56899999999976554433
Q ss_pred CccccccCcccCccccccc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 YTEYITTLQYRAPEMLLMS--GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.....++..|+|||++... ..++.++||||+||++|+|++|..||..... ....+.......
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~-------------- 227 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD-------------- 227 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC--------------
Confidence 3445688899999998754 3689999999999999999999999976541 111111111000
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.+... ......++.++.+|+++||+.||++|||++++++||||+..
T Consensus 228 ----~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 228 ----PPILS----NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ----CCcCC----CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 00000 00113478899999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=314.05 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=202.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec------CCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE------NYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------~~~ 75 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+|+..+.++.+||||+++++.+.. ...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc--HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 4689999999999999999999999999999998754332 33456788888888789999999999864 246
Q ss_pred EEEEEEcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
++++|||+++ ++.+.+... ...+++..+..++.|++.||+|||+++|+|+||+|+||+++ ++.++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 8999999985 676666653 34589999999999999999999999999999999999995 56899999999876543
Q ss_pred C-CCCccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHH
Q 039371 153 C-PPYTEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 153 ~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
. .......++..|+|||++.. ...++.++|+||+||++|+|++|..||...........+...
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~------------ 231 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------------ 231 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC------------
Confidence 2 23344578899999998853 235788999999999999999999999765443322222110
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.. .......++.++.+|+.+||..||.+|||++++++||||
T Consensus 232 ---------~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 ---------PA-------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ---------CC-------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00 000113467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=311.15 Aligned_cols=255 Identities=31% Similarity=0.507 Sum_probs=207.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||.|++|.||+|.+..+++.+++|++...... ......+|+.+++++ +||||+++++.+.+++.+|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999999755433 334556889999998 89999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
+++| ++.+.+......+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||.+....... ....
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 9986 55555555546799999999999999999999999999999999999995 5689999999987654422 2234
Q ss_pred ccccCcccCccccccc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 159 YITTLQYRAPEMLLMS--GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
..++..|+|||.+... ..++.++|+||+||++|+|++|..||...+.......+......++.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 225 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK--------------- 225 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc---------------
Confidence 5678899999988632 26788999999999999999999999877655444333221100000
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~ 283 (346)
. .....++.++.+++++||..||.+|||+.+++.|||
T Consensus 226 ----~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 226 ----L------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----c------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 001245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=308.00 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=208.4
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++.+.||+|++|.||+|.+..+++.|++|.+...... .......+|+.+++++ +||||+++++.+.+++..+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEE
Confidence 589999999999999999999999999999998754333 3344556899999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCC-Cc
Q 039371 82 YMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP-YT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~-~~ 157 (346)
|+.| ++.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||++++ +.++|+|||++........ ..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 9975 777766554 456899999999999999999999999999999999999964 6999999999876554332 23
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+++.|+|||++. ...++.++|+|||||++|+|++|..||...+..+....+.....
T Consensus 160 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 218 (256)
T cd08529 160 TIVGTPYYLSPELCE-DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF-------------------- 218 (256)
T ss_pred ccccCccccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence 346788999999887 55688999999999999999999999988775554444432211
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+. ....++.++.+++++|++.+|++||++.++++|||+
T Consensus 219 -~~--------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 -PP--------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -CC--------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 10 112467889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=321.08 Aligned_cols=261 Identities=27% Similarity=0.394 Sum_probs=218.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++.|..-+.||+|+||.|+-++.+.||+-||+|.+.+.....+ +...++|-.++.++ +.|.||.+-..|++.+.+|+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEE
Confidence 4678899999999999999999999999999999976655443 34557899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
||..|+| +|...+.+.+ ..++|..++.++.+|+.||++||+.+||+||+||+|||+| .|+++|+|+|+|..+....+
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 9999996 5655554443 3599999999999999999999999999999999999995 57999999999999998888
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||.+|||||++. ++.|+.+.|.|||||++|+|+.|+.||.......-...+-+....
T Consensus 343 ~~~rvGT~GYMAPEvl~-ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~----------------- 404 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQ-NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE----------------- 404 (591)
T ss_pred cccccCcccccCHHHHc-CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-----------------
Confidence 88889999999999998 455999999999999999999999999765443322222111111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCLQ 289 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~~ 289 (346)
.........|++++++.+.+|+.||.+|.. ++++.+||||+....
T Consensus 405 ---------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 405 ---------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred ---------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 111122477999999999999999999975 889999999998643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=352.99 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=220.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++++.||+|+||.|.+++++.|++.||+|++++-..-. .....++|..-....++.+-|+.++..|+++.++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 68999999999999999999999999999999997632221 12233455555555558999999999999999999999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CC
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~ 156 (346)
||+. |++...+.+.. +++|..++.++..|+.||.-||+.|+|||||||+|||+| .|++||+|||.+-..+... ..
T Consensus 155 dY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred ecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 9998 57888888776 799999999999999999999999999999999999996 6899999999997766333 45
Q ss_pred ccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 157 TEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
+..+|||.|.+||++.. .+.|+..+|+||+|+++|||+.|..||.+.+-.+++.+|++...
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~--------------- 298 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE--------------- 298 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh---------------
Confidence 66799999999999863 26799999999999999999999999999999999999987622
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT---AAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~ell~hp~~~~~~~ 289 (346)
.+.||.. ..+|.++++||++.+. +|+.|.. ++++..||||.+...
T Consensus 299 --~l~FP~~---------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 299 --SLSFPDE---------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred --hcCCCcc---------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 1233311 3589999999999986 7889988 999999999998765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=307.83 Aligned_cols=318 Identities=31% Similarity=0.450 Sum_probs=253.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------C
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASEN------Y 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------~ 74 (346)
.||.-++.+|.|.- .|.-|.+.-++++||+|....+... ....+..+|+..+..+ +|+||++++.+|.-. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHHH
Confidence 47899999999999 8889999999999999988655333 2345567899999888 899999999998533 4
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~ 153 (346)
..|+|||+|++++...+... ++-..+..++.|++.|++|||+.||+||||||+||++ .++.+|+.|||+|...+..
T Consensus 95 e~y~v~e~m~~nl~~vi~~e---lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILME---LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHh---cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 67999999999999888743 7889999999999999999999999999999999999 5669999999999988876
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
...++.+.|..|.|||++.+.+ +.+.+||||+||++.||++|...|++.+.-++..++.+.+|.|.+....+.......
T Consensus 172 ~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 6778899999999999999655 999999999999999999999999999999999999999999998887766555443
Q ss_pred cCCCCCCcCCCCcccc------------cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC---CCCCCcccc
Q 039371 234 HGYKFPKLQGNNLSLL------------IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ---VPSMSIDSC 298 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~---~~~~~~~~~ 298 (346)
.....++......... .+..+..+++++.+||..||++|.|++++|+|||++-+.. .....++..
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe~~ 330 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPEIY 330 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCchh
Confidence 3223232222111111 1234567899999999999999999999999999983321 111111111
Q ss_pred -c-ccCCccccccCccchhhhhhcccCcch
Q 039371 299 -K-MRLTPSAKKSGWKAKLIVWFLRWEPFS 326 (346)
Q Consensus 299 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (346)
+ ....... -..|+..+..+++++.+||
T Consensus 331 d~~~d~~~~t-~~e~ke~If~ev~~f~~~~ 359 (369)
T KOG0665|consen 331 DKQLDEREHT-IEEWKELIFKEVQRFEEFN 359 (369)
T ss_pred hhhcccccCC-HHHHHHHHHHHHHhhcccc
Confidence 1 1111111 5678889999999998876
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=311.22 Aligned_cols=250 Identities=31% Similarity=0.521 Sum_probs=202.3
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--------HhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--------ECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
+|.+.+.||+|++|.||+|.+..+++.+|+|.+........ .....+|+.+++++ +||||+++++++.+.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Confidence 58899999999999999999999999999998865433211 12345788889999 7999999999999999
Q ss_pred EEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
..+++|||++| ++.+.+.. .+.+++..+..++.|++.||+|||++|++|+||+|+||+++ ++.++|+|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999986 55555544 45589999999999999999999999999999999999995 55899999999876542
Q ss_pred CC-------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHH
Q 039371 153 CP-------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 153 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (346)
.. ......++..|+|||.+. ...++.++|+||+||++|+|++|+.||...+.......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------- 227 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN---------- 227 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhc-cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc----------
Confidence 11 111235788999999886 456789999999999999999999999876554333322111
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.. ......++..+.++|++||+.||.+||++.++++||||
T Consensus 228 -----------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 -----------AS--------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -----------CC--------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 00 01113567889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=307.83 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=209.7
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++.+.||+|++|.||+|.+..++..+|+|.+...... .......+|+.+++++ +|||++++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999998765433 2334456789999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeecccccccCCCCCCc
Q 039371 82 YMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
+++| ++.+.+... +..+++..+..++.|++.||+|||++|++|+||+|+||++++ +.++|+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 9985 777777654 345899999999999999999999999999999999999964 368999999998776554444
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...++..|+|||.+. ...++.++|+||+|+++|+|++|+.||...+.......+......+
T Consensus 160 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------------------ 220 (256)
T cd08220 160 TVVGTPCYISPELCE-GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP------------------ 220 (256)
T ss_pred ccccCCcccCchhcc-CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC------------------
Confidence 567888999999886 4567899999999999999999999998776655444443221110
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
....++.++.+++.+||+.||.+|||+.|+++||||
T Consensus 221 -----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 221 -----------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -----------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 112467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.24 Aligned_cols=258 Identities=25% Similarity=0.341 Sum_probs=207.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||.||++.+..+++.|++|.+...... .......+|+.+++.+ +||||+++++.+..++.++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEE
Confidence 5799999999999999999999999999999998755432 1223445788888888 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--- 154 (346)
||+++| ++.+.+.. .+.+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||.+.......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 80 MEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999986 55555544 45699999999999999999999999999999999999995 5699999999875321100
Q ss_pred -------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 155 -------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 155 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
......++..|+|||.+. ...++.++||||+||++|+|++|..||.+.+..+....+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~-- 235 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW-- 235 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC--
Confidence 111235678899999886 4568999999999999999999999998776655555443321110
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCCC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT---AAEALQHPLFQGCLQ 289 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~ell~hp~~~~~~~ 289 (346)
+. .....+.++.++|++||+.||++||+ +.++++||||.+...
T Consensus 236 -----------------~~--------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 236 -----------------PE--------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred -----------------CC--------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 00 01246788999999999999999998 899999999987543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=314.30 Aligned_cols=253 Identities=28% Similarity=0.429 Sum_probs=208.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+.|+.++.||.|+||.||+|.+..++..||+|++.............+|+.+++++ +||||+++++.+.+++..++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEe
Confidence 36889999999999999999999999999999987665445555667899999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|++| +|.+.+.. .++++.++..++.|++.||++||+.+++|+||+|+||+++ ++.++|+|||++....... ....
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 9986 66666543 3589999999999999999999999999999999999995 4589999999986654432 2233
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||.+. ...++.++|+||+||++|+|++|..||...........+....
T Consensus 161 ~~~~~~y~apE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---------------------- 217 (277)
T cd06640 161 FVGTPFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---------------------- 217 (277)
T ss_pred ccCcccccCHhHhc-cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC----------------------
Confidence 45788899999886 5568999999999999999999999998765543333221100
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.......++..+.+++.+||+.+|++||+++++++||||...
T Consensus 218 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 218 -------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred -------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 011123456788999999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=310.04 Aligned_cols=251 Identities=29% Similarity=0.470 Sum_probs=206.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|++|.||+|.+..+++.+++|.+..... .....+|+..++++ +||||+++++.+.++...|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEEe
Confidence 689999999999999999999998899999999865432 34556899999999 89999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
+++| ++.+.+......+++..+..++.|++.|+.|||+.|++|+||+|+||+++ ++.++|+|||++....... ....
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 9986 66666665566799999999999999999999999999999999999995 5689999999987665433 2233
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||++. ...++.++||||+|+++|+|++|..||...........+.... .
T Consensus 159 ~~~~~~y~~PE~~~-~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~ 216 (256)
T cd06612 159 VIGTPFWMAPEVIQ-EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP---------------------P 216 (256)
T ss_pred ccCCccccCHHHHh-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC---------------------C
Confidence 45788999999886 5568999999999999999999999997665443322211100 0
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+. ......++.++.++|.+||+.||++|||+.|+++||||
T Consensus 217 ~~------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 217 PT------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CC------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 00112457789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=316.11 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=215.6
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
|.++++||.|+||.||+|.++.+|..+|+|.+..+. .....++|+.+++++ +.|++|++|+.|-....+|||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEeehhhc
Confidence 678899999999999999999999999999986543 344567899999999 8999999999998888999999999
Q ss_pred C-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCC-CCCcccc
Q 039371 84 D-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSC-PPYTEYI 160 (346)
Q Consensus 84 ~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~-~~~~~~~ 160 (346)
+ |+..+.++.++.+++|.++..++++-++||+|||...-+|||||.-|||+ .+|..||.|||.|-...+. ...++..
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence 8 78999999999999999999999999999999999999999999999999 5789999999999655433 3567789
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (346)
|||.|||||++. .-.|+.++||||||++..||..|++||..-.+......| ...|++. +.
T Consensus 191 GTPFWMAPEVI~-EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPT-F~--------------- 250 (502)
T KOG0574|consen 191 GTPFWMAPEVIE-EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPT-FK--------------- 250 (502)
T ss_pred cCcccccHHHHH-HhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCC-CC---------------
Confidence 999999999998 445899999999999999999999999766544322222 1112211 00
Q ss_pred cCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
. ....|.++.+|+++||...|++|.|+.++++|||+++....
T Consensus 251 --K------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 251 --K------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred --C------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 0 12467889999999999999999999999999999986543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=328.40 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=219.0
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
.+.||+|.||+||-|+++++|+.||+|++++..+..+ +....+|+.+|+.+ .||.||.+.-.|++.+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEEEEehhhcc
Confidence 3689999999999999999999999999987766544 34445799999999 799999999999999999999999999
Q ss_pred CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC----cEEEeecccccccCCCCCCcccc
Q 039371 86 NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYI 160 (346)
Q Consensus 86 ~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~----~vkl~Dfg~a~~~~~~~~~~~~~ 160 (346)
+.++.+... .+.++|...+.++.||+.||.|||-++|+|+||||+|||+.+. .+||||||+|+.++...-..+.+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV 727 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV 727 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence 999887644 6779999999999999999999999999999999999999432 89999999999999888788889
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (346)
|||.|+|||++. ++.|+..-|+||+|+|+|.-++|..||+.+. +.-.+|.+.-...+++.|.
T Consensus 728 GTPAYLaPEVLr-nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~--------------- 789 (888)
T KOG4236|consen 728 GTPAYLAPEVLR-NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWS--------------- 789 (888)
T ss_pred CCccccCHHHHh-hccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchh---------------
Confidence 999999999998 5668999999999999999999999996543 2233333333333444444
Q ss_pred cCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
++++.+.+||..+|+..-.+|.|.++.|.|||+++..
T Consensus 790 -----------eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 790 -----------EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred -----------hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 6899999999999999999999999999999999754
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=316.72 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=210.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+++|++.+.||+|++|+||+|.+..+++.||+|.++.............|+..+.+..+||||+++++++.++...|++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 46899999999999999999999999999999999766554445555677777777767999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|++++.+...+......+++..+..++.|++.|++|||+ .|++|+||+|+||+++ ++.++|+|||.+...........
T Consensus 94 e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (296)
T cd06618 94 ELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR 173 (296)
T ss_pred eccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccC
Confidence 999988877776656679999999999999999999997 5999999999999995 56999999999876654444444
Q ss_pred ccccCcccCccccccc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 159 YITTLQYRAPEMLLMS---GQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
..++..|+|||.+... ..++.++||||+|+++|+|++|..||...... +.+..+.....
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 236 (296)
T cd06618 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----------------- 236 (296)
T ss_pred CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-----------------
Confidence 5678899999988633 34788999999999999999999999764322 22222221100
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+... ....++.++.+++.+||+.||.+||+++++++||||+..
T Consensus 237 ----~~~~------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 237 ----PSLP------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred ----CCCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 0000 001367889999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=314.02 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=209.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc--CCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN--NHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~hp~iv~~~~~~~~~~~~~iv 79 (346)
..|++.+.||+|+||.||+|.+..+++.||+|.++............+|+.+++++. .|||++++++++.++...+++
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 358999999999999999999999999999999876554444455667888888885 499999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CC
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PY 156 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~ 156 (346)
|||+.| +|.+.+.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+....... ..
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 999986 56555543 3589999999999999999999999999999999999995 5699999999987665432 23
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....++..|+|||.+.....++.++|+||+||++|+|++|..||.+.........+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--------------------- 217 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--------------------- 217 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---------------------
Confidence 34568889999998875566789999999999999999999999766443222111000
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
..+.. .....+.++.+++++||+.||++||++.++++||||++....
T Consensus 218 ~~~~~-------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~ 264 (277)
T cd06917 218 KPPRL-------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT 264 (277)
T ss_pred CCCCC-------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence 00000 011367889999999999999999999999999999876543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=313.71 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=209.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|++|.||+|.++.+++.+++|.+.............+|+..++++ +||||+++++.+..++.+++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEEE
Confidence 57999999999999999999999999999999997765555556677899999998 69999999999999999999999
Q ss_pred cCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 82 YMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
+++ ++|.+.+......+++..+..++.|++.||+|||+ .|++|+||+|+||+++ ++.++|+|||.+......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 158 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-T 158 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-c
Confidence 999 57777776654679999999999999999999999 9999999999999995 558999999998655432222 2
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE-----DDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
..++..|+|||.+. ...++.++||||+||++|+|++|..||..... .+....+... +
T Consensus 159 ~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~-------------- 220 (265)
T cd06605 159 FVGTSSYMAPERIQ-GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---P-------------- 220 (265)
T ss_pred ccCChhccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---C--------------
Confidence 67888999999886 45789999999999999999999999966531 1111111110 0
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.+.. ....++.++.++|.+||..||++|||+.++++||||+..
T Consensus 221 ----~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 221 ----PPRL-------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ----CCCC-------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 0000 001267889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=312.77 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=201.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee------cCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS------ENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~------~~~~ 75 (346)
++|++.+.||+|+||.||+|.+..+++.+|+|++..... .......|+.++.++.+||||+++++++. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 478999999999999999999999999999999865432 23345578888888878999999999984 3467
Q ss_pred EEEEEEcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
+|++|||+++ ++.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++.....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 8999999985 676666543 34588999999999999999999999999999999999995 56899999999875543
Q ss_pred C-CCCccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHH
Q 039371 153 C-PPYTEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 153 ~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
. .......+++.|+|||.+.. ...++.++|+||+||++|+|++|..||...........+.....
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 243 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP---------- 243 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC----------
Confidence 2 22334568899999998752 34578899999999999999999999976554333222211100
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.......++.++.++|++||+.||.+|||+.|+++||||
T Consensus 244 ------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 ------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000113567899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=315.93 Aligned_cols=255 Identities=30% Similarity=0.456 Sum_probs=210.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|++|+||+|.+..+++.||+|++...... .......+|+.+++.+ +||||+++.+++.+++..++|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEE
Confidence 5799999999999999999999999999999998644322 2234456899999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
+||+.|++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++...... ..
T Consensus 94 ~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~ 170 (307)
T cd06607 94 MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS 170 (307)
T ss_pred HHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence 99999999888876666799999999999999999999999999999999999995 569999999998654432 34
Q ss_pred ccccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 159 YITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
..++..|+|||++.. ...++.++||||+|+++|+|++|..||...+.......+.....
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~------------------- 231 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS------------------- 231 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-------------------
Confidence 467889999998742 35588899999999999999999999987665544333321100
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+. ......+..+.++|++||+.||++||++.++++||||....
T Consensus 232 --~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 232 --PT-------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred --CC-------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 00 00123567899999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=305.15 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=210.6
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++++.||.|+||.||.+++..+++.+++|.+...... .......+|+.+++++ +||||+++++++.+++.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEE
Confidence 699999999999999999999999999999998765433 3334456899999998 89999999999999999999999
Q ss_pred cCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCc
Q 039371 82 YMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~ 157 (346)
|++| +|.+.+... ...+++.++..++.|++.||.|||+.|++|+||+|+||+++ ++.+||+|||++....... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 9985 777777654 34589999999999999999999999999999999999995 4589999999987654433 234
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+++.|+|||.+. ...++.++|+||+||++|+|++|..||...+..+....+......+
T Consensus 160 ~~~~~~~y~ape~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------------ 220 (256)
T cd08221 160 TVVGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP------------------ 220 (256)
T ss_pred ccCCCccccCHhhcC-CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 456889999999886 4457889999999999999999999998877666655553321111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
..+.++.++.+++.+||..||.+|||++++++|||+
T Consensus 221 -----------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 -----------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 013567889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=310.12 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=200.3
Q ss_pred CceeeeeeecccCceEEEEEEEc---cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++.+.||+|+||.||+|.++ ..+..||+|.++............+|+..+.++ +||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcEE
Confidence 57999999999999999999765 446689999998765544455667899999998 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
||||++| ++.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++ ++.++++|||.+.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 9999986 55555555455689999999999999999999999999999999999995 558999999987554322211
Q ss_pred c--cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 157 T--EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 157 ~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
. ...++..|+|||.+. ...++.++||||+||++|++++ |..||......+....+.+....+
T Consensus 164 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 228 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP-------------- 228 (266)
T ss_pred cccCCCCceeecCHHHHh-hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC--------------
Confidence 1 223457899999886 5678999999999999999775 999998877665555443221111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+.++..+.+++.+|++.+|.+|||++++++
T Consensus 229 ---------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 ---------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 11356788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=318.36 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=206.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+.|+..+.||+|++|.||+|.+..+++.||+|.++............+|+..++++ +||||+++++.+..++..++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEE
Confidence 35888999999999999999999999999999987655444445567899999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|++| ++.+.+.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++ ++.++|+|||++....... ....
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 9986 55555543 3589999999999999999999999999999999999995 5689999999987654432 2223
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||.+. ...++.++|+||+||++|+|++|..||...........+... .
T Consensus 161 ~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------------~- 217 (277)
T cd06642 161 FVGTPFWMAPEVIK-QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------------S- 217 (277)
T ss_pred ccCcccccCHHHhC-cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------------C-
Confidence 45788999999887 556889999999999999999999999765443332221110 0
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
........+.++.+++.+|++.+|++|||+.++++||||+..
T Consensus 218 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 218 -------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred -------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 001113467789999999999999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=306.55 Aligned_cols=251 Identities=32% Similarity=0.497 Sum_probs=208.4
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++.+.||+|+||+||++.+..+|+.||+|.+....... ......+|+.+++++ +||||+++.+.+.+.+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEEe
Confidence 6999999999999999999999999999999987543332 334556889999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-Cc
Q 039371 82 YMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-YT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-~~ 157 (346)
|+.| ++.+.+.... ..+++..+..++.|++.|+.|||++|++|+||+|+||+++ ++.++|+|||.+........ ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 9975 7777775543 3589999999999999999999999999999999999995 56999999999876544321 22
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+++.|+|||+.. ....+.++|+||+||++|+|++|..||...+..+....+......
T Consensus 160 ~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~------------------- 219 (256)
T cd08218 160 TCIGTPYYLSPEICE-NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP------------------- 219 (256)
T ss_pred hccCCccccCHHHhC-CCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-------------------
Confidence 345788899999886 556888999999999999999999999877666555544322111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
......+.++.++|.+||+.+|.+||++.++++||||
T Consensus 220 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 ----------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ----------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0113567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=310.82 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=206.8
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+|++.+.||.|+||.||+|.+..+++.||+|++...... .......+|+..++++ +||||+++++.+.++...++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence 699999999999999999999999999999999754432 2344557889999998 8999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
||+.| +|.+.+... .++++..+..++.|+++||.|||++|++|+||+|+||+++ ++.++|+|||.+...........
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 99986 566555544 5699999999999999999999999999999999999995 56999999999977665444455
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED--DQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
..++..|+|||.+. ...++.++|+||+|+++|+|++|..||...+.. +.+...... .
T Consensus 159 ~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------------- 217 (258)
T cd05578 159 TSGTPGYMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-A------------------- 217 (258)
T ss_pred cCCChhhcCHHHHc-ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-c-------------------
Confidence 67888999999886 455899999999999999999999999877642 111111110 0
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH--HHHhcCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA--AEALQHPLF 284 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~--~ell~hp~~ 284 (346)
.....+..+.++.++|++||+.||.+||++ +|+++||||
T Consensus 218 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 ---------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ---------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001113467899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.20 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=199.0
Q ss_pred CceeeeeeecccCceEEEEEEE-----ccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIK-----KQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||+||+|++ ..++..||+|+++............+|+.++..+.+||||+++++++.+++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4799999999999999999974 34567899999976554445556678999999997899999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc------------------------------------------------------------
Q 039371 77 YFVFEYMD-CNLHQLMSNRK------------------------------------------------------------ 95 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~------------------------------------------------------------ 95 (346)
++||||++ |+|.+.+....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999998 57777664321
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCCC---c
Q 039371 96 --------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPY---T 157 (346)
Q Consensus 96 --------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~~---~ 157 (346)
..+++..+..++.||+.||.|||++|++||||||+||++++ +.+||+|||++......... .
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 24788899999999999999999999999999999999965 48999999999765433221 1
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...++..|+|||++. ...++.++|||||||++|+|++ |..||..........+......
T Consensus 275 ~~~~~~~y~aPE~~~-~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------------------- 334 (375)
T cd05104 275 NARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY------------------- 334 (375)
T ss_pred CCCCCcceeChhHhc-CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-------------------
Confidence 223456799999886 5678999999999999999997 8899977654443333322110
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
... .....+.++.+++.+||+.||++|||+.|+++.
T Consensus 335 ~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 335 RML---------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred cCC---------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 000 012346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=309.57 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=195.8
Q ss_pred Cceeeeeee--cccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQI--GEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.+ |+|+||.||++.++.++..+|+|.+........ |......+.+||||+++++.+..++..|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 467777777 999999999999999999999999865433211 222333334799999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C-cEEEeecccccccCCCCCC
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D-TIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~-~vkl~Dfg~a~~~~~~~~~ 156 (346)
|||++ |+|.+.+.... .+++.++..++.|++.||.|||+.|++|+||+|+||++++ + .++|+|||.+.......
T Consensus 88 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-- 164 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-- 164 (267)
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--
Confidence 99997 47777766543 6999999999999999999999999999999999999954 4 79999999987655322
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ-LYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
...++..|+|||++. ...++.++|+||+|+++|+|++|..||......+. ..........
T Consensus 165 -~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 225 (267)
T PHA03390 165 -CYDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----------------- 225 (267)
T ss_pred -cCCCCCcccChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-----------------
Confidence 346788999999886 55688999999999999999999999986543321 1111110000
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-AAEALQHPLFQG 286 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-~~ell~hp~~~~ 286 (346)
.....+..++.+.++|.+||+.||.+||+ ++++++||||++
T Consensus 226 ----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 ----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 00112357899999999999999999996 699999999974
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=337.93 Aligned_cols=246 Identities=28% Similarity=0.425 Sum_probs=200.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeee-ee----c--CCE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQEL-AS----E--NYR 75 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~-~~----~--~~~ 75 (346)
+++|.+.|.+|||+.||+|.+...|..||+|++-.. .........+|+.+|++|.+|||||.+++. .. . .-.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 678999999999999999999998899999998655 444455567999999999999999999993 21 1 135
Q ss_pred EEEEEEcCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEe-CCcEEEeeccccccc
Q 039371 76 LYFVFEYMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQG--YFHRDLISKNLLVS-NDTIKIADFGLAWEV 150 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dikp~NIli~-~~~vkl~Dfg~a~~~ 150 (346)
+.|+||||. |+|.+.+..+ ...|+|.++.+|+.|+++|+.+||..+ |+|||||-+|||++ +|..||||||.|+..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 789999999 6999988755 334999999999999999999999997 99999999999995 668999999999654
Q ss_pred CCCCC-Cc---------cccccCcccCccccc--ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 039371 151 DSCPP-YT---------EYITTLQYRAPEMLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGS 218 (346)
Q Consensus 151 ~~~~~-~~---------~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 218 (346)
-.... .. ....|+.|+|||++. .+...+.|+|||+|||+||-|+....||+....... +.+
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI----lng--- 269 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI----LNG--- 269 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE----Eec---
Confidence 33221 11 134699999999885 345688999999999999999999999977633221 111
Q ss_pred CChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 219 PTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+.+|.. +.++..+++||+.||+.||.+||++.+++.+
T Consensus 270 ----------------~Y~~P~~---------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 270 ----------------NYSFPPF---------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ----------------cccCCCC---------ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 2333332 5788999999999999999999999999875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=310.69 Aligned_cols=254 Identities=29% Similarity=0.436 Sum_probs=203.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------CE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN------YR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------~~ 75 (346)
++|++.+.||+|++|+||+|.++.+++.+++|++..... ......+|+.+++++.+||||+++++++.+. ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 689999999999999999999999999999999875543 2344568999999987899999999998654 45
Q ss_pred EEEEEEcCCC-CHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc
Q 039371 76 LYFVFEYMDC-NLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV 150 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~ 150 (346)
++++|||+++ ++.+.+... +..+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 8999999996 555555432 35699999999999999999999999999999999999995 568999999998665
Q ss_pred CCCC-CCccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHH
Q 039371 151 DSCP-PYTEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 151 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (346)
.... ......++..|+|||.+.. ...++.++||||+||++|+|++|..||...........+.....
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 235 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP-------- 235 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC--------
Confidence 4322 2334568889999998753 23467899999999999999999999976655444443322110
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+.. ......+.++.++|++||..||++|||++++++|||+
T Consensus 236 -------------~~~------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 -------------PTL------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -------------CCC------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0012367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=311.12 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=201.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-----CEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN-----YRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-----~~~ 76 (346)
++|++.+.||+|+||.||+|.+..+++.+|+|++..... ......+|+.+++++.+|||++++++++... +..
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 679999999999999999999999999999999865422 2233457888888887899999999998643 468
Q ss_pred EEEEEcCCC-CHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC
Q 039371 77 YFVFEYMDC-NLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD 151 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~ 151 (346)
++||||++| ++.+.+.. ....+++..++.++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||++....
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999985 66665532 345689999999999999999999999999999999999995 5589999999987654
Q ss_pred CCC-CCccccccCcccCcccccccC----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHH
Q 039371 152 SCP-PYTEYITTLQYRAPEMLLMSG----QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 152 ~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (346)
... ......++..|+|||.+.... .++.++||||+||++|+|++|..||...........+..... .
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~---~----- 251 (291)
T cd06639 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP---P----- 251 (291)
T ss_pred cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC---C-----
Confidence 322 223346788999999875332 367899999999999999999999987655444333321100 0
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
.. ......+..+.++|.+||+.||++||++.++++||||+
T Consensus 252 -------------~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 -------------TL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -------------CC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00 00124567899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=307.96 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=201.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----EECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
+|++.+.||+|+||+||+|.+ .+++.+|+|.+....... ......+|+..++++ +||||+++++++.+.+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEE
Confidence 689999999999999999986 478899999886543221 123345788999999 7999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC--
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-- 153 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-- 153 (346)
+++||+.| +|.+.+.. ..++++..+..++.|++.||+|||+.|++|+||+|+||+++ ++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999986 55555544 34589999999999999999999999999999999999995 669999999998654221
Q ss_pred -----CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 154 -----PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 154 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
.......++..|+|||.+. ...++.++|+||+||++|+|++|..||...+.......+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVIN-ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL---------- 226 (265)
T ss_pred cccccccccccCCCccccChhhhc-CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----------
Confidence 1223356788999999886 556889999999999999999999999776544333322211100
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
...+...++.++.++|++||+.+|.+||++.++++||||
T Consensus 227 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 -----------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=325.05 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=198.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCC-----cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG-----EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||.||+|++..++ ..||+|+++............+|+.+++.+.+||||+++++.+..++..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 47999999999999999999865443 5799999976654444455678999999987899999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc------------------------------------------------------------
Q 039371 77 YFVFEYMD-CNLHQLMSNRK------------------------------------------------------------ 95 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~------------------------------------------------------------ 95 (346)
++||||+. |+|.+.+....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999998 57766654321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCC---Ccccccc
Q 039371 96 ---------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP---YTEYITT 162 (346)
Q Consensus 96 ---------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~---~~~~~~t 162 (346)
.++++..+..++.|++.||.|||++|++||||||+||++++ +.++|+|||++........ .....++
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 23788899999999999999999999999999999999965 5899999999876543221 1122345
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCc
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
..|+|||++. ...++.++||||+||++|+|++ |..||..................+.
T Consensus 278 ~~y~aPE~~~-~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--------------------- 335 (374)
T cd05106 278 VKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--------------------- 335 (374)
T ss_pred cceeCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc---------------------
Confidence 6799999886 5678999999999999999997 9999987654443333322211100
Q ss_pred CCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....++++.+++.+||+.||.+|||+.++++
T Consensus 336 -------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 336 -------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01235789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=310.50 Aligned_cols=251 Identities=29% Similarity=0.402 Sum_probs=193.8
Q ss_pred eecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhh--cCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKI--NNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l--~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
.||+|+||.||++.+..+++.+|+|.+...... .......+|...++.+ .+||+|+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998654332 1222233343333322 379999999999999999999999998
Q ss_pred C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcccccc
Q 039371 85 C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITT 162 (346)
Q Consensus 85 g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t 162 (346)
| +|.+.+.. .+.+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++....... .....++
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT 158 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCC
Confidence 6 55555543 45599999999999999999999999999999999999995 5699999999987654432 2334689
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
..|+|||.+.....++.++||||+||++|+|++|..||......... .+..... ..
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~-------------------~~---- 214 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL-------------------TV---- 214 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh-------------------cC----
Confidence 99999998864556889999999999999999999999764332111 1100000 00
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGCL 288 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~~ 288 (346)
...+.+.++.++.++|++||+.||++|| |++++++||||++..
T Consensus 215 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 215 ---NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ---CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 0112235788999999999999999999 699999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=309.82 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=206.0
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
-|++++.||+|+||.||+|.+..+++.||+|++.............+|+.++.++ +||||+++++.+.+++..++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEe
Confidence 3788999999999999999999999999999987655444445566789999998 799999999999999999999999
Q ss_pred CCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCccc
Q 039371 83 MDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEY 159 (346)
Q Consensus 83 ~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~ 159 (346)
++| ++.+.+.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++ ++.++|+|||++....... .....
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 986 55555543 3589999999999999999999999999999999999995 5589999999986654322 22334
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (346)
.++..|+|||.+. ....+.++|+||+||++|+|++|..||...........+... .
T Consensus 162 ~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~---------------------- 217 (277)
T cd06641 162 VGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N---------------------- 217 (277)
T ss_pred cCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C----------------------
Confidence 6788999999886 556788999999999999999999999766544333332110 0
Q ss_pred CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
...+...++.++.+++.+||+.+|.+||++.++++||||+..
T Consensus 218 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 218 ------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 011123567889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=311.81 Aligned_cols=267 Identities=23% Similarity=0.341 Sum_probs=206.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|++|+||+|.+..+++.||+|++.............+|+.+++.+ +||||+++++.+...+.+++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999987654444455667899999998 79999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEY 159 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~ 159 (346)
|++|+.+..+....+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++ ++.++|+|||++...... .....
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~ 162 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTF 162 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCcc
Confidence 99864444443344569999999999999999999997 5999999999999995 468999999998654322 22345
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (346)
.++..|+|||++. ...++.++||||+||++|+|++|..||......+.... ......+........ ..+
T Consensus 163 ~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~--~~~ 231 (284)
T cd06620 163 VGTSTYMSPERIQ-GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------DPMGILDLLQQIVQE--PPP 231 (284)
T ss_pred ccCcccCCHHHHc-cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------hhhHHHHHHHHHhhc--cCC
Confidence 7899999999886 45788999999999999999999999986554311000 000000000000000 000
Q ss_pred CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.. ....++.++.+|+.+|++.||.+|||++|+++||||....
T Consensus 232 ~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 232 RL-------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CC-------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 0012567899999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=310.65 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=200.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee-----cCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS-----ENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~-----~~~~~ 76 (346)
++|++.+.||+|+||+||+|.+..+++.+|+|++..... ......+|+.+++++.+||||+++++++. .++..
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 689999999999999999999999999999998864322 22334578888989877999999999873 45678
Q ss_pred EEEEEcCCC-CHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC
Q 039371 77 YFVFEYMDC-NLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD 151 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~ 151 (346)
+++|||++| +|.+.+. .....+++..+..++.|++.||.|||+.+++|+||||+||+++ ++.++|+|||++....
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999985 6655543 2334589999999999999999999999999999999999995 5689999999987654
Q ss_pred CCC-CCccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHH
Q 039371 152 SCP-PYTEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 152 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (346)
... ......+++.|+|||++.. ...++.++||||+||++|+|++|..||...........+....
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~---------- 245 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP---------- 245 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC----------
Confidence 322 2334568899999998753 2447889999999999999999999997665433322211100
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.+.. .....++..+.+++.+||+.||++|||+.|+++|+||
T Consensus 246 -----------~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 -----------PPTL------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -----------CCcc------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0000 0012356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=305.18 Aligned_cols=248 Identities=31% Similarity=0.493 Sum_probs=205.6
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
+|++.+.||.|+||.||++.+..++..||+|.++............+|..+++.+ +||||+++++.+.+++.+|++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEee
Confidence 6999999999999999999999999999999987554444444556788888888 799999999999999999999999
Q ss_pred CCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 83 MDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 83 ~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
++| ++.+.+... ...+++..+..++.|++.||.+||++|++|+||+|+||+++ ++.++++|||.+....... ....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 984 777766543 34589999999999999999999999999999999999995 5699999999987654432 2334
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+++.|+|||++. ...++.++|+||+|+++|+|++|..||...+.......+......+
T Consensus 160 ~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 219 (255)
T cd08219 160 YVGTPYYVPPEIWE-NMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP------------------- 219 (255)
T ss_pred ccCCccccCHHHHc-cCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence 56888999999886 4568999999999999999999999998776655544443221111
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....++..+.+++++||+.||++|||+.++++-
T Consensus 220 ----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ----------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 113467789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=306.19 Aligned_cols=254 Identities=29% Similarity=0.422 Sum_probs=210.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|++|.||+|.+..+++.|++|++.............+|+..+.++ +|||++++++.+..++..++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEEE
Confidence 57999999999999999999999999999999997665544455667899999999 69999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC-c
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY-T 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~-~ 157 (346)
|++| +|.+.+... ..+++..+..++.|++.|+.|||+ .|++|+||+|+||+++ ++.++|+|||.+......... .
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 9995 666666544 559999999999999999999999 9999999999999995 569999999998766543332 2
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE---DDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
...++..|+|||.+. ...++.++|+||||+++|+|++|..||..... .+....+....
T Consensus 159 ~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------------------ 219 (264)
T cd06623 159 TFVGTVTYMSPERIQ-GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP------------------ 219 (264)
T ss_pred ceeecccccCHhhhC-CCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC------------------
Confidence 456788999999886 55788999999999999999999999977642 22222221100
Q ss_pred CCCCCCcCCCCcccccCC-CCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPS-ANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
. ...... ++..+.++|++||..+|++|||+.++++|||++..
T Consensus 220 ---~--------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 220 ---P--------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ---C--------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 0 001123 67889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=309.12 Aligned_cols=255 Identities=25% Similarity=0.446 Sum_probs=202.8
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----EECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
+|+..+.||+|++|.||+|.+..+++.||+|++....... ......+|+..++++ +||||+++++++.+++..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEE
Confidence 5899999999999999999999999999999986543221 233456799999998 7999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C-cEEEeecccccccCCCC
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D-TIKIADFGLAWEVDSCP 154 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~-~vkl~Dfg~a~~~~~~~ 154 (346)
+++||+.| +|.+.+. ..+++++..+..++.|++.||.|||++|++|+||+|+||+++. + .++|+|||.+.......
T Consensus 80 ~v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 80 LFVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEeccCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999986 5555554 4456899999999999999999999999999999999999953 3 69999999986654321
Q ss_pred -----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 155 -----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 155 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
......++..|+|||.+. ...++.++|+||+||++|+|++|..||...........+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------- 226 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA----------- 226 (268)
T ss_pred ccCCccccccccccceeCHhHhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-----------
Confidence 112345788999999886 466889999999999999999999999765433222222111000
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
.. .....+..++++.+++.+||+.||.+|||+.++++||||+
T Consensus 227 ------~~--------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 ------TT--------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ------CC--------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00 0111235678899999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.34 Aligned_cols=282 Identities=22% Similarity=0.335 Sum_probs=200.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCC-cEEEEEEc--------------ccc--ccCHHHhhhHHHHHHHHhhcCCCCee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG-EYVAIKAL--------------KQR--IYSWEECLNLKEVKCLRKINNHPNIV 64 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~--------------~~~--~~~~~~~~~~~e~~~l~~l~~hp~iv 64 (346)
++|+++++||+|+||+||+|..+... ...+.|.+ .+. ..........+|+.++.++ +||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnIv 226 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENIL 226 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCcC
Confidence 68999999999999999998765322 22222211 100 1111223345799999999 799999
Q ss_pred eeeeeeecCCEEEEEEEcCCCCHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcE
Q 039371 65 KLQELASENYRLYFVFEYMDCNLHQLMSNRK----QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTI 139 (346)
Q Consensus 65 ~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~v 139 (346)
++++++.+.+..|+++|++.+++.+.+.... ......+++.++.||+.||.|||++||+||||||+|||++ ++.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred cEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999888765432 2245677889999999999999999999999999999995 5699
Q ss_pred EEeecccccccCCCC--CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCC-CCCCC--ChHHHHHHHHH
Q 039371 140 KIADFGLAWEVDSCP--PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHP-LFPGT--CEDDQLYKICN 214 (346)
Q Consensus 140 kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~~--~~~~~~~~i~~ 214 (346)
||+|||++....... ......||..|+|||++. ...++.++|||||||++|+|++|.. ||... .....+.+++.
T Consensus 307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA-GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEeCCCceecCcccccccccccCCcCCCCchhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 999999997665432 223457899999999987 4568999999999999999999875 44432 33455555555
Q ss_pred HhCCCChhhH---HHHHHHHHhcCCCCCCcCCCCcccc--cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 215 AIGSPTEESW---AEGLELAKAHGYKFPKLQGNNLSLL--IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 215 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.......+.. ....+....... ... ....... ....+.++.++|.+||+.||.+|||+.|+|+||||+...
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~--~~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEI--DHA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhc--ccC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 4433222110 011111111111 000 0000000 123567888999999999999999999999999998754
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=304.94 Aligned_cols=252 Identities=29% Similarity=0.476 Sum_probs=205.9
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC----HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS----WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+|+..+.||+|++|+||+|.+..+++.|++|.+...... .......+|+.+++.+ +||||+++++++.++..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence 688999999999999999999989999999998654321 2234456789999998 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
++||++| ++.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.+||+|||.+.........
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 80 FLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 9999986 666665543 4589999999999999999999999999999999999995 569999999998766544434
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....++..|+|||.+.....++.++|+||+||++|+|++|..||......+....+.....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------- 219 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE------------------- 219 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-------------------
Confidence 4566888999999886434489999999999999999999999977654333333221100
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.....+.++.++.+++++||+.+|.+|||++++++|||+
T Consensus 220 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 ---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 011123567889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=307.05 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=198.3
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
++.||+|++|.||+|.+..+++.||+|++....... .......|...+....+|||++++++.+..++.+|+++||++
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 367999999999999999999999999986543322 122234555555555589999999999999999999999998
Q ss_pred C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcccccc
Q 039371 85 C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITT 162 (346)
Q Consensus 85 g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t 162 (346)
| +|...+. ..+.+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++..... .....++
T Consensus 81 ~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 81 GGDCASLIK-TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCC
Confidence 6 5555554 445699999999999999999999999999999999999995 56999999998865433 2234578
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+.......+...... .+
T Consensus 157 ~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~--- 213 (260)
T cd05611 157 PDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-------------------WP--- 213 (260)
T ss_pred cCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-------------------CC---
Confidence 89999998874 44899999999999999999999999877665554444322110 00
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPT---AAEALQHPLFQGC 287 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~ell~hp~~~~~ 287 (346)
......+++.+.+++.+||+.||++||| ++|+++||||+..
T Consensus 214 ----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 214 ----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 0111356889999999999999999995 5799999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=306.36 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=199.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC----HHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS----WEECLNLKEVKCLRKINNHPNIVKLQELASE--NYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~ 75 (346)
.+|++.+.||+|++|.||+|.+..+++.|++|.+...... .......+|+.+++++ +||||+++++.+.+ +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence 3799999999999999999999999999999998654322 1223456789999999 79999999998865 467
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
+++++|+++| +|.+.+... ..+++..+..++.|++.||+|||+++++|+||+|+||+++ ++.++|+|||++......
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 8999999985 666666543 4589999999999999999999999999999999999995 458999999998754321
Q ss_pred C----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 P----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
. ......++..|+|||.+. ...++.++||||+||++|+|++|+.||...........+......+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 228 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVIS-GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP---------- 228 (266)
T ss_pred cccCCccccCCccccccCHHHhC-CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC----------
Confidence 1 122345788999999886 4668899999999999999999999997665443333221111000
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
.....+++.+++++ +|+..+|++|||++|+++||||+
T Consensus 229 ------------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 ------------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ------------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 11124567888898 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=290.65 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=196.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec-----CCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE-----NYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-----~~~~ 76 (346)
+||++.+.||.|||+-||++++..+++.||+|.+.-.. ........+|+...+++ +|||+++++++... ....
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCceeE
Confidence 68999999999999999999999999999999997665 33455667899999888 79999999987633 3458
Q ss_pred EEEEEcCC-CCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEeC-CcEEEeecccccc
Q 039371 77 YFVFEYMD-CNLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQG--YFHRDLISKNLLVSN-DTIKIADFGLAWE 149 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dikp~NIli~~-~~vkl~Dfg~a~~ 149 (346)
||+++|.. |++.+.+... +..++|.++..|+.++++||++||+.. ++||||||.||++++ +.++|.|||+++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999986 8898887543 346999999999999999999999998 999999999999965 8999999999875
Q ss_pred cCCCCCC----------ccccccCcccCccccccc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 039371 150 VDSCPPY----------TEYITTLQYRAPEMLLMS--GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG 217 (346)
Q Consensus 150 ~~~~~~~----------~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 217 (346)
..-.-.. .....|..|+|||.+.-. ...+.++|||||||++|.|+.|..||+..- ...+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~Gg 249 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGG 249 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCC
Confidence 4321111 123468899999987532 346789999999999999999999994321 1000
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 218 SPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.-... .....+.+|+ .+.+|..+.++|.+||+.||.+||++.+++.+
T Consensus 250 SlaLA--------v~n~q~s~P~---------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALA--------VQNAQISIPN---------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEe--------eeccccccCC---------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00000 0000111111 13588999999999999999999999999874
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=304.33 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=203.5
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
||++.+.||+|++|.||+|.+..+++.|++|+++..... .......+|+.+++++ +||||+++++.+.+.+.+++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEe
Confidence 799999999999999999999999999999999766544 2344556899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC----
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP---- 155 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~---- 155 (346)
|++| ++.+.+. .+..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 80 YCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred cCCCCcHHHHHh-hcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9986 5555554 445589999999999999999999999999999999999995 56899999999877654322
Q ss_pred -CccccccCcccCcccccccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 156 -YTEYITTLQYRAPEMLLMSG--QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 156 -~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.....++..|+|||.+.... ..+.++||||+|+++|++++|..||..................+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 225 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP------------- 225 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC-------------
Confidence 12346788999999886432 37889999999999999999999997654332222111110000
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.++. ...++..+.++|++||+.||.+|||+.++++|||+
T Consensus 226 ----~~~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 ----PIPD---------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----CCCc---------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 12457889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=300.62 Aligned_cols=286 Identities=34% Similarity=0.568 Sum_probs=232.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc-CHHHhhhHHHHHHHHhhcCCCCeeeeeeeee--------c
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINNHPNIVKLQELAS--------E 72 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~--------~ 72 (346)
+.|+-..++|+|.||+||+|+++.+|+.||+|.+-.+.. ..-....++|+.++..+ +|+|++.+++.+. +
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcccc
Confidence 457788899999999999999999999999987643221 11223457899999999 7999999988763 2
Q ss_pred CCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccC
Q 039371 73 NYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVD 151 (346)
Q Consensus 73 ~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~ 151 (346)
...+|+|+.+|..+|...+......++...+.+++.+++.||.|+|+..|+|||+||+|+||+. |.+||.|||+++...
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 3468999999999999999888788999999999999999999999999999999999999976 799999999997654
Q ss_pred CCC-----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHH
Q 039371 152 SCP-----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 152 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (346)
... .+...+.|..|++||.+.+...|+++.|||..||++.+|+++.+.|.+.+...++..|....|+.+.+.|..
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 322 344556799999999999999999999999999999999999999999999999999999999999998875
Q ss_pred HHHHHHhcCCCCCCcCCCC---cccccC--CCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNN---LSLLIP--SANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
....--......+...... ..+... .-++++.+|+.++|..||.+|++++++++|.||....
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 4433222222222111111 111111 2346889999999999999999999999999998654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=306.08 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=201.9
Q ss_pred ecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-C
Q 039371 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-N 86 (346)
Q Consensus 10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~ 86 (346)
||.|++|.||+|++..+++.|++|++...... .......+|+.+++++ +||||+++++.+.++...++++||++| +
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 69999999999999999999999999755432 2334566889999888 799999999999999999999999985 6
Q ss_pred HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccccccCcc
Q 039371 87 LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQY 165 (346)
Q Consensus 87 l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y 165 (346)
|.+.+... ..+++..+..++.|++.||+|||++|++|+||+|+||+++ ++.++|+|||++.............+++.|
T Consensus 80 L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 80 LWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence 66666544 4589999999999999999999999999999999999995 569999999999776654333445678899
Q ss_pred cCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCC
Q 039371 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTC--EDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQG 243 (346)
Q Consensus 166 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
+|||.+. ...++.++|+||+|+++|+|++|..||.... ..+....+......+ .
T Consensus 159 ~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------~------ 214 (262)
T cd05572 159 VAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL-----------------E------ 214 (262)
T ss_pred cChhHhc-CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC-----------------C------
Confidence 9999876 5568899999999999999999999998766 333333332111000 0
Q ss_pred CCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 244 NNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 244 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
.....++++.++|.+||+.||++||+ ++|+++||||++.
T Consensus 215 -----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 215 -----FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred -----CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 11234788999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=313.68 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=206.0
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
.|.....||.|+||.||++.+..++..||+|.+..... .......+|+..++.+ +||||+++++.+..++..+++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeC
Confidence 45667889999999999999999999999999865432 2334456899999888 799999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcccc
Q 039371 83 MDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEYI 160 (346)
Q Consensus 83 ~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~~ 160 (346)
++|+.+..+... +.+++..+..++.|++.||.|||++|++||||||+||+++ ++.++|+|||++....... ......
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 179 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence 987544444333 3489999999999999999999999999999999999996 5699999999986543322 223456
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (346)
++..|+|||.+. ...++.++|+||+|+++|+|++|..||...+.......+.........
T Consensus 180 ~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------------- 239 (292)
T cd06658 180 GTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK------------------- 239 (292)
T ss_pred cCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc-------------------
Confidence 888999999886 556889999999999999999999999876655444333221110000
Q ss_pred cCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
.....+..+.+++++|++.||.+|||++++++||||+.....
T Consensus 240 --------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 240 --------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred --------cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 012467889999999999999999999999999999975543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=304.50 Aligned_cols=253 Identities=24% Similarity=0.413 Sum_probs=200.2
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC----HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--C
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS----WEECLNLKEVKCLRKINNHPNIVKLQELASEN--Y 74 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~ 74 (346)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... .......+|+.+++++ +||||+++++++.+. .
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 79 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMER 79 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCc
Confidence 46899999999999999999999999999999988543211 1223445789999999 799999999998763 5
Q ss_pred EEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
.++++|||++| +|.+.+... ..+++..+..++.|++.||+|||++|++|+||+|+||+++ ++.++|+|||.+.....
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 78899999985 666665543 4589999999999999999999999999999999999995 46999999999875432
Q ss_pred C----CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 153 C----PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 153 ~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
. .......++..|+|||.+. ...++.++|||||||++|+|++|..||...........+... +..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~------- 227 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ---PTN------- 227 (265)
T ss_pred ccccccccccCCCCccccChhhhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC---CCC-------
Confidence 1 1123345788999999887 456899999999999999999999999766544333322111 100
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
....+..+..+.++|++|+. +|++||+++++++|||+.
T Consensus 228 ------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 ------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 00113457788999999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=306.33 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=202.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH---------HhhhHHHHHHHHhhcCCCCeeeeeeeeecC
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---------ECLNLKEVKCLRKINNHPNIVKLQELASEN 73 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~ 73 (346)
+|.+.+.||.|++|.||+|.+..+|+.+|+|.++....... ......|+..++++ +|||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence 68999999999999999999999999999998854322111 12335688889888 799999999999999
Q ss_pred CEEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC
Q 039371 74 YRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD 151 (346)
Q Consensus 74 ~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~ 151 (346)
+..++||||+.| ++.+.+... +.+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999985 566665544 5699999999999999999999999999999999999995 6699999999987544
Q ss_pred CCC---CCccccccCcccCcccccccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHH
Q 039371 152 SCP---PYTEYITTLQYRAPEMLLMSG-QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 152 ~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
... ......++..|+|||.+.... .++.++|+||+|+++|++++|..||...........+......+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 231 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP-------- 231 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC--------
Confidence 321 123346788999999886443 47899999999999999999999997654443332221110000
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.......+.++.++.+++.+||+.||++|||++++++||||
T Consensus 232 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 ----------------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----------------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00111224568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=328.79 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=202.7
Q ss_pred eecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-CH
Q 039371 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-NL 87 (346)
Q Consensus 9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l 87 (346)
.||+|.||+||-|++..|....|||.+......... -...|+...+++ +|.|||+++|.+.+++++-|.||-++| +|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~Q-PLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQ-PLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhc-cHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 699999999999999999999999999765433222 223567777777 799999999999999999999999986 55
Q ss_pred HHHHhcccCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe--CCcEEEeecccccccCC-CCCCcccccc
Q 039371 88 HQLMSNRKQCF--SEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS--NDTIKIADFGLAWEVDS-CPPYTEYITT 162 (346)
Q Consensus 88 ~~~~~~~~~~l--~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~--~~~vkl~Dfg~a~~~~~-~~~~~~~~~t 162 (346)
...+...=+++ .|+.+..+.+||++||.|||++.|||||||-+|||++ .|.+||+|||-+..... .+-..++.||
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 56666555667 8899999999999999999999999999999999995 68999999999876544 4456778999
Q ss_pred CcccCccccccc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCC
Q 039371 163 LQYRAPEMLLMS-GQYNSKVDMWALGLIMAELITFHPLFPGTCEDD-QLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240 (346)
Q Consensus 163 ~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (346)
..|||||++..+ ..|+.++|||||||++.||.||++||....... .+.++--....|
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP--------------------- 798 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHP--------------------- 798 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCC---------------------
Confidence 999999999733 348999999999999999999999996544332 222211011111
Q ss_pred cCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
......|.+++.||.+|+.+||.+||++.++|+.||++..
T Consensus 799 -------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 799 -------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred -------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 1123567889999999999999999999999999999876
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=304.11 Aligned_cols=251 Identities=31% Similarity=0.477 Sum_probs=205.9
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeee--cCCEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELAS--ENYRLYFV 79 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~--~~~~~~iv 79 (346)
+|++.+.||+|++|.||+|.+..++..||+|++....... .......|+..++++ +||||+++++.+. .+...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 6999999999999999999999999999999987654433 334456788999999 7999999999775 44678999
Q ss_pred EEcCCC-CHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCCEEEe-CCcEEEeecccccc
Q 039371 80 FEYMDC-NLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMH-----RQGYFHRDLISKNLLVS-NDTIKIADFGLAWE 149 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH-----~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~ 149 (346)
|||+++ +|.+.+... ...+++..+..++.|++.||.+|| +.+++|+||+|+||+++ ++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999985 676666543 456899999999999999999999 88999999999999996 46999999999987
Q ss_pred cCCCCC-CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 150 VDSCPP-YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 150 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
...... .....+++.|+|||.+. ...++.++|+||||+++|+|++|..||...+.......+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 226 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK------------ 226 (265)
T ss_pred ccCCcccccccccCCCccChhhhc-CCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC------------
Confidence 655433 34457899999999886 4568899999999999999999999998876444333332111
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
. .......+..+.+++.+||+.+|++|||+.++++|||+
T Consensus 227 ---------~--------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 ---------F--------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------C--------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0 11123567899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.16 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=209.9
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.|...++||+|++|+||+|++..+++.|++|++...... .......+|+.+++.+ +|||++++++++.+....|++|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEE
Confidence 466778999999999999999999999999998654332 2223456789999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEY 159 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~ 159 (346)
||+.|++.+.+.....++++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++.... ..+..
T Consensus 101 e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~ 177 (313)
T cd06633 101 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSF 177 (313)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCc
Confidence 9999999888877667799999999999999999999999999999999999995 5689999999885432 23345
Q ss_pred cccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 160 ITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 160 ~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
.++..|+|||.+.. ...++.++||||+||++|+|++|..||...+.......+.....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 237 (313)
T cd06633 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-------------------- 237 (313)
T ss_pred cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--------------------
Confidence 68889999998742 35688899999999999999999999987766555444422110
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+. ...+.++..+++++.+||+.+|.+||++.++++||||+...
T Consensus 238 -~~-------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 238 -PT-------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred -CC-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 00 01134567899999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=311.10 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=197.1
Q ss_pred CceeeeeeecccCceEEEEEEEcc----------------CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ----------------SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVK 65 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~ 65 (346)
++|++.++||+|+||.||+|.+.. ++..||+|++.............+|+.++.++ +||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCeeE
Confidence 489999999999999999997543 34479999997655444455567899999999 7999999
Q ss_pred eeeeeecCCEEEEEEEcCCC-CHHHHHhccc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Q 039371 66 LQELASENYRLYFVFEYMDC-NLHQLMSNRK------------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRD 126 (346)
Q Consensus 66 ~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~------------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~d 126 (346)
+++++.+.+..+++|||+.+ +|.+.+.... ..+++..+..++.|++.||.|||+.||+|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 99999999999999999974 7776664321 2367788999999999999999999999999
Q ss_pred CCCCCEEEe-CCcEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh--CCCCC
Q 039371 127 LISKNLLVS-NDTIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT--FHPLF 200 (346)
Q Consensus 127 ikp~NIli~-~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf 200 (346)
|||+||+++ ++.+||+|||++........ .....++..|+|||++. ...++.++|||||||++|+|++ +..||
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-cCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 999999996 45899999999976543221 12234577899999886 5668999999999999999986 56788
Q ss_pred CCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 201 PGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 201 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
......+....+......... .. .....+.++..+.+++.+|++.||++|||++++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~--------------~~--------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGR--------------QV--------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccc--------------cc--------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 776655544433221100000 00 00112356788999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=312.82 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=205.6
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
|+....||+|+||.||+|.+..+++.||+|++...... ......+|+..+..+ +||||+++++.+..++..++++||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecC
Confidence 45567899999999999999999999999998654333 234456888888888 7999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCccccc
Q 039371 84 DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEYIT 161 (346)
Q Consensus 84 ~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~~~ 161 (346)
+|+.+..+... ..+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++....... ......+
T Consensus 101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence 86444333333 3489999999999999999999999999999999999995 5699999999986544322 2234568
Q ss_pred cCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCc
Q 039371 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241 (346)
Q Consensus 162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
+..|+|||.+. ...++.++|+||+||++|+|++|..||......+....+.... .+
T Consensus 180 ~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------- 235 (297)
T cd06659 180 TPYWMAPEVIS-RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PP---------------------- 235 (297)
T ss_pred CccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CC----------------------
Confidence 89999999886 5568999999999999999999999998766554443332110 00
Q ss_pred CCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
........+..+.++|++||+.||++||+++++++||||..+...
T Consensus 236 ----~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 236 ----KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred ----CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 000113567889999999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=309.57 Aligned_cols=250 Identities=23% Similarity=0.416 Sum_probs=203.4
Q ss_pred CCceeeeeeecccCceEEEEEEEccCC-----cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSG-----EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYR 75 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~ 75 (346)
+++|++.+.||+|+||.||+|.+...+ ..|++|.+.............+|+..+.++ +||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCCc
Confidence 468999999999999999999876655 679999987655444445567899999998 79999999999999999
Q ss_pred EEEEEEcCC-CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-Cc
Q 039371 76 LYFVFEYMD-CNLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DT 138 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~ 138 (346)
.+++|||++ |+|.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+||++++ +.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 999999998 57777665431 34788999999999999999999999999999999999954 58
Q ss_pred EEEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 039371 139 IKIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 139 vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 214 (346)
++|+|||++....... ......+++.|+|||.+. ...++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhc-cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999987653322 122345678899999886 5668999999999999999998 9999988776655544432
Q ss_pred HhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.... .....++.++.+++.+||+.||.+|||+.+++++
T Consensus 242 ~~~~-----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 242 RQLL-----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCcC-----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2110 1123578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=310.62 Aligned_cols=258 Identities=28% Similarity=0.489 Sum_probs=207.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||++.+..+++.|++|.+...... ......+|+.+++.+ +|||++++++.+..++..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMREN-KHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEEEEe
Confidence 5899999999999999999999989999999998654332 334557888889888 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|++| ++.+.+... .+++.++..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++....... ....
T Consensus 97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 97 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred cCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 9985 666665432 388999999999999999999999999999999999995 4589999999886554332 2233
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+++.|+|||.+. ...++.++|+||+||++|++++|..||...+..+....+... +.+.
T Consensus 175 ~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~------------------ 234 (293)
T cd06647 175 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE------------------ 234 (293)
T ss_pred ccCChhhcCchhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCCC------------------
Confidence 46788899999886 456889999999999999999999999876554332222110 0000
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~ 291 (346)
......++..+++++++||+.+|++||+++++++||||+.+....
T Consensus 235 --------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~ 279 (293)
T cd06647 235 --------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLS 279 (293)
T ss_pred --------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccc
Confidence 001124567899999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.13 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=199.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc--EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE--YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||.||+|..+.++. .+++|.++............+|+.++.++.+||||+++++++.+.+.++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 789999999999999999999887765 468888874443334445678999999997799999999999999999999
Q ss_pred EEcCC-CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEe
Q 039371 80 FEYMD-CNLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIA 142 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~ 142 (346)
+||++ |+|.+.+.... ..+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99997 57777775432 2488999999999999999999999999999999999995 5589999
Q ss_pred ecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 143 DFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 143 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
|||++..............+..|+|||.+. ...++.++|||||||++|+|++ |..||......+....+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~--- 237 (297)
T cd05089 162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLN-YSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM--- 237 (297)
T ss_pred CcCCCccccceeccCCCCcCccccCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---
Confidence 999986433221112223345799999886 5668999999999999999997 99999887766554443221100
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.....++..+.+++.+||+.||.+|||++++++.
T Consensus 238 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 238 --------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=305.48 Aligned_cols=251 Identities=29% Similarity=0.387 Sum_probs=193.8
Q ss_pred eecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHh--hcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRK--INNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~--l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
.||+|+||.||+|.+..+++.||+|.+....... .......|...+.. ..+||+|+.+++.+.+++..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987654321 12222333333222 2379999999999999999999999998
Q ss_pred C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcccccc
Q 039371 85 C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITT 162 (346)
Q Consensus 85 g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t 162 (346)
| +|...+. ..+.+++..+..++.|++.||.|||+.+++|+||||+||+++ ++.++|+|||++....... .....++
T Consensus 81 g~~L~~~l~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLS-QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT 158 (278)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCC
Confidence 6 4544444 455699999999999999999999999999999999999995 5699999999987654322 2345789
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
..|+|||.+.+...++.++||||+||++|+|++|..||............ ..... .
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~------------------~----- 214 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLT------------------M----- 214 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhhc------------------c-----
Confidence 99999999875556899999999999999999999999776332111100 00000 0
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGCL 288 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~~ 288 (346)
........+.++.+++++||..||.+|| ++.++++||||+...
T Consensus 215 ---~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 215 ---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred ---CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 0011134688999999999999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=307.49 Aligned_cols=251 Identities=29% Similarity=0.354 Sum_probs=200.6
Q ss_pred ecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-C
Q 039371 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-N 86 (346)
Q Consensus 10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~ 86 (346)
||+|+||+||+|.+..+|+.||+|++...... .......+|+.+++++ +||||+++++.++..+..|+||||++| +
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 69999999999999999999999998654322 2233346789999999 699999999999999999999999985 6
Q ss_pred HHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccccccCc
Q 039371 87 LHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQ 164 (346)
Q Consensus 87 l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~ 164 (346)
|.+.+.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||.+.............++..
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 766665543 3599999999999999999999999999999999999995 46999999999876554334444567889
Q ss_pred ccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCC
Q 039371 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGN 244 (346)
Q Consensus 165 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
|+|||.+. ...++.++||||+||++|+|++|..||...........+......
T Consensus 160 y~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------- 212 (277)
T cd05577 160 YMAPEVLQ-GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-------------------------- 212 (277)
T ss_pred cCCHHHhc-CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--------------------------
Confidence 99999887 445889999999999999999999999765542211111111000
Q ss_pred CcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 039371 245 NLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGCL 288 (346)
Q Consensus 245 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~~ 288 (346)
......+..++.+.++|++||+.||.+|| ++.++++||||+...
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 00111235688999999999999999999 899999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=310.97 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=198.1
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcE--EEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEY--VAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||.||+|.++.++.. +++|.++............+|+.++.++.+||||+++++++.+++.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 36899999999999999999998877764 5777765443334444566799999999789999999999999999999
Q ss_pred EEEcCC-CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEE
Q 039371 79 VFEYMD-CNLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKI 141 (346)
Q Consensus 79 v~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl 141 (346)
+|||++ |+|.+.+...+ ..+++..+..++.|++.||+|||++|++||||||+||+++ ++.++|
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 999997 57777665432 2478999999999999999999999999999999999995 569999
Q ss_pred eecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 039371 142 ADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPT 220 (346)
Q Consensus 142 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 220 (346)
+|||++..............+..|+|||.+. ...++.++||||+||++|+|++ |..||...+..+....+...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----- 239 (303)
T cd05088 166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG----- 239 (303)
T ss_pred CccccCcccchhhhcccCCCcccccCHHHHh-ccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-----
Confidence 9999986433211122223456799999886 5568899999999999999998 99999876655443332110
Q ss_pred hhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+ .....+.++.+++.+||+.+|++||++++++++
T Consensus 240 ---------------~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 ---------------YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ---------------CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0000 012357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.66 Aligned_cols=245 Identities=29% Similarity=0.498 Sum_probs=205.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+.|++...+|.|+||.|-.+.+..++..+++|++.++..+ ..+|..++....+||||+++.+.+.++.+.|+|||
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccccc-----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5789999999999999999999999999999999876222 33567677777799999999999999999999999
Q ss_pred cCCCCH-HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE--eCCcEEEeecccccccCCCCCCcc
Q 039371 82 YMDCNL-HQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV--SNDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 82 ~~~g~l-~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli--~~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
.+.|.. ++.+..... +. .++..|+.+|+.|+.|||++|++|||+||+|||+ +.++++|+|||.+...... ..+
T Consensus 397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~t 472 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDT 472 (612)
T ss_pred hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcc
Confidence 999754 444444332 33 8888999999999999999999999999999999 3568999999999876654 556
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
.+-|..|.|||+.. ...|++++||||||++||+|++|+.||...... +...++ +.+...
T Consensus 473 p~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s--------------- 532 (612)
T KOG0603|consen 473 PALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS--------------- 532 (612)
T ss_pred cchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccc---------------
Confidence 67899999999987 777999999999999999999999999877665 333322 222111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
..+|+.+++||++||+.||.+|++++++..|||+.+..
T Consensus 533 -------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~ 570 (612)
T KOG0603|consen 533 -------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHP 570 (612)
T ss_pred -------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCC
Confidence 36899999999999999999999999999999994433
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=304.87 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=203.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--NYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~~~iv 79 (346)
++|+..+.||.|++|.||+|.+..+++.+|+|.+.............+|+..++++ +||||+++++++.+ .+.++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 58999999999999999999999999999999997665544555677899999998 79999999998854 3578999
Q ss_pred EEcCCC-CHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 80 FEYMDC-NLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
|||++| +|.+.+. .....+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999985 6655443 2345589999999999999999999999999999999999995 5689999999986554322
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhhHHHHHH
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE-----DDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.....++..|+|||.+. ...++.++||||+||++|+|++|..||..... .+....+... ...
T Consensus 160 -~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~-------- 226 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQ-GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNP-------- 226 (287)
T ss_pred -cccccCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cch--------
Confidence 22345788999999886 56689999999999999999999999976532 1111111100 000
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
..+.. .......++.+.+++.+||+.||.+|||+.|+++||||+...
T Consensus 227 -------~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 227 -------ELKDE-----PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred -------hhccC-----CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 00000 000012456889999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.68 Aligned_cols=254 Identities=30% Similarity=0.419 Sum_probs=210.6
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.|+..+.||+|+||.||+|.+..++..||+|.+...... .......+|+.+++++ +|||++++++++.+++..++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeEEEEE
Confidence 478889999999999999999999999999998654322 2233456899999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEY 159 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~ 159 (346)
||+.|++.+.+.....++++.++..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++..... ....
T Consensus 105 e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~~ 181 (317)
T cd06635 105 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANSF 181 (317)
T ss_pred eCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---cccc
Confidence 9999998888776667799999999999999999999999999999999999995 56899999998865443 2345
Q ss_pred cccCcccCccccc--ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 160 ITTLQYRAPEMLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 160 ~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
.+++.|+|||.+. ..+.++.++|+||+||++|+|++|..||...........+......+.
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------- 244 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL----------------- 244 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC-----------------
Confidence 6888999999874 235688999999999999999999999977665555554433211110
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
....+++.+.+++.+||+.+|.+||++.++++|+|+....
T Consensus 245 -----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 245 -----------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred -----------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0124567899999999999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=304.45 Aligned_cols=249 Identities=22% Similarity=0.407 Sum_probs=201.1
Q ss_pred CceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|++|.||+|.+.. ++..|++|.+.............+|+.+++.+ +||||+++++++.+.+..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCc
Confidence 578999999999999999999887 77889999987655555555677899999999 799999999999888889
Q ss_pred EEEEEcCCC-CHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC----cEEEeecc
Q 039371 77 YFVFEYMDC-NLHQLMSNRK------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND----TIKIADFG 145 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~----~vkl~Dfg 145 (346)
+++|||+.| +|.+.+.... ..+++..+..++.||+.||+|||+++++|+||||+||++++. .+||+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 999999974 7777765442 248999999999999999999999999999999999999632 59999999
Q ss_pred cccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 146 LAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 146 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
++........ ......+..|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+..... +
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~-- 240 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR-L-- 240 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-C--
Confidence 9976533211 11223346799999986 5668999999999999999996 9999987766554433321110 0
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.....++..+.+++++|++.||++|||+.++++|
T Consensus 241 --------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 --------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0113567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=304.34 Aligned_cols=255 Identities=24% Similarity=0.413 Sum_probs=201.8
Q ss_pred CceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||.||+|.++. .+..||+|.++............+|+.+++.+ +||||+++++++.+++..
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCc
Confidence 689999999999999999997652 34589999987554444444566888889888 799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecc
Q 039371 77 YFVFEYMD-CNLHQLMSNRK---------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFG 145 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg 145 (346)
+++|||+. |+|.+.+.... ...+...+..++.|++.||.|||++|++||||||+||+++ ++.++|+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCC
Confidence 99999997 57777775421 2246678899999999999999999999999999999995 5699999999
Q ss_pred cccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 146 LAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 146 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
++........ .....++..|+|||.+. ...++.++||||+||++|+|++ |..||.+....+....+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--- 240 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL--- 240 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhc-cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence 9875443221 11223466799999886 5668999999999999999998 78999877665544443221100
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc------CCCCCCC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ------HPLFQGC 287 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~------hp~~~~~ 287 (346)
......++.+.+++.+||+.||++|||+.++++ ||||.+.
T Consensus 241 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 241 --------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 001245688999999999999999999999987 8998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=298.90 Aligned_cols=251 Identities=33% Similarity=0.530 Sum_probs=209.7
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++.+.||+|++|.||++.+..++..|++|++...... .......+|+.+++.+ +|||++++.+.+..++..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEEE
Confidence 699999999999999999999999999999999765543 3334456788999999 69999999999999999999999
Q ss_pred cCCC-CHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCC-C
Q 039371 82 YMDC-NLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP-P 155 (346)
Q Consensus 82 ~~~g-~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~-~ 155 (346)
+++| ++.+.+... +..+++..+..++.|++.||.+||++|++|+||+|+||++++ +.++|+|||.+....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 9985 777777654 366999999999999999999999999999999999999965 699999999987665433 2
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+++.|+|||... ...++.++|+||+|+++++|++|..||...+..+..........
T Consensus 160 ~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------ 220 (258)
T cd08215 160 AKTVVGTPYYLSPELCQ-NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY------------------ 220 (258)
T ss_pred ecceeeeecccChhHhc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC------------------
Confidence 33456888999999876 55688999999999999999999999987765544444322111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.......+..+.+++++||..+|++|||+.++++||||
T Consensus 221 -----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 -----------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 01112567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=304.26 Aligned_cols=255 Identities=28% Similarity=0.485 Sum_probs=206.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
+|...+.||+|++|.||++.+..+++.+++|+++..... ......+|+.+++.+ +|||++++++++..++..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ-RRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEec
Confidence 456678999999999999999999999999998644322 333456888888888 799999999999999999999999
Q ss_pred CCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCccc
Q 039371 83 MDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEY 159 (346)
Q Consensus 83 ~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~ 159 (346)
+.| +|.+.+.. ..+++..+..++.|++.||++||++|++||||+|+||+++ ++.++|+|||.+....... .....
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 975 66666554 4589999999999999999999999999999999999995 5699999999876544322 22334
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (346)
.+++.|+|||.+. ...++.++|+||+||++|+|++|..||...+.......+..... +
T Consensus 176 ~~~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~-~-------------------- 233 (285)
T cd06648 176 VGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-P-------------------- 233 (285)
T ss_pred cCCccccCHHHhc-CCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC-C--------------------
Confidence 6888999999886 45688999999999999999999999987665544443322110 0
Q ss_pred CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.. .....++..+.+++++||+.||++|||+.++++||||+.+..
T Consensus 234 ~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 234 KL------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred CC------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 00 001236788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=304.78 Aligned_cols=239 Identities=23% Similarity=0.275 Sum_probs=193.6
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeec----CCEEEEEEE
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASE----NYRLYFVFE 81 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~----~~~~~iv~e 81 (346)
..||+|++|.||+|.. +|+.||+|+++....... .....+|+.++.++ +||||+++++++.+ ...++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 6789999999999976 588999999976543322 23445899999999 79999999999866 457899999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|++| +|.+.+.. ...+++.....++.|++.||.|||+. +++||||||+||+++ ++.+||+|||++....... ..
T Consensus 103 y~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~ 179 (283)
T PHA02988 103 YCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FK 179 (283)
T ss_pred eCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--cc
Confidence 9996 56666554 44589999999999999999999985 999999999999995 5699999999987654322 23
Q ss_pred ccccCcccCccccccc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 159 YITTLQYRAPEMLLMS-GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......++
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 242 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------- 242 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence 4678899999988642 5689999999999999999999999998876666555543221111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+++.+++++.+||+.||++|||++|+++
T Consensus 243 -----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 -----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01256789999999999999999999999986
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=309.23 Aligned_cols=254 Identities=29% Similarity=0.433 Sum_probs=208.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|+..+.||.|++|.||+|++..+++.+++|.+..... ........+|+.+++.+ +|||++++.+++..+...++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEE
Confidence 357888999999999999999999999999999864322 22333456799999998 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|||+.|++.+.+......+++..+..++.|++.||.|||+++++|+||+|+||+++ ++.++|+|||++...... ..
T Consensus 94 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~ 170 (308)
T cd06634 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NX 170 (308)
T ss_pred EEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---cc
Confidence 99999998888776666799999999999999999999999999999999999995 568999999998665432 33
Q ss_pred ccccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 159 YITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
..++..|+|||.+.. ...++.++||||+||++|+|++|..||...+..+....+.....
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------------- 231 (308)
T cd06634 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------------- 231 (308)
T ss_pred ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-------------------
Confidence 467889999998742 34578899999999999999999999977655444443322111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+ .......+..+.++|++||+.+|.+||+++++++|||+...
T Consensus 232 --~-------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 232 --P-------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred --C-------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0 00113567889999999999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=299.48 Aligned_cols=242 Identities=24% Similarity=0.415 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-C
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-N 86 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~ 86 (346)
+.||+|+||+||+|++..+++.||+|.+.............+|+.+++++ +||||+++++++...+..++||||+.| +
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 47999999999999999999999999987655444455667899999998 799999999999999999999999975 6
Q ss_pred HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC---cccccc
Q 039371 87 LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY---TEYITT 162 (346)
Q Consensus 87 l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~---~~~~~t 162 (346)
+.+.+......+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.+||+|||.+......... .....+
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 7777665555689999999999999999999999999999999999996 458999999998754432111 111224
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCc
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
..|+|||.+. ...++.++||||+||++|+|++ |..||...........+..... .
T Consensus 160 ~~y~aPE~~~-~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~--------------------~--- 215 (252)
T cd05084 160 VKWTAPEALN-YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR--------------------L--- 215 (252)
T ss_pred eeecCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC--------------------C---
Confidence 5699999886 5568999999999999999997 8899976655443333221100 0
Q ss_pred CCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....++..+.+++.+||+.||++|||+.++++
T Consensus 216 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 ------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=301.07 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=202.9
Q ss_pred CceeeeeeecccCceEEEEEEEccC---CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS---GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++.+.||+|+||+||+|.+..+ ...||+|.++............+|+..+.++ +||||+++++.+.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCceEE
Confidence 5799999999999999999988654 4579999987665555555667899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-C
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-P 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~ 155 (346)
+||++.| +|.+.+....+.+++..+..++.|++.||.|||++||+|+||||+||+++ ++.++|+|||++....... .
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 9999985 77777766566799999999999999999999999999999999999996 4589999999998764211 1
Q ss_pred C--ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 156 Y--TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 156 ~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
. ....++..|+|||.+. ...++.++||||+|+++|+|++ |..||......+....+......+.
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 229 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP------------ 229 (266)
T ss_pred eeccCCCCCccccChhhhc-cCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 1 1223456899999886 5668999999999999999997 9999977665554444422111110
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...++..+.+++.+|++.+|++||++++++++
T Consensus 230 -----------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 230 -----------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=299.92 Aligned_cols=251 Identities=34% Similarity=0.575 Sum_probs=205.5
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++.+.||+|++|.||+|.++.+|..+|+|.+....... ......+|+.+++.+ +||||+++++.+.+++..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEEe
Confidence 6899999999999999999999999999999986643322 233446899999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC--cEEEeecccccccCCCCC-C
Q 039371 82 YMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND--TIKIADFGLAWEVDSCPP-Y 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~--~vkl~Dfg~a~~~~~~~~-~ 156 (346)
|+.| ++.+.+.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++++ .++|+|||.+........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 9975 7777665543 347999999999999999999999999999999999999654 579999999876554322 2
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+++.|+|||+.. ...++.++|+||+|+++|+|++|..||...+..+....+....
T Consensus 160 ~~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------- 218 (257)
T cd08225 160 YTCVGTPYYLSPEICQ-NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------------- 218 (257)
T ss_pred cccCCCccccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc--------------------
Confidence 2345788999999876 4568899999999999999999999998766544433332110
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.....+..+.++.+++++|++.+|++|||+.++++||||
T Consensus 219 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ---------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 011124567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=310.50 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=198.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcE----EEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEY----VAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
.+|++.+.||+|+||+||+|.+..+++. ||+|+++............+|+.+++.+ +||||+++++++..+ ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-Cce
Confidence 5799999999999999999998766654 8999987654444455567888888888 899999999998765 467
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
+++|++. |++.+.+......+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 8999987 678888877666689999999999999999999999999999999999995 46899999999986654322
Q ss_pred C---ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 Y---TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
. ....++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....+.. .+.....
T Consensus 165 ~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~-------------- 228 (316)
T cd05108 165 EYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGE-------------- 228 (316)
T ss_pred ceeccCCccceeecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCC--------------
Confidence 1 1223456899999886 5668999999999999999997 99999876554432 2222111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..+. .+.++.++.+++.+|+..||.+|||+.+++.+
T Consensus 229 -----~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 229 -----RLPQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----CCCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1111 13456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=305.14 Aligned_cols=251 Identities=33% Similarity=0.496 Sum_probs=207.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|++|.||+|.+..++..|++|++..... ........+|..++.++.+||||+++++.+.+++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 589999999999999999999999999999999976432 223344567888898984599999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
||++. ++|.+.+... +.+++..+..++.|++.||.+||+.|++|+||+|+||+++ ++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 99995 5777776654 3599999999999999999999999999999999999995 56999999999876543221
Q ss_pred -------------------CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 039371 156 -------------------YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216 (346)
Q Consensus 156 -------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 216 (346)
.....++..|+|||... ...++.++|+||||++++++++|..||...........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 12345678999999876 4568899999999999999999999998876544444433211
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH----HHHhcCCCC
Q 039371 217 GSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA----AEALQHPLF 284 (346)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~----~ell~hp~~ 284 (346)
. . ....+++.+.+++++||+.||.+|||+ +++++||||
T Consensus 239 ~-------------------~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 Y-------------------S-----------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred C-------------------C-----------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 1 1 113457889999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=285.64 Aligned_cols=278 Identities=24% Similarity=0.477 Sum_probs=223.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN--YRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~~iv 79 (346)
++|++++++|+|.+|+||.|.+..+++.+++|+++.- +.....+|+++++.+++||||++++++..+. ..+.+|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 7899999999999999999999999999999999743 3344568999999999999999999998765 567899
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeecccccccCCCCCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
+|+++..-...+-. .++..+++.++.+++.||.|||+.||.|||+||.|++++. ..++|+|+|+|....+....+
T Consensus 114 FE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred hhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 99998644433332 2889999999999999999999999999999999999975 489999999999888888888
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPL-FPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
-.+.+..|--||.+..-..|+.+-|+|||||++..|++.+-| |.+.+..+++.+|.+.+|......+-...+. ..+-
T Consensus 191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i--~Ldp 268 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI--DLDP 268 (338)
T ss_pred eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc--CCCh
Confidence 888999999999998778899999999999999999998766 5788889999999998876432222111100 0000
Q ss_pred CCCC----cCCCCcccc-----cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 237 KFPK----LQGNNLSLL-----IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 237 ~~~~----~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.+.. .....+... ..-+++++.+|+.++|..|-++|+|+.|++.||||....
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 0111 000111111 123578999999999999999999999999999998653
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=295.14 Aligned_cols=251 Identities=30% Similarity=0.536 Sum_probs=207.2
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
+|++.+.||+|++|.||++.+..+++.+++|++..... .......+|+..++++ +|||++++++.+..++..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEec
Confidence 58999999999999999999998999999999976544 2344566899999998 699999999999999999999999
Q ss_pred CCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcccc
Q 039371 83 MDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYI 160 (346)
Q Consensus 83 ~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~ 160 (346)
++| ++.+.+......+++..+..++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||.+.............
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 994 66666666546699999999999999999999999999999999999996 5689999999997766543344567
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (346)
++..|+|||.+. ....+.++|+||+|+++|+|++|..||...+............ .+.
T Consensus 159 ~~~~~~~PE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~~~ 216 (253)
T cd05122 159 GTPYWMAPEVIN-GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG---------------------PPG 216 (253)
T ss_pred cCCcccCHHHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC---------------------CCC
Confidence 889999999887 4558899999999999999999999998765444333322110 000
Q ss_pred cCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 039371 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283 (346)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~ 283 (346)
... ...++..+.++|++||+.||++|||+.++++|||
T Consensus 217 ~~~------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 LRN------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cCc------ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000 0123788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=313.00 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=196.5
Q ss_pred CceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec-CCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE-NYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-~~~ 75 (346)
++|++.+.||+|+||.||+|.+.. +++.||+|+++............+|+.++.++.+||||+++++.+.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 589999999999999999997543 45789999997554444444567899999999789999999998754 467
Q ss_pred EEEEEEcCCC-CHHHHHhccc-----------------------------------------------------------
Q 039371 76 LYFVFEYMDC-NLHQLMSNRK----------------------------------------------------------- 95 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~----------------------------------------------------------- 95 (346)
++++|||++| ++.+.+....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 8999999985 6666654321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---CCccccccCcccCccc
Q 039371 96 -QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP---PYTEYITTLQYRAPEM 170 (346)
Q Consensus 96 -~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~ 170 (346)
..+++..+..++.|++.||+|||++||+||||||+||+++ ++.++|+|||++....... ......++..|+|||+
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 2578999999999999999999999999999999999996 5689999999997653322 1222345678999998
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccc
Q 039371 171 LLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLL 249 (346)
Q Consensus 171 ~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
+. ...++.++||||+||++|+|++ |..||.+....+.+.........+ ..
T Consensus 247 ~~-~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~ 297 (337)
T cd05054 247 IF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM----------------------------RA 297 (337)
T ss_pred hc-CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC----------------------------CC
Confidence 87 5678999999999999999998 999997754443333322211000 00
Q ss_pred cCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 250 IPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 250 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....++++.+++.+||+.+|++||+++|+++|
T Consensus 298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=299.52 Aligned_cols=251 Identities=26% Similarity=0.349 Sum_probs=198.3
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
.....||+|+||.||+|.+..++..|++|.+...... ......+|+.+++++ +||||+++++++..++..++++|++.
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCC
Confidence 3456899999999999999999999999988654332 333456889999988 79999999999999999999999998
Q ss_pred C-CHHHHHhcccCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe--CCcEEEeecccccccCCCC-CCcc
Q 039371 85 C-NLHQLMSNRKQCF--SEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS--NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 85 g-~l~~~~~~~~~~l--~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~--~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
| +|.+.+......+ ++..+..++.|++.||.|||++||+|+||||+||+++ ++.++|+|||.+....... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 168 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence 5 7777776554445 8899999999999999999999999999999999996 4589999999987654322 2333
Q ss_pred ccccCcccCccccccc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 159 YITTLQYRAPEMLLMS-GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..+++.|+|||.+... ..++.++|+||+|+++|+|++|..||................
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 227 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--------------------- 227 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---------------------
Confidence 4678899999988643 347889999999999999999999996543221110000000
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.........+++++++++++||+.+|++|||+.++++||||
T Consensus 228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00011123567889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=301.74 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=198.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc----EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++++.||+|+||+||+|++..+++ .||+|++.............+|..++..+ +||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcCC-CcE
Confidence 589999999999999999999877776 48999987665555555667888888888 799999999998764 467
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
+++|+++ |++.+.+....+.+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||++........
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 8999997 688888776666699999999999999999999999999999999999995 56899999999976543222
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....++..|+|||... ...++.++|||||||++|+|++ |..||...........+... ..++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~----------- 231 (279)
T cd05109 165 EYHADGGKVPIKWMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERLP----------- 231 (279)
T ss_pred eeecCCCccchhhCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCC-----------
Confidence 11223467899999886 5568999999999999999998 89999776554433322211 1110
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+.++.++.+++.+||+.||++||++.++++
T Consensus 232 -----------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 -----------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=297.07 Aligned_cols=245 Identities=28% Similarity=0.419 Sum_probs=198.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||.||+|..+. +..+|+|.+...... .....+|+.+++++ +||||+++++++.+.+..+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS--EEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc--HHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEEEE
Confidence 579999999999999999998754 557999988654433 33456799999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC--c
Q 039371 82 YMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY--T 157 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~--~ 157 (346)
|++ |+|.+.+....+.+++..+..++.|++.||+|||++|++|+||+|+||+++ ++.++|+|||.+......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 997 577777765555689999999999999999999999999999999999995 558999999998765432221 1
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...++..|+|||.+. ...++.++||||+|+++|+|++ |..||...+..+....+......+
T Consensus 160 ~~~~~~~y~aPE~~~-~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~----------------- 221 (256)
T cd05114 160 GAKFPVKWSPPEVFN-FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY----------------- 221 (256)
T ss_pred CCCCchhhCChhhcc-cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-----------------
Confidence 223456799999886 4568899999999999999999 899998877666655553321100
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+..+.+++++|++.||++|||++++++
T Consensus 222 ------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 ------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01234678899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=301.40 Aligned_cols=249 Identities=23% Similarity=0.392 Sum_probs=197.3
Q ss_pred CceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|++|.||+|.++. +++.||+|++.............+|+.+++.+ +||||+++++++.+++..
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCe
Confidence 589999999999999999998652 35679999986544333444567899999888 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecc
Q 039371 77 YFVFEYMDC-NLHQLMSNRK---------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFG 145 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg 145 (346)
++||||+++ +|.+.+.... ..++...+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCC
Confidence 999999985 6766665422 2357788999999999999999999999999999999996 5699999999
Q ss_pred cccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 146 LAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 146 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
++........ .....++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--- 240 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL--- 240 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC---
Confidence 9875543221 11224467899999886 5668999999999999999998 78999877665554443321110
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
......+..+.+++.+||+.||++|||+.|++++
T Consensus 241 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 --------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112467789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=302.33 Aligned_cols=250 Identities=22% Similarity=0.416 Sum_probs=199.7
Q ss_pred CCceeeeeeecccCceEEEEEEE----ccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIK----KQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
+++|++.+.||+|+||+||+|.. ..++..+++|.+.............+|+.+++++ +||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCce
Confidence 46899999999999999999985 3456789999997654444445566899999999 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcc----------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-Cc
Q 039371 77 YFVFEYMDC-NLHQLMSNR----------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DT 138 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~----------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~ 138 (346)
|++|||+++ +|.+.+... ...+++.++..++.|++.||.|||++|++|+||||+||++++ +.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 999999984 777666422 123788999999999999999999999999999999999964 58
Q ss_pred EEEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 039371 139 IKIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 139 vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 214 (346)
+||+|||++....... ......++..|+|||++. ...++.++|+|||||++|+|++ |..||.+....+....+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999997653322 122234566799999886 4568999999999999999998 8999987765544444322
Q ss_pred HhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.... .....+++.+.+++.+|++.||.+||++.+++++
T Consensus 242 ~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 242 RQLL-----------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCcC-----------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 1100 0113467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=304.38 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=200.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCC-----cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG-----EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|++|.||++.+...+ ..+|+|.+.............+|+.+++++.+||||+++++++..++.+
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 57999999999999999999876443 6899999876544444455678999999887799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcE
Q 039371 77 YFVFEYMD-CNLHQLMSNR---------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTI 139 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~---------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~v 139 (346)
+++|||+. |++...+... ...+++..+..++.|++.||+|||++||+|+||||+||+++ ++.+
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeE
Confidence 99999997 5777666432 34589999999999999999999999999999999999995 5689
Q ss_pred EEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 039371 140 KIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNA 215 (346)
Q Consensus 140 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 215 (346)
+|+|||.+........ .....++..|+|||++. ...++.++||||+||++|+|++ |..||.+....+....+...
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 250 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhc-cCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999976544221 12223456799999876 5668999999999999999997 99999877665554443221
Q ss_pred hCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 216 IGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.. . ......+.++.+|+.+|+..||++|||+.+++++
T Consensus 251 ~~--------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 251 YR--------------------M---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred Cc--------------------C---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 10 0 0112467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=314.87 Aligned_cols=250 Identities=23% Similarity=0.404 Sum_probs=197.1
Q ss_pred CceeeeeeecccCceEEEEEEEccC-----CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS-----GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|++... +..||+|++.............+|+.++.++..||||+++++++.+.+.+
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 5788999999999999999987533 34699999976555444556778999999996699999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc------------------------------------------------------------
Q 039371 77 YFVFEYMD-CNLHQLMSNRK------------------------------------------------------------ 95 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~------------------------------------------------------------ 95 (346)
|+||||+. |+|.+.+....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 99999998 57766554321
Q ss_pred -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcE
Q 039371 96 -----------------------------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTI 139 (346)
Q Consensus 96 -----------------------------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~v 139 (346)
..+++..+..++.|++.||.|||+.+++|+||||+||++++ +.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEE
Confidence 23778889999999999999999999999999999999965 589
Q ss_pred EEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 039371 140 KIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNA 215 (346)
Q Consensus 140 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 215 (346)
||+|||++........ .....++..|+|||.+. ...++.++|||||||++|+|++ |..||...............
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~ 355 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc
Confidence 9999999876533221 22234567899999886 5668999999999999999997 89999776544333322221
Q ss_pred hCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 216 IGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.. ..+ ....++.++.+++.+||+.||++|||+.++.+
T Consensus 356 ~~-------------------~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 356 GY-------------------RMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CC-------------------CCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 10 110 11356788999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=297.82 Aligned_cols=246 Identities=26% Similarity=0.441 Sum_probs=200.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
.+|++.+.||+|++|.||+|.++.+++.||+|++.... .......+|+..++++ +||||+++++++..++.++++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEEEE
Confidence 46899999999999999999999999999999987543 2334466899999998 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC--
Q 039371 82 YMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY-- 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~-- 156 (346)
|++ |+|.+.+... ...+++..+..++.|+++||+|||++|++|+||||+||+++ ++.+||+|||.+.........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 997 5777776543 34589999999999999999999999999999999999995 568999999998765543211
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+..|+|||.+. ...++.++|||||||++|+|++ |..||++.+..+....+.....
T Consensus 163 ~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------ 223 (263)
T cd05052 163 AGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR------------------ 223 (263)
T ss_pred CCCCCccccCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------------
Confidence 1123356799999886 5668899999999999999998 9999988766554444322110
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
. .....++.++.+++.+||+.||++|||+.++++
T Consensus 224 --~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 224 --M---------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --C---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 011356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=303.05 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=201.4
Q ss_pred CceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|.+.+.||+|+||.||+|.+.. +++.||+|.++............+|+.+++.+ +||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCCCe
Confidence 578999999999999999998753 36789999997665544455667899999999 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhccc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEE
Q 039371 77 YFVFEYMDC-NLHQLMSNRK-------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKI 141 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~-------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl 141 (346)
+++|||+.| +|.+.+...+ ..+++.++..++.|++.||.+||++|++|+||||+||+++ ++.++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 999999985 6766665432 3478999999999999999999999999999999999995 569999
Q ss_pred eecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 039371 142 ADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIG 217 (346)
Q Consensus 142 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 217 (346)
+|||++....... ......+++.|+|||++. ...++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhc-cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999987543322 122334567899999887 5668999999999999999998 9999987766655444432111
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 218 SPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
. .....++..+.+++++||+.||.+|||+.|+++
T Consensus 243 ~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 243 L-----------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred C-----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1 011356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=299.32 Aligned_cols=251 Identities=30% Similarity=0.489 Sum_probs=201.8
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc----CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY----SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
||.+.+.||+|++|.||++.+..++..+++|+++.... .........|..+++.+ +||||+++++.+.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEE
Confidence 69999999999999999999988877777777653221 12233445688888888 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccccCCCC
Q 039371 79 VFEYMDC-NLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~ 154 (346)
++||+.+ ++.+.+.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++++.++|+|||.+.......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCc
Confidence 9999986 66555532 3446899999999999999999999999999999999999998999999999986653322
Q ss_pred -CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 155 -PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 155 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......+++.|+|||.+. ...++.++|+||+|+++|+|++|..||...........+.....
T Consensus 160 ~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~---------------- 222 (260)
T cd08222 160 DLATTFTGTPYYMSPEALK-HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT---------------- 222 (260)
T ss_pred ccccCCCCCcCccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCC----------------
Confidence 233456788999999875 45578899999999999999999999976655444433322110
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
......++.++.++|++||+.||++||++.++++||||
T Consensus 223 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 -------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 01123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=303.91 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=199.1
Q ss_pred CCceeeeeeecccCceEEEEEEEccC-----CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQS-----GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYR 75 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~ 75 (346)
+++|++.++||+|+||+||+|.+..+ +..||+|+++............+|..++..+ +||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCc
Confidence 35789999999999999999987543 5789999997654433334456788888888 79999999999999999
Q ss_pred EEEEEEcCCC-CHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCc
Q 039371 76 LYFVFEYMDC-NLHQLMSNR---------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDT 138 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~---------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~ 138 (346)
.++++||+.+ ++.+.+... ...+++..+..++.|++.||.|||++|++||||||+||+++ ++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 9999999985 666665321 23478889999999999999999999999999999999995 458
Q ss_pred EEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 039371 139 IKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 139 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 214 (346)
+||+|||++........ .....+++.|+|||.+. ...++.++||||+||++|+|++ |..||.+....+....+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999876543221 22334567899999886 4568999999999999999998 8889988776665555433
Q ss_pred HhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....+ ....++..+.+++.+|++.+|.+||+++++++.
T Consensus 242 ~~~~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 242 RQVLP-----------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCcCC-----------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 21111 113567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=296.09 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=198.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|++|+||+|.+.. +..+|+|.+...... .....+|+..++++ +||||+++++++.+....+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS--EDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc--HHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEEEE
Confidence 579999999999999999997654 456999998754433 23456899999999 79999999999999889999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC--c
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY--T 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~--~ 157 (346)
|+.+ ++.+.+......+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.+||+|||.+......... .
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 9975 67777766555689999999999999999999999999999999999995 468999999998765432211 1
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...++..|+|||.+. ...++.++|||||||++|+|++ |..||......+....+......+.
T Consensus 160 ~~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 222 (256)
T cd05113 160 GSKFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---------------- 222 (256)
T ss_pred CCccChhhCCHHHHh-cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC----------------
Confidence 223456799999886 4568999999999999999998 9999987776555454433211100
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....+..+++++.+||+.||.+|||+.+++++
T Consensus 223 -------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 223 -------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 12356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=297.63 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=199.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc-C-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-S-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||.||+|++..+++.||+|.+..... + .......+|+.+++.+ +||||+++++++.+.+..++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEE
Confidence 5799999999999999999999999999999998864322 2 2233456899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 79 VFEYMDC-NLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 79 v~e~~~g-~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
++||+++ ++.+.+. .....+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999985 6655553 2334589999999999999999999999999999999999995 568999999998765442
Q ss_pred CC-CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 154 PP-YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 154 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.. .....+++.|+|||.+. ...++.++|+||+|+++|+|++|+.||...... ............++.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 228 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL---------- 228 (267)
T ss_pred hHHHhcCCCCccccChhhhc-cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC----------
Confidence 21 22346788999999886 455889999999999999999999999654322 111121111111110
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.....+..+.+++++||+.+|++|||+.++++.
T Consensus 229 -----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 -----------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -----------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 112456789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=301.99 Aligned_cols=255 Identities=31% Similarity=0.506 Sum_probs=209.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+.|++.+.||+|++|.||+|.+..++..|++|++..... ......+|+..++++ +|||++++++.+..++..++++|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEEEe
Confidence 468899999999999999999998999999999976543 344456789999888 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|++ ++|.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+....... ....
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence 999 577777766544699999999999999999999999999999999999996 5699999999886544322 2233
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||.+. ...++.++|+||+|+++|+|++|..||...+.......+......+..
T Consensus 176 ~~~~~~y~~PE~~~-~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------- 237 (286)
T cd06614 176 VVGTPYWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK----------------- 237 (286)
T ss_pred ccCCcccCCHhHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-----------------
Confidence 45778999999886 556899999999999999999999999877665444433221100000
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
..+.++..+.++|++||+.+|.+|||+.++++||||+..
T Consensus 238 ----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 238 ----------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ----------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 012367889999999999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=302.33 Aligned_cols=250 Identities=25% Similarity=0.426 Sum_probs=200.1
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||.||+|.+. .++..||+|+++............+|+.+++++.+||||+++++.+...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 57999999999999999999753 3456899999876554444455678999999997799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCC
Q 039371 77 YFVFEYMD-CNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSC 153 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~ 153 (346)
+++|||+. |+|.+.+.... ..+++.++..++.|++.||.|||+++++|+||||+||++++ +.++|+|||++......
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 99999998 57777775433 34899999999999999999999999999999999999964 58999999998755432
Q ss_pred CC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 PP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.. .....++..|+|||.+. ...++.++||||+||++|+|++ |..||......+...........
T Consensus 195 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------- 262 (302)
T cd05055 195 SNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR----------- 262 (302)
T ss_pred CceeecCCCCcccccCCHhhhc-cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc-----------
Confidence 21 12234567899999886 5568999999999999999998 99999877655444333221100
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.+ .....+..+.+++.+||..+|++|||+.|+++
T Consensus 263 --------~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 --------MA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------CC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 01245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=292.66 Aligned_cols=250 Identities=30% Similarity=0.521 Sum_probs=206.3
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++.+.||+|++|.||+|.+..+++.|++|.+...... .......+|+.++.++ +|||++++++++.+++..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEe
Confidence 699999999999999999999999999999999766543 2334456899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCC-Ccc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP-YTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~-~~~ 158 (346)
+++| +|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+........ ...
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence 9986 565555544 56999999999999999999999999999999999999964 6999999999977654332 234
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..++..|+|||.... ...+.++|+||+|+++|+|++|..||...+........... ..
T Consensus 159 ~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~~ 216 (254)
T cd06627 159 VVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---------------------DH 216 (254)
T ss_pred cccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---------------------CC
Confidence 567889999998864 44889999999999999999999999776543333332110 00
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
....+.++..+.+++.+||..+|++|||+.++++||||
T Consensus 217 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 217 --------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 01123567899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=310.71 Aligned_cols=282 Identities=22% Similarity=0.320 Sum_probs=199.8
Q ss_pred eeeeccc--CceEEEEEEEccCCcEEEEEEccccccCHHH-hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcC
Q 039371 7 MKQIGEG--SFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-CLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 7 ~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
...||+| +||+||+|.+..+|+.||+|++......... ....+|+.+++.+ +||||+++++++..++..++++|++
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecc
Confidence 4567777 8999999999999999999999765544333 3345667766666 7999999999999999999999999
Q ss_pred CC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-----
Q 039371 84 DC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP----- 155 (346)
Q Consensus 84 ~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~----- 155 (346)
.+ ++.+.+... ...+++..+..++.|++.||+|||++|++||||||+||+++ ++.++++||+.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 85 666665543 23489999999999999999999999999999999999996 56899999986533221110
Q ss_pred ---CccccccCcccCccccccc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh-h-HHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMS-GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE-S-WAEGLE 229 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~-~~~~~~ 229 (346)
.....++..|+|||++.+. ..++.++||||+||++|+|++|..||...................+.. . +.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 0112345679999998643 347899999999999999999999998876655544443322111100 0 000000
Q ss_pred HHHhcCCCC--------------CCcCCCCcc-cccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 230 LAKAHGYKF--------------PKLQGNNLS-LLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 230 ~~~~~~~~~--------------~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......... ......... .....+++.+.+|+++||+.||++|||++|+++||||+...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000000000 000000000 011245678999999999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=299.16 Aligned_cols=247 Identities=32% Similarity=0.482 Sum_probs=200.9
Q ss_pred ecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-C
Q 039371 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-N 86 (346)
Q Consensus 10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~ 86 (346)
||+|++|.||+|.+..+|+.+++|++...... .......+|+..+.++ +||||+++++.+..+...|+++|++.| +
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 68999999999999999999999998755432 2334456788889898 699999999999999999999999986 6
Q ss_pred HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---------CC
Q 039371 87 LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP---------PY 156 (346)
Q Consensus 87 l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~---------~~ 156 (346)
+.+.+...+ .+++..+..++.|+++||.|||++|++|+||+|+||+++ ++.++|+|||++....... ..
T Consensus 80 L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 80 LASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 666665444 699999999999999999999999999999999999995 5699999999986543321 22
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....++..|+|||... ....+.++|+||||+++|++++|..||......+....+.....
T Consensus 159 ~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------- 218 (265)
T cd05579 159 KRIVGTPDYIAPEVIL-GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI------------------- 218 (265)
T ss_pred cCcccCccccCHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-------------------
Confidence 3345788999999886 45588999999999999999999999988776655544432111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH---HHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA---AEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~---~ell~hp~~~~~ 287 (346)
..+. ....+..+.+++++||+.+|++|||+ .++++||||++.
T Consensus 219 ~~~~---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 219 EWPE---------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCCc---------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0110 01247889999999999999999999 999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=316.65 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=205.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHh-hhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEEC-LNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++..+...||+|+||+||+|.+- | .||||+++......... .+.+|+..+++. +|-||+-+.|++..+.. .||+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred HHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce-eeee
Confidence 35678899999999999999876 3 39999998777666543 445899999999 79999999999998887 9999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeeccccccc---CCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEV---DSCPP 155 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~---~~~~~ 155 (346)
.+|+| +|+..+......|.....+.|++|+++|+.|||.++|+|+|||..||++.+ ++|||+|||+++.. .....
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q 546 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ 546 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence 99998 677888777778999999999999999999999999999999999999966 69999999998643 22334
Q ss_pred CccccccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 YTEYITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.....|...|||||++.. ..+|++.+||||+||++|||++|..||.....+..+..+-++...|.
T Consensus 547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd------------- 613 (678)
T KOG0193|consen 547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD------------- 613 (678)
T ss_pred cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc-------------
Confidence 555678889999999863 45699999999999999999999999986555544443322222221
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+......+++++++|+..|+..++++||+..+||.
T Consensus 614 ------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 ------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 22233467789999999999999999999999987
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=316.47 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=206.0
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccc---cCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE--EEEE
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRI---YSWEECLNLKEVKCLRKINNHPNIVKLQELASENYR--LYFV 79 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~--~~iv 79 (346)
+....||+|+|-+||+|.|..+|..||.-.++.+. ......+...|+.+|+.| +||||+++|+++.+... +.+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeee
Confidence 34568999999999999999999999876554332 233345677899999999 89999999999987654 8899
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCCEEEe--CCcEEEeecccccccCCCC
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ--GYFHRDLISKNLLVS--NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~ivH~dikp~NIli~--~~~vkl~Dfg~a~~~~~~~ 154 (346)
+|.+. |+|..++.+.+. .+...++.|++||++||.|||++ -|+|||||.+||+|+ .|.|||+|+|+|+......
T Consensus 122 TEL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99998 677777766544 89999999999999999999998 499999999999995 4699999999998877644
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
.. ...|||.|||||++. ..|+...||||||+.+.||+|+..||.......+.++-+.....|. .
T Consensus 201 ak-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~--s----------- 264 (632)
T KOG0584|consen 201 AK-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA--A----------- 264 (632)
T ss_pred cc-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH--H-----------
Confidence 44 379999999999884 7799999999999999999999999988776666555433222111 1
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+..--.+++++||.+||.. .+.|+|+.|||+||||...
T Consensus 265 --------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 265 --------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred --------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 1122368899999999999 9999999999999999874
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.56 Aligned_cols=249 Identities=26% Similarity=0.447 Sum_probs=200.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCC-----cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSG-----EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYR 75 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~ 75 (346)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.............+|+.++..+ +||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCCC
Confidence 368999999999999999999887543 789999987655444445567888999888 79999999999999999
Q ss_pred EEEEEEcCC-CCHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeec
Q 039371 76 LYFVFEYMD-CNLHQLMSNRK---------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADF 144 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Df 144 (346)
.+++|||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.+||+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence 999999997 57777665321 2368889999999999999999999999999999999995 569999999
Q ss_pred ccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 039371 145 GLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPT 220 (346)
Q Consensus 145 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 220 (346)
|++....... ......++..|+|||.+. ...++.++|||||||++|++++ |..||.+.+..+....+... ..+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~- 240 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GHL- 240 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHh-cCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CCC-
Confidence 9987654322 122334577899999886 5568999999999999999998 99999877665554444311 000
Q ss_pred hhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....++.++.+++.+||+.+|++|||+.++++
T Consensus 241 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 ---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=307.48 Aligned_cols=275 Identities=20% Similarity=0.295 Sum_probs=194.6
Q ss_pred CceEEEEEEEccCCcEEEEEEccccc-cCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-CHHHHH
Q 039371 14 SFGKVWQAIKKQSGEYVAIKALKQRI-YSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLM 91 (346)
Q Consensus 14 ~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l~~~~ 91 (346)
++|.||.+++..+++.||+|+++... .........+|+..++++ +||||+++++++.+.+..+++|||+++ ++.+.+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 44567777777799999999997653 233344567899999998 799999999999999999999999985 566666
Q ss_pred hcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--------CCccccc
Q 039371 92 SNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--------PYTEYIT 161 (346)
Q Consensus 92 ~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--------~~~~~~~ 161 (346)
... ...+++..+..++.|++.||+|||++||+|+||||+||+++ ++.++|+|||.+....... ......+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 543 34589999999999999999999999999999999999995 5799999999886443211 1223456
Q ss_pred cCcccCccccccc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-h-hhHHHHHHHHHhc--CC
Q 039371 162 TLQYRAPEMLLMS-GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPT-E-ESWAEGLELAKAH--GY 236 (346)
Q Consensus 162 t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~-~~~~~~~~~~~~~--~~ 236 (346)
+..|+|||++... ..++.++|+||+||++|+|++|..||.................... . ..+.......... ..
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 7789999988643 3578999999999999999999999987655443322222111000 0 0000000000000 00
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..+..............+.++.+++++||+.||++|||++++++||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~ 303 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR 303 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence 00000000011111234567889999999999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.77 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=196.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
|++|++.+.||+|+||+||+|.+..+++.||+|++...... .......+|+.++.++ +||||+++++++.+++..++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEE
Confidence 68999999999999999999999999999999999754332 2234567899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcc----------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccc
Q 039371 79 VFEYMDC-NLHQLMSNR----------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGL 146 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~----------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~ 146 (346)
+|||++| +|.+.+... ....+...+..++.||+.||+|||++||+||||||+||+++ ++.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999985 666655421 12356678889999999999999999999999999999995 56999999999
Q ss_pred ccccCCC-------------------CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 039371 147 AWEVDSC-------------------PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD 207 (346)
Q Consensus 147 a~~~~~~-------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 207 (346)
+...... .......||+.|+|||.+. +..++.++||||+||++|+|++|..||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9755210 0112246899999999886 5668999999999999999999999997754432
Q ss_pred HHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 208 QLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 208 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..... ....|.. ......+++.+.+++.+||+.||++|++..+.+.+
T Consensus 239 i~~~~--~i~~P~~-------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYRD--VILSPIE-------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhh--hccChhh-------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22110 0000000 00013567889999999999999999876665543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.73 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=203.4
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
+...+||+|+||.||++.++.+++.||+|.+..... .......+|+..++.+ +|||++++++.+..++..+++|||++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEEecCC
Confidence 334679999999999999999999999998854332 3444567899989888 79999999999999999999999998
Q ss_pred CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcccccc
Q 039371 85 CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEYITT 162 (346)
Q Consensus 85 g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~~~t 162 (346)
++.+..+... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++ ++.++|+|||.+....... ......++
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 7444444333 3489999999999999999999999999999999999996 5689999999886554322 22335678
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
..|+|||.+. ...++.++|+||+|+++|+|++|..||.+....+....+....... .
T Consensus 180 ~~y~~pE~~~-~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------------~---- 236 (292)
T cd06657 180 PYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK------------------L---- 236 (292)
T ss_pred ccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc------------------c----
Confidence 8999999876 5667899999999999999999999998766554443332211100 0
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.....++..+.+++.+||+.||.+||++.++++||||.....
T Consensus 237 -----~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 237 -----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred -----CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 011346788999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=294.47 Aligned_cols=251 Identities=24% Similarity=0.422 Sum_probs=200.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccc----cCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRI----YSWEECLNLKEVKCLRKINNHPNIVKLQELASEN--YR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~ 75 (346)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... .........+|+.+++++ +||||+++++.+.+. +.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 57999999999999999999999999999999875332 122233456799999999 799999999998654 56
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
+++++|+++| +|.+.+... +.+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||.+......
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 8999999985 666666543 4489999999999999999999999999999999999995 568999999999765321
Q ss_pred ----CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 ----PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.......++..|+|||.+. ....+.++|+||+||++|+|++|..||......+...++.. .+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-------- 227 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVIS-GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTK-------- 227 (264)
T ss_pred cccCccccccCCcccccCHhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCC--------
Confidence 1122346788999999887 45578999999999999999999999977654443333321 1110
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
....+.+++.+.+++++||+ +|..|||+.++++|||.
T Consensus 228 -----------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 -----------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -----------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 11124578899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=296.45 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=200.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc---EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++.+.||+|+||.||+|.+..++. .+|+|.++............+|+.++.++ +||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEE
Confidence 589999999999999999998865443 79999987655444455667899999998 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~- 155 (346)
+|||++| +|.+.+....+.+++.++..++.|++.||.+||++|++|+||||+||+++ ++.++|+|||.+........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 9999985 67777766556689999999999999999999999999999999999995 56899999999876544221
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....++..|+|||.+. ...++.++|+||+||++|++++ |..||......+....+.+...
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------------- 227 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-------------- 227 (267)
T ss_pred eeecCCCccceeecCHhHhc-cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc--------------
Confidence 11122346799999886 4568999999999999999886 9999987765554444422111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.+. ...+++.+.+++.+|++.+|.+|||+.++++
T Consensus 228 ------~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 ------LPA---------PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------CCC---------CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 110 1246788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=293.90 Aligned_cols=250 Identities=30% Similarity=0.515 Sum_probs=206.2
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+|++.+.||.|++|.||++.+..+++.+++|.+....... ......+|+.+++.+ +||||+++++++.+....++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEeh
Confidence 6999999999999999999999999999999987654332 334446888999999 69999999999999999999999
Q ss_pred cCCC-CHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 82 YMDC-NLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
+++| ++...+... +..+++..+..++.|++.||.+||+.|++|+||+|+||+++ ++.++|+|||++...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~ 158 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA 158 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence 9975 666665442 34589999999999999999999999999999999999995 458999999999776554 33
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+++.|+|||.+. ...++.++|+||+|+++|+|++|+.||...+..+....+.....
T Consensus 159 ~~~~~~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------- 218 (256)
T cd08530 159 KTQIGTPHYMAPEVWK-GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY------------------- 218 (256)
T ss_pred ccccCCccccCHHHHC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------------------
Confidence 3456788999999886 56688899999999999999999999987765544333322111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
+ ......+.++++++.+||+.+|.+|||+.++++||++
T Consensus 219 --~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 --P--------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --C--------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0 1112467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=302.03 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=199.2
Q ss_pred CceeeeeeecccCceEEEEEEEcc-------CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-------SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|.+.+.||+|+||.||+|.+.. +...+|+|.++............+|+.+++.+.+||||+++++++..++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 579999999999999999998653 2346999999765444444556789999999878999999999999999
Q ss_pred EEEEEEEcCC-CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC
Q 039371 75 RLYFVFEYMD-CNLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND 137 (346)
Q Consensus 75 ~~~iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~ 137 (346)
..|++|||+. |+|.+.+.... ..++..++..++.|++.||+|||++|++|+||||+||+++ ++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 9999999998 57877776532 2478899999999999999999999999999999999995 56
Q ss_pred cEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.++|+|||.+........ .....++..|+|||++. ...++.++||||+||++|+|++ |..||.+....+....+.
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 256 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhc-cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 899999999876543221 11122346899999886 4668999999999999999998 889997766544444332
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.... .......+.++.+++.+||..+|++|||+.+++++
T Consensus 257 ~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 257 EGHR-----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCCC-----------------------------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 1100 00113567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=294.93 Aligned_cols=245 Identities=26% Similarity=0.464 Sum_probs=198.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|+++++||+|++|.||+|.+. ++..||+|.+..... ......+|+.+++.+ +||||+++++.+.+.+..+++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch--hHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEe
Confidence 68999999999999999999865 556799998865432 234456799999998 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCC--C
Q 039371 82 YMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP--Y 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~--~ 156 (346)
++. |++.+.+... ...+++..+..++.|++.||+|||+.+++|+||||+||++++ +.++|+|||++........ .
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 997 5777776543 345899999999999999999999999999999999999964 5899999999976654221 2
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||.+. ...++.++||||+||++|+|++ |..||......+....+.....
T Consensus 162 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------------ 222 (261)
T cd05072 162 EGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR------------------ 222 (261)
T ss_pred CCCccceecCCHHHhc-cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 2234566899999886 5668899999999999999998 9999987766555444422111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.+ ....++.++.+++.+|+..+|++|||++++.+
T Consensus 223 --~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 --MP---------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --CC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 10 11346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=294.06 Aligned_cols=243 Identities=31% Similarity=0.518 Sum_probs=201.7
Q ss_pred eeecccCceEEEEEEEccC---CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 8 KQIGEGSFGKVWQAIKKQS---GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
+.||+|+||.||+|.+... +..|++|.+.............+|+..+..+ +|||++++++++.++..++++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEecc
Confidence 4799999999999999866 8899999998766554455567899999999 59999999999999999999999995
Q ss_pred -CCHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCC
Q 039371 85 -CNLHQLMSNR--------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 85 -g~l~~~~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~ 154 (346)
|+|.+.+... ...+++..+..++.|++.||++||++|++|+||+|+||++++ +.++|+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 6777777665 366999999999999999999999999999999999999965 799999999997765432
Q ss_pred ---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 155 ---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 155 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
......++..|+|||.+. ...++.++||||+||++|+|++ |..||......+....+....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------- 224 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLK-DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-------------- 224 (262)
T ss_pred ccccccCCCcCccccCHHHhc-cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 233445788999999887 4468999999999999999999 699998886655544443210
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.. .....++.++.+++.+||+.||++|||+++++++
T Consensus 225 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ------RL---------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------CC---------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00 1113568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=291.94 Aligned_cols=251 Identities=30% Similarity=0.493 Sum_probs=205.6
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASEN--YRLYFV 79 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~~iv 79 (346)
+|.+.+.||+|++|.||+|.+..+++.|++|++...... .......+|+..++++ +||||+++++.+.+. ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 589999999999999999999999999999998765432 2334456889999999 699999999999988 899999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCC--
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~-- 155 (346)
+|+++| ++.+.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||++++ +.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 999965 6666665544 6999999999999999999999999999999999999964 6999999999987765443
Q ss_pred -CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 -YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.....++..|+|||... ....+.++||||+|+++|+|++|..||...... .....+..
T Consensus 159 ~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------- 218 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIR-GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS------------------- 218 (260)
T ss_pred cccCCCCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-------------------
Confidence 34567888999999886 455899999999999999999999999776521 11111110
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
...........+..+.+++.+|++.||.+||++.++++||||
T Consensus 219 ---------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 ---------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000111223457899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=294.25 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=198.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
.+|++.+.||+|++|.||+|.++ ++..+|+|.+....... ....+|+.+++++ +||||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~--~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSE--DDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCH--HHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEEe
Confidence 47899999999999999999876 46679999986544332 3456799999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC--c
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY--T 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~--~ 157 (346)
+++| ++.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||.+......... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 9975 77777766556789999999999999999999999999999999999995 568999999998765432211 1
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...++..|+|||.+. ...++.++||||+|+++|+|++ |..||...+..+....+.....
T Consensus 160 ~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------- 219 (256)
T cd05059 160 GTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------------- 219 (256)
T ss_pred CCCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-------------------
Confidence 122345799999887 4668999999999999999998 8999987665554443322110
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+ ....++..+.+++.+||..+|++|||+.++++.
T Consensus 220 -~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 -LY---------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -CC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00 112467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=301.43 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=199.2
Q ss_pred CceeeeeeecccCceEEEEEEEcc-------CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-------SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|.+.+.||+|+||.||+|++.. .+..+|+|.++............+|+.+++++.+||||+++++++.+++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 579999999999999999997642 3457999998765444444556789999998877999999999999999
Q ss_pred EEEEEEEcCC-CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC
Q 039371 75 RLYFVFEYMD-CNLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND 137 (346)
Q Consensus 75 ~~~iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~ 137 (346)
.++++|||+. |+|.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence 9999999998 57777765432 3488899999999999999999999999999999999995 56
Q ss_pred cEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.+||+|||.+........ .....++..|+|||++. ...++.++||||+||++|+|++ |..||.+....+....+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 250 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHc-cCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 899999999976543221 11223446799999886 5668999999999999999999 889998776655554442
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.... ......++.++.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 251 EGHR-----------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred cCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 2100 0011356778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=298.19 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=197.6
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|.+.+.||+|+||+||++.+. .++..+|+|.+.... ........+|+.++.++ +||||+++++++...+.+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence 47899999999999999999853 345679999886543 22334456899999999 799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEe
Q 039371 77 YFVFEYMD-CNLHQLMSNRK------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIA 142 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~ 142 (346)
+++|||++ |+|.+.+.... ..+++..+..++.|++.||+|||++|++||||||+||+++ ++.++|+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999998 57766665332 2489999999999999999999999999999999999995 5689999
Q ss_pred ecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 039371 143 DFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGS 218 (346)
Q Consensus 143 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 218 (346)
|||++........ .....++..|+|||.+. ...++.++|||||||++|+|++ |..||......+....+......
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999876543221 22234567899999886 5668999999999999999998 89999887766555544332110
Q ss_pred CChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 219 PTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+ .....+.++.+++.+||+.||.+|||+.++++
T Consensus 242 ~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 Q-----------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred C-----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 01246788999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=295.13 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=199.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc---EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
.+|++.+.||+|+||.||+|.++.+++ .||+|+++.............|+.+++.+ +||||+++++++.++...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCceEE
Confidence 579999999999999999999887665 59999987654444445567899999888 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~~ 156 (346)
+|||++| ++.+.+....+.+++.++..++.|++.||.|||++|++|+||||+||++++ +.++|+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 9999986 666666655566899999999999999999999999999999999999954 59999999998655432211
Q ss_pred ---cccc---ccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 157 ---TEYI---TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 157 ---~~~~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.... .+..|+|||.+. ...++.++||||+||++|+|++ |..||...+..+....+......+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~---------- 231 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP---------- 231 (269)
T ss_pred cccccccCCCcceeecCHhHhc-cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCC----------
Confidence 1111 134799999886 5668999999999999999886 999998776655444442211100
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
. ...++..+.+++.+||+.+|.+||++.++++
T Consensus 232 ----------~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 232 ----------P---------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ----------C---------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 1246778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=296.00 Aligned_cols=246 Identities=26% Similarity=0.449 Sum_probs=201.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||.|++|+||+|.+.. +..+++|++...... ......+|+..++.+ +||||+++++++.+....+++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL-KQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh-hHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEEEe
Confidence 479999999999999999999887 888999998765432 233456788999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-Cc
Q 039371 82 YMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-YT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-~~ 157 (346)
|+++ +|.+.+... +..+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||.+........ ..
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 9985 787777653 34589999999999999999999999999999999999995 45999999999876543221 22
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...++..|+|||.+. ...++.++||||||+++|+|++ |..||...+..+....+......+
T Consensus 163 ~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 224 (261)
T cd05148 163 DKKIPYKWTAPEAAS-HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP----------------- 224 (261)
T ss_pred CCCCceEecCHHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-----------------
Confidence 334567899999886 5668999999999999999998 899998877666555543221110
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+++.+.+++.+||+.||++|||++++++
T Consensus 225 ------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 ------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=314.64 Aligned_cols=235 Identities=26% Similarity=0.486 Sum_probs=198.1
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
.-++-||+|+.|.||+|+.. ++.||||.++.-. -.+++.|++| +||||+.+.+++...-.+|||||||.
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~elk--------ETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK--------ETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHhhhh--------hhhHHHHHhc-cCcceeeEeeeecCCceeEEeeeccc
Confidence 34678999999999999765 7889999885321 2477889999 79999999999999999999999998
Q ss_pred -CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcccccc
Q 039371 85 -CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITT 162 (346)
Q Consensus 85 -g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t 162 (346)
|-|.+.+...+ .++......|..+|+.|+.|||.+.|+|||||.-||||+ ++.|||+|||-+....+......++||
T Consensus 196 ~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT 274 (904)
T KOG4721|consen 196 QGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT 274 (904)
T ss_pred cccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence 67777766654 499999999999999999999999999999999999995 669999999999888877777789999
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
..|||||++. +.+.+.+.|||||||+||||+||..||.+-+.....--+ |
T Consensus 275 VaWMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----G------------------------- 324 (904)
T KOG4721|consen 275 VAWMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----G------------------------- 324 (904)
T ss_pred HhhhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchheeEEec----c-------------------------
Confidence 9999999998 788999999999999999999999999765543321111 0
Q ss_pred CCCccc-ccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 243 GNNLSL-LIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 243 ~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+.+.. +...+++-++=|++.||+-.|.+||++.+++.|
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 011111 124678889999999999999999999999998
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=298.82 Aligned_cols=255 Identities=26% Similarity=0.377 Sum_probs=199.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCC----------------cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG----------------EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVK 65 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~ 65 (346)
++|++++.||+|+||.||+|.+..++ ..||+|.+.............+|+.++.++ +||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEeE
Confidence 68999999999999999999876544 568999987665444455567899999999 7999999
Q ss_pred eeeeeecCCEEEEEEEcCCC-CHHHHHhccc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE
Q 039371 66 LQELASENYRLYFVFEYMDC-NLHQLMSNRK----------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV 134 (346)
Q Consensus 66 ~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli 134 (346)
+++++..++..+++||++.+ +|...+.... ..+++..+..++.|++.||+|||++|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 99999999999999999985 6666665433 258999999999999999999999999999999999999
Q ss_pred eC-CcEEEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh--CCCCCCCCChHHH
Q 039371 135 SN-DTIKIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT--FHPLFPGTCEDDQ 208 (346)
Q Consensus 135 ~~-~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~ 208 (346)
++ +.++|+|||.+....... ......++..|+|||.+. ...++.++||||+||++|+|++ +..||......+.
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh-cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 54 599999999987543322 122334567899999886 4568999999999999999998 6788877665555
Q ss_pred HHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 209 LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 209 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+........... ........+.++.++.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 243 IENAGHFFRDDG----------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHhcccccc----------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 444432210000 00000011346789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=295.88 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=193.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc----EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++++.||+|+||+||+|.+..+++ .+++|.+..............|+..+.++ +||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-CccE
Confidence 579999999999999999999887776 47777775433222223445677777777 79999999998764 4567
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCC-
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~- 154 (346)
+++|++. |+|.+.+....+.+++..+..++.|++.||.|||++|++|+||||+||++++ +.+||+|||.+.......
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 8899987 6888888776667999999999999999999999999999999999999964 589999999997653321
Q ss_pred --CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 155 --PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 155 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
......++..|+|||.+. ...++.++|||||||++|+|++ |..||.+.........+ .....++
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~----------- 231 (279)
T cd05111 165 KYFYSEHKTPIKWMALESIL-FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLA----------- 231 (279)
T ss_pred ccccCCCCCcccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCC-----------
Confidence 122345667899999886 5668999999999999999998 99999877554432222 1111100
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....++.++.+++.+|+..||.+|||+.|+++
T Consensus 232 -----------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 232 -----------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01134567889999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=291.96 Aligned_cols=245 Identities=26% Similarity=0.465 Sum_probs=198.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|++|.||+|.+.. ++.||+|.++..... .....+|+.+++++ +||||+++++++...+..+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD--PKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc--HHHHHHHHHHHHHC-CCCCccceeEEEecCCCeeeeee
Confidence 579999999999999999998754 567999998755433 33456799999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC--
Q 039371 82 YMD-CNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY-- 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~-- 156 (346)
++. +++.+.+.... ..+++..+..++.|++.||.+||++|++|+||||+||+++ ++.++|+|||++.........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 995 67877776543 4589999999999999999999999999999999999995 568999999999776532211
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+..|+|||.+. ...++.++||||||+++|+|++ |+.||.+.........+......+
T Consensus 162 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 224 (261)
T cd05068 162 EGAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP---------------- 224 (261)
T ss_pred CCCcCceeccCccccc-cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 1112245799999886 5668999999999999999999 999998877655555442211100
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+..+.+++.+|++.||.+||+++++++
T Consensus 225 -------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 225 -------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred -------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=298.83 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=203.1
Q ss_pred ceeeeeeecccCceEEEEEEEc---cCCcEEEEEEccccccC---HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYS---WEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
+|++.+.||.|+||.||+|.+. .+|+.||+|++...... .......+|+.++.++.+||||+.+++.++.+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 47899999998654321 12233457889999997899999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
|++|||++| ++.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 999999985 676666554 4589999999999999999999999999999999999995 5699999999987654322
Q ss_pred --CCccccccCcccCccccccc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 155 --PYTEYITTLQYRAPEMLLMS-GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 155 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
......++..|+|||.+... ..++.++||||+|+++|+|++|..||...........+.......
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------ 227 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------------ 227 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc------------
Confidence 22335688899999988632 346789999999999999999999997543322222221111000
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGCL 288 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~~ 288 (346)
. + .....++..+.+++++||+.||++|| +++++++||||+...
T Consensus 228 ---~---~--------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 228 ---E---P--------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ---C---C--------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 0 0 00124678899999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=292.20 Aligned_cols=244 Identities=30% Similarity=0.471 Sum_probs=195.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.++||+|++|+||+|.+..++ .||+|.++...... ....+|+.+++++ +||||+++++.+.+ ...+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~--~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP--EAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCH--HHHHHHHHHHHhC-CCCCcceEEEEECC-CCcEEEEE
Confidence 68999999999999999999887654 59999997644432 3456799999998 79999999998755 45799999
Q ss_pred cCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--C
Q 039371 82 YMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP--Y 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~--~ 156 (346)
|+++ ++.+.+... ...+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||.+........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 9985 777777653 33589999999999999999999999999999999999995 45899999999976543321 1
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||... ...++.++||||+||++|+|++ |..||.+....+....+......
T Consensus 161 ~~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------- 222 (262)
T cd05071 161 QGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------- 222 (262)
T ss_pred cCCcccceecCHhHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-----------------
Confidence 2234566899999876 5668999999999999999999 88999877665544443221100
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+ ....++..+.+++.+|++.||++|||++++++
T Consensus 223 ---~---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 ---P---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ---C---------CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 11356788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.34 Aligned_cols=251 Identities=25% Similarity=0.451 Sum_probs=194.8
Q ss_pred CceeeeeeecccCceEEEEEEE-----ccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec-CCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIK-----KQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE-NYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-~~~ 75 (346)
++|++.+.||+|+||+||+|.+ ..+++.||+|+++............+|+.++.++.+||||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5899999999999999999984 3567899999997655444455667899999999889999999998754 456
Q ss_pred EEEEEEcCCC-CHHHHHhccc-----------------------------------------------------------
Q 039371 76 LYFVFEYMDC-NLHQLMSNRK----------------------------------------------------------- 95 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~----------------------------------------------------------- 95 (346)
.+++|||++| +|.+.+....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 8999999984 6766664321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC---CccccccCc
Q 039371 96 -------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP---YTEYITTLQ 164 (346)
Q Consensus 96 -------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~ 164 (346)
..++...+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++........ .....++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 2367788899999999999999999999999999999995 56999999999876432211 112234567
Q ss_pred ccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCC
Q 039371 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQG 243 (346)
Q Consensus 165 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
|+|||.+. ...++.++||||+|+++|+|++ |..||................. ..+
T Consensus 247 y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~---- 302 (343)
T cd05103 247 WMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-------------------RMR---- 302 (343)
T ss_pred eECcHHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC-------------------CCC----
Confidence 99999886 5668999999999999999997 8999976543322222211110 000
Q ss_pred CCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 244 NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 244 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.....++++.+++..|++.||++|||+.++++|
T Consensus 303 -----~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 -----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=297.02 Aligned_cols=245 Identities=36% Similarity=0.533 Sum_probs=195.8
Q ss_pred eeeeeecccCceEEEEEEEc----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 5 TLMKQIGEGSFGKVWQAIKK----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.+.+.||.|.||.||+|... ..+..|++|.++............+|+..++++ +||||+++++++...+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccccccccccc
Confidence 57889999999999999888 446689999996654444466778999999999 8999999999999888899999
Q ss_pred EcCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 81 EYMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 81 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
||+. |+|.+.+... ...+++..+..++.|++.||.|||+++++|++|+++||+++ ++.+||+|||++........
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9998 6888888776 56699999999999999999999999999999999999997 56999999999977632221
Q ss_pred -CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 -YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.........|+|||.+. ...++.++||||||+++|||++ |..||...+..+....+.+....+
T Consensus 161 ~~~~~~~~~~~~aPE~~~-~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~-------------- 225 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLK-DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP-------------- 225 (259)
T ss_dssp ESTTSESGGGGS-HHHHH-HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT--------------
T ss_pred cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccce--------------
Confidence 22345677899999887 4558999999999999999999 689998887776666653321111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....++..+.+++..||..||++|||+.++++
T Consensus 226 ---------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 ---------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11356888999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=292.22 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=199.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc---EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|+..+.||+|++|.||+|.+..++. .+++|.+.............+|+.++.++ +|||++++.+++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcEE
Confidence 478999999999999999999876654 79999987654444445567899999888 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
+||++++ +|.+.+....+.+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 9999985 66666665556689999999999999999999999999999999999995 458999999998765432211
Q ss_pred ----ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 157 ----TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 157 ----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....+..|+|||.+. ...++.++||||+||++|+|++ |..||...+..+....+......|.
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~----------- 231 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA----------- 231 (268)
T ss_pred ceeccCCCcCceecCHHHhh-cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC-----------
Confidence 1112345799999886 4568999999999999999997 9999987766555544432211110
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+.++.+++.+|++.||++||++.++++
T Consensus 232 ------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 ------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=294.07 Aligned_cols=243 Identities=27% Similarity=0.428 Sum_probs=191.7
Q ss_pred eeecccCceEEEEEEEccCCc--EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC-
Q 039371 8 KQIGEGSFGKVWQAIKKQSGE--YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD- 84 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~- 84 (346)
+.||+|+||.||+|.+..++. .+++|.++............+|+.++.++.+||||+++++++...+..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999988776 46888887544444444567899999999889999999999999999999999997
Q ss_pred CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccc
Q 039371 85 CNLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAW 148 (346)
Q Consensus 85 g~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~ 148 (346)
|+|.+.+.... ..+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 57777765432 2478999999999999999999999999999999999995 5699999999985
Q ss_pred ccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHH
Q 039371 149 EVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 149 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
.............+..|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------------ 227 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------------ 227 (270)
T ss_pred ccchhhhccCCCCccccCChHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC------------
Confidence 433211112223356799999886 5668999999999999999997 99999776655444333111
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+ .....+.++.+++.+|++.||.+|||++++++
T Consensus 228 --------~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 --------YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred --------CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0000 11245778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=298.55 Aligned_cols=250 Identities=27% Similarity=0.441 Sum_probs=199.9
Q ss_pred CceeeeeeecccCceEEEEEEEc-------cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-------QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|++.+.||+|+||.||+|++. .++..||+|.+.............+|+..++.+.+||||+++++.+...+
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 57999999999999999999753 23457999998765444444556789999988878999999999999999
Q ss_pred EEEEEEEcCCC-CHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND 137 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~ 137 (346)
..+++|||+.+ +|.+.+.... ..++...+..++.|++.||.|||++|++|+||||+||+++ ++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~ 174 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN 174 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence 99999999984 7777765431 2477888999999999999999999999999999999995 56
Q ss_pred cEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.+||+|||.+........ .....++..|+|||++. ...++.++||||||+++|+|++ |..||.+....+....+.
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 253 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 899999999976643221 22234567899999886 4668999999999999999998 789998776655544442
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.... . .....++..+.+++.+||+.+|.+|||+.++++.
T Consensus 254 ~~~~--------------------~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 254 EGHR--------------------M---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred cCCc--------------------C---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 2110 0 0113567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=296.66 Aligned_cols=247 Identities=27% Similarity=0.449 Sum_probs=196.0
Q ss_pred ceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
+|++.+.||+|+||+||+|.+.. ....+++|.+.............+|+..+..+ +||||+++++.+..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCcE
Confidence 58999999999999999998753 23579999887655444445567899999998 7999999999999999999
Q ss_pred EEEEcCC-CCHHHHHhcc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEE
Q 039371 78 FVFEYMD-CNLHQLMSNR-----------------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLL 133 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~-----------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIl 133 (346)
+++||+. |++.+.+... ...+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999998 4666665431 124788999999999999999999999999999999999
Q ss_pred Ee-CCcEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 039371 134 VS-NDTIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQ 208 (346)
Q Consensus 134 i~-~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 208 (346)
++ ++.++|+|||++........ .....++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....+.
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 238 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHc-cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 95 56899999999875433221 12234567899999876 5668999999999999999998 9999987765544
Q ss_pred HHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 209 LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 209 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+.... ..+ ....++.++.+++.+||+.||++||+++++++
T Consensus 239 ~~~~~~~~--------------------~~~---------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 239 FNLLKTGY--------------------RME---------RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHhCCC--------------------CCC---------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 33322110 000 11356789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=294.07 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=200.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc----EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++.+.||+|+||+||+|.++.+|+ .+|+|...............+|+..+.++ +||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-CceE
Confidence 579999999999999999999877665 58999887665544455667899999999 79999999999887 6789
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
++||++. |++.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++ ++.++|+|||.+........
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 9999997 578887777666799999999999999999999999999999999999995 56999999999976543222
Q ss_pred C---ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 Y---TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
. ....++..|+|||.+. ...++.++||||+||++|++++ |..||.+....+....+......+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 231 (279)
T cd05057 165 EYHAEGGKVPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP------------ 231 (279)
T ss_pred ceecCCCcccccccCHHHhh-cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC------------
Confidence 1 1122356799999886 5668999999999999999998 999998876655544443211100
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+.++.+++.+||..||.+|||+.++++
T Consensus 232 -----------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 232 -----------------QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01235678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=294.44 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=198.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|++|.||+|.+..+++.+++|.+....... ......+|+.+++.+ +||||+++++++.+++..++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEE
Confidence 578999999999999999999999999999999886543222 223456899999998 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 79 VFEYMDC-NLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
+||++.| ++.+.+.. ....+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999986 66665542 234589999999999999999999999999999999999995 568999999998765433
Q ss_pred C-CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhhHHHHHHH
Q 039371 154 P-PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED--DQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 154 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
. ......++..|+|||.+. ...++.++|+||+|+++|+|++|..||.+.... .....+...
T Consensus 160 ~~~~~~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 223 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--------------- 223 (267)
T ss_pred CcccccccCCcCccCHHHhc-CCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC---------------
Confidence 2 223456888999999886 456889999999999999999999999654332 111111110
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+. ......+..+.+++.+||+.||++|||+.++++
T Consensus 224 ------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 224 ------DYPP-------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ------CCCC-------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0000 001246788999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=342.35 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=213.9
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH-hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-CLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
|++-...||.|.||.||.|.+..+|+..|+|-++-.....+. ....+|+.++..+ +|||+|++|++-...+.++|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHHHHHHH
Confidence 456778999999999999999999999999988655444222 2335788999888 89999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-----C
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-----P 155 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-----~ 155 (346)
||.|+.+..+...++-.+|...+.+..|++.|+.|||+.|||||||||+||+++ +|.+|++|||.|..+.... .
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999877777766666688999999999999999999999999999999999994 6799999999998776542 2
Q ss_pred CccccccCcccCcccccccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLMSG--QYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.+...||+.|||||++.+.. ....+.|||||||+..||+||+.||...+.. ..++.+..+..++.+
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P----------- 1463 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP----------- 1463 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc-----------
Confidence 34578999999999997543 3567999999999999999999999776654 334444332221111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
..+|.+.++||..||..||++|.++.|+++|.|-+.+...
T Consensus 1464 ------------------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1464 ------------------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred ------------------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence 2478999999999999999999999999999999876543
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.13 Aligned_cols=240 Identities=23% Similarity=0.332 Sum_probs=190.3
Q ss_pred eecccCceEEEEEEEc--cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-
Q 039371 9 QIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC- 85 (346)
Q Consensus 9 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g- 85 (346)
.||+|+||.||+|.+. .++..||+|++.............+|+.+++++ +||||+++++.++. ...++||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999765 445679999997664443444567899999998 79999999998864 467999999975
Q ss_pred CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCC----Ccccc
Q 039371 86 NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP----YTEYI 160 (346)
Q Consensus 86 ~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~----~~~~~ 160 (346)
+|.+.+......+++..+..++.|++.||.|||++|++|+||||+||++++ +.+||+|||++........ .....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 677776655667999999999999999999999999999999999999964 5899999999875443221 11122
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (346)
++..|+|||.+. ...++.++|||||||++|++++ |..||......+....+......
T Consensus 160 ~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------------- 217 (257)
T cd05115 160 WPLKWYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL--------------------- 217 (257)
T ss_pred CCcccCCHHHHc-cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---------------------
Confidence 356899999886 4568999999999999999996 99999887665554443222110
Q ss_pred CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+.+++++.+++.+|+..||++||+++++.+
T Consensus 218 --------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 218 --------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011356789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=290.57 Aligned_cols=240 Identities=23% Similarity=0.378 Sum_probs=189.3
Q ss_pred eeecccCceEEEEEEE--ccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 8 KQIGEGSFGKVWQAIK--KQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
++||+|+||+||+|.. ..++..+|+|+++....+.. .....+|+.++..+ +||||++++++++. +..+++||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCC
Confidence 3689999999999964 46678999999875544332 33456788888888 79999999998764 46789999998
Q ss_pred C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCCC----cc
Q 039371 85 C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPY----TE 158 (346)
Q Consensus 85 g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~~----~~ 158 (346)
+ ++.+.+... ..+++..+..++.|++.||+|||++|++|+||||+||++++ +.++|+|||.+......... ..
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 79 LGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 5 566666543 45999999999999999999999999999999999999964 58999999999765443221 11
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..++..|+|||.+. ...++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 158 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~------------------- 217 (257)
T cd05116 158 GKWPVKWYAPECMN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM------------------- 217 (257)
T ss_pred CCCCccccCHhHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC-------------------
Confidence 23357899999886 5668899999999999999998 99999887666555444321110
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....++.++.++|.+|++.||++||++++|.+
T Consensus 218 ----------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 ----------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ----------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 011357889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=307.01 Aligned_cols=251 Identities=24% Similarity=0.413 Sum_probs=198.9
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|.+.+.||+|+||.||+|++. .+++.||+|+++............+|+.++.++..||||+++++.+..++..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 56888999999999999999854 3456899999986654444445678999999995699999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc------------------------------------------------------------
Q 039371 77 YFVFEYMD-CNLHQLMSNRK------------------------------------------------------------ 95 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~------------------------------------------------------------ 95 (346)
++||||+. |+|.+.+...+
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999998 57777664321
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C
Q 039371 96 -------------------------------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D 137 (346)
Q Consensus 96 -------------------------------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~ 137 (346)
..+++..+..++.|++.||.|||+.+++|+||||+||++++ +
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence 13577788999999999999999999999999999999964 5
Q ss_pred cEEEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.++|+|||++....... ......++..|+|||.+. ...++.++||||+||++|+|++ |..||......+......
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~ 355 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF-NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhc-CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence 89999999997543221 122335678899999886 5668999999999999999998 889997765554433332
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..... .+ ....++.++.+++.+|+..+|.+||+++++++.
T Consensus 356 ~~~~~-------------------~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 356 KRGYR-------------------MA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HcCCC-------------------CC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 21110 00 113467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.19 Aligned_cols=244 Identities=30% Similarity=0.469 Sum_probs=194.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.++||+|++|.||+|.+. ++..+|+|.+....... ....+|+.+++++ +|||++++++++.. ...+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~--~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP--ESFLEEAQIMKKL-RHDKLVQLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH--HHHHHHHHHHHhc-CCCceEEEEeEECC-CCcEEEEE
Confidence 68999999999999999999766 45679999987654432 3356899999999 79999999998864 45789999
Q ss_pred cCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCC--C
Q 039371 82 YMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP--Y 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~--~ 156 (346)
++.| ++.+.+... ...+++..+..++.|++.||.|||++|++|+||+|+||++++ +.++|+|||.+........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 9985 777776543 345899999999999999999999999999999999999965 5899999999976543221 1
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||... ...++.++||||||+++|+|++ |..||.+.+..+....+......+
T Consensus 161 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 223 (260)
T cd05070 161 QGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP---------------- 223 (260)
T ss_pred cCCCCCccccChHHHh-cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 1223456799999876 5668999999999999999999 899998876655555443211100
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+..+.+++.+|+..||++|||++++.+
T Consensus 224 -------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 224 -------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 11246788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=289.42 Aligned_cols=242 Identities=35% Similarity=0.524 Sum_probs=199.3
Q ss_pred ecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC-CC
Q 039371 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD-CN 86 (346)
Q Consensus 10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~-g~ 86 (346)
||.|++|.||++.+..+++.+++|++....... .......|+.+++++ +||||+++++.++.+..++++||++. ++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999999899999999987654432 333456788888888 69999999999999999999999995 57
Q ss_pred HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCccccccCc
Q 039371 87 LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTEYITTLQ 164 (346)
Q Consensus 87 l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~~~~t~~ 164 (346)
+.+.+.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++ ++.++|+|||.+...... .......++..
T Consensus 80 L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 80 LFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence 777766543 589999999999999999999999999999999999995 569999999998765543 22344567889
Q ss_pred ccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCC
Q 039371 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGN 244 (346)
Q Consensus 165 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
|+|||... ....+.++|+||||+++|++++|..||...+.......+... ...
T Consensus 159 ~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~------- 211 (250)
T cd05123 159 YLAPEVLL-GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD-------------------PLR------- 211 (250)
T ss_pred ccChHHhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-------------------CCC-------
Confidence 99999886 455788999999999999999999999777654444433221 001
Q ss_pred CcccccCCCCchHHHHHHHhcccCCCCCCCH---HHHhcCCCC
Q 039371 245 NLSLLIPSANDDEMSLIELLCSWDPCKRPTA---AEALQHPLF 284 (346)
Q Consensus 245 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~---~ell~hp~~ 284 (346)
.....+..+.+++++||..||++|||+ +++++||||
T Consensus 212 ----~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 ----FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ----CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 112457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=288.83 Aligned_cols=246 Identities=28% Similarity=0.478 Sum_probs=199.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.++|++.+.||+|++|+||+|.+. ++..+|+|.+....... ....+|+..++++ +||||+++++++.++...+++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~--~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSP--EAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCH--HHHHHHHHHHhhC-CCCCEeeeeeeeecCCceEEEE
Confidence 378999999999999999999876 45779999987654433 3456799999998 7999999999999989999999
Q ss_pred EcCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 81 EYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
|+++| ++.+.+.... ..+++..+..++.|++.|+.|||++|++|+||+|+||+++ ++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 99985 7777776543 4589999999999999999999999999999999999995 56999999999876553211
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
......+..|+|||.+. ...++.++|+||+||++|+|++ |..||.+.+.......+......+.
T Consensus 161 ~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 225 (261)
T cd05034 161 REGAKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR-------------- 225 (261)
T ss_pred hhccCCCccccCHHHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 11223456899999886 5668999999999999999998 9999988776655555433211110
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+.++.+++.+|++.+|++||+++++.+
T Consensus 226 ---------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 226 ---------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ---------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1235778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.11 Aligned_cols=260 Identities=26% Similarity=0.372 Sum_probs=193.2
Q ss_pred Cce-eeeeeecccCceEEEEEE----EccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CC
Q 039371 2 EKY-TLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--NY 74 (346)
Q Consensus 2 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~ 74 (346)
+|| ++++.||+|+||+||++. ...++..||+|+++............+|+..++++ +||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence 577 999999999999998865 34567899999997664444445566899999999 79999999998764 34
Q ss_pred EEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
..+++|||+.+ ++.+.+... .+++.++..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 68999999985 565655442 499999999999999999999999999999999999995 45899999999876543
Q ss_pred CCC----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCChhhHHHH
Q 039371 153 CPP----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG-SPTEESWAEG 227 (346)
Q Consensus 153 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~ 227 (346)
... .....++..|+|||.+. ...++.++|||||||++|+|++|..||...... ......... ......+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLK-ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhc-ccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh
Confidence 221 12234566799999886 566899999999999999999999998664422 111111100 0000000000
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....... ......+..+.+++.+|++.||++|||++++++
T Consensus 237 ----~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 ----LERGMRL---------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ----hhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000 112356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=310.56 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=224.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++.+++..||-|+||.|-++..+.....+|+|++++...- ........|-.++..+ +.|.||++|..|.++.++|+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhh
Confidence 35678889999999999999988776667999999766543 3344557899999999 69999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
+||.|-| .++..+. .++.+++...+.++.-+++|++|||++||++|||||+|.+++ +|.+||.|||+|..++.....
T Consensus 498 LmEaClGGElWTiLr-dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 498 LMEACLGGELWTILR-DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hHHhhcCchhhhhhh-hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 9999976 5555554 456699999999999999999999999999999999999995 679999999999999999999
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
.+++|||.|.|||++. +.-.+.++|.||||+++|||++|.+||.+.++....+.|++++.. .
T Consensus 577 wTFcGTpEYVAPEIIL-nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-----------------i 638 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIIL-NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-----------------I 638 (732)
T ss_pred eeecCCcccccchhhh-ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------------h
Confidence 9999999999999998 455799999999999999999999999999999999999887532 1
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCL 288 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~ 288 (346)
.+| ..++..+.+||++++..+|.+|.. +.++-+|.||.+..
T Consensus 639 ~~P-----------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 639 EFP-----------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred hcc-----------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 122 367899999999999999999987 99999999998754
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=288.85 Aligned_cols=242 Identities=26% Similarity=0.442 Sum_probs=198.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|++|.||+|... |+.||+|.++.... ......+|+.+++++ +||||+++++++.+.+..+++||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEEEE
Confidence 68999999999999999999765 78899999976543 344567899999999 79999999999998999999999
Q ss_pred cCC-CCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 82 YMD-CNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
+++ +++.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||.+........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~ 158 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--S 158 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--c
Confidence 998 47777765543 2589999999999999999999999999999999999995 56899999999977643222 2
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+..|+|||.+. ...++.++||||+|+++|+|++ |..||......+....+.... .
T Consensus 159 ~~~~~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------------------~ 217 (256)
T cd05039 159 GKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY--------------------R 217 (256)
T ss_pred CCCcccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------------------C
Confidence 33456799999886 5668899999999999999997 999998776555443332110 0
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.......++.+.+++++||..+|++|||++++++
T Consensus 218 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 218 ---------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0011346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=297.94 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=217.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH--hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE--CLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
.+|..+..||+|+||.|-+|..+.+.+.||||+++++..-... .-.+.|-.+|....+-|.+++++..|++-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4788899999999999999999999999999999876543222 22245667776666789999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccc-cCCCCCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWE-VDSCPPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~-~~~~~~~~ 157 (346)
|||++|+-+-+-.++-+.+.|+.+..++..|+-||-+||++||++||||.+|||++ +|++||.|||++.. +-......
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTk 508 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTK 508 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCccee
Confidence 99999644444444445699999999999999999999999999999999999995 67999999999964 33345667
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
+++|||.|+|||++. -.+|+.++|+||+|++||||+.|++||++.+.++.++.|.+.....+
T Consensus 509 TFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----------------- 570 (683)
T KOG0696|consen 509 TFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----------------- 570 (683)
T ss_pred eecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc-----------------
Confidence 899999999999987 67799999999999999999999999999999999999987643222
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCLQ 289 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~~ 289 (346)
...|.++.++....|...|.+|.. -.++-+||||+....
T Consensus 571 -------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 571 -------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred -------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 357899999999999999999976 467999999987543
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=300.83 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=199.3
Q ss_pred CceeeeeeecccCceEEEEEEEccC-------CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS-------GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
.+|++++.||+|+||.||+|.+... +..||+|.++............+|+.+++++.+||||+++++.+..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 3799999999999999999986432 236899988765444444556789999999978999999999999999
Q ss_pred EEEEEEEcCCC-CHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND 137 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~ 137 (346)
..++++||+++ +|.+.+.... ..++...+..++.|++.||.|||++|++||||||+||+++ ++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 99999999974 7777765422 2367788999999999999999999999999999999995 56
Q ss_pred cEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.+||+|||+++....... .....++..|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 250 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhc-cCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999876544221 11223346799999886 5668899999999999999998 889998877665554442
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.... . ......+..+.+++.+|++.+|.+|||+.|++++
T Consensus 251 ~~~~--------------------~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 251 EGHR--------------------M---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred cCCC--------------------C---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 2110 0 0113467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=296.79 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=196.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCC--------------cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG--------------EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQ 67 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~ 67 (346)
++|++.+.||+|+||.||+|++..++ ..||+|.+.............+|+.++.++ +|||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeEE
Confidence 48999999999999999999875432 358999997654444445567899999999 799999999
Q ss_pred eeeecCCEEEEEEEcCCC-CHHHHHhccc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe
Q 039371 68 ELASENYRLYFVFEYMDC-NLHQLMSNRK-----------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS 135 (346)
Q Consensus 68 ~~~~~~~~~~iv~e~~~g-~l~~~~~~~~-----------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~ 135 (346)
+++...+..++||||+.| ++.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 999999999999999985 6666654321 1368889999999999999999999999999999999995
Q ss_pred -CCcEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh--CCCCCCCCChHHHH
Q 039371 136 -NDTIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT--FHPLFPGTCEDDQL 209 (346)
Q Consensus 136 -~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~ 209 (346)
++.+||+|||++........ .....++..|+|||.+. ...++.++|||||||++|+|++ +..||......+..
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhc-cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 45899999999875433221 12234467899999886 5668999999999999999988 66888877665544
Q ss_pred HHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 210 YKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 210 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+........ ...+ ....+..++.+.+++++|++.||++|||++++++
T Consensus 243 ~~~~~~~~~~~--------------~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 243 ENTGEFFRNQG--------------RQIY--------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHhhhhcc--------------cccc--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 44322110000 0000 0012346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=289.04 Aligned_cols=242 Identities=24% Similarity=0.427 Sum_probs=194.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeee-ecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELA-SENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~-~~~~~~~iv 79 (346)
+++|++.+.||+|++|.||++... |..+++|.++... ......+|+..++++ +|||++++++++ .+++..+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEE
Confidence 468999999999999999999765 7889999986432 233456899999998 799999999975 556778999
Q ss_pred EEcCCC-CHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 80 FEYMDC-NLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|||+++ ++.+.+..... .+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999984 77777765433 489999999999999999999999999999999999995 5699999999987654322
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+..|+|||++. ...++.++||||+||++|+|++ |..||......+....+.....
T Consensus 157 ~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------ 217 (256)
T cd05082 157 DTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------------ 217 (256)
T ss_pred CCCccceeecCHHHHc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------------------
Confidence 2234456899999886 5668899999999999999997 9999987665554444322100
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+.+++.+.+++.+|++.||++|||+.++++
T Consensus 218 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 -----------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112356889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=291.90 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=194.0
Q ss_pred eeeeeeecccCceEEEEEEEccC---CcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-----
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQS---GEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENY----- 74 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~----- 74 (346)
|++.+.||+|+||.||+|....+ +..||+|.++....... .....+|+..++.+ +||||+++++.+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 67899999999999999987654 47899999876544433 33456888989888 7999999999876544
Q ss_pred -EEEEEEEcCCC-CHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeeccc
Q 039371 75 -RLYFVFEYMDC-NLHQLMSNR-----KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGL 146 (346)
Q Consensus 75 -~~~iv~e~~~g-~l~~~~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~ 146 (346)
..++++||+.+ ++...+... ...+++..+..++.|++.||.|||++|++|+||||+||++++ +.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 37999999984 666665332 235899999999999999999999999999999999999954 5999999999
Q ss_pred ccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 039371 147 AWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEE 222 (346)
Q Consensus 147 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 222 (346)
+........ ......+..|+|||.+. ...++.++||||+||++|+|++ |..||.+....+....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 233 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR----- 233 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 876543221 11223466899999875 5668999999999999999999 8899987766554443322110
Q ss_pred hHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 223 SWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
......++.++.+++++||+.||++|||+.|++++
T Consensus 234 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00113567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=288.36 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=199.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc-C-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-S-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
.++|++.+.||+|++|.||+|.+..+|+.||+|.++.... . .......+|+.+++++ +|+|++++++.+.+++..++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEE
Confidence 4789999999999999999999999999999998864322 2 2244556899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 79 VFEYMDC-NLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
+|||++| +|...+.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999985 77666643 234589999999999999999999999999999999999995 669999999998755432
Q ss_pred C-CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhhHHHHHHH
Q 039371 154 P-PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED--DQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 154 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
. ......++..|+|||.+. ...++.++|+||+||++|+|++|..||...... +....+....
T Consensus 160 ~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 224 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-------------- 224 (267)
T ss_pred CcccceecCCccccCHHHhc-cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--------------
Confidence 2 223456788999999886 566889999999999999999999999654321 1111111110
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.+. ...+..+..+.++|.+||..+|++|||+.++++
T Consensus 225 -------~~~-------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 -------YPP-------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -------CCC-------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000 001246778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.83 Aligned_cols=248 Identities=26% Similarity=0.426 Sum_probs=198.0
Q ss_pred CceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||.||+|.+.. ++..||+|++.............+|+.++.++ +||||+++++++.++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCcc
Confidence 589999999999999999998753 67889999987654444444566799999998 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhccc---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE
Q 039371 77 YFVFEYMDC-NLHQLMSNRK---------------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV 134 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~---------------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli 134 (346)
+++||++++ +|.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 999999984 7777765321 237888999999999999999999999999999999999
Q ss_pred e-CCcEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 039371 135 S-NDTIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQL 209 (346)
Q Consensus 135 ~-~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~ 209 (346)
+ ++.++|+|||.+........ ......+..|+|||.+. ...++.++|||||||++|+|++ |..||.+....+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4 56999999999875443221 12223456799999886 4568999999999999999997 88899776665544
Q ss_pred HHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 210 YKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 210 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+..... ....+..+.++.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 243 YYVRDGNV-----------------------------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHhcCCC-----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 44322110 0011245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.87 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=196.3
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.++||+|+||+||++... .++..+++|.+.... ........+|+..+..+ +||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVL-QHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCCce
Confidence 47899999999999999999743 356789999886443 23334566899999998 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhccc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEE
Q 039371 77 YFVFEYMDC-NLHQLMSNRK--------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIK 140 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~--------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vk 140 (346)
+++|||+.+ +|.+.+.... ..+++..+..++.|++.|++|||++|++|+||||+||+++ ++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 999999984 6766665432 2478999999999999999999999999999999999995 45899
Q ss_pred EeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 039371 141 IADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAI 216 (346)
Q Consensus 141 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 216 (346)
|+|||++........ .....+++.|+|||.+. ...++.++|||||||++|+|++ |.+||......+....+....
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 999999865433221 12233467899999886 5668999999999999999998 899997776655544443221
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 217 GSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.. .....+++.+.+++.+||+.||.+||++.++++
T Consensus 242 ~~-----------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 242 EL-----------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 10 011356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=286.63 Aligned_cols=241 Identities=24% Similarity=0.451 Sum_probs=193.9
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC-CC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD-CN 86 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~-g~ 86 (346)
+.||+|+||.||+|... ++..+|+|.++............+|+..++++ +||||+++++++...+..+++|||+. |+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 46899999999999864 67889999987665444444567899999998 79999999999999999999999997 57
Q ss_pred HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC--ccccccC
Q 039371 87 LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY--TEYITTL 163 (346)
Q Consensus 87 l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~--~~~~~t~ 163 (346)
+.+.+......+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||++......... ....++.
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 7777665555689999999999999999999999999999999999995 458999999998654432211 1123456
Q ss_pred cccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 164 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
.|+|||++. ...++.++||||+|+++|++++ |..||...........+.... ..
T Consensus 159 ~y~aPE~~~-~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--------------------~~---- 213 (250)
T cd05085 159 KWTAPEALN-YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--------------------RM---- 213 (250)
T ss_pred cccCHHHhc-cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--------------------CC----
Confidence 799999886 5668999999999999999998 999998776554444332110 00
Q ss_pred CCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 243 GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....++.++.+++.+|++.+|++|||+.++++
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 214 -----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 111346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=288.13 Aligned_cols=246 Identities=30% Similarity=0.508 Sum_probs=202.0
Q ss_pred eeeeeeecccCceEEEEEEEccCC----cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSG----EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+++.+.||.|+||.||+|.+..++ ..||+|++..............|+..+..+ +||||+++++.+.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEE
Confidence 467899999999999999998766 899999997665544555667899999999 899999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeecccccccCCCCCC
Q 039371 80 FEYMDC-NLHQLMSNRKQC-FSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~-l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~~~~~ 156 (346)
||++.| ++.+.+...... +++..+..++.|++.||++||+.|++|+||+|+||+++++ .++|+|||.+.........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999985 777776654444 8999999999999999999999999999999999999654 8999999999766543222
Q ss_pred c--cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 157 T--EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 157 ~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
. ...++..|+|||.+. ...++.++||||+||++|+|++ |.+||...+..+....+......
T Consensus 160 ~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 223 (258)
T smart00219 160 KKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL--------------- 223 (258)
T ss_pred ccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---------------
Confidence 2 233678899999885 5678999999999999999998 78999886666555554322110
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
......+.++.+++.+|+..||++|||+.++++
T Consensus 224 --------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 224 --------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 011246789999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=288.41 Aligned_cols=240 Identities=24% Similarity=0.378 Sum_probs=191.4
Q ss_pred eeecccCceEEEEEEEccCC---cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSG---EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
++||+|+||.||+|....++ ..+|+|.+.............+|+.+++.+ +||||+++++++.. +..+++||++.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 47999999999999876554 789999998666544455667899999998 79999999998764 45799999997
Q ss_pred -CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc----c
Q 039371 85 -CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT----E 158 (346)
Q Consensus 85 -g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~----~ 158 (346)
|++.+.+.... .+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||.+.......... .
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 47777766544 689999999999999999999999999999999999995 5689999999987654332211 1
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..++..|+|||.+. ...++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 158 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------- 217 (257)
T cd05060 158 GRWPLKWYAPECIN-YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL------------------- 217 (257)
T ss_pred ccccccccCHHHhc-CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-------------------
Confidence 12345799999886 5668999999999999999998 99999877665544443221100
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....++..+++++.+||..||++|||+.++++
T Consensus 218 ----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 218 ----------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011356788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=295.51 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=200.5
Q ss_pred ceeeeeeecccCceEEEEEEEc---cCCcEEEEEEccccccCH---HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYSW---EECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
+|++.+.||+|++|.||++++. .+++.||+|+++...... ......+|+.++.++.+||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 467899999986543221 2234467999999997899999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
++||||+.| ++.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 999999985 666665543 4589999999999999999999999999999999999995 5689999999987654322
Q ss_pred C--CccccccCcccCcccccccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 155 P--YTEYITTLQYRAPEMLLMSG-QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 155 ~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
. .....++..|+|||.+.+.. ..+.++||||+|+++|+|++|..||...........+....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------------- 224 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--------------- 224 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH---------------
Confidence 1 22345788999999876432 36889999999999999999999996543221111111110
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT---AAEALQHPLFQGCL 288 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~ell~hp~~~~~~ 288 (346)
... . .......+..+.+++.+||+.||++||| +.++++||||+...
T Consensus 225 ~~~--~---------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 225 LKS--K---------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred Hcc--C---------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 000 0 0011246788999999999999999998 57789999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=290.71 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=192.1
Q ss_pred eeeeeeecccCceEEEEEEEccCCc--EEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeec------CC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGE--YVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASE------NY 74 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------~~ 74 (346)
|.+.+.||+|+||.||+|.+..++. .+|+|.++....... .....+|..+++.+ +||||+++++.+.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999887775 689999876543333 34456788999998 79999999987632 23
Q ss_pred EEEEEEEcCC-CCHHHHHhc-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccc
Q 039371 75 RLYFVFEYMD-CNLHQLMSN-----RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLA 147 (346)
Q Consensus 75 ~~~iv~e~~~-g~l~~~~~~-----~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a 147 (346)
..+++|||+. |++...+.. ....+++..+..++.|++.||+|||++||+||||||+||+++ ++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 5689999998 566665532 223489999999999999999999999999999999999995 568999999999
Q ss_pred cccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhh
Q 039371 148 WEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEES 223 (346)
Q Consensus 148 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 223 (346)
........ .....+++.|+|||... ...++.++||||+||++|+|++ |..||.+....+....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR------ 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHcc-CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 76543221 12234567899999886 5668999999999999999999 7899987665544443322110
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. ...+.++..+.+++.+||+.||++|||+++++++
T Consensus 233 --------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 --------------L---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --------------C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0113567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=290.61 Aligned_cols=248 Identities=29% Similarity=0.445 Sum_probs=198.5
Q ss_pred CceeeeeeecccCceEEEEEEEccC---CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS---GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|.+.+.||.|++|.||+|.+..+ ...|++|...............+|+.+++++ +||||+++++++.++ ..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~-~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITEN-PVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcCC-CcEE
Confidence 4789999999999999999987644 4579999887655444445567899999999 799999999998764 4689
Q ss_pred EEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
+||++. |++.+.+......+++..+..++.|++.||+|||+.|++|+||||+||+++ ++.++|+|||++.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 999997 577777766555689999999999999999999999999999999999995 469999999998765443221
Q ss_pred --ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 157 --TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 157 --~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
....++..|+|||.+. ...++.++|||||||++|++++ |..||......+....+......
T Consensus 164 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--------------- 227 (270)
T cd05056 164 KASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL--------------- 227 (270)
T ss_pred ecCCCCccccccChhhhc-cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---------------
Confidence 1223346799999876 5568899999999999999986 99999887766555444221100
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+.++..+.+++.+|+..+|.+|||+.++++.
T Consensus 228 --------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 228 --------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0123567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=287.90 Aligned_cols=244 Identities=28% Similarity=0.477 Sum_probs=195.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|+++++||+|+||.||+|... +++.||+|.+....... ....+|+.+++++ +||||+++++++.. +..+++||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~--~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSP--EAFLAEANLMKQL-QHPRLVRLYAVVTQ-EPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcH--HHHHHHHHHHHhc-CCcCeeeEEEEEcc-CCcEEEEE
Confidence 57999999999999999999865 56789999987655433 3456799999999 79999999998754 56899999
Q ss_pred cCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--C
Q 039371 82 YMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP--Y 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~--~ 156 (346)
++. |++.+.+... +..+++.++..++.|++.||+|||+.|++|+||+|+||+++ ++.++|+|||.+........ .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 997 5777776543 34689999999999999999999999999999999999995 45899999999876542221 1
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||++. ...++.++||||+|+++|+|++ |..||.+.+..+....+......+
T Consensus 161 ~~~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 223 (260)
T cd05067 161 EGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP---------------- 223 (260)
T ss_pred cCCcccccccCHHHhc-cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC----------------
Confidence 2234567899999886 5668899999999999999998 999998776655544432211100
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+.++.+++++||+.+|++|||++++++
T Consensus 224 -------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 224 -------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11245778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=322.73 Aligned_cols=146 Identities=30% Similarity=0.477 Sum_probs=125.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-H-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-W-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
|++|+++++||+|+||+||+|.+..+++.||+|++...... . .......|+.++..+ +||||+++++.+.....+|+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEE
Confidence 68999999999999999999999999999999999754322 1 223445678888777 89999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccc
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAW 148 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~ 148 (346)
||||+.| +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 82 VmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999975 666666543 4589999999999999999999999999999999999995 5699999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=293.95 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=195.7
Q ss_pred CceeeeeeecccCceEEEEEEEcc----------------CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ----------------SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVK 65 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~ 65 (346)
++|++.+.||+|+||+||++.+.. ++..+|+|++.............+|+.+++.+ +||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcce
Confidence 489999999999999999986443 34479999997654444445567899999999 7999999
Q ss_pred eeeeeecCCEEEEEEEcCC-CCHHHHHhccc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE
Q 039371 66 LQELASENYRLYFVFEYMD-CNLHQLMSNRK----------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV 134 (346)
Q Consensus 66 ~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli 134 (346)
+++++..++..+++||++. |+|.+.+.... ..+++..+..++.|++.||+|||++|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999997 57777765432 236778999999999999999999999999999999999
Q ss_pred e-CCcEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh--CCCCCCCCChHHH
Q 039371 135 S-NDTIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT--FHPLFPGTCEDDQ 208 (346)
Q Consensus 135 ~-~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~ 208 (346)
+ ++.++|+|||++........ .....++..|+|||... .+.++.++||||+||++|+|++ |..||......+.
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL-LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh-cCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 5 56899999999876543221 11223457899999876 4668999999999999999998 7789977655544
Q ss_pred HHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 209 LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 209 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
......... .. ......+ ..+.+++.+.+++.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~------------~~-~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 243 IENTGEFFR------------DQ-GRQVYLP---------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHh------------hc-cccccCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 332211000 00 0000000 11346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=286.86 Aligned_cols=244 Identities=30% Similarity=0.483 Sum_probs=194.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|++|.||+|.+..+ ..+|+|.+...... .....+|+.+++++ +|||++++++++.. +..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~--~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM--PEAFLQEAQIMKKL-RHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc--HHHHHHHHHHHHhC-CCCCeeeEEEEEcC-CCcEEEEE
Confidence 6899999999999999999987655 45899988654332 23456799999998 79999999998864 45789999
Q ss_pred cCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CC
Q 039371 82 YMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~ 156 (346)
|+.+ ++.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+....... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 9985 788777653 33489999999999999999999999999999999999995 5689999999997654322 11
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||... ...++.++||||+|+++|+|++ |..||.+....+....+......+
T Consensus 161 ~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 223 (260)
T cd05069 161 QGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP---------------- 223 (260)
T ss_pred CCCccchhhCCHHHhc-cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 2234567899999876 5668999999999999999999 899998876655544443211100
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+..+.+++++||+.||.+||+++++++
T Consensus 224 -------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 224 -------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11245788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=291.91 Aligned_cols=262 Identities=25% Similarity=0.446 Sum_probs=195.7
Q ss_pred ceeeeeeecccCceEEEEEEE----ccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIK----KQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN--YRL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~ 76 (346)
-|++++.||+|+||.||+|.. ..++..||+|.++............+|+.+++++ +|||++++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCce
Confidence 368999999999999999974 4578899999987654444445567899999999 799999999998765 578
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
+++|||++| +|.+.+......+++..+..++.|++.||+|||++|++||||||+||+++ ++.++|+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 999999975 67666655555689999999999999999999999999999999999995 4589999999997654332
Q ss_pred C----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh-HHHHHH
Q 039371 155 P----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES-WAEGLE 229 (346)
Q Consensus 155 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~ 229 (346)
. .....++..|+|||.+. ...++.++||||+||++|+|+++..|+..... .. ....+....+. ......
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLI-QSKFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cceeecCCCCCCccccCHHHhc-cCCCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccccHHHHHH
Confidence 1 12345667899999886 45688999999999999999998776533211 11 11111111110 011111
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.. ..+...+ ....++..+.+|+.+||+.||++|||+++++++
T Consensus 238 ~~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VL-EEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HH-HcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11 1111111 123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.75 Aligned_cols=256 Identities=33% Similarity=0.511 Sum_probs=198.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec---------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--------- 72 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--------- 72 (346)
++|+.++.||+||||.||+++++-+|+.||||.+.............+|+..+.++ +|||||+++..+.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcccccc
Confidence 57889999999999999999999999999999998776555556678999999999 89999999753210
Q ss_pred --------------------------------------------------------------------------------
Q 039371 73 -------------------------------------------------------------------------------- 72 (346)
Q Consensus 73 -------------------------------------------------------------------------------- 72 (346)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CEEEEEEEcCCCCHHHHHhcccCCC-CHHHHHHHHHHHHHHHHHHHHCC
Q 039371 73 ----------------------N--------YRLYFVFEYMDCNLHQLMSNRKQCF-SEAEVKNWCFQILQGLNYMHRQG 121 (346)
Q Consensus 73 ----------------------~--------~~~~iv~e~~~g~l~~~~~~~~~~l-~~~~~~~i~~ql~~~l~~LH~~~ 121 (346)
+ ..+||-||||+-+++..+..++... ....+++++++|++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 2468999999988887777666534 57889999999999999999999
Q ss_pred ccccCCCCCCEEEe-CCcEEEeecccccccC-------------------CCCCCccccccCcccCcccccccC--CCCC
Q 039371 122 YFHRDLISKNLLVS-NDTIKIADFGLAWEVD-------------------SCPPYTEYITTLQYRAPEMLLMSG--QYNS 179 (346)
Q Consensus 122 ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~--~~~~ 179 (346)
|+||||||.||+++ ++.|||+|||+|+... .....+..+||.-|+|||++.+.. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 99999999999996 5699999999997621 112345678999999999997665 6999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHH
Q 039371 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMS 259 (346)
Q Consensus 180 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (346)
|+|+||||++++||+. ||...-+. .. ++..+..+. +|.. ..+....-+....
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMER--a~-iL~~LR~g~-----------------iP~~-----~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMER--AS-ILTNLRKGS-----------------IPEP-----ADFFDPEHPEEAS 849 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHH--HH-HHHhcccCC-----------------CCCC-----cccccccchHHHH
Confidence 9999999999999985 46433222 11 222211111 0000 0011122345568
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 260 LIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 260 li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
+|++|++.||.+||||.|+|++.||-.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 999999999999999999999999873
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=315.97 Aligned_cols=203 Identities=27% Similarity=0.476 Sum_probs=177.6
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC------EEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY------RLY 77 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~------~~~ 77 (346)
+...+.||+|+||.||+++++.+|+.||+|.++.........+..+|+++++++ +|||||+++++-++.. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccce
Confidence 456688999999999999999999999999998876666666778999999999 6999999999876544 568
Q ss_pred EEEEcCCC-CHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC---C--cEEEeecccccc
Q 039371 78 FVFEYMDC-NLHQLMSNR--KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN---D--TIKIADFGLAWE 149 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~---~--~vkl~Dfg~a~~ 149 (346)
++||||.| +|...+... ...++|.++..++.++..|+.|||++||+||||||.||++-. | ..||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999985 566655432 234999999999999999999999999999999999999932 3 579999999999
Q ss_pred cCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 039371 150 VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD 207 (346)
Q Consensus 150 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 207 (346)
.++.....+..||+.|.+||.+...++|+..+|.||+||++|+++||..||.......
T Consensus 174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk 231 (732)
T KOG4250|consen 174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK 231 (732)
T ss_pred CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence 9999999999999999999999766889999999999999999999999997665543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=284.65 Aligned_cols=246 Identities=25% Similarity=0.440 Sum_probs=198.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|++|.||+|.+. .++.+|+|.+....... ....+|+.+++++ +|||++++++++......+++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~--~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE--EDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH--HHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEEE
Confidence 57999999999999999999875 46789999987554432 2356799999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--Cc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP--YT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~--~~ 157 (346)
|+.| +|.+.+....+.+++..+..++.|++.|+++||+.|++|+||+|+||+++ ++.++|+|||.+........ ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 9985 66666665556689999999999999999999999999999999999996 55899999999875543221 11
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...++..|+|||.+. ...++.++||||+|+++|+|++ |..||......+....+.......
T Consensus 160 ~~~~~~~~~aPe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 221 (256)
T cd05112 160 GTKFPVKWSSPEVFS-FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY----------------- 221 (256)
T ss_pred CCccchhhcCHhHhc-cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC-----------------
Confidence 223456899999886 4668899999999999999998 999998776655444432211000
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.....+..+.+++.+||+.+|++|||+++++++
T Consensus 222 ------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 222 ------------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 012356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=285.13 Aligned_cols=241 Identities=26% Similarity=0.466 Sum_probs=194.0
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-C
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-N 86 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~ 86 (346)
++||.|++|.||+|.+.. ++.|++|.+.............+|+.+++++ +||||+++++++.+.+..+++||++.| +
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 479999999999999887 8999999987665543445567899999988 799999999999999999999999975 6
Q ss_pred HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC---cccccc
Q 039371 87 LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY---TEYITT 162 (346)
Q Consensus 87 l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~---~~~~~t 162 (346)
+.+.+......+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.++|+|||.+......... .....+
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 7777766555689999999999999999999999999999999999995 568999999998765421111 112335
Q ss_pred CcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCc
Q 039371 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241 (346)
Q Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
..|+|||.+. ...++.++|||||||++|+|++ |..||...........+..... .+
T Consensus 159 ~~y~~PE~~~-~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~--------------------~~-- 215 (251)
T cd05041 159 IKWTAPEALN-YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR--------------------MP-- 215 (251)
T ss_pred eccCChHhhc-cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC--------------------CC--
Confidence 6799999886 5568999999999999999998 8899977665443333321100 00
Q ss_pred CCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+..+.+++.+|++.+|.+|||++|+++
T Consensus 216 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 216 -------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 01245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=292.32 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=196.2
Q ss_pred CceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
.+|.+.+.||+|+||.||+|.+.. ++..+++|.+...... ......+|+..++++ +||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTNL-QHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH-HHHHHHHHHHHHhcC-CCCCcceEEEEEccCCce
Confidence 479999999999999999997543 4556889988654332 223456889999998 799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcE
Q 039371 77 YFVFEYMD-CNLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTI 139 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~v 139 (346)
++||||++ +++.+.+.... +.+++..+..++.||+.||+|||++|++|+||||+||+++ ++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999997 57777665422 3488999999999999999999999999999999999995 5589
Q ss_pred EEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 039371 140 KIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNA 215 (346)
Q Consensus 140 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 215 (346)
+|+|||++....... ......++..|+|||.+. ...++.++||||+||++|+|++ |..||...+..+....+...
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 999999987654322 122344577899999886 5668999999999999999998 99999877665544433211
Q ss_pred hCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 216 IGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.. + ......+..+.+++.+||+.||++|||+.++++
T Consensus 242 ~~---------------------~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 242 RV---------------------L--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CC---------------------C--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 10 0 011245788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=287.82 Aligned_cols=250 Identities=28% Similarity=0.458 Sum_probs=200.5
Q ss_pred ceeeeeeecccCceEEEEEEEcc-CCcEEEEEEccccc---------cCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQ-SGEYVAIKALKQRI---------YSWEECLNLKEVKCLRKINNHPNIVKLQELASE 72 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~ 72 (346)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .........+|+.++.+..+||||+++++.+.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999887 68899999885332 112223446788888775589999999999999
Q ss_pred CCEEEEEEEcCCC-CHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-CCcEEEeeccc
Q 039371 73 NYRLYFVFEYMDC-NLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS-NDTIKIADFGL 146 (346)
Q Consensus 73 ~~~~~iv~e~~~g-~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~-~~~vkl~Dfg~ 146 (346)
++..+++|||+.| ++.+.+. .....+++..+..++.|++.||.|||+ .|++|+||+|+||+++ ++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999985 6655542 334568999999999999999999996 6899999999999995 55899999999
Q ss_pred ccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHH
Q 039371 147 AWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 147 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (346)
+.............++..|+|||.+. ...++.++|+||+|+++|+|++|..||...........+......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 234 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP----- 234 (269)
T ss_pred eeecccccccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC-----
Confidence 97765544444567888999999887 566899999999999999999999999776655444443322111110
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+++.+.+++++||+.||++||++.|+.++
T Consensus 235 -----------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 -----------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -----------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 12457889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=293.32 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=196.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc----EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|+..+.||+|+||.||+|.+..++. .+|+|.+.............+|..++..+ +||||+++++.+... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-Cce
Confidence 578999999999999999999887776 47888887554444444556888888888 799999999998765 467
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
+++|+++ |++.+.+......+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++........
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 8999998 678888776666789999999999999999999999999999999999995 56899999999976543221
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....++..|+|||.+. ...++.++|||||||++|+|++ |+.||.+....+... +......
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~------------- 229 (303)
T cd05110 165 EYNADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-LLEKGER------------- 229 (303)
T ss_pred ccccCCCccccccCCHHHhc-cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHCCCC-------------
Confidence 22234567899999886 5668999999999999999997 899997765433322 2211110
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+ ..+..+.++.+++.+|+..||++||+++++++.
T Consensus 230 ------~~---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 230 ------LP---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 012456789999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=289.04 Aligned_cols=248 Identities=23% Similarity=0.398 Sum_probs=196.8
Q ss_pred CceeeeeeecccCceEEEEEEEcc----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec-CCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE-NYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-~~~~ 76 (346)
++|++.+.||+|+||.||+|.+.. ++..|++|.+.............+|+.+++++ +||||+++++++.. +...
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCC
Confidence 589999999999999999999876 35789999987554444455567899999999 89999999998655 5778
Q ss_pred EEEEEcCC-CCHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccc
Q 039371 77 YFVFEYMD-CNLHQLMSNRK-------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLA 147 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a 147 (346)
++++|++. |++.+.+.... ..+++..+..++.|++.||+|||+++++|+||||+||+++ ++.+||+|||++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 99999997 57777665432 3589999999999999999999999999999999999995 569999999999
Q ss_pred cccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhh
Q 039371 148 WEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEES 223 (346)
Q Consensus 148 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 223 (346)
+...... ......++..|+|||.+. ...++.++||||+||++|++++ |..||...+..+....+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------- 235 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLV-NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-------- 235 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHh-cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC--------
Confidence 7543321 112234566799999886 5568999999999999999998 99999876654433322211
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+ ....+++++.+++.+|++.||++|||+.++++
T Consensus 236 ------------~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 ------------YRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ------------CCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 01245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=287.04 Aligned_cols=238 Identities=18% Similarity=0.287 Sum_probs=182.9
Q ss_pred eeecccCceEEEEEEEccC------------CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE
Q 039371 8 KQIGEGSFGKVWQAIKKQS------------GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYR 75 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~------------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~ 75 (346)
+.||+|+||.||+|+.... ...+++|++..... ........|+.++..+ +||||+++++++.++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQV-SHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCC
Confidence 4689999999999975322 23588898765432 2233455677888888 79999999999999888
Q ss_pred EEEEEEcCCCC-HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC--------cEEEeeccc
Q 039371 76 LYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND--------TIKIADFGL 146 (346)
Q Consensus 76 ~~iv~e~~~g~-l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~--------~vkl~Dfg~ 146 (346)
.+++|||++++ +...+......+++..+..++.|+++||+|||++|++||||||+||++++. .++++|||.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999964 444554445669999999999999999999999999999999999999532 289999998
Q ss_pred ccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCChhhHH
Q 039371 147 AWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELI-TFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 147 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (346)
+...... ....++..|+|||.+.....++.++||||+||++|+|+ +|..||......+... ....
T Consensus 159 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~---------- 224 (262)
T cd05077 159 PITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG---------- 224 (262)
T ss_pred CccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc----------
Confidence 8654322 23457788999998875677899999999999999998 5888887654332211 1000
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
... .....+.++.+++.+||+.||.+||++.+++++
T Consensus 225 -----------~~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 -----------QCM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -----------Ccc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 000 012335678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=289.62 Aligned_cols=238 Identities=17% Similarity=0.277 Sum_probs=185.2
Q ss_pred eeecccCceEEEEEEEccCCc-------EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 8 KQIGEGSFGKVWQAIKKQSGE-------YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+.||+|+||+||+|.++.++. .+++|.+..... ........|..+++.+ +|||++++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhH-HHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEE
Confidence 479999999999998876544 388888754322 2223445677888887 7999999999999988999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC---------cEEEeeccccccc
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND---------TIKIADFGLAWEV 150 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~---------~vkl~Dfg~a~~~ 150 (346)
||+++ +|...+...+..+++..+..++.|++.||+|||++||+||||||+||+++++ .++++|||.+...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 99985 6666766655568999999999999999999999999999999999999543 2799999988654
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFH-PLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.. .....++..|+|||++.+...++.++||||+||++|+|++|. .||............ ..
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~-------------- 220 (258)
T cd05078 159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-ED-------------- 220 (258)
T ss_pred CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hc--------------
Confidence 43 233467889999999975566899999999999999999984 666554433322111 10
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
... .....+.++.+++.+||+.||++|||++++++.
T Consensus 221 -----~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 -----RHQ-----------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -----ccc-----------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 001 112345778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=304.39 Aligned_cols=248 Identities=26% Similarity=0.444 Sum_probs=206.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc---E-EEEEEcccc--ccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE---Y-VAIKALKQR--IYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~ 75 (346)
++..+.++||+|+||.||+|+.+..+. . ||+|..+.+ ........+++|.++++++ +|||||++||+......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCc
Confidence 355677999999999999998775432 3 899998852 3344556678999999998 89999999999999999
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeecccccccCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~~ 153 (346)
++||||+|.| +|.+++.+.++.++..+...++.+.+.||+|||+++++||||-..|+|++.+ .+||+|||+++....-
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 9999999985 8888888887779999999999999999999999999999999999999875 5699999998765421
Q ss_pred CCCc-cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh-CCCChhhHHHHHHH
Q 039371 154 PPYT-EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAI-GSPTEESWAEGLEL 230 (346)
Q Consensus 154 ~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~ 230 (346)
.... .......|+|||.+. ...|+.++||||+||++||+.+ |..||.+....+....|.... ..+.+
T Consensus 316 ~~~~~~~klPirWLAPEtl~-~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--------- 385 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLN-TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--------- 385 (474)
T ss_pred eeccccccCcceecChhhhc-cCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC---------
Confidence 1111 223567899999997 5689999999999999999998 889999999988888884432 11111
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+.++..++.+|+..||++|||+.++.+
T Consensus 386 --------------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 386 --------------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --------------------CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 245678889999999999999999998866
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=288.27 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=198.6
Q ss_pred CceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|+.+. +.+.+++|.+.............+|+.+++++ +||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCCcc
Confidence 589999999999999999999764 34679999886554433445567899999999 799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccc
Q 039371 77 YFVFEYMD-CNLHQLMSNRK--------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGL 146 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~ 146 (346)
+++||+++ |+|.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++++|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 99999998 57777765443 1589999999999999999999999999999999999995 56899999998
Q ss_pred ccccCCCC--CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhh
Q 039371 147 AWEVDSCP--PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEES 223 (346)
Q Consensus 147 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 223 (346)
+....... ......++..|+|||.+. ....+.++||||+|+++|+|++ |..||...........+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~------ 236 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL------ 236 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc------
Confidence 86443221 223345677899999886 4557899999999999999998 7889976655444333321110
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.. .....++..+.+++.+||+.||++|||+.+++++
T Consensus 237 -------------~~---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 -------------EL---------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------CC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 0113567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=284.38 Aligned_cols=242 Identities=25% Similarity=0.378 Sum_probs=196.0
Q ss_pred eeecccCceEEEEEEEcc-CCc--EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 8 KQIGEGSFGKVWQAIKKQ-SGE--YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
+.||+|++|.||+|.+.. +++ .||+|.+.............+|+..++++ +||||+++++.+.+ ...+++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998765 333 69999998766644455567899999999 79999999999988 88999999997
Q ss_pred -CCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC----Cc
Q 039371 85 -CNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP----YT 157 (346)
Q Consensus 85 -g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~----~~ 157 (346)
|+|.+.+.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++ ++.+||+|||++........ ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 57887776654 4689999999999999999999999999999999999995 56999999999876544211 11
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...++..|+|||.+. ...++.++||||+||++|+|++ |..||...+..+....+.......
T Consensus 159 ~~~~~~~y~~pE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 220 (257)
T cd05040 159 HLKVPFAWCAPESLR-TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL----------------- 220 (257)
T ss_pred CCCCCceecCHHHhc-ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC-----------------
Confidence 234677899999876 5668999999999999999998 999998777666555543211000
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+ .....+..+.+++.+||+.+|++|||+.++++
T Consensus 221 --~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 --E---------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred --C---------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0 01245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=285.60 Aligned_cols=262 Identities=23% Similarity=0.324 Sum_probs=214.0
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
.+-++.||.|+||+|++..++.+|+..|+|.+.....+.+..+.+.|.....+..++||||++|+..-.++..||-||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34567899999999999999999999999999988887788888899999888889999999999988888899999999
Q ss_pred CCCHHHHHh----cccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 84 DCNLHQLMS----NRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 84 ~g~l~~~~~----~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
+-++..... ..+..++|+.+..|.--.+.||.||-.. .|+|||+||+|||++ .|.+||||||.+-...++-..+
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 976655432 2344599999999999999999999965 899999999999996 5799999999997666554455
Q ss_pred cccccCcccCcccccccCC-CCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 158 EYITTLQYRAPEMLLMSGQ-YNSKVDMWALGLIMAELITFHPLFPGTCE-DDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.-.|...|||||.+..... |+.+||+||||+++||+.||..||..-+. -+++..++.+ .|+.-.
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g--dpp~l~------------ 291 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG--DPPILL------------ 291 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC--CCCeec------------
Confidence 5678889999999986665 89999999999999999999999976433 2333333222 222100
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
++ .---.++..++.+|..||..|-..||..++++++||++....
T Consensus 292 --~~--------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 292 --FD--------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred --Cc--------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 00 000147889999999999999999999999999999986543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=287.16 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=187.8
Q ss_pred eeecccCceEEEEEEEcc--CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQ--SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
++||+|+||+||+|.... ....+++|.+.............+|+..++.+ +||||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCC
Confidence 469999999999996443 34578888876554444445567888888888 799999999999999999999999985
Q ss_pred -CHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---CC
Q 039371 86 -NLHQLMSNRKQ----CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP---PY 156 (346)
Q Consensus 86 -~l~~~~~~~~~----~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~---~~ 156 (346)
+|.+.+..... ..++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++....... ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 77776655332 246788899999999999999999999999999999995 5599999999986533221 11
Q ss_pred ccccccCcccCcccccc------cCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 157 TEYITTLQYRAPEMLLM------SGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
....++..|+|||++.. ...++.++||||+||++|+|++ |..||......+.+..+......+.+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------- 231 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP-------- 231 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC--------
Confidence 22345677999998752 2356889999999999999999 78899877666555554332211110
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
. .......+....+++..|+ .||++|||++++++
T Consensus 232 ----------~------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 232 ----------K------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ----------C------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0 0112356788889999888 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=301.73 Aligned_cols=281 Identities=27% Similarity=0.427 Sum_probs=228.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcC-----CCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINN-----HPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-----hp~iv~~~~~~~~~~~~ 76 (346)
++|.+....|+|-||+|..|.+..-|..||||++.....-.+. -+.|+.+|++|.. --|+++++..|...+++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~Kt--Gl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKT--GLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhh--hhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 5899999999999999999999999999999999765443322 3579999999852 34799999999999999
Q ss_pred EEEEEcCCCCHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC--cEEEeecccccccCC
Q 039371 77 YFVFEYMDCNLHQLMSNRKQ--CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND--TIKIADFGLAWEVDS 152 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~--~vkl~Dfg~a~~~~~ 152 (346)
|+|+|.+.-+|.+.+.+.+. .+....++.++.|++.||..|-..||+|.||||+|||++.+ .+||||||.|...+.
T Consensus 510 ClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 510 CLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred EEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccc
Confidence 99999999999999877643 48889999999999999999999999999999999999654 899999999977765
Q ss_pred CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
. ..+++..+..|.|||++. +..|+.+.|+||+||+||||.||+..|++.+....+...+...|..+..+...++-.-.
T Consensus 590 n-eitPYLVSRFYRaPEIiL-G~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 590 N-EITPYLVSRFYRAPEIIL-GLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred c-cccHHHHHHhccCcceee-cCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 3 345566788899999998 67799999999999999999999999999999999999999999888877665433222
Q ss_pred hcCC--CCCCc-----CCCC-------------c-ccc---------cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCC
Q 039371 233 AHGY--KFPKL-----QGNN-------------L-SLL---------IPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282 (346)
Q Consensus 233 ~~~~--~~~~~-----~~~~-------------~-~~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp 282 (346)
.++. .|-.. .... + +.+ .+.+-..+++|+.+||..||++|.|..++|+||
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 2111 11111 0000 0 000 011223678999999999999999999999999
Q ss_pred CCCC
Q 039371 283 LFQG 286 (346)
Q Consensus 283 ~~~~ 286 (346)
||++
T Consensus 748 Fi~~ 751 (752)
T KOG0670|consen 748 FITE 751 (752)
T ss_pred cccC
Confidence 9975
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=297.98 Aligned_cols=259 Identities=27% Similarity=0.398 Sum_probs=196.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-EEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY-RLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~-~~~iv~ 80 (346)
++|.-.+.||+|+||+||+|.... |+.||||.++...... ...+.+|+.++.++ +|||+++++|++.+.+ ..++|+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSRL-RHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhcC-CCcCcccEEEEEecCCceEEEEE
Confidence 356667899999999999998664 4899999887655442 33488999999999 5999999999999988 599999
Q ss_pred EcCC-CCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCCEEEeCC-cEEEeecccccccCC-C
Q 039371 81 EYMD-CNLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQG---YFHRDLISKNLLVSND-TIKIADFGLAWEVDS-C 153 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~-~ 153 (346)
||+. |+|.+.+..... ++++....+|+.+++.||+|||... |+||||||+|||+|.+ ..||+|||+|..... .
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 9998 788888877765 7999999999999999999999863 9999999999999855 999999999966554 3
Q ss_pred CCCccc-cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 154 PPYTEY-ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE--DDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 154 ~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
...... .||.+|+|||++. .+..+.++||||+|+++.|+++|+.|.+.... ...+......
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~-~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~--------------- 295 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYAS-TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP--------------- 295 (361)
T ss_pred cceeeecCCCCccCChhhhc-cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH---------------
Confidence 333333 7999999999886 57899999999999999999999988765431 1111111100
Q ss_pred HHhcCCCCCCcCCCCccc-ccC--CCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 231 AKAHGYKFPKLQGNNLSL-LIP--SANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+ ....+....+.. ..+ ..-..+..+...|++.+|++||+..|+++
T Consensus 296 ~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 296 LLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00000 222222222210 001 11223567889999999999999999755
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=284.68 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=186.5
Q ss_pred eeecccCceEEEEEEEcc---CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee-cCCEEEEEEEcC
Q 039371 8 KQIGEGSFGKVWQAIKKQ---SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS-ENYRLYFVFEYM 83 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~-~~~~~~iv~e~~ 83 (346)
+.||+|+||.||+|.+.. ++..+|+|.+.............+|..+++.+ +||||+++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998653 34579999886543333344556788888888 8999999999764 456689999999
Q ss_pred C-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-----CC
Q 039371 84 D-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-----PY 156 (346)
Q Consensus 84 ~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-----~~ 156 (346)
. |++.+.+.......++..+..++.|++.||.|||+.+++|+||||+||+++ ++.+||+|||++....... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 8 577777766555578888999999999999999999999999999999995 4589999999987543311 11
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||.+. ...++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 160 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~------------------ 220 (262)
T cd05058 160 TGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR------------------ 220 (262)
T ss_pred ccCcCCccccChhHhc-cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC------------------
Confidence 2234567899999886 4668999999999999999999 4677876655443333221100
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+ .....++.+.+++.+||+.+|++||++.++++.
T Consensus 221 --~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 --LL---------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred --CC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00 012356789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=287.06 Aligned_cols=237 Identities=16% Similarity=0.258 Sum_probs=182.5
Q ss_pred eecccCceEEEEEEEccC------------------------CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCee
Q 039371 9 QIGEGSFGKVWQAIKKQS------------------------GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64 (346)
Q Consensus 9 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv 64 (346)
.||+|+||.||+|....+ ...|++|++..... .......+|+.+++.+ +||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l-~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQV-SHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcC-CCCCee
Confidence 699999999999975322 23588898865432 2233455677777777 799999
Q ss_pred eeeeeeecCCEEEEEEEcCCCC-HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC------
Q 039371 65 KLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND------ 137 (346)
Q Consensus 65 ~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~------ 137 (346)
++++++.++...++||||++|+ +...+....+.+++..+..++.|++.||+|||++||+||||||+||+++..
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999999964 545554545668999999999999999999999999999999999999532
Q ss_pred --cEEEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHH
Q 039371 138 --TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELI-TFHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 138 --~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~ 214 (346)
.++++|||.+...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||......+..... .
T Consensus 160 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~ 235 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-E 235 (274)
T ss_pred cceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH-H
Confidence 4899999987543321 22356788999998875567899999999999999985 689999776544322211 1
Q ss_pred HhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. ....+ ...++.+.++|.+||+.+|++|||+.+++++
T Consensus 236 ~-------------------~~~~~-----------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 236 K-------------------KHRLP-----------EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred h-------------------ccCCC-----------CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 0 00111 1235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=282.80 Aligned_cols=245 Identities=24% Similarity=0.427 Sum_probs=195.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.++|++.+.||+|+||.||+|.+. .+..+++|.+..... ......+|+.+++++ +|+||+++++.+.+ ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--SVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh--HHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEEE
Confidence 478999999999999999999755 456699998865422 234456799999998 79999999999887 6789999
Q ss_pred EcCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 81 EYMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 81 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
||++ |++.+.+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||.+........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 9997 5888777653 34578899999999999999999999999999999999995 45999999999876543221
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
.....++..|+|||.+. ...++.++|+||+||++|++++ |..||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------------- 221 (260)
T cd05073 160 REGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR----------------- 221 (260)
T ss_pred ccCCcccccccCHhHhc-cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------------
Confidence 12223456799999886 5668999999999999999998 8999987766554443322110
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
. ......+.++.+++.+|++.||++||+++++++
T Consensus 222 ---~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 ---M---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ---C---------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 011356788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=286.21 Aligned_cols=242 Identities=28% Similarity=0.473 Sum_probs=191.9
Q ss_pred eeecccCceEEEEEEEccCC------cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 8 KQIGEGSFGKVWQAIKKQSG------EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+.||+|+||.||+|++.... ..+|+|.+.............+|+.+++.+ +||||+++++++...+..+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEe
Confidence 46899999999999876544 689999887654444455567899999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC------cEEEeeccccc
Q 039371 82 YMD-CNLHQLMSNR------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND------TIKIADFGLAW 148 (346)
Q Consensus 82 ~~~-g~l~~~~~~~------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~------~vkl~Dfg~a~ 148 (346)
+++ |++.+.+... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 998 5777776542 2347889999999999999999999999999999999999643 69999999986
Q ss_pred ccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhH
Q 039371 149 EVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 149 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (346)
....... .....++..|+|||.+. ...++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------- 230 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-------- 230 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHc-cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC--------
Confidence 5533211 12234567899999886 5668999999999999999998 999998776655444332110
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.. ......+..+.++|.+||+.+|.+||+++++++
T Consensus 231 ------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 ------------RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 011346788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=282.53 Aligned_cols=227 Identities=23% Similarity=0.329 Sum_probs=181.1
Q ss_pred cCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-CHHHHH
Q 039371 13 GSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLM 91 (346)
Q Consensus 13 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l~~~~ 91 (346)
|.+|+||++.++.+++.||+|.+...... .+|...+... .||||+++++++.+.+..+++|||++| +|.+.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~------~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY------SRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh------hhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 88999999999999999999999764321 1233334444 699999999999999999999999985 676666
Q ss_pred hcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccccccCcccCccc
Q 039371 92 SNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170 (346)
Q Consensus 92 ~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~ 170 (346)
... ..+++..+..++.|+++||.|||++|++|+||||+||+++ ++.++++|||.+...... .....++..|+|||.
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~ 153 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV 153 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence 554 3499999999999999999999999999999999999995 568999999987655432 233456778999998
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCccccc
Q 039371 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLI 250 (346)
Q Consensus 171 ~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
.. ...++.++|+||+||++|+|++|..||........ ... .....
T Consensus 154 ~~-~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------------------~~~------~~~~~ 198 (237)
T cd05576 154 GG-ISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------------------THT------TLNIP 198 (237)
T ss_pred cC-CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------------------ccc------ccCCc
Confidence 75 45678999999999999999999988743211000 000 00112
Q ss_pred CCCCchHHHHHHHhcccCCCCCCCH-----HHHhcCCCC
Q 039371 251 PSANDDEMSLIELLCSWDPCKRPTA-----AEALQHPLF 284 (346)
Q Consensus 251 ~~~~~~~~~li~~~l~~dP~~Rps~-----~ell~hp~~ 284 (346)
+.+++.+.++|++||+.||++|||+ +++++||||
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 3467889999999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=310.99 Aligned_cols=245 Identities=29% Similarity=0.494 Sum_probs=209.5
Q ss_pred ceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
+.+..++||+|+||+||+|.... +...||||.++.........++.+|+..+..+ +|||||+++|++.+++.+|
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCeeE
Confidence 56788999999999999997553 33579999999887777888889999999999 8999999999999999999
Q ss_pred EEEEcCC-CCHHHHHhccc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEe
Q 039371 78 FVFEYMD-CNLHQLMSNRK-------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIA 142 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~-------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~ 142 (346)
+|+|||. |+|.+.+.... .+++..+...|+.||+.|++||-++.+|||||-..|.||.++ .|||+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEec
Confidence 9999998 89998886432 238889999999999999999999999999999999999776 99999
Q ss_pred ecccccccCCCCCCc---cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 039371 143 DFGLAWEVDSCPPYT---EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGS 218 (346)
Q Consensus 143 Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 218 (346)
|||+++.+=...-+. ...-...|||||.+. .++++.+|||||+||++||+++ |..||.+....+..+.+.++.
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~-- 722 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ-- 722 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhh-cCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC--
Confidence 999997654432221 223456899999998 6779999999999999999997 889999999999888875532
Q ss_pred CChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHH
Q 039371 219 PTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEA 278 (346)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~el 278 (346)
+-.....++.++.+|+..|++.+|++||+++||
T Consensus 723 ---------------------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 723 ---------------------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred ---------------------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 112235789999999999999999999999998
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=284.74 Aligned_cols=263 Identities=24% Similarity=0.406 Sum_probs=192.9
Q ss_pred CceeeeeeecccCceEEEEEE----EccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee--cCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS--ENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~--~~~~ 75 (346)
++|++++.||+|+||+||+|. +..+++.||+|.+..... .......+|+.++.++ +||||+++++++. +...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCc
Confidence 478999999999999999997 446788999999865432 2233456899999998 7999999999764 3456
Q ss_pred EEEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
++++|||+. |+|.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++ ++.++|+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 899999997 578777766556689999999999999999999999999999999999995 568999999999765432
Q ss_pred CCC----ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 PPY----TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
... ....++..|+|||.+. ...++.++||||+||++|+|++|..|+...... ....+ .... ..........+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~-~~~~-~~~~~~~~~~~ 237 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMM-GNDK-QGQMIVYHLIE 237 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhc-cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhc-cccc-ccccchHHHHH
Confidence 211 1122344699999886 566899999999999999999988776443221 11110 0000 00000000111
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.. ......+ ....++.++.+++.+||+.+|++|||+.++++
T Consensus 238 ~~-~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 LL-KNNGRLP---------APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HH-hcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 1111111 12356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=283.07 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=187.4
Q ss_pred eeecccCceEEEEEEEc--cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC-
Q 039371 8 KQIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD- 84 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~- 84 (346)
+.||+|+||.||+|... .++..+|+|.++............+|+.+++++ +||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 46899999999999754 345679999987665544455667899999999 79999999999999889999999998
Q ss_pred CCHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCC---C
Q 039371 85 CNLHQLMSNRK----QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP---Y 156 (346)
Q Consensus 85 g~l~~~~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~---~ 156 (346)
|+|.+.+.... ...++..+..++.|++.|++|||+.|++|+||||+||+++. +.++|+|||.+........ .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 56766665322 23577788899999999999999999999999999999964 5899999999865433221 1
Q ss_pred ccccccCcccCccccccc------CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 157 TEYITTLQYRAPEMLLMS------GQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
....++..|+|||++... ..++.++||||+||++|+|++ |..||......+..........
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------ 227 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ------------ 227 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc------------
Confidence 224567789999988532 135789999999999999996 9999987665544332221110
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+. .......++.+.++++.|+ .+|++|||+++|+.
T Consensus 228 ------~~~~~------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 228 ------LKLPK------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ------CCCCC------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00100 0111245678889999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=281.44 Aligned_cols=241 Identities=27% Similarity=0.441 Sum_probs=192.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+++|++.+.||+|+||.||++. .+++.||+|.++... ......+|+.+++++ +|||++++++++..++ .+++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~-~~~v~ 77 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKL-HHKNLVRLLGVILHNG-LYIVM 77 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCCC-cEEEE
Confidence 3689999999999999999995 468889999986542 223456789999888 7999999999987654 79999
Q ss_pred EcCC-CCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 81 EYMD-CNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||+. |++.+.+.... ..+++..+..++.|++.||.|||+.|++||||||+||+++ ++.++|+|||++...... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~ 155 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VD 155 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CC
Confidence 9998 47877776543 3589999999999999999999999999999999999995 568999999998654332 12
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+..|+|||.+. ...++.++|+||+||++|+|++ |..||......+....+....
T Consensus 156 ~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------------- 214 (254)
T cd05083 156 NSKLPVKWTAPEALK-HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-------------------- 214 (254)
T ss_pred CCCCCceecCHHHhc-cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC--------------------
Confidence 233456899999886 5668999999999999999997 999998776554433332111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+ ....++..+.+++++||+.+|++||+++++++
T Consensus 215 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 RME---------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCC---------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 11356788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=316.56 Aligned_cols=247 Identities=26% Similarity=0.461 Sum_probs=211.5
Q ss_pred ceeeeeeecccCceEEEEEEEccCCc-----EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGE-----YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
+.++.+.||+|.||.||.|....-.- .||+|.++......+...+++|..+++.+ +||||++++++.-+....+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCCcE
Confidence 45788999999999999998664322 49999999888888888899999999999 8999999999998899999
Q ss_pred EEEEcCC-CCHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccc
Q 039371 78 FVFEYMD-CNLHQLMSNR------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWE 149 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~ 149 (346)
|++|||. |+|+.++++. ...++..+...++.||++|+.||+++++|||||...|.|++. ..|||+|||+|+.
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence 9999998 6899999877 556999999999999999999999999999999999999965 5899999999985
Q ss_pred cCCCCCCcc---ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHH
Q 039371 150 VDSCPPYTE---YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 150 ~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (346)
+-....+.. ..-...|||||.+. .+.++.++|||||||++||+++ |..||++.+..+.+....++.
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~-d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--------- 921 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLK-DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--------- 921 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHh-hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---------
Confidence 443322111 12346899999997 6889999999999999999998 889999999888887665543
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+.+. .+.+++.+.+++..||+.+|++||++..|++
T Consensus 922 -----------RL~~---------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -----------RLDP---------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -----------ccCC---------CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 2221 1478899999999999999999999999988
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=282.18 Aligned_cols=235 Identities=20% Similarity=0.318 Sum_probs=183.8
Q ss_pred eeecccCceEEEEEEEccCC----------cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 8 KQIGEGSFGKVWQAIKKQSG----------EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
+.||+|+||.||+|.+..++ ..+++|++...... .....+|+.+++++ +||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQL-SHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcC-CCcchhheeeEEec-CCcE
Confidence 47899999999999998777 35788877654332 44556788888888 79999999999887 7789
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC--------cEEEeeccccc
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND--------TIKIADFGLAW 148 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~--------~vkl~Dfg~a~ 148 (346)
+||||+.+ +|.+.+......+++..+..++.|++.||.|||++||+|+||||+||+++.. .++|+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999985 5666665555469999999999999999999999999999999999999643 59999999987
Q ss_pred ccCCCCCCccccccCcccCccccccc-CCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHH
Q 039371 149 EVDSCPPYTEYITTLQYRAPEMLLMS-GQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 149 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (346)
.... .....++..|+|||++... ..++.++||||+||++|+|++ |..||...+..+.......
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~------------ 221 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD------------ 221 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc------------
Confidence 6543 2234566789999998744 368999999999999999999 5788866543222111110
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+ ......+.+++.+||..+|.+|||+.++++
T Consensus 222 --------~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 --------QHRLP-----------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred --------CCCCC-----------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 112378889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=285.92 Aligned_cols=254 Identities=19% Similarity=0.216 Sum_probs=184.9
Q ss_pred CceeeeeeecccCceEEEEEEEccC---CcEEEEEEccccccCHHH----------hhhHHHHHHHHhhcCCCCeeeeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS---GEYVAIKALKQRIYSWEE----------CLNLKEVKCLRKINNHPNIVKLQE 68 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~----------~~~~~e~~~l~~l~~hp~iv~~~~ 68 (346)
++|++.+.||+|+||+||+|.+..+ +..+|+|+.......... .....+...+..+ +|++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~ 90 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYYG 90 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEEE
Confidence 5899999999999999999998877 677888865433221110 0112233334445 7999999998
Q ss_pred eeecCC----EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEee
Q 039371 69 LASENY----RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIAD 143 (346)
Q Consensus 69 ~~~~~~----~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~D 143 (346)
...... ..++++|++..++.+.+... ...++..+..++.|++.||+|||+++++||||||+||+++ ++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 765432 45788898877776665543 3368899999999999999999999999999999999995 56999999
Q ss_pred cccccccCCC--------CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 039371 144 FGLAWEVDSC--------PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNA 215 (346)
Q Consensus 144 fg~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 215 (346)
||+|...... .......||+.|+|||+.. ...++.++||||+||++|+|++|..||.+.............
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 9999765321 1122346899999999887 566899999999999999999999999877433222211110
Q ss_pred hCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 216 IGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+.......... ..+..++.+.++++.|++.+|++||+.+++++
T Consensus 249 ----------~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 ----------DFIKRLHEGKI------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ----------HHHHHhhhhhh------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00000000000 11345788999999999999999999999976
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=282.88 Aligned_cols=284 Identities=30% Similarity=0.461 Sum_probs=208.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC-------CCeeeeeeeee---
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH-------PNIVKLQELAS--- 71 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h-------p~iv~~~~~~~--- 71 (346)
.||.+.++||=|-|+|||+|.+.++.+.||+|+.+... .-....+.|+++|++++.+ .+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 48999999999999999999999999999999997442 2233456899999988733 36999999996
Q ss_pred -cCCEEEEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEeCC-----------
Q 039371 72 -ENYRLYFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVSND----------- 137 (346)
Q Consensus 72 -~~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~~~----------- 137 (346)
.+.++|+|+|+++.+|+..+...+ ..++...++.|++||+.||.|||.. ||+|.||||+|||+..+
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a 235 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREA 235 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhh
Confidence 456999999999999999887664 3499999999999999999999976 99999999999997210
Q ss_pred --------------------------------------------------------------------------------
Q 039371 138 -------------------------------------------------------------------------------- 137 (346)
Q Consensus 138 -------------------------------------------------------------------------------- 137 (346)
T Consensus 236 ~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~ 315 (590)
T KOG1290|consen 236 GEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNEST 315 (590)
T ss_pred ccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccc
Confidence
Q ss_pred ----------------------------------------------------------------------------cEEE
Q 039371 138 ----------------------------------------------------------------------------TIKI 141 (346)
Q Consensus 138 ----------------------------------------------------------------------------~vkl 141 (346)
++||
T Consensus 316 v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKI 395 (590)
T KOG1290|consen 316 VERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKI 395 (590)
T ss_pred hhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEE
Confidence 0011
Q ss_pred eecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHHH
Q 039371 142 ADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGT------CEDDQLYKICNA 215 (346)
Q Consensus 142 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~ 215 (346)
.|||-|.-... .++.-..|..|+|||++. +..|++.+||||++|+++||+||...|+.. .+++.++.|++.
T Consensus 396 aDlGNACW~~k--hFT~DIQTRQYRapEVll-GsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~EL 472 (590)
T KOG1290|consen 396 ADLGNACWVHK--HFTEDIQTRQYRAPEVLL-GSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMEL 472 (590)
T ss_pred eeccchhhhhh--hhchhhhhhhccCcceee-cCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHH
Confidence 11111100000 001123477899999999 556999999999999999999999999543 367889999999
Q ss_pred hCCCChhhHHHHHHHHHhcCC--CCCCcCCCC---ccc-------ccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 039371 216 IGSPTEESWAEGLELAKAHGY--KFPKLQGNN---LSL-------LIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283 (346)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~-------~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~ 283 (346)
++..|......+..+...++- ....+.... +.. .......++.+|+.-||+.+|++||||.++|+|||
T Consensus 473 LG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPw 552 (590)
T KOG1290|consen 473 LGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPW 552 (590)
T ss_pred HhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCcc
Confidence 998776554433222221111 111111000 000 01133456779999999999999999999999999
Q ss_pred CCCCCCC
Q 039371 284 FQGCLQV 290 (346)
Q Consensus 284 ~~~~~~~ 290 (346)
+.....+
T Consensus 553 Ln~~~~~ 559 (590)
T KOG1290|consen 553 LNPVAGP 559 (590)
T ss_pred ccCCCCC
Confidence 9976543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=277.42 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=211.4
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH--hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE--CLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+.+|.+++.||+|+|++|-++++++|.+.||+|++++...+..+ .-...|-.+..+..+||.+|.++.+|+++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 57899999999999999999999999999999999877654433 2224677788888899999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccc-cCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWE-VDSCPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~-~~~~~~ 155 (346)
|.||++| +|...+.++ .+++|+.++.+...|+.||.|||++||++||+|.+|++++ .|++||+|+|.+.. ..+...
T Consensus 329 vieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 9999996 555555544 4599999999999999999999999999999999999995 68999999999865 455567
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGT-------CEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
.++++|||.|.|||++. +..|+.+.|+|+||++++||+.|+.||+-- +.++.+.++
T Consensus 408 tstfcgtpnyiapeilr-geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv---------------- 470 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV---------------- 470 (593)
T ss_pred cccccCCCcccchhhhc-ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH----------------
Confidence 88899999999999887 677999999999999999999999999521 122222222
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC------HHHHhcCCCCCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT------AAEALQHPLFQGCL 288 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps------~~ell~hp~~~~~~ 288 (346)
.-....+.|. ..|-.+-.+++..|+.||++|.. ..++..|+||+...
T Consensus 471 --ilekqiripr-----------slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 471 --ILEKQIRIPR-----------SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred --Hhhhcccccc-----------eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 1122223322 35566778999999999999964 78999999998653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=305.52 Aligned_cols=273 Identities=21% Similarity=0.269 Sum_probs=180.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccC----CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeee------e
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQS----GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQEL------A 70 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~------~ 70 (346)
.++|++.+.||+|+||+||+|++..+ +..||+|.+...... +. ...+ .+... .+.++..+... .
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~-~~~e--~l~~~-~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EI-WMNE--RVRRA-CPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HH-HHHH--HHHhh-chhhHHHHHHhhhccccc
Confidence 36899999999999999999999988 899999987643211 10 1111 11122 12222222221 2
Q ss_pred ecCCEEEEEEEcCCC-CHHHHHhcccCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 039371 71 SENYRLYFVFEYMDC-NLHQLMSNRKQC-------------------FSEAEVKNWCFQILQGLNYMHRQGYFHRDLISK 130 (346)
Q Consensus 71 ~~~~~~~iv~e~~~g-~l~~~~~~~~~~-------------------l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~ 130 (346)
..+...++|+||+++ +|.+.+...... ..+..+..++.|++.||+|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 455678999999985 666665533211 123457789999999999999999999999999
Q ss_pred CEEEeC--CcEEEeecccccccCCC--CCCccccccCcccCcccccccC---------------------CCCChhhHHH
Q 039371 131 NLLVSN--DTIKIADFGLAWEVDSC--PPYTEYITTLQYRAPEMLLMSG---------------------QYNSKVDMWA 185 (346)
Q Consensus 131 NIli~~--~~vkl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~Diws 185 (346)
|||+++ +.+||+|||+|...... .......+++.|+|||.+.... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999964 58999999999754332 2234567899999999764222 1344669999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhc
Q 039371 186 LGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC 265 (346)
Q Consensus 186 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 265 (346)
+||++|+|+++..|+ ......+..++...+.. ...|....... ..+. ...........+....+||.+||
T Consensus 365 lGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~-~~~~~~~~~~~-----~~~~--~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 365 AGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYD-LVAWRKLVEPR-----ASPD--LRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCc-HHHHHHhhccc-----cchh--hhhhhhhccccchHHHHHHHHHc
Confidence 999999999866553 33333444444333221 22222111100 0000 00000111223456779999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 266 SWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 266 ~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
+.||++|||++|+|+||||++...
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999999987543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=282.51 Aligned_cols=263 Identities=28% Similarity=0.452 Sum_probs=196.8
Q ss_pred CceeeeeeecccCceEEEEEEEc----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--NYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~ 75 (346)
++|++.+.||+|+||.||+|... .+++.+|+|++.............+|+..++.+ +||||+++++++.. +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCc
Confidence 46889999999999999999864 347899999997665443445567899999998 79999999999877 568
Q ss_pred EEEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
.+++|||+. |++.+.+......+++..+..++.|++.||+|||++|++|+||||+||+++ ++.++|+|||.+......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 899999997 578777776665699999999999999999999999999999999999995 458999999999776532
Q ss_pred CC----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 PP----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.. .....++..|+|||... ...++.++||||+||++|+|++|..||........ .+... ...........+
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~--~~~~~~~~~~~~ 237 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLR-TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL--RMIGI--AQGQMIVTRLLE 237 (284)
T ss_pred CcceeccCCCCCcccccCcHHHc-cCCCCcccchHHHhhhhheeeccCCCcccccchhc--ccccc--ccccccHHHHHH
Confidence 21 11223456799999886 45688999999999999999999999865432110 00000 000000000001
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.. ......+. ...++.++.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~-~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LL-KEGERLPR---------PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HH-HcCCcCCC---------CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 11111111 1245678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=303.44 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=214.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee-----cCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS-----ENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~-----~~~~~ 76 (346)
+.+++.+.+|.|.+|.||+++++.+++.+|+|+........++. -.|..+++....|||++.+|++|. .++.+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEi--E~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEI--ELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHH--HHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 45899999999999999999999999999999997666554443 357888999999999999999984 46789
Q ss_pred EEEEEcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCC-
Q 039371 77 YFVFEYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDS- 152 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~- 152 (346)
|+|||||+| +.-+.+..- +..+.|..+..|++.++.|+.+||.+.++|||||-.|||+ +++.|||+|||.+.....
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 999999995 555555433 4569999999999999999999999999999999999999 577999999998876554
Q ss_pred CCCCccccccCcccCcccccccC----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSG----QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
....++..|||.|||||++.... .|+..+|+||||++..||.-|.+|+-...+...+..|-+ .|++...
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPkLk---- 249 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPKLK---- 249 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCcccc----
Confidence 34677889999999999997543 367799999999999999999999988877766665532 2222110
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.....++++-++|..||..|..+||+..++|+|||+++..
T Consensus 250 --------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 250 --------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred --------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 0135678899999999999999999999999999999543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.54 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=209.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--H----hhhHHHHHHHHhhcCCCCeeeeeeeee-cCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--E----CLNLKEVKCLRKINNHPNIVKLQELAS-ENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~----~~~~~e~~~l~~l~~hp~iv~~~~~~~-~~~ 74 (346)
+||-+++.||+|+|+.||+|.+....+.||+|+-.....+.+ . ....+|..+.+.+ +||.||++|++|. +.+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeeccc
Confidence 588999999999999999999999999999998644333322 2 2336789999999 8999999999996 557
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCCEEEeCC----cEEEeeccccc
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ--GYFHRDLISKNLLVSND----TIKIADFGLAW 148 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~ivH~dikp~NIli~~~----~vkl~Dfg~a~ 148 (346)
.+|-|+|||+|+-++...+....++|.+++.|+.||+.||.||... .|+|-||||.|||+.+| .+||+|||++.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 7899999999988887777777899999999999999999999987 59999999999999554 89999999998
Q ss_pred ccCCCC--------CCccccccCcccCccccccc---CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 039371 149 EVDSCP--------PYTEYITTLQYRAPEMLLMS---GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG 217 (346)
Q Consensus 149 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 217 (346)
..++.. ..+...||..|++||.+.-. ...+.+.||||+|+|+|.++.|+.||....... +|+....
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dILqeNT 698 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DILQENT 698 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HHHhhhc
Confidence 776432 23456899999999988632 347889999999999999999999997654332 2222110
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 218 SPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
..++....||. -|.++.++++||++||++.-++|....++-.||+|..
T Consensus 699 ------------IlkAtEVqFP~---------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 699 ------------ILKATEVQFPP---------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred ------------hhcceeccCCC---------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 01111122222 1578999999999999999999999999999999976
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=276.28 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=186.9
Q ss_pred eeecccCceEEEEEEEccC--CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQS--GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
++||+|+||+||+|....+ ...+++|.+.............+|...++.+ +||||+++++.+.+....+++|||+.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCC
Confidence 4699999999999975433 3456777776554444555677888888888 899999999999999999999999984
Q ss_pred -CHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC---CCCc
Q 039371 86 -NLHQLMSNRK---QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC---PPYT 157 (346)
Q Consensus 86 -~l~~~~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~---~~~~ 157 (346)
+|.+.+.... ...++..+..++.|++.||+|||+++++|+||||+||+++ ++.++|+|||++...... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 7777765432 3467788899999999999999999999999999999995 569999999987543221 1223
Q ss_pred cccccCcccCcccccc------cCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 158 EYITTLQYRAPEMLLM------SGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
...++..|+|||++.. ...++.++||||+||++|+|++ |..||......+....+.......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~----------- 228 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK----------- 228 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc-----------
Confidence 4567889999998742 1235789999999999999997 567887776665555543321110
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.+. .......++.+.++++.|+ .+|++|||++++++
T Consensus 229 -------~~~------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 -------LFK------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -------cCC------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 000 1111346788899999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=275.01 Aligned_cols=282 Identities=33% Similarity=0.525 Sum_probs=230.2
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-----EE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENY-----RL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~-----~~ 76 (346)
+.+-.+.||.|+||.||.+++..+|+.||+|.+..-..+. ...+.++|++.+.-. +|.|++..+++....+ .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHH
Confidence 3456789999999999999999999999999885332221 234567899999888 7999999988775443 46
Q ss_pred EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC--
Q 039371 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-- 153 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-- 153 (346)
|+++|.|..+|...+.. ..+++.+.++-++.||+.||+|||+.||.||||||.|.+++ +..+||+|||+++..+..
T Consensus 133 YV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 88999999888877665 45599999999999999999999999999999999999995 559999999999876543
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
..++..+.|-+|+|||++-+...|+.+.||||+|||+.|++..+..|...++.+++..|.+.+|.|..+.....-+-++.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 34555678999999999999999999999999999999999999999999999999999999999999888766655554
Q ss_pred cCCCCCCcCCCC--cccccC--CCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 234 HGYKFPKLQGNN--LSLLIP--SANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 234 ~~~~~~~~~~~~--~~~~~~--~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.-.+-+....+. +-.+.. ....+...++.+++..||.+|.+.++.+.|++..+
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 443332221111 111111 33456788999999999999999999999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=295.22 Aligned_cols=256 Identities=26% Similarity=0.447 Sum_probs=204.2
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHh--hhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEEC--LNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
|..++.||-|+||+|.+++...|...||+|.+.+...-.+.. ....|..+|... +++-||++|..|++.+.+|+||+
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEe
Confidence 678999999999999999999999999999997654433322 223577788777 89999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-------
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS------- 152 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~------- 152 (346)
|+.| ++..++.+.+- |+|..++.++..+..|+++.|+.|++||||||+||||| +|++||+|||+++-+.-
T Consensus 710 YIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred ccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 9985 66666665544 99999999999999999999999999999999999997 56999999999863310
Q ss_pred ----------CC--------------------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhC
Q 039371 153 ----------CP--------------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF 196 (346)
Q Consensus 153 ----------~~--------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 196 (346)
.. ..-..+||+.|+|||++. ...|+..+|+||.|+|||+|+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-RTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-ccCccccchhhHhhHHHHHHhhC
Confidence 00 001257899999999998 45589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC--
Q 039371 197 HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-- 274 (346)
Q Consensus 197 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-- 274 (346)
++||.+.+..+...++.+ |...+ .++. -.+.|+++.++|.+++. +++.|..
T Consensus 868 ~~pf~~~tp~~tq~kv~n---------w~~~l--------~~~~---------~~~ls~e~~~li~kLc~-sad~RLGkn 920 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVIN---------WRNFL--------HIPY---------QGNLSKEALDLIQKLCC-SADSRLGKN 920 (1034)
T ss_pred CCCccCCCCCcceeeeee---------hhhcc--------cccc---------ccccCHHHHHHHHHHhc-Chhhhhccc
Confidence 999988877666555432 11100 0110 13678999999998775 7888875
Q ss_pred -HHHHhcCCCCCCCCC
Q 039371 275 -AAEALQHPLFQGCLQ 289 (346)
Q Consensus 275 -~~ell~hp~~~~~~~ 289 (346)
++++..||||+++..
T Consensus 921 g~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 921 GADQVKAHPFFKGIDF 936 (1034)
T ss_pred chhhhhcCccccccch
Confidence 888999999998654
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=276.82 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=190.8
Q ss_pred eeeeeeecccCceEEEEEEEc---cCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-----
Q 039371 4 YTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENY----- 74 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~----- 74 (346)
|.+.+.||+|+||+||+|... .++..||+|++....... ......+|+..++++ +||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999865 357889999997655443 344456899999999 7999999999875432
Q ss_pred -EEEEEEEcCC-CCHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccc
Q 039371 75 -RLYFVFEYMD-CNLHQLMSNR-----KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGL 146 (346)
Q Consensus 75 -~~~iv~e~~~-g~l~~~~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~ 146 (346)
..++++||+. |++...+... ...+++..+..++.|++.||+|||++||+|+||||+||+++ ++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 3478899997 5665554322 12478999999999999999999999999999999999996 55999999999
Q ss_pred ccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 039371 147 AWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEE 222 (346)
Q Consensus 147 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 222 (346)
+....... ......+++.|++||.+. ...++.++||||+||++|+|++ |.+||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----- 233 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLA-DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR----- 233 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHh-cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc-----
Confidence 87654322 112234457899999886 5568899999999999999999 8899987665544333322100
Q ss_pred hHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 223 SWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. ...+..+..+.+++.+||+.+|++|||+.+++++
T Consensus 234 ---------------~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 ---------------L---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ---------------C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0113467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=287.98 Aligned_cols=244 Identities=27% Similarity=0.477 Sum_probs=206.2
Q ss_pred eeeeeeecccCceEEEEEEEccC----CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQS----GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
..+.+.||.|-||.||.|....- .-.||+|+.+.+........++.|..+++.+ +||||++++|++.+. ..|||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-ceeEE
Confidence 34567899999999999975532 2369999999888777788889999999999 899999999999875 47999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||.+. |.|..++..++..++......++.||+.||.|||+.++|||||-..|||++ ..-|||+|||+++...+..-+.
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 99998 899999999888899999999999999999999999999999999999995 5589999999999887765433
Q ss_pred cc--cccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 158 EY--ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 158 ~~--~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
.. ....-|||||.+. -..++.+||||.||+.+||++. |..||.+-...+....+.++-.-|
T Consensus 549 aS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP--------------- 612 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP--------------- 612 (974)
T ss_pred ccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC---------------
Confidence 33 3356799999886 4669999999999999999875 889999887776666554432221
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL 279 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell 279 (346)
..+.+++.+..|+.+||.+||.+||+..++.
T Consensus 613 --------------~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 613 --------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred --------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 1257899999999999999999999977654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=299.14 Aligned_cols=244 Identities=28% Similarity=0.411 Sum_probs=193.1
Q ss_pred eeeecccCceE-EEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 7 MKQIGEGSFGK-VWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 7 ~~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
-+.+|.|+.|+ ||+|... |+.||+|.+-.... ..+.+|+..++...+||||++++....+.+..||..|.|..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~----~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFF----DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhhHhH----HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 35688999886 8999765 88999998864432 34568999999999999999999999999999999999999
Q ss_pred CHHHHHhcccC--C-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC----C--cEEEeecccccccCCCC--
Q 039371 86 NLHQLMSNRKQ--C-FSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN----D--TIKIADFGLAWEVDSCP-- 154 (346)
Q Consensus 86 ~l~~~~~~~~~--~-l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~----~--~vkl~Dfg~a~~~~~~~-- 154 (346)
+|.+.+..... . ...-..+.++.|+++||++||+.+||||||||.||||+. + .++|+|||++...+..+
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 99999987411 1 111456788999999999999999999999999999953 3 79999999998876543
Q ss_pred --CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 155 --PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 155 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
...+..||.+|+|||++.. ..-..++||+|+||++|+.++| ..||...-.. ..+|+.+..
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~-------------- 730 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNY-------------- 730 (903)
T ss_pred hhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCcc--------------
Confidence 2455689999999999984 4456799999999999999886 7999765332 223332211
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.+..+.+....++.+||.+|+.+||..||+|.++|.||+|=.
T Consensus 731 -------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 731 -------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred -------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 111111222228899999999999999999999999999944
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=263.81 Aligned_cols=242 Identities=40% Similarity=0.636 Sum_probs=197.4
Q ss_pred CceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-CHHHHHh
Q 039371 14 SFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMS 92 (346)
Q Consensus 14 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l~~~~~ 92 (346)
+||.||+|.+..+++.+++|++.............+|+..++++ +|+|++++++.+......++++|++++ ++.+.+.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999999889999999997665443245566899999888 899999999999999999999999997 7777766
Q ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccccccCcccCcccc
Q 039371 93 NRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEML 171 (346)
Q Consensus 93 ~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~ 171 (346)
.... +++..+..++.+++.++.+||+.+++|+||+|+||+++ ++.++|+|||.+.............++..|+|||..
T Consensus 80 ~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 80 KRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred hccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 5443 89999999999999999999999999999999999995 469999999999877665455566788899999988
Q ss_pred cccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccC
Q 039371 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIP 251 (346)
Q Consensus 172 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
. ...++.++||||+|++++++++|..||...................... ...
T Consensus 159 ~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~ 211 (244)
T smart00220 159 L-GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP--------------------------PEW 211 (244)
T ss_pred c-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc--------------------------ccc
Confidence 6 5667889999999999999999999998743333322222211100000 001
Q ss_pred CCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 252 SANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 252 ~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
.++.++.+++.+|+..||++||++.++++||||
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 167889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.95 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=212.4
Q ss_pred CceeeeeeecccCceEEEEEEEccC-C--cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS-G--EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++..+.++||+|.||.|++|.+..- | -.||||++...........+++|+.+|.++ +|||++++|++..+ ....+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc-chhhH
Confidence 3456789999999999999987743 3 369999998877776777889999999999 79999999999988 66889
Q ss_pred EEEcCC-CCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCCCC
Q 039371 79 VFEYMD-CNLHQLMSN-RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 79 v~e~~~-g~l~~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~~~ 155 (346)
|+|++. |+|++.+.+ ....|.-.....++.||+.|+.||.++++|||||-..|+++ +...|||+|||+.+..+....
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999998 788888877 45668889999999999999999999999999999999999 677999999999998776554
Q ss_pred Cccc----cccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 156 YTEY----ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 156 ~~~~----~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
.... .....|+|||.+. ...++.++|+|++||++|||++ |+.||.+....+.+.+|-++
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------------- 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------------- 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------------
Confidence 3222 2355799999987 7789999999999999999998 67999999998888887421
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
-+.+ ..+.++.++.+++..||..+|.+|||+..|-+.-+..
T Consensus 332 -----erLp---------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 332 -----ERLP---------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred -----ccCC---------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 1111 1247889999999999999999999999987654444
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=244.69 Aligned_cols=211 Identities=22% Similarity=0.373 Sum_probs=183.5
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
...+..||+|++|.|-+.++..+|...|+|.+.....+....+.++|+.+..+...+|.+|.+|+....+..++|.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34567899999999999999999999999999988888888888999999999889999999999999999999999999
Q ss_pred CCCHHHH---HhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 84 DCNLHQL---MSNRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 84 ~g~l~~~---~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
+-++... ....++.++|..+.+|+..++.||.|||++ .++|||+||+|||++ .|++|+||||.+-...++...+.
T Consensus 128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~ 207 (282)
T KOG0984|consen 128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM 207 (282)
T ss_pred hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH
Confidence 9776544 345677799999999999999999999987 899999999999996 67999999999987766555555
Q ss_pred ccccCcccCcccccc---cCCCCChhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 039371 159 YITTLQYRAPEMLLM---SGQYNSKVDMWALGLIMAELITFHPLFPG-TCEDDQLYKICN 214 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~ 214 (346)
..|...|||||.+.. +..|+.++||||||+++.||.+++.||+. .++-+++.++++
T Consensus 208 daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 208 DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 678889999998852 33589999999999999999999999965 445566666654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=279.73 Aligned_cols=268 Identities=21% Similarity=0.331 Sum_probs=180.0
Q ss_pred CceeeeeeecccCceEEEEEEEc----------------cCCcEEEEEEccccccCHH-------------HhhhHHHHH
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK----------------QSGEYVAIKALKQRIYSWE-------------ECLNLKEVK 52 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~~~-------------~~~~~~e~~ 52 (346)
++|++.++||+|+||+||+|... ..++.||+|.++....... ......|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 68999999999999999999752 3456799999864332111 111234666
Q ss_pred HHHhhcCCC----Ceeeeeeeeec--------CCEEEEEEEcCCC-CHHHHHhccc-----------------------C
Q 039371 53 CLRKINNHP----NIVKLQELASE--------NYRLYFVFEYMDC-NLHQLMSNRK-----------------------Q 96 (346)
Q Consensus 53 ~l~~l~~hp----~iv~~~~~~~~--------~~~~~iv~e~~~g-~l~~~~~~~~-----------------------~ 96 (346)
.+.++.+++ +++++++++.. .+..++|+||+.+ +|.+.+.... .
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 676774332 23566666542 3567999999984 6666554321 1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccc--cccCcccCcccccc
Q 039371 97 CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEY--ITTLQYRAPEMLLM 173 (346)
Q Consensus 97 ~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~--~~t~~y~aPE~~~~ 173 (346)
.+++..++.++.|++.+|.|||+.+|+||||||+||+++ ++.+||+|||++............ .+++.|+|||.+..
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 245678899999999999999999999999999999995 468999999999765443322222 34789999998753
Q ss_pred cCC-------------------C--CChhhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 174 SGQ-------------------Y--NSKVDMWALGLIMAELITFHP-LFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 174 ~~~-------------------~--~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
... + ....||||+||++|+|++|.. ||............. ......|.. .
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~----~~~~~~~r~----~ 456 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY----DNDLNRWRM----Y 456 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc----cchHHHHHh----h
Confidence 221 1 124799999999999999874 775432211100000 000011110 0
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCC---CCCCCHHHHhcCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDP---CKRPTAAEALQHPLFQG 286 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP---~~Rps~~ell~hp~~~~ 286 (346)
+.....++ .....++..++|+.+||..+| .+|+|++|+|+||||..
T Consensus 457 ~~~~~~~~---------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 457 KGQKYDFS---------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccCCCcc---------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 11111111 234678999999999999866 68999999999999963
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=269.70 Aligned_cols=281 Identities=26% Similarity=0.431 Sum_probs=210.0
Q ss_pred CceeeeeeecccCceEEEEEEEcc---CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ---SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+.|.++++||.|.|++||+|++.. ..+.||+|.+...... .+..+|+..+..+.++.||+++.+.+..++.+.+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 568899999999999999999887 7889999999655433 3366899999999999999999999999999999
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeecccccccCC----
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWEVDS---- 152 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~~~~---- 152 (346)
|+||++..-...+... ++-.+++.+++.++.||.++|++||+||||||+|++.+. ++-.|+|||+|...+.
T Consensus 113 vlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred EecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 9999997544444432 789999999999999999999999999999999999964 5889999999861100
Q ss_pred ----------CCC-------------------------------CccccccCcccCcccccccCCCCChhhHHHHHHHHH
Q 039371 153 ----------CPP-------------------------------YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMA 191 (346)
Q Consensus 153 ----------~~~-------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 191 (346)
..+ .-...||++|+|||++..-...+.++||||.|+|+.
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 000 012468999999999998888899999999999999
Q ss_pred HHHhCCCCC-CCCChHHHHHHHHHHhCCCChh----------hHH-HHHHHHHhcCCCCCCc-----CC-----CCcccc
Q 039371 192 ELITFHPLF-PGTCEDDQLYKICNAIGSPTEE----------SWA-EGLELAKAHGYKFPKL-----QG-----NNLSLL 249 (346)
Q Consensus 192 ~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~----------~~~-~~~~~~~~~~~~~~~~-----~~-----~~~~~~ 249 (346)
.++++..|| ...++.+.+..++...|.-.-. .|. +...........+... .. .....-
T Consensus 270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 999999887 4455556666655544322111 111 0000000000111111 11 011111
Q ss_pred cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 250 IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 250 ~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
....+..+.+|+++||..||.+|.|++++|+||||....
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 223344788999999999999999999999999998643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=284.38 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=216.7
Q ss_pred eeeeeeecccCceEEEEEEEccCCc---EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
..|.+.||.|.||+|++|+.+..|+ .||||.++....+.....++.|..+|-+. +||||+++.++......++||+
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEEh
Confidence 4678899999999999999887664 69999999988888888999999999999 8999999999999999999999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeecccccccCCCC--CC
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~~~--~~ 156 (346)
|||+ |+|...++.+.+.++.-++.-+++.|+.|++||.+.|+|||||-..|||++.+ ..|++|||+++...+.+ .+
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 9997 88888888888889999999999999999999999999999999999999766 88999999999775544 12
Q ss_pred ccccc--cCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 157 TEYIT--TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 157 ~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
++..| ...|.|||.+. -.+++.+|||||+|+++||.++ |.-||=..+..+.+..|.++..-|++
T Consensus 790 tt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP------------ 856 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP------------ 856 (996)
T ss_pred cccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC------------
Confidence 22222 46899999998 5679999999999999999876 88999888888888888765444333
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+++..+.+|+..|++.|-.+||+++||+.+
T Consensus 857 -----------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 -----------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred -----------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3688999999999999999999999998874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=284.55 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=215.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|+++..+|+|++|.||+|+++.+++..|+|+++....+. -....+|+.+++.. +||||+.+++.+-....++|.||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc-~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecC-CCcChHHHHhhhhhhcCcEEEEE
Confidence 68999999999999999999999999999999998665432 22334677777777 79999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCC-CCCccc
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSC-PPYTEY 159 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~-~~~~~~ 159 (346)
||+|+.++.+..-.++++|.++...++..+.|++|||++|-+|||||-.||++ +.|.+|+.|||.+..+... .....+
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence 99988888888778889999999999999999999999999999999999999 6789999999988655443 244568
Q ss_pred cccCcccCccccc--ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 160 ITTLQYRAPEMLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 160 ~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
.||++|||||+.. ..+.|+..+|||++|++..|+--.++|....-+...+...-+....|+.-
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l--------------- 237 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL--------------- 237 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc---------------
Confidence 9999999999864 34568999999999999999999888866555555544443333222211
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
. -....++.+.+|++.+|..+|++|||++.+|+|||....
T Consensus 238 ----k------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 238 ----K------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ----c------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 0 013567889999999999999999999999999999754
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=270.69 Aligned_cols=243 Identities=27% Similarity=0.477 Sum_probs=203.6
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
+..+.++||.|.||.||.|.+++..-.||+|.++.+..+ ...++.|..+++.+ +|||+|++++++..+..+|||+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEEec
Confidence 356778999999999999999999999999999876544 44578899999999 899999999999999999999999
Q ss_pred CC-CCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeecccccccCCCCCCccc
Q 039371 83 MD-CNLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEY 159 (346)
Q Consensus 83 ~~-g~l~~~~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~~~~~~~~ 159 (346)
|. |+|+++++..+. .++.-...+++.||..|++||..++++||||-..|.|+..+ .||+.|||+++..... .+...
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYTAH 423 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYTAH 423 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC-ceecc
Confidence 97 899999987654 36777888999999999999999999999999999999654 8999999999876542 22222
Q ss_pred c---ccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 160 I---TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 160 ~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
. -...|.|||-+. -..++.++|||+||++|||+.| |-.||++-+....+..+.+ +
T Consensus 424 AGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk--------------------g 482 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK--------------------G 482 (1157)
T ss_pred cCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc--------------------c
Confidence 2 256799999887 4568999999999999999998 6699998876655554433 3
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL 279 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell 279 (346)
+++... .++++.+.+|++.||+++|.+||++.|+-
T Consensus 483 yRM~~P---------eGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 483 YRMDGP---------EGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ccccCC---------CCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 344333 36889999999999999999999998873
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=268.93 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=206.7
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
+..+.++||+|-||.|.+|.-. .+..||+|.++..........+.+|+++|.++ +||||+.+++++..++.+++|+||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHHHHH
Confidence 3568899999999999999644 36899999999887777778889999999999 899999999999999999999999
Q ss_pred CC-CCHHHHHhcccCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCCC---
Q 039371 83 MD-CNLHQLMSNRKQC-FSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPY--- 156 (346)
Q Consensus 83 ~~-g~l~~~~~~~~~~-l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~~--- 156 (346)
|+ |+|...+.+...+ .....-.+|+.||+.|++||.+.++||||+.+.|+|++. .++||+|||.++..-....+
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 98 8888888776332 355666779999999999999999999999999999975 59999999999855433322
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT--FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
...+....|||||.+. .++++.++|+|++|+++||+++ ...||....+++...+.......+..
T Consensus 697 gr~vlpiRwmawEsil-lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~------------- 762 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR------------- 762 (807)
T ss_pred cceeeeeeehhHHHHH-hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc-------------
Confidence 2345578999999998 6779999999999999999865 67999887777666555443322211
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.......+.++..+.+++-.|++.|-++|||.+++-.
T Consensus 763 ---------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 763 ---------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ---------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1122233577889999999999999999999999843
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=269.61 Aligned_cols=199 Identities=29% Similarity=0.459 Sum_probs=174.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-------HHhhhHHHHHHHHhhc--CCCCeeeeeeeeec
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-------EECLNLKEVKCLRKIN--NHPNIVKLQELASE 72 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~--~hp~iv~~~~~~~~ 72 (346)
.+|..++++|.|+||.|++|.++.+...|++|.+.++..-. +......|+.+|..+. .|+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 47999999999999999999999999999999997654321 1122356999998884 39999999999999
Q ss_pred CCEEEEEEEcCC-C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccc
Q 039371 73 NYRLYFVFEYMD-C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWE 149 (346)
Q Consensus 73 ~~~~~iv~e~~~-g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~ 149 (346)
++++||+||--+ | +|.+.+...+ .++|.+++.|++|++.|+++||++||+|||||-+||.++ +|-+||+|||.|..
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999886 4 6777776654 499999999999999999999999999999999999994 67999999999876
Q ss_pred cCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 039371 150 VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPG 202 (346)
Q Consensus 150 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 202 (346)
... .++..+.||..|.|||++.+..+.+.+-|||++|+++|.++....||..
T Consensus 720 ~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 654 6788899999999999999888899999999999999999999999853
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=276.63 Aligned_cols=246 Identities=29% Similarity=0.505 Sum_probs=202.8
Q ss_pred eeeeeecccCceEEEEEEEcc-------CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQ-------SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
.+.+.||+|.||.|++|.-.. ....||+|.++......+......|+.+++.+..||||+.+.+.+...+.++
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 566799999999999997441 1457999999888887777788899999999999999999999999999999
Q ss_pred EEEEcCC-CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEE
Q 039371 78 FVFEYMD-CNLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIK 140 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vk 140 (346)
+|+||+. |+|.+.+...+ ..++..+...++.||+.|++||++.+++||||-..|||+.++ .+|
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~k 458 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIK 458 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEE
Confidence 9999998 89999888776 348999999999999999999999999999999999999766 899
Q ss_pred EeecccccccCCCCCCcc--cc--ccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHHHH
Q 039371 141 IADFGLAWEVDSCPPYTE--YI--TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTC-EDDQLYKICN 214 (346)
Q Consensus 141 l~Dfg~a~~~~~~~~~~~--~~--~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~-~~~~~~~i~~ 214 (346)
|+|||+|+.......+.. .. -...|||||.+.. ..|+.++||||+|+++||+++ |..||++-. ..+....+..
T Consensus 459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~ 537 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE 537 (609)
T ss_pred EccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc
Confidence 999999986555443321 12 2345999999984 789999999999999999998 789998854 3333332222
Q ss_pred HhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+.+.+.+ ..+++++.++++.|++.+|++||+..++.+
T Consensus 538 --------------------G~r~~~P---------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 538 --------------------GNRMEQP---------EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred --------------------CCCCCCC---------CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 2222221 356889999999999999999999998866
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=294.04 Aligned_cols=250 Identities=20% Similarity=0.310 Sum_probs=179.3
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
.|...+.||+|+||.||+|.+..++..||+|.+...... ...|+..++++ +||||+++++++.+++..++||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEEEeC
Confidence 455667899999999999999999999999998643321 12457778888 899999999999999999999999
Q ss_pred CCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCCEEEeCC-cEEEeecccccccCCCCCCc
Q 039371 83 MDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH---RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 83 ~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~~~~~~ 157 (346)
++| +|.+.+.. +++..+..++.|++.|++||| +.+++||||||+||+++++ ..++. +|.+..... ..
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~ 836 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT 836 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence 985 66666642 889999999999999999999 6699999999999999754 44543 554432221 12
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC-CCChhhHHHHHHHHHhcC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIG-SPTEESWAEGLELAKAHG 235 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~ 235 (346)
...+++.|+|||++. ...++.++||||+||++|||++|+.||...... .......+... ......|
T Consensus 837 ~~~~t~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 904 (968)
T PLN00113 837 KCFISSAYVAPETRE-TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW----------- 904 (968)
T ss_pred CccccccccCccccc-CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe-----------
Confidence 236789999999886 567899999999999999999999999543211 11111111000 0000000
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..+..... . ........++.+++.+|++.||++|||++|+++.
T Consensus 905 -~~~~~~~~-~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 -IDPSIRGD-V-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred -eCccccCC-C-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00000000 0 0001122356789999999999999999999885
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=240.94 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=200.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeee-eecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQEL-ASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~-~~~~~~~~iv~ 80 (346)
|.|.+.+.||.|.||.+-+|.|+.+++.+++|.+..+.... ..+.+|..---.|+.|.||+.-|+. |++.+.+++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~--~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQ--ADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhH--HHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 67999999999999999999999999999999998776543 3466788776677789999998875 78888999999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eC--CcEEEeecccccccCCCCCC
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SN--DTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~--~~vkl~Dfg~a~~~~~~~~~ 156 (346)
||++ |+|...+...+ +-|..-+.++.|+++|+.|+|++++||||||.+|||| +. .++||||||.++..+.....
T Consensus 102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 9998 88888877644 8999999999999999999999999999999999999 33 39999999999887753322
Q ss_pred ccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 157 TEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
..-+..|.+||.... .-...+.+|||.||+++|.+++|.+||......+. +-..|. +...
T Consensus 180 --~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-----------~Y~~~~---~w~~ 243 (378)
T KOG1345|consen 180 --LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-----------PYWEWE---QWLK 243 (378)
T ss_pred --hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-----------hHHHHH---HHhc
Confidence 234567999997642 22367899999999999999999999974432221 111111 1111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCC---CCHHHHhcCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR---PTAAEALQHPLFQ 285 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R---ps~~ell~hp~~~ 285 (346)
...... ...+...++.+..+.++-|..+|++| -+++.-...-|..
T Consensus 244 rk~~~~--------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 244 RKNPAL--------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ccCccC--------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 111122 22345778999999999999999999 6666666666664
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=247.55 Aligned_cols=261 Identities=26% Similarity=0.312 Sum_probs=182.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc-CCCCeeeeeeeeecCC----EE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN-NHPNIVKLQELASENY----RL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~hp~iv~~~~~~~~~~----~~ 76 (346)
+..++++.+|+|+||.||+|... ++.||||++... ......+|-.+..... .|+||+++++.-+... .+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 34567889999999999999654 699999999643 2233445555554332 7999999999876555 88
Q ss_pred EEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCCEEEe-CCcEEEeecc
Q 039371 77 YFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ---------GYFHRDLISKNLLVS-NDTIKIADFG 145 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---------~ivH~dikp~NIli~-~~~vkl~Dfg 145 (346)
++|++|.+ |+|.+++...- ++..+..+++..++.||+|||+- .|+|||||..|||+. +.+..|+|||
T Consensus 284 wLVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999997 88888887654 89999999999999999999963 499999999999995 5599999999
Q ss_pred cccccCCCCC---CccccccCcccCcccccccCCCC-----ChhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHh
Q 039371 146 LAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYN-----SKVDMWALGLIMAELITFHPLFP-GTCEDDQLYKICNAI 216 (346)
Q Consensus 146 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~ 216 (346)
+|.......+ .-..+||..|||||++.+.-.+. .+.||||+|.++|||++...-+. +..++-++.--.+..
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 9987765432 33478999999999997654444 36899999999999998544332 111111111111122
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHH
Q 039371 217 GSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAE 277 (346)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e 277 (346)
..|..+...+.+-..+ ..|.+....... ..-..+++.+..|+..||+.|.|+.=
T Consensus 442 ~hPt~e~mq~~VV~kK----~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKK----QRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred CCCCHHHHHHHHHhhc----cCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 2233222221111111 111111111110 22356789999999999999999653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=261.80 Aligned_cols=244 Identities=26% Similarity=0.398 Sum_probs=203.3
Q ss_pred eeeeeecccCceEEEEEEEccCCc----EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+..++||+|+||+||+|..-..|+ +||+|++............+.|+.++.++ +|||+++++++..... +.||+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HHHHH
Confidence 456799999999999998776555 68999987776666677788999999999 8999999999987765 78999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCCCCC--
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPY-- 156 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~~~~-- 156 (346)
++++ |.|+++++..++++.......|..||++|+.|||.++++||||-..|||+ +.+.+|+.|||+++........
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 9998 79999999998899999999999999999999999999999999999999 4579999999999876654321
Q ss_pred -ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 157 -TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 157 -~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
..-.-.+.|||=|.+. ...|+.++||||+||++||++| |..|+.+....+.-..+..+
T Consensus 857 ~~~gK~pikwmale~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g------------------- 916 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG------------------- 916 (1177)
T ss_pred ccccccCcHHHHHHHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-------------------
Confidence 2223356799999887 6779999999999999999987 88999888766554443222
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.+.++ .+-++-++..++.+||..|+..||+++++..
T Consensus 917 -eRLsq---------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 917 -ERLSQ---------PPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -ccCCC---------CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 11222 2567889999999999999999999998865
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=242.96 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=180.8
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHh-hcCCCCeeeeeeeeecC----CEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK-INNHPNIVKLQELASEN----YRLY 77 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~-l~~hp~iv~~~~~~~~~----~~~~ 77 (346)
+.++.+.||+|+||+||+|.++ |+.||+|++... ++...++|.++.+. +.+|+||+.+++.-..+ ..+|
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 6789999999999999999877 889999999643 22233455555543 23899999999875432 3689
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCEEE-eCCcEEEeecccc
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ--------GYFHRDLISKNLLV-SNDTIKIADFGLA 147 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------~ivH~dikp~NIli-~~~~vkl~Dfg~a 147 (346)
+|++|.+ |+|.+++... .++.+...+++..++.||++||.. .|.|||||..|||+ .++...|+|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999998 8999988873 489999999999999999999953 39999999999999 6779999999999
Q ss_pred cccCCCC-----CCccccccCcccCcccccccCCC-----CChhhHHHHHHHHHHHHh----------CCCCCCCC----
Q 039371 148 WEVDSCP-----PYTEYITTLQYRAPEMLLMSGQY-----NSKVDMWALGLIMAELIT----------FHPLFPGT---- 203 (346)
Q Consensus 148 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~ll~----------g~~pf~~~---- 203 (346)
...+... ..+..+||..|||||++...-.. -..+||||||.++||++. .++||.+-
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 7665432 45678999999999999644321 136899999999999984 35777442
Q ss_pred ChHHHHHHHHHH--hCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 204 CEDDQLYKICNA--IGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 204 ~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+.+.+++.. ..++.++.|.. ...-..+-.+++.|+..||..|.|+--+-+
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s------------------------~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKS------------------------DPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCHHHHhcceeecccCCCCCccccc------------------------CHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 222333332221 11222222221 001123447899999999999999866643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=224.29 Aligned_cols=211 Identities=41% Similarity=0.643 Sum_probs=180.2
Q ss_pred ecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC-CCHH
Q 039371 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD-CNLH 88 (346)
Q Consensus 10 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~-g~l~ 88 (346)
||+|++|.||++....+++.+++|++.............+|+..++.+ .|++++++++++......++++|+++ +++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999998889999999997665443345567899999999 68999999999999999999999999 5777
Q ss_pred HHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeecccccccCCCC-CCccccccCcc
Q 039371 89 QLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWEVDSCP-PYTEYITTLQY 165 (346)
Q Consensus 89 ~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y 165 (346)
+.+......+++..+..++.+++.++.+||+.|++|+||+|.||++++ +.++|+|||.+....... ......+...|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 776655345899999999999999999999999999999999999976 799999999997665432 13335678899
Q ss_pred cCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCC
Q 039371 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNN 245 (346)
Q Consensus 166 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
++||........+.++|+|++|+++++|
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------------- 187 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------------- 187 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------------
Confidence 9999886433788999999999999998
Q ss_pred cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCC
Q 039371 246 LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282 (346)
Q Consensus 246 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp 282 (346)
..+.+++.+|++.||.+||++.++++|+
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1245799999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-31 Score=223.73 Aligned_cols=210 Identities=37% Similarity=0.525 Sum_probs=175.5
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
|.+.+.||+|++|+||++.+..+++.+++|.+.............+|+..+.++ +|+|++++++.+......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEecc
Confidence 678899999999999999999889999999997665442344556799999999 7999999999999989999999999
Q ss_pred CC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCC--CCccc
Q 039371 84 DC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP--PYTEY 159 (346)
Q Consensus 84 ~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~--~~~~~ 159 (346)
++ ++.+.+......+++..+..++.+++.++.+||+.+++|+|++|+||+++. +.++|+|||.+....... .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 97 777776654433899999999999999999999999999999999999964 699999999987765543 33455
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCC-CChH-HHHHHHHH
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPG-TCED-DQLYKICN 214 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~-~~~~~i~~ 214 (346)
.++..|++||.......++.++|+|++|+++++|++|+.||.. .... .....+..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 7788999999874456678899999999999999999999977 4444 44444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=270.53 Aligned_cols=195 Identities=19% Similarity=0.199 Sum_probs=144.0
Q ss_pred CCeeeeeeee-------ecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEE
Q 039371 61 PNIVKLQELA-------SENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLL 133 (346)
Q Consensus 61 p~iv~~~~~~-------~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIl 133 (346)
+||+.+++++ .....++.++|+++++|.+.+......+++.++..+++||+.||+|||++||+||||||+|||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiL 112 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFV 112 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEE
Confidence 5777777776 223467888999999999998766666999999999999999999999999999999999999
Q ss_pred EeC-C-------------------cEEEeecccccccCCCC-----------------CCccccccCcccCcccccccCC
Q 039371 134 VSN-D-------------------TIKIADFGLAWEVDSCP-----------------PYTEYITTLQYRAPEMLLMSGQ 176 (346)
Q Consensus 134 i~~-~-------------------~vkl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~ 176 (346)
++. + .+|++|||+++...... ......+|+.|+|||++. ...
T Consensus 113 l~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~ 191 (793)
T PLN00181 113 MSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN-GSS 191 (793)
T ss_pred EcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc-cCC
Confidence 942 2 56667777665321100 001135788899999887 556
Q ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCch
Q 039371 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDD 256 (346)
Q Consensus 177 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (346)
++.++|||||||++|||++|.+|+.... .....+.... .|+. .......
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~----------------------------~~~~~~~ 240 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ----------------------------ILLNWPK 240 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh----------------------------hhhcCHH
Confidence 8999999999999999999988875321 1111111110 0000 0012345
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 257 EMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 257 ~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
..+++.+||+.||.+|||+.|+++||||++.
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 6789999999999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=222.32 Aligned_cols=248 Identities=18% Similarity=0.321 Sum_probs=197.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCC-----cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeee-ecCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG-----EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELA-SENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~-~~~~~ 75 (346)
+|+++...+-+|.||.||.|.++... +.|-+|.++.....-.....+.|-..+..+ .|||+..+.++. ++...
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeeccCc
Confidence 36677788899999999999766433 345667777766665666667888888888 699999999986 45578
Q ss_pred EEEEEEcCC-CCHHHHHhcc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeeccc
Q 039371 76 LYFVFEYMD-CNLHQLMSNR-------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGL 146 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~-------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~ 146 (346)
.++++++++ |+|...+... ...++..++..++.|++.|++|||++|++|.||-..|.+|++. ++||+|=.+
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchh
Confidence 899999998 7888777622 2247778889999999999999999999999999999999776 999999999
Q ss_pred ccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChh
Q 039371 147 AWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEE 222 (346)
Q Consensus 147 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 222 (346)
++..-+.. ..+..-....||+||.+. +..|+.++|+||||+++|||+| |+.|+..-++.+...-+.+
T Consensus 443 SRDLFP~DYhcLGDnEnRPvkWMslEal~-n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd-------- 513 (563)
T KOG1024|consen 443 SRDLFPGDYHCLGDNENRPVKWMSLEALQ-NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD-------- 513 (563)
T ss_pred ccccCcccccccCCCCCCcccccCHHHHh-hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc--------
Confidence 97654432 122233466899999998 6779999999999999999998 7899988777665444432
Q ss_pred hHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 223 SWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+++..++ .++++++..++.-||+.+|++||+.+|+..
T Consensus 514 ------------GyRlaQP---------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 ------------GYRLAQP---------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ------------cceecCC---------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 3444443 368999999999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=206.24 Aligned_cols=165 Identities=21% Similarity=0.288 Sum_probs=125.8
Q ss_pred CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccccccC
Q 039371 85 CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTL 163 (346)
Q Consensus 85 g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~ 163 (346)
|+|.+.+...+..+++.+++.++.|++.||.|||+++ ||+||+++ ++.+++ ||.+....... ..||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 6788888776667999999999999999999999998 99999995 457888 99987654422 26889
Q ss_pred cccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcC
Q 039371 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQ 242 (346)
Q Consensus 164 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
.|+|||++. ...++.++||||+||++|+|++|..||...... .....+...........
T Consensus 69 ~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------- 128 (176)
T smart00750 69 YFMAPEVIQ-GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD------------------- 128 (176)
T ss_pred cccChHHhc-CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-------------------
Confidence 999999987 566899999999999999999999999765432 22233322211110000
Q ss_pred CCCcccccCCCCc--hHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 243 GNNLSLLIPSAND--DEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 243 ~~~~~~~~~~~~~--~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
.. ....++. ++.+++++||+.||.+|||+.|+++|+|+.
T Consensus 129 ~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 129 RS----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cc----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00 0011223 689999999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-29 Score=236.18 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=194.5
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccc----cccCHHH-hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQ----RIYSWEE-CLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~-~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
...+.+|.|++|.|+.+......+.++.|.... ......- .....|+.+-..+ .|||++.......+.....-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhh
Confidence 456789999999999998887777777775542 1111111 1134455555566 799998888877666555555
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCC-----
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSC----- 153 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~----- 153 (346)
||||+++|...+... +.++..++..++.|++.||+|+|+.||.|||+||+|+++.. |.+||+|||.+......
T Consensus 400 mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 999999666666554 45899999999999999999999999999999999999964 59999999988654332
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......+|+..|+|||++.+..+-....||||.|+++..|.+|+.||......+....-..
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~------------------- 539 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN------------------- 539 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-------------------
Confidence 2345578999999999998666566789999999999999999999976654433220000
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..........+..+....+...+.+|.+||++||.+|.|+++|++.+||++...
T Consensus 540 --~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 540 --YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred --cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 000111111222333456778889999999999999999999999999997653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-26 Score=204.04 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=188.3
Q ss_pred ceeeeeeecccCceEEEEEEEccCC-cEEEEEEccccccCHHHhhhHHHHHHHHhhc---CCCCeeeeeeee-ecCCEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSG-EYVAIKALKQRIYSWEECLNLKEVKCLRKIN---NHPNIVKLQELA-SENYRLY 77 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~---~hp~iv~~~~~~-~~~~~~~ 77 (346)
+|.+.+.||+|+||.||+|.+..++ +.+|+|+.......... ....|..++..+. ..+++..+++.. ..+..-+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 7999999999999999999988775 67899988654333222 3446777887775 346899999999 5788889
Q ss_pred EEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC------CcEEEeeccccc--
Q 039371 78 FVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN------DTIKIADFGLAW-- 148 (346)
Q Consensus 78 iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~------~~vkl~Dfg~a~-- 148 (346)
|||+.++.+|.+...... +.++...+..++.|++.+|+++|+.|++||||||+|+.+.. ..+.|.|||+++
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 999999999999886554 67999999999999999999999999999999999999943 369999999998
Q ss_pred ccC-CC-----C--C-CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 039371 149 EVD-SC-----P--P-YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP 219 (346)
Q Consensus 149 ~~~-~~-----~--~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 219 (346)
... .. + . .....||..|+++.+.. ....+.+.|+||++.++.++..|..||.+.................
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhC-CCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 321 11 1 1 23456999999999776 6778999999999999999999999997765433322222111000
Q ss_pred ChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. ... .....+..+.++...+-..+...+|....+.+.
T Consensus 257 ~-----------------~~~--------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 257 L-----------------TDR--------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred c-----------------ccc--------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 0 000 001233455555555556788888887776554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=207.45 Aligned_cols=172 Identities=17% Similarity=0.231 Sum_probs=127.9
Q ss_pred CCceeeeeeecccCceEEEEEEEcc-CCcEEEEEEccccc----cCHHHhhhHHHHHHHHhhcCCCCeee-eeeeeecCC
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQ-SGEYVAIKALKQRI----YSWEECLNLKEVKCLRKINNHPNIVK-LQELASENY 74 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~hp~iv~-~~~~~~~~~ 74 (346)
+++|++.+.||+|+||+||+|.++. +++.+|+|++.... .........+|+.+++++ +|+|++. +++. +
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~----~ 91 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT----G 91 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc----C
Confidence 4789999999999999999998876 67888999875331 122334467899999999 7999885 5432 3
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCCEEEe-CCcEEEeecccccccCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDL-ISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~di-kp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
..|+||||++|..+..... .. ...++.|++++|.|||++||+|||| ||+||+++ ++.++|+|||+|.....
T Consensus 92 ~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 5799999999755443211 11 1467899999999999999999999 99999995 56899999999986544
Q ss_pred CCC---------CccccccCcccCccccccc-----CCCCChhhHH
Q 039371 153 CPP---------YTEYITTLQYRAPEMLLMS-----GQYNSKVDMW 184 (346)
Q Consensus 153 ~~~---------~~~~~~t~~y~aPE~~~~~-----~~~~~~~Diw 184 (346)
... .....+++.|.|||.+... ...+..+|-|
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 321 1344677889999987522 1233446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-25 Score=196.85 Aligned_cols=262 Identities=32% Similarity=0.474 Sum_probs=200.2
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
|.+.+.||.|+||.||++.+. ..+++|.+....... ......+|...+..+..+++++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999887 778999997666554 355667888889999534489999999988888899999
Q ss_pred cCCCCHHHHHhcccC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC--cEEEeecccccccCCCC--
Q 039371 82 YMDCNLHQLMSNRKQ---CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND--TIKIADFGLAWEVDSCP-- 154 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~---~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~--~vkl~Dfg~a~~~~~~~-- 154 (346)
++.|..+..+..... .+++..+..++.|++.++.++|+.+++|||+||+||+++.. .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999644444433332 69999999999999999999999999999999999999654 69999999987544332
Q ss_pred -----CCccccccCcccCccccccc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhhH
Q 039371 155 -----PYTEYITTLQYRAPEMLLMS--GQYNSKVDMWALGLIMAELITFHPLFPGTCE---DDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 155 -----~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 224 (346)
......++..|++||.+... ...+...|+||+|++++++++|..||..... .............+
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----- 233 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP----- 233 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----
Confidence 34667899999999998753 5789999999999999999999999877764 23333332222211
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
........... ......+.+++..++..+|..|.+..+...+++.....
T Consensus 234 ------------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 234 ------------SLASPLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred ------------ccccccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 00000000000 11235788999999999999999999999987766543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=182.57 Aligned_cols=203 Identities=24% Similarity=0.341 Sum_probs=171.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
..|.++++||+|+||.+|+|....+|+.||+|+-...... -....|..+.+.+.+...|+.+..+..+..+-.+||+
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4799999999999999999999999999999987544322 2235688888888888899999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CCcEEEeecccccccCCCC---
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~~vkl~Dfg~a~~~~~~~--- 154 (346)
.++.+|.+.+.-....++...+..++-|++.-++|+|.++++||||||+|+|.. ...+.|+|||+|...-+..
T Consensus 92 LLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 92 LLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred ccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence 999999998887777799999999999999999999999999999999999994 3489999999997654322
Q ss_pred -----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 039371 155 -----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ 208 (346)
Q Consensus 155 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 208 (346)
......||..|.+--... ....+...|+=|+|.++.++..|..||.+......
T Consensus 172 HIpyre~r~ltGTaRYASinAh~-g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAHL-GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred cCccccCCccceeeeehhhhhhh-hhhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 123467899998876554 34568889999999999999999999988765433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=200.40 Aligned_cols=197 Identities=27% Similarity=0.327 Sum_probs=149.3
Q ss_pred cCCCCeeeeeeeeec---------------------------CCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHH
Q 039371 58 NNHPNIVKLQELASE---------------------------NYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQI 110 (346)
Q Consensus 58 ~~hp~iv~~~~~~~~---------------------------~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql 110 (346)
.+|||||.+...|.+ +..+|+||...+.+|.+++..+. .+....+-++.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHH
Confidence 379999999887632 45789999999999999988764 6778888899999
Q ss_pred HHHHHHHHHCCccccCCCCCCEEE--eCC---cEEEeecccccccCC-------CCCCccccccCcccCcccccccCC--
Q 039371 111 LQGLNYMHRQGYFHRDLISKNLLV--SND---TIKIADFGLAWEVDS-------CPPYTEYITTLQYRAPEMLLMSGQ-- 176 (346)
Q Consensus 111 ~~~l~~LH~~~ivH~dikp~NIli--~~~---~vkl~Dfg~a~~~~~-------~~~~~~~~~t~~y~aPE~~~~~~~-- 176 (346)
++|+.|||++|+.|||+|.+||++ +++ .+.++|||++-.-+. ........|+..-||||+......
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 999999999999999999999999 333 789999998743322 112233567888999998752111
Q ss_pred ---CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCC
Q 039371 177 ---YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSA 253 (346)
Q Consensus 177 ---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (346)
--.++|.|+.|.+.||+++...||.+....-. ....+...++.-+...+
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----------------------------~~r~Yqe~qLPalp~~v 482 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----------------------------DTRTYQESQLPALPSRV 482 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchhee----------------------------chhhhhhhhCCCCcccC
Confidence 12489999999999999999999976322100 11112233444455688
Q ss_pred CchHHHHHHHhcccCCCCCCC---HHHHhcCCCC
Q 039371 254 NDDEMSLIELLCSWDPCKRPT---AAEALQHPLF 284 (346)
Q Consensus 254 ~~~~~~li~~~l~~dP~~Rps---~~ell~hp~~ 284 (346)
++.+++++..+|+.||++|++ ++.+++-..+
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence 999999999999999999999 5666664433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-27 Score=212.81 Aligned_cols=241 Identities=27% Similarity=0.374 Sum_probs=193.6
Q ss_pred eecccCceEEEEEEE---ccCCcEEEEEEccccccCHHHh-hhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 9 QIGEGSFGKVWQAIK---KQSGEYVAIKALKQRIYSWEEC-LNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 9 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
.+|.|+||.|++++. ...|..||+|+.++.....+.. ....|..++....+||.++++...++.++..++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998643 2446789999986554433222 334677888888779999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccccccC
Q 039371 85 CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTL 163 (346)
Q Consensus 85 g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~ 163 (346)
|+...........+.+...+.+...++-+++++|+.+++|+|+|++||+++ +|++++.|||+++..-..... +||.
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~ 157 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTY 157 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccch
Confidence 744444444444588999999999999999999999999999999999995 679999999999765443322 8999
Q ss_pred cccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCC
Q 039371 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQG 243 (346)
Q Consensus 164 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
.|||||++. ....++|.||+|+++++|++|..||.. +....|.......+
T Consensus 158 eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p----------------------- 207 (612)
T KOG0603|consen 158 EYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP----------------------- 207 (612)
T ss_pred hhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-----------------------
Confidence 999999886 367899999999999999999999987 66666655322222
Q ss_pred CCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCCC
Q 039371 244 NNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCLQ 289 (346)
Q Consensus 244 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~~ 289 (346)
...+..++++++.++..+|.+|.- +.|+++|+||+....
T Consensus 208 -------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 208 -------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred -------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 235678899999999999999986 589999999987643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=190.09 Aligned_cols=233 Identities=19% Similarity=0.252 Sum_probs=148.2
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhh-cC---------CCCeeeeeeee--
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKI-NN---------HPNIVKLQELA-- 70 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l-~~---------hp~iv~~~~~~-- 70 (346)
+...+.||.|+++.||.+++..||+.+|+|++........ ....++|......+ .+ |-.++..++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 5678899999999999999999999999999865543222 22222333222222 11 11222223321
Q ss_pred -------ecC---C-----EEEEEEEcCCCCHHHHHhc---ccC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 039371 71 -------SEN---Y-----RLYFVFEYMDCNLHQLMSN---RKQ---CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLIS 129 (346)
Q Consensus 71 -------~~~---~-----~~~iv~e~~~g~l~~~~~~---~~~---~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp 129 (346)
+.. . +.+++|+-+.++|.+.+.. ... .+.......+..|++..+++||+.|++|+||+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 111 1 2378899999988776532 211 122334456679999999999999999999999
Q ss_pred CCEEEe-CCcEEEeecccccccCCCCCCccccccCcccCccccccc-------CCCCChhhHHHHHHHHHHHHhCCCCCC
Q 039371 130 KNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMS-------GQYNSKVDMWALGLIMAELITFHPLFP 201 (346)
Q Consensus 130 ~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~ 201 (346)
+|++++ +|.+.|+||+.....+..... ...+..|.|||..... ..++.+.|.|+||+++|.|++|..||.
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred eeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 999995 679999999988776653332 3455789999976532 247889999999999999999999997
Q ss_pred CCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCC
Q 039371 202 GTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR 272 (346)
Q Consensus 202 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 272 (346)
........ + .....+. ++++.+++||+.+|+.||.+|
T Consensus 252 ~~~~~~~~-----------~----------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEADP-----------E----------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGSTS-----------G----------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCccccc-----------c----------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 65432100 0 0223333 678999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=182.27 Aligned_cols=143 Identities=22% Similarity=0.284 Sum_probs=108.7
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH-------------------------hhhHHHHHHHHhhcCC
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-------------------------CLNLKEVKCLRKINNH 60 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------------------------~~~~~e~~~l~~l~~h 60 (346)
+.+.||+|++|+||+|.+. +|+.||+|+++........ .....|...+.++ .+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~ 78 (190)
T cd05147 1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VT 78 (190)
T ss_pred CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HH
Confidence 3578999999999999987 8999999999754321111 1113488888888 56
Q ss_pred CCeeeeeeeeecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCCEEEeCCcE
Q 039371 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM-HRQGYFHRDLISKNLLVSNDTI 139 (346)
Q Consensus 61 p~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~ivH~dikp~NIli~~~~v 139 (346)
+++.......... .+|||||++|+.+.........+++..+..++.|++.+|.++ |+.||+||||||+||+++++.+
T Consensus 79 ~~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v 156 (190)
T cd05147 79 AGIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKL 156 (190)
T ss_pred CCCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcE
Confidence 6664433332222 389999999854433222234689999999999999999999 6999999999999999998999
Q ss_pred EEeecccccccCC
Q 039371 140 KIADFGLAWEVDS 152 (346)
Q Consensus 140 kl~Dfg~a~~~~~ 152 (346)
+|+|||+|...+.
T Consensus 157 ~LiDFG~a~~~~~ 169 (190)
T cd05147 157 YIIDVSQSVEHDH 169 (190)
T ss_pred EEEEccccccCCC
Confidence 9999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=217.14 Aligned_cols=245 Identities=25% Similarity=0.329 Sum_probs=179.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--H-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--E-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+|...+.||+++|=+|.+|++.+ | .|++|++-+..... + -.+.+.|++ ..+.++||++.+.-..+.+...|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHH
Confidence 46778899999999999998764 3 38899985544322 1 122344555 3444899999999888888888999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeeccccccc----CCCC
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEV----DSCP 154 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~----~~~~ 154 (346)
-+|+..+|.+.+..++- +..-+.+.|+.|++.||..||+.||+|||||.+|||++. +-+.|+||..-+.. ++..
T Consensus 100 RqyvkhnLyDRlSTRPF-L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRPF-LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhhhhhhhhccchH-HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 99999999999988765 888999999999999999999999999999999999965 58899999754321 1111
Q ss_pred C----CccccccCcccCcccccccC----------CCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 039371 155 P----YTEYITTLQYRAPEMLLMSG----------QYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSP 219 (346)
Q Consensus 155 ~----~~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 219 (346)
. +++...-.+|.|||.+.... ..+++.||||+||++.||++ |.+||.-. ++-...++. ..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~-~~ 253 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGN-AD 253 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccC-cc
Confidence 1 12233345899999876321 16789999999999999987 78998421 111111110 11
Q ss_pred ChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..+... ..-.+..+++||..|++.||.+|.++++.|+.
T Consensus 254 ~~e~~L------------------------e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLL------------------------EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHH------------------------HhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111100 01124578899999999999999999999997
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-24 Score=178.82 Aligned_cols=200 Identities=23% Similarity=0.294 Sum_probs=170.2
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
.|+++++||.|+||..+.|++.-++++||||.-.....-. ....|....+.|.+.++|...|.+..++.+-.+|+|+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP---QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP---QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcc---hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 5899999999999999999999999999999764433222 2235777777787899999999999999888999999
Q ss_pred CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe------CCcEEEeecccccccCCCCC-
Q 039371 83 MDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS------NDTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 83 ~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~------~~~vkl~Dfg~a~~~~~~~~- 155 (346)
++.+|.+.+.-.+..|+...+..++.|++.-++++|++.++.|||||+|+||. ...+.++|||+|...-+...
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 99999999988888899999999999999999999999999999999999993 23799999999976544321
Q ss_pred -------CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH
Q 039371 156 -------YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED 206 (346)
Q Consensus 156 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 206 (346)
..+..||..||+--... +.+.+...|.=|||-++.+.+.|..||.+...+
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHl-GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred ccCccccccccccceeeeEeeccc-cchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 23457899999977666 556789999999999999999999999876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=208.29 Aligned_cols=221 Identities=27% Similarity=0.371 Sum_probs=167.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|..++.+..|++|.||+++|+.+..++|+| +++...- ++. ++... ++|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li------lRn--ilt~a-~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI------LRN--ILTFA-GNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh------hhc--ccccc-CCccee-----------------
Confidence 47889999999999999999999999999994 4433211 111 22222 444444
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCCC------
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCP------ 154 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~~------ 154 (346)
|+=.. +.+.-++++... +.+++|||+.||+|||+||+|.+| .-|++|++|||++.......
T Consensus 136 ---gDc~t-llk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 ---GDCAT-LLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred ---chhhh-hcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 22222 222223344333 778999999999999999999999 56899999999986432111
Q ss_pred ----------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhH
Q 039371 155 ----------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 155 ----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (346)
.....+||+.|.|||++. ..-|+..+|+|++|+|+|+.+-|..||.+++.++.+...+.....-++.+
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVil-rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d- 281 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED- 281 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhh-hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC-
Confidence 112348999999999998 45589999999999999999999999999999999988876544333322
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCCC
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP---TAAEALQHPLFQGCLQ 289 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp---s~~ell~hp~~~~~~~ 289 (346)
...++++++++..+|+.+|..|. .+-++.+|+||+....
T Consensus 282 --------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 282 --------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred --------------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 35689999999999999999995 4888999999987543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=177.45 Aligned_cols=170 Identities=14% Similarity=0.105 Sum_probs=126.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHh--h------hHHHHHHHHhhcCCCCeeeeeeeeecC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEEC--L------NLKEVKCLRKINNHPNIVKLQELASEN 73 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~--~------~~~e~~~l~~l~~hp~iv~~~~~~~~~ 73 (346)
++|++++.+|.|+||.||++.. ++..+|+|++.......... . ..+|+..+.++ .||+|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLLA 107 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeeec
Confidence 5899999999999999999754 46689999997554433322 1 24677889999 799999999886533
Q ss_pred --------CEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecc
Q 039371 74 --------YRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFG 145 (346)
Q Consensus 74 --------~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg 145 (346)
+..+++|||++|..+..+. .+++. ...+++.++..||+.|++|||++|+||+++++.++|+|||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~liDfg 179 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRIIDLS 179 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEEECC
Confidence 3579999999984433332 13432 4569999999999999999999999999976559999999
Q ss_pred cccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHH
Q 039371 146 LAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELI 194 (346)
Q Consensus 146 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 194 (346)
.+.......... .+.....++.++||||||+++....
T Consensus 180 ~~~~~~e~~a~d------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAKD------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhHH------------HHHHHhHhcccccccceeEeehHHH
Confidence 875543211111 1222344678999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=173.20 Aligned_cols=142 Identities=20% Similarity=0.263 Sum_probs=110.0
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-------------------------HhhhHHHHHHHHhhcCC
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-------------------------ECLNLKEVKCLRKINNH 60 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------------------------~~~~~~e~~~l~~l~~h 60 (346)
+.+.||+|++|.||+|.+. +|+.||+|+++....... ......|...+.++ .+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~ 78 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YE 78 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-Hh
Confidence 4678999999999999987 899999999876532100 11123677888888 68
Q ss_pred CCeeeeeeeeecCCEEEEEEEcCCCC-HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEeCCc
Q 039371 61 PNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVSNDT 138 (346)
Q Consensus 61 p~iv~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~~~~ 138 (346)
+++.....+.... .++||||++|. +...... ...+++.++..++.|++.++.++|+ .||+||||||+||+++++.
T Consensus 79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~ 155 (190)
T cd05145 79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGK 155 (190)
T ss_pred CCCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECCC
Confidence 8875544443332 38999999975 3333222 2458889999999999999999999 9999999999999999889
Q ss_pred EEEeecccccccCC
Q 039371 139 IKIADFGLAWEVDS 152 (346)
Q Consensus 139 vkl~Dfg~a~~~~~ 152 (346)
++|+|||++...+.
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999976554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=164.75 Aligned_cols=187 Identities=16% Similarity=0.129 Sum_probs=138.7
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH---HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE---ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
..+...|++|+||+|+++.. .+..++.+.+........ ...+.+|+.+++++.+++++++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678899999999998854 577888777765544222 12456899999999777899999886 3469999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCCEEEe-CCcEEEeecccccccCCCCCC--
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDL-ISKNLLVS-NDTIKIADFGLAWEVDSCPPY-- 156 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~di-kp~NIli~-~~~vkl~Dfg~a~~~~~~~~~-- 156 (346)
||+.|..+.... +.. ...++.|++.+|.++|++||+|||| ||+||+++ ++.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRP------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhh------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 999986543221 111 2357889999999999999999999 79999995 568999999999865543321
Q ss_pred --c----------cccccCcccCcccccccCCCC-ChhhHHHHHHHHHHHHhCCCCCCCC
Q 039371 157 --T----------EYITTLQYRAPEMLLMSGQYN-SKVDMWALGLIMAELITFHPLFPGT 203 (346)
Q Consensus 157 --~----------~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~ 203 (346)
. -...++.|++|+....-...+ ...+.++.|+-+|.++|+..|+-++
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 012477888888654333344 5778889999999999999886443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-22 Score=164.91 Aligned_cols=241 Identities=20% Similarity=0.304 Sum_probs=179.0
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
+..++-+|.....|+.|+|++. |..++.|+++......+..+.++|.---.++..||||+.+++.+....++.++..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 3455667888899999999876 44567788877666655555555443333444899999999999999999999999
Q ss_pred CC-CCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEeCC---cEEEeecccccccCCCCC
Q 039371 83 MD-CNLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQG--YFHRDLISKNLLVSND---TIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 83 ~~-g~l~~~~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dikp~NIli~~~---~vkl~Dfg~a~~~~~~~~ 155 (346)
|+ |+|...+..... -.+..++.+++.+++.|++|||+.. |---.+....+++|++ ++..+|--++....
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~---- 344 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV---- 344 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecc----
Confidence 99 788887765533 3677899999999999999999984 4445688999999876 45555544443221
Q ss_pred CccccccCcccCcccccccCC--CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 YTEYITTLQYRAPEMLLMSGQ--YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
...-.|.|++||.+..... --.++|+|||++++||+.|...||..-.+.+.-.+|.-.
T Consensus 345 --gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale------------------ 404 (448)
T KOG0195|consen 345 --GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE------------------ 404 (448)
T ss_pred --ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc------------------
Confidence 2244679999999874322 235899999999999999999999887766543333211
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL 279 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell 279 (346)
+. ...+.|+++.....|+.-|+..||.+||..+.++
T Consensus 405 -gl---------rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 405 -GL---------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -cc---------cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 00 1123468889999999999999999999987764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=190.08 Aligned_cols=190 Identities=22% Similarity=0.320 Sum_probs=154.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc--CCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN--NHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~hp~iv~~~~~~~~~~~~~iv 79 (346)
+.|.|-+.+|.|+||+||.|.+.. |+.||+|+=+....++ ++--.+++.+|. --+.|..+...+...+.-++|
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 578999999999999999999887 9999999987776552 111223333441 235666666666667777999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--------CcEEEeeccccccc
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--------DTIKIADFGLAWEV 150 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--------~~vkl~Dfg~a~~~ 150 (346)
+||.+ |+|++.+...+ .+++..+..+..|++..|+.||..+||||||||+|+++.+ ..++|+|||.+...
T Consensus 773 ~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred eeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 99998 89999988544 4999999999999999999999999999999999999942 26999999998543
Q ss_pred ---CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCC
Q 039371 151 ---DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHP 198 (346)
Q Consensus 151 ---~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 198 (346)
.+...+....+|..+-.+|+.. +..++..+|-|.|+.+++.|++|+.
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~-grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMRE-GRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhc-CCCCchhhhhHHHHHHHHHHHHHHH
Confidence 3444566677899999999776 7789999999999999999999863
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=164.38 Aligned_cols=145 Identities=21% Similarity=0.236 Sum_probs=109.7
Q ss_pred eeeeeeecccCceEEEEEE-EccCCcEEEEEEccccccCH-----------------------HHhhhHHHHHHHHhhcC
Q 039371 4 YTLMKQIGEGSFGKVWQAI-KKQSGEYVAIKALKQRIYSW-----------------------EECLNLKEVKCLRKINN 59 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~~ 59 (346)
|++.+.||+|++|.||+|. +..+|+.||+|+++...... ......+|...+.++..
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7789999999999999998 77789999999987543210 01123468888888842
Q ss_pred -CCCeeeeeeeeecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCCEEEeCC
Q 039371 60 -HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG-YFHRDLISKNLLVSND 137 (346)
Q Consensus 60 -hp~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-ivH~dikp~NIli~~~ 137 (346)
...++++++. . ..++|||+++|..+.........+.+..+..++.|++.++.+||+.| ++|+||||+||+++++
T Consensus 110 ~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~ 185 (237)
T smart00090 110 AGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVHDG 185 (237)
T ss_pred cCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEECC
Confidence 1334444432 2 34899999998544333222334677778899999999999999999 9999999999999988
Q ss_pred cEEEeecccccccCC
Q 039371 138 TIKIADFGLAWEVDS 152 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~ 152 (346)
.++|+|||.+...+.
T Consensus 186 ~i~LiDFg~a~~~~~ 200 (237)
T smart00090 186 KVVIIDVSQSVELDH 200 (237)
T ss_pred CEEEEEChhhhccCC
Confidence 999999998865443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-20 Score=153.50 Aligned_cols=136 Identities=15% Similarity=0.197 Sum_probs=104.1
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc----CCCCeeeeeeeeecCC---EE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN----NHPNIVKLQELASENY---RL 76 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~----~hp~iv~~~~~~~~~~---~~ 76 (346)
+.-.+.||+|++|.||. +..++.. +||++...... ......+|+..++.+. +||||++++++++++. .+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34457899999999995 7777666 68988654332 3344678999999884 4899999999998873 43
Q ss_pred E-EEEEcCC---CCHHHHHhcccCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCCEEEeC-----CcEEEeeccc
Q 039371 77 Y-FVFEYMD---CNLHQLMSNRKQCFSEAEVKNWCFQILQGL-NYMHRQGYFHRDLISKNLLVSN-----DTIKIADFGL 146 (346)
Q Consensus 77 ~-iv~e~~~---g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l-~~LH~~~ivH~dikp~NIli~~-----~~vkl~Dfg~ 146 (346)
+ +|+||.+ |+|.+.+... .+++. ..++.|++.++ +|||+++|+||||||+||+++. +.++|+|++.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 4 7899954 5777777543 36666 35678888777 9999999999999999999952 2799999543
Q ss_pred c
Q 039371 147 A 147 (346)
Q Consensus 147 a 147 (346)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-21 Score=185.81 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=198.3
Q ss_pred CceeeeeeecccCceEEEEEEEccC-CcEEEEEEccccc-cCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS-GEYVAIKALKQRI-YSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
..|.+.+.||+|+++.|-.+....+ ...+|.|.+.... ..........|..+-..+.+|+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4689999999999999999876433 3456666664443 1122223334666666775699999999999999999999
Q ss_pred EEcCCC-CHHHHH-hcccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCEEEe-CC-cEEEeecccccccCC-C
Q 039371 80 FEYMDC-NLHQLM-SNRKQCFSEAEVKNWCFQILQGLNYMH-RQGYFHRDLISKNLLVS-ND-TIKIADFGLAWEVDS-C 153 (346)
Q Consensus 80 ~e~~~g-~l~~~~-~~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~ivH~dikp~NIli~-~~-~vkl~Dfg~a~~~~~-~ 153 (346)
+++..| ++.+.+ .......+...+..++.|+..++.|+| ..++.|+|+||+|.+++ ++ .+++.|||+|+.... .
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 999876 455555 333325888999999999999999999 99999999999999995 45 799999999976554 2
Q ss_pred ---CCCccccc-cCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 ---PPYTEYIT-TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ---~~~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
......+| ++.|+|||...+.....+..|+||.|+++.-+++|..|+......+....-
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~----------------- 242 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS----------------- 242 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee-----------------
Confidence 23344577 999999999886667889999999999999999999999765543311000
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
+.......-...+...+....+++.+++..+|.+|.+.+++..+||+..
T Consensus 243 --------~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 243 --------WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred --------ecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0000011112334578889999999999999999999999999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.8e-19 Score=147.71 Aligned_cols=135 Identities=21% Similarity=0.278 Sum_probs=107.8
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCH-------HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-------EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++.||+|++|.||+|.+ +|..+++|+........ ......+|...+..+ .|+++.....++.+.+..+++
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIV 77 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEE
Confidence 36799999999999976 57789999865433211 122345788888888 688888777777677778999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccc
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWE 149 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~ 149 (346)
|||++| ++.+.+... .. ....++.+++.+|.++|+.|++|+|++|.||+++++.++++|||.+..
T Consensus 78 ~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence 999987 555554432 22 888999999999999999999999999999999988999999998854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-20 Score=164.49 Aligned_cols=175 Identities=33% Similarity=0.460 Sum_probs=129.0
Q ss_pred CEEEEEEEcCCC-CHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccc
Q 039371 74 YRLYFVFEYMDC-NLHQLMSNR--KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWE 149 (346)
Q Consensus 74 ~~~~iv~e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~ 149 (346)
.++||.|++|.- +|.+.+..+ ....+......++.|+..|++| +|.+|+|+||.||+.. ++.+||+|||+.+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 357999999985 455544322 2346778899999999999999 9999999999999995 55799999999987
Q ss_pred cCCCC-------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 150 VDSCP-------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 150 ~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
..... ..+...||..||+||.+. +..|+.++||||||.+++|++.- ..+|.. ...+..+.. +..++
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~--g~ip~ 479 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIR-GQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRD--GIIPP 479 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHh-hhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhc--CCCCh
Confidence 76555 456678999999999998 67799999999999999999972 222211 011111111 11111
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
..+ ...+.-.+|+.+|+...|.+||++.+.--|+|.
T Consensus 480 ~~~---------------------------~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 480 EFL---------------------------QDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHh---------------------------hcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 111 123455689999999999999988888777775
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=159.29 Aligned_cols=201 Identities=22% Similarity=0.327 Sum_probs=152.6
Q ss_pred hhcCCCCeeeeeeeeecCCEEEEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCCCEE
Q 039371 56 KINNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY-FHRDLISKNLL 133 (346)
Q Consensus 56 ~l~~hp~iv~~~~~~~~~~~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~i-vH~dikp~NIl 133 (346)
.+ .|.|+.++++...++...++|.++|. |+|.+.+......++......++++++.|+.|||+..| +|+.+++.|.+
T Consensus 3 ~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl 81 (484)
T KOG1023|consen 3 QL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL 81 (484)
T ss_pred cc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence 44 79999999999999999999999998 89999988877779999999999999999999998865 99999999999
Q ss_pred EeCC-cEEEeecccccccCCC---CCCccccccCcccCcccccccCC------CCChhhHHHHHHHHHHHHhCCCCCCCC
Q 039371 134 VSND-TIKIADFGLAWEVDSC---PPYTEYITTLQYRAPEMLLMSGQ------YNSKVDMWALGLIMAELITFHPLFPGT 203 (346)
Q Consensus 134 i~~~-~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwslG~il~~ll~g~~pf~~~ 203 (346)
++.. .+||+|||+....... ...........|.|||.+..... .+.+.||||+|++++|+++...||+..
T Consensus 82 vd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~ 161 (484)
T KOG1023|consen 82 VDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLR 161 (484)
T ss_pred eeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccc
Confidence 9765 9999999998665421 11222234567999998875311 466899999999999999999999763
Q ss_pred ChH----HHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 039371 204 CED----DQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL 279 (346)
Q Consensus 204 ~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell 279 (346)
... +....+.+....+.. |.... . ....+++..+++.|+..+|.+||+++++-
T Consensus 162 ~~~~~~~eii~~~~~~~~~~~r-----------------P~i~~-----~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 162 NLVEDPDEIILRVKKGGSNPFR-----------------PSIEL-----L-NELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred cccCChHHHHHHHHhcCCCCcC-----------------cchhh-----h-hhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 322 233332221111111 11000 0 13455789999999999999999999885
Q ss_pred c
Q 039371 280 Q 280 (346)
Q Consensus 280 ~ 280 (346)
.
T Consensus 219 ~ 219 (484)
T KOG1023|consen 219 S 219 (484)
T ss_pred h
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=142.77 Aligned_cols=130 Identities=19% Similarity=0.276 Sum_probs=98.7
Q ss_pred eecccCceEEEEEEEccCCcEEEEEEccccccCH-------HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-------EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
.||+|++|+||+|.. ++..+++|+........ ......+|..++..+ .|+++.....++...+..+++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999974 57789999865432211 123345788889888 56665555445555566789999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWE 149 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~ 149 (346)
+++| ++.+.+... . . .++.|++.+|.+||+.|++|+|++|.||+++++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~-~----~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEG-N----D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhc-H----H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcC
Confidence 9987 454444321 1 1 889999999999999999999999999999988999999998855
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=141.93 Aligned_cols=137 Identities=25% Similarity=0.262 Sum_probs=101.9
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH---------------------HHhhhHHHHHHHHhhcCCC-
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW---------------------EECLNLKEVKCLRKINNHP- 61 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------------~~~~~~~e~~~l~~l~~hp- 61 (346)
|.+.+.||+|++|.||+|... +|+.||+|++..+.... .......|...+..+ .++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence 788899999999999999875 79999999876433111 011234677778777 455
Q ss_pred -CeeeeeeeeecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcE
Q 039371 62 -NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTI 139 (346)
Q Consensus 62 -~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~v 139 (346)
.++..++ ....+++||+++|..+..+.. ......++.+++.++.++|+.|++|+||+|+||+++ ++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 3444443 234589999999854433321 144567889999999999999999999999999996 5689
Q ss_pred EEeecccccccCC
Q 039371 140 KIADFGLAWEVDS 152 (346)
Q Consensus 140 kl~Dfg~a~~~~~ 152 (346)
+|+|||.+.....
T Consensus 165 ~liDfg~~~~~~~ 177 (198)
T cd05144 165 YIIDWPQMVSTDH 177 (198)
T ss_pred EEEECCccccCCC
Confidence 9999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.7e-18 Score=139.98 Aligned_cols=139 Identities=25% Similarity=0.345 Sum_probs=97.1
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhh-----------------------HHHHHHHHhhcCC-C
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-----------------------LKEVKCLRKINNH-P 61 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-----------------------~~e~~~l~~l~~h-p 61 (346)
+.+.||+|+||+||+|.+. +++.||+|++............ ..|...+.++..+ .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999876 7899999998654322111110 2344455555322 2
Q ss_pred CeeeeeeeeecCCEEEEEEEcCCCC-HHH-HHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEeCCc
Q 039371 62 NIVKLQELASENYRLYFVFEYMDCN-LHQ-LMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVSNDT 138 (346)
Q Consensus 62 ~iv~~~~~~~~~~~~~iv~e~~~g~-l~~-~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~~~~ 138 (346)
.+.++++. ...+++||+++|+ +.. .+.... ...++..++.+++.++.++|+ .|++|+||||+||+++++.
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~~~ 152 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVDDGK 152 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEECCc
Confidence 24444433 2358999999972 111 111111 116788999999999999999 9999999999999999889
Q ss_pred EEEeecccccccCC
Q 039371 139 IKIADFGLAWEVDS 152 (346)
Q Consensus 139 vkl~Dfg~a~~~~~ 152 (346)
++|+|||.+.....
T Consensus 153 ~~liDfg~a~~~~~ 166 (187)
T cd05119 153 VYIIDVPQAVEIDH 166 (187)
T ss_pred EEEEECcccccccC
Confidence 99999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.5e-18 Score=160.29 Aligned_cols=135 Identities=17% Similarity=0.198 Sum_probs=104.3
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccc-cC------HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRI-YS------WEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~------~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
|...+.||+|+||+||+|..... .+++|+..... .. .......+|..++..+ +|++++....+..++...
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCCCC
Confidence 45678999999999999976543 34444321111 11 1123456899999999 799998877777776678
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeeccccccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEV 150 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~ 150 (346)
++||||++| ++.+.+. ....++.|++.+|.+||+.|++||||||+||+++++.++|+|||++...
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCcccccC
Confidence 999999987 5555443 3567899999999999999999999999999998889999999998553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2e-17 Score=151.42 Aligned_cols=252 Identities=21% Similarity=0.223 Sum_probs=197.4
Q ss_pred ceeeeeeecc--cCceEEEEEEE--ccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 3 KYTLMKQIGE--GSFGKVWQAIK--KQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 3 ~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
.+.+.+.+|+ |.+|.||.+.. ..++..+|+|.-+..... .......+|......+..|++.++.+..+++.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4567788999 99999999998 888999999985444332 223344678888888888999999999999999999
Q ss_pred EEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCCEEEe-C-CcEEEeecccccccC
Q 039371 78 FVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQ----GLNYMHRQGYFHRDLISKNLLVS-N-DTIKIADFGLAWEVD 151 (346)
Q Consensus 78 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~----~l~~LH~~~ivH~dikp~NIli~-~-~~vkl~Dfg~a~~~~ 151 (346)
+-+|.++.++..........+++..++..+.+... ||.++|+.+++|.|+||+||+.. + ...+++|||+...++
T Consensus 195 iqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS 274 (524)
T ss_pred eeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEcc
Confidence 99999999999888877777999999999999999 99999999999999999999994 4 588999999998877
Q ss_pred CCCCCcc------ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCChhhH
Q 039371 152 SCPPYTE------YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGT-CEDDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 152 ~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~ 224 (346)
+...... ..+...|++||.. .+-++..+||+++|-+..+..++..+.... ... |
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~--~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----------------W 335 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELL--NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----------------W 335 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhh--ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----------------c
Confidence 6542211 2567789999977 466899999999999999888776544222 110 0
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.. ........+.....+.++...+..|++.+|..|+++..++.|+++.+
T Consensus 336 ~~-------------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 336 SQ-------------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cc-------------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 00 00000111122345566677999999999999999999999999984
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.4e-16 Score=124.35 Aligned_cols=132 Identities=21% Similarity=0.224 Sum_probs=107.9
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC-CCeeeeeeeeecCCEEEEEEEcCC
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH-PNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h-p~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
+++.||+|.++.||++.... ..+++|....... .....+|...++.+.++ +++++++.+.+..+..+++||++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 56889999999999998754 6799999865543 33456788888888544 689999998888888999999998
Q ss_pred CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCEEEeC-CcEEEeecccccc
Q 039371 85 CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ---GYFHRDLISKNLLVSN-DTIKIADFGLAWE 149 (346)
Q Consensus 85 g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dikp~NIli~~-~~vkl~Dfg~a~~ 149 (346)
|...... +......++.++++++..+|.. +++|+|++|+||++++ +.++++|||.+..
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7543322 5566778899999999999985 6999999999999976 7999999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-15 Score=129.49 Aligned_cols=133 Identities=18% Similarity=0.262 Sum_probs=96.5
Q ss_pred eeec-ccCceEEEEEEEccCCcEEEEEEcccccc------------CHHHhhhHHHHHHHHhhcCCCCe--eeeeeeeec
Q 039371 8 KQIG-EGSFGKVWQAIKKQSGEYVAIKALKQRIY------------SWEECLNLKEVKCLRKINNHPNI--VKLQELASE 72 (346)
Q Consensus 8 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~e~~~l~~l~~hp~i--v~~~~~~~~ 72 (346)
..|| .|+.|+||.+... +..+++|.+..... ........+|+..+.++ .|+++ +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4577 7888999998654 67889998853211 12234456799999999 57664 666665433
Q ss_pred C-C---EEEEEEEcCCC--CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecc
Q 039371 73 N-Y---RLYFVFEYMDC--NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFG 145 (346)
Q Consensus 73 ~-~---~~~iv~e~~~g--~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg 145 (346)
. . ..++|||+++| ++.+.+.. ..+++.. +.|++.+|.+||++||+|+||||+|||++ ++.++|+|||
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 2 23599999996 55555543 2355543 57899999999999999999999999996 4589999999
Q ss_pred cccc
Q 039371 146 LAWE 149 (346)
Q Consensus 146 ~a~~ 149 (346)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8744
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-14 Score=118.61 Aligned_cols=140 Identities=18% Similarity=0.186 Sum_probs=100.7
Q ss_pred eeeecccCceEEEEEEEcc------CCcEEEEEEccccccC---------------------HHHhhh----HHHHHHHH
Q 039371 7 MKQIGEGSFGKVWQAIKKQ------SGEYVAIKALKQRIYS---------------------WEECLN----LKEVKCLR 55 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~---------------------~~~~~~----~~e~~~l~ 55 (346)
...||.|--+.||.|.... .+..+|+|+.+....+ ...... .+|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4689999999999997653 3578999987421110 001111 26888888
Q ss_pred hhcCC-CCeeeeeeeeecCCEEEEEEEcCCCC-HHHHHhcccCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCCE
Q 039371 56 KINNH-PNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYM-HRQGYFHRDLISKNL 132 (346)
Q Consensus 56 ~l~~h-p~iv~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~ivH~dikp~NI 132 (346)
++... -+++.++++ ..-+||||+++|+ +.....+ ...+++.+...+..+++.++..| |+.|++|||+++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 88533 456666654 3357999999874 2111111 22356677888899999999998 899999999999999
Q ss_pred EEeCCcEEEeecccccccC
Q 039371 133 LVSNDTIKIADFGLAWEVD 151 (346)
Q Consensus 133 li~~~~vkl~Dfg~a~~~~ 151 (346)
+++++.+.|+|||.+...+
T Consensus 157 L~~~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWHDGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEECCcEEEEECCCceeCC
Confidence 9999999999999886654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.3e-14 Score=132.84 Aligned_cols=169 Identities=23% Similarity=0.364 Sum_probs=128.3
Q ss_pred EE-EEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCCCHHHHHhcccC
Q 039371 18 VW-QAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQ 96 (346)
Q Consensus 18 V~-~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~ 96 (346)
+| .|..+.++.+|.+.+.+.+.. .......+.++.++.+ +||||+++++.++.++..|||+|.+.. +...+.+
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~--- 100 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE--- 100 (690)
T ss_pred cccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeecccc-HHHHHHH---
Confidence 44 577788899999998876655 2333345677788888 799999999999999999999999863 3333433
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-CccccccCcccCcccccc
Q 039371 97 CFSEAEVKNWCFQILQGLNYMH-RQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-YTEYITTLQYRAPEMLLM 173 (346)
Q Consensus 97 ~l~~~~~~~i~~ql~~~l~~LH-~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~ 173 (346)
+....+...+.||+.||.||| +.+++|++|..+.|+++ .|+.||++|..+........ ......-..|..|+.+..
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 347788889999999999998 56899999999999995 67999999998866554332 122222334666765431
Q ss_pred cCCCCChhhHHHHHHHHHHHHhC
Q 039371 174 SGQYNSKVDMWALGLIMAELITF 196 (346)
Q Consensus 174 ~~~~~~~~DiwslG~il~~ll~g 196 (346)
+ ....|.|.|||++++++.|
T Consensus 180 s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 S---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c---ccchhhhhHHHHHHHHhCc
Confidence 1 2457999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.8e-15 Score=135.37 Aligned_cols=249 Identities=24% Similarity=0.286 Sum_probs=184.6
Q ss_pred CceeeeeeecccCceEEEEEEEc-cCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-QSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
.+|..+..||.|.|+.|+....+ .++..|++|.......... +...+.|..+...+..|.+++..+..+......||-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 46788999999999999988655 6788899998876655433 334467888888888899999999999888888899
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeecccccccCCCCCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
.|||.|........-...+.+...+++..|++.++.++|+..++|+|++|+||++.+ +.-+++|||..+...... .
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~--~ 422 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS--G 422 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec--c
Confidence 999986444433333344899999999999999999999999999999999999966 688999999886532211 1
Q ss_pred cccccCccc-CcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYR-APEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~-aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
.......+. .+|++.....+..+.|++|||..+.+.++|.+.-..... ...+..+
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~--------------------- 478 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSG--------------------- 478 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecc---------------------
Confidence 112233444 366666677889999999999999999998644322111 0011000
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
.....+....+++.+...+...|+..||++.++..|+=|.
T Consensus 479 ---------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 479 ---------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0011133446778899999999999999999999886554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.4e-14 Score=113.06 Aligned_cols=128 Identities=13% Similarity=0.084 Sum_probs=93.3
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCCC
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDCN 86 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g~ 86 (346)
++.++.|.++.||+++.. +..|++|+....... .....+|...++.+.+...+++++....+ ..++|||+++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCCC
Confidence 578899999999999765 778999998654321 12234688888877543334555555433 347999999985
Q ss_pred HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCCEEEeCCcEEEeeccccc
Q 039371 87 LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY-----FHRDLISKNLLVSNDTIKIADFGLAW 148 (346)
Q Consensus 87 l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~i-----vH~dikp~NIli~~~~vkl~Dfg~a~ 148 (346)
..... ......++.+++++|..||+.++ +|+|++|.||+++++.++++||+.+.
T Consensus 77 ~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG 135 (170)
T ss_pred ccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence 43221 11123457899999999999985 99999999999998899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.9e-15 Score=142.42 Aligned_cols=258 Identities=22% Similarity=0.229 Sum_probs=186.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+.+.+.+.+-+|.++.++.+.-..+|...+.|+......-.. ......+-.++... .+|-++.....+.-....+++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchh
Confidence 567888899999999999998777786666666532211000 00001111111111 345555555555556778999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCC----
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSC---- 153 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~---- 153 (346)
+++.+| ++...+...+ ..+++-.+..+..+..++++||+..+.|+|++|.|++. .++..++.|||.....+..
T Consensus 883 ~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 999985 5666655554 47888888889999999999999999999999999999 5678999999843222110
Q ss_pred ----------------------------CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh
Q 039371 154 ----------------------------PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE 205 (346)
Q Consensus 154 ----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 205 (346)
.......+|+.|.+||... ....+.++|+|+.|+++++.++|.+||+....
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-g~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-GRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccc-cccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0011246799999999887 55678899999999999999999999999988
Q ss_pred HHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHH---HHhcCC
Q 039371 206 DDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA---EALQHP 282 (346)
Q Consensus 206 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~---ell~hp 282 (346)
...+.++....... .......+..+++++...+..+|.+|..+. ++-.||
T Consensus 1041 q~~f~ni~~~~~~~---------------------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~ 1093 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPW---------------------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHP 1093 (1205)
T ss_pred hhhhhccccCCCCC---------------------------CCCccccChhhhhhhhhhhccCchhccCcccccccccCC
Confidence 87777665432211 112235678899999999999999999987 999999
Q ss_pred CCCCCCC
Q 039371 283 LFQGCLQ 289 (346)
Q Consensus 283 ~~~~~~~ 289 (346)
||+....
T Consensus 1094 ~~~~~~~ 1100 (1205)
T KOG0606|consen 1094 FFQDVDW 1100 (1205)
T ss_pred ccCCCCc
Confidence 9997543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=9.7e-15 Score=124.27 Aligned_cols=196 Identities=24% Similarity=0.350 Sum_probs=134.4
Q ss_pred CCCCeeeeeeeeecC-----CEEEEEEEcCC-CCHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCC
Q 039371 59 NHPNIVKLQELASEN-----YRLYFVFEYMD-CNLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMHRQ--GYFHRDL 127 (346)
Q Consensus 59 ~hp~iv~~~~~~~~~-----~~~~iv~e~~~-g~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~ivH~di 127 (346)
-|.||++++.++.+. ....++.|||. |++...+. +.+..+....-.+|+.||+.||.|||+. -|+|+++
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 599999999998654 35788999998 56655553 3344688999999999999999999998 5999999
Q ss_pred CCCCEEEe-CCcEEEeecccccccCCC-----CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCC-C
Q 039371 128 ISKNLLVS-NDTIKIADFGLAWEVDSC-----PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPL-F 200 (346)
Q Consensus 128 kp~NIli~-~~~vkl~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f 200 (346)
..+.|++. +|-+|++--.-....... ...+...+-++|.+||.-. ....+.++|||++|....+|..|..- -
T Consensus 205 Tc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~t 283 (458)
T KOG1266|consen 205 TCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQST 283 (458)
T ss_pred chhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccC
Confidence 99999995 556665432211111000 0112234577899999554 44567799999999999999887643 3
Q ss_pred CCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 201 PGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 201 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
++......-..+.+.+ +.-..+.-++++++|++..|..||++.+++-
T Consensus 284 nseS~~~~ee~ia~~i---------------------------------~~len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 284 NSESKVEVEENIANVI---------------------------------IGLENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred CCcceeehhhhhhhhe---------------------------------eeccCccccCcCcccccCCCCCCcchhhhhc
Confidence 3322222211221110 0011223346899999999999999999999
Q ss_pred CCCCCCCC
Q 039371 281 HPLFQGCL 288 (346)
Q Consensus 281 hp~~~~~~ 288 (346)
||..-+..
T Consensus 331 HpllfeVh 338 (458)
T KOG1266|consen 331 HPLLFEVH 338 (458)
T ss_pred Cceeeecc
Confidence 99876543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.5e-13 Score=125.96 Aligned_cols=140 Identities=23% Similarity=0.301 Sum_probs=90.4
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCH---------------------------------------HHhhhH
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW---------------------------------------EECLNL 48 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------------------------------~~~~~~ 48 (346)
+.||+|++|.||+|+.+ +|+.||||+........ .+....
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999865 68999999975432110 001122
Q ss_pred HHHHHHHhhc----CCCCeeeeeeeeecCCEEEEEEEcCCCC-HHHHHhcccCCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 039371 49 KEVKCLRKIN----NHPNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQ-GLNYMHRQGY 122 (346)
Q Consensus 49 ~e~~~l~~l~----~hp~iv~~~~~~~~~~~~~iv~e~~~g~-l~~~~~~~~~~l~~~~~~~i~~ql~~-~l~~LH~~~i 122 (346)
+|...+.++. +++++.-..-+.+..+..+++|||++|. +.+.........+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 3444444432 3444433222233344568999999974 4333322111122 3445556655 4678999999
Q ss_pred cccCCCCCCEEEe-CCcEEEeecccccccC
Q 039371 123 FHRDLISKNLLVS-NDTIKIADFGLAWEVD 151 (346)
Q Consensus 123 vH~dikp~NIli~-~~~vkl~Dfg~a~~~~ 151 (346)
+|+|++|.||+++ ++.++++|||++...+
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999995 5699999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-13 Score=129.70 Aligned_cols=142 Identities=21% Similarity=0.335 Sum_probs=89.4
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH---------------------------------------H
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW---------------------------------------E 43 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------------------------------~ 43 (346)
.|+. +.||+|++|.||+|+.+.+|+.||+|+........ .
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4565 78999999999999998889999999986432100 0
Q ss_pred HhhhHHHHHHHHhhc---CCCCeeeeeeeee-cCCEEEEEEEcCCC-CHHHH--HhcccC---CCCHHHHHHHHHHHHHH
Q 039371 44 ECLNLKEVKCLRKIN---NHPNIVKLQELAS-ENYRLYFVFEYMDC-NLHQL--MSNRKQ---CFSEAEVKNWCFQILQG 113 (346)
Q Consensus 44 ~~~~~~e~~~l~~l~---~hp~iv~~~~~~~-~~~~~~iv~e~~~g-~l~~~--~~~~~~---~l~~~~~~~i~~ql~~~ 113 (346)
+....+|...+.++. .+.+.+.+-.++. -.+..++||||++| .+.+. +...+. .+.+..+..++.|++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 011223333333332 1222233323332 23456799999998 44332 222211 244444555555554
Q ss_pred HHHHHHCCccccCCCCCCEEEeC-C----cEEEeecccccccCC
Q 039371 114 LNYMHRQGYFHRDLISKNLLVSN-D----TIKIADFGLAWEVDS 152 (346)
Q Consensus 114 l~~LH~~~ivH~dikp~NIli~~-~----~vkl~Dfg~a~~~~~ 152 (346)
..|++|+|++|.||+++. + .++++|||++...+.
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 589999999999999953 4 899999999876643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.8e-12 Score=101.59 Aligned_cols=132 Identities=18% Similarity=0.188 Sum_probs=94.9
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEcc-ccccCH------HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSW------EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~------~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
..+++|+-+.++.+... |..+++|.-. +.-..+ ...+..+|..++.++. --.|....=++.+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence 45789999999999553 4456666532 222111 1233467888888884 445555555555666668999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWE 149 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~ 149 (346)
||++|.++....... ...+++.+-.-+.-||..||+||||+++||+++++.+.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence 999997766443322 24567777777888999999999999999999999999999999853
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-11 Score=97.66 Aligned_cols=142 Identities=20% Similarity=0.227 Sum_probs=101.7
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEccccc-----cCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRI-----YSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
.+..+-+|+-+.|+++... |+.++||.-.... .+. ...+..+|...+.++. --.|.-..=++.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence 4677889999999999654 7887777542221 111 1234467888888874 3355444445666666689
Q ss_pred EEEcCCC--CHHHHHhcccCCCCHHH-HHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C---cEEEeeccccccc
Q 039371 79 VFEYMDC--NLHQLMSNRKQCFSEAE-VKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D---TIKIADFGLAWEV 150 (346)
Q Consensus 79 v~e~~~g--~l~~~~~~~~~~l~~~~-~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~---~vkl~Dfg~a~~~ 150 (346)
+||+++| ++.+.+......-.++. ...+++++-+.+.-||..+|+||||..+||++.. + .+.++|||++...
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999998 67777665543334444 4789999999999999999999999999999932 2 5699999998543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-10 Score=102.72 Aligned_cols=251 Identities=14% Similarity=0.104 Sum_probs=156.2
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeee------eecC-CEEE
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQEL------ASEN-YRLY 77 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~------~~~~-~~~~ 77 (346)
...+.||+|+-+.+|..-.- +..| .|++......... +.+..|...-.||-+-.-+.+ .-++ ..+-
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~V-AKIYh~Pppa~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQV-AKIYHAPPPAAQA----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchh--hchh-heeecCCCchHHH----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 35678999999999987332 3344 4888655433221 233334444456644331111 1122 2367
Q ss_pred EEEEcCCC--CHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccc
Q 039371 78 FVFEYMDC--NLHQLMSNR-----KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWE 149 (346)
Q Consensus 78 iv~e~~~g--~l~~~~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~ 149 (346)
+.|+.+.| .+....... -....++...+..+.++.+.+.||..|.+-||++++|+|++ ++.|.|.|=..-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 88998887 344333211 12367789999999999999999999999999999999995 55899998765444
Q ss_pred cCCCCCCccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChH----HHH-HHHHHHhCCC
Q 039371 150 VDSCPPYTEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITF-HPLFPGTCED----DQL-YKICNAIGSP 219 (346)
Q Consensus 150 ~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~----~~~-~~i~~~~~~~ 219 (346)
.......-..+|...|.+||.-.- ...-+..+|-|.||+++++++.| ..||.+-... .-. ..|..+...
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~- 245 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA- 245 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee-
Confidence 444455666789999999995431 12346789999999999999886 8999764211 000 011111000
Q ss_pred ChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhccc--CCCCCCCHH
Q 039371 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSW--DPCKRPTAA 276 (346)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~--dP~~Rps~~ 276 (346)
...+ .-+.......+-.+...+++++.|..+|+.. +++-|||++
T Consensus 246 ------------ya~~-~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 246 ------------YASD-QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred ------------echh-ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 0000 1111111111222345678889999999864 467899964
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.1e-11 Score=96.81 Aligned_cols=128 Identities=27% Similarity=0.342 Sum_probs=80.6
Q ss_pred EEEEEEEccCCcEEEEEEccccccC-----------------------H--HHhhhHHHHHHHHhhcCC-CCeeeeeeee
Q 039371 17 KVWQAIKKQSGEYVAIKALKQRIYS-----------------------W--EECLNLKEVKCLRKINNH-PNIVKLQELA 70 (346)
Q Consensus 17 ~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------~--~~~~~~~e~~~l~~l~~h-p~iv~~~~~~ 70 (346)
.||.|... +|..+|+|+......+ . ......+|...|.++... -++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999764 5778999987422110 0 112335788999998533 2566666553
Q ss_pred ecCCEEEEEEEcCC--CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCCEEEeCCcEEEeecccc
Q 039371 71 SENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY-MHRQGYFHRDLISKNLLVSNDTIKIADFGLA 147 (346)
Q Consensus 71 ~~~~~~~iv~e~~~--g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~-LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a 147 (346)
. -+|||||++ |.....+.... ++......++.+++..+.. +|+.||+|||+++.||+++++.+.++|||.+
T Consensus 80 ~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iIDf~qa 153 (188)
T PF01163_consen 80 R----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYIIDFGQA 153 (188)
T ss_dssp T----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE--GTTE
T ss_pred C----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEEecCcc
Confidence 2 269999999 74433333322 2245567778888885444 6799999999999999999999999999988
Q ss_pred cccC
Q 039371 148 WEVD 151 (346)
Q Consensus 148 ~~~~ 151 (346)
....
T Consensus 154 v~~~ 157 (188)
T PF01163_consen 154 VDSS 157 (188)
T ss_dssp EETT
T ss_pred eecC
Confidence 6654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.4e-11 Score=99.33 Aligned_cols=141 Identities=17% Similarity=0.194 Sum_probs=98.7
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcC-CCCeeeeeeeeecC---CEEEEEEEc
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINN-HPNIVKLQELASEN---YRLYFVFEY 82 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-hp~iv~~~~~~~~~---~~~~iv~e~ 82 (346)
.+.|+.|..+.||++.... |+.+++|+..............+|..++..+.. +..+++++.+.... +..+++||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999997653 578999998654332123344678888888853 23466677766553 366899999
Q ss_pred CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 039371 83 MDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR------------------------------------------- 119 (346)
Q Consensus 83 ~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~------------------------------------------- 119 (346)
++|......... ..+++.+...++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998533222211 236677777777777777777773
Q ss_pred -------------CCccccCCCCCCEEEeC--C-cEEEeecccccc
Q 039371 120 -------------QGYFHRDLISKNLLVSN--D-TIKIADFGLAWE 149 (346)
Q Consensus 120 -------------~~ivH~dikp~NIli~~--~-~vkl~Dfg~a~~ 149 (346)
..++|+|+.|.||++++ + .+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999976 4 578999997743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-09 Score=99.10 Aligned_cols=247 Identities=20% Similarity=0.210 Sum_probs=165.8
Q ss_pred ceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec----CCEEEEEEEcCCC--CHH
Q 039371 15 FGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE----NYRLYFVFEYMDC--NLH 88 (346)
Q Consensus 15 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~----~~~~~iv~e~~~g--~l~ 88 (346)
..+.|++....+|..|++|++.....-.- .....-++..+++ .|+|+|++.++|.. +..+++|++|.++ +|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 45799999999999999999933221111 0112345667888 69999999999863 4568999999985 677
Q ss_pred HHHhcc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeecccccccCCC
Q 039371 89 QLMSNR--------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSC 153 (346)
Q Consensus 89 ~~~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~~ 153 (346)
+..-.. +...+|..++.++.|+..||.++|+.|+..+-|.|.+|+++.. +++|+.-|........
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 654321 2347899999999999999999999999999999999999877 9999988877554432
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHHhCCCChhhHHHHHHHH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPL-FPGTCEDDQ-LYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
+ . |.+. --.+-|.=.||.++..|.+|..- +........ +..
T Consensus 447 ~-----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------------------- 489 (655)
T KOG3741|consen 447 P-----------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------------------- 489 (655)
T ss_pred C-----------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------------------
Confidence 2 0 1122 12357999999999999998532 111111111 111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC---CCCCCCCCCCCCCcccccccCCccccc
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH---PLFQGCLQVPSMSIDSCKMRLTPSAKK 308 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h---p~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (346)
+.+.++.++++++.-....++++ -++.+++.| .||...... ..+.
T Consensus 490 -----------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~--------------q~~~ 537 (655)
T KOG3741|consen 490 -----------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESV--------------QLKT 537 (655)
T ss_pred -----------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhH--------------HHHH
Confidence 11356778888888888888877 778888776 333321110 1112
Q ss_pred cCccchhhhhhcccCcchhHHHHH
Q 039371 309 SGWKAKLIVWFLRWEPFSSLLLFV 332 (346)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~ 332 (346)
....+.+..++-+.+.|.+++...
T Consensus 538 d~mE~~Ls~emENGRLfRll~Kln 561 (655)
T KOG3741|consen 538 DVMETELSREMENGRLFRLLLKLN 561 (655)
T ss_pred HHHHHHHHHHHhcchHHHHHHHHh
Confidence 223445666666666666665543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6e-12 Score=117.45 Aligned_cols=153 Identities=19% Similarity=0.262 Sum_probs=110.7
Q ss_pred HHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCC-----CCcc-----ccccCcccCcccccccCC
Q 039371 109 QILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-----PYTE-----YITTLQYRAPEMLLMSGQ 176 (346)
Q Consensus 109 ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-----~~~~-----~~~t~~y~aPE~~~~~~~ 176 (346)
++..|+.|+|.. ++||++|.|++|.++ ++.+||++|+++....... .++. ......|.|||++.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 344899999966 999999999999996 5699999999886554411 1111 234668999998874 66
Q ss_pred CCChhhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCc
Q 039371 177 YNSKVDMWALGLIMAELI-TFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSAND 255 (346)
Q Consensus 177 ~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (346)
.+.++|++|+||++|.+. .|...+.+.........-....+ .........++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~--------------------------~~~~~~s~~~p~ 239 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN--------------------------AGAFGYSNNLPS 239 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc--------------------------cccccccccCcH
Confidence 889999999999999998 45555554433222111110000 001111257889
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 256 DEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 256 ~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
++++-+.+++..++..||++.+++..|||....
T Consensus 240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 999999999999999999999999999998743
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=4e-09 Score=91.33 Aligned_cols=131 Identities=11% Similarity=0.052 Sum_probs=87.2
Q ss_pred eEEEEEEEccCCcEEEEEEccccccCH----------HHhhhHHHHHHHHhhcCCCCee--eeeeeeec-----CCEEEE
Q 039371 16 GKVWQAIKKQSGEYVAIKALKQRIYSW----------EECLNLKEVKCLRKINNHPNIV--KLQELASE-----NYRLYF 78 (346)
Q Consensus 16 g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~e~~~l~~l~~hp~iv--~~~~~~~~-----~~~~~i 78 (346)
..|.++.. .|+.|.+|......... ......+|...+.++. .-+|. ....+.+. ...-++
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEE
Confidence 34556543 46789999764322110 0012456777766663 22222 22333332 235689
Q ss_pred EEEcCCC--CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--------CcEEEeecccc
Q 039371 79 VFEYMDC--NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--------DTIKIADFGLA 147 (346)
Q Consensus 79 v~e~~~g--~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--------~~vkl~Dfg~a 147 (346)
|||+++| ++.+.+... ....++.....++.+++..+.-||..||+|+|+++.|||+++ ..+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9999998 465655421 234667788899999999999999999999999999999963 38999999977
Q ss_pred cc
Q 039371 148 WE 149 (346)
Q Consensus 148 ~~ 149 (346)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 43
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.8e-08 Score=84.25 Aligned_cols=103 Identities=18% Similarity=0.299 Sum_probs=74.6
Q ss_pred hhHHHHHHHHhhcC-CCCeeeeeeeeecC----CEEEEEEEcCCC--CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Q 039371 46 LNLKEVKCLRKINN-HPNIVKLQELASEN----YRLYFVFEYMDC--NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118 (346)
Q Consensus 46 ~~~~e~~~l~~l~~-hp~iv~~~~~~~~~----~~~~iv~e~~~g--~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH 118 (346)
...+|...+.++.. .-..++.+.+.+.. ...++|+|.++| ++.+.+..... .+......++.+++..+.-||
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHH
Confidence 34566666665531 12233444444332 345899999997 45565554333 677888999999999999999
Q ss_pred HCCccccCCCCCCEEEeCC----cEEEeecccccc
Q 039371 119 RQGYFHRDLISKNLLVSND----TIKIADFGLAWE 149 (346)
Q Consensus 119 ~~~ivH~dikp~NIli~~~----~vkl~Dfg~a~~ 149 (346)
..||+|+|+++.|||++.+ .+.++||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999655 599999997744
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.6e-08 Score=84.30 Aligned_cols=142 Identities=19% Similarity=0.251 Sum_probs=93.5
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH-----------------------hhhHHHHHHHHhhcC-CC
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-----------------------CLNLKEVKCLRKINN-HP 61 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----------------------~~~~~e~~~l~~l~~-hp 61 (346)
+...|.+|.-+.||+|.. .++..+|+|++.......+. .-..+|..-|.++.. +-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 345777888889999964 46889999998533322211 001235555555531 22
Q ss_pred CeeeeeeeeecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEeCCcEE
Q 039371 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVSNDTIK 140 (346)
Q Consensus 62 ~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~~~~vk 140 (346)
.+++.+.+.. -.+|||+++....-.-.-....++..+...+..++++.+.-|-. .++||+||+.-|||+.++.+.
T Consensus 131 rvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~p~ 206 (268)
T COG1718 131 RVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGEPY 206 (268)
T ss_pred CCCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCeEE
Confidence 3333333333 26999999854111111111123444788888999999888877 899999999999999999999
Q ss_pred EeecccccccCC
Q 039371 141 IADFGLAWEVDS 152 (346)
Q Consensus 141 l~Dfg~a~~~~~ 152 (346)
++|||.|.....
T Consensus 207 iID~~QaV~~~h 218 (268)
T COG1718 207 IIDVSQAVTIDH 218 (268)
T ss_pred EEECccccccCC
Confidence 999998866553
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.6e-09 Score=86.88 Aligned_cols=135 Identities=23% Similarity=0.256 Sum_probs=92.8
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEcccccc------------------C---HHHhhhHHHHHHHHhhcCC-CC
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY------------------S---WEECLNLKEVKCLRKINNH-PN 62 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~---~~~~~~~~e~~~l~~l~~h-p~ 62 (346)
.++.+||-|--|.||.|.+. .|..+|+|.-+.... + -......+|..+|.++... -.
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46789999999999999876 578899997421111 1 1122345789999999433 24
Q ss_pred eeeeeeeeecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEE
Q 039371 63 IVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKI 141 (346)
Q Consensus 63 iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl 141 (346)
+++.+++ +.-.+|||+++|-.+.... ++......++..|++-+.-.-..|++|||+++-||++++ |.+.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 5555543 3347999999994432222 234445555666666666556889999999999999965 59999
Q ss_pred eecccccc
Q 039371 142 ADFGLAWE 149 (346)
Q Consensus 142 ~Dfg~a~~ 149 (346)
+||--+..
T Consensus 244 IDwPQ~v~ 251 (304)
T COG0478 244 IDWPQAVP 251 (304)
T ss_pred EeCccccc
Confidence 99976543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.9e-08 Score=81.24 Aligned_cols=137 Identities=18% Similarity=0.234 Sum_probs=85.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhh--------hHHHHHHHHhhc--CCCCeeeeee---
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECL--------NLKEVKCLRKIN--NHPNIVKLQE--- 68 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~--------~~~e~~~l~~l~--~hp~iv~~~~--- 68 (346)
.+|.+.+.+-......|-+. ..+|+.+++|............. ..+.+....++. +.-....++-
T Consensus 31 ~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35777777777777777777 34578899998865433221110 112333333331 2222222222
Q ss_pred --eeecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeeccc
Q 039371 69 --LASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGL 146 (346)
Q Consensus 69 --~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~ 146 (346)
.+......+++|||++|--+..... +++ .+...+.+++.-+|+.|++|||..|.|++++++.++++||+.
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID~~~ 180 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIIDTQG 180 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEECcc
Confidence 2233345678999999943322211 333 244567778899999999999999999999999999999986
Q ss_pred cc
Q 039371 147 AW 148 (346)
Q Consensus 147 a~ 148 (346)
..
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 53
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.4e-10 Score=106.02 Aligned_cols=245 Identities=17% Similarity=0.122 Sum_probs=174.7
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCC-eeeeeeeeecCCEEEEEEEc
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN-IVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~-iv~~~~~~~~~~~~~iv~e~ 82 (346)
|...+.+++|+++++++.+...+...+ .+.+... ....-+++.|.++ +||| .+..++-++.+...++.+++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHc-cCCCCcccccccCCcccccchhhhh
Confidence 455667889999999999777665554 6666544 1122467778888 8999 66667777778889999999
Q ss_pred CCCC--HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccccCCCCCCcccc
Q 039371 83 MDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYI 160 (346)
Q Consensus 83 ~~g~--l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~~~~~~~ 160 (346)
+.++ ...........+.+-+...+.+.-..+++++|+..=+|+| ||+-+++..+..||+............+..
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCcccccccCC
Confidence 9854 3333333333466677778888889999999998778988 899999999999999987777666677788
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (346)
+++.++|||+.. ...+....|.|++|.-..++.-|.+|-...... .. ..+..+ ..+.
T Consensus 392 ~~~~~~~pev~~-~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~----~~g~~p----------------~s~~ 448 (829)
T KOG0576|consen 392 GTPEPLAPEVIQ-ENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--LP----MIGNGP----------------NSPM 448 (829)
T ss_pred CCCCCCCchhhc-ccccccCCCccCCCcchhhcCCCCCCCCCCccc--cC----CCCCCC----------------Cccc
Confidence 999999999886 566889999999998888888888776442110 00 000000 0000
Q ss_pred cCCCCcccccCCCCchHH-HHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 241 LQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~-~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.... ...+.... ++...|+..-|..|+...+++-|.+|.+|.-
T Consensus 449 L~~~------~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 449 LTDK------SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred cchh------hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 0000 01111112 4778899999999999999999999998864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=4e-07 Score=75.00 Aligned_cols=134 Identities=12% Similarity=0.193 Sum_probs=93.1
Q ss_pred cccCceEEEEEEEccCCcEEEEEEcccccc-----CHHHhhhHHHHHHHHhhcC--CCCeeeeeeeee---c--CCEEEE
Q 039371 11 GEGSFGKVWQAIKKQSGEYVAIKALKQRIY-----SWEECLNLKEVKCLRKINN--HPNIVKLQELAS---E--NYRLYF 78 (346)
Q Consensus 11 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~l~~l~~--hp~iv~~~~~~~---~--~~~~~i 78 (346)
|+||-|.|+..... |..+=+|.-..... ......+.+|...+.++.. -| ++++. ++. . ...-+|
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEEE
Confidence 56889999998644 33566776531110 1134456788888877742 23 44443 222 1 124589
Q ss_pred EEEcCCC--CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCc--EEEeeccccc
Q 039371 79 VFEYMDC--NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDT--IKIADFGLAW 148 (346)
Q Consensus 79 v~e~~~g--~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~--vkl~Dfg~a~ 148 (346)
|+|-++| +|.+.+... -.+.++.....++.+++..+.-||+.|+.|+|+.+.||+++ +|. ++++||.-++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9998886 666655442 22467888899999999999999999999999999999996 555 9999998664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.1e-07 Score=75.33 Aligned_cols=134 Identities=16% Similarity=0.143 Sum_probs=80.8
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCC-CeeeeeeeeecCCEEEEEEEcCCCC
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP-NIVKLQELASENYRLYFVFEYMDCN 86 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp-~iv~~~~~~~~~~~~~iv~e~~~g~ 86 (346)
.+||+|..+.||+. .+..+++|....... .....+|.+++..+.... .+++.+++.+.++...++||+++|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 244577898864331 222457888888875332 2577788877787888999999984
Q ss_pred -HHH-HHh---------------------ccc-CCCCHHH-HHHHHHH----------HHHH-HHHHHH----CCccccC
Q 039371 87 -LHQ-LMS---------------------NRK-QCFSEAE-VKNWCFQ----------ILQG-LNYMHR----QGYFHRD 126 (346)
Q Consensus 87 -l~~-~~~---------------------~~~-~~l~~~~-~~~i~~q----------l~~~-l~~LH~----~~ivH~d 126 (346)
... ... .-. ...+... ...+..+ +.+. ..+|.+ ..++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 111 110 000 0011100 0111100 1111 122221 2478999
Q ss_pred CCCCCEEEeCCcEEEeeccccc
Q 039371 127 LISKNLLVSNDTIKIADFGLAW 148 (346)
Q Consensus 127 ikp~NIli~~~~vkl~Dfg~a~ 148 (346)
+.|.||+++++.+.++||+.+.
T Consensus 160 ~~~~Nii~~~~~~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKGTYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCCcEEEechhcC
Confidence 9999999977669999999773
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=8.2e-07 Score=83.45 Aligned_cols=142 Identities=23% Similarity=0.374 Sum_probs=87.2
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCH---------------------------------------HHhhhH
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW---------------------------------------EECLNL 48 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------------------------------~~~~~~ 48 (346)
+.|++++-|.||+|+.+. |+.||||+......+. .+.+..
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578899999999998765 8999999863221110 011112
Q ss_pred HHHHHHHhhc----CCCCeeeeeeeeecCCEEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 039371 49 KEVKCLRKIN----NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYF 123 (346)
Q Consensus 49 ~e~~~l~~l~----~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~iv 123 (346)
+|...+.++. +.|++.-..=+++-.+.-.++|||++| .+.+........++...+.....++. +..+=..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 3443333332 345554444455555667899999999 33333211112255444333222221 2233347999
Q ss_pred ccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 124 HRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 124 H~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
|+|..|-||+++ +|++.+.|||.....++
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999995 56999999999866654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.7e-06 Score=70.94 Aligned_cols=75 Identities=15% Similarity=0.228 Sum_probs=50.5
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC-CCeeeeeeee---ecCCEEEEEEEc
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH-PNIVKLQELA---SENYRLYFVFEY 82 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h-p~iv~~~~~~---~~~~~~~iv~e~ 82 (346)
++.++.|..+.||++.... ..+++|..... .......+|..+++.+..+ ..+++++... ......+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 5789999999999998665 47899987654 2333344677777776533 2355666533 333467999999
Q ss_pred CCCC
Q 039371 83 MDCN 86 (346)
Q Consensus 83 ~~g~ 86 (346)
++|.
T Consensus 77 i~g~ 80 (239)
T PF01636_consen 77 IPGR 80 (239)
T ss_dssp ESSE
T ss_pred eccc
Confidence 9984
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.9e-06 Score=72.25 Aligned_cols=74 Identities=14% Similarity=0.122 Sum_probs=51.7
Q ss_pred eeecccCc-eEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCCC
Q 039371 8 KQIGEGSF-GKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDCN 86 (346)
Q Consensus 8 ~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g~ 86 (346)
..|-.|.+ +.||+.... +..+.+|...... .....+|..+++.+.++--+++++++...++..++|||+++|.
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 34555655 789999653 3678888876442 1233468888888866655777888777767789999999984
Q ss_pred H
Q 039371 87 L 87 (346)
Q Consensus 87 l 87 (346)
.
T Consensus 78 ~ 78 (244)
T cd05150 78 P 78 (244)
T ss_pred c
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.4e-06 Score=84.01 Aligned_cols=200 Identities=18% Similarity=0.163 Sum_probs=132.1
Q ss_pred HHHHHHHhhcCCCCeeeeeeeeecCCEEE----EEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 039371 49 KEVKCLRKINNHPNIVKLQELASENYRLY----FVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124 (346)
Q Consensus 49 ~e~~~l~~l~~hp~iv~~~~~~~~~~~~~----iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH 124 (346)
.|...+... .|+|++.++.+-......- +..+++.+.-.......-+..+....+.+..++++|+.++|+....|
T Consensus 231 ~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 231 IELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 455666666 7999999998865543332 34466665333333334455889999999999999999999986555
Q ss_pred cCCCCCC---EEEe-CCcEEEe--ecccccccCCCCCCccccccCcccCcccccccCCC--CChhhHHHHHHHHHHHHhC
Q 039371 125 RDLISKN---LLVS-NDTIKIA--DFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY--NSKVDMWALGLIMAELITF 196 (346)
Q Consensus 125 ~dikp~N---Ili~-~~~vkl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~DiwslG~il~~ll~g 196 (346)
.-+..+- --.+ .+.+.++ ||+.+..............+..+.+||... .... ....|+|.+|.....+..|
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~-~~~~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLK-ENTAKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccc-cccchhhhhhHHHHHHHHHhhhhhc
Confidence 5444331 1111 2345555 888887766655444455666788888765 2323 3347999999999999887
Q ss_pred CCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCC-chHHHHHHHhcccCCCCCCCH
Q 039371 197 HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSAN-DDEMSLIELLCSWDPCKRPTA 275 (346)
Q Consensus 197 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~dP~~Rps~ 275 (346)
..+-..... .... .+..+ ....+++.+|+..++++|+++
T Consensus 389 ~~i~~~~~~---~~~~-------------------------------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 389 EDISEKSAV---PVSL-------------------------------------LDVLSTSELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred Ccccccccc---hhhh-------------------------------------hccccchhhhhhhhhhcchhhhhccch
Confidence 654311110 0000 01111 256788999999999999999
Q ss_pred HHHhcCCCCCCCCCC
Q 039371 276 AEALQHPLFQGCLQV 290 (346)
Q Consensus 276 ~ell~hp~~~~~~~~ 290 (346)
.+++.|||.+.....
T Consensus 429 ~~ll~~~f~~~~~~~ 443 (1351)
T KOG1035|consen 429 LELLTHPFLRFPTDN 443 (1351)
T ss_pred hhhhhchhccccccc
Confidence 999999999865543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.8e-06 Score=68.37 Aligned_cols=130 Identities=22% Similarity=0.271 Sum_probs=87.5
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
++.+.||+|++|.||++... |..+|+|+-..+.. ......|.+++..+..----.+++.+.++ ++.|||.+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~ 95 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID 95 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence 45678999999999999765 66889987654432 33345688888777544444555555444 35599999
Q ss_pred C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC--CCEEEeCCcEEEeecccccccC
Q 039371 85 C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLIS--KNLLVSNDTIKIADFGLAWEVD 151 (346)
Q Consensus 85 g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp--~NIli~~~~vkl~Dfg~a~~~~ 151 (346)
| .|.+..... + ++-+..+++.---|-..||-|+.|+- .||++.++++.|+||..|+...
T Consensus 96 G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 96 GRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred Ccchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 8 454433321 1 23344455554456677999999875 6777777799999999887433
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.40 E-value=4e-06 Score=84.60 Aligned_cols=81 Identities=15% Similarity=0.267 Sum_probs=55.9
Q ss_pred eeeeecccCceEEEEEEEccCC--cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCe--eeeeeeeecC---CEEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSG--EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI--VKLQELASEN---YRLYF 78 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~i--v~~~~~~~~~---~~~~i 78 (346)
-++.++.|.+..+|+.....++ ..+++|+..............+|..+++.+..|+++ ++++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3678899999999998765433 467788765433222233455899999888545554 6777776654 46789
Q ss_pred EEEcCCCC
Q 039371 79 VFEYMDCN 86 (346)
Q Consensus 79 v~e~~~g~ 86 (346)
|||+++|.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999884
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.9e-05 Score=74.29 Aligned_cols=138 Identities=24% Similarity=0.295 Sum_probs=84.3
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCH------------------------------------HHhhhHHHH
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW------------------------------------EECLNLKEV 51 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------~~~~~~~e~ 51 (346)
+.||..+.|.|++|+.+. |+.||+|+=+...... .+.++.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 578999999999998776 9999999843111100 111222333
Q ss_pred HHHHhhc---CCCC------eeeeeeeeecCCEEEEEEEcCCC---CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH
Q 039371 52 KCLRKIN---NHPN------IVKLQELASENYRLYFVFEYMDC---NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119 (346)
Q Consensus 52 ~~l~~l~---~hp~------iv~~~~~~~~~~~~~iv~e~~~g---~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~ 119 (346)
+-..+.. .|-+ |++++-. -...-.++||||+| +-.+.+.+.+ ++...+..-+.+... +-+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~--~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYL--EQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHH--HHHHh
Confidence 3222221 2333 3333322 23456899999998 3445555543 565544433333222 22335
Q ss_pred CCccccCCCCCCEEEe-----CCcEEEeecccccccCC
Q 039371 120 QGYFHRDLISKNLLVS-----NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 120 ~~ivH~dikp~NIli~-----~~~vkl~Dfg~a~~~~~ 152 (346)
.|++|+|-.|-||+++ +..+.+-|||+......
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 6899999999999997 34899999999866554
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.5e-05 Score=69.07 Aligned_cols=144 Identities=20% Similarity=0.247 Sum_probs=97.3
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccccC----------------------HHH---hhhHHHHHHHHhhcC
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS----------------------WEE---CLNLKEVKCLRKINN 59 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~---~~~~~e~~~l~~l~~ 59 (346)
.+-.+|..|--+.||.|+. .+|..+|||+++.+... ++. .-+-.|+.-|.++ +
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~ 224 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-N 224 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-H
Confidence 3456788899999999975 46777999998533211 000 1112466666666 3
Q ss_pred CCCeeeeeeeeecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCCEEEeCCc
Q 039371 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH-RQGYFHRDLISKNLLVSNDT 138 (346)
Q Consensus 60 hp~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~ivH~dikp~NIli~~~~ 138 (346)
...|+-.--+... .-++||++++++-+..-.-....++...+..+-.|++..+.-|- ..++||.||+--|+|+.+|.
T Consensus 225 ~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~ 302 (520)
T KOG2270|consen 225 NAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGK 302 (520)
T ss_pred hcCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCE
Confidence 3333322222222 23799999986444333333445788888888888888887765 45999999999999999999
Q ss_pred EEEeecccccccCC
Q 039371 139 IKIADFGLAWEVDS 152 (346)
Q Consensus 139 vkl~Dfg~a~~~~~ 152 (346)
+.++|.+-+...+.
T Consensus 303 lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 303 LYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEccccccCCC
Confidence 99999988765554
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.6e-05 Score=65.15 Aligned_cols=73 Identities=14% Similarity=0.188 Sum_probs=47.3
Q ss_pred eeeecccCceEEEEEEEcc-CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 7 MKQIGEGSFGKVWQAIKKQ-SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
++.|..|-...+|++.... .++.|++|+....... .....+|..++..+..+.-.++++..... .++|||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCC
Confidence 5678888889999996543 3567889977543211 11223678888877544445555554432 379999987
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.07 E-value=9.8e-05 Score=60.56 Aligned_cols=127 Identities=18% Similarity=0.217 Sum_probs=83.8
Q ss_pred CceeeeeeecccCc-eEEEEEEEccCCcEEEEEEcc---cccc-------CH----------HHhhhHHHHHHHHhhc--
Q 039371 2 EKYTLMKQIGEGSF-GKVWQAIKKQSGEYVAIKALK---QRIY-------SW----------EECLNLKEVKCLRKIN-- 58 (346)
Q Consensus 2 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~---~~~~-------~~----------~~~~~~~e~~~l~~l~-- 58 (346)
.+++.++.||.|.- |.||++.- +|+.||+|++. .... .. ...-+..|-....++.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 46889999999999 99999954 48899999931 1111 10 0111234555544443
Q ss_pred CCCCe--eeeeeeeec------------------CCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Q 039371 59 NHPNI--VKLQELASE------------------NYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118 (346)
Q Consensus 59 ~hp~i--v~~~~~~~~------------------~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH 118 (346)
++.++ ++++++..= .....||-|++...- .++... +.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 34455 899988621 112357888776433 134444 455666677799
Q ss_pred HCCccccCCCCCCEEEeCCcEEEeecccc
Q 039371 119 RQGYFHRDLISKNLLVSNDTIKIADFGLA 147 (346)
Q Consensus 119 ~~~ivH~dikp~NIli~~~~vkl~Dfg~a 147 (346)
+.||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc----CCEEEecccC
Confidence 999999999999986 3489999865
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00016 Score=59.74 Aligned_cols=128 Identities=17% Similarity=0.268 Sum_probs=85.3
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEcccccc---------------CHHHhhhHHHHHHHHhhc-----CCCCeeee
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY---------------SWEECLNLKEVKCLRKIN-----NHPNIVKL 66 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~~~e~~~l~~l~-----~hp~iv~~ 66 (346)
...||+|+.-.||.--+ ....+||+...... ........+|+.....+. .+.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 45789999999998633 23457899876650 001122234444443332 47899999
Q ss_pred eeeeecCCEEEEEEEcCC---C----CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe---C
Q 039371 67 QELASENYRLYFVFEYMD---C----NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS---N 136 (346)
Q Consensus 67 ~~~~~~~~~~~iv~e~~~---g----~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~---~ 136 (346)
+|..+++...-+|+|.+. | +|.+.+... .+++ .+.. .+-+-..+|-+.+|+.+|++|.||++. +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999999999999873 3 455555332 2555 4433 334445678889999999999999993 2
Q ss_pred C--cEEEee
Q 039371 137 D--TIKIAD 143 (346)
Q Consensus 137 ~--~vkl~D 143 (346)
+ .+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.99 E-value=9.7e-05 Score=67.57 Aligned_cols=77 Identities=16% Similarity=0.132 Sum_probs=51.1
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEcccc-----cc-CHHHhhhHHHHHHHHhhcCC--CCeeeeeeeeecCCEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQR-----IY-SWEECLNLKEVKCLRKINNH--PNIVKLQELASENYRLYF 78 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~-~~~~~~~~~e~~~l~~l~~h--p~iv~~~~~~~~~~~~~i 78 (346)
.+.||.|.+..||++....+++.+++|.-... .. .....+...|...|..+..+ .++++++.+.. +..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 46899999999999998654467999985311 10 11223345577777766433 45777777644 44679
Q ss_pred EEEcCCC
Q 039371 79 VFEYMDC 85 (346)
Q Consensus 79 v~e~~~g 85 (346)
|||++++
T Consensus 109 VME~L~~ 115 (401)
T PRK09550 109 VMEDLSD 115 (401)
T ss_pred EEecCCC
Confidence 9999875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.1e-05 Score=64.42 Aligned_cols=71 Identities=10% Similarity=0.167 Sum_probs=43.1
Q ss_pred eeeecccCce-EEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC--CCeeeeeeeeecC---CEEEEEE
Q 039371 7 MKQIGEGSFG-KVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH--PNIVKLQELASEN---YRLYFVF 80 (346)
Q Consensus 7 ~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h--p~iv~~~~~~~~~---~~~~iv~ 80 (346)
++.++.|+.. .||+. +..+++|...... ......+|...+..+..+ -.+.++++..+.. ...+++|
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 4678877776 49987 2347788765422 222455788888877533 1344444433322 2458899
Q ss_pred EcCCC
Q 039371 81 EYMDC 85 (346)
Q Consensus 81 e~~~g 85 (346)
++++|
T Consensus 74 ~~i~G 78 (235)
T cd05155 74 RWLEG 78 (235)
T ss_pred EeecC
Confidence 99987
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.93 E-value=8.5e-05 Score=64.40 Aligned_cols=134 Identities=15% Similarity=0.218 Sum_probs=74.9
Q ss_pred eecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCCCHH
Q 039371 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDCNLH 88 (346)
Q Consensus 9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g~l~ 88 (346)
.+..|-.+.+|+.. .+++.+++|......... .....+|..+++.+..+.-.++++.... -++|+|+++|...
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccc
Confidence 45678888999986 446678889765432111 1123467778887754422344443332 2689999987322
Q ss_pred H-----------HH-------hccc---CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCccccCCCC
Q 039371 89 Q-----------LM-------SNRK---QCFSE-AEVKNWCFQI---------LQGLNYMHR--------QGYFHRDLIS 129 (346)
Q Consensus 89 ~-----------~~-------~~~~---~~l~~-~~~~~i~~ql---------~~~l~~LH~--------~~ivH~dikp 129 (346)
. .+ ...+ .+++. ..+..+..++ ...+..+-+ ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 1 11 1110 11111 1122222111 111222222 2489999999
Q ss_pred CCEEEeCCcEEEeecccccc
Q 039371 130 KNLLVSNDTIKIADFGLAWE 149 (346)
Q Consensus 130 ~NIli~~~~vkl~Dfg~a~~ 149 (346)
.||+++++.+.++||+.|..
T Consensus 156 ~Nil~~~~~~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQGLKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCCCEEEeccccCc
Confidence 99999877799999998744
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00029 Score=62.68 Aligned_cols=73 Identities=12% Similarity=0.105 Sum_probs=46.5
Q ss_pred eeeecccCceEEEEEEEcc------CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQ------SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++.+..|-...+|++.... .++.+++|+...... ......+|..++..+..+--.++++..+.. .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 4567777778999997543 257899999754321 122345677777777544334555655543 2578
Q ss_pred EcCCC
Q 039371 81 EYMDC 85 (346)
Q Consensus 81 e~~~g 85 (346)
|+++|
T Consensus 77 e~i~G 81 (302)
T cd05156 77 EFIPS 81 (302)
T ss_pred heeCC
Confidence 88877
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00057 Score=60.95 Aligned_cols=136 Identities=18% Similarity=0.200 Sum_probs=73.9
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC-CCeeeeeee------eecCCEEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH-PNIVKLQEL------ASENYRLYFV 79 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h-p~iv~~~~~------~~~~~~~~iv 79 (346)
++.++.|....+|++... +| .+++|+....... . ....|..++..+.++ -.+++++.. ...++..+++
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~~-~--~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVKA-E--ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ccccCCccccceEEEEeC-CC-cEEEEEecCCCCH-H--HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 567778877899998643 33 5778987543211 1 122455555555311 113444332 1234567899
Q ss_pred EEcCCCCH-----HHH----------HhcccCCCC--------HH---H--HH----------HHHHHHHHHHHHHHH--
Q 039371 80 FEYMDCNL-----HQL----------MSNRKQCFS--------EA---E--VK----------NWCFQILQGLNYMHR-- 119 (346)
Q Consensus 80 ~e~~~g~l-----~~~----------~~~~~~~l~--------~~---~--~~----------~i~~ql~~~l~~LH~-- 119 (346)
+|+++|.. ... +......++ .. . .. .....+...++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 99998721 111 111000010 00 0 00 001122334555532
Q ss_pred -----CCccccCCCCCCEEEeCCc-EEEeecccc
Q 039371 120 -----QGYFHRDLISKNLLVSNDT-IKIADFGLA 147 (346)
Q Consensus 120 -----~~ivH~dikp~NIli~~~~-vkl~Dfg~a 147 (346)
.+++|+|+.+.||+++++. +.++||+.+
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 5899999999999997765 579999877
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00035 Score=61.89 Aligned_cols=135 Identities=15% Similarity=0.109 Sum_probs=75.7
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCC-Ceeeeeee------eecCCEEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP-NIVKLQEL------ASENYRLYFV 79 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp-~iv~~~~~------~~~~~~~~iv 79 (346)
++.+..|....+|+.... +..+++|+.... . ......|..++..+..+- .+++++.. ...++..+++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~--~--~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV--S--AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCCC--C--hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 567778888899998543 446888988641 1 122345666666663221 24444332 2334567899
Q ss_pred EEcCCCCHHH-----HH----------hcccCCCC--------HHHH----H--------HHHHHHHHHHHHHHH-----
Q 039371 80 FEYMDCNLHQ-----LM----------SNRKQCFS--------EAEV----K--------NWCFQILQGLNYMHR----- 119 (346)
Q Consensus 80 ~e~~~g~l~~-----~~----------~~~~~~l~--------~~~~----~--------~i~~ql~~~l~~LH~----- 119 (346)
+++++|.... .. ......+. ..-. . .....+..++.++.+
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9999873211 00 00000000 0000 0 011112233444443
Q ss_pred --CCccccCCCCCCEEEeCCcE-EEeecccc
Q 039371 120 --QGYFHRDLISKNLLVSNDTI-KIADFGLA 147 (346)
Q Consensus 120 --~~ivH~dikp~NIli~~~~v-kl~Dfg~a 147 (346)
.+++|+|+.|.||+++++.+ .|+||+.+
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 37999999999999987765 79999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0011 Score=59.48 Aligned_cols=29 Identities=34% Similarity=0.589 Sum_probs=25.4
Q ss_pred CCccccCCCCCCEEEeCCcE-EEeeccccc
Q 039371 120 QGYFHRDLISKNLLVSNDTI-KIADFGLAW 148 (346)
Q Consensus 120 ~~ivH~dikp~NIli~~~~v-kl~Dfg~a~ 148 (346)
.++||+|+.|.||+++++.+ -++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 38999999999999988776 799999773
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00044 Score=63.95 Aligned_cols=175 Identities=20% Similarity=0.287 Sum_probs=111.1
Q ss_pred HhhhHHHHHHHHhhcCCCCeeeeeeeeecC-CEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 039371 44 ECLNLKEVKCLRKINNHPNIVKLQELASEN-YRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122 (346)
Q Consensus 44 ~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~i 122 (346)
....+.....++.+ .|+|...+.++-+.. ....+|+|+++-++.+....++ +...... .+|+
T Consensus 26 s~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~--------------~~~~ 88 (725)
T KOG1093|consen 26 SIQILGRFQYLKSL-QHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL--------------AHGV 88 (725)
T ss_pred HHHHhhhhHHHHhh-cCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc--------------cccc
Confidence 33445566777777 799999999887654 4578899999988888776553 1111111 1122
Q ss_pred cccCCCCCCEEEeCCcEEEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCC
Q 039371 123 FHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPG 202 (346)
Q Consensus 123 vH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 202 (346)
.| -|+ ++.+| -+++. | | ...++++||||+|.++.++.-|...+..
T Consensus 89 ~~-----~~~------~~~td-~~~t~---------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 89 LH-----LNI------IYITD-HFLTK---------------Y--P------SPIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ce-----ehh------hhccc-ccccc---------------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 21 122 22223 00100 0 1 1112599999999999999999988877
Q ss_pred CChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCC
Q 039371 203 TCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282 (346)
Q Consensus 203 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp 282 (346)
....+....+.+....+.....-.... . ..-.++.....+..+|+...|..||...++.+++
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~-~-----------------~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~ 195 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEH-L-----------------IQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRC 195 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHH-H-----------------HHHhhhHhHHHHhccCCccccccccchhHHhcCc
Confidence 777777777766544433221110000 0 0013456778899999999999999999999999
Q ss_pred CCCCCC
Q 039371 283 LFQGCL 288 (346)
Q Consensus 283 ~~~~~~ 288 (346)
-|.+..
T Consensus 196 i~~ev~ 201 (725)
T KOG1093|consen 196 SFTEVY 201 (725)
T ss_pred cHHHHH
Confidence 988753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00014 Score=63.54 Aligned_cols=132 Identities=20% Similarity=0.285 Sum_probs=88.0
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC------------------H---HHhhhHHHHHHHHhhcCCCC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS------------------W---EECLNLKEVKCLRKINNHPN 62 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------~---~~~~~~~e~~~l~~l~~hp~ 62 (346)
|.++++||-|.-|.||.+-+. .|++.++|.-.....+ + ......+|...++.+..|-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467899999999999999755 4778888864211111 0 11223567777777754322
Q ss_pred -eeeeeeeeecCCEEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcE
Q 039371 63 -IVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTI 139 (346)
Q Consensus 63 -iv~~~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~v 139 (346)
+++.++ .+..++|||++.| .+.....- ..+..+...+..-+.-|-.+|++|||..--||+++ ++.+
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 333332 2345899999987 44332211 22334555666667778899999999999999996 6689
Q ss_pred EEeecccc
Q 039371 140 KIADFGLA 147 (346)
Q Consensus 140 kl~Dfg~a 147 (346)
+++||--+
T Consensus 242 ~vIDFPQm 249 (465)
T KOG2268|consen 242 VVIDFPQM 249 (465)
T ss_pred EEeechHh
Confidence 99999654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.002 Score=57.87 Aligned_cols=76 Identities=14% Similarity=0.244 Sum_probs=46.2
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccc------cccCHHHhhhHHHHHHHHhhcCC-C-CeeeeeeeeecCCEEEEE
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQ------RIYSWEECLNLKEVKCLRKINNH-P-NIVKLQELASENYRLYFV 79 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~~~e~~~l~~l~~h-p-~iv~~~~~~~~~~~~~iv 79 (346)
+.||.|....||++....+++.++||.-.. ........+...|...|+..... | .+++++.+-.+ ...+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e--~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTE--MAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccc--cceeh
Confidence 368999999999999764446799997521 11111223334577777665432 3 35555544333 34689
Q ss_pred EEcCCC
Q 039371 80 FEYMDC 85 (346)
Q Consensus 80 ~e~~~g 85 (346)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00051 Score=56.37 Aligned_cols=98 Identities=18% Similarity=0.252 Sum_probs=74.8
Q ss_pred HHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC-CHHHH---HhcccCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 039371 49 KEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQL---MSNRKQCFSEAEVKNWCFQILQGLNYMHR---QG 121 (346)
Q Consensus 49 ~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g-~l~~~---~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ 121 (346)
.|..+++.+.+.+++++++|++-. +++.|+.+. ++... +.. -...++..+.+++.++++.+++|+. ..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 477778788665799999999843 578899884 44321 111 0125899999999999999999998 35
Q ss_pred ccccCCCCCCEEEeC-CcEEEeecccccccC
Q 039371 122 YFHRDLISKNLLVSN-DTIKIADFGLAWEVD 151 (346)
Q Consensus 122 ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~ 151 (346)
+.-.|++|+|+-+++ +++|++|...+...+
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 788999999999965 599999998775443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.42 E-value=4.5e-05 Score=78.33 Aligned_cols=150 Identities=12% Similarity=0.024 Sum_probs=105.6
Q ss_pred HHHHHHHhhcCCCCeeeeeeeeec--CCEEEEEEEcCC-CCHHHHHhcccC---CCCHHHHHHHHHHHHHHHHHHHHC-C
Q 039371 49 KEVKCLRKINNHPNIVKLQELASE--NYRLYFVFEYMD-CNLHQLMSNRKQ---CFSEAEVKNWCFQILQGLNYMHRQ-G 121 (346)
Q Consensus 49 ~e~~~l~~l~~hp~iv~~~~~~~~--~~~~~iv~e~~~-g~l~~~~~~~~~---~l~~~~~~~i~~ql~~~l~~LH~~-~ 121 (346)
.|...++.. .|+++...+.-... ....++.++++. |.+...+.+.-. .+.+.-+.....+...+..-+|+. +
T Consensus 1278 ~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344444444 68888887765543 345588899987 567777765432 233444444444446666666655 2
Q ss_pred ----ccccCCCCCCEEEe-CCcEEEeecccccc-cCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh
Q 039371 122 ----YFHRDLISKNLLVS-NDTIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT 195 (346)
Q Consensus 122 ----ivH~dikp~NIli~-~~~vkl~Dfg~a~~-~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 195 (346)
-+|+++|+-|.++. +..++++++|+.+. ...........+++.|+.|++.. .-.++.++|||..|+.+|....
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHHhc
Confidence 68999999999995 55899999999983 33333445567788899999665 5667888999999999999998
Q ss_pred CCCCC
Q 039371 196 FHPLF 200 (346)
Q Consensus 196 g~~pf 200 (346)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 88777
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0024 Score=57.87 Aligned_cols=137 Identities=16% Similarity=0.222 Sum_probs=78.5
Q ss_pred eeeeecccCceEEEEEEEcc----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQ----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
-+..+-.|-...+|++.... +++.|++|+..... + .-....+|..+++.+..+.--+++++.+..+ .|.+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 34566667888999986432 24678999885432 1 1222346888888886555555666666443 4788
Q ss_pred cCCCCHHH-----------HH-------hccc--C---CCCHHHHHHHHHHH-----------------HHHHHHH----
Q 039371 82 YMDCNLHQ-----------LM-------SNRK--Q---CFSEAEVKNWCFQI-----------------LQGLNYM---- 117 (346)
Q Consensus 82 ~~~g~l~~-----------~~-------~~~~--~---~l~~~~~~~i~~ql-----------------~~~l~~L---- 117 (346)
|++|..+. .+ .... . ......+..+..++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 88762211 00 0000 0 01122333333222 1111112
Q ss_pred H----HCCccccCCCCCCEEEeC--CcEEEeeccccc
Q 039371 118 H----RQGYFHRDLISKNLLVSN--DTIKIADFGLAW 148 (346)
Q Consensus 118 H----~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~ 148 (346)
. ...++|+|+++.||++++ +.+.++||..|.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 225899999999999964 479999998773
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.002 Score=58.08 Aligned_cols=74 Identities=9% Similarity=0.110 Sum_probs=45.5
Q ss_pred eeeecccCceEEEEEEEccC---CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcC
Q 039371 7 MKQIGEGSFGKVWQAIKKQS---GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
++.|..|-...+|++..... +..|++|+...... .-....+|..+++.+..+.--+++++++.. + +|.+|+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCC-c---Eeehhh
Confidence 45666677788999865432 23788998754322 122234688888887654444566666643 2 478888
Q ss_pred CCC
Q 039371 84 DCN 86 (346)
Q Consensus 84 ~g~ 86 (346)
+|.
T Consensus 93 ~g~ 95 (330)
T PLN02421 93 NAR 95 (330)
T ss_pred cCC
Confidence 763
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0093 Score=52.88 Aligned_cols=145 Identities=14% Similarity=0.233 Sum_probs=79.8
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcC-CCCeeeeeeeeecCC--EEEEEEEc
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINN-HPNIVKLQELASENY--RLYFVFEY 82 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-hp~iv~~~~~~~~~~--~~~iv~e~ 82 (346)
+++..-.|....+|..... ++.++++.-.............+|+.++..+.. ..-+...++.+.++. ..+.||++
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 4445544444456666443 777888822112223333344578888888843 223444455555554 67999999
Q ss_pred CCCC----------HH-HHHh-----------c---cc-------CCCCHHHHHHHHHHH--------------HHHHHH
Q 039371 83 MDCN----------LH-QLMS-----------N---RK-------QCFSEAEVKNWCFQI--------------LQGLNY 116 (346)
Q Consensus 83 ~~g~----------l~-~~~~-----------~---~~-------~~l~~~~~~~i~~ql--------------~~~l~~ 116 (346)
+.|. .. .... . .+ ......++..+..+. ..-..+
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 9872 11 0111 0 00 001122222222222 222445
Q ss_pred HHHC--------CccccCCCCCCEEEeCC-cEEEeecccccccCC
Q 039371 117 MHRQ--------GYFHRDLISKNLLVSND-TIKIADFGLAWEVDS 152 (346)
Q Consensus 117 LH~~--------~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~ 152 (346)
|+.+ .++|||+.+.|++++++ .+-++||+.+..-++
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 5543 38999999999999655 688999999866554
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0077 Score=52.75 Aligned_cols=29 Identities=21% Similarity=0.247 Sum_probs=24.3
Q ss_pred CccccCCCCCCEEEeC-Cc-EEEeecccccc
Q 039371 121 GYFHRDLISKNLLVSN-DT-IKIADFGLAWE 149 (346)
Q Consensus 121 ~ivH~dikp~NIli~~-~~-vkl~Dfg~a~~ 149 (346)
.++|+|++|.||++++ +. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999986 65 46999998744
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0092 Score=54.72 Aligned_cols=75 Identities=17% Similarity=0.181 Sum_probs=46.7
Q ss_pred eeeeecccCceEEEEEEEccCC-cE-----EEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSG-EY-----VAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~-~~-----vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
.++.|..|-...+|++...... .. |.+++... ....-....+|..+++.+..+..-.++++.+.. +++
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~--~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l 127 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST--YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI 127 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC--CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence 3456666888899999654321 22 44443211 111112234688889888777777778887764 489
Q ss_pred EEcCCCC
Q 039371 80 FEYMDCN 86 (346)
Q Consensus 80 ~e~~~g~ 86 (346)
.||++|.
T Consensus 128 ~efIeGr 134 (383)
T PTZ00384 128 QEWVEGN 134 (383)
T ss_pred EEEeccc
Confidence 9999873
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.017 Score=53.05 Aligned_cols=76 Identities=14% Similarity=0.217 Sum_probs=49.4
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEcccccc------CHHHhhhHHHHHHHHhhcCC--CCeeeeeeeeecCCEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY------SWEECLNLKEVKCLRKINNH--PNIVKLQELASENYRLY 77 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~l~~l~~h--p~iv~~~~~~~~~~~~~ 77 (346)
..+.||.|....||+..+. +..++||.-..... .....+...|...|+.+... .++++++.+.++. .+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--AL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CE
Confidence 4678899999999999863 44588997641111 01223334566666655322 4778888777744 46
Q ss_pred EEEEcCCC
Q 039371 78 FVFEYMDC 85 (346)
Q Consensus 78 iv~e~~~g 85 (346)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0061 Score=55.56 Aligned_cols=76 Identities=20% Similarity=0.193 Sum_probs=47.3
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEcc----cc-ccCHHHhhhHHHHHHHHhhcC-CC-CeeeeeeeeecCCEEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALK----QR-IYSWEECLNLKEVKCLRKINN-HP-NIVKLQELASENYRLYFV 79 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~~-~~~~~~~~~~~e~~~l~~l~~-hp-~iv~~~~~~~~~~~~~iv 79 (346)
.+.||.|.-..||++.+..+++.++||.-. .. .......+...|...|+.... .| .+++++.+-.+ ...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e--~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSV--MNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcH--HhhHH
Confidence 678999999999999875445678898742 11 111122334457777776643 23 45556554433 34678
Q ss_pred EEcCC
Q 039371 80 FEYMD 84 (346)
Q Consensus 80 ~e~~~ 84 (346)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 88875
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.016 Score=51.37 Aligned_cols=105 Identities=13% Similarity=0.094 Sum_probs=69.7
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC--CCeeeeeeeeec---CCEEEEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH--PNIVKLQELASE---NYRLYFVF 80 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h--p~iv~~~~~~~~---~~~~~iv~ 80 (346)
-.+.||.|..+.||...... + .+.+|..+... . ......|...++.+.++ -.++++++.+.. .+..++||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~-~--~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPLMARSFS-T--PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEEEecccc-c--chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 45689999999999995432 3 46667743311 1 12345788888887554 367778876643 36689999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~ 120 (346)
|+++|...... ..+......+..+++++|.-||+.
T Consensus 93 E~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 93 ERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99998433221 133445666778888889989874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0075 Score=53.80 Aligned_cols=85 Identities=18% Similarity=0.324 Sum_probs=62.7
Q ss_pred CCCeeeeeeee-ecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEeCC
Q 039371 60 HPNIVKLQELA-SENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVSND 137 (346)
Q Consensus 60 hp~iv~~~~~~-~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~~~ 137 (346)
.++..+.+-+- .++.+.|++|++-++++.- +.. -..+++..++++.+..++-+..+ ..-||++...||++++|
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdhgt~is~-ik~----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~G 358 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDHGTPISI-IKA----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEG 358 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecCCceeee-eec----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecC
Confidence 34443333333 3445678888877665542 111 46788889999999888877766 78999999999999999
Q ss_pred cEEEeecccccc
Q 039371 138 TIKIADFGLAWE 149 (346)
Q Consensus 138 ~vkl~Dfg~a~~ 149 (346)
+|.|+||-+++.
T Consensus 359 nvtLIDfklsRl 370 (488)
T COG5072 359 NVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEeeeeec
Confidence 999999999974
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0062 Score=51.04 Aligned_cols=27 Identities=33% Similarity=0.619 Sum_probs=19.1
Q ss_pred CccccCCCCCCEEE--eCCcEEEeecccc
Q 039371 121 GYFHRDLISKNLLV--SNDTIKIADFGLA 147 (346)
Q Consensus 121 ~ivH~dikp~NIli--~~~~vkl~Dfg~a 147 (346)
.++|+|+.|.||++ .++.++++||..|
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya 172 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYA 172 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHH
Confidence 48999999999999 6789999999877
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.04 Score=49.17 Aligned_cols=29 Identities=17% Similarity=0.045 Sum_probs=24.9
Q ss_pred CccccCCCCCCEEEeC-CcEEEeecccccc
Q 039371 121 GYFHRDLISKNLLVSN-DTIKIADFGLAWE 149 (346)
Q Consensus 121 ~ivH~dikp~NIli~~-~~vkl~Dfg~a~~ 149 (346)
++||+|+.+.|+++++ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 7999999999999965 5899999987743
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.047 Score=51.13 Aligned_cols=75 Identities=12% Similarity=0.092 Sum_probs=44.4
Q ss_pred eeeeecccCceEEEEEEEccC--------CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQS--------GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
-++.|..|=.-.+|++..... ++.|.+++.-..... -....+|..+++.+..+---.++++.+.. +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~--lIdR~~E~~v~~~ls~~gi~P~l~~~f~g----g 182 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE--LYNPISEFEVYKTMSKYRIAPQLLNTFSG----G 182 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc--eeCHHHHHHHHHHHHHCCCCCceEEEeCC----C
Confidence 456677777778998875422 467889987543221 11234577777666544333455565542 3
Q ss_pred EEEEcCCCC
Q 039371 78 FVFEYMDCN 86 (346)
Q Consensus 78 iv~e~~~g~ 86 (346)
.|.||++|.
T Consensus 183 ~I~efi~g~ 191 (442)
T PTZ00296 183 RIEEWLYGD 191 (442)
T ss_pred EEEEeeCCc
Confidence 578888764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.22 Score=51.85 Aligned_cols=29 Identities=38% Similarity=0.495 Sum_probs=24.4
Q ss_pred CCccccCCCCCCEEEeCC---cEE-Eeeccccc
Q 039371 120 QGYFHRDLISKNLLVSND---TIK-IADFGLAW 148 (346)
Q Consensus 120 ~~ivH~dikp~NIli~~~---~vk-l~Dfg~a~ 148 (346)
.+++|+|+.+.||+++.+ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 479999999999999755 455 99999874
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.031 Score=49.79 Aligned_cols=28 Identities=25% Similarity=0.654 Sum_probs=25.5
Q ss_pred CCccccCCCCCCEEEeCCcEEEeecccc
Q 039371 120 QGYFHRDLISKNLLVSNDTIKIADFGLA 147 (346)
Q Consensus 120 ~~ivH~dikp~NIli~~~~vkl~Dfg~a 147 (346)
.+++|||+.+.||+++++.+.++||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECccc
Confidence 4789999999999998888999999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.086 Score=43.99 Aligned_cols=114 Identities=15% Similarity=0.182 Sum_probs=66.2
Q ss_pred cCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCCCHHHHHh
Q 039371 13 GSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS 92 (346)
Q Consensus 13 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~ 92 (346)
|+.++.-.+..+- |.. .+|.+......-......++..++.+. ..|+++..- ++..+-+++|.|...-.
T Consensus 73 ~gNsTl~~~kt~i-G~L-~lKKi~slp~~~~~~~y~nky~v~Arm---hGilrL~ND--n~~~yGvIlE~Cy~~~i---- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GPL-FLKKIRSLPCCINDALYFNKYRVFARM---HGILRLKND--NNYKYGVILERCYKIKI---- 141 (308)
T ss_pred CCceEEEEecccc-chh-hhhhccCCCcccchhhhhhhhhHHHHh---hheeEeecC--CCceeEEEEeeccCccc----
Confidence 3444444443222 333 344443322222233345677777665 367777632 55677899998863110
Q ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCCEEEe-CCcEEEeeccc
Q 039371 93 NRKQCFSEAEVKNWCFQILQGLNYMHRQ--GYFHRDLISKNLLVS-NDTIKIADFGL 146 (346)
Q Consensus 93 ~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~ivH~dikp~NIli~-~~~vkl~Dfg~ 146 (346)
.+ ..++..=+.+|.-.|+. +..|||-.|+||+.| .|.+||.|=+.
T Consensus 142 -----~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 -----NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -----ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 01 11122224567778843 799999999999996 57999998664
|
The function of this family is unknown. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.45 Score=41.91 Aligned_cols=75 Identities=12% Similarity=0.219 Sum_probs=44.9
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc--CCCCeeeeeeeeecCCEEEEEEEc
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN--NHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
+-.+.++.|....+|+.. .+++.+-+|+-...... .+..|..-|+.+. ..-.+++++.+....+..+++||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~----~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRD----MFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCC----HHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhhHH----HHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 456788999999999986 56778888987633222 2335666666652 345677888888777677999999
Q ss_pred CCC
Q 039371 83 MDC 85 (346)
Q Consensus 83 ~~g 85 (346)
++.
T Consensus 94 l~~ 96 (288)
T PF03881_consen 94 LEM 96 (288)
T ss_dssp ---
T ss_pred ecC
Confidence 864
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.025 Score=46.08 Aligned_cols=30 Identities=27% Similarity=0.378 Sum_probs=26.2
Q ss_pred ccccCCCCCCEEEeCCcEEEeecccccccC
Q 039371 122 YFHRDLISKNLLVSNDTIKIADFGLAWEVD 151 (346)
Q Consensus 122 ivH~dikp~NIli~~~~vkl~Dfg~a~~~~ 151 (346)
.+|+|+.|.|++++++.++++||+.+...+
T Consensus 79 p~H~D~~~~N~~~~~~~~~lIDwe~a~~gD 108 (188)
T PRK10271 79 PLHMDVHAGNLVHSASGLRLIDWEYAGDGD 108 (188)
T ss_pred eecCCCCCccEEEECCCEEEEeCCcccCCC
Confidence 699999999999988889999999885443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.0074 Score=55.85 Aligned_cols=71 Identities=24% Similarity=0.337 Sum_probs=60.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN 73 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~ 73 (346)
++++.+..+|.|+||+|+.+..+.++..+|||.+.............+|...+..+ .|++++++...|..+
T Consensus 49 ~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~f-eh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 49 NDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEF-EHPGIKRYFHAWYER 119 (516)
T ss_pred ccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhh-cccchhhheeceecC
Confidence 56788999999999999999999888899999998887777777777888888888 699999998877543
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.059 Score=46.92 Aligned_cols=44 Identities=20% Similarity=0.210 Sum_probs=32.5
Q ss_pred HHHHHHHHHHHHHHC--CccccCCCCCCEEEeC-CcEEEeecccccc
Q 039371 106 WCFQILQGLNYMHRQ--GYFHRDLISKNLLVSN-DTIKIADFGLAWE 149 (346)
Q Consensus 106 i~~ql~~~l~~LH~~--~ivH~dikp~NIli~~-~~vkl~Dfg~a~~ 149 (346)
.+..+-.++.-.+.. -++|+|+.|+|++.++ +.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 333444444444433 4899999999999988 9999999988744
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 346 | ||||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-51 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-51 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-51 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-50 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-50 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-50 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-50 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-50 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-50 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-50 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-50 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-50 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-50 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-50 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-50 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-50 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-50 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-50 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-50 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-50 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-50 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-50 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-50 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-50 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-50 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-50 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-50 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-50 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-50 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-50 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-50 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-50 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-50 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-49 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-49 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-47 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-47 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-46 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-43 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-42 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-42 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-42 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-42 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-41 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-41 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-41 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-40 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-40 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-40 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-40 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-40 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-39 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-39 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-39 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-39 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-38 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-37 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-37 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-37 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-36 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-36 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-36 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-36 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-36 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-35 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-35 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-35 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-35 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-35 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-35 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-35 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-35 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-35 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-35 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-35 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-35 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-35 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-35 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-35 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-35 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-35 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-35 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-35 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-35 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-35 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-35 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-35 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-35 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-35 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-35 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-35 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-35 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-35 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-35 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-35 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-35 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-35 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-34 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-34 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-34 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-34 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-34 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-34 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-34 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-34 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-34 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-34 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-34 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-34 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-34 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-34 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-34 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-34 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-34 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-34 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-34 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-34 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-34 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-34 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-34 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-34 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-34 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-34 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-34 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-34 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-34 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-34 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-34 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-34 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-34 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-34 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-34 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-34 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-34 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-34 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-34 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-34 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-34 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-34 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-34 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-34 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-34 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-34 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-34 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-34 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-34 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-34 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-34 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-34 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-34 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-34 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-34 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-34 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-34 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-34 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-34 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-34 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-34 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-34 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-34 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-33 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-33 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-33 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-33 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-33 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-33 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-33 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-33 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-33 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-33 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-33 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-33 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-33 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-33 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-33 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-33 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-33 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-33 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-32 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-32 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-32 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-31 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-31 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-31 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-31 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-31 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-31 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-31 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-31 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-31 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-31 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-30 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-30 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-30 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-30 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-30 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-30 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-30 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-30 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-30 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-30 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-30 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-30 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-30 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-30 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-30 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-29 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-29 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-29 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-29 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-29 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-28 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-28 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-27 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-27 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-26 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-26 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-26 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-26 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-25 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-25 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-25 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-25 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-25 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-25 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-25 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-24 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-24 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-24 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-24 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-24 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-23 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-23 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-23 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-23 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-22 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-22 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-22 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-21 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-21 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-21 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-21 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-21 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-21 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-21 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-21 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-21 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-21 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-21 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-21 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-21 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-21 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-21 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-20 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-20 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-20 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-20 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-20 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-20 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-20 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-20 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-20 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-20 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-20 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-20 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-20 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-20 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-19 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-19 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-19 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-19 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-19 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-19 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-19 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-19 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-19 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-19 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-19 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-19 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-19 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-19 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-19 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-19 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-19 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-19 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-19 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-19 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-19 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-19 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-19 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-19 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-19 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-19 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-19 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-19 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-19 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-19 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-19 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-19 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-19 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-19 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-19 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-19 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-19 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-19 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-19 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-19 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-19 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-19 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-19 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-19 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-19 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-19 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-18 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-18 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-18 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-18 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-18 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-17 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-17 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-17 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-17 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-16 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-16 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-16 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-16 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-16 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-16 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-16 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-16 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-15 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-15 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-15 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-15 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-15 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-15 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-15 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-15 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-14 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-14 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-13 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-13 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-11 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 7e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 |
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-115
Identities = 93/289 (32%), Positives = 151/289 (52%), Gaps = 5/289 (1%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINN 59
MEKY + +IGEGS+G V++ + +G+ VAIK + + + L+E++ L+++
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK- 60
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
HPN+V L E+ RL+ VFEY D + + ++ E VK+ +Q LQ +N+ H+
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSGQY 177
HRD+ +N+L++ IK+ DFG A + Y + + T YR+PE+L+ QY
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
VD+WA+G + AEL++ PL+PG + DQLY I +G G K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 238 FPKLQ-GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
P + L L P+ + + L++ DP +R T + L HP F+
Sbjct: 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-112
Identities = 90/289 (31%), Positives = 145/289 (50%), Gaps = 5/289 (1%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINN 59
MEKY + +GEGS+G V + K +G VAIK + + + ++E+K L+++
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR- 82
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
H N+V L E+ + R Y VFE++D + + V+ + FQI+ G+ + H
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSGQY 177
HRD+ +N+LVS +K+ DFG A + + Y + + T YRAPE+L+ +Y
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
VD+WA+G ++ E+ PLFPG + DQLY I +G+ + G +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 238 FPKLQ-GNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
P+++ L P ++ + L + DP KRP AE L H FQ
Sbjct: 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-103
Identities = 99/297 (33%), Positives = 153/297 (51%), Gaps = 22/297 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
YT K IG GSFG V+QA SGE VAIK + Q ++ +E++ +RK++ H
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLD-HC 107
Query: 62 NIVKL-------QELASENYRLYFVFEYMDCNLHQLM---SNRKQCFSEAEVKNWCFQIL 111
NIV+L E E Y L V +Y+ ++++ S KQ VK + +Q+
Sbjct: 108 NIVRLRYFFYSSGEKKDEVY-LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT--IKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
+ L Y+H G HRD+ +NLL+ DT +K+ DFG A ++ P YI + YRAPE
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 226
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
++ + Y S +D+W+ G ++AEL+ P+FPG DQL +I +G+PT E E
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE--M 284
Query: 230 LAKAHGYKFPKLQGNNLS-LLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+KFP+++ + + + P + ++L L + P R T EA H F
Sbjct: 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-101
Identities = 100/293 (34%), Positives = 156/293 (53%), Gaps = 13/293 (4%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN------LKEVKCL 54
++Y + +GEG F V++A K + + VAIK K ++ E + L+E+K L
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK--KIKLGHRSEAKDGINRTALREIKLL 66
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
++++ HPNI+ L + + VF++M+ +L ++ + + + +K + LQGL
Sbjct: 67 QELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 115 NYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLL 172
Y+H+ HRDL NLL+ + +K+ADFGLA S YT + T YRAPE+L
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
+ Y VDMWA+G I+AEL+ P PG + DQL +I +G+PTEE W + L
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
F G L + +A DD + LI+ L ++PC R TA +AL+ F
Sbjct: 246 YV--TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-101
Identities = 98/298 (32%), Positives = 153/298 (51%), Gaps = 23/298 (7%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
YT K IG GSFG V+QA +S E VAIK + Q ++ +E++ +R + H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ-----DKRFKNRELQIMRIVK-H 91
Query: 61 PNIVKLQ-------ELASENYRLYFVFEYMDCNLHQLM---SNRKQCFSEAEVKNWCFQI 110
PN+V L+ + E + L V EY+ +++ + KQ +K + +Q+
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVF-LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 111 LQGLNYMHRQGYFHRDLISKNLLV--SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAP 168
L+ L Y+H G HRD+ +NLL+ + +K+ DFG A + + P YI + YRAP
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAP 210
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
E++ + Y + +D+W+ G +MAEL+ PLFPG DQL +I +G+P+ E
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT-- 268
Query: 229 ELAKAHGYKFPKLQGNNLS-LLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+KFP+++ + S + P D + LI L + P R TA EAL HP F
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = e-100
Identities = 101/290 (34%), Positives = 174/290 (60%), Gaps = 9/290 (3%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRKI 57
MEKY ++++GEG++G V++A G VA+K + R+ + +E + ++E+ L+++
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALK--RIRLDAEDEGIPSTAIREISLLKEL 76
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
+ HPNIV L ++ L VFE+M+ +L +++ K ++++K + +Q+L+G+ +
Sbjct: 77 H-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 118 HRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSG 175
H+ HRDL +NLL+++D +K+ADFGLA YT + TL YRAP++L+ S
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
+Y++ VD+W++G I AE+IT PLFPG +DDQL KI + +G+P W + EL
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
F + S +IP + + L+ + +DP KR +A +A+ HP F+
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 2e-99
Identities = 101/290 (34%), Positives = 158/290 (54%), Gaps = 9/290 (3%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE---CLNLKEVKCLRKI 57
ME Y + ++GEG++ V++ K + VA+K ++ EE C ++EV L+ +
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLE---HEEGAPCTAIREVSLLKDL 57
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
H NIV L ++ L VFEY+D +L Q + + + VK + FQ+L+GL Y
Sbjct: 58 K-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 118 HRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSG 175
HRQ HRDL +NLL++ +K+ADFGLA Y + TL YR P++LL S
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
Y++++DMW +G I E+ T PLFPG+ ++QL+ I +G+PTEE+W L +
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
Y +PK + L P + D L+ L ++ R +A +A++HP F
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 292 bits (751), Expect = 8e-99
Identities = 100/290 (34%), Positives = 163/290 (56%), Gaps = 10/290 (3%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRKI 57
MEKY +++IGEG++G V++A GE A+K K R+ +E + ++E+ L+++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALK--KIRLEKEDEGIPSTTIREISILKEL 57
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
H NIVKL ++ RL VFE++D +L +L+ + K++ Q+L G+ Y
Sbjct: 58 K-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 118 HRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSG 175
H + HRDL +NLL++ + +KIADFGLA YT I TL YRAP++L+ S
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
+Y++ +D+W++G I AE++ PLFPG E DQL +I +G+P ++W EL K
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
F + + ++ + L+ + DP +R TA +AL+H F+
Sbjct: 237 -NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 9e-98
Identities = 96/300 (32%), Positives = 153/300 (51%), Gaps = 21/300 (7%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN------LKEVKCL 54
+Y + +IG G++G V++A SG +VA+K R+ + ++EV L
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK--SVRVPNGGGGGGGLPISTVREVALL 65
Query: 55 RKIN--NHPNIVKLQEL-----ASENYRLYFVFEYMDCNLHQLMSNRKQ-CFSEAEVKNW 106
R++ HPN+V+L ++ ++ VFE++D +L + +K+
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQY 165
Q L+GL+++H HRDL +N+LV++ T+K+ADFGLA T + TL Y
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY 185
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
RAPE+LL S Y + VDMW++G I AE+ PLF G E DQL KI + IG P E+ W
Sbjct: 186 RAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ L + FP + ++P + L+ + +++P KR +A ALQH
Sbjct: 245 RDVSLPR---GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 2e-97
Identities = 100/292 (34%), Positives = 165/292 (56%), Gaps = 12/292 (4%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRKI 57
M+KY +++IGEG++G V++A +++ E VA+K + R+ +E + L+E+ L+++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK--RVRLDDDDEGVPSSALREICLLKEL 58
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
H NIV+L ++ + +L VFE+ D +L + + VK++ FQ+L+GL +
Sbjct: 59 K-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 118 HRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSG 175
H + HRDL +NLL++ + +K+A+FGLA Y+ + TL YR P++L +
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 176 QYNSKVDMWALGLIMAELITFH-PLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
Y++ +DMW+ G I AEL PLFPG DDQL +I +G+PTEE W +L
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 235 GYKFPKLQG-NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+P +L ++P N L++ L +P +R +A EALQHP F
Sbjct: 238 --PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 1e-95
Identities = 104/296 (35%), Positives = 168/296 (56%), Gaps = 16/296 (5%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRKI 57
+++Y + ++GEG++G+V++AI + E VAIK + R+ EE + ++EV L+++
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK--RIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
H NI++L+ + N+RL+ +FEY + +L + M S +K++ +Q++ G+N+
Sbjct: 91 Q-HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFC 148
Query: 118 HRQGYFHRDLISKNLLVSNDT------IKIADFGLAWEVDS-CPPYTEYITTLQYRAPEM 170
H + HRDL +NLL+S +KI DFGLA +T I TL YR PE+
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
LL S Y++ VD+W++ I AE++ PLFPG E DQL+KI +G P + +W L
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDE-MSLIELLCSWDPCKRPTAAEALQHPLFQ 285
FPK +G L ++ + DDE + L+ + DP KR +A AL+HP F
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 3e-95
Identities = 101/298 (33%), Positives = 160/298 (53%), Gaps = 19/298 (6%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAI-KKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRK 56
++Y + +IGEG++GKV++A K G +VA+K + R+ + EE + ++EV LR
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK--RVRVQTGEEGMPLSTIREVAVLRH 67
Query: 57 IN--NHPNIVKLQE-----LASENYRLYFVFEYMDCNLHQLMSNRKQCF-SEAEVKNWCF 108
+ HPN+V+L + +L VFE++D +L + + +K+ F
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRA 167
Q+L+GL+++H HRDL +N+LV++ IK+ADFGLA T + TL YRA
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE+LL S Y + VD+W++G I AE+ PLF G+ + DQL KI + IG P EE W
Sbjct: 188 PEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ L + F + + ++ L+ +++P KR +A AL HP FQ
Sbjct: 247 VALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 2e-94
Identities = 96/303 (31%), Positives = 152/303 (50%), Gaps = 22/303 (7%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRKI 57
+ KY + +IG+G+FG+V++A +++G+ VA+K K + + +E L+E+K L+ +
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLL 73
Query: 58 NNHPNIVKLQELASENYR--------LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQ 109
H N+V L E+ +Y VF++ + +L L+SN F+ +E+K
Sbjct: 74 K-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA-----WEVDSCPPYTEYITTL 163
+L GL Y+HR HRD+ + N+L++ D +K+ADFGLA + YT + TL
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES 223
YR PE+LL Y +D+W G IMAE+ T P+ G E QL I GS T E
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252
Query: 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDE--MSLIELLCSWDPCKRPTAAEALQH 281
W + K Q + + + D + LI+ L DP +R + +AL H
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312
Query: 282 PLF 284
F
Sbjct: 313 DFF 315
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 4e-93
Identities = 90/300 (30%), Positives = 159/300 (53%), Gaps = 20/300 (6%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE---CLNLKEVKCLRKI 57
++ ++++G G++ V++ + K +G YVA+K +K EE ++E+ ++++
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKEL 60
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLM-----SNRKQCFSEAEVKNWCFQILQ 112
H NIV+L ++ +L VFE+MD +L + M N + VK + +Q+LQ
Sbjct: 61 K-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEM 170
GL + H HRDL +NLL++ +K+ DFGLA ++ + TL YRAP++
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDV 179
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
L+ S Y++ +D+W+ G I+AE+IT PLFPGT +++QL I + +G+P E W +L
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMS-----LIELLCSWDPCKRPTAAEALQHPLFQ 285
K + + +L ++ + + + L +P R +A +AL HP F
Sbjct: 240 PKYN-PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-85
Identities = 83/310 (26%), Positives = 139/310 (44%), Gaps = 39/310 (12%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK------ALKQRIYSWEECLNLKEVKCL 54
M+++ + + G+G+FG V +K +G VAIK + R L+ ++ L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--------LQIMQDL 73
Query: 55 RKINNHPNIVKLQ--------ELASENYRLYFVFEYMDCNLHQLM---SNRKQCFSEAEV 103
++ HPNIV+LQ + Y L V EY+ LH+ R+ +
Sbjct: 74 AVLH-HPNIVQLQSYFYTLGERDRRDIY-LNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 104 KNWCFQILQGLNYMHRQ--GYFHRDLISKNLLV--SNDTIKIADFGLAWEVDSCPPYTEY 159
K + FQ+++ + +H HRD+ N+LV ++ T+K+ DFG A ++ P Y
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP 219
I + YRAPE++ + Y + VD+W++G I AE++ P+F G QL++I +G P
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 220 TEESWAE-GLELAKAHGYKFPKLQGNNLS----LLIPSANDDEMSLIELLCSWDPCKRPT 274
+ E + +G S + L+ L + P +R
Sbjct: 252 SREVLRKLNPSHTD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK 308
Query: 275 AAEALQHPLF 284
EAL HP F
Sbjct: 309 PYEALCHPYF 318
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 2e-84
Identities = 94/312 (30%), Positives = 152/312 (48%), Gaps = 38/312 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK--------QRIYSWEECLNLKEVKC 53
+ L +GEG++G V A K +GE VAIK ++ R +E+K
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--------REIKI 62
Query: 54 LRKINNHPNIVKLQEL----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCF 108
L+ H NI+ + + + EN+ +Y + E M +LH+++S Q S+ ++ + +
Sbjct: 63 LKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIY 119
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA-----------WEVDSCPPY 156
Q L+ + +H HRDL NLL++++ +K+ DFGLA
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216
E++ T YRAPE++L S +Y+ +D+W+ G I+AEL P+FPG QL I I
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239
Query: 217 GSPTEESWAEGLELAKAHGY--KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT 274
G+P ++ +E +A Y P L + P N + L++ + +DP KR T
Sbjct: 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299
Query: 275 AAEALQHPLFQG 286
A EAL+HP Q
Sbjct: 300 AKEALEHPYLQT 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 3e-84
Identities = 86/304 (28%), Positives = 145/304 (47%), Gaps = 22/304 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN----------LKEV 51
YT+ + I GS+G V + G VAIK + + L+E+
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 52 KCLRKINNHPNIVKLQEL----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNW 106
+ L + HPNI+ L+++ LY V E M +L Q++ +++ S ++ +
Sbjct: 81 RLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYF 139
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQY 165
+ IL GL+ +H G HRDL N+L++++ I I DF LA E + T Y+T Y
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWY 199
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
RAPE+++ + VDMW+ G +MAE+ LF G+ +QL KI +G+P E
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV- 258
Query: 226 EGLELAKAHGY---KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
A Y + + ++P+A+ + LI + ++P +R + +AL+HP
Sbjct: 259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 283 LFQG 286
F+
Sbjct: 319 YFES 322
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 1e-83
Identities = 87/312 (27%), Positives = 139/312 (44%), Gaps = 38/312 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK-------ALKQRIYSWEECLNLKEVKCL 54
+Y +K +G G G V+ A+ + VAIK + +E+K +
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--------REIKII 62
Query: 55 RKINNHPNIVKLQEL-------------ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSE 100
R+++ H NIVK+ E+ + +Y V EYM+ +L ++ + E
Sbjct: 63 RRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL--EQGPLLE 119
Query: 101 AEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV--SNDTIKIADFGLA----WEVDSCP 154
+ + +Q+L+GL Y+H HRDL NL + + +KI DFGLA
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICN 214
+E + T YR+P +LL Y +DMWA G I AE++T LF G E +Q+ I
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT 274
+I EE E L + + L+ L+P + + + +E + ++ P R T
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299
Query: 275 AAEALQHPLFQG 286
A EAL HP
Sbjct: 300 AEEALSHPYMSI 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 4e-83
Identities = 104/302 (34%), Positives = 154/302 (50%), Gaps = 31/302 (10%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK---------QRIYSWEECLNLKEVK 52
+ Y +G G++G V AI K+SGE VAIK L +R Y +E+
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--------RELL 75
Query: 53 CLRKINNHPNIVKLQEL-----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNW 106
L+ + H N++ L ++ + N+ Y V +M +L ++M FSE +++
Sbjct: 76 LLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYL 131
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQY 165
+Q+L+GL Y+H G HRDL NL V+ D +KI DFGLA D T Y+ T Y
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWY 189
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
RAPE++L YN VD+W++G IMAE++T LF G DQL +I G P E
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 226 E-GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
+ + AK++ P+ + + L P A+ L+E + D KR TAA+AL HP F
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
Query: 285 QG 286
+
Sbjct: 310 EP 311
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 7e-83
Identities = 73/302 (24%), Positives = 143/302 (47%), Gaps = 29/302 (9%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK----QRIYSWEECLNLKEVKCLRK 56
+ Y L++++G G + +V++AI + E V +K LK ++I +E+K L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI--------KREIKILEN 86
Query: 57 INNHPNIVKLQEL--ASENYRLYFVFEY-MDCNLHQLMSNRKQCFSEAEVKNWCFQILQG 113
+ PNI+ L ++ + VFE+ + + QL Q ++ +++ + ++IL+
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKA 142
Query: 114 LNYMHRQGYFHRDLISKNLLVSNDT--IKIADFGLAWEVDSCPPYTEYITTLQYRAPEML 171
L+Y H G HRD+ N+++ ++ +++ D+GLA Y + + ++ PE+L
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202
Query: 172 LMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
+ Y+ +DMW+LG ++A +I P F G DQL +I +G+ + + +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 231 AKAHGYK--FPKLQGNNLSLLIPSANDDEMS-----LIELLCSWDPCKRPTAAEALQHPL 283
+ + + S N +S ++ L +D R TA EA++HP
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 284 FQ 285
F
Sbjct: 323 FY 324
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-82
Identities = 94/304 (30%), Positives = 154/304 (50%), Gaps = 30/304 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK--------QRIYSWEECLNLKEVKC 53
+YT + IGEG++G V A + VAIK + QR +E+K
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--------REIKI 78
Query: 54 LRKINNHPNIVKLQEL----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCF 108
L + H NI+ + ++ E + +Y V + M+ +L++L+ + Q S + + +
Sbjct: 79 LLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDHICYFLY 135
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA----WEVDSCPPYTEYITTL 163
QIL+GL Y+H HRDL NLL++ +KI DFGLA + D TEY+ T
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES 223
YRAPE++L S Y +D+W++G I+AE+++ P+FPG DQL I +GSP++E
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 224 WAE-GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
A+ + P + L P+A+ + L++ + +++P KR +AL HP
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 283 LFQG 286
+
Sbjct: 316 YLEQ 319
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-82
Identities = 85/330 (25%), Positives = 148/330 (44%), Gaps = 56/330 (16%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK-ALKQRIYSWEECLNLKEVKCLRKINN 59
+KY+L K +G GSFG V + +SG+ A+K L+ Y +E+ ++ ++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NRELDIMKVLD- 58
Query: 60 HPNIVKL---------------------------------------QELASENYRLYFVF 80
H NI+KL + Y L +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY-LNVIM 117
Query: 81 EYMDCNLHQLM---SNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV--S 135
EY+ LH+++ + + + +Q+ + + ++H G HRD+ +NLLV
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 136 NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT 195
++T+K+ DFG A ++ P YI + YRAPE++L + +Y +D+W++G + ELI
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 196 FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSAND 255
PLF G DQL +I +G+PT+E +FP L+ + ++P
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV--RFPTLKAKDWRKILPEGTP 295
Query: 256 DE-MSLIELLCSWDPCKRPTAAEALQHPLF 284
+ L+E + ++P R EA+ HP F
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 1e-81
Identities = 96/302 (31%), Positives = 158/302 (52%), Gaps = 30/302 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK---------QRIYSWEECLNLKEVK 52
Y ++ +G G++G V A+ ++G VAIK L +R Y +E++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--------RELR 76
Query: 53 CLRKINNHPNIVKLQEL-----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNW 106
L+ + H N++ L ++ +++ Y V +M +L +LM + + E ++
Sbjct: 77 LLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGEDRIQFL 133
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQY 165
+Q+L+GL Y+H G HRDL NL V+ D +KI DFGLA + D T Y+ T Y
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWY 191
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
RAPE++L +Y VD+W++G IMAE+IT LF G+ DQL +I G+P E
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251
Query: 226 E-GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
+ AK + P+L+ + + ++ +A+ ++L+E + D +R TA EAL HP F
Sbjct: 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
Query: 285 QG 286
+
Sbjct: 312 ES 313
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 2e-81
Identities = 98/301 (32%), Positives = 152/301 (50%), Gaps = 30/301 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK---------QRIYSWEECLNLKEVK 52
E+Y + +G G++G V A ++G VA+K L +R Y +E++
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--------RELR 80
Query: 53 CLRKINNHPNIVKLQEL-----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNW 106
L+ + H N++ L ++ + E + +Y V M +L+ ++ + Q ++ V+
Sbjct: 81 LLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFL 137
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQY 165
+QIL+GL Y+H HRDL NL V+ D +KI DFGLA T Y+ T Y
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWY 195
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
RAPE++L YN VD+W++G IMAEL+T LFPGT DQL I +G+P E
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 226 E-GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
+ E A+ + ++ N + + AN + L+E + D KR TAA+AL H F
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 285 Q 285
Sbjct: 316 A 316
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 1e-79
Identities = 100/360 (27%), Positives = 158/360 (43%), Gaps = 85/360 (23%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK---------QRIYSWEECLNLKEVK 52
++Y + IG GS+G V +A K VAIK + +RI L+E+
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI--------LREIA 104
Query: 53 CLRKINNHPNIVKLQEL----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWC 107
L ++N H ++VK+ ++ E + LY V E D + +L +E +K
Sbjct: 105 ILNRLN-HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF-RTPVYLTELHIKTLL 162
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA------------------- 147
+ +L G+ Y+H G HRDL N LV+ D ++K+ DFGLA
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 148 ---------WEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-- 196
+ T ++ T YRAPE++L+ Y +D+W++G I AEL+
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282
Query: 197 ---------HPLFPGT--------------------CEDDQLYKICNAIGSPTEESWAE- 226
PLFPG+ DQL I N +G+P+EE
Sbjct: 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342
Query: 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
E AK + FPK +G +L+ P+++ D + L++ + ++P KR T E L HP F+
Sbjct: 343 EKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 2e-79
Identities = 88/316 (27%), Positives = 152/316 (48%), Gaps = 44/316 (13%)
Query: 9 QIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKL 66
++G G++G V++A +K + + A+K ++ S +E+ LR++ HPN++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELK-HPNVISL 83
Query: 67 QE--LASENYRLYFVFEYMDCNLHQLM--------SNRKQCFSEAEVKNWCFQILQGLNY 116
Q+ L+ + +++ +F+Y + +L ++ + + VK+ +QIL G++Y
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 117 MHRQGYFHRDLISKNLLVSND-----TIKIADFGLAWEVDS-CPPYTEYIT---TLQYRA 167
+H HRDL N+LV + +KIAD G A +S P + T YRA
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED---------DQLYKICNAIGS 218
PE+LL + Y +D+WA+G I AEL+T P+F ED DQL +I N +G
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
Query: 219 PTEESWAEGLELAKAHGYKFPKLQGNN---------LSLLIPSANDDEMSLIELLCSWDP 269
P ++ W E ++ H + N + + L++ L + DP
Sbjct: 264 PADKDW-EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322
Query: 270 CKRPTAAEALQHPLFQ 285
KR T+ +A+Q P F
Sbjct: 323 IKRITSEQAMQDPYFL 338
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 5e-78
Identities = 95/314 (30%), Positives = 143/314 (45%), Gaps = 41/314 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK---------QRIYSWEECLNLKEV 51
+++Y +K IG G+ G V A VAIK L +R Y +E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--------REL 75
Query: 52 KCLRKINNHPNIVKLQEL-----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKN 105
++ +N H NI+ L + + E ++ +Y V E MD NL Q++ + +
Sbjct: 76 VLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSY 131
Query: 106 WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQ 164
+Q+L G+ ++H G HRDL N++V +D T+KI DFGLA + T Y+ T
Sbjct: 132 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224
YRAPE++L G Y VD+W++G IM E+I LFPGT DQ K+ +G+P E
Sbjct: 192 YRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250
Query: 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSA------------NDDEMSLIELLCSWDPCKR 272
+ + + PK G + L P L+ + D KR
Sbjct: 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 310
Query: 273 PTAAEALQHPLFQG 286
+ EALQHP
Sbjct: 311 ISVDEALQHPYINV 324
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 6e-78
Identities = 92/336 (27%), Positives = 159/336 (47%), Gaps = 61/336 (18%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK---------QRIYSWEECLNLKEVK 52
KY L+K++G+G++G VW++I +++GE VA+K + QR + +E+
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--------REIM 60
Query: 53 CLRKINNHPNIVKLQE-LASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQI 110
L +++ H NIV L L ++N R +Y VF+YM+ +LH ++ R + +Q+
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI--RANILEPVHKQYVVYQL 118
Query: 111 LQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLA---------------------- 147
++ + Y+H G HRD+ N+L+ + +K+ADFGL+
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 148 WEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD 207
D P T+Y+ T YRAPE+LL S +Y +DMW+LG I+ E++ P+FPG+ +
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 208 QLYKICNAIGSPTEESWA-----------------EGLELAKAHGYKFPKLQGNNLSLLI 250
QL +I I P+ E + +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 251 PSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
N++ + L++ L ++P KR +A +AL+HP
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 7e-78
Identities = 93/313 (29%), Positives = 141/313 (45%), Gaps = 41/313 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK---------QRIYSWEECLNLKEVK 52
++Y +K IG G+ G V A VAIK L +R Y +E+
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--------RELV 113
Query: 53 CLRKINNHPNIVKLQEL-----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNW 106
++ +N H NI+ L + E ++ +Y V E MD NL Q++ + +
Sbjct: 114 LMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYL 169
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQY 165
+Q+L G+ ++H G HRDL N++V +D T+KI DFGLA + T Y+ T Y
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
RAPE++L G Y VD+W++G IM E++ LFPG DQ K+ +G+P E
Sbjct: 230 RAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSA------------NDDEMSLIELLCSWDPCKRP 273
+ + + PK G L P + L+ + DP KR
Sbjct: 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348
Query: 274 TAAEALQHPLFQG 286
+ +ALQHP
Sbjct: 349 SVDDALQHPYINV 361
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-75
Identities = 97/352 (27%), Positives = 151/352 (42%), Gaps = 77/352 (21%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK---------QRIYSWEECLNLKEVK 52
+ Y + IG GS+G V+ A K + + VAIK + +RI +E+
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--------REIT 77
Query: 53 CLRKINNHPNIVKLQEL----ASENYR-LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWC 107
L ++ I++L +L + LY V E D +L +L +E +K
Sbjct: 78 ILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTIL 135
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPY---------- 156
+ +L G N++H G HRDL N L++ D ++K+ DFGLA ++S
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 157 -------------TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFH------ 197
T ++ T YRAPE++L+ Y +D+W+ G I AEL+
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 198 -----PLFPGTCED-----------------DQLYKICNAIGSPTEES-WAEGLELAKAH 234
PLFPG+ DQL I N IG+PTE+ +
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
FP + NL PS +DD ++L+E + ++P KR T +AL HP +
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-67
Identities = 64/287 (22%), Positives = 110/287 (38%), Gaps = 35/287 (12%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINN 59
+ + + ++G GS+G+V++ K+ G A+K ++ L EV K+
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
HP V+L++ E LY E +L Q EA+V + L L ++H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYN 178
QG H D+ N+ + K+ DFGL E+ + +Y APE+L G Y
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL--QGSYG 233
Query: 179 SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
+ D+++LGL + E+ L + ++ P +F
Sbjct: 234 TAADVFSLGLTILEVACNMELP---HGGEGWQQLRQGYLPP-----------------EF 273
Query: 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
LS ++ ++ DP R TA L P+ +
Sbjct: 274 TA----GLS---SELRS----VLVMMLEPDPKLRATAEALLALPVLR 309
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-64
Identities = 78/314 (24%), Positives = 119/314 (37%), Gaps = 61/314 (19%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + +G+G+FG+V +A Y AIK ++ L+ EV L +N H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS--EVMLLASLN-HQ 62
Query: 62 NIVKLQE-------------LASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWC 107
+V+ + L+ EY + L+ L+ + E
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 108 FQILQGLNYMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYIT----- 161
QIL+ L+Y+H QG HRDL N + + +KI DFGLA V + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 162 ----------TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYK 211
T Y A E+L +G YN K+DM++LG+I E+I +P G E + K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGM-ERVNILK 239
Query: 212 ICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK 271
++ +FP +N E +I LL DP K
Sbjct: 240 KLRSV------------------SIEFPPDFDDNKM-------KVEKKIIRLLIDHDPNK 274
Query: 272 RPTAAEALQHPLFQ 285
RP A L
Sbjct: 275 RPGARTLLNSGWLP 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 6e-61
Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 38/295 (12%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINN 59
MEKY +++IGEGSFGK + G IK + S +E +EV L +
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK- 81
Query: 60 HPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYM 117
HPNIV+ +E EN LY V +Y + +L + ++ +K F E ++ +W QI L ++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 118 HRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTE-YITTLQYRAPEMLLMSG 175
H + HRD+ S+N L + T+++ DFG+A ++S I T Y +PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
YN+K D+WALG ++ EL T F + + KI +
Sbjct: 202 -YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-------------------- 240
Query: 236 YKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289
FP + ++ SL+ L +P RP+ L+ ++
Sbjct: 241 -SFPP---------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-58
Identities = 73/330 (22%), Positives = 127/330 (38%), Gaps = 63/330 (19%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+ + ++ +G G FG V++A K AIK ++ ++EVK L K+ H
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 62
Query: 61 PNIVKL------------QELASENYRLYFVFEYMD-CNLHQLMSNRKQC--FSEAEVKN 105
P IV+ + +S LY + NL M+ R + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 106 WCFQILQGLNYMHRQGYFHRDLISKN-LLVSNDTIKIADFGLA-------------WEVD 151
QI + + ++H +G HRDL N +D +K+ DFGL +
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYK 211
+ +T + T Y +PE + Y+ KVD+++LGLI+ EL+ +P L
Sbjct: 183 AYARHTGQVGTKLYMSPEQ-IHGNSYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTD 239
Query: 212 ICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK 271
+ N KFP L E +++ + S P +
Sbjct: 240 VRN---------------------LKFPPLFTQKYP--------CEYVMVQDMLSPSPME 270
Query: 272 RPTAAEALQHPLFQGCLQVPSMSIDSCKMR 301
RP A +++ +F+ L P ++ + R
Sbjct: 271 RPEAINIIENAVFE-DLDFPGKTVLRQRSR 299
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 6e-58
Identities = 77/304 (25%), Positives = 123/304 (40%), Gaps = 47/304 (15%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL-KEVKCLRKINN 59
E Y ++ IG GS+G+ + +K G+ + K L + E L EV LR++
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-K 63
Query: 60 HPNIVKLQE--LASENYRLYFVFEYMDC-NLHQLMSNRKQ---CFSEAEVKNWCFQILQG 113
HPNIV+ + + N LY V EY + +L +++ + E V Q+
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 114 LNYMHRQGYF-----HRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTE-YITTLQYR 166
L HR+ HRDL N L +K+ DFGLA ++ + + ++ T Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 167 APEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226
+PE + YN K D+W+LG ++ EL P F + + KI
Sbjct: 184 SPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------- 231
Query: 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQHPLFQ 285
KF + IP DE+ +I + + RP+ E L++PL
Sbjct: 232 ----------KFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
Query: 286 GCLQ 289
Sbjct: 273 EHHH 276
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-57
Identities = 57/312 (18%), Positives = 110/312 (35%), Gaps = 31/312 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ L +G+G+ V++ K++G+ AIK + + ++E + L+K+ NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHK 67
Query: 62 NIVKLQEL--ASENYRLYFVFEYMDCNLHQLMS-----NRKQCFSEAEVKNWCFQILQGL 114
NIVKL + + + E+ C L + + E+E ++ G+
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEF--CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 115 NYMHRQGYFHRDLISKNLLVS-----NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
N++ G HR++ N++ K+ DFG A E++ + T +Y P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 170 ML-------LMSGQYNSKVDMWALGLIMAELIT----FHPLFPGTCEDDQLYKICNAIGS 218
M +Y + VD+W++G+ T F P + +YKI G
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GK 243
Query: 219 PTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEA 278
P+ + +LS ++ + D K +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLS---RGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 279 LQHPLFQGCLQV 290
Sbjct: 301 FAETSDILHRGN 312
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-57
Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 42/293 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNL-KEVKCLRKIN 58
+ + + K+IG G F +V++A G VA+K ++ + + + KE+ L+++N
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQC---FSEAEVKNWCFQILQGL 114
HPN++K E+ L V E D +L +++ + K+ E V + Q+ L
Sbjct: 91 -HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 115 NYMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDS--CPPYTEYITTLQYRAPEML 171
+MH + HRD+ N + + +K+ D GL S ++ + T Y +PE +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 208
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ--LYKICNAIGSPTEESWAEGLE 229
+G YN K D+W+LG ++ E+ F G + KI
Sbjct: 209 HENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-------------- 253
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
+P L ++ S ++ L+ + + DP KRP
Sbjct: 254 -------DYPPLPSDHYS-------EELRQLVNMCINPDPEKRPDVTYVYDVA 292
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-56
Identities = 73/304 (24%), Positives = 118/304 (38%), Gaps = 60/304 (19%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+ ++ IG G FG+V++A + G+ IK +K Y+ E+ EVK L K++ H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAER--EVKALAKLD-H 63
Query: 61 PNIVKLQE----------------LASENYRLYFVFEYMD-CNLHQLMSNRK-QCFSEAE 102
NIV S+ L+ E+ D L Q + R+ + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 103 VKNWCFQILQGLNYMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYIT 161
QI +G++Y+H + +RDL N LV +KI DFGL + + T
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG 183
Query: 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTE 221
TL+Y +PE + Y +VD++ALGLI+AEL+ H + +
Sbjct: 184 TLRYMSPEQISSQD-YGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------- 233
Query: 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
+ E +L++ L S P RP +E L+
Sbjct: 234 --------------GIIS-----------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRT 268
Query: 282 PLFQ 285
Sbjct: 269 LTVW 272
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-56
Identities = 62/301 (20%), Positives = 119/301 (39%), Gaps = 46/301 (15%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKIN- 58
Y+++KQIG G KV+Q + + + AIK + + + + E+ L K+
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
+ I++L + + +Y V E + +L+ + +K E K++ +L+ ++ +H
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH 144
Query: 119 RQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYIT---TLQYRAPEMLLMSG 175
+ G H DL N L+ + +K+ DFG+A ++ + T+ Y PE +
Sbjct: 145 QHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 176 ----------QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ-LYKICNAIGSPTEESW 224
+ + K D+W+LG I+ + F L+ I +
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------- 254
Query: 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
H +FP + D +++ DP +R + E L HP
Sbjct: 255 -------PNHEIEFP----DIPE---KDLQD----VLKCCLKRDPKQRISIPELLAHPYV 296
Query: 285 Q 285
Q
Sbjct: 297 Q 297
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-55
Identities = 67/309 (21%), Positives = 123/309 (39%), Gaps = 60/309 (19%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNH 60
++ +++IG G FG V++ +K+ G AIK K+ + + N L+EV + H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQ---CFSEAEVKNWCFQILQGLNY 116
++V+ +E+ + EY + +L +S + F EAE+K+ Q+ +GL Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 117 MHRQGYFHRDLISKNLLVSND--------------------TIKIADFGLAWEVDSCPPY 156
+H H D+ N+ +S KI D G + S P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--PQ 188
Query: 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216
E ++ A E+L + + K D++AL L + PL DQ ++I
Sbjct: 189 VE-EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQG- 243
Query: 217 GSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA 276
+ P++ LS + L++++ DP +RP+A
Sbjct: 244 --------------------RLPRIPQ-VLS---QEFTE----LLKVMIHPDPERRPSAM 275
Query: 277 EALQHPLFQ 285
++H +
Sbjct: 276 ALVKHSVLL 284
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-55
Identities = 62/300 (20%), Positives = 118/300 (39%), Gaps = 46/300 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKIN-N 59
Y+++KQIG G KV+Q + + + AIK + + + + E+ L K+ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
I++L + + +Y V E + +L+ + +K E K++ +L+ ++ +H+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQ 126
Query: 120 QGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYIT---TLQYRAPEMLLMSG- 175
G H DL N L+ + +K+ DFG+A ++ + T+ Y PE +
Sbjct: 127 HGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 176 ---------QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ-LYKICNAIGSPTEESWA 225
+ + K D+W+LG I+ + F L+ I +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----------- 235
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
H +FP D +++ DP +R + E L HP Q
Sbjct: 236 ------PNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 7e-55
Identities = 82/302 (27%), Positives = 137/302 (45%), Gaps = 38/302 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINNH 60
E Y +K++G G++G+V K + AIK +++ S L EV L+ ++ H
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-H 95
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQGLNYMH 118
PNI+KL + + Y V E +L + F+E + Q+L G+ Y+H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMEC--YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 119 RQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMS 174
+ HRDL +NLL+ + IKI DFGL+ ++ E + T Y APE+L
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL--R 211
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
+Y+ K D+W++G+I+ L+ +P F G + + L K+
Sbjct: 212 KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK------------------ 253
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMS 294
Y F + N+S A D LI+ + +D +R +A +AL+HP +
Sbjct: 254 -YTFDSPEWKNVS---EGAKD----LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESG 305
Query: 295 ID 296
I+
Sbjct: 306 IE 307
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-54
Identities = 60/296 (20%), Positives = 103/296 (34%), Gaps = 43/296 (14%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
+ +G G+ G + VA+K + +S+ + +EV+ LR+ + HPN
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFAD----REVQLLRESDEHPN 79
Query: 63 IVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
+++ + Y E L + + + E Q GL ++H
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNI 139
Query: 123 FHRDLISKNLLVSNDT------IKIADFGLAWEVDSCPPYTEYITTLQ----YRAPEMLL 172
HRDL N+L+S I+DFGL ++ + + + APEML
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 173 --MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
VD+++ G + +I+ G Q + A +
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
A+ LIE + + DP KRP+A L+HP F
Sbjct: 260 ARE--------------------------LIEKMIAMDPQKRPSAKHVLKHPFFWS 289
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-54
Identities = 58/312 (18%), Positives = 110/312 (35%), Gaps = 31/312 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ L +G+G+ V++ K++G+ AIK + + ++E + L+K+ NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHK 67
Query: 62 NIVKLQEL--ASENYRLYFVFEYMDCNLHQLMS-----NRKQCFSEAEVKNWCFQILQGL 114
NIVKL + + + E+ C L + + E+E ++ G+
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEF--CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 115 NYMHRQGYFHRDLISKNLLVS-----NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
N++ G HR++ N++ K+ DFG A E++ + T +Y P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 170 ML-------LMSGQYNSKVDMWALGLIMAELIT----FHPLFPGTCEDDQLYKICNAIGS 218
M +Y + VD+W++G+ T F P + +YKI S
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 219 PTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEA 278
+ P +LS ++ + D K +
Sbjct: 246 GAISGVQKAENGPIDWSGDMP--VSCSLS---RGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 279 LQHPLFQGCLQV 290
V
Sbjct: 301 FAETSDILHRMV 312
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-54
Identities = 56/303 (18%), Positives = 103/303 (33%), Gaps = 52/303 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINNH 60
+ Y ++++GEG F V G + A+K + EE E R N H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR--EADMHRLFN-H 85
Query: 61 PNIVKLQELASE----NYRLYFVFEYMDC-NLHQLMSNRKQ---CFSEAEVKNWCFQILQ 112
PNI++L + + + + L + K +E ++ I +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 113 GLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLA----------WEVDSCPPYTEYIT 161
GL +H +GY HRDL N+L+ + D G + + +
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 162 TLQYRAPEMLLMSG--QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP 219
T+ YRAPE+ + + + D+W+LG ++ ++ + +
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-------- 257
Query: 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL 279
LA + P+ P + L+ + + DP +RP L
Sbjct: 258 ----------LAVQNQLSIPQS---------PRHSSALWQLLNSMMTVDPHQRPHIPLLL 298
Query: 280 QHP 282
Sbjct: 299 SQL 301
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-54
Identities = 87/296 (29%), Positives = 140/296 (47%), Gaps = 39/296 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKINN 59
++Y + +G+GSFG+V K +G+ A+K + K+++ + +L EV+ L++++
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 84
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQGLNYM 117
HPNI+KL E + Y V E +L ++ FSE + Q+L G+ YM
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEV--YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 118 HRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
H+ HRDL +NLL+ + I+I DFGL+ ++ + I T Y APE+L
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-- 200
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
G Y+ K D+W+ G+I+ L++ P F G E D L K+
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK----------------- 243
Query: 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289
Y F Q +S SA D LI + ++ P R +A +AL H Q +
Sbjct: 244 --YTFELPQWKKVS---ESAKD----LIRKMLTYVPSMRISARDALDHEWIQTYTK 290
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-53
Identities = 84/302 (27%), Positives = 138/302 (45%), Gaps = 38/302 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINNH 60
E+Y ++ +G+GSFG+V + + + + A+K + + ++ + EV+ L+K++ H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-H 80
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQGLNYMH 118
PNI+KL E+ ++ Y V E +L +++ FSE + Q+ G+ YMH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGEL--YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 119 RQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMS 174
+ HRDL +N+L+ + IKI DFGL+ + I T Y APE+L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL--R 196
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
G Y+ K D+W+ G+I+ L++ P F G E D L ++
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG------------------- 237
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMS 294
Y F Q +S A D LI + ++ P R TA + L+HP Q
Sbjct: 238 KYAFDLPQWRTIS---DDAKD----LIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTI 290
Query: 295 ID 296
D
Sbjct: 291 SD 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-53
Identities = 61/301 (20%), Positives = 117/301 (38%), Gaps = 46/301 (15%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKIN- 58
Y+++KQIG G KV+Q + + + AIK + + + + E+ L K+
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
+ I++L + + +Y V E + +L+ + +K E K++ +L+ ++ +H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH 172
Query: 119 RQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYIT---TLQYRAPEMLLMSG 175
+ G H DL N L+ + +K+ DFG+A ++ + + Y PE +
Sbjct: 173 QHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 176 ----------QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ-LYKICNAIGSPTEESW 224
+ + K D+W+LG I+ + F L+ I +
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---------- 282
Query: 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
H +FP D +++ DP +R + E L HP
Sbjct: 283 -------PNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324
Query: 285 Q 285
Q
Sbjct: 325 Q 325
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-53
Identities = 90/341 (26%), Positives = 151/341 (44%), Gaps = 51/341 (14%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNH 60
+Y ++K IG+GSFG+V +A + ++VA+K ++ + +E++ L +
Sbjct: 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQ 153
Query: 61 P-----NIVKLQELASENYR--LYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQILQ 112
N++ + E + +R + FE + NL++L+ N+ Q FS V+ + ILQ
Sbjct: 154 DKDNTMNVIHMLE--NFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND---TIKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
L+ +H+ H DL +N+L+ IK+ DFG + YT YI + YRAPE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-RVYT-YIQSRFYRAPE 269
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP---------- 219
++L + Y +DMW+LG I+AEL+T +PL PG E DQL + +G P
Sbjct: 270 VILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328
Query: 220 -----------------TEESWAEGLELAKA-HGYKFPKLQGNNLSLLIPSANDDEM-SL 260
T + L ++ G + + +D
Sbjct: 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDF 388
Query: 261 IELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCKMR 301
++ WDP R T +AL+HP + L P + R
Sbjct: 389 LKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR 429
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 46/301 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-------EVKCL 54
++Y + K +G G+ G+V A ++++ + VAI+ + +R ++ E++ L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSN--RKQCFSEAEVKNWCFQILQ 112
+K+N HP I+K++ + Y V E M+ +L + EA K + +Q+L
Sbjct: 195 KKLN-HPCIIKIKN-FFDAEDYYIVLELMEGG--ELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAP 168
+ Y+H G HRDL +N+L+S+ IKI DFG + + T Y AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 169 EMLLMSGQ--YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY-KICNAIGSPTEESWA 225
E+L+ G YN VD W+LG+I+ ++ +P F L +I +
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK--------- 361
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
Y F +S A D L++ L DP R T EAL+HP Q
Sbjct: 362 ----------YNFIPEVWAEVS---EKALD----LVKKLLVVDPKARFTTEEALRHPWLQ 404
Query: 286 G 286
Sbjct: 405 D 405
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-52
Identities = 75/309 (24%), Positives = 115/309 (37%), Gaps = 63/309 (20%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKA-LKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + + + EG F V++A SG A+K L ++EV ++K++ HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--IQEVCFMKKLSGHP 86
Query: 62 NIVKL--------QELASENYRLYFVFEYMDCNLHQLMSNR--KQCFSEAEVKNWCFQIL 111
NIV+ +E + + E L + + + S V +Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 112 QGLNYMHRQG--YFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT----------- 157
+ + +MHRQ HRDL +NLL+S TIK+ DFG A + P Y+
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 158 --EYITTLQYRAPEML-LMSGQ-YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKIC 213
TT YR PE++ L S K D+WALG I+ L F ED +I
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKLRIV 262
Query: 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP 273
N Y P + SLI + +P +R
Sbjct: 263 NGK-------------------YSIPPH---------DTQYTVFHSLIRAMLQVNPEERL 294
Query: 274 TAAEALQHP 282
+ AE +
Sbjct: 295 SIAEVVHQL 303
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-52
Identities = 84/299 (28%), Positives = 146/299 (48%), Gaps = 37/299 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINNH 60
+ Y + +++G+G+F V + + K +G A K + + S + L+ E + RK+ H
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QH 64
Query: 61 PNIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
PNIV+L + E Y VF+ + +++ ++ +SEA+ + QIL+ + Y H
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCH 122
Query: 119 RQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMS 174
G HR+L +NLL+++ +K+ADFGLA EV+ + + T Y +PE+L
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
Y+ VD+WA G+I+ L+ +P F ED ++ I KA
Sbjct: 183 P-YSKPVDIWACGVILYILLVGYPPFWD--EDQH--RLYAQI---------------KAG 222
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSM 293
Y +P + + ++ P A LI+ + + +P KR TA +AL+ P +V S
Sbjct: 223 AYDYPSPEWDTVT---PEAKS----LIDSMLTVNPKKRITADQALKVPWICNRERVASA 274
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-52
Identities = 80/303 (26%), Positives = 142/303 (46%), Gaps = 37/303 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINNH 60
+ Y + +++G+G+F V + + K +G A K + + S + L+ E + RK+ H
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-H 87
Query: 61 PNIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
PNIV+L + E Y VF+ + +++ ++ +SEA+ + QIL+ + Y H
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCH 145
Query: 119 RQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMS 174
G HR+L +NLL+++ +K+ADFGLA EV+ + + T Y +PE+L
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
Y+ VD+WA G+I+ L+ +P F + +I
Sbjct: 206 P-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA------------------ 246
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMS 294
Y +P + + ++ P A LI+ + + +P KR TA +AL+ P +V S
Sbjct: 247 -YDYPSPEWDTVT---PEAKS----LIDSMLTVNPKKRITADQALKVPWICNRERVASAI 298
Query: 295 IDS 297
Sbjct: 299 HRQ 301
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-52
Identities = 85/312 (27%), Positives = 137/312 (43%), Gaps = 51/312 (16%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK----------- 49
E Y ++++G G++G+V +K AIK + K + + K
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 50 EVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC---NLHQLMSNRKQCFSEAEVKNW 106
E+ L+ ++ HPNI+KL ++ + Y V E+ L + + NR + F E + N
Sbjct: 96 EISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEF--YEGGELFEQIINRHK-FDECDAANI 151
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITT 162
QIL G+ Y+H+ HRD+ +N+L+ N IKI DFGL+ + + T
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE 222
Y APE+L +YN K D+W+ G+IM L+ +P F G + D + K+
Sbjct: 212 AYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK------ 263
Query: 223 SWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
Y F N+S A + LI+L+ ++D KR TA EAL
Sbjct: 264 -------------YYFDFNDWKNIS---DEAKE----LIKLMLTYDYNKRCTAEEALNSR 303
Query: 283 LFQGCLQVPSMS 294
+ + S
Sbjct: 304 WIKKYANNINKS 315
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-52
Identities = 77/310 (24%), Positives = 135/310 (43%), Gaps = 51/310 (16%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ Y + + IG GS+ + I K + A+K + + + +E++ L + HP
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-----KRDPTEEIEILLRYGQHP 76
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSN--------RKQCFSEAEVKNWCFQILQG 113
NI+ L+++ + +Y V E LM R++ FSE E F I +
Sbjct: 77 NIITLKDVYDDGKYVYVVTE--------LMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 114 LNYMHRQGYFHRDLISKNLLVSN-----DTIKIADFGLAWEVDSC-PPYTEYITTLQYRA 167
+ Y+H QG HRDL N+L + ++I+I DFG A ++ + T + A
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE+L G Y++ D+W+LG+++ ++T + F +D +I IG
Sbjct: 189 PEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEILARIG---------- 236
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287
+ N++S +A D L+ + DP +R TAA L+HP
Sbjct: 237 ----SGK-FSLSGGYWNSVS---DTAKD----LVSKMLHVDPHQRLTAALVLRHPWIVHW 284
Query: 288 LQVPSMSIDS 297
Q+P ++
Sbjct: 285 DQLPQYQLNR 294
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-51
Identities = 75/325 (23%), Positives = 126/325 (38%), Gaps = 40/325 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + +G G GKV Q K++ E A+K L+ +EV+ + + P
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKA-RREVELHWRASQCP 115
Query: 62 NIVKLQE----LASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
+IV++ + L + L V E +D ++ Q F+E E I + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 116 YMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEML 171
Y+H HRD+ +NLL ++ +K+ DFG A E S T T Y APE+L
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
Y+ DMW+LG+IM L+ +P F + I
Sbjct: 236 GPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-------------- 280
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291
Y+FP + + +S LI L +P +R T E + HP +VP
Sbjct: 281 MGQ-YEFPNPEWSEVS---EEVKM----LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
Query: 292 SMSIDSCK-MRLTPSAKKSGWKAKL 315
+ + + ++ + +
Sbjct: 333 QTPLHTSRVLKEDKERWEDVKEEMT 357
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 77/328 (23%), Positives = 126/328 (38%), Gaps = 64/328 (19%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
K +G GS G V Q G VA+K + E+K L + ++HP
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIAL----MEIKLLTESDDHP 69
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRK------QCFSEAEVKNWCFQILQGLN 115
N+++ + + LY E + NL L+ ++ + E + QI G+
Sbjct: 70 NVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 116 YMHRQGYFHRDLISKNLLVS--------------NDTIKIADFGLAWEVDSCPPYTEYIT 161
++H HRDL +N+LVS N I I+DFGL ++DS
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 162 -----TLQYRAPEMLLMSGQ------YNSKVDMWALGLIMAELIT--FHPLFPGTCEDDQ 208
T +RAPE+L S +D++++G + +++ HP F + +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP-FGD--KYSR 246
Query: 209 LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWD 268
I I + +++ + LI A D LI + D
Sbjct: 247 ESNIIRGI-------------------FSLDEMKCLHDRSLIAEATD----LISQMIDHD 283
Query: 269 PCKRPTAAEALQHPLFQGCLQVPSMSID 296
P KRPTA + L+HPLF + +
Sbjct: 284 PLKRPTAMKVLRHPLFWPKSKKLEFLLK 311
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-51
Identities = 84/294 (28%), Positives = 138/294 (46%), Gaps = 42/294 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINNH 60
E+Y ++ +G+GSFG+V + + + + A+K + K + + L+EV+ L+K++ H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-H 80
Query: 61 PNIVKLQELASENYRLYFVFEYMDCN----LHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
PNI+KL E+ ++ Y V E +++ ++ FSE + Q+ G+ Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGEL--YTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITY 136
Query: 117 MHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLL 172
MH+ HRDL +N+L+ + IKI DFGL+ + I T Y APE+L
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL- 195
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
G Y+ K D+W+ G+I+ L++ P F G E D L ++
Sbjct: 196 -RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK---------------- 238
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
Y F Q +S A D LI + ++ P R TA + L+HP Q
Sbjct: 239 ---YAFDLPQWRTIS---DDAKD----LIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-51
Identities = 74/326 (22%), Positives = 123/326 (37%), Gaps = 42/326 (12%)
Query: 2 EKYTLMKQ-IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+ Y L KQ +G G GKV + +++G+ A+K L +EV + +
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGG 81
Query: 61 PNIVKLQEL----ASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGL 114
P+IV + ++ L + E M+ ++ Q F+E E I +
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 115 NYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170
++H HRD+ +NLL ++ +K+ DFG A E T Y APE+
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEV 200
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
L Y+ DMW+LG+IM L+ P F + I
Sbjct: 201 LGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI-------------- 245
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290
+ Y FP + + +S A LI LL DP +R T + + HP + V
Sbjct: 246 -RLGQYGFPNPEWSEVS---EDAKQ----LIRLLLKTDPTERLTITQFMNHPWINQSMVV 297
Query: 291 PSMSIDSCK-MRLTPSAKKSGWKAKL 315
P + + + ++ +
Sbjct: 298 PQTPLHTARVLQEDKDHWDEVKEEMT 323
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-51
Identities = 76/302 (25%), Positives = 132/302 (43%), Gaps = 42/302 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ YTL IG GS+G+V A++K + A K + + + +E++ ++ ++ HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF-KQEIEIMKSLD-HP 66
Query: 62 NIVKLQELASENYRLYFVFEYMDCN----LHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
NI++L E +N +Y V E C +++ K+ F E++ +L + Y
Sbjct: 67 NIIRLYETFEDNTDIYLVMEL--CTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYC 122
Query: 118 HRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
H+ HRDL +N L D +K+ DFGLA + T Y +P++L
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-- 180
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
G Y + D W+ G++M L+ +P F + + + KI
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT----------------- 223
Query: 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSM 293
+ FP+ N+S P A LI L + P +R T+ +AL+H F+ L
Sbjct: 224 --FTFPEKDWLNVS---PQAES----LIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274
Query: 294 SI 295
++
Sbjct: 275 NL 276
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 9e-51
Identities = 89/330 (26%), Positives = 141/330 (42%), Gaps = 52/330 (15%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN---- 58
+Y L++++G G F VW A + +VA+K ++ E E+K L+++N
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA--EDEIKLLQRVNDADN 77
Query: 59 ------NHPNIVKLQELASENYR------LYFVFEYMDCNLHQLM-SNRKQCFSEAEVKN 105
+I+KL L N++ + VFE + NL L+ + VK
Sbjct: 78 TKEDSMGANHILKL--LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 106 WCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-------NDTIKIADFGLAWEVDSCPPYT 157
Q+L GL+YMHR+ G H D+ +N+L+ IKIAD G A D YT
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYT 193
Query: 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPG------TCEDDQLYK 211
I T +YR+PE+LL + + D+W+ ++ ELIT LF T +DD + +
Sbjct: 194 NSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 212 ICNAIGSP----------TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLI 261
I +G T + L KF L+ + L+ + D+ +
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE-DVLTEKYKFSKDEAKEIS 311
Query: 262 ELL--C-SWDPCKRPTAAEALQHPLFQGCL 288
+ L DP KR A + HP + L
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-50
Identities = 82/302 (27%), Positives = 135/302 (44%), Gaps = 48/302 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-------EVKCL 54
++Y + K +G G+ G+V A ++++ + VAIK + +R ++ E++ L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNR---KQCFSEAEVKNWCFQIL 111
+K+ NHP I+K++ + Y V E M+ +L ++ + EA K + +Q+L
Sbjct: 70 KKL-NHPCIIKIKN-FFDAEDYYIVLELMEGG--ELF-DKVVGNKRLKEATCKLYFYQML 124
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRA 167
+ Y+H G HRDL +N+L+S+ IKI DFG + + T Y A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 168 PEMLLMSGQ--YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY-KICNAIGSPTEESW 224
PE+L+ G YN VD W+LG+I+ ++ +P F L +I +
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-------- 236
Query: 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
Y F +S A D L++ L DP R T EAL+HP
Sbjct: 237 -----------YNFIPEVWAEVS---EKALD----LVKKLLVVDPKARFTTEEALRHPWL 278
Query: 285 QG 286
Q
Sbjct: 279 QD 280
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-50
Identities = 77/296 (26%), Positives = 129/296 (43%), Gaps = 38/296 (12%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKIN 58
+E + + + +G+G FG V+ A +KQS +A+K L K ++ L+ EV+ +
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL- 66
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HPNI++L + R+Y + EY +++ + + F E + ++ L+Y
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYC 125
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
H + HRD+ +NLL+ S +KIADFG + S TL Y PEM+
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRM- 183
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
++ KVD+W+LG++ E + P F + +I +
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-------------------F 224
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPS 292
FP + ++ A D LI L +P +RP E L+HP PS
Sbjct: 225 TFP----DFVT---EGARD----LISRLLKHNPSQRPMLREVLEHPWITANSSKPS 269
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-50
Identities = 80/301 (26%), Positives = 125/301 (41%), Gaps = 44/301 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK--------EVKC 53
E Y + +G G V + I K + + A+K + ++ EV
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQIL 111
LRK++ HPNI++L++ N + VF+ M L K SE E + +L
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALL 134
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170
+ + +H+ HRDL +N+L+ +D IK+ DFG + ++D E T Y APE+
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 171 LLMSGQ-----YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
+ S Y +VDMW+ G+IM L+ P F + L I +
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN--------- 245
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
Y+F + ++ S + D L+ P KR TA EAL HP FQ
Sbjct: 246 ----------YQFGSPEWDDYS---DTVKD----LVSRFLVVQPQKRYTAEEALAHPFFQ 288
Query: 286 G 286
Sbjct: 289 Q 289
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-50
Identities = 80/295 (27%), Positives = 127/295 (43%), Gaps = 44/295 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINNH 60
+ + +++G G+FG V ++ SG IK + K R E + E++ L+ ++ H
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI-EAEIEVLKSLD-H 79
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQL------MSNRKQCFSEAEVKNWCFQILQGL 114
PNI+K+ E+ + + +Y V E C +L R + SE V Q++ L
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMET--CEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 115 NYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170
Y H Q H+DL +N+L + IKI DFGLA S T T Y APE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
K D+W+ G++M L+T F GT ++ K + E
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR------ 249
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
L+ P A D L++ + + DP +RP+AA+ L H F+
Sbjct: 250 --------------PLT---PQAVD----LLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-50
Identities = 68/318 (21%), Positives = 131/318 (41%), Gaps = 35/318 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINNH 60
+ Y +++++G G+FG V + ++K +G K + N E+ + +++ H
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN--EISIMNQLH-H 107
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
P ++ L + + Y + + E++ L ++ SEAEV N+ Q +GL +MH
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 120 QGYFHRDLISKNLLVSN---DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
H D+ +N++ ++KI DFGLA +++ T ++ APE++
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP- 226
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
DMWA+G++ L++ F G + + L + E++++ AK
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK---- 282
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSID 296
I+ L +P KR T +AL+HP +G + I
Sbjct: 283 ----------------------DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320
Query: 297 SCKMRLTPSAKKSGWKAK 314
S + K +
Sbjct: 321 SSRYNKIRQKIKEKYADW 338
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-50
Identities = 79/310 (25%), Positives = 135/310 (43%), Gaps = 44/310 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK----EVKCLRKI 57
+ Y L + IG+G F V + I +++G+ A+K + ++ L+ + E +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMD----CNLHQLMSNRKQCFSEAEVKNWCFQILQG 113
HP+IV+L E S + LY VFE+MD C ++ +SEA ++ QIL+
Sbjct: 84 -KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 114 LNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEV-DSCPPYTEYITTLQYRAP 168
L Y H HRD+ +L+++ +K+ FG+A ++ +S + T + AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY-KICNAIGSPTEESWAEG 227
E++ Y VD+W G+I+ L++ F GT ++L+ I
Sbjct: 203 EVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKG------------ 247
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287
YK Q +++S SA D L+ + DP +R T EAL HP +
Sbjct: 248 -------KYKMNPRQWSHIS---ESAKD----LVRRMLMLDPAERITVYEALNHPWLKER 293
Query: 288 LQVPSMSIDS 297
+
Sbjct: 294 DRYAYKIHLP 303
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-49
Identities = 85/326 (26%), Positives = 142/326 (43%), Gaps = 43/326 (13%)
Query: 2 EKYTLM---KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN 58
+ Y L K +GEGSF + + K+S + A+K + +R+ + + KE+ L+
Sbjct: 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ----KEITALKLCE 63
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
HPNIVKL E+ + + V E ++ ++ +K+ FSE E +++ +++
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK--KKKHFSETEASYIMRKLVSAVSH 121
Query: 117 MHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEV-DSCPPYTEYITTLQYRAPEML 171
MH G HRDL +NLL +++ IKI DFG A P TL Y APE+L
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY---KICNAIGSPTEESWAEGL 228
+G Y+ D+W+LG+I+ +++ F +I I
Sbjct: 182 NQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK----------- 229
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288
K + F N+S A D LI+ L + DP KR + + Q
Sbjct: 230 ---KGD-FSFEGEAWKNVS---QEAKD----LIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278
Query: 289 QVPSMSIDS-CKMRLTPSAKKSGWKA 313
Q+ S + + + + +A + KA
Sbjct: 279 QLSSNPLMTPDILGSSGAAVHTCVKA 304
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 169 bits (428), Expect = 1e-49
Identities = 44/318 (13%), Positives = 86/318 (27%), Gaps = 58/318 (18%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLR----- 55
K L++ + G V+ + E A+K + L +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 56 ------------------KINNHPNIVKLQELASENYR--LYFVFEYMDCNLHQLMS--- 92
+ + P +L + + +L L S
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 93 ---NRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAW 148
+ + Q+++ + +G H NL + D + + D W
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 149 EVDSCPPYTEYITTLQYRAPEMLLMSG-QYNSKVDMWALGLIMAELITFHPLFPGTCEDD 207
+V + + Y E L S + ++ W LGL + + F
Sbjct: 243 KVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 208 QLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSW 267
+ ++ P +S A F +P LI ++
Sbjct: 301 KGSWKRPSLRVPGTDSLA------------FGSCTP------LPDFVKT---LIGRFLNF 339
Query: 268 DPCKRPTAAEALQHPLFQ 285
D +R EA++ P F
Sbjct: 340 DRRRRLLPLEAMETPEFL 357
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 85/337 (25%), Positives = 133/337 (39%), Gaps = 80/337 (23%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL---KQRIYSWEECLNLK-EVKCLRKI 57
+KY L IG+GS+G V AI+ Q+ AIK + K R + ++ +K EV+ ++K+
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 58 NNHPNIVKLQELASENYRLYFVFEYM---------------------------------- 83
+ HPNI +L E+ + + V E
Sbjct: 86 H-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 84 ------DCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND 137
+ ++H + E + N QI L+Y+H QG HRD+ +N L S +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 138 ---TIKIADFGLAWEVDSCPPYTEYIT-----TLQYRAPEMLLMSGQ-YNSKVDMWALGL 188
IK+ DFGL+ E Y T + APE+L + + Y K D W+ G+
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 189 IMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSL 248
++ L+ FPG + D + ++ N F N LS
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQVLNK-------------------KLCFENPNYNVLS- 304
Query: 249 LIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
P A D L+ L + + +R A ALQHP
Sbjct: 305 --PLARD----LLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-49
Identities = 76/309 (24%), Positives = 125/309 (40%), Gaps = 46/309 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKIN 58
+Y + +G+G F K ++ + E A K + K + + + E+ R +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQGLNY 116
H ++V +N ++ V E C L+ R++ +E E + + QI+ G Y
Sbjct: 74 -HQHVVGFHGFFEDNDFVFVVLEL--CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 117 MHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTL----QYRAPEML 171
+HR HRDL NL + + +KI DFGLA +V+ E L Y APE+L
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPEVL 187
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
G ++ +VD+W++G IM L+ P F +C + +I
Sbjct: 188 SKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------------- 231
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291
Y PK +++ P A LI+ + DP RPT E L F
Sbjct: 232 ----YSIPK----HIN---PVAAS----LIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276
Query: 292 SMSIDSCKM 300
+ I +
Sbjct: 277 RLPITCLTI 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-49
Identities = 81/315 (25%), Positives = 142/315 (45%), Gaps = 35/315 (11%)
Query: 2 EKYTLMKQ-IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+ Y L + +GEG+ +V I + + A+K ++++ + +EV+ L + H
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV-FREVEMLYQCQGH 70
Query: 61 PNIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
N+++L E E R Y VFE M L + +++ F+E E + L+++H
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH--KRRHFNELEASVVVQDVASALDFLH 128
Query: 119 RQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYIT--------TLQYR 166
+G HRDL +N+L + +KI DF L + + T + +Y
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 167 APEMLLMSGQ----YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE 222
APE++ + Y+ + D+W+LG+I+ L++ +P F G C D + G
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD----RGEACPA 244
Query: 223 SWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
E + Y+FP ++S +A D LI L D +R +AA+ LQHP
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHIS---CAAKD----LISKLLVRDAKQRLSAAQVLQHP 297
Query: 283 LFQGCLQVPSMSIDS 297
QGC P ++ +
Sbjct: 298 WVQGC--APENTLPT 310
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 8e-49
Identities = 80/337 (23%), Positives = 135/337 (40%), Gaps = 64/337 (18%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINNH 60
+ +++++G+G+FG+V + +Y A+K ++ + Y+ E L+KI N
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---KIEADILKKIQND 91
Query: 61 P----NIVKLQELASENYR--LYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQILQG 113
NIVK Y + +FE + +L++++ N F ++K +C +IL+
Sbjct: 92 DINNNNIVKYHG--KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 114 LNYMHRQGYFHRDLISKN-LLVSND-------------------------TIKIADFGLA 147
LNY+ + H DL +N LL IK+ DFG A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 148 WEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD 207
+ I T QYRAPE++L G ++ DMW+ G ++AEL T LF +
Sbjct: 210 TFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
Query: 208 QLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNL-----------------SLLI 250
L + + I + E K +G K+ L L +
Sbjct: 267 HLAMMESIIQPIPKNMLYEA---TKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323
Query: 251 PSANDDEM--SLIELLCSWDPCKRPTAAEALQHPLFQ 285
E+ + + DP RP+ AE L+H +
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 44/289 (15%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINNHPNIVKL 66
+IG GSF V++ + ++ VA L+ R + E K E + L+ + HPNIV+
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRF 90
Query: 67 ----QELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+ + V E M L + R + +++WC QIL+GL ++H +
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 122 YF--HRDLISKNLLVSNDT--IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
HRDL N+ ++ T +KI D GLA + I T ++ APEM +Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKY 206
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
+ VD++A G+ M E+ T + Q+Y+ + P
Sbjct: 207 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------------------ 248
Query: 238 FPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQHPLFQ 285
E+ +IE + +R + + L H FQ
Sbjct: 249 ----------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-48
Identities = 69/318 (21%), Positives = 130/318 (40%), Gaps = 36/318 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINNH 60
+ Y + +++G G+FG V + ++ +G A K + E E++ + + H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK--EIQTMSVLR-H 213
Query: 61 PNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
P +V L + ++ + ++E+M L + +++ SE E + Q+ +GL +MH
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 120 QGYFHRDLISKNLLVSN---DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
Y H DL +N++ + + +K+ DFGL +D T ++ APE+
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP- 332
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
DMW++G++ L++ F G E+D + + K+ +
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGG--ENDD--ETLRNV---------------KSCDW 373
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP-LFQGCLQVPSMSI 295
+ +S D I L DP R T +AL+HP L G I
Sbjct: 374 NMDDSAFSGIS---EDGKD----FIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426
Query: 296 DSCKMRLTPSAKKSGWKA 313
S + + K+ + A
Sbjct: 427 PSSRYTKIRDSIKTKYDA 444
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-48
Identities = 85/294 (28%), Positives = 137/294 (46%), Gaps = 45/294 (15%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKIN 58
+E + + +G+GSF V++A +G VAIK + K+ +Y ++ EVK ++
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCN---LHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
HP+I++L ++ +Y V E C+ +++ + NR + FSE E +++ QI+ G+
Sbjct: 70 -HPSILELYNYFEDSNYVYLVLEM--CHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 116 YMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYIT---TLQYRAPEML 171
Y+H G HRDL NLL+ N IKIADFGLA P+ ++ T T Y +PE+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
S + + D+W+LG + L+ P F + L K+ A
Sbjct: 185 TRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--------------- 228
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
Y+ P + LS A D LI L +P R + + L HP
Sbjct: 229 ----YEMP----SFLS---IEAKD----LIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 88/310 (28%), Positives = 145/310 (46%), Gaps = 50/310 (16%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINNH 60
E+Y L +++G+G+F V + +K +G+ A + + S + L+ E + R + H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-H 69
Query: 61 PNIVKLQELASENYRLYFVFEYMD--------CNLHQLMSNRKQCFSEAEVKNWCFQILQ 112
PNIV+L + SE Y +F+ + ++ +SEA+ + QIL+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV--------AREYYSEADASHCIQQILE 121
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSC-PPYTEYITTLQYRA 167
+ + H+ G HR+L +NLL+++ +K+ADFGLA EV+ + + T Y +
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE+L Y VD+WA G+I+ L+ +P F ED ++ I
Sbjct: 182 PEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWD--EDQH--RLYQQI----------- 225
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287
KA Y FP + + ++ P A D LI + + +P KR TAAEAL+HP
Sbjct: 226 ----KAGAYDFPSPEWDTVT---PEAKD----LINKMLTINPSKRITAAEALKHPWISHR 274
Query: 288 LQVPSMSIDS 297
V S
Sbjct: 275 STVASCMHRQ 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 172 bits (436), Expect = 2e-48
Identities = 74/307 (24%), Positives = 124/307 (40%), Gaps = 23/307 (7%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
+ + +++G G FG V + I + +GE VAIK +Q + E++ ++K+ NHPN
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPN 73
Query: 63 IVKLQEL------ASENYRLYFVFEYMDC-NLHQLMSNRKQC--FSEAEVKNWCFQILQG 113
+V +E+ + N EY + +L + ++ + C E ++ I
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 114 LNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
L Y+H HRDL +N+++ KI D G A E+D TE++ TLQY APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 170 MLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
+ L +Y VD W+ G + E IT F P P K+
Sbjct: 194 L-LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL-- 250
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288
KF + + L ++ + W +R T + FQ
Sbjct: 251 ----TGAVKFSSVL-PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305
Query: 289 QVPSMSI 295
+ S+ +
Sbjct: 306 SILSLKL 312
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-48
Identities = 76/313 (24%), Positives = 125/313 (39%), Gaps = 54/313 (17%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKIN 58
+Y + +G+G F K ++ + E A K + K + + + E+ R +
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQGLNY 116
H ++V +N ++ V E C L+ R++ +E E + + QI+ G Y
Sbjct: 100 -HQHVVGFHGFFEDNDFVFVVLEL--CRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 117 MHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVD--------SCPPYTEYITTLQYRA 167
+HR HRDL NL + + +KI DFGLA +V+ C T Y A
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-------GTPNYIA 209
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE+L G ++ +VD+W++G IM L+ P F +C + +I
Sbjct: 210 PEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE----------- 257
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287
Y PK +++ P A LI+ + DP RPT E L F
Sbjct: 258 --------YSIPK----HIN---PVAAS----LIQKMLQTDPTARPTINELLNDEFFTSG 298
Query: 288 LQVPSMSIDSCKM 300
+ I +
Sbjct: 299 YIPARLPITCLTI 311
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-48
Identities = 70/289 (24%), Positives = 124/289 (42%), Gaps = 38/289 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKIN 58
++ + + + +G+G FG V+ A +KQ+ +A+K L K ++ L+ E++ +
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL- 71
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HPNI+++ + R+Y + E+ L++ + + F E + ++ L+Y
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRSATFMEELADALHYC 130
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
H + HRD+ +NLL+ +KIADFG + S T TL Y PEM+
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-MCGTLDYLPPEMIEGKT- 188
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
++ KVD+W G++ E + P F + +I N
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-------------------L 229
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
KFP LS + D LI L + P +R ++HP +
Sbjct: 230 KFP----PFLS---DGSKD----LISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-48
Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 57/306 (18%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK-----ALKQRIYSWEECLN--LKEVKCL 54
+KY IG G V + + + +G A+K A + EE +E L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSN--------RKQCFSEAEVKNW 106
R++ HP+I+ L + + ++ VF+ LM K SE E ++
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFD--------LMRKGELFDYLTEKVALSEKETRSI 205
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQY 165
+L+ ++++H HRDL +N+L+ ++ I+++DFG + ++ E T Y
Sbjct: 206 MRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY 265
Query: 166 RAPEMLLMSGQ-----YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPT 220
APE+L S Y +VD+WA G+I+ L+ P F + L I
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ---- 321
Query: 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIE-LLCSWDPCKRPTAAEAL 279
Y+F + ++ S + D LI LL DP R TA +AL
Sbjct: 322 ---------------YQFSSPEWDDRS---STVKD----LISRLLQV-DPEARLTAEQAL 358
Query: 280 QHPLFQ 285
QHP F+
Sbjct: 359 QHPFFE 364
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-48
Identities = 75/287 (26%), Positives = 126/287 (43%), Gaps = 38/287 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + M+ +G G+F +V+ ++ +G+ A+K +K+ + L E+ L+KI H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL-ENEIAVLKKI-KHE 66
Query: 62 NIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
NIV L+++ Y V + + +++ + ++E + Q+L + Y+H
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 120 QGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSG 175
G HRDL +NLL I I DFGL+ + + T Y APE+L
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKP 183
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
Y+ VD W++G+I L+ +P F E + K+ I K
Sbjct: 184 -YSKAVDCWSIGVITYILLCGYPPFYE--ETES--KLFEKI---------------KEGY 223
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
Y+F +++S SA D I L DP +R T +AL HP
Sbjct: 224 YEFESPFWDDIS---ESAKD----FICHLLEKDPNERYTCEKALSHP 263
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-47
Identities = 74/310 (23%), Positives = 126/310 (40%), Gaps = 41/310 (13%)
Query: 2 EKYTLMKQ--IGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKIN 58
YT+ K +G G FG+V + + +G +A K + + + EE N E+ + +++
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKN--EISVMNQLD 144
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
H N+++L + + V EY+D L + + +E + + QI +G+ +M
Sbjct: 145 -HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 118 HRQGYFHRDLISKNLLVSN---DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMS 174
H+ H DL +N+L N IKI DFGLA T ++ APE++
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD 263
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ--LYKICNAIGSPTEESWAEGLELAK 232
+ DMW++G+I L++ F G ++D L I +E + + E AK
Sbjct: 264 F-VSFPTDMWSVGVIAYMLLSGLSPFLG--DNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPS 292
I L + R +A+EAL+HP
Sbjct: 321 --------------------------EFISKLLIKEKSWRISASEALKHPWLSDHKLHSR 354
Query: 293 MSIDSCKMRL 302
+S K R
Sbjct: 355 LSAQKKKNRG 364
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-46
Identities = 90/336 (26%), Positives = 141/336 (41%), Gaps = 64/336 (19%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINNH 60
++Y + IG+GSFG+V +A + E+VAIK +K ++ + + EV+ L +N H
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA---QIEVRLLELMNKH 110
Query: 61 P-----NIVKLQELASENYR--LYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQILQ 112
IV L+ +R L VFE + NL+ L+ + + S + + Q+
Sbjct: 111 DTEMKYYIVHLKR--HFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 113 GLNYMHRQ--GYFHRDLISKNLLVSND---TIKIADFGLAWEVDSCPPYTEYITTLQYRA 167
L ++ H DL +N+L+ N IKI DFG + ++ +YI + YR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRS 226
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE+LL Y+ +DMW+LG I+ E+ T PLF G E DQ+ KI +G P
Sbjct: 227 PEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI---- 281
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSAN--------------------------------- 254
L+ A F KL +L
Sbjct: 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGH 341
Query: 255 --DDEMSLIELLCS---WDPCKRPTAAEALQHPLFQ 285
D + +L+ +DP R ALQH F+
Sbjct: 342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-46
Identities = 76/308 (24%), Positives = 133/308 (43%), Gaps = 42/308 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-----EVKCLRK 56
+ Y + +++G G F V + +K +G+ A K +K+R S + EV LR+
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGL 114
I HPNI+ L ++ + + E + L K+ +E E + QIL G+
Sbjct: 65 IR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGV 121
Query: 115 NYMHRQGYFHRDLISKNLLVSNDT-----IKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
+Y+H + H DL +N+++ + IK+ DFG+A ++++ + T ++ APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
++ + DMW++G+I L++ F G E Q + I
Sbjct: 182 IVNYEP-LGLEADMWSIGVITYILLSGASPFLG--ETKQ--ETLTNI------------- 223
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289
A Y F + +N S A D I L DP +R T A++L+H + +
Sbjct: 224 --SAVNYDFDEEYFSNTS---ELAKD----FIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274
Query: 290 VPSMSIDS 297
DS
Sbjct: 275 RNVRGEDS 282
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 81/327 (24%), Positives = 129/327 (39%), Gaps = 45/327 (13%)
Query: 2 EKYTLM-KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINN 59
Y L K++G G F V Q I K +G+ A K LK+R + + E+ L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCN----LHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
P ++ L E+ + + EY + + SE +V QIL+G+
Sbjct: 88 CPRVINLHEVYENTSEIILILEY--AAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 116 YMHRQGYFHRDLISKNLLVSNDT----IKIADFGLAWEVDSCPPYTEYITTLQYRAPEML 171
Y+H+ H DL +N+L+S+ IKI DFG++ ++ E + T +Y APE+L
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL 205
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ--LYKICNAIGSPTEESWAEGLE 229
+ DMW +G+I L+T F G ED+Q I +EE+++ +
Sbjct: 206 NYDP-ITTATDMWNIGIIAYMLLTHTSPFVG--EDNQETYLNISQVNVDYSEETFSSVSQ 262
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289
LA I+ L +P KRPTA L H Q
Sbjct: 263 LAT--------------------------DFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296
Query: 290 VPSMSID--SCKMRLTPSAKKSGWKAK 314
+ S + + +S
Sbjct: 297 ENLFHPEETSSSSQTQDHSVRSSEDKT 323
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-46
Identities = 68/322 (21%), Positives = 128/322 (39%), Gaps = 40/322 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
EKY + + +G G FG V + ++ S + K +K + E+ L H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK--EISILNIAR-HR 61
Query: 62 NIVKLQELASENYRLYFVFEYMDCN---LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
NI+ L E L +FE+ + + + ++ +E E+ ++ Q+ + L ++H
Sbjct: 62 NILHLHESFESMEELVMIFEF--ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 119 RQGYFHRDLISKNLLVSNDT---IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSG 175
H D+ +N++ IKI +FG A ++ + T +Y APE+
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
++ DMW+LG ++ L++ F + I NA + EE++
Sbjct: 180 -VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF----------- 227
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSI 295
+S A D ++ L + R TA+EALQHP + ++ S +
Sbjct: 228 --------KEIS---IEAMD----FVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
Query: 296 DSCKMRLTPSAKKSGWKAKLIV 317
++ + K L +
Sbjct: 273 IR-TLKHR-RYYHTLIKKDLNM 292
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 5e-46
Identities = 78/333 (23%), Positives = 137/333 (41%), Gaps = 60/333 (18%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-KKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKIN- 58
+Y ++ +GEG+FGKV + I K G +VA+K +K Y E++ L +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA---RSEIQVLEHLNT 70
Query: 59 ----NHPNIVKLQELASENYR--LYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQIL 111
+ V++ E + + VFE + + + + N F ++ +QI
Sbjct: 71 TDPNSTFRCVQMLE--WFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 112 QGLNYMHRQGYFHRDLISKN-LLVSND-------------------TIKIADFGLAWEVD 151
+ +N++H H DL +N L V +D IK+ DFG A D
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYK 211
T ++T YRAPE++L G ++ D+W++G I+ E +FP + L
Sbjct: 189 E-HHST-LVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245
Query: 212 ICNAIGSPTEESWAEGLELAKAHGY----KFPKLQGN-----------NLSLLIPSANDD 256
+ +G + ++ + Y + + + L + S + +
Sbjct: 246 MERILGPLPKHM----IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301
Query: 257 EMSLIELLC---SWDPCKRPTAAEALQHPLFQG 286
L +L+ +DP KR T EAL+HP F
Sbjct: 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-46
Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 52/298 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + + ++G G+ V++ +K + + A+K LK+ + ++ + E+ L +++ HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLS-HP 108
Query: 62 NIVKLQELASENYRLYFVFEYM------DCNLHQLMSNR---KQCFSEAEVKNWCFQILQ 112
NI+KL+E+ + V E + D R K +SE + + QIL+
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFD---------RIVEKGYYSERDAADAVKQILE 159
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAP 168
+ Y+H G HRDL +NLL + +KIADFGL+ V+ T Y AP
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
E+L Y +VDMW++G+I L+ F D +++
Sbjct: 220 EILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI--------------- 263
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
Y F + +S +A D L+ L DP KR T +ALQHP G
Sbjct: 264 ---LNCEYYFISPWWDEVS---LNAKD----LVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 67/324 (20%), Positives = 119/324 (36%), Gaps = 60/324 (18%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + +G G GKV Q K++ E A+K L+ +EV+ + + P
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKA-RREVELHWRASQCP 71
Query: 62 NIVKLQEL----ASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
+IV++ ++ + L V E +D ++ Q F+E E I + +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 116 YMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEML 171
Y+H HRD+ +NLL ++ +K+ DFG A E
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETT 171
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
+Y+ DMW+LG+IM L+ +P F + I
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-------------- 215
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291
Y+FP + + +S LI L +P +R T E + HP +VP
Sbjct: 216 MGQ-YEFPNPEWSEVS---EEVKM----LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267
Query: 292 SMSIDSCKMRLTPSAKKSGWKAKL 315
+ + ++ + K ++
Sbjct: 268 QTPLHTSRVLKEDKERWEDVKEEM 291
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-45
Identities = 75/329 (22%), Positives = 127/329 (38%), Gaps = 52/329 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-KKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKIN- 58
E+Y ++ +GEG+FGKV + + + VA+K ++ Y E+ L+KI
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---RLEINVLKKIKE 75
Query: 59 ----NHPNIVKLQELASENYR--LYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQIL 111
N V + + N+ + FE + N + + N Q + V++ +Q+
Sbjct: 76 KDKENKFLCVLMSD--WFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT--------------------IKIADFGLAWEVD 151
L ++H H DL +N+L N I++ADFG A
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYK 211
+T + T YR PE++L G + D+W++G I+ E LF + L
Sbjct: 194 E--HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250
Query: 212 ICNAIGSPTEESWAEG-------------LELAKAHGYKFPKLQGNNLSLLIPSANDDEM 258
+ +G E + Y + +L S ++
Sbjct: 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL 310
Query: 259 -SLIELLCSWDPCKRPTAAEALQHPLFQG 286
L+ + +DP +R T AEAL HP F G
Sbjct: 311 FDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-45
Identities = 77/332 (23%), Positives = 134/332 (40%), Gaps = 47/332 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-----EVKCLRK 56
+ Y + +++G G F V + +K +G A K +K+R + EV LR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
+ H N++ L ++ + + E + L ++ +K+ SE E ++ QIL G+N
Sbjct: 72 VL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVN 129
Query: 116 YMHRQGYFHRDLISKNLLVSNDT-----IKIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170
Y+H + H DL +N+++ + IK+ DFGLA E++ + T ++ APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ--LYKICNAIGSPTEESWAEGL 228
+ + DMW++G+I L++ F G + Q L I + EE ++
Sbjct: 190 VNYEP-LGLEADMWSIGVITYILLSGASPFLG--DTKQETLANITSVSYDFDEEFFSHTS 246
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288
ELAK I L + KR T EAL+HP
Sbjct: 247 ELAK--------------------------DFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 289 QVPSMSID---SCKMRLTPSAKKSGWKAKLIV 317
+M + WK +
Sbjct: 281 NQQAMVRRESVVNLENFRKQYVRRRWKLSFSI 312
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 78/317 (24%), Positives = 130/317 (41%), Gaps = 50/317 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-----EVKCLRK 56
+ Y + +++G G F V + +K +G A K +K+R + EV LR+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 57 INNHPNIVKLQELASENYRLYFVFEYM------DCNLHQLMSNRKQCFSEAEVKNWCFQI 110
+ HPNI+ L ++ + + E + D L K+ SE E ++ QI
Sbjct: 72 VL-HPNIITLHDVYENRTDVVLILELVSGGELFD----FLAQ--KESLSEEEATSFIKQI 124
Query: 111 LQGLNYMHRQGYFHRDLISKNLLVSNDT-----IKIADFGLAWEVDSCPPYTEYITTLQY 165
L G+NY+H + H DL +N+++ + IK+ DFGLA E++ + T ++
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
APE++ + DMW++G+I L++ F G + Q + I
Sbjct: 185 VAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLG--DTKQ--ETLANI--------- 230
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
A Y F + + S A D I L + KR T EAL+HP
Sbjct: 231 ------TAVSYDFDEEFFSQTS---ELAKD----FIRKLLVKETRKRLTIQEALRHPWIT 277
Query: 286 GCLQVPSMSIDSCKMRL 302
+M + L
Sbjct: 278 PVDTQQAMVRRESVVNL 294
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-45
Identities = 67/290 (23%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNHPN 62
+ +G+G FG+ + +++GE + +K L + EE LKEVK +R + HPN
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPN 68
Query: 63 IVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
++K + ++ RL F+ EY+ L ++ + + ++ ++ I G+ Y+H
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 122 YFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYIT---------------TLQY 165
HRDL S N LV N + +ADFGLA + E + +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
APEM + Y+ KVD+++ G+++ E+I P P +
Sbjct: 189 MAPEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRTMDFG 233
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPT 274
+ L P + C DP KRP+
Sbjct: 234 LNVR--------------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPS 269
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-45
Identities = 72/293 (24%), Positives = 121/293 (41%), Gaps = 42/293 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-----EVKCLRK 56
+ Y +++G G F V + +K +G A K +K+R + EV L++
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGL 114
I HPN++ L E+ + + E + L K+ +E E + QIL G+
Sbjct: 71 IQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGV 127
Query: 115 NYMHRQGYFHRDLISKNLLVSNDT-----IKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
Y+H H DL +N+++ + IKI DFGLA ++D + T ++ APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
++ + DMW++G+I L++ F G + + L + +E ++
Sbjct: 188 IVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
LAK I L DP KR T ++LQHP
Sbjct: 247 LAK--------------------------DFIRRLLVKDPKKRMTIQDSLQHP 273
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-44
Identities = 80/313 (25%), Positives = 126/313 (40%), Gaps = 55/313 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL--KEVKCLRKINN 59
+ ++ +++IG GSFG V+ A ++ E VAIK + E KEV+ L+K
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-LR 112
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
HPN ++ + + + V EY + L+ K+ E E+ LQGL Y+H
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPE--MLLMSGQ 176
HRD+ + N+L+S +K+ DFG A + P ++ T + APE + + GQ
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQ 229
Query: 177 YNSKVDMWALGLIMA-ELIT-------FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
Y+ KVD+W+LG I EL + + LY I ES
Sbjct: 230 YDGKVDVWSLG-ITCIELAERKPPLFNMNAM-------SALYHI------AQNES----- 270
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288
P LQ + S + ++ P RPT+ L+H
Sbjct: 271 ----------PALQSGHWS---EYFRN----FVDSCLQKIPQDRPTSEVLLKHRFVLRER 313
Query: 289 QVPSMS--IDSCK 299
+ I K
Sbjct: 314 PPTVIMDLIQRTK 326
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 4e-44
Identities = 72/345 (20%), Positives = 129/345 (37%), Gaps = 34/345 (9%)
Query: 2 EKYTLMKQIGEG--SFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL-KEVKCLRKIN 58
Y L+ IG+G V A K +GEYV ++ + S E L E+ + N
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQC-FSEAEVKNWCFQILQGLNY 116
HPNIV + + L+ V +M + L+ +E + +L+ L+Y
Sbjct: 85 -HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 117 MHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS--------CPPYTEYITTLQYRA 167
+H GY HR + + ++L+S D + ++ + S + L + +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 168 PEMLLMSGQ-YNSKVDMWALGLIMA-ELITFHP----------LF------PGTCEDDQL 209
PE+L + Q Y++K D++++G I A EL H L D
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVG-ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262
Query: 210 YKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDP 269
SP+ GL + P + + + +E +P
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322
Query: 270 CKRPTAAEALQHPLFQGCLQVPSMSIDSCKMRLTPSAKKSGWKAK 314
RP+A+ L H F+ + S ++ +TP G +++
Sbjct: 323 DARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQ 367
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-44
Identities = 53/327 (16%), Positives = 115/327 (35%), Gaps = 71/327 (21%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK---------- 49
+ Y +++ + +G F K+ ++ ++ A+K K + +
Sbjct: 30 INDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 50 -----EVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD--------CNLHQLMSNRKQ 96
E++ + I + + + + + +Y ++EYM+ L N
Sbjct: 88 DDFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 97 CFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLV-SNDTIKIADFGLAWEVD--- 151
+K +L +Y+H + HRD+ N+L+ N +K++DFG + +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 152 ---SCPPYTEYITTLQYRAPEMLLMSGQY-NSKVDMWALGLIMAELITFHPLFPGTCEDD 207
S T ++ PE Y +KVD+W+LG+ + + F
Sbjct: 207 IKGSR-------GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259
Query: 208 QLY-KICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMS------- 259
+L+ I ++P + + L L + +
Sbjct: 260 ELFNNIRTKN-------------------IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300
Query: 260 -LIELLCSWDPCKRPTAAEALQHPLFQ 285
++L +P +R T+ +AL+H
Sbjct: 301 DFLKLFLRKNPAERITSEDALKHEWLA 327
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-44
Identities = 40/328 (12%), Positives = 87/328 (26%), Gaps = 82/328 (25%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLR----- 55
+G+ +A +++GE + +K EV LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 56 -------------------KINNHPNIVKLQELASENYRL--YFVFEYMDCNLHQL---- 90
K +++++ + + L +F++ M NL
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 91 --MSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLA 147
S+ + Q+++ L +H G H L ++++ + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 148 WEVDSCPPYTEYITTLQYRAPEMLLMSG----------QYNSKVDMWALGLIMAELITFH 197
+ + + PE+ D WALGL++ +
Sbjct: 254 VRDGA---RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 198 PLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDE 257
D I ++ K N+
Sbjct: 311 LPI----TKDAALGGSEWI-------------------FRSCK----NIP---QPVRA-- 338
Query: 258 MSLIELLCSWDPCKRPTAAEALQHPLFQ 285
L+E + R +A++ P ++
Sbjct: 339 --LLEGFLRYPKEDRLLPLQAMETPEYE 364
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 70/294 (23%), Positives = 113/294 (38%), Gaps = 49/294 (16%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN------LKEVKCLRKIN 58
KQIG+G FG V + + VAIK+L E + +EV + +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL- 80
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
NHPNIVKL L R+ V E++ C +L+ + ++ + I G+ YM
Sbjct: 81 NHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 118 HRQGYF--HRDLISKNLLVSND------TIKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
Q HRDL S N+ + + K+ADFGL+ + + + Q+ APE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPE 196
Query: 170 MLLMSGQ-YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
+ + Y K D ++ +I+ ++T F S + + +
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY--------------SYGKIKFINMI 242
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMS-LIELLCSWDPCKRPTAAEALQH 281
L IP + +IEL S DP KRP + ++
Sbjct: 243 RE-------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 41/284 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKIN 58
+ T+ ++IG GSFG V++ G+ VA+K L + + L EV LRK
Sbjct: 23 DGQITVGQRIGSGSFGTVYKGKWH--GD-VAVKMLNVTAPT-PQQLQAFKNEVGVLRKTR 78
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
H NI+ S +L V ++ + +L+ + + F ++ + Q +G++Y+
Sbjct: 79 -HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYIT---TLQYRAPEMLLM 173
H + HRDL S N+ + ++T+KI DFGLA E ++ ++ + APE++ M
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 174 --SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
S Y+ + D++A G+++ EL+T + DQ I +G
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVG-------------- 239
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC-SWDPCKRPT 274
G P L + S M + C +RP+
Sbjct: 240 --RGSLSPDL------SKVRSNCPKRMKRLMAECLKKKRDERPS 275
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-43
Identities = 66/324 (20%), Positives = 128/324 (39%), Gaps = 64/324 (19%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYS--WEECLNLK----EVKC 53
+KY+ M +G G+FG VW A+ K+ + V +K + K+++ W E L E+
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 54 LRKINNHPNIVKLQELASENYRLYFV----------FEYMDCNLHQLMSNRKQCFSEAEV 103
L ++ H NI+K+ ++ V F ++D R E
Sbjct: 83 LSRV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID---------RHPRLDEPLA 132
Query: 104 KNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITT 162
Q++ + Y+ + HRD+ +N+++ + TIK+ DFG A ++ + + T
Sbjct: 133 SYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGT 192
Query: 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE 222
++Y APE+L+ + +++MW+LG+ + L+ F +L + A
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAA------ 240
Query: 223 SWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
P +S + MSL+ L P +R T + + P
Sbjct: 241 -------------IHPPY----LVS-------KELMSLVSGLLQPVPERRTTLEKLVTDP 276
Query: 283 LFQGCLQVPSMSIDSCKMRLTPSA 306
+ + + + P +
Sbjct: 277 WVTQPVNLADYTWEEVFRVNKPES 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-43
Identities = 60/291 (20%), Positives = 110/291 (37%), Gaps = 45/291 (15%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+ T ++G GSFG+V + KQ+G A+K ++ E ++E+ ++
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLS-S 109
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
P IV L E + E ++ +L QL+ C E + Q L+GL Y+H
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHT 168
Query: 120 QGYFHRDLISKNLLVSND--TIKIADFGLAWEVDSCPPYTEYIT------TLQYRAPEML 171
+ H D+ + N+L+S+D + DFG A + +T T + APE++
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
+ ++KVD+W+ +M ++ + KI + E
Sbjct: 229 MGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-------- 279
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
+ + P I+ +P R +A E +
Sbjct: 280 ------------PSCA---PLTAQ----AIQEGLRKEPVHRASAMELRRKV 311
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-43
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 38/281 (13%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQEL 69
+G+G++G V+ + +AIK + +R + + L+ +E+ + + H NIV+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH-EEIALHKHLK-HKNIVQYLGS 87
Query: 70 ASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAE--VKNWCFQILQGLNYMHRQGYFHRD 126
SEN + E + +L L+ ++ + E + + QIL+GL Y+H HRD
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 127 LISKNLLVSND--TIKIADFGLAWEVDSCPPYTEYIT-TLQYRAPEMLLMSGQ-YNSKVD 182
+ N+L++ +KI+DFG + + P TE T TLQY APE++ + Y D
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 183 MWALGLIMAELITFHPLFPGTCEDDQ-LYKICNAIGSPTEESWAEGLELAKAHGYKFPKL 241
+W+LG + E+ T P F E ++K+ P P
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE-----------------IP-- 248
Query: 242 QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282
++S A I DP KR A + L
Sbjct: 249 --ESMS---AEAKA----FILKCFEPDPDKRACANDLLVDE 280
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-42
Identities = 79/294 (26%), Positives = 126/294 (42%), Gaps = 53/294 (18%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN---LKEVKCLRKINNHP 61
TL + IG G FGKV++A G+ VA+KA + +E K + HP
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HP 66
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NI+ L+ + + L V E+ L++++S ++ + NW QI +G+NY+H +
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDE 124
Query: 121 GYF---HRDLISKNLLV---------SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAP 168
HRDL S N+L+ SN +KI DFGLA E + AP
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAP 183
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
E++ + ++ D+W+ G+++ EL+T F G +GL
Sbjct: 184 EVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGI----------------------DGL 220
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMS-LIELLCSWDPCKRPTAAEALQH 281
+A N L+L IPS + + L+E + DP RP+ L
Sbjct: 221 AVAYGVAM-------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 71/298 (23%), Positives = 134/298 (44%), Gaps = 50/298 (16%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLN--LKEVKCLRKINN 59
KY + +GEGS+GKV + + ++ A+K L K+++ KE++ LR++
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 60 HPNIVKLQE---LASENYRLYFVFEYMDCNLHQL---MSNRKQCFSEAEVKNWCFQILQG 113
H N+++L + + +Y V EY C + ++ + ++ F + + Q++ G
Sbjct: 65 HKNVIQLVDVLYNEEKQK-MYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDG 121
Query: 114 LNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQ----YRAP 168
L Y+H QG H+D+ NLL+ + T+KI+ G+A + + T Q ++ P
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA-DDTCRTSQGSPAFQPP 180
Query: 169 EMLLMSGQYN-SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
E+ ++ KVD+W+ G+ + + T F E D +YK+ IG
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF----EGDNIYKLFENIGK------GS- 229
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
Y P + P +D L++ + ++P KR + + QH F+
Sbjct: 230 --------YAIPG----DCG---PPLSD----LLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 73/287 (25%), Positives = 129/287 (44%), Gaps = 44/287 (15%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNHPN 62
+ ++IG GSFG V +A G VA+K L ++ + E +N L+EV ++++ HPN
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFH-AERVNEFLREVAIMKRLR-HPN 95
Query: 63 IVKLQELASENYRLYFVFEYMDC-NLHQLM--SNRKQCFSEAEVKNWCFQILQGLNYMHR 119
IV ++ L V EY+ +L++L+ S ++ E + + + +G+NY+H
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 120 QGYF--HRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYIT-TLQYRAPEMLLMSG 175
+ HR+L S NLLV T+K+ DFGL+ S ++ T ++ APE+L
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE- 214
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
N K D+++ G+I+ EL T + + +
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF--------------------- 253
Query: 236 YKFPKLQGNNLSLLIPSANDDEMS-LIELLCSWDPCKRPTAAEALQH 281
L IP + +++ +IE + +P KRP+ A +
Sbjct: 254 --------KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-42
Identities = 70/317 (22%), Positives = 125/317 (39%), Gaps = 55/317 (17%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK----EVKCLRKI 57
+Y + +G G FG V+ I+ VAIK + K RI W E N EV L+K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 58 NN-HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSN---RKQCFSEAEVKNWCFQILQG 113
++ +++L + + E Q + + + E +++ +Q+L+
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER--PEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 114 LNYMHRQGYFHRDLISKNLLVSNDT--IKIADFGL-AWEVDSCPPYTEYITTLQYRAPEM 170
+ + H G HRD+ +N+L+ + +K+ DFG A D+ YT++ T Y PE
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEW 219
Query: 171 LLMSGQYN-SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
+ +Y+ +W+LG+++ +++ F E D+ +I
Sbjct: 220 -IRYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDE--EIIRGQ------------- 259
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ-GCL 288
F + +S + LI + P RPT E HP Q L
Sbjct: 260 ------VFFRQ----RVS-------SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302
Query: 289 QVPSMSIDSCKMRLTPS 305
+ I + PS
Sbjct: 303 PQETAEIHLHSLSPGPS 319
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-42
Identities = 59/295 (20%), Positives = 108/295 (36%), Gaps = 52/295 (17%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNHPN 62
+ + IG+G FG+V+ GE VAI+ + + E+ L +EV R+ H N
Sbjct: 36 EIGELIGKGRFGQVYHGRWH--GE-VAIRLIDIERDN-EDQLKAFKREVMAYRQTR-HEN 90
Query: 63 IVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+V L + L+ ++ + K + + +I++G+ Y+H +G
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 122 YFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYIT------TLQYRAPEMLLMSG 175
H+DL SKN+ N + I DFGL L + APE++
Sbjct: 151 ILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 176 Q--------YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
++ D++ALG I EL F + ++++
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM--------------- 255
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMS-LIELLCSWDPCKRPTAAEALQH 281
G K L E+S ++ +++ +RPT + +
Sbjct: 256 -----GTGMKPN---------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 80/324 (24%), Positives = 128/324 (39%), Gaps = 81/324 (25%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNL------------- 48
+YTL +IG+GS+G V A + Y A+K L K+++
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 49 -----------KEVKCLRKINNHPNIVKLQE---LASENYRLYFVFEYMDCNLHQLMS-N 93
+E+ L+K++ HPN+VKL E +E++ LY VFE N +M
Sbjct: 74 IQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDH-LYMVFEL--VNQGPVMEVP 129
Query: 94 RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDS 152
+ SE + + + +++G+ Y+H Q HRD+ NLLV + IKIADFG++ E
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 153 CPPYTEYIT---TLQYRAPEMLL-MSGQYN-SKVDMWALGLIMAELITFHPLFPGTC--E 205
T + APE L ++ +D+WA+G+ + + G C
Sbjct: 190 SDALLS--NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF------GQCPFM 241
Query: 206 DD---QLY-KICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLI 261
D+ L+ KI + +FP P +D LI
Sbjct: 242 DERIMCLHSKIKSQA-------------------LEFPDQ---------PDIAEDLKDLI 273
Query: 262 ELLCSWDPCKRPTAAEALQHPLFQ 285
+ +P R E HP
Sbjct: 274 TRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 69/297 (23%), Positives = 113/297 (38%), Gaps = 54/297 (18%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK----EVKCLRKI 57
+Y L +G+G FG V+ + VAIK + + R+ W + EV L K+
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 58 NN---HPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQ 112
HP +++L + V E L K E + + Q++
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERP-LPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 113 GLNYMHRQGYFHRDLISKNLLVSNDT--IKIADFGL-AWEVDSCPPYTEYITTLQYRAPE 169
+ + H +G HRD+ +N+L+ K+ DFG A D PYT++ T Y PE
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPE 208
Query: 170 MLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
+ + +W+LG+++ +++ P F E DQ +I A
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIP-F----ERDQ--EILEAE------------ 249
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
FP ++S D +LI + P RP+ E L P Q
Sbjct: 250 -------LHFPA----HVS-------PDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 78/311 (25%), Positives = 130/311 (41%), Gaps = 56/311 (18%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNL--KEVKCLRKINN 59
+ Y L + IG G+ V A E VAIK + + + ++ KE++ + + +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQTSMDELLKEIQAMSQC-H 71
Query: 60 HPNIVKLQELASENYRLYFVFEYMDC--------NLHQLMSNRKQCFSEAEVKNWCFQIL 111
HPNIV L+ V + + ++ ++ E+ + ++L
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYR---- 166
+GL Y+H+ G HRD+ + N+L+ D +++IADFG V + IT + R
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG----VSAFLATGGDITRNKVRKTFV 187
Query: 167 ------APEMLLMSGQYNSKVDMWALGLIMA-ELITFHPLFPGTCEDDQ---LYKICNAI 216
APE++ Y+ K D+W+ G I A EL T + + L
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFG-ITAIELATGAAPY---HKYPPMKVLMLTLQN- 242
Query: 217 GSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA 276
P+ E+ + E+ K +G F K+ + L + DP KRPTAA
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMI--------------SLCLQK-----DPEKRPTAA 283
Query: 277 EALQHPLFQGC 287
E L+H FQ
Sbjct: 284 ELLRHKFFQKA 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-41
Identities = 60/358 (16%), Positives = 113/358 (31%), Gaps = 105/358 (29%)
Query: 1 MEKYTLMKQIGEGSFGKVWQ----------AIKK-------------------------- 24
+ + ++ +G G FG V++ AIK+
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 25 --------------------QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64
++ ++ + S + N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 65 KLQELASENYRLYFVFEYMDC-NLHQLMSNRK--QCFSEAEVKNWCFQILQGLNYMHRQG 121
+ +S LY + NL M+ R + + QI + + ++H +G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 122 YFHRDLISKN-LLVSNDTIKIADFGLA-------------WEVDSCPPYTEYITTLQYRA 167
HRDL N +D +K+ DFGL + + +T + T Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE + Y+ KVD+++LGLI+ EL + + + N
Sbjct: 245 PEQ-IHGNNYSHKVDIFSLGLILFEL--LYSFSTQMERVRIITDVRN------------- 288
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
KFP L E +++ + S P +RP A + +++ +F+
Sbjct: 289 --------LKFPL--------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-41
Identities = 76/305 (24%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINNHP 61
Y L+K IG+G+F KV A +G VAIK + K ++ +EV+ ++ + NHP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHP 74
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQGLNYMHR 119
NIVKL E+ LY + EY + ++ E E ++ QI+ + Y H+
Sbjct: 75 NIVKLFEVIETEKTLYLIMEY--ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 120 QGYFHRDLISKNLLV-SNDTIKIADFGLAWEVD-------SC--PPYTEYITTLQYRAPE 169
+ HRDL ++NLL+ ++ IKIADFG + E C PPY APE
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA---------APE 183
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
+ +VD+W+LG+I+ L++ F G + ++
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK------------- 230
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289
Y+ P +S + L++ +P KR T + ++ +
Sbjct: 231 ------YRIPF----YMS---TDCEN----LLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273
Query: 290 VPSMS 294
+
Sbjct: 274 EDELK 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 62/293 (21%), Positives = 115/293 (39%), Gaps = 40/293 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINN 59
+E + L++ +GEG++G+V A+ + + E VA+K + +R E + KE+ + + N
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKML-N 63
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
H N+VK E Y EY ++ + E + + + Q++ G+ Y+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYL 121
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYIT---TLQYRAPEMLLM 173
H G HRD+ +NLL+ D +KI+DFGLA TL Y APE+L
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY-KICNAIGSPTEESWAEGLELAK 232
+ VD+W+ G+++ ++ + + Q Y
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----------------- 224
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ + L+ + +P R T + + +
Sbjct: 225 --KTYLNPW--KKID---SAPLA----LLHKILVENPSARITIPDIKKDRWYN 266
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-40
Identities = 65/315 (20%), Positives = 128/315 (40%), Gaps = 78/315 (24%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ L++ +G G++G+V++ ++G+ AIK + EE +E+ L+K ++H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI--KQEINMLKKYSHHR 81
Query: 62 NIVKL------QELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQG 113
NI + + +L+ V E+ + + + E + C +IL+G
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 114 LNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYR------ 166
L+++H+ HRD+ +N+L++ + +K+ DFG++ ++D T+ R
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR---------TVGRRNTFIGT 192
Query: 167 ----APEMLL----MSGQYNSKVDMWALGLIMA-ELIT-------FHPLFPGTCEDDQLY 210
APE++ Y+ K D+W+LG I A E+ HP+ L+
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPM-------RALF 244
Query: 211 KICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPC 270
I P + P+L+ S IE +
Sbjct: 245 LI------PRNPA---------------PRLKSKKWS---KKFQS----FIESCLVKNHS 276
Query: 271 KRPTAAEALQHPLFQ 285
+RP + ++HP +
Sbjct: 277 QRPATEQLMKHPFIR 291
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 39/319 (12%), Positives = 79/319 (24%), Gaps = 75/319 (23%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKIN------- 58
+G+ +A +++GE + +K EV LR +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 59 --------------NHPNIVKLQELASENYR-----LYFVFEYMDCNLHQLMS------N 93
P K+ + + +F++ M NL +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 94 RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS 152
+ Q+++ L +H G H L ++++ + + F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 153 C--PPYTEYITTLQYRAPEMLLMS----GQYNSKVDMWALGLIMAELITFHPLFPGTCED 206
P + A ML D W LGL + +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD---- 319
Query: 207 DQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCS 266
++ G E P L+E
Sbjct: 320 ---------------DAALGGSEWIFRSCKNIP-----------QPVRA----LLEGFLR 349
Query: 267 WDPCKRPTAAEALQHPLFQ 285
+ R +A++ P ++
Sbjct: 350 YPKEDRLLPLQAMETPEYE 368
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 48/290 (16%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
++ + + +G G+FG V +A + + VAIK ++ E + E++ L ++N H
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES---ESERKAFIVELRQLSRVN-H 60
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQC--FSEAEVKNWCFQILQGLNYM 117
PNIVKL V EY + +L+ ++ + ++ A +WC Q QG+ Y+
Sbjct: 61 PNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 118 HR---QGYFHRDLISKNLLVSND--TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLL 172
H + HRDL NLL+ +KI DFG A ++ + T + + APE+
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVF- 175
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
Y+ K D+++ G+I+ E+IT F ++I A+
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV---------------- 217
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMS-LIELLCSWDPCKRPTAAEALQH 281
N + + L+ S DP +RP+ E ++
Sbjct: 218 ----------HNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 8e-40
Identities = 40/308 (12%), Positives = 96/308 (31%), Gaps = 64/308 (20%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
+ + +GEG+F +V++A + ++ + +K K WE + + ++ L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-PWEFYIGTQLMERLKP 123
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRK----QCFSEAEVKNWCFQIL 111
+K V E L ++ K + + V ++ ++L
Sbjct: 124 SM-QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT------------IKIADFGLAWEVDSCPP---Y 156
+ +H H D+ N ++ N + + D G + ++ P +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216
T T ++ EML +N ++D + + + ++ + + K
Sbjct: 243 TAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMK--VKNEGGECKPEGLF 299
Query: 217 -GSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA 275
P + W E ++ + C +
Sbjct: 300 RRLPHLDMWNE---------------------------------FFHVMLNIPDCHHLPS 326
Query: 276 AEALQHPL 283
+ L+ L
Sbjct: 327 LDLLRQKL 334
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-40
Identities = 49/288 (17%), Positives = 105/288 (36%), Gaps = 47/288 (16%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNHPNI 63
+ ++ E G++W+ + G + +K LK R +S + + +E LR + HPN+
Sbjct: 13 NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNV 69
Query: 64 VKLQ--ELASENYRLYFVFEYMDC-NLHQLM-SNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+ + + + +M +L+ ++ +++ + + +G+ ++H
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 120 QGYF--HRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM--S 174
L S+++++ + T +I+ + + S + + APE L
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPE 185
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
DMW+ +++ EL+T F S E LE
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADL--------------SNMEIGMKVALE----- 226
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMS-LIELLCSWDPCKRPTAAEALQH 281
L IP +S L+++ + DP KRP +
Sbjct: 227 ----------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 77/313 (24%), Positives = 139/313 (44%), Gaps = 55/313 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E + +++++GEGS+G V++AI K++G+ VAIK + + +KE+ +++ + P
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQ-CDSP 84
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
++VK +N L+ V EY ++ ++ R + +E E+ L+GL Y+H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEV-DSCPPYTEYITTLQYRAPEMLLMSGQYN 178
HRD+ + N+L++ + K+ADFG+A ++ D+ I T + APE ++ YN
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE-VIQEIGYN 203
Query: 179 SKVDMWALGLIMA-ELIT-------FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
D+W+LG I A E+ HP+ ++ I PT
Sbjct: 204 CVADIWSLG-ITAIEMAEGKPPYADIHPM-------RAIFMI------PTNPP------- 242
Query: 231 AKAHGYKFPKLQG-NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289
P + S + D ++ P +R TA + LQHP +
Sbjct: 243 --------PTFRKPELWS---DNFTD----FVKQCLVKSPEQRATATQLLQHPFVRSAKG 287
Query: 290 VPSMS--IDSCKM 300
V + I+
Sbjct: 288 VSILRDLINEAMD 300
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 79/306 (25%), Positives = 118/306 (38%), Gaps = 60/306 (19%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKC------ 53
E + K +GEGSF V A + + AIK L K+ I + +V
Sbjct: 29 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI------IKENKVPYVTRERD 82
Query: 54 -LRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQI 110
+ ++ +HP VKL ++ +LYF Y +L+ + F E + + +I
Sbjct: 83 VMSRL-DHPFFVKLYFTFQDDEKLYFGLSY--AKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 111 LQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYIT---TLQYR 166
+ L Y+H +G HRDL +N+L++ D I+I DFG A + + T QY
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 167 APEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226
+PE+L D+WALG I+ +L+ P F Y I I
Sbjct: 200 SPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPF----RAGNEYLIFQKI---------- 244
Query: 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT------AAEALQ 280
Y FP+ P A D L+E L D KR
Sbjct: 245 -----IKLEYDFPE----KFF---PKARD----LVEKLLVLDATKRLGCEEMEGYGPLKA 288
Query: 281 HPLFQG 286
HP F+
Sbjct: 289 HPFFES 294
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 62/295 (21%), Positives = 117/295 (39%), Gaps = 44/295 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINN 59
+E + L++ +GEG++G+V A+ + + E VA+K + +R E + KE+ + +N
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLN- 63
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
H N+VK E Y EY ++ + E + + + Q++ G+ Y+
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYL 121
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYIT---TLQYRAPEMLLM 173
H G HRD+ +NLL+ D +KI+DFGLA TL Y APE+L
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-- 179
Query: 174 SGQ-YN-SKVDMWALGLIMAELITFHPLFPGTCEDDQLY-KICNAIGSPTEESWAEGLEL 230
+ ++ VD+W+ G+++ ++ + + Q Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--------------- 224
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ + L+ + +P R T + + +
Sbjct: 225 ----KTYLNPW--KKID---SAPLA----LLHKILVENPSARITIPDIKKDRWYN 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-39
Identities = 82/302 (27%), Positives = 136/302 (45%), Gaps = 67/302 (22%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKINNH 60
Y + + +GEGSFGKV A ++ + VA+K + +Q + + + ++ E+ L+ + H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RH 68
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
P+I+KL ++ + + V EY L + +K+ +E E + + QI+ + Y HR
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRH 127
Query: 121 GYFHRDLISKNLLV-SNDTIKIADFGL-AWEVD------SC--PPYTEYITTLQYRAPEM 170
HRDL +NLL+ N +KIADFGL D SC P Y APE+
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA---------APEV 178
Query: 171 LLMSGQ-YN-SKVDMWALGLIMAELITFHPLFPGTCEDDQ----LY-KICNAIGSPTEES 223
+ +G+ Y +VD+W+ G+++ ++ F DD+ L+ K+ + +
Sbjct: 179 I--NGKLYAGPEVDVWSCGIVLYVMLVGRLPF-----DDEFIPNLFKKVNSCV------- 224
Query: 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283
Y P LS P A LI + DP +R T E + P
Sbjct: 225 ------------YVMPD----FLS---PGAQS----LIRRMIVADPMQRITIQEIRRDPW 261
Query: 284 FQ 285
F
Sbjct: 262 FN 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-39
Identities = 84/305 (27%), Positives = 133/305 (43%), Gaps = 68/305 (22%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKIN 58
+ Y L +G G+FGKV + +G VA+K L +Q+I S + +K E++ L+
Sbjct: 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF- 68
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HP+I+KL ++ S + V EY+ L + + E E + QIL ++Y
Sbjct: 69 RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC-KHGRVEEMEARRLFQQILSAVDYC 127
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGL-AWEVD------SC--PPYTEYITTLQYRA 167
HR HRDL +N+L+ ++ KIADFGL D SC P Y A
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA---------A 178
Query: 168 PEMLLMSGQ-YN-SKVDMWALGLIMAELITFHPLFPGTCEDDQ----LY-KICNAIGSPT 220
PE++ SG+ Y +VD+W+ G+I+ L+ F DD+ L+ KI +
Sbjct: 179 PEVI--SGRLYAGPEVDIWSCGVILYALLCGTLPF-----DDEHVPTLFKKIRGGV---- 227
Query: 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280
+ P+ L+ S L+ + DP KR T + +
Sbjct: 228 ---------------FYIPE----YLN---RSVAT----LLMHMLQVDPLKRATIKDIRE 261
Query: 281 HPLFQ 285
H F+
Sbjct: 262 HEWFK 266
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-39
Identities = 66/308 (21%), Positives = 112/308 (36%), Gaps = 55/308 (17%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINNHPNI 63
TL++ +G+G +G+VW+ + GE VA+K R SW E+ + H NI
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSW---FRETELYNTVMLR-HENI 64
Query: 64 VKL----QELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
+ + +L+ + Y + +L+ + + I GL ++H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 119 RQGYF--------HRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT-----TLQ 164
+ + HRDL SKN+LV + IAD GLA + T +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 165 YRAPEML-----LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP 219
Y APE+L + +VD+WA GL++ E+ + +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEM---SLIELL--CSW--DPCKR 272
E+ + IP+ + SL +L+ C W +P R
Sbjct: 243 FEDMRKVVCV--------------DQQRPNIPNRWFSDPTLTSLAKLMKEC-WYQNPSAR 287
Query: 273 PTAAEALQ 280
TA +
Sbjct: 288 LTALRIKK 295
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-39
Identities = 71/303 (23%), Positives = 138/303 (45%), Gaps = 56/303 (18%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINNH 60
E + ++ ++G+G+FGKV++A K++G A K ++ + E+ + E++ L +H
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV--EIEILATC-DH 75
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
P IVKL + +L+ + E+ + +M + +E +++ C Q+L+ LN++H
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEV-DSCPPYTEYITTLQYRAPEMLLMS--- 174
+ HRDL + N+L++ + I++ADFG++ + + +I T + APE+++
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 175 -GQYNSKVDMWALGLIMA-ELIT-------FHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
Y+ K D+W+LG I E+ +P+ L KI +
Sbjct: 196 DTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPM-------RVLLKI------AKSDP-- 239
Query: 226 EGLELAKAHGYKFPKL-QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284
P L + S D +++ +P RP+AA+ L+HP
Sbjct: 240 -------------PTLLTPSKWS---VEFRD----FLKIALDKNPETRPSAAQLLEHPFV 279
Query: 285 QGC 287
Sbjct: 280 SSI 282
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 67/309 (21%), Positives = 114/309 (36%), Gaps = 57/309 (18%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINNHPNI 63
++KQIG+G +G+VW + GE VA+K SW E+ + H NI
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASW---FRETEIYQTVLMR-HENI 93
Query: 64 VKLQELASENY------RLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
+ +A++ +LY + +Y + +L+ + + + + + GL +
Sbjct: 94 LGF--IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCH 149
Query: 117 MHRQGYF--------HRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT-----T 162
+H + + HRDL SKN+LV + T IAD GLA + S + T
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 163 LQYRAPEML-----LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG 217
+Y PE+L Q DM++ GLI+ E+ E Y
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 218 SPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDE------MSLIELLCSWDPCK 271
E ++ + K L P+ + L+ + +P
Sbjct: 270 PSYE-------DMREIVCIK-------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 272 RPTAAEALQ 280
R TA +
Sbjct: 316 RLTALRVKK 324
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 84/313 (26%), Positives = 140/313 (44%), Gaps = 55/313 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+KYT ++IG+G+ G V+ A+ +G+ VAI+ + + +E L + E+ +R+ N +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRE-NKNP 77
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV + L+ V EY+ +L +++ C E ++ C + LQ L ++H
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN 135
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEV-DSCPPYTEYITTLQYRAPEMLLMSGQYN 178
HRD+ S N+L+ D ++K+ DFG ++ + + T + APE ++ Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 194
Query: 179 SKVDMWALGLIMA-ELI-------TFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
KVD+W+LG IMA E+I +PL LY I T +
Sbjct: 195 PKVDIWSLG-IMAIEMIEGEPPYLNENPL-------RALYLI------ATNGT------- 233
Query: 231 AKAHGYKFPKLQG-NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289
P+LQ LS D + D KR +A E LQH +
Sbjct: 234 --------PELQNPEKLS---AIFRD----FLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278
Query: 290 VPSMS--IDSCKM 300
+ S++ I + K
Sbjct: 279 LSSLTPLIAAAKE 291
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 78/313 (24%), Positives = 132/313 (42%), Gaps = 53/313 (16%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+IGEGS G V A +K SG VA+K + R E L EV +R H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE-LLFNEVVIMRD-YQHF 102
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
N+V++ + L+ + E++ L ++S +E ++ C +LQ L Y+H Q
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQ 160
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEV-DSCPPYTEYITTLQYRAPEMLLMSGQYN 178
G HRD+ S ++L++ D +K++DFG ++ P + T + APE++ S Y
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-YA 219
Query: 179 SKVDMWALGLIMA-ELI-------TFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
++VD+W+LG IM E++ + P+ + ++
Sbjct: 220 TEVDIWSLG-IMVIEMVDGEPPYFSDSPV-------QAMKRL------RDSPP------- 258
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290
PKL+ + + P D +E + DP +R TA E L HP
Sbjct: 259 --------PKLKNS--HKVSPVLRD----FLERMLVRDPQERATAQELLDHPFLLQTGLP 304
Query: 291 PSMS--IDSCKMR 301
+ I + +
Sbjct: 305 ECLVPLIQLYRKQ 317
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-38
Identities = 77/297 (25%), Positives = 135/297 (45%), Gaps = 56/297 (18%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIK--ALKQRIYSWEECLNLKEVKCLRKINN 59
E +T +++IG+GSFG+V++ I ++ + VAIK L++ E+ +E+ L + +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI--QQEITVLSQC-D 78
Query: 60 HPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
P + K ++ +L+ + EY+ + L+ E ++ +IL+GL+Y+H
Sbjct: 79 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH 136
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGL-AWEVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
+ HRD+ + N+L+S +K+ADFG+ D+ ++ T + APE ++
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSA 195
Query: 177 YNSKVDMWALGLIMA-ELIT-------FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
Y+SK D+W+LG I A EL HP+ L+ I P
Sbjct: 196 YDSKADIWSLG-ITAIELARGEPPHSELHPM-------KVLFLI------PKNNP----- 236
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
P L+G N S + +E + +P RPTA E L+H
Sbjct: 237 ----------PTLEG-NYS---KPLKE----FVEACLNKEPSFRPTAKELLKHKFIL 275
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-38
Identities = 69/308 (22%), Positives = 120/308 (38%), Gaps = 55/308 (17%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINNHPNI 63
L + IG+G FG+VW+ + GE VA+K R SW E+ + H NI
Sbjct: 45 VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSW---FREAEIYQTVMLR-HENI 98
Query: 64 VKL----QELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
+ + +L+ V +Y + +L + + + + GL ++H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 119 RQGYF--------HRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT-----TLQ 164
+ HRDL SKN+LV + T IAD GLA DS + T +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 165 YRAPEML-----LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP 219
Y APE+L + + + D++A+GL+ E+ + + Y++ P
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED----YQLPYYDLVP 272
Query: 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSA---NDDEMSLIELL--CSW--DPCKR 272
++ S E+ K + L IP+ + + +++ C W + R
Sbjct: 273 SDPSVE---EMRKVVCEQ-------KLRPNIPNRWQSCEALRVMAKIMREC-WYANGAAR 321
Query: 273 PTAAEALQ 280
TA +
Sbjct: 322 LTALRIKK 329
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
T+ ++G G +G+V++ + K+ VA+K LK+ EE LKE +++I HP
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEI-KHP 276
Query: 62 NIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
N+V+L + + Y + E+M L L +Q S + QI + Y+ +
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 120 QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR--APEMLLMSGQ 176
+ + HR+L ++N LV N +K+ADFGL+ + + APE L +
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 395
Query: 177 YNSKVDMWALGLIMAELITF 196
++ K D+WA G+++ E+ T+
Sbjct: 396 FSIKSDVWAFGVLLWEIATY 415
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 66/306 (21%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC------- 53
++++ +K +G GSFG+V K+SG + A+K L + ++ + LK+++
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRI 94
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQIL 111
L+ + N P +VKL+ +N LY V EY ++ S R FSE + + QI+
Sbjct: 95 LQAV-NFPFLVKLEFSFKDNSNLYMVMEY--VAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-----CPPYTEYITTLQY 165
Y+H +RDL +NLL+ I++ DFG A V C T +
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-------GTPEA 204
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
APE++L G YN VD WALG+++ E+ +P F DQ +I I
Sbjct: 205 LAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPF----FADQPIQIYEKI--------- 250
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR-----PTAAEALQ 280
+ +FP + S D L+ L D KR +
Sbjct: 251 ------VSGKVRFPS----HFS---SDLKD----LLRNLLQVDLTKRFGNLKNGVNDIKN 293
Query: 281 HPLFQG 286
H F
Sbjct: 294 HKWFAT 299
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 89/321 (27%), Positives = 140/321 (43%), Gaps = 68/321 (21%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKIN 58
+ Y L +G G+FGKV + +G VA+K L +Q+I S + ++ E++ L+
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF- 73
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HP+I+KL ++ S ++ V EY+ L + + E E + QIL G++Y
Sbjct: 74 RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYC 132
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGL-AWEVD------SC--PPYTEYITTLQYRA 167
HR HRDL +N+L+ ++ KIADFGL D SC P Y A
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA---------A 183
Query: 168 PEMLLMSGQ-YN-SKVDMWALGLIMAELITFHPLFPGTCEDDQ----LY-KICNAIGSPT 220
PE++ SG+ Y +VD+W+ G+I+ L+ F DD L+ KIC+ I
Sbjct: 184 PEVI--SGRLYAGPEVDIWSSGVILYALLCGTLPF-----DDDHVPTLFKKICDGI---- 232
Query: 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280
+ P+ L+ PS L++ + DP KR T + +
Sbjct: 233 ---------------FYTPQ----YLN---PSVIS----LLKHMLQVDPMKRATIKDIRE 266
Query: 281 HPLFQGCLQVPSMSIDSCKMR 301
H F+ L D
Sbjct: 267 HEWFKQDLPKYLFPEDPSYSS 287
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 76/294 (25%), Positives = 118/294 (40%), Gaps = 42/294 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLK-EVKCLRKIN 58
++Y +K IG G+FG K + E VA+K + + +E N++ E+ R +
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DE--NVQREIINHRSL- 73
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HPNIV+ +E+ L + EY L++ + N FSE E + + Q+L G++Y
Sbjct: 74 RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYC 132
Query: 118 HRQGYFHRDLISKNLLVSNDT---IKIADFGL-AWEVDSCPPYTEYITTLQYRAPEMLLM 173
H HRDL +N L+ +KI DFG V P + + T Y APE+L
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL-- 189
Query: 174 SGQ-YN-SKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
Q Y+ D+W+ G+ + ++ F E K I
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI--------------- 234
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ Y P +S P LI + DP R + E H F
Sbjct: 235 LSVKYSIPD--DIRIS---PECCH----LISRIFVADPATRISIPEIKTHSWFL 279
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 73/310 (23%), Positives = 124/310 (40%), Gaps = 53/310 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINNH 60
L++ G FG VW+A EYVA+K + SW+ N EV L + H
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQ---NEYEVYSLPGMK-H 77
Query: 61 PNIVKL----QELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
NI++ + S + L+ + + + +L + + S E+ + + +GL
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLA 135
Query: 116 YMH----------RQGYFHRDLISKNLLVSND-TIKIADFGLA--WEVDSCPPYTEYIT- 161
Y+H + HRD+ SKN+L+ N+ T IADFGLA +E T
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 162 TLQYRAPEML----LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG 217
T +Y APE+L ++DM+A+GL++ EL + G ++ L
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 218 SPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSA---NDDEMSLIELL--CSW--DPC 270
P+ E ++ + +K ++ + L E + C W D
Sbjct: 256 HPSLE------DMQEVVVHK-------KKRPVLRDYWQKHAGMAMLCETIEEC-WDHDAE 301
Query: 271 KRPTAAEALQ 280
R +A +
Sbjct: 302 ARLSAGCVGE 311
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 71/308 (23%), Positives = 128/308 (41%), Gaps = 70/308 (22%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC------- 53
++ + +++ +G GSFG+V + +G Y A+K LK+ E + LK+V+
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDERLM 59
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQIL 111
L + HP I+++ + +++ + +Y +L S + Q F K + ++
Sbjct: 60 LSIV-THPFIIRMWGTFQDAQQIFMIMDY--IEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYT-----EYITTLQY 165
L Y+H + +RDL +N+L+ + IKI DFG A V YT +YI
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYTLCGTPDYI----- 170
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLY-KICNAIGSPTEES 223
APE++ YN +D W+ G+++ E++ + F + + Y KI NA
Sbjct: 171 -APEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPF--YDSNTMKTYEKILNAE------- 219
Query: 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR-----PTAAEA 278
+FP + D L+ L + D +R +
Sbjct: 220 ------------LRFPP----FFN---EDVKD----LLSRLITRDLSQRLGNLQNGTEDV 256
Query: 279 LQHPLFQG 286
HP F+
Sbjct: 257 KNHPWFKE 264
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 63/287 (21%), Positives = 124/287 (43%), Gaps = 38/287 (13%)
Query: 5 TLMKQIGEGSFGKVWQA----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
++Q+G+G+FG V ++ +GE VA+K L+ +E++ L+ + H
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF-EREIEILKSLQ-H 70
Query: 61 PNIVKLQE--LASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
NIVK + ++ L + EY+ +L + K+ ++ + QI +G+ Y+
Sbjct: 71 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEM 170
+ Y HRDL ++N+LV + + +KI DFGL + + + APE
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--FKVKEPGESPIFWYAPES 188
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
L +++ D+W+ G+++ EL T+ + IG+ + L
Sbjct: 189 LTE-SKFSVASDVWSFGVVLYELFTY-----IEKSKSPPAEFMRMIGNDKQGQMI-VFHL 241
Query: 231 AKA--HGYKFPKLQGNNLSLLIPSANDDEMSLIELLC-SWDPCKRPT 274
+ + + P+ P DE+ +I C + + +RP+
Sbjct: 242 IELLKNNGRLPR----------PDGCPDEIYMIMTECWNNNVNQRPS 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-36
Identities = 73/305 (23%), Positives = 121/305 (39%), Gaps = 56/305 (18%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCL---RKI 57
E Y ++K IG G+FG+V K + + A+K L + E + + R I
Sbjct: 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-----FEMIKRSDSAFFWEERDI 122
Query: 58 ---NNHPNIVKLQELASENYRLYFVFEYM---DCNLHQLMSNRKQCFSEAEVKNWCFQIL 111
N P +V+L ++ LY V EYM D L LMSN E + + +++
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD--LVNLMSNYD--VPEKWARFYTAEVV 178
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYIT--TLQYRAP 168
L+ +H G+ HRD+ N+L+ +K+ADFG +++ T Y +P
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238
Query: 169 EMLLMSG---QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
E+L G Y + D W++G+ + E++ F D L + I
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF----YADSLVGTYSKI--------- 285
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIE-LLCSWDPCKR---PTAAEALQH 281
+ + FP N++S + +LI L D R E +H
Sbjct: 286 ----MNHKNSLTFPD--DNDIS-------KEAKNLICAFLT--DREVRLGRNGVEEIKRH 330
Query: 282 PLFQG 286
F+
Sbjct: 331 LFFKN 335
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-36
Identities = 65/285 (22%), Positives = 123/285 (43%), Gaps = 34/285 (11%)
Query: 5 TLMKQIGEGSFGKVWQA----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
++Q+G+G+FG V ++ +GE VA+K L+ +E++ L+ + H
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF-EREIEILKSLQ-H 101
Query: 61 PNIVKLQE--LASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
NIVK + ++ L + EY+ +L + K+ ++ + QI +G+ Y+
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEM 170
+ Y HRDL ++N+LV + + +KI DFGL + Y Y APE
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--YKVKEPGESPIFWYAPES 219
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
L +++ D+W+ G+++ EL T+ + + G E L+
Sbjct: 220 LTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK- 277
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC-SWDPCKRPT 274
+ + P+ P DE+ +I C + + +RP+
Sbjct: 278 ---NNGRLPR----------PDGCPDEIYMIMTECWNNNVNQRPS 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-36
Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 36/286 (12%)
Query: 5 TLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
++ +GEG FGKV +GE VA+K+LK KE++ LR + H
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-H 82
Query: 61 PNIVKLQELASENYR--LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
NIVK + + +E+ + + E++ +L + + K + + + QI +G++Y+
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEM 170
+ Y HRDL ++N+LV S +KI DFGL +++ Y Y APE
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY--YTVKDDRDSPVFWYAPEC 200
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE-SWAEGLE 229
L+ ++ D+W+ G+ + EL+T+ + + IG + + +
Sbjct: 201 LMQ-SKFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC-SWDPCKRPT 274
K G + P P DE+ + C + P R +
Sbjct: 255 TLK-EGKRLPC----------PPNCPDEVYQLMRKCWEFQPSNRTS 289
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 61/303 (20%), Positives = 117/303 (38%), Gaps = 56/303 (18%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC------- 53
+ + +++ IG+GSFGKV K + + A+K + + ++C+ EV+
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-----QKCVERNEVRNVFKELQI 68
Query: 54 LRKINNHPNIVKL----QELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWC 107
++ + HP +V L Q + ++ V + + L + F E VK +
Sbjct: 69 MQGL-EHPFLVNLWYSFQ----DEEDMFMVVDLL--LGGDLRYHLQQNVHFKEETVKLFI 121
Query: 108 FQILQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYR 166
+++ L+Y+ Q HRD+ N+L+ + I DF +A + T T Y
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 167 APEMLLMSGQ--YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224
APEM Y+ VD W+LG+ EL+ + +I +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTF-------- 232
Query: 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ-HPL 283
+ +P + + + +SL++ L +P +R + +Q P
Sbjct: 233 -------ETTVVTYP-----------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274
Query: 284 FQG 286
Sbjct: 275 MND 277
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-35
Identities = 61/294 (20%), Positives = 114/294 (38%), Gaps = 38/294 (12%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKIN 58
+ + ++G G+ G+VW+ +++G +A+K + R +E L ++ + K +
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSH 81
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
+ P IV+ N ++ E M +L + E + I++ L Y+
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 119 RQ-GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPE----MLL 172
+ G HRD+ N+L+ IK+ DFG++ + Y APE
Sbjct: 142 EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLELA 231
Y+ + D+W+LG+ + EL T + D + L K+ P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------ 247
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
P L G+ + D S ++ + D KRP + L+H +
Sbjct: 248 -------PLLPGH------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 69/306 (22%), Positives = 123/306 (40%), Gaps = 54/306 (17%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCL---RKI 57
E + ++K IG G+FG+V K + + A+K L + E L E C R +
Sbjct: 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK-----WEMLKRAETACFREERDV 127
Query: 58 ---NNHPNIVKLQELASENYRLYFVFEYM---DCNLHQLMSNRKQCFSEAEVKNWCFQIL 111
+ I L ++ LY V +Y D L L+S + E + + +++
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD--LLTLLSKFEDRLPEEMARFYLAEMV 185
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYIT--TLQYRAP 168
++ +H+ Y HRD+ N+L+ + I++ADFG ++ + T Y +P
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 169 EMLL----MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224
E+L G+Y + D W+LG+ M E++ F + L + I
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF----YAESLVETYGKI-------- 293
Query: 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIE-LLCSWDPCKR---PTAAEALQ 280
+ ++FP ++ + +A D LI L+C R + +
Sbjct: 294 -----MNHKERFQFPT----QVTDVSENAKD----LIRRLIC--SREHRLGQNGIEDFKK 338
Query: 281 HPLFQG 286
HP F G
Sbjct: 339 HPFFSG 344
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 80/360 (22%), Positives = 135/360 (37%), Gaps = 82/360 (22%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN--- 58
+Y +++++G G F VW + Q ++VA+K +K + E L+ E++ L+ +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSD 94
Query: 59 -NHPN---IVKLQ---ELASENYR-LYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQ 109
N PN +V+L +++ N + VFE + +L + + + Q VK Q
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 110 ILQGLNYMHRQ-GYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPY------------ 156
+LQGL+Y+H + H D+ +N+L+S + I
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 157 ------------------------------------TEYITTLQYRAPEMLLMSGQYNSK 180
TE I T QYR+ E+L+ SG YN+
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG-YNTP 273
Query: 181 VDMWALGLIMAELITFHPLFPG------TCEDDQLYKICNAIGSPTEESWAEG------- 227
D+W+ + EL T LF T ++D + I +G + G
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333
Query: 228 ---LELAKAHGYKFPKLQGNNLSLLIPSANDDEM--SLIELLCSWDPCKRPTAAEALQHP 282
+L K L + S + + + P KR TAAE L+HP
Sbjct: 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 70/308 (22%), Positives = 114/308 (37%), Gaps = 56/308 (18%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCL---RKI 57
+ + ++K IG G+F +V KQ+G+ A+K + + + L EV C R +
Sbjct: 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNK-----WDMLKRGEVSCFREERDV 114
Query: 58 ---NNHPNIVKLQELASENYRLYFVFEYM---DCNLHQLMSNRKQCFSEAEVKNWCFQIL 111
+ I +L + LY V EY D +S + + + +I+
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTL--LSKFGERIPAEMARFYLAEIV 172
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYIT--TLQYRAP 168
++ +HR GY HRD+ N+L+ I++ADFG ++ + + T Y +P
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 169 EMLLMSG------QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE 222
E+L G Y + D WALG+ E+ F D + I
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF----YADSTAETYGKI------ 282
Query: 223 SWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIE-LLCSWDPCKR---PTAAEA 278
+ P + A D I+ LLC P R A +
Sbjct: 283 -------VHYKEHLSLPL-VDEGVP---EEARD----FIQRLLC--PPETRLGRGGAGDF 325
Query: 279 LQHPLFQG 286
HP F G
Sbjct: 326 RTHPFFFG 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L +QIG G+FG+V+ + VA+K+ ++ + + L+E + L++ +HP
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHP 172
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV+L + ++ +Y V E + + + + G+ Y+ +
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 121 GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR-------APEMLL 172
HRDL ++N LV+ + +KI+DFG++ E Y + R APE L
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD----GVYAASGGLRQVPVKWTAPEALN 288
Query: 173 MSGQYNSKVDMWALGLIMAELITF 196
G+Y+S+ D+W+ G+++ E +
Sbjct: 289 Y-GRYSSESDVWSFGILLWETFSL 311
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L ++G+G FG+VW + VAIK LK S E L +E + ++K+ H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL--QEAQVMKKLR-HE 322
Query: 62 NIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+V+L + SE +Y V EYM L L + ++ + QI G+ Y+ R
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 120 QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR--APEMLLMSGQ 176
Y HRDL + N+LV N K+ADFGLA ++ + APE L G+
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 440
Query: 177 YNSKVDMWALGLIMAELITF 196
+ K D+W+ G+++ EL T
Sbjct: 441 FTIKSDVWSFGILLTELTTK 460
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-35
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
T+ ++G G +G+V++ + K+ VA+K LK+ EE LKE +++I HP
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEI-KHP 69
Query: 62 NIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
N+V+L + + Y + E+M L L +Q S + QI + Y+ +
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 120 QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEMLL 172
+ + HRDL ++N LV N +K+ADFGL+ + Y + APE L
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWTAPESLA 185
Query: 173 MSGQYNSKVDMWALGLIMAELITF 196
+++ K D+WA G+++ E+ T+
Sbjct: 186 Y-NKFSIKSDVWAFGVLLWEIATY 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 82/300 (27%), Positives = 129/300 (43%), Gaps = 54/300 (18%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC------- 53
+E + L K +G+GSFGKV+ A K++ ++ AIKALK+ + L +V+C
Sbjct: 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-----DVVLMDDDVECTMVEKRV 70
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQIL 111
L HP + + L+FV EY N LM F + + +I+
Sbjct: 71 LSLAWEHPFLTHMFCTFQTKENLFFVMEY--LNGGDLMYHIQSCHKFDLSRATFYAAEII 128
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYIT---TLQYRA 167
GL ++H +G +RDL N+L+ D IKIADFG+ E + + T T Y A
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGTPDYIA 186
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE+LL YN VD W+ G+++ E++ F G E++ + I
Sbjct: 187 PEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------ 233
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ-HPLFQG 286
+P+ L + L+ L +P KR ++ HPLF+
Sbjct: 234 -NP------FYPR----WLE-------KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L ++G+G FG+VW + VAIK LK S E L +E + ++K+ H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL--QEAQVMKKLR-HE 239
Query: 62 NIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+V+L + SE +Y V EYM L L + ++ + QI G+ Y+ R
Sbjct: 240 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 120 QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR--APEMLLMSGQ 176
Y HRDL + N+LV N K+ADFGLA ++ + APE L G+
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 357
Query: 177 YNSKVDMWALGLIMAELITF 196
+ K D+W+ G+++ EL T
Sbjct: 358 FTIKSDVWSFGILLTELTTK 377
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 56/302 (18%), Positives = 115/302 (38%), Gaps = 21/302 (6%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+ + + ++G G+ G V++ K SG +A K + I ++E++ L + N
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNS 90
Query: 61 PNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
P IV + + E+MD L Q++ + E + +++GL Y+
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 120 QGY-FHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
+ HRD+ N+LV++ IK+ DFG++ ++ + ++ T Y +PE L + Y
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTH-Y 207
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
+ + D+W++GL + E+ P + + E+ +
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 238 FPKLQGNN--LSLL-------IPSANDDEMS-----LIELLCSWDPCKRPTAAEALQHPL 283
+ LL P S + +P +R + + H
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 284 FQ 285
+
Sbjct: 328 IK 329
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 31/232 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC------- 53
++ + ++ +G+GSFGKV A K++G+ A+K LK+ + L +V+C
Sbjct: 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK-----DVILQDDDVECTMTEKRI 76
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQIL 111
L NHP + +L RL+FV E+ N LM + + F EA + + +I+
Sbjct: 77 LSLARNHPFLTQLFCCFQTPDRLFFVMEF--VNGGDLMFHIQKSRRFDEARARFYAAEII 134
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWE--VDSCPPYT-----EYITTL 163
L ++H +G +RDL N+L+ ++ K+ADFG+ E + T +YI
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYI--- 191
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNA 215
APE+L Y VD WA+G+++ E++ H F EDD I N
Sbjct: 192 ---APEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 70/307 (22%), Positives = 126/307 (41%), Gaps = 60/307 (19%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKC------ 53
M +++ + IG G FG+V+ K +G+ A+K L K+RI +
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI------KMKQGETLALNERI 241
Query: 54 -LRKINN--HPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCF 108
L ++ P IV + +L F+ + M N L ++ FSEA+++ +
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMRFYAA 299
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYRA 167
+I+ GL +MH + +RDL N+L+ ++I+D GLA + P+ + T Y A
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMA 358
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD--QLY-KICNAIGSPTEESW 224
PE+L Y+S D ++LG ++ +L+ H F D ++
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------- 409
Query: 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR----PTAAEAL- 279
+ + P + S + SL+E L D +R A+ +
Sbjct: 410 ----AV------ELPD----SFS-------PELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448
Query: 280 QHPLFQG 286
+ P F+
Sbjct: 449 ESPFFRS 455
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 42/298 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSW-EECLNLKEVKCLRKIN 58
+ + +G+G FG+V + +G+ A K L K+RI E + L E + L K+
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV- 241
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCN----LHQLMSNRKQCFSEAEVKNWCFQILQGL 114
N +V L L V M N + + F EA + +I GL
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLM--NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 115 NYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
+HR+ +RDL +N+L+ + I+I+D GLA V + T+ Y APE++
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
Y D WALG ++ E+I F + + ++ + E
Sbjct: 360 ER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE------------ 406
Query: 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR-----PTAAEALQHPLFQG 286
++ + S SL L DP +R +A E +HPLF+
Sbjct: 407 ---EYSE----RFS-------PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 31/232 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC------- 53
+ + + +G+GSFGKV + +K + E A+K LK+ + + +V+C
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEKRV 73
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQIL 111
L P + +L RLYFV EY N LM + F E + +I
Sbjct: 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEY--VNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWE--VDSCPPYT-----EYITTL 163
GL ++ +G +RDL N+++ ++ IKIADFG+ E D T +YI
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI--- 188
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNA 215
APE++ Y VD WA G+++ E++ F G ED+ I
Sbjct: 189 ---APEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 68/287 (23%), Positives = 121/287 (42%), Gaps = 39/287 (13%)
Query: 5 TLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+ Q+G+G+FG V +G VA+K L+ + +E++ L+ ++
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF-QREIQILKALH-S 83
Query: 61 PNIVKLQELASENYR--LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
IVK + ++ R L V EY+ L + + + + + QI +G+ Y+
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEM 170
+ HRDL ++N+LV S +KIADFGLA + Y Y+ + APE
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY--YVVREPGQSPIFWYAPES 201
Query: 171 LLMSGQYNSKVDMWALGLIMAELITF--HPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228
L ++ + D+W+ G+++ EL T+ P + + + + L
Sbjct: 202 LSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP------ALSRLL 254
Query: 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC-SWDPCKRPT 274
EL + G + P P A E+ + LC + P RP+
Sbjct: 255 ELLE-EGQRLPA----------PPACPAEVHELMKLCWAPSPQDRPS 290
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-34
Identities = 73/286 (25%), Positives = 117/286 (40%), Gaps = 38/286 (13%)
Query: 5 TLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
++ +GEG FGKV +GE VA+KALK +E+ LR + H
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-H 92
Query: 61 PNIVKLQELASENYR--LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
+I+K + + L V EY+ +L + + A++ + QI +G+ Y+
Sbjct: 93 EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYL 150
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEM 170
H Q Y HRDL ++N+L+ ++ +KI DFGLA V Y Y APE
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY--YRVREDGDSPVFWYAPEC 208
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE-SWAEGLE 229
L ++ D+W+ G+ + EL+T K IG + + E
Sbjct: 209 LKE-YKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC-SWDPCKRPT 274
L + G + P+ P E+ + C + RPT
Sbjct: 263 LLE-RGERLPR----------PDKCPAEVYHLMKNCWETEASFRPT 297
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 60/295 (20%), Positives = 111/295 (37%), Gaps = 39/295 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+ + ++G G++G V + SG+ +A+K ++ + S E+ L ++ + +
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNLHQLM---SNRKQCFSEAEVKNWCFQILQGLNYM 117
P V ++ E MD +L + ++ Q E + I++ L ++
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 118 HRQGYF-HRDLISKNLLVSND-TIKIADFGLAWE-VDSCPPYTEYITTLQYRAPEMLLMS 174
H + HRD+ N+L++ +K+ DFG++ VD Y APE +
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-DAGCKPYMAPERINPE 184
Query: 175 GQ---YNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLEL 230
Y+ K D+W+LG+ M EL + QL ++
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE--EPS----------- 231
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
P+L + S D + +RPT E +QHP F
Sbjct: 232 --------PQLPADKFS---AEFVD----FTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-34
Identities = 66/231 (28%), Positives = 106/231 (45%), Gaps = 30/231 (12%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCL---RKI 57
M + +K +G+G+FGKV +K +G Y A+K L++ E + EV ++
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-----EVIIAKDEVAHTVTESRV 58
Query: 58 ---NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQ 112
HP + L+ + RL FV EY N +L +R++ F+E + + +I+
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEY--ANGGELFFHLSRERVFTEERARFYGAEIVS 116
Query: 113 GLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWE--VDSCPPYT-----EYITTLQ 164
L Y+H + +RD+ +NL++ D IKI DFGL E D T EY+
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL---- 172
Query: 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNA 215
APE+L + Y VD W LG++M E++ F + I
Sbjct: 173 --APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 8e-34
Identities = 79/307 (25%), Positives = 118/307 (38%), Gaps = 65/307 (21%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC------- 53
+ +K IG+GSFGKV A K + A+K L++ + L KE K
Sbjct: 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQK-----KAILKKKEEKHIMSERNV 91
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQIL 111
L K HP +V L +LYFV +Y+ N +L R++CF E + + +I
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYI--NGGELFYHLQRERCFLEPRARFYAAEIA 149
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWE--VDSCPPYT-----EYITTL 163
L Y+H +RDL +N+L+ + I + DFGL E + T EY+
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYL--- 206
Query: 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEES 223
APE+L Y+ VD W LG ++ E++ P F + I N
Sbjct: 207 ---APEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-------- 254
Query: 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR----PTAAEAL 279
L + N++ + L+E L D KR E
Sbjct: 255 -----PL------QLKP----NIT-------NSARHLLEGLLQKDRTKRLGAKDDFMEIK 292
Query: 280 QHPLFQG 286
H F
Sbjct: 293 SHVFFSL 299
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-34
Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 5 TLMKQIGEGSFGKVWQAI-KKQSGEY--VAIKALKQRIYSWEECLN--LKEVKCLRKINN 59
L++++G+GSFG V + SG+ VA+K LK + S E ++ ++EV + ++
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD- 79
Query: 60 HPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
H N+++L + + V E +L + + F + + Q+ +G+ Y+
Sbjct: 80 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 119 RQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEML 171
+ + HRDL ++NLL+ + D +KI DFGL + + Y+ + APE L
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAPESL 196
Query: 172 LMSGQYNSKVDMWALGLIMAELITF 196
++ D W G+ + E+ T+
Sbjct: 197 KT-RTFSHASDTWMFGVTLWEMFTY 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 23/223 (10%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC------- 53
++ + L++ IG GS+ KV K++ A+K +K+ E + +++
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK-----ELVNDDEDIDWVQTEKHV 62
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQIL 111
+ +NHP +V L RL+FV EY N LM R++ E + + +I
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEY--VNGGDLMFHMQRQRKLPEEHARFYSAEIS 120
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYIT---TLQYRA 167
LNY+H +G +RDL N+L+ ++ IK+ D+G+ E P T T T Y A
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS-TFCGTPNYIA 178
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY 210
PE+L Y VD WALG++M E++ F D
Sbjct: 179 PEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 73/304 (24%), Positives = 119/304 (39%), Gaps = 51/304 (16%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCL---RK 56
+ + + +G G FG+V+ K +G+ A K L K+R+ K + +K
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL------KKRKGYQGAMVEKK 237
Query: 57 I---NNHPNIVKLQELASENYRLYFVFEYM---DCNLH-QLMSNRKQCFSEAEVKNWCFQ 109
I + IV L L V M D H + F E + Q
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTE-YITTLQYRA 167
I+ GL ++H++ +RDL +N+L+ +D ++I+D GLA E+ + T+ Y T + A
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE+LL Y+ VD +ALG+ + E+I F E + ++ +
Sbjct: 358 PELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV------ 410
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR----PTAAEAL-QHP 282
+P S E L DP KR + + L HP
Sbjct: 411 ---------TYPD----KFS-------PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450
Query: 283 LFQG 286
LF+
Sbjct: 451 LFRD 454
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+K +G G+FG V++ + GE VAIK L++ L E + ++ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-N 76
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
P++ +L + + + + + M L + K + NWC QI +G+NY+
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 120 QGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEMLL 172
+ HRDL ++N+LV + +KI DFGLA + + + + A E +L
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKWMALESIL 192
Query: 173 MSGQYNSKVDMWALGLIMAELITF 196
Y + D+W+ G+ + EL+TF
Sbjct: 193 H-RIYTHQSDVWSYGVTVWELMTF 215
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64
T +++IG G FG V + VAIK +++ S E+ + +E + + K++ HP +V
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFI--EEAEVMMKLS-HPKLV 66
Query: 65 KLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYF 123
+L + E + V E+M+ L + ++ F+ + C + +G+ Y+
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 124 HRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEMLLMSGQ 176
HRDL ++N LV N IK++DFG+ V +Y ++ + +PE+ +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWASPEVFSF-SR 181
Query: 177 YNSKVDMWALGLIMAELITF 196
Y+SK D+W+ G++M E+ +
Sbjct: 182 YSSKSDVWSFGVLMWEVFSE 201
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 55/198 (27%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64
L++ IG+G FG V + G VA+K +K + L E + ++ H N+V
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAF---LAEASVMTQLR-HSNLV 249
Query: 65 KLQELASENY-RLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
+L + E LY V EYM +L L S + + + + + + Y+
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 122 YFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR--APEMLLMSGQYN 178
+ HRDL ++N+LVS ++ K++DFGL E T+ L + APE L +++
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALRE-KKFS 364
Query: 179 SKVDMWALGLIMAELITF 196
+K D+W+ G+++ E+ +F
Sbjct: 365 TKSDVWSFGILLWEIYSF 382
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEY----VAIKALKQRIYSWEECLNLKEVKCLRKI 57
T K IG G FG+V++ + K S VAIK LK + L E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
+ H NI++L+ + S+ + + EYM+ L + FS ++ I G+
Sbjct: 104 S-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMK 161
Query: 116 YMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITT-----LQYRAPE 169
Y+ Y HRDL ++N+LV SN K++DFGL+ ++ P Y T+ +++ APE
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSGGKIPIRWTAPE 220
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITF 196
+ ++ S D+W+ G++M E++T+
Sbjct: 221 AISY-RKFTSASDVWSFGIVMWEVMTY 246
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-33
Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 23/223 (10%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC------- 53
++ + L++ IG GS+ KV K++ A++ +K+ E + +++
Sbjct: 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK-----ELVNDDEDIDWVQTEKHV 105
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQIL 111
+ +NHP +V L RL+FV EY N LM R++ E + + +I
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEY--VNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYIT---TLQYRA 167
LNY+H +G +RDL N+L+ ++ IK+ D+G+ E P T T T Y A
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS-TFCGTPNYIA 221
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY 210
PE+L Y VD WALG++M E++ F D
Sbjct: 222 PEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-33
Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L K++G G FG+VW A + + VA+K +K S E L E ++ + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFL--AEANVMKTLQ-HD 243
Query: 62 NIVKLQELASENYRLYFVFEYMD-CNLHQ-LMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+VKL + ++ +Y + E+M +L L S+ ++ ++ QI +G+ ++ +
Sbjct: 244 KLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 120 QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR--APEMLLMSGQ 176
+ Y HRDL + N+LVS + KIADFGLA ++ + APE + G
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GS 361
Query: 177 YNSKVDMWALGLIMAELITF 196
+ K D+W+ G+++ E++T+
Sbjct: 362 FTIKSDVWSFGILLMEIVTY 381
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKIN 58
++ K +G G FG+V K + VAIK LK + L E + + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 59 NHPNIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
HPNI++L+ + +++ + V EYM+ L + Q F+ ++ I G+ Y
Sbjct: 105 -HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKY 162
Query: 117 MHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITT-----LQYRAPEM 170
+ GY HRDL ++N+L+ SN K++DFGL ++ P Y T +++ +PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED-DPEAAYTTRGGKIPIRWTSPEA 221
Query: 171 LLMSGQYNSKVDMWALGLIMAELITF 196
+ ++ S D+W+ G+++ E++++
Sbjct: 222 IAY-RKFTSASDVWSYGIVLWEVMSY 246
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 21/227 (9%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKC------- 53
+ + + +G+GSFGKV + +K + E A+K LK+ + + +V+C
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEKRV 394
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQIL 111
L P + +L RLYFV EY N LM + F E + +I
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEY--VNGGDLMYHIQQVGRFKEPHAVFYAAEIA 452
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWE--VDSCPPYTEYITTLQYRAP 168
GL ++ +G +RDL N+++ ++ IKIADFG+ E D T + T Y AP
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAP 511
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNA 215
E++ Y VD WA G+++ E++ F G ED+ I
Sbjct: 512 EIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 36/218 (16%), Positives = 86/218 (39%), Gaps = 34/218 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEY-------VAIKALKQRIYSWEECLNLKEVKCL 54
E + +G+G+F K+++ ++++ G+Y V +K L + ++ E + +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF-FEAASMM 66
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQG 113
K++ H ++V + V E++ +L + K C + Q+
Sbjct: 67 SKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125
Query: 114 LNYMHRQGYFHRDLISKNLLVSND---------TIKIADFGLAWEVDSCPPYTEYITTLQ 164
++++ H ++ +KN+L+ + IK++D G++ V +
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----KDI----- 176
Query: 165 YR------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ PE + N D W+ G + E+ +
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEY---VAIKALKQRIYSWEECLN-LKEVKCLRKI 57
L K +GEG FG V + KQ VA+K +K S E L E C++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 58 NNHPNIVKL-----QELASENYRLYFVFEYMDC-NLHQ-LMSNR----KQCFSEAEVKNW 106
+HPN+++L + + + + +M +LH L+ +R + + +
Sbjct: 94 -SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQY 165
I G+ Y+ + + HRDL ++N ++ + T+ +ADFGL+ ++ S +Y Y
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS----GDY-----Y 203
Query: 166 R------------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
R A E L Y SK D+WA G+ M E+ T
Sbjct: 204 RQGRIAKMPVKWIAIES-LADRVYTSKSDVWAFGVTMWEIATR 245
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 60/204 (29%), Positives = 112/204 (54%), Gaps = 19/204 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E+ TL+K++G G FG V K + VA+K +K+ S +E +E + + K++ HP
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFF--QEAQTMMKLS-HP 63
Query: 62 NIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+VK + S+ Y +Y V EY+ C L+ L S+ K +++ C+ + +G+ ++
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLES 122
Query: 120 QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEMLL 172
+ HRDL ++N LV + +K++DFG+ V +Y++++ + APE+
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPVKWSAPEVFH 178
Query: 173 MSGQYNSKVDMWALGLIMAELITF 196
+Y+SK D+WA G++M E+ +
Sbjct: 179 Y-FKYSSKSDVWAFGILMWEVFSL 201
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
++ L++ IG+G FG V + G VA+K +K + + L E + ++ H
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFL--AEASVMTQLR-HS 74
Query: 62 NIVKLQELASENY-RLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
N+V+L + E LY V EYM + L S + + + + + + Y+
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 119 RQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR--APEMLLMSG 175
+ HRDL ++N+LVS ++ K++DFGL E T+ L + APE L
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALRE-K 189
Query: 176 QYNSKVDMWALGLIMAELITF 196
++++K D+W+ G+++ E+ +F
Sbjct: 190 KFSTKSDVWSFGILLWEIYSF 210
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEY---VAIKALKQRIYSWEECLN-LKEVKCLRKINNH 60
+ IG G FG V+ + A+K+L RI E L E ++ + H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFS-H 85
Query: 61 PNIVKLQELASENYR-LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
PN++ L + + V YM +L + N + ++ + Q+ +G+ Y+
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 119 RQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITT---LQYR--APEMLL 172
+ + HRDL ++N ++ T+K+ADFGLA ++ Y+ + T L + A E L
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES-L 204
Query: 173 MSGQYNSKVDMWALGLIMAELITF 196
+ ++ +K D+W+ G+++ EL+T
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTR 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEY---VAIKALKQRIYSWEECLN-LKEVKCLRKI 57
+++TL + +G+G FG V +A KQ VA+K LK I + + L+E C+++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 58 NNHPNIVKL------QELASENYRLYFVFEYMDC-NLHQ-LMSNR----KQCFSEAEVKN 105
+HP++ KL + +M +LH L+++R +
Sbjct: 83 -DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 106 WCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQ 164
+ I G+ Y+ + + HRDL ++N +++ + T+ +ADFGL+ ++ S +Y
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS----GDY----- 192
Query: 165 YR------------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
YR A E L Y D+WA G+ M E++T
Sbjct: 193 YRQGCASKLPVKWLALES-LADNLYTVHSDVWAFGVTMWEIMTR 235
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 52/203 (25%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ T +K++G G FG V + + VAIK +K+ S +E + +E K + ++ H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFI--EEAKVMMNLS-HE 79
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
+V+L + ++ ++ + EYM L + + F ++ C + + + Y+ +
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 121 GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEMLLM 173
+ HRDL ++N LV+ +K++DFGL+ V EY +++ + PE+L+
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWSPPEVLMY 195
Query: 174 SGQYNSKVDMWALGLIMAELITF 196
+++SK D+WA G++M E+ +
Sbjct: 196 -SKFSSKSDIWAFGVLMWEIYSL 217
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 49/204 (24%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+K +G G FG V + + GE V IK ++ + + + ++ H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-H 74
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+IV+L L + L V +Y+ +L + + + NW QI +G+ Y+
Sbjct: 75 AHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 120 QGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEMLL 172
G HR+L ++N+L+ S +++ADFG+A + + + + + A E +
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP---DDKQLLYSEAKTPIKWMALESIH 190
Query: 173 MSGQYNSKVDMWALGLIMAELITF 196
G+Y + D+W+ G+ + EL+TF
Sbjct: 191 F-GKYTHQSDVWSYGVTVWELMTF 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEY---VAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ K IG G G+V + G+ VAIKALK + L E + + + HP
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HP 110
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NI++L+ + + V EYM+ +L + F+ ++ + G+ Y+
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 121 GYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITT-----LQYRAPEMLLMS 174
GY HRDL ++N+LV SN K++DFGL+ ++ P Y TT +++ APE +
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTAPEAIAF- 228
Query: 175 GQYNSKVDMWALGLIMAELITF 196
++S D+W+ G++M E++ +
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAY 250
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L++++G G FG+VW + VA+K+LKQ S + L E ++++ H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFL--AEANLMKQLQ-HQ 68
Query: 62 NIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+V+L + ++ +Y + EYM+ + L + + ++ + QI +G+ ++
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 120 QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYR--APEMLLMSGQ 176
+ Y HRDL + N+LVS + KIADFGLA ++ + APE + G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GT 186
Query: 177 YNSKVDMWALGLIMAELITF 196
+ K D+W+ G+++ E++T
Sbjct: 187 FTIKSDVWSFGILLTEIVTH 206
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKIN 58
E+ L + IGEG FG V Q I VAIK K L+E +R+ +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 59 NHPNIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
HP+IVKL + +EN ++ + E L + A + + +Q+ L Y
Sbjct: 75 -HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 131
Query: 117 MHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APE 169
+ + + HRD+ ++N+LV SND +K+ DFGL+ ++ + Y + + APE
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED----STYYKASKGKLPIKWMAPE 187
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITF 196
+ ++ S D+W G+ M E++
Sbjct: 188 SINF-RRFTSASDVWMFGVCMWEILMH 213
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 61/238 (25%), Positives = 115/238 (48%), Gaps = 34/238 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIK---KQSGEYVAIKAL-KQRIYSWEECLNLKEVKC--- 53
+E + L+K +G G++GKV+ K +G+ A+K L K I K +
Sbjct: 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRT 107
Query: 54 ----LRKINNHPNIVKL----QELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEV 103
L I P +V L Q +L+ + +Y N +L + ++++ F+E EV
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQT----ETKLHLILDY--INGGELFTHLSQRERFTEHEV 161
Query: 104 KNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWEVDSCPPYTEYIT- 161
+ + +I+ L ++H+ G +RD+ +N+L+ ++ + + DFGL+ E + Y
Sbjct: 162 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DF 220
Query: 162 --TLQYRAPEMLLMSGQ-YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216
T++Y AP+++ ++ VD W+LG++M EL+T F E + +I I
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 65/295 (22%), Positives = 117/295 (39%), Gaps = 35/295 (11%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
E + +IG G++G V + + K SG+ +A+K ++ + E+ L ++ + + ++
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 61 PNIVKLQELASENYRLYFVFEYMDCNL----HQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
P IV+ + E M + + S E + ++ LN+
Sbjct: 81 PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 117 MHRQGY-FHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMS 174
+ HRD+ N+L+ IK+ DFG++ ++ T Y APE + S
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 175 GQ---YNSKVDMWALGLIMAELITFHPLFPGT-CEDDQLYKICNAIGSPTEESWAEGLEL 230
Y+ + D+W+LG+ + EL T +P DQL ++ G P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP----------- 247
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
P+L + PS + + L + D KRP E L+HP
Sbjct: 248 --------PQLSNSEEREFSPSFIN----FVNLCLTKDESKRPKYKELLKHPFIL 290
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 7e-32
Identities = 65/319 (20%), Positives = 105/319 (32%), Gaps = 58/319 (18%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINN 59
++ L++ IG G +G V++ VA+K ++ +N K + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNF---INEKNIYRVPLM-E 65
Query: 60 HPNIVKL-----QELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQG 113
H NI + + A V EY +L + + + +G
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRG 123
Query: 114 LNYMHRQGYF---------HRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT-- 161
L Y+H + HRDL S+N+LV ND T I+DFGL+ +
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 162 -------TLQYRAPEML------LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ 208
T++Y APE+L +VDM+ALGLI E+ C D
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-------RCTDLF 236
Query: 209 LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCS-- 266
+ + + P A + + L
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVL----VSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 267 ---W--DPCKRPTAAEALQ 280
W D R TA A +
Sbjct: 293 EDCWDQDAEARLTAQXAEE 311
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-32
Identities = 69/227 (30%), Positives = 110/227 (48%), Gaps = 21/227 (9%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCL---RKI 57
M ++ +K +G+G+FGKV +K +G Y A+K LK+ E + EV ++
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-----EVIVAKDEVAHTLTENRV 201
Query: 58 ---NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQILQ 112
+ HP + L+ + RL FV EY N +L +R++ FSE + + +I+
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEY--ANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 113 GLNYMH-RQGYFHRDLISKNLLVSNDT-IKIADFGLAWE--VDSCPPYTEYITTLQYRAP 168
L+Y+H + +RDL +NL++ D IKI DFGL E D T + T +Y AP
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAP 318
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNA 215
E+L + Y VD W LG++M E++ F + I
Sbjct: 319 EVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+K +G G+FG V++ + GE VAIK L++ L E + ++ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-N 76
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
P++ +L + + + + + M L + K + NWC QI +G+NY+
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 120 QGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITT-----LQYRAPEMLLM 173
+ HRDL ++N+LV + +KI DFGLA + + Y +++ A E +L
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMALESILH 193
Query: 174 SGQYNSKVDMWALGLIMAELITF 196
Y + D+W+ G+ + EL+TF
Sbjct: 194 -RIYTHQSDVWSYGVTVWELMTF 215
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 56/223 (25%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
EK T+ +++G+GSFG V++ + K + VAIK + + E L E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN--------W 106
N ++V+L + S+ + E M +L L S R + +
Sbjct: 85 F-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQY 165
+I G+ Y++ + HRDL ++N +V+ D T+KI DFG+ ++ T+Y Y
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDY-----Y 194
Query: 166 R------------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
R +PE L G + + D+W+ G+++ E+ T
Sbjct: 195 RKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATL 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEY---VAIKALKQRIYSWEECLNLKEVKCLRKIN 58
E+ L + IGEG FG V Q I VAIK K L+E +R+ +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HP+IVKL + +EN ++ + E L + RK A + + +Q+ L Y+
Sbjct: 450 -HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEM 170
+ + HRD+ ++N+LV SND +K+ DFGL+ ++ + Y + + APE
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED----STYYKASKGKLPIKWMAPES 563
Query: 171 LLMSGQYNSKVDMWALGLIMAELITF 196
+ ++ S D+W G+ M E++
Sbjct: 564 INF-RRFTSASDVWMFGVCMWEILMH 588
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLN-LKEVKCLRKINNH 60
+ IG G FG V+ + + A+K+L RI E L E ++ + H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFS-H 149
Query: 61 PNIVKLQELASENYR-LYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
PN++ L + + V YM +L + N + ++ + Q+ +G+ ++
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 119 RQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITT---LQYR--APEMLL 172
+ + HRDL ++N ++ T+K+ADFGLA ++ + + T L + A E L
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES-L 268
Query: 173 MSGQYNSKVDMWALGLIMAELITF 196
+ ++ +K D+W+ G+++ EL+T
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTR 292
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 52/206 (25%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 5 TLMKQIGEGSFGKVWQAIKKQSGEY---VAIKALKQRIYSWEECLN-LKEVKCLRKINNH 60
+ IG+G FG V+ + AIK+L + I ++ L+E +R +N H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLN-H 81
Query: 61 PNIVKLQELA---SENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
PN++ L + + + YM +L Q + + ++ + ++ ++ Q+ +G+ Y
Sbjct: 82 PNVLAL--IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 117 MHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITT---LQYR--APEM 170
+ Q + HRDL ++N ++ + T+K+ADFGLA ++ Y+ L + A E
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 171 LLMSGQYNSKVDMWALGLIMAELITF 196
L ++ +K D+W+ G+++ EL+T
Sbjct: 200 LQT-YRFTTKSDVWSFGVLLWELLTR 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 48/207 (23%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKIN 58
E L + +GEG FG+V++ + VA+K K+ + + E ++ ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 59 NHPNIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
HP+IVKL + E + + E H L N+ + + QI + + Y
Sbjct: 72 -HPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAY 128
Query: 117 MHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APE 169
+ HRD+ +N+LV S + +K+ DFGL+ ++ +Y R +PE
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED----EDYYKASVTRLPIKWMSPE 184
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITF 196
+ ++ + D+W + M E+++F
Sbjct: 185 SINF-RRFTTASDVWMFAVCMWEILSF 210
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 69/235 (29%), Positives = 111/235 (47%), Gaps = 34/235 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIK---KQSGEYVAIKAL-KQRIYSWEECLNLKEVKCL-- 54
E + L++ +G+G +GKV+Q K +G+ A+K L K I N K+
Sbjct: 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKA 70
Query: 55 -RKI---NNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCF 108
R I HP IV L +LY + EY + +L R+ F E +
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEY--LSGGELFMQLEREGIFMEDTACFYLA 128
Query: 109 QILQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWE--VDSCPPYT-----EYI 160
+I L ++H++G +RDL +N+++++ +K+ DFGL E D +T EY+
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNA 215
APE+L+ SG +N VD W+LG +M +++T P F G + KI
Sbjct: 189 ------APEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE--YVAIKALKQRIYSWEECLN-LKEVKCLRKIN 58
IGEG+FG+V +A K+ G AIK +K+ S ++ + E++ L K+
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLG 83
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKNW---------- 106
+HPNI+ L LY EY NL L +R A
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 107 ----CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT 161
+ +G++Y+ ++ + HRDL ++N+LV + KIADFGL+ + Y+
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------VYVK 197
Query: 162 TLQYR------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
R A E L Y + D+W+ G+++ E+++
Sbjct: 198 KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL 237
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 46/200 (23%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEY--VAIKALKQRIYSWEECLN-LKEVKCLRKINNHPNIV 64
K++G G+FG V + + VA+K LK L E +++++ +P IV
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 81
Query: 65 KLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYF 123
++ + V E + L++ + + + + Q+ G+ Y+ +
Sbjct: 82 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 124 HRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEMLLMSGQ 176
HRDL ++N+L+ + KI+DFGL+ + + Y Y + APE + +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPECINY-YK 196
Query: 177 YNSKVDMWALGLIMAELITF 196
++SK D+W+ G++M E ++
Sbjct: 197 FSSKSDVWSFGVLMWEAFSY 216
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 50/206 (24%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 2 EKYTLMK-QIGEGSFGKVWQAIKKQSGE--YVAIKALKQRIYSWEECLNLKEVKCLRKIN 58
+ + ++G G+FG V Q + + + VAIK LKQ + ++E + + +++
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
+P IV+L + L V E LH+ + +++ + V Q+ G+ Y+
Sbjct: 69 -NPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEM 170
+ + HRDL ++N+L+ + KI+DFGL+ + + Y Y + APE
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPEC 184
Query: 171 LLMSGQYNSKVDMWALGLIMAELITF 196
+ +++S+ D+W+ G+ M E +++
Sbjct: 185 INF-RKFSSRSDVWSYGVTMWEALSY 209
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 80/315 (25%), Positives = 133/315 (42%), Gaps = 80/315 (25%)
Query: 2 EKYTLMKQIGEGSFGKVWQA----IKKQSGEY---VAIKALKQRIYSWEECLNLKEVKCL 54
+K TL K +GEG FG+V A I K + VA+K LK + + E++ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN------- 105
+ I H NI+ L +++ LY + EY NL + L + R + N
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 106 -------WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT 157
+Q+ +G+ Y+ Q HRDL ++N+LV+ + +KIADFGLA ++++
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----I 256
Query: 158 EYITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF--HPLFPGT 203
+Y Y+ APE L Y + D+W+ G++M E+ T P +PG
Sbjct: 257 DY-----YKKTTNGRLPVKWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGI 309
Query: 204 CEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIEL 263
E +L K G++ K P+ +E+ ++
Sbjct: 310 -------------------PVEELFKLLK-EGHRMDK----------PANCTNELYMMMR 339
Query: 264 LC-SWDPCKRPTAAE 277
C P +RPT +
Sbjct: 340 DCWHAVPSQRPTFKQ 354
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 46/229 (20%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
L +++GEG+FGKV+ A + VA+KALK + + +E + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF-QREAELLTN 73
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN--------- 105
+ H +IVK + + L VFEYM +L++ L ++ + +
Sbjct: 74 L-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 106 -----WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEY 159
QI G+ Y+ Q + HRDL ++N LV + +KI DFG++ +V S T+Y
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS----TDY 188
Query: 160 ITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
YR PE ++ ++ ++ D+W+ G+I+ E+ T+
Sbjct: 189 -----YRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTY 231
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 46/231 (19%)
Query: 2 EKYTLMKQIGEGSFGKVWQA----IKKQSGEY---VAIKALKQRIYSWEECLNLKEVKCL 54
+K TL K +GEG+FG+V A I K + VA+K LK + + E++ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN------- 105
+ I H NI+ L +++ LY + EY NL + L + R + N
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 106 -------WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT 157
+Q+ +G+ Y+ Q HRDL ++N+LV+ + +KIADFGLA ++++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----I 210
Query: 158 EYITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
+Y Y+ APE L Y + D+W+ G++M E+ T
Sbjct: 211 DY-----YKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 39/223 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
+ TL++ +G G+FG+V++ S VA+K L + +E L E + K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQC-----FSEAEVKNWCFQ 109
NH NIV+ ++ ++ + + E M +L L R + + ++ +
Sbjct: 90 F-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCPPYTEYITTLQY 165
I G Y+ + HRD+ ++N L++ KI DFG+A ++ Y Y
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----ASY-----Y 199
Query: 166 R------------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
R PE + G + SK D W+ G+++ E+ +
Sbjct: 200 RKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSL 241
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 49/199 (24%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 8 KQIGEGSFGKVWQAIKKQSGEY--VAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVK 65
++G G+FG V Q + + + VAIK LKQ + ++E + + +++ +P IV+
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVR 400
Query: 66 LQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
L + L V E LH+ + +++ + V Q+ G+ Y+ + + H
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 125 RDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYR------APEMLLMSGQY 177
R+L ++N+L+ + KI+DFGL+ + + Y Y + APE + ++
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPECINF-RKF 516
Query: 178 NSKVDMWALGLIMAELITF 196
+S+ D+W+ G+ M E +++
Sbjct: 517 SSRSDVWSYGVTMWEALSY 535
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 73/316 (23%), Positives = 122/316 (38%), Gaps = 82/316 (25%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
++ L K +G G+FG+V +A K + VA+K LK+ E + E+K L
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 57 INNHPNIVKLQELAS---ENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN------ 105
I +H N+V L L + L + E+ NL L S R +
Sbjct: 87 IGHHLNVVNL--LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 106 --------WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPY 156
+ FQ+ +G+ ++ + HRDL ++N+L+S +KI DFGLA ++
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK---- 200
Query: 157 TEYITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF--HPLFPG 202
Y APE + Y + D+W+ G+++ E+ + P +PG
Sbjct: 201 DPD-----YVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP-YPG 253
Query: 203 TCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIE 262
D++ + L+ G + P EM
Sbjct: 254 VKIDEEFCRR---------------LK----EGTRMRA----------PDYTTPEMYQTM 284
Query: 263 LLC-SWDPCKRPTAAE 277
L C +P +RPT +E
Sbjct: 285 LDCWHGEPSQRPTFSE 300
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 63/233 (27%), Positives = 111/233 (47%), Gaps = 32/233 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIK---KQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRK 56
++ L+K +G+GSFGKV+ K + + A+K L K + + E L +
Sbjct: 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 57 INNHPNIVKL----QELASENYRLYFVFEYMDCNLHQLMS--NRKQCFSEAEVKNWCFQI 110
+ NHP IVKL Q +LY + ++ L + +++ F+E +VK + ++
Sbjct: 83 V-NHPFIVKLHYAFQ----TEGKLYLILDF--LRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 111 LQGLNYMHRQGYFHRDLISKNLLVSNDT-IKIADFGLAWE--VDSCPPYT-----EYITT 162
L+++H G +RDL +N+L+ + IK+ DFGL+ E Y+ EY+
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM-- 193
Query: 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNA 215
APE++ G + D W+ G++M E++T F G + + I A
Sbjct: 194 ----APEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-30
Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 39/223 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
+ TL++ +G G+FG+V++ S VA+K L + +E L E + K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQC-----FSEAEVKNWCFQ 109
NH NIV+ ++ ++ + + E M +L L R + + ++ +
Sbjct: 131 F-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCPPYTEYITTLQY 165
I G Y+ + HRD+ ++N L++ KI DFG+A ++ Y Y
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----AGY-----Y 240
Query: 166 R------------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
R PE + G + SK D W+ G+++ E+ +
Sbjct: 241 RKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSL 282
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 65/306 (21%)
Query: 2 EKYTLMKQIGEGSFGKVWQA----IKKQSGEY-VAIKALKQRIYSWEECLNLKEVKCLRK 56
K +G G+FGKV +A + K+ VA+K LK ++ E+ + E+K +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN--------- 105
+ H NIV L + + + EY +L L + ++
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 106 ---WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT 161
+ Q+ QG+ ++ + HRD+ ++N+L++N KI DFGLA ++ + YI
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIV 222
Query: 162 TLQYR------APEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNA 215
R APE + Y + D+W+ G+++ E+ +
Sbjct: 223 KGNARLPVKWMAPES-IFDCVYTVQSDVWSYGILLWEIFSL------------------- 262
Query: 216 IGS---PTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC-SWDPCK 271
G P ++ +L K GY+ + P+ + I C + +P
Sbjct: 263 -GLNPYPGILVNSKFYKLVK-DGYQMAQ----------PAFAPKNIYSIMQACWALEPTH 310
Query: 272 RPTAAE 277
RPT +
Sbjct: 311 RPTFQQ 316
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 76/332 (22%), Positives = 133/332 (40%), Gaps = 83/332 (25%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLR 55
L ++GEG+FGKV+ A +Q VA+KALK+ S + +E + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLT 98
Query: 56 KINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN-------- 105
+ H +IV+ + +E L VFEYM +L++ L S+ A ++
Sbjct: 99 ML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 106 -----WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEY 159
Q+ G+ Y+ + HRDL ++N LV +KI DFG++ ++ S T+Y
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDY 213
Query: 160 ITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF--HPLFPGTCE 205
YR PE +L ++ ++ D+W+ G+++ E+ T+ P +
Sbjct: 214 -----YRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQP-WYQ--- 263
Query: 206 DDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC 265
S E ++ G + + P A E+ I C
Sbjct: 264 ----------------LSNTEAIDCIT-QGRELER----------PRACPPEVYAIMRGC 296
Query: 266 -SWDPCKRPTAAEALQHPLFQGCLQVPSMSID 296
+P +R + + Q Q P + +D
Sbjct: 297 WQREPQQRHSIKDVHAR--LQALAQAPPVYLD 326
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 61/248 (24%), Positives = 102/248 (41%), Gaps = 49/248 (19%)
Query: 2 EKYTLMKQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
+ + K +G G+FGKV +A IK + VA+K LK + E + E+K L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN--------- 105
+ NH NIV L + + EY +L L R
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 106 -------WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT 157
+ +Q+ +G+ ++ + HRDL ++N+L+++ KI DFGLA ++ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN----D 198
Query: 158 EYITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF--HPLFPGT 203
Y APE + + Y + D+W+ G+ + EL + P +PG
Sbjct: 199 SN-----YVVKGNARLPVKWMAPE-SIFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGM 251
Query: 204 CEDDQLYK 211
D + YK
Sbjct: 252 PVDSKFYK 259
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 47/230 (20%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLR 55
M+++GE FGKV++ + + VAIK LK + E LR
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEA-MLR 66
Query: 56 KINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNR--------------KQCFS 99
HPN+V L + +++ L +F Y +LH+ L+ K
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 100 EAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTE 158
+ + QI G+ Y+ H+DL ++N+LV + +KI+D GL EV + +
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA----AD 182
Query: 159 YITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
Y Y+ APE ++ G+++ D+W+ G+++ E+ ++
Sbjct: 183 Y-----YKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSY 226
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 76/315 (24%), Positives = 130/315 (41%), Gaps = 80/315 (25%)
Query: 2 EKYTLMKQIGEGSFGKVWQA----IKKQSGEY---VAIKALKQRIYSWEECLNLKEVKCL 54
++ L K +GEG+FG+V A + K VA+K LK + + E++ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN------- 105
+ I H NI+ L +++ LY + EY NL + L + R + +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 106 -------WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT 157
+Q+ +G+ Y+ + HRDL ++N+LV+ D +KIADFGLA ++
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH----I 244
Query: 158 EYITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF--HPLFPGT 203
+Y Y+ APE L Y + D+W+ G+++ E+ T P +PG
Sbjct: 245 DY-----YKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSP-YPGV 297
Query: 204 CEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIEL 263
E +L K G++ K PS +E+ ++
Sbjct: 298 -------------------PVEELFKLLK-EGHRMDK----------PSNCTNELYMMMR 327
Query: 264 LC-SWDPCKRPTAAE 277
C P +RPT +
Sbjct: 328 DCWHAVPSQRPTFKQ 342
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 49/219 (22%), Positives = 88/219 (40%), Gaps = 40/219 (18%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQ-SGEYVAIKALK-----------QRIYSWEECLNLKEV 51
Y + I G G ++ A+ + +G V +K L E L EV
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMA-----ERQFLAEV 136
Query: 52 KCLRKINNHPNIVKL-----QELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKN 105
HP+IV++ + Y V EY+ +L + + Q AE
Sbjct: 137 -------VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRS---KGQKLPVAEAIA 186
Query: 106 WCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYIT-TLQ 164
+ +IL L+Y+H G + DL +N++++ + +K+ D G ++S Y+ T
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINS----FGYLYGTPG 242
Query: 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGT 203
++APE++ D++ +G +A L P G
Sbjct: 243 FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGR 279
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 55/238 (23%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLR 55
++ IGEG+FG+V+QA + VA+K LK+ S + + +E +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMA 105
Query: 56 KINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKNW------- 106
+ ++PNIVKL + + + +FEYM +L++ L S +
Sbjct: 106 EF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 107 ---------------CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEV 150
Q+ G+ Y+ + + HRDL ++N LV + +KIADFGL+ +
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
Query: 151 DSCPPYTEYITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
S +Y Y+ PE + +Y ++ D+WA G+++ E+ ++
Sbjct: 225 YS----ADY-----YKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSY 272
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 76/320 (23%), Positives = 134/320 (41%), Gaps = 84/320 (26%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
E K +G G+FGKV A K VA+K LK++ S E + E+K + +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN--------- 105
+ +H NIV L + + +Y +FEY +L L S R++ +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 106 ------------WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS 152
+ +Q+ +G+ ++ + HRDL ++N+LV++ +KI DFGLA ++
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI-- 222
Query: 153 CPPYTEYITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF--HP 198
++ Y APE L G Y K D+W+ G+++ E+ + +P
Sbjct: 223 -------MSDSNYVVRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
Query: 199 LFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEM 258
+PG D YK+ ++ +G+K + P +E+
Sbjct: 275 -YPGIPVDANFYKL---------------IQ----NGFKMDQ----------PFYATEEI 304
Query: 259 SLIELLC-SWDPCKRPTAAE 277
+I C ++D KRP+
Sbjct: 305 YIIMQSCWAFDSRKRPSFPN 324
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 53/237 (22%)
Query: 2 EKYTLMKQIGEGSFGKVWQA----IKKQSGEY-VAIKALKQRIYSWEECLNLKEVKCLRK 56
+ L K +GEG FGKV +A +K ++G VA+K LK+ E L E L++
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQ-LMSNRKQCFSEAEVKN--------- 105
+ NHP+++KL S++ L + EY +L L +RK
Sbjct: 83 V-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 106 -------------WCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVD 151
+ +QI QG+ Y+ HRDL ++N+LV+ +KI+DFGL+ +V
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 152 SCPPYTEYITTLQYR------------APEMLLMSGQYNSKVDMWALGLIMAELITF 196
+ Y A E L Y ++ D+W+ G+++ E++T
Sbjct: 202 E----EDS-----YVKRSQGRIPVKWMAIES-LFDHIYTTQSDVWSFGVLLWEIVTL 248
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-27
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNHP 61
Y ++ ++G G V+ A VAIKA+ EE L +EV ++ +H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71
Query: 62 NIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV + ++ E+ Y V EY++ L + + + S N+ QIL G+ + H
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDM 130
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT-------TLQYRAPEMLL 172
HRD+ +N+L+ ++ T+KI DFG+A + +T T+QY +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-----LTQTNHVLGTVQYFSPE-QA 184
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPG 202
+ D++++G+++ E++ P F G
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 51/214 (23%), Positives = 91/214 (42%), Gaps = 21/214 (9%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNHP 61
Y L + +G G +V A + VA+K L+ + +E + + NHP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72
Query: 62 NIVKL----QELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
IV + + Y V EY+D L ++ + + + Q LN+
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNF 131
Query: 117 MHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT-------TLQYRAP 168
H+ G HRD+ N+++S +K+ DFG+A + +T T QY +P
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS---GNSVTQTAAVIGTAQYLSP 188
Query: 169 EMLLMSGQYNSKVDMWALGLIMAELITFHPLFPG 202
E +++ D+++LG ++ E++T P F G
Sbjct: 189 E-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 11/206 (5%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNHP 61
Y L + +G G G V++A VA+K + + + S +E + ++ P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EP 94
Query: 62 NIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
++V + + + +LY ++ +L ++ R+ + QI L+ H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 121 GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE---YITTLQYRAPEMLLMSGQ 176
G HRD+ +N+LVS +D + DFG+A T+ + TL Y APE
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYMAPE-RFSESH 211
Query: 177 YNSKVDMWALGLIMAELITFHPLFPG 202
+ D++AL ++ E +T P + G
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQG 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-21
Identities = 30/210 (14%), Positives = 61/210 (29%), Gaps = 35/210 (16%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINNHP 61
Y L+ G + WQA+ VA+ + + ++ L L L +I+ P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KP 91
Query: 62 NIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
+ ++ ++ V E++ +L ++ S + + HR
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA 148
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
G + VS D + +A + + P
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMPDAN---PQD---------------------- 183
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQL 209
D+ +G + L+ P L
Sbjct: 184 --DIRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-20
Identities = 34/151 (22%), Positives = 62/151 (41%), Gaps = 9/151 (5%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
+ + K+IG G+FG++ + EYVAIK + E + +++ +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDG 66
Query: 63 IVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
I ++ V E + +L L + FS V Q++ + Y+H +
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 123 FHRDLISKNLLV------SNDTIKIADFGLA 147
+RD+ +N L+ + I I DF LA
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 7/150 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
K+ L ++IG GSFG+++ Q+ E VAIK + + L E K R +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGT 63
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
I ++ E V + + +L L + + S V Q++ + ++H +
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 122 YFHRDLISKNLLV----SNDTIKIADFGLA 147
+ HRD+ N L+ + + I DFGLA
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-19
Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 7/150 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+Y L ++IG GSFG ++ +GE VAIK + + E K + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGV 65
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
I ++ +E V E + +L L + + FS V Q++ + Y+H +
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 122 YFHRDLISKNLLV----SNDTIKIADFGLA 147
+ HRD+ N L+ + + I DFGLA
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 33/152 (21%), Positives = 63/152 (41%), Gaps = 9/152 (5%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
Y + ++IGEGSFG +++ + + VAIK +R + E + + +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCT 66
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
I + E V + + +L L+ + FS V Q+L + +H +
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 122 YFHRDLISKNLLV------SNDTIKIADFGLA 147
+RD+ N L+ + + I + DFG+
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 82.2 bits (202), Expect = 9e-18
Identities = 51/272 (18%), Positives = 78/272 (28%), Gaps = 65/272 (23%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-------------KQRIYSWEECLNL 48
EK ++IGEG FG+V+Q I VAIK + K E +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 49 KEVKCLR--KINNHPNIVKL----------------------QELASENYR--------L 76
KE+ L N + L S N R L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLV- 134
+ V E+ + L R + S A K+ Q+ L + HRDL N+L+
Sbjct: 138 FIVLEFEFGGID-LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 135 SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELI 194
K+ P ++ Y ++ ++
Sbjct: 197 KTSLKKLHYTLNGKSS--TIPSCGLQVSI-----------IDYTLSRLERDGIVVFCDVS 243
Query: 195 TFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226
LF G + D + I + W E
Sbjct: 244 MDEDLFTG--DGDYQFDIYRLMKKENNNRWGE 273
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 24/166 (14%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK------------QRIYSWEECLNLKE 50
++ L K+IG G FG ++ A E A +K + Y + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 51 VKCLRKINNHPNIVKL-----QELASENYRLYFVFEYMDCNLHQLM-SNRKQCFSEAEVK 104
RK ++ I E +YR + V E + +L ++ N F ++ V
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYR-FMVMERLGIDLQKISGQNGT--FKKSTVL 154
Query: 105 NWCFQILQGLNYMHRQGYFHRDLISKNLLV---SNDTIKIADFGLA 147
++L L Y+H Y H D+ + NLL+ + D + +AD+GL+
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 70/367 (19%), Positives = 121/367 (32%), Gaps = 112/367 (30%)
Query: 2 EKYTLMKQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKC--- 53
++ L K +G G+FG+V +A K + VA+K LK+ E + E+K
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 54 ------------------------------------LRKINNHPNIVKLQELASENYRLY 77
LR N K + + Y
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 78 FVFEYMD----------------------------CNLHQLMSNRKQCFSEAEVKNWCFQ 109
+D K + + + FQ
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 110 ILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT-EYITTLQYR- 166
+ +G+ ++ + HRDL ++N+L+S +KI DFGLA ++ P Y + L +
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 167 -APEMLLMSGQYNSKVDMWALGLIMAELITF--HPLFPGTCEDDQLYKICNAIGSPTEES 223
APE + Y + D+W+ G+++ E+ + P +PG D++ +
Sbjct: 262 MAPET-IFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRLK--------- 310
Query: 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLC-SWDPCKRPTAAEALQHP 282
G + P EM L C +P +RPT +E ++H
Sbjct: 311 ----------EGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH- 349
Query: 283 LFQGCLQ 289
LQ
Sbjct: 350 -LGNLLQ 355
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 3e-15
Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 33/206 (16%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQEL 69
+G G FGKV++ G VA+K LK+ E EV+ + H N+++L+
Sbjct: 38 LGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGF 95
Query: 70 ASENYRLYFVFEYM-----DCNLHQLMSNRKQCFSEAEVKNW------CFQILQGLNYMH 118
V+ YM L + ++ +W +GL Y+H
Sbjct: 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPL-------DWPKRQRIALGSARGLAYLH 148
Query: 119 RQGY---FHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYIT-----TLQYRAPE 169
HRD+ + N LL + DFGLA + ++T T+ + APE
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIGHIAPE 205
Query: 170 MLLMSGQYNSKVDMWALGLIMAELIT 195
L +G+ + K D++ G+++ ELIT
Sbjct: 206 -YLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 3e-15
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 30/203 (14%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW---EECLNLKEVKCLRKINNHPNIVKL 66
IG G FGKV++ + + G VA+K S EE E++ L HP++V L
Sbjct: 47 IGHGVFGKVYKGVLR-DGAKVALKRRTPE--SSQGIEEFET--EIETLSFCR-HPHLVSL 100
Query: 67 QELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNW------CFQILQGLNYMHR 119
E + +++YM+ NL + + +W C +GL+Y+H
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSD---LPTMSMSWEQRLEICIGAARGLHYLHT 157
Query: 120 QGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTE-YITT-----LQYRAPEMLL 172
+ HRD+ S N LL N KI DFG++ + +++T L Y PE
Sbjct: 158 RAIIHRDVKSINILLDENFVPKITDFGIS---KKGTELDQTHLSTVVKGTLGYIDPEY-F 213
Query: 173 MSGQYNSKVDMWALGLIMAELIT 195
+ G+ K D+++ G+++ E++
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 32/167 (19%), Positives = 62/167 (37%), Gaps = 23/167 (13%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQ---------RIYSWEECLNL 48
+ + IG+G FG ++ A S +K + Y
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 49 KEVKCLRKINNHPNIVKL-----QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEV 103
+ + + + K + ++YR + + + +L ++ + FS V
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR-FMIMDRFGSDLQKIYEANAKRFSRKTV 154
Query: 104 KNWCFQILQGLNYMHRQGYFHRDLISKNLLV---SNDTIKIADFGLA 147
+IL L Y+H Y H D+ + NLL+ + D + + D+GLA
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 28/176 (15%), Positives = 64/176 (36%), Gaps = 39/176 (22%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSG--------EYVAIK--ALKQRIYSWEECLNLKEV 51
++ L + G +++A + + ++K A R+++ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFN--------EQ 93
Query: 52 KCLRKINNHPNIVKLQELAS----------------ENYRLYFVFEYMDCNLHQLM-SNR 94
++ + K ++L S + YR + V + +L + +
Sbjct: 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSLGRSLQSALDVSP 152
Query: 95 KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV---SNDTIKIADFGLA 147
K SE V ++L L ++H Y H ++ ++N+ V + +A +G A
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 45/211 (21%)
Query: 10 IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-----WEECLNLKEVKCLRKINNHPNIV 64
+GEG FG V++ VA+K L + ++ E+K + K H N+V
Sbjct: 39 MGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQ--EIKVMAKCQ-HENLV 93
Query: 65 KLQEL---ASENYRLYFVFEYM-----DCNLHQLMSNRKQCFSEAEVKNW------CFQI 110
+L L + + V+ YM L C +W
Sbjct: 94 EL--LGFSSDGDDLC-LVYVYMPNGSLLDRLS--------CLDGTPPLSWHMRCKIAQGA 142
Query: 111 LQGLNYMHRQGYFHRDLISKN-LLVSNDTIKIADFGLAWEVDSCPPYTEYIT-----TLQ 164
G+N++H + HRD+ S N LL T KI+DFGLA + +T T
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK--FAQTVMTSRIVGTTA 200
Query: 165 YRAPEMLLMSGQYNSKVDMWALGLIMAELIT 195
Y APE + G+ K D+++ G+++ E+IT
Sbjct: 201 YMAPEA--LRGEITPKSDIYSFGVVLLEIIT 229
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 1e-05
Identities = 50/289 (17%), Positives = 86/289 (29%), Gaps = 85/289 (29%)
Query: 36 KQRIYSWEECLNLKEVKCLRKINNHPNIV--------KLQELASENYRLYFVFEYMDCNL 87
K + + L L+ + L ++ N++ K +A + Y V MD +
Sbjct: 128 KYNVSRLQPYLKLR--QALLELRPAKNVLIDGVLGSGK-TWVALDVCLSYKVQCKMDFKI 184
Query: 88 HQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLA 147
L N K C S V ++LQ L Y + R S N+ + +I+
Sbjct: 185 FWL--NLKNCNSPETV----LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL---- 234
Query: 148 WEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKV--DMWALGLIMAELITFHPLFPGTCE 205
+ + Y LL V ++ A F +C+
Sbjct: 235 ---------RRLLKSKPY--ENCLL--------VLLNVQNAKAWNA--------FNLSCK 267
Query: 206 ------DDQLYKICNAIGSPT-------EESW----AEGLEL-AKAHGYKFPKL-----Q 242
Q + + + + T S E L K + L
Sbjct: 268 ILLTTRFKQ---VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT 324
Query: 243 GNNLSL-LIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290
N L +I S+ + L +WD K + L + + L V
Sbjct: 325 TNPRRLSIIAE------SIRDGLATWDNWKHVN-CDKLTT-IIESSLNV 365
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 346 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.7 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.34 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.15 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.03 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.91 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.54 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.39 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.18 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.07 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.04 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.22 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.37 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-67 Score=452.37 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=207.3
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|+++.+|+.||+|++++..... ......+|+.+++++ +||||+++++++++++.+|+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEE
Confidence 478999999999999999999999999999999997654432 234467899999999 79999999999999999999
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||||++|+|.+.+.+.+ .+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.........
T Consensus 91 vmEy~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 169 (275)
T 3hyh_A 91 VIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK 169 (275)
T ss_dssp EEECCCEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence 99999999999887654 599999999999999999999999999999999999995 5699999999998877666667
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+..+....+.......
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~------------------ 231 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL------------------ 231 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC------------------
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 78999999999999866666899999999999999999999999988877777765532211
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.+.+|+++++||++||+.||++|||++|+++||||+.
T Consensus 232 ------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 232 ------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1357899999999999999999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-65 Score=449.52 Aligned_cols=254 Identities=29% Similarity=0.430 Sum_probs=221.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|+++.+|+.||+|++++... ........+|+.+++++ +||||++++++|++++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 689999999999999999999999999999999975432 22234567899999999 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC---C
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC---P 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~---~ 154 (346)
||||+| +|.+.+.+. +.++|.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|...... .
T Consensus 111 mEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999985 777777654 4599999999999999999999999999999999999995 569999999999876432 2
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
...+.+||+.|||||++. ...|+.++||||+||++|+|++|.+||.+.+..+.+.++.+....
T Consensus 190 ~~~~~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~---------------- 252 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD---------------- 252 (311)
T ss_dssp CBCCCCSCGGGCCHHHHH-HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------------
T ss_pred cccCcccCcccCCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 455678999999999987 566899999999999999999999999999888888888654221
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAE------ALQHPLFQGCL 288 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e------ll~hp~~~~~~ 288 (346)
+| +.+|+++++||++||+.||++|||++| +++||||++..
T Consensus 253 ---~p-----------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 253 ---FP-----------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp ---CC-----------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ---CC-----------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 11 357899999999999999999999988 58999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-65 Score=453.03 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=220.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|+++++||+|+||+||+|+++.+|+.||+|+++..... ......+|+.+++++ +|||||++++++++++.+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEe
Confidence 4699999999999999999999999999999999765443 334567899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~ 158 (346)
||+| +|.+.+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|...... ....+
T Consensus 152 y~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 152 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred CCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9986 56665543 3599999999999999999999999999999999999995 579999999999876543 34567
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
.+||+.|||||++. ...|+.++||||+||++|+|++|.+||.+.+..+.+..+........ .
T Consensus 230 ~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-~---------------- 291 (346)
T 4fih_A 230 LVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-K---------------- 291 (346)
T ss_dssp CCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-S----------------
T ss_pred cccCcCcCCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-C----------------
Confidence 89999999999886 56789999999999999999999999999888888777755322111 0
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
..+.+|+++++||++||+.||++|||++|+|+||||+...
T Consensus 292 ----------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 292 ----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ----------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 1135789999999999999999999999999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-65 Score=457.08 Aligned_cols=256 Identities=30% Similarity=0.487 Sum_probs=218.1
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
||+|+++++||+|+||+||+|+++.+|+.||+|+++....... .....+|+.+++++ +|||||++++++++++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEE
Confidence 7899999999999999999999999999999999976655443 34567899999999 799999999999999999999
Q ss_pred EEcCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-C
Q 039371 80 FEYMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-P 155 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~ 155 (346)
||||+ |+|.+.+... +..++|.+++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+...... .
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99998 5888888654 34579999999999999999999999999999999999995 5699999999998765432 2
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
..+.+||+.|||||++. +..|+.++|||||||++|+|++|.+||.+.+..+.+.++......+
T Consensus 182 ~~~~~GT~~YmAPE~l~-~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---------------- 244 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---------------- 244 (350)
T ss_dssp HHHHHSCCTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----------------
T ss_pred ccccCCCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC----------------
Confidence 34568999999999987 5678999999999999999999999999999888888886643211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
....+|+++++||.+||+.||++|||++|+|+||||+..
T Consensus 245 -------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 245 -------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred -------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 113678999999999999999999999999999999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-64 Score=457.51 Aligned_cols=286 Identities=31% Similarity=0.539 Sum_probs=240.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeec------CC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASE------NY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------~~ 74 (346)
++|++++.||+|+||+||+|+++.+|+.||||+++....... .....+|+.+++.+ +||||+++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCC
Confidence 579999999999999999999999999999999976554433 34567899999999 79999999998753 46
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
.+|||||||+|+|.+.+... +.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.....
T Consensus 133 ~~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 89999999999988888765 4599999999999999999999999999999999999995 569999999999765432
Q ss_pred -----CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 154 -----PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 154 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
....+.+||+.|+|||++.+..+++.++||||+||++|+|++|.+||.+.+..+++..|....+.|+...|....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 234567999999999998877788999999999999999999999999999999999999999999887664322
Q ss_pred H-HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 229 E-LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 229 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
. ........++......+..+.+.+++++++||++||+.||++|||++|+|+||||+....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 1 111111233344444455667788999999999999999999999999999999997654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-63 Score=453.65 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=220.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|+++++||+|+||+||+|+++.+|+.||||+++..... ......+|+.+++++ +|||||+++++|.+++.+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEe
Confidence 4699999999999999999999999999999999765433 334567899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~ 158 (346)
||+| +|.+.+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|...... ....+
T Consensus 229 y~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 229 FLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp CCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred CCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9986 56665543 3499999999999999999999999999999999999995 579999999999876543 34567
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
.+||+.|||||++. ...|+.++|||||||++|+|++|.+||.+.+..+.+..+........
T Consensus 307 ~~GTp~YmAPEvl~-~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~------------------ 367 (423)
T 4fie_A 307 LVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL------------------ 367 (423)
T ss_dssp CEECTTTCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC------------------
T ss_pred cccCcCcCCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC------------------
Confidence 89999999999886 56789999999999999999999999999988888877755321110
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.....+|+++++||++||+.||++|||++|+|+||||+...
T Consensus 368 ---------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 368 ---------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp ---------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ---------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 01236789999999999999999999999999999998653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-62 Score=430.06 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=209.2
Q ss_pred ce-eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeec----CCEE
Q 039371 3 KY-TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASE----NYRL 76 (346)
Q Consensus 3 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~----~~~~ 76 (346)
|| ++.++||+|+||+||+|.++.++..||+|++........ ...+.+|+.+++++ +|||||++++++++ ++.+
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEE
Confidence 45 778899999999999999999999999999976654443 34567899999999 79999999999865 4568
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEe--CCcEEEeecccccccC
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG--YFHRDLISKNLLVS--NDTIKIADFGLAWEVD 151 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dikp~NIli~--~~~vkl~Dfg~a~~~~ 151 (346)
|||||||+| +|.+.+.+ .+.+++..++.++.||+.||+|||++| |+||||||+|||++ ++.+||+|||+|+...
T Consensus 105 ~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999985 66666654 456999999999999999999999998 99999999999995 4699999999997654
Q ss_pred CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
. ....+.+||+.|||||++. +.|+.++|||||||++|+|++|..||.+......+...+.....|+
T Consensus 184 ~-~~~~~~~GTp~YmAPE~~~--~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~----------- 249 (290)
T 3fpq_A 184 A-SFAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----------- 249 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-----------
T ss_pred C-CccCCcccCccccCHHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC-----------
Confidence 3 3455678999999999885 4599999999999999999999999987665554444332211111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
...+..++++++||.+||+.||++|||++|+|+||||++
T Consensus 250 ----------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 ----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 112356789999999999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-63 Score=438.87 Aligned_cols=253 Identities=27% Similarity=0.434 Sum_probs=211.6
Q ss_pred CceeeeeeecccCceEEEEEEEc---cCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++++.||+|+||+||+|++. .+++.||+|+++...... ......+|+.+++++ +||||+++++++++++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEE
Confidence 58999999999999999999874 467899999997554322 223456799999988 7999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CC
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CP 154 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~ 154 (346)
||||||+| +|.+.+.+. +.+++.+++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+.... ..
T Consensus 103 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp EEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 99999985 777777654 4599999999999999999999999999999999999995 56999999999986443 33
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
...+.+||+.|||||++. ...|+.++||||+||++|+|++|.+||.+.+..+.+..+.+.....
T Consensus 182 ~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--------------- 245 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM--------------- 245 (304)
T ss_dssp CCCSCCCCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------------
T ss_pred cccccccCcccCCHHHhc-cCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC---------------
Confidence 456678999999999987 5679999999999999999999999999999888888876542211
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
.+.+|+++++||++||+.||++||| ++|+++||||++.
T Consensus 246 ---------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 246 ---------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp ---------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 1357899999999999999999998 5899999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-62 Score=434.39 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=214.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+.|++.++||+|+||+||+|+++.+|+.||+|+++.... ..+|+.+++++ +|||||++++++++++.+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGL-SSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEe
Confidence 578999999999999999999999999999999975432 24799999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C-cEEEeecccccccCCCC----
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D-TIKIADFGLAWEVDSCP---- 154 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~-~vkl~Dfg~a~~~~~~~---- 154 (346)
||+| +|.+.+... +.+++.+++.++.||+.||+|||++||+||||||+|||++. | .+||+|||+|+......
T Consensus 131 y~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred ccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9985 677766554 56999999999999999999999999999999999999964 4 69999999998765322
Q ss_pred --CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 155 --PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 155 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.....+||+.|||||++. ...|+.++||||+||++|+|++|.+||.+.+..+....+..... +
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~--~------------ 274 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVM-GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP--P------------ 274 (336)
T ss_dssp ----CCCCCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC--G------------
T ss_pred eecCCccccCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC--C------------
Confidence 123357999999999997 56799999999999999999999999998877766666654311 0
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHH-------------hcCCCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEA-------------LQHPLFQGCLQVP 291 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~el-------------l~hp~~~~~~~~~ 291 (346)
.....+.+++++.+||.+||+.||.+|||++|+ ++|||+++..++.
T Consensus 275 -------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 275 -------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp -------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred -------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 112235789999999999999999999999997 6799998765543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=432.29 Aligned_cols=279 Identities=24% Similarity=0.377 Sum_probs=217.6
Q ss_pred CceeeeeeecccCceEEEEEEEc---cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++.++||+|+||+||+|+++ .+++.||+|++..... .....+|+.+++.+.+||||++++++|++++++|+
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 57999999999999999999875 4578999999865432 33456899999999889999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeecccccccCCCC-
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~~~~~~- 154 (346)
||||++| +|.+.+. .+++.+++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|+......
T Consensus 98 vmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 98 AMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999985 7777663 3999999999999999999999999999999999999964 589999999997543321
Q ss_pred ----------------------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCh
Q 039371 155 ----------------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLF-PGTCE 205 (346)
Q Consensus 155 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~ 205 (346)
...+.+||+.|+|||++.+...|+.++||||+||++|+|++|+.|| .+.+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 2234579999999999986677999999999999999999999998 45566
Q ss_pred HHHHHHHHHHhCCCChhhHHH-------------------HHHHHHhcCCCCCCcCC-----CCcccccCCCCchHHHHH
Q 039371 206 DDQLYKICNAIGSPTEESWAE-------------------GLELAKAHGYKFPKLQG-----NNLSLLIPSANDDEMSLI 261 (346)
Q Consensus 206 ~~~~~~i~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li 261 (346)
.+++..|....+.+....+.. ..+.........+.... ......++.+|+++++||
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 788888888776543332221 11111111111111111 011123457899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 262 ELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 262 ~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
++||+.||++|||++|+|+||||++.
T Consensus 334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-60 Score=418.30 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=195.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY------- 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~------- 74 (346)
++|++++.||+|+||+||+|+++.+|+.||+|+++............+|+.+++++ +|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence 67999999999999999999999999999999997665544555677999999999 7999999999986543
Q ss_pred -----EEEEEEEcCCC-CHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecc
Q 039371 75 -----RLYFVFEYMDC-NLHQLMSNRKQ--CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFG 145 (346)
Q Consensus 75 -----~~~iv~e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg 145 (346)
.+|||||||+| +|.+.+..... ..++..++.++.||++||+|||++||+||||||+|||++ ++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 47999999985 77777765432 245677899999999999999999999999999999995 5699999999
Q ss_pred cccccCCCC-------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 039371 146 LAWEVDSCP-------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKI 212 (346)
Q Consensus 146 ~a~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 212 (346)
+|+..+... ...+.+||+.|||||++. ...|+.++|||||||++|+|++ ||.+.. +....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHc-CCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHH
Confidence 997665322 123457999999999987 5679999999999999999996 775432 222222
Q ss_pred HHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 213 CNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
........++.+ +..++.+.+||++||+.||++|||++|+++||||++..
T Consensus 238 ~~~~~~~~p~~~--------------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNLKFPPLF--------------------------TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTTCCCHHH--------------------------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcCCCCCCC--------------------------cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 221111111111 13456788999999999999999999999999999754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-59 Score=447.05 Aligned_cols=260 Identities=24% Similarity=0.423 Sum_probs=230.4
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
|++|++++.||+|+||+||+|+++.+|+.||+|++...... ......+|+.+|+.+ +||||++++++|++++.+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~-~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh-hHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEE
Confidence 47899999999999999999999999999999999765432 334556899999999 7999999999999999999999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC---CcEEEeecccccccCCCCCC
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN---DTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~---~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|||+ |+|.+.+....+.+++.+++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|.........
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 9998 4888888777777999999999999999999999999999999999999953 68999999999988776667
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+||+.|+|||++. ...|+.++||||+||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 314 ~~~~GT~~y~APEv~~-~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------- 379 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA------------- 379 (573)
T ss_dssp EEECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG-------------
T ss_pred eeeEECccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc-------------
Confidence 7789999999999987 56689999999999999999999999999999888888876544333322
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.+.+|+++++||++||+.||.+|||++|+|+||||+....
T Consensus 380 -------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 380 -------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp -------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred -------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 2467999999999999999999999999999999997544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-57 Score=398.98 Aligned_cols=250 Identities=25% Similarity=0.326 Sum_probs=201.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+++++.++||+|+||+||+|+++ ..||+|+++....... ...+.+|+.+++++ +|||||++++++.+ +.+||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEEEEE
Confidence 57889999999999999999764 3599999976554443 34567899999999 79999999998865 4589999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-cEEEeecccccccCCC---CC
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSC---PP 155 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~vkl~Dfg~a~~~~~~---~~ 155 (346)
|||+ |+|.+.+......+++.++..++.|++.||+|||+++|+||||||+|||++++ .+||+|||+|+..... ..
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 9998 57888887777779999999999999999999999999999999999999754 9999999999765432 23
Q ss_pred CccccccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 YTEYITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
....+||+.|||||++.. ...|+.++|||||||++|||++|+.||.+.+.......++.....++
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p------------- 257 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP------------- 257 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC-------------
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-------------
Confidence 445689999999999863 34689999999999999999999999998777665555543321111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.+....+.+++++.+|+.+||+.||++|||++|+++
T Consensus 258 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 258 -----------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp -----------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred -----------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 111223467899999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-58 Score=435.81 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=209.4
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHH---HHHHHhhcCCCCeeeeeeeeecCCE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKE---VKCLRKINNHPNIVKLQELASENYR 75 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e---~~~l~~l~~hp~iv~~~~~~~~~~~ 75 (346)
|++|++++.||+|+||+||+|+++.+|+.||+|++++..... ......+| +.++..+ +|||||+++++|++++.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCE
Confidence 589999999999999999999999999999999996543221 11122233 3444455 79999999999999999
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
+|||||||+| +|...+.+. +.++|..++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|......
T Consensus 267 lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999985 677776654 5599999999999999999999999999999999999995 579999999999877653
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhhHHHHHHH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED---DQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
...+.+||+.|||||++.....|+.++|||||||++|+|++|.+||.+.+.. +....+...
T Consensus 346 -~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--------------- 409 (689)
T 3v5w_A 346 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------------- 409 (689)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---------------
T ss_pred -CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---------------
Confidence 3456799999999999975567999999999999999999999999764332 222222221
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGCL 288 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~~ 288 (346)
...+ .+.+|+++++||++||+.||.+|++ ++|+++||||++..
T Consensus 410 ----~~~~-----------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 410 ----AVEL-----------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp ----CCCC-----------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred ----CCCC-----------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 1111 2367899999999999999999998 79999999999753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=400.89 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=209.0
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++++++++||+|+||+||+|+.. .+++.||||+++..........+.+|+.++.++ +|||||++++++.+++.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEE
Confidence 57889999999999999999853 467899999997665555556678999999999 799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcE
Q 039371 77 YFVFEYMD-CNLHQLMSNR---------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTI 139 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~---------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~v 139 (346)
+||||||+ |+|.+.+... ...+++.++..++.||+.||+|||+++|+||||||+|||+++ +.+
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCE
Confidence 99999998 5888877543 235899999999999999999999999999999999999964 599
Q ss_pred EEeecccccccCCC---CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 039371 140 KIADFGLAWEVDSC---PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNA 215 (346)
Q Consensus 140 kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 215 (346)
||+|||+|+..... .......||+.|||||++. .+.|+.++|||||||++|||+| |..||.+.+..+....+...
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~ 263 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 263 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHh-CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999765332 2344567999999999987 5679999999999999999998 89999998887777666443
Q ss_pred hCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 216 IGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...|. .+.+++++.+|+.+||+.||++|||++||+++
T Consensus 264 ~~~~~-----------------------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 264 QVLPC-----------------------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCC-----------------------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 21111 13678899999999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=400.05 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=208.0
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|.+.++||+|+||+||+|++. .++..||+|+++... ......+.+|+.+++++ +|||||++++++.+++.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEE
Confidence 57999999999999999999875 357889999997543 23345567999999999 799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhcc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEe
Q 039371 77 YFVFEYMD-CNLHQLMSNR------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIA 142 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~ 142 (346)
|||||||+ |+|.+.+... ...+++.++..++.|++.||+|||+++|+||||||+|||++ ++.+||+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence 99999998 5788877643 24599999999999999999999999999999999999996 4599999
Q ss_pred ecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 039371 143 DFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGS 218 (346)
Q Consensus 143 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 218 (346)
|||+|+...... ......||+.|||||++. ...|+.++|||||||++|||+| |+.||.+.+..+....+..+...
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~ 249 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999997654332 223356899999999997 5679999999999999999998 89999998888877777554221
Q ss_pred CChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 219 PTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
+. .+.+++++.+|+.+||+.||++|||++|+. +|+++
T Consensus 250 ~~-----------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 250 QR-----------------------------PRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp CC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred CC-----------------------------CccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 11 135789999999999999999999999994 45553
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=399.06 Aligned_cols=286 Identities=34% Similarity=0.638 Sum_probs=241.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+++|++++.||+|+||+||+|++. +++.||+|++....... ......+|+.+++++ +||||+++++++.+++..++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEEEE
Confidence 479999999999999999999985 58999999997554332 234456899999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~ 157 (346)
|||++|++.+.+......+++..++.++.|++.||.|||++||+||||||+||+++ ++.+||+|||++...+.. ....
T Consensus 98 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 177 (311)
T 3niz_A 98 FEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177 (311)
T ss_dssp EECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence 99999999999988777799999999999999999999999999999999999995 569999999999876533 2344
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+.+..+....+.+.+..|....+........
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence 56789999999998766778999999999999999999999999999999999999999988887776544433333334
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+............+.+++++.+||++||+.||++|||++|+++||||++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 444444455556678899999999999999999999999999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-57 Score=405.11 Aligned_cols=289 Identities=34% Similarity=0.617 Sum_probs=243.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
|++|++++.||+|+||+||+|.+..+++.||+|++.............+|+.+++++ +||||+++++++.+++..++||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEe
Confidence 789999999999999999999999999999999997655444444456799999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~ 158 (346)
||++|++.+.+...+..+++..++.++.|++.||.|||++||+||||||+||+++ ++.+||+|||++...... .....
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 80 EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred cccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 9999999999888777799999999999999999999999999999999999995 569999999999765532 23445
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.|....|.............+
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 57899999999987667789999999999999999999999999999999999999999999888876555444444555
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
+...........+.+++++.+||++||+.||++|||++|+++||||++..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 5555555555667889999999999999999999999999999999976543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=399.71 Aligned_cols=248 Identities=23% Similarity=0.365 Sum_probs=201.8
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|.+.++||+|+||+||+|+++ .+++.||||+++... ......+.+|+.++.++ +|||||++++++.+++.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence 46889999999999999999865 468899999997543 23345567999999999 799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhcc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEE
Q 039371 77 YFVFEYMD-CNLHQLMSNR--------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIK 140 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vk 140 (346)
|||||||+ |+|.+.+... .+++++.++..++.|++.||+|||+++|+||||||+|||+++ +.+|
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence 99999998 5777777543 245899999999999999999999999999999999999965 5999
Q ss_pred EeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 039371 141 IADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAI 216 (346)
Q Consensus 141 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 216 (346)
|+|||+|+...... ......||+.|||||++. ...++.++|||||||++|||+| |+.||.+.+..+....+..+.
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhc-CCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998654332 233467899999999887 6679999999999999999998 899999988887777765532
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 217 GSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..+ ..+.+++++.+|+.+||+.||++|||++|++++
T Consensus 278 ~~~-----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 278 ELE-----------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCC-----------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCC-----------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 111 113578999999999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-56 Score=391.31 Aligned_cols=285 Identities=34% Similarity=0.582 Sum_probs=239.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
|++|++++.||+|+||+||+|.+..+++.||+|++....... ......+|+.+++++ +||||+++++++.+++..++|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEE
Confidence 689999999999999999999999999999999997654433 334556899999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~ 157 (346)
||+++|++.+.+...++.+++..++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||++...+.. ....
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence 99999999998888777899999999999999999999999999999999999995 569999999999876533 3345
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPL-FPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+|+.|+|||++.+...++.++||||+||++|+|++|..| |.+.+..+.+..+.+..+.+....|............
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence 567899999999998666689999999999999999987665 7788888899999999998888777643322111111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.............+.+++++++||++||+.||++|||++|+++||||++.
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 240 -PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp -CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred -ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 11111223344456789999999999999999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=400.72 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=208.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCC-----cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec-CCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG-----EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE-NYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-~~~ 75 (346)
++|+++++||+|+||+||+|.+..++ +.||+|+++............+|+.++.++.+|||||++++++.+ ++.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 58999999999999999999877543 579999998766555566678999999999767999999999865 567
Q ss_pred EEEEEEcCC-CCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCc
Q 039371 76 LYFVFEYMD-CNLHQLMSNR---------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDT 138 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~---------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~ 138 (346)
++||||||+ |+|.+.+... ...+++.++..++.||+.||+|||+++|+||||||+|||++ ++.
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 223 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 223 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence 899999998 5788877543 23489999999999999999999999999999999999995 569
Q ss_pred EEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 039371 139 IKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 139 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 214 (346)
+||+|||+|+....... .....||+.|||||++. ...|+.++|||||||++|||+| |..||.+.+..+.+..++.
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~ 302 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 302 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHh-cCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 99999999987654332 23457899999999997 5679999999999999999998 8999998765555444433
Q ss_pred HhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....++ ..+.+++++.+++.+||+.||++|||++|+++|
T Consensus 303 ~g~~~~----------------------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 303 EGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC----------------------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 322111 113578899999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-55 Score=392.02 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=222.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+++|++++.||+|+||+||+|.+..+|+.||+|++........ .....+|+.+++.+ +||||+++++++.+++.+|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999977655443 34456899999999 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
|||++| ++.+.+... +.+++.+++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||++..........
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence 999975 677766554 4599999999999999999999999999999999999995 5699999999998776666666
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+.......
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------------------ 233 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI------------------ 233 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------------
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC------------------
Confidence 77899999999999865555689999999999999999999999988877777665432211
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
| ..+++++.+||++||+.||.+|||++|+++||||+....
T Consensus 234 -p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 234 -P-----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp -C-----------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred -C-----------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 1 246889999999999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=387.44 Aligned_cols=283 Identities=34% Similarity=0.606 Sum_probs=232.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
|++|++++.||+|+||+||+|++ .+++.||+|++........ .....+|+.+++++ +||||+++++++.+++..++|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEE
Confidence 68999999999999999999998 6789999999865433221 23446899999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~ 157 (346)
||+++|++.+.+....+.+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++...... ....
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 99999999998887767799999999999999999999999999999999999995 569999999999765532 2334
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.+....|....... .....
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 237 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP-KYDPN 237 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST-TCCTT
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc-ccccc
Confidence 55789999999998766678999999999999999999999999999999999999988888776665322211 11111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
++...........+.+++++.+||++||+.||++|||++|+++||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 2222222333445678999999999999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-55 Score=407.79 Aligned_cols=282 Identities=31% Similarity=0.489 Sum_probs=227.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------C
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN------Y 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------~ 74 (346)
++|++++.||+|+||+||+|.+..+++.||+|++....... ......+|+.+++.+ +||||+++++++... .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccCC
Confidence 68999999999999999999999999999999997654433 334557899999999 799999999998544 4
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
.+|+||||++|++...+.. .+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 6899999999998887754 389999999999999999999999999999999999996 569999999999887766
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.......||+.|+|||++. ...++.++||||+||++|+|++|++||.+.+..+++..+++..+.|.++.+.........
T Consensus 218 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp CCC----CCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred cccCCCcccccccCHHHHc-CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 6667788999999999987 457899999999999999999999999999999999999999999988776543332222
Q ss_pred cCCCCCCcCCCCcccccCC------------CCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPS------------ANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.....+...........+. .++++++||++||+.||++|||++|+|+||||+...
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 2112222222121111111 156789999999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=391.13 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=223.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----EECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|.++.+|+.||+|+++...... ......+|+.+++++ +||||+++++++++++.+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCCEE
Confidence 57999999999999999999999999999999997654332 123456899999999 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C----cEEEeeccccccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D----TIKIADFGLAWEV 150 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~----~vkl~Dfg~a~~~ 150 (346)
++||||+.| +|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+||++++ + .+||+|||++...
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999975 67666654 456999999999999999999999999999999999999953 3 6999999999887
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
..........||+.|+|||++. ...++.++||||+||++|+|++|.+||.+.+..+.+..+.......+.+.|
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------ 242 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF------ 242 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH------
T ss_pred CCCCccccCCCCccEECchHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc------
Confidence 7666666778999999999886 566899999999999999999999999999888888877665444443332
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+.+++++++||++||+.||.+|||++|+++||||++.
T Consensus 243 --------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 243 --------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp --------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred --------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 3678999999999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=389.84 Aligned_cols=288 Identities=31% Similarity=0.576 Sum_probs=223.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.++|++++.||+|+||+||+|.++.+|+.||+|+++............+|+.+++++ +||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEE
Confidence 368999999999999999999999999999999997655433334566899999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-
Q 039371 81 EYMDCNLHQLMSNRK-----QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC- 153 (346)
Q Consensus 81 e~~~g~l~~~~~~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~- 153 (346)
||++|+|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 999999988876542 3589999999999999999999999999999999999995 569999999999876533
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++...|........
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 241 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK- 241 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT-
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh-
Confidence 2344567899999999987666789999999999999999999999999999999999999888887776654322111
Q ss_pred cCCCCCCcCCCCc-----ccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 234 HGYKFPKLQGNNL-----SLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 234 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
.....+......+ ......++.++.+||++||+.||++|||++|+++||||++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 0001111111111 11223678899999999999999999999999999999986553
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=382.36 Aligned_cols=284 Identities=33% Similarity=0.574 Sum_probs=231.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH----HHhhhHHHHHHHHhhc--CCCCeeeeeeeeecCC-
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW----EECLNLKEVKCLRKIN--NHPNIVKLQELASENY- 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~--~hp~iv~~~~~~~~~~- 74 (346)
++|++++.||+|+||+||+|++..+++.||+|++....... ......+|+.+++++. +||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 68999999999999999999999999999999996543221 1122345666666553 5999999999987654
Q ss_pred ----EEEEEEEcCCCCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccc
Q 039371 75 ----RLYFVFEYMDCNLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAW 148 (346)
Q Consensus 75 ----~~~iv~e~~~g~l~~~~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~ 148 (346)
.++++||+++|+|.+.+..... .+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 168 (308)
T 3g33_A 89 DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168 (308)
T ss_dssp SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence 5899999999999988876543 499999999999999999999999999999999999995 5699999999998
Q ss_pred ccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 149 EVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 149 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
............+|+.|+|||++. ...++.++|||||||++|+|++|.+||.+.+..+....+....+.++...|....
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (308)
T 3g33_A 169 IYSYQMALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 247 (308)
T ss_dssp TSTTCCCSGGGGCCCSSCCHHHHH-TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred ccCCCcccCCccccccccCchHHc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence 877666667788999999999987 5668999999999999999999999999999999999999998888877664321
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
... ...++...........+.+++++.+||++||+.||++|||++|+|+||||+....
T Consensus 248 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 248 SLP---RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp SSC---GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred hcc---ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 110 0112222233344456788999999999999999999999999999999997543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=403.54 Aligned_cols=286 Identities=34% Similarity=0.573 Sum_probs=223.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeee-----cCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELAS-----ENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~-----~~~~ 75 (346)
++|++++.||+|+||+||+|+++.+++.||+|++........ .....+|+.+++++ +||||+++++++. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCce
Confidence 689999999999999999999999999999999976544433 34557899999999 7999999999984 3467
Q ss_pred EEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 76 LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
+|+|||+++|++...+... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 9999999999998888764 4599999999999999999999999999999999999996 4599999999997654221
Q ss_pred ----------------------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-----------
Q 039371 155 ----------------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT----------- 195 (346)
Q Consensus 155 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~----------- 195 (346)
.....+||+.|+|||++.....++.++|||||||++|+|++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 23445789999999987667779999999999999999998
Q ss_pred CCCCCCCCC--------------------hHHHHHHHHHHhCCCChhhHHHHHH-HHHhcCCCCCCcCCCCcccccCCCC
Q 039371 196 FHPLFPGTC--------------------EDDQLYKICNAIGSPTEESWAEGLE-LAKAHGYKFPKLQGNNLSLLIPSAN 254 (346)
Q Consensus 196 g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (346)
|.++|++.+ ..+++..+.+..+.|+.+.+..... ........++......+....+..+
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 778887654 3577888888999998877653221 1112222344445555666678889
Q ss_pred chHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 255 DDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 255 ~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
+++.+||++||+.||++|||++|+|+||||++...
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 99999999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=379.67 Aligned_cols=289 Identities=32% Similarity=0.548 Sum_probs=231.4
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+++|++++.||+|+||+||+|.+..+|+.||+|++........ .....+|+.+++++ +||||+++++++.+++..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEE
Confidence 6899999999999999999999999999999999876654433 34456899999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~ 157 (346)
||+++|+++..+......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++...... ....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 99999887777766666799999999999999999999999999999999999996 569999999999876533 2345
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+....+...+.............+..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 56789999999999866778999999999999999999999999999999998888888777665443322222222222
Q ss_pred CCCcCC-CCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 238 FPKLQG-NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
.+.... .......+.++.++.+||++||+.||.+|||++|+++||||++..+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 222211 11222345788999999999999999999999999999999986553
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-54 Score=393.12 Aligned_cols=287 Identities=30% Similarity=0.578 Sum_probs=221.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN--YRLY 77 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 77 (346)
+++|++++.||+|+||+||+|.+..+|+.||+|++....... ......+|+.+++++.+||||+++++++..+ ..+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 378999999999999999999999999999999986554433 3445578999999997799999999999754 4789
Q ss_pred EEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC----
Q 039371 78 FVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS---- 152 (346)
Q Consensus 78 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~---- 152 (346)
+||||++|++...+... .+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|+....
T Consensus 88 lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 99999999988888653 599999999999999999999999999999999999995 56999999999976532
Q ss_pred ------------------CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 039371 153 ------------------CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 153 ------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 214 (346)
.......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+++..+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 11234467999999999998667899999999999999999999999999999999999999
Q ss_pred HhCCCChhhHHHH--------HHHHHhcCCCCCCcCCCCc---------ccccCCCCchHHHHHHHhcccCCCCCCCHHH
Q 039371 215 AIGSPTEESWAEG--------LELAKAHGYKFPKLQGNNL---------SLLIPSANDDEMSLIELLCSWDPCKRPTAAE 277 (346)
Q Consensus 215 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e 277 (346)
..+.|+.+.+... ................... ......+++++.+||++||+.||++|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 9998887654321 1111100000000000000 0011267889999999999999999999999
Q ss_pred HhcCCCCCCCCC
Q 039371 278 ALQHPLFQGCLQ 289 (346)
Q Consensus 278 ll~hp~~~~~~~ 289 (346)
+|+||||+....
T Consensus 326 ~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 326 ALKHPFVSIFHN 337 (388)
T ss_dssp HTTSTTTTTTCC
T ss_pred HhCCHHHHHhcC
Confidence 999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-54 Score=387.84 Aligned_cols=286 Identities=35% Similarity=0.616 Sum_probs=228.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+++|++++.||+|+||+||+|++..+++.||+|+++...... ......+|+.+++++ +||||+++++++.+++.+++|
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEEE
Confidence 479999999999999999999999999999999997554433 234456899999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC------CcEEEeecccccccCCC
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN------DTIKIADFGLAWEVDSC 153 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~------~~vkl~Dfg~a~~~~~~ 153 (346)
|||++|+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++......
T Consensus 112 ~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 112 FEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 9999999988887654 4999999999999999999999999999999999999942 25999999999766532
Q ss_pred -CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 154 -PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 154 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+....+.|+...|...... .
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 269 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL-P 269 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS-T
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh-h
Confidence 23445678999999999986667899999999999999999999999999999999999999888877666432111 1
Q ss_pred hcCCCCCCcCCCCcccc-cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLL-IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.....++.......... ...+++++.+||++||+.||++|||++|+++||||++...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 11112222222211111 1237889999999999999999999999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=397.67 Aligned_cols=287 Identities=33% Similarity=0.559 Sum_probs=231.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-----CE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN-----YR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-----~~ 75 (346)
++|++++.||+|+||+||+|++..+++.||+|++....... ......+|+.+++++ +||||+++++++... +.
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCCe
Confidence 68999999999999999999999999999999997654443 334567899999999 799999999998766 57
Q ss_pred EEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 76 LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
+|+|||+++|+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|.......
T Consensus 105 ~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 9999999999998888664 4599999999999999999999999999999999999996 4599999999998664332
Q ss_pred -----------------------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-----------CCCCC
Q 039371 155 -----------------------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-----------FHPLF 200 (346)
Q Consensus 155 -----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-----------g~~pf 200 (346)
.....+||+.|+|||++.....++.++||||+||++|+|++ |.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 23567889999999987667789999999999999999998 45556
Q ss_pred CCCC-----------------hHHHHHHHHHHhCCCChhhHHHHHHH-HHhcCCCCCCcCCCCcccccCCCCchHHHHHH
Q 039371 201 PGTC-----------------EDDQLYKICNAIGSPTEESWAEGLEL-AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIE 262 (346)
Q Consensus 201 ~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 262 (346)
.+.+ ..+++..+.+..+.|+.+.+...... ........+...........+.+++++.+||+
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 5543 36788889999999988766532111 11111122223333344455678999999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 263 LLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 263 ~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
+||+.||++|||++|+|+||||++....
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 9999999999999999999999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=384.72 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=227.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ........+|+.+++.+ +||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEE
Confidence 37899999999999999999999999999999998744 23344556899999998 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe---CCcEEEeecccccccCCCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS---NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~---~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
||++| +|.+.+......+++.++..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 99985 78888877666799999999999999999999999999999999999996 569999999999887765556
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+|+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+......++...|
T Consensus 161 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------ 227 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF------------ 227 (321)
T ss_dssp EEEESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH------------
T ss_pred ccccCChhhcCcHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh------------
Confidence 6678999999999886 456799999999999999999999999999888888888776555444333
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+.++.++.+||++||+.||.+|||++|+++||||++..
T Consensus 228 --------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 228 --------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp --------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred --------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 36789999999999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=388.69 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=213.1
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|+++.+++.||+|+++...... ......+|..++..+.+||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 579999999999999999999999999999999997543211 223346788889888789999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~ 155 (346)
||||++| +|...+... +.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|.... ....
T Consensus 102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence 9999986 666666554 4599999999999999999999999999999999999995 5699999999997633 2234
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 181 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--------------- 244 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQ-EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--------------- 244 (353)
T ss_dssp -----CCGGGCCHHHHH-HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------
T ss_pred ccccCCCcCeEChhhcC-CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 55678999999999887 55689999999999999999999999999988888887765422111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA------AEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~------~ell~hp~~~~~ 287 (346)
..+++++.++|++||+.||++||++ +|+++||||++.
T Consensus 245 ---------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 245 ---------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred ---------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 2468899999999999999999998 899999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=381.32 Aligned_cols=254 Identities=29% Similarity=0.474 Sum_probs=216.6
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|+++.+|+.||+|+++.... ........+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEE
Confidence 5799999999999999999999999999999999975432 22233456899999988 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~ 155 (346)
||||++| +|...+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++.... ....
T Consensus 83 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 9999986 66665554 44599999999999999999999999999999999999995 5799999999997643 3334
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 162 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------------ 222 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------ 222 (337)
T ss_dssp BCCCEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------
T ss_pred ccccccChhhCChhhhc-CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 56678999999999887 56689999999999999999999999998887776666654211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
.++ ..++++++++|++||+.||++|| +++|+++||||++.
T Consensus 223 -~~p-----------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 223 -RFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp -CCC-----------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred -CCC-----------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 111 35789999999999999999999 89999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=387.31 Aligned_cols=285 Identities=32% Similarity=0.544 Sum_probs=238.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-----CEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN-----YRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-----~~~ 76 (346)
++|++++.||+|+||+||+|.+..+++.||+|++.............+|+.++.++ +||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccceE
Confidence 48999999999999999999999999999999997554444445667899999999 799999999998654 478
Q ss_pred EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-
Q 039371 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~- 154 (346)
|+|||+++|+|.+.+... .+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 106 ~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 999999999998887653 499999999999999999999999999999999999996 4599999999997655322
Q ss_pred ---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 155 ---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 155 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
......||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....+.|+.+.+.......
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 23445899999999988766778999999999999999999999999999999999999999999887665322111
Q ss_pred -HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 232 -KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.......+...........+.+++++.+||++||+.||++|||++|+++||||++...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 1111122222233344455678999999999999999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=387.44 Aligned_cols=283 Identities=34% Similarity=0.539 Sum_probs=231.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecC------C
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASEN------Y 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------~ 74 (346)
++|++++.||+|+||+||+|.+..+|+.||+|++........ .....+|+.+++.+ +||||+++++++... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccccCc
Confidence 589999999999999999999999999999999966544433 34557899999999 799999999999765 3
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
.+|+|||+++++|.+.+.. ..+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++.....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-
Confidence 4699999998788877765 3599999999999999999999999999999999999996 56999999999987654
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH-HH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL-AK 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~ 232 (346)
......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+++..+.+..+.|+.+.+...... ..
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 181 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 2345678999999999986577999999999999999999999999999999999999999999987765432111 01
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..-...+...........+..++++.+||++||+.||.+|||++|+|+||||++...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 111123334444555666788999999999999999999999999999999998654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-54 Score=384.86 Aligned_cols=303 Identities=24% Similarity=0.354 Sum_probs=233.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||+||+|.+..+++.||+|++....... ......+|+.+++.+ +||||+++++++.+++..++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEE
Confidence 378999999999999999999999999999999986543221 123456899999888 79999999999999999999
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCCCc
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||||++|++.+.+...+ .+++.+++.++.|++.||.|||++||+||||||+||++++ +.+||+|||++..........
T Consensus 87 v~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 87 VIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred EEECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence 99999999998887654 4999999999999999999999999999999999999964 599999999998777666667
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.........+
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------------------------- 220 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV------------------------- 220 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-------------------------
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-------------------------
Confidence 7789999999999975554588999999999999999999999765432111100
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCCCccccc-----ccC-CccccccCc
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSIDSCK-----MRL-TPSAKKSGW 311 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~-----~~~-~~~~~~~~~ 311 (346)
..........+++++.+||++||+.||.+|||++|+++||||+.............. .+. .......++
T Consensus 221 -----~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
T 3h4j_B 221 -----NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGF 295 (336)
T ss_dssp -----CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCCGGGSCCCCCCCCCCCHHHHHHHHHTTCC
T ss_pred -----HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCccccCCchhcccccCCHHHHHHHHHHcCC
Confidence 000111224578999999999999999999999999999999864321100000000 000 001123344
Q ss_pred cchhhhhhcccCcchhHHHHHHHH
Q 039371 312 KAKLIVWFLRWEPFSSLLLFVACI 335 (346)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~ 335 (346)
....+...+....++...+++.++
T Consensus 296 ~~~~i~~~l~~~~~~~~~~~y~ll 319 (336)
T 3h4j_B 296 SEDYIVEALRSDENNEVKEAYNLL 319 (336)
T ss_dssp CHHHHHHHTTSSSCCSSTTHHHHH
T ss_pred CHHHHHHHHhcCCCCHHHHHHHHH
Confidence 445555566666777666665543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=384.65 Aligned_cols=288 Identities=32% Similarity=0.516 Sum_probs=232.4
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeec-------
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASE------- 72 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------- 72 (346)
+++|++++.||+|+||+||+|++..+|+.||+|++....... ......+|+.+++++ +||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence 478999999999999999999999999999999986554332 223456899999999 79999999999876
Q ss_pred -CCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc
Q 039371 73 -NYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV 150 (346)
Q Consensus 73 -~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~ 150 (346)
++.+++||||++|++...+......+++.+++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 457899999999999999988777799999999999999999999999999999999999996 569999999999765
Q ss_pred CCC-----CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHH
Q 039371 151 DSC-----PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 151 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (346)
... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.++.+.|.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 421 233456789999999998766778999999999999999999999999999999999999888888776665
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccc--CCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLLI--PSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......................... ...++++.+||++||+.||++|||++|+++||||++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 3322111111111110000000000 013677999999999999999999999999999987544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=377.33 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=220.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----EECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||+||+|.++.+|+.||+|++....... ......+|+.+++++ +||||+++++++.+++..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEE
Confidence 47999999999999999999999999999999997654322 233456899999999 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C----cEEEeeccccccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D----TIKIADFGLAWEV 150 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~----~vkl~Dfg~a~~~ 150 (346)
++||||+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||++++ + .+||+|||++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999975 66666654 456999999999999999999999999999999999999953 3 6999999999887
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
..........||+.|+|||++. ...++.++|||||||++|+|++|..||.+....+.+..+.......+...
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------- 240 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY------- 240 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred CCCCccccccCCcCcCCceeec-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc-------
Confidence 6655566678999999999886 56789999999999999999999999999888777777665443333222
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.+.++..+.+||++||+.||++|||++|+++||||+..
T Consensus 241 -------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 241 -------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp -------------------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 13578899999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=383.99 Aligned_cols=285 Identities=35% Similarity=0.615 Sum_probs=232.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH----HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE----ECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++++.||+|+||+||+|.+..+|+.||+|++........ .....+|+.+++++ +||||+++++++.+.+..+
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCceE
Confidence 689999999999999999999999999999999975433221 22456899999999 7999999999999999999
Q ss_pred EEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CC
Q 039371 78 FVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PP 155 (346)
Q Consensus 78 iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~ 155 (346)
+|||+++|++...+......+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++...... ..
T Consensus 89 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (346)
T 1ua2_A 89 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168 (346)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred EEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCccc
Confidence 9999999999988887777799999999999999999999999999999999999995 569999999999876433 33
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.|.+.......
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-- 246 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY-- 246 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC--
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc--
Confidence 455678999999999876667899999999999999999999999999999999999999888887766532111000
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..+............+.+++++++||++||+.||++|||++|+++||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 011111111222334677899999999999999999999999999999987653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=387.11 Aligned_cols=278 Identities=30% Similarity=0.541 Sum_probs=232.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec---------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--------- 72 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--------- 72 (346)
++|++++.||+|+||+||+|++..+|+.||+|++...... ..+|+.+++.+ +||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTC-CCTTBCCEEEEEEEC--------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHc-CCCCccchhheeeecCccccccc
Confidence 6899999999999999999999999999999998654222 23699999999 79999999999843
Q ss_pred -----------------------------CCEEEEEEEcCCCCHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHC
Q 039371 73 -----------------------------NYRLYFVFEYMDCNLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMHRQ 120 (346)
Q Consensus 73 -----------------------------~~~~~iv~e~~~g~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~ 120 (346)
+..+++||||++|++.+.+. ..+..+++..++.++.||+.||.|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34589999999998776654 3456699999999999999999999999
Q ss_pred CccccCCCCCCEEEe--CCcEEEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCC
Q 039371 121 GYFHRDLISKNLLVS--NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHP 198 (346)
Q Consensus 121 ~ivH~dikp~NIli~--~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 198 (346)
||+||||||+||+++ ++.+||+|||++.............+|+.|+|||++.+...++.++||||+||++|+|++|..
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 999999999999996 468999999999877666666677889999999998866679999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccc-cCCCCchHHHHHHHhcccCCCCCCCHHH
Q 039371 199 LFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLL-IPSANDDEMSLIELLCSWDPCKRPTAAE 277 (346)
Q Consensus 199 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rps~~e 277 (346)
||.+.+..+.+..+....+.|+.+.+...... .....++......+... ....++++.+||++||+.||++|||+.|
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH--YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT--C--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcc--cccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99999999999999999999988766532211 11223333333333322 3457889999999999999999999999
Q ss_pred HhcCCCCCCC
Q 039371 278 ALQHPLFQGC 287 (346)
Q Consensus 278 ll~hp~~~~~ 287 (346)
+++||||++.
T Consensus 319 ~l~hp~f~~~ 328 (383)
T 3eb0_A 319 AMAHPFFDHL 328 (383)
T ss_dssp HHTSGGGHHH
T ss_pred HhcCHHHHHH
Confidence 9999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=391.61 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=220.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++++.||+|+||+||+|.++.+|+.||+|++........ .....+|+.+++++ +||||+++++++.+++..|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976554333 34456899999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CCcEEEeecccccccCCCC-
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~~vkl~Dfg~a~~~~~~~- 154 (346)
||+.| +|.+.+... +.+++.++..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 90 E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 90 DLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99985 777777654 4599999999999999999999999999999999999995 3589999999997765433
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
......||+.|+|||++. ...++.++||||+||++|+|++|.+||.+.+..+....+.......+.+.|
T Consensus 169 ~~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---------- 237 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW---------- 237 (444)
T ss_dssp BCCCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT----------
T ss_pred eeecccCCcccCCHHHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc----------
Confidence 335568999999999886 557899999999999999999999999999888888877665444333222
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+.+++++.+||++||+.||++|||++|+|+||||+..
T Consensus 238 ----------------~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 238 ----------------DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ----------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ----------------ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 3678999999999999999999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=382.97 Aligned_cols=257 Identities=30% Similarity=0.492 Sum_probs=222.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH-hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-CLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++.+.||+|+||+||+|.++.+|+.||+|++......... ....+|+.+++++ +||||+++++++.+++..|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEE
Confidence 4799999999999999999999999999999999766554433 3456899999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC----CcEEEeecccccccCCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN----DTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~----~~vkl~Dfg~a~~~~~~~~ 155 (346)
||+.| +|.+.+... ..+++.++..++.||+.||.|||++||+||||||+||+++. +.+||+|||++........
T Consensus 108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99986 676666554 45999999999999999999999999999999999999953 3699999999988776666
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....||+.|+|||++. ...++.++|||||||++|+|++|.+||.+.+..+....+.......+...|
T Consensus 187 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------- 254 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW----------- 254 (362)
T ss_dssp CCCSCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG-----------
T ss_pred cccCCCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc-----------
Confidence 66678999999999886 567899999999999999999999999998888777777665443333222
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+.+++++++||.+||+.||++|||++|+++||||+..
T Consensus 255 ---------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 255 ---------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ---------------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ---------------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 3578999999999999999999999999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=383.79 Aligned_cols=264 Identities=26% Similarity=0.429 Sum_probs=211.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|+++.+++.||+|++++...... .....+|..++.++.+||||+++++++.+++.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4789999999999999999999999999999999976654332 23346788888888789999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccc-cCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWE-VDSCPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~-~~~~~~ 155 (346)
||||++| +|...+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|.. ......
T Consensus 131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence 9999986 66666554 44599999999999999999999999999999999999995 56999999999976 333345
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||+.|+|||++. ...++.++|||||||++|+|++|.+||......+.... .......+......
T Consensus 210 ~~~~~gt~~Y~aPE~l~-~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~----------~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ----------NTEDYLFQVILEKQ 278 (396)
T ss_dssp BCCCCBCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC----------------CCHHHHHHHHHHCC
T ss_pred cccccCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch----------hhHHHHHHHHhccc
Confidence 66678999999999987 56789999999999999999999999965432111000 00000111111111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA------AEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~------~ell~hp~~~~~ 287 (346)
..+| +.+++++++||++||+.||++||++ +|+++||||++.
T Consensus 279 ~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 279 IRIP-----------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp CCCC-----------TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred cCCC-----------CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 1222 3578999999999999999999995 899999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-53 Score=380.12 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=217.3
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||+||+|+++.+|+.||+|+++.... .........|..++..+.+||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 5799999999999999999999999999999999975432 12233345788888887789999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~ 155 (346)
||||++| +|.+.+... +.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++..... ...
T Consensus 96 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence 9999975 676666553 4599999999999999999999999999999999999995 56999999999976432 234
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 175 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------------- 236 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF----------------- 236 (345)
T ss_dssp BCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred ccCCCCCcccCChhhhc-CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 55678999999999987 566899999999999999999999999998887777766543211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA-EALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~-ell~hp~~~~~~ 288 (346)
+ ...+++++++||++||+.||++||++. ++++||||++..
T Consensus 237 --~-----------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 237 --Y-----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp --C-----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred --C-----------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 1 124688999999999999999999998 999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=371.04 Aligned_cols=255 Identities=26% Similarity=0.446 Sum_probs=216.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+..+++.||+|++....... .....+|+.+++++ +||||+++++++.+++..++|||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEE
Confidence 58999999999999999999999999999999987554433 33456899999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
|++| +|.+.+... .+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++....... ....
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred CCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 9975 666666543 499999999999999999999999999999999999995 5699999999987665433 3445
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+.......+.........
T Consensus 176 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------- 237 (297)
T 3fxz_A 176 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ----------------- 237 (297)
T ss_dssp CCSCGGGCCHHHHH-CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-----------------
T ss_pred ccCCcCccChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-----------------
Confidence 68999999999987 567899999999999999999999999988877666655443221110
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
....+++.+.++|.+||+.||++|||++|+++||||+...
T Consensus 238 ----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 238 ----------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp ----------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------CccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 0135688899999999999999999999999999998643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=376.88 Aligned_cols=285 Identities=32% Similarity=0.535 Sum_probs=234.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
+++|++++.||+|+||+||+|++..+|+.||+|++........ .....+|+.+++++ +||||+++++++.+++..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEE
Confidence 5799999999999999999999999999999999876655443 33446899999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~ 157 (346)
||+++|+++..+......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++...... ....
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence 99999988877766666799999999999999999999999999999999999995 569999999999765432 2344
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+|+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+....+...+.............+..
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence 56789999999999766678999999999999999999999999999999999999888887766554333332233333
Q ss_pred CCCcCC-CCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 238 FPKLQG-NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.+.... .......+.+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 333222 1223334578999999999999999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=386.37 Aligned_cols=283 Identities=32% Similarity=0.476 Sum_probs=218.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCC------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENY------ 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~------ 74 (346)
++|++++.||+|+||+||+|.+..+++.||+|++........ .....+|+.+++.+ +||||+++++++...+
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccccccc
Confidence 689999999999999999999999999999999976544433 34456899999998 7999999999987654
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
..|+|||+++|++.+.+.. .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 7899999999998888753 389999999999999999999999999999999999996 569999999999877665
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.......+|+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+.+..+....+.|.++.+.........
T Consensus 181 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 181 FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ---------CTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred cccCCceecCCccCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 5556678999999999987 466899999999999999999999999999999999999998888877665432222111
Q ss_pred cCCCCCCcCCCCcccccC------------CCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIP------------SANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.....+...........+ ..+.++++||++||+.||++|||++|+++||||+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 111111111111111111 12567899999999999999999999999999987543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=383.02 Aligned_cols=279 Identities=35% Similarity=0.559 Sum_probs=230.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------CE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN------YR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------~~ 75 (346)
.+|++++.||+|+||+||+|++..+++ +|+|.+..... ...+|+.+++.+ +||||+++++++... ..
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-----~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-----FKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-----SCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-----hHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceE
Confidence 479999999999999999999987776 77777654321 123689999999 799999999998543 34
Q ss_pred EEEEEEcCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe--CCcEEEeeccccccc
Q 039371 76 LYFVFEYMDCNLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS--NDTIKIADFGLAWEV 150 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~--~~~vkl~Dfg~a~~~ 150 (346)
+++||||+++++...+.. ....+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|...
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 889999999987765542 345699999999999999999999999999999999999997 569999999999877
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
..........+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+.+..+.|+.+.+.....
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~- 271 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP- 271 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG-
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh-
Confidence 6666666778999999999997666799999999999999999999999999999999999999999998877654321
Q ss_pred HHhcCCCCCCcCCCCccc-ccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSL-LIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......++......... ..+.+++++.+||++||+.||.+|||+.|+++||||++...
T Consensus 272 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 272 -NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp -GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred -hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 11223333333333322 23458899999999999999999999999999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=382.32 Aligned_cols=259 Identities=24% Similarity=0.423 Sum_probs=222.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.++.+|+.||+|++..... .......+|+.+++++ +||||+++++++.+++.+++|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEE
Confidence 689999999999999999999999999999999975432 2334556899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe---CCcEEEeecccccccCCCCCCc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS---NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~---~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
|+.| +|.+.+......+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++..........
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 9975 77777776666799999999999999999999999999999999999995 3479999999998877655555
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 209 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~---------------- 271 (387)
T 1kob_A 209 VTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE---------------- 271 (387)
T ss_dssp EECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS----------------
T ss_pred eeccCCCccCchhcc-CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----------------
Confidence 668999999999887 566899999999999999999999999998877777666543222111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.....+++++++||++||+.||++|||++|+++||||++...
T Consensus 272 ----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 272 ----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp ----------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred ----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 112467899999999999999999999999999999997543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=374.94 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=210.6
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+++|++++.||+|+||+||+|.+..+++.||+|++.............+|+.+++.+ +||||+++++++.+++..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999997655544445567899999998 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCC---CC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSC---PP 155 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~---~~ 155 (346)
||++| +|.+.+. ....+++..+..++.|++.||+|||++||+||||||+||+++. +.+||+|||++...... ..
T Consensus 85 e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 85 EYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp ECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 99986 5655554 4445999999999999999999999999999999999999964 69999999999754322 23
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....||+.|+|||++.+...++.++|||||||++|+|++|..||....................
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 228 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--------------- 228 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS---------------
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC---------------
Confidence 34567999999999997555568899999999999999999999987655422222211111000
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.....+++.+.+||++||+.||++|||++|+++||||+....
T Consensus 229 ------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 229 ------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp ------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred ------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 011357889999999999999999999999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=386.89 Aligned_cols=279 Identities=33% Similarity=0.555 Sum_probs=231.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec------CCEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE------NYRL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------~~~~ 76 (346)
+|++.+.||+|+||+||+|++..+|+.||+|++..... ...+|+.+++++ +||||+++++++.. ...+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeE
Confidence 69999999999999999999999999999999865421 234799999999 79999999998743 2347
Q ss_pred EEEEEcCCCCHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--CcEEEeecccccccC
Q 039371 77 YFVFEYMDCNLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--DTIKIADFGLAWEVD 151 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~~vkl~Dfg~a~~~~ 151 (346)
++||||+++++...+. .....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++....
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 8999999998776654 33456999999999999999999999999999999999999973 368999999998766
Q ss_pred CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.........+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+++..+.|..+.+.....
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~-- 286 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP-- 286 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS--
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh--
Confidence 555556678999999999987666799999999999999999999999999999999999999999998877754211
Q ss_pred HhcCCCCCCcCCCCccc-ccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSL-LIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
....+.++......+.. ..+..++++.+||++||+.||.+|||+.|+++||||++...
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 11122333332222222 23467899999999999999999999999999999987644
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=378.10 Aligned_cols=255 Identities=26% Similarity=0.420 Sum_probs=217.2
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|+++.+++.||+|+++.... .........|..++..+.+||+|+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 5799999999999999999999999999999999975432 11223446788888887789999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~ 155 (346)
||||++| +|.+.+... +.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++.... ....
T Consensus 99 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence 9999985 676666544 4599999999999999999999999999999999999995 5699999999997643 2334
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 178 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----------------- 239 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA----------------- 239 (353)
T ss_dssp BCCCCSCGGGCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred cccccCCccccChhhhc-CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 55678999999999887 566899999999999999999999999998888777777653211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
+ ...+++++++||++||+.||.+||+ ++++++||||+..
T Consensus 240 --~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 240 --Y-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp --C-----------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred --C-----------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 1 1357899999999999999999994 7999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=372.70 Aligned_cols=252 Identities=27% Similarity=0.464 Sum_probs=215.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|+++.+|+.||+|+++..... .......+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEE
Confidence 47999999999999999999999999999999999754321 1223345788888888 89999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
||||+.| +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++..... ..
T Consensus 84 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~ 160 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VT 160 (318)
T ss_dssp EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CB
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--cc
Confidence 9999986 666666554 4599999999999999999999999999999999999995 56999999999987654 23
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 161 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------------------ 221 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR------------------ 221 (318)
T ss_dssp CCCCSCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC------------------
T ss_pred ccccCCccccCHhHhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------------
Confidence 4568999999999887 566899999999999999999999999988887777776553211
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
+ .+.++++++++|++||+.||++|| +++++++||||++.
T Consensus 222 -~-----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 222 -F-----------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp -C-----------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -C-----------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 1 135688999999999999999999 99999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=383.31 Aligned_cols=283 Identities=33% Similarity=0.512 Sum_probs=218.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC------C
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASEN------Y 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~------~ 74 (346)
++|++++.||+|+||+||+|.+..+|+.||+|++....... ......+|+.+++.+ +||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccCC
Confidence 68999999999999999999999999999999997654433 334557899999999 799999999998653 5
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
..|+++|+++++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 6899999998888777654 3599999999999999999999999999999999999996 56999999999976554
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH-HH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL-AK 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~ 232 (346)
......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.|+.+.+...... ..
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred -cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 2345678999999999876577999999999999999999999999999999999999999999887665432111 01
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......+......+....+..++++.+||++||+.||.+|||++|+|+||||+....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 111122223333444556678999999999999999999999999999999998654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=374.53 Aligned_cols=265 Identities=26% Similarity=0.413 Sum_probs=211.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|+++.+++.||+|+++...... ......+|..++.++.+||||+++++++.+++.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 478999999999999999999999999999999997664432 233446788888888789999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~ 155 (346)
||||++| +|.+.+... +.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++.... ....
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence 9999985 666666543 4599999999999999999999999999999999999995 5699999999997633 3334
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||+.|+|||++. ...++.++|||||||++|+|++|..||......+... ........+......
T Consensus 167 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------~~~~~~~~~~i~~~~ 235 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD----------QNTEDYLFQVILEKQ 235 (345)
T ss_dssp BCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----------------CHHHHHHHHHHCC
T ss_pred ccccCCCccccCccccC-CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc----------cccHHHHHHHHHcCC
Confidence 55678999999999987 5668999999999999999999999997532211000 000000111111111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH------HHHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA------AEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~------~ell~hp~~~~~~ 288 (346)
..++ ..++.++++||++||+.||++||++ +|+++||||++..
T Consensus 236 ~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 236 IRIP-----------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp CCCC-----------TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred CCCC-----------CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 1221 3578999999999999999999995 8999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=380.33 Aligned_cols=282 Identities=36% Similarity=0.557 Sum_probs=229.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE----
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRL---- 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~---- 76 (346)
++|++.+.||+|+||+||+|.+..+|+.||+|++........ .....+|+.+++.+ +||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcccce
Confidence 589999999999999999999999999999999976554433 34556899999999 799999999999877654
Q ss_pred --EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 77 --YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 77 --~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
++|||+++|++.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++...+.
T Consensus 121 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CCEEEEECCCEEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 99999999988877643 399999999999999999999999999999999999996 56999999999976554
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH-H
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA-K 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~ 232 (346)
......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+....... .
T Consensus 197 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 197 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred -CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 33456789999999998765789999999999999999999999999999999999999998888766543211100 0
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......+...........+.+++++.+||++||+.||++|||++|+++||||+....
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 000011222223334445678999999999999999999999999999999997644
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=382.44 Aligned_cols=283 Identities=30% Similarity=0.485 Sum_probs=227.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc-----CCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN-----NHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|.+..+++.||+|++.... .......+|+.+++.+. +|+||+++++.+...+.+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 57999999999999999999999999999999997542 22233456777777664 578999999999999999
Q ss_pred EEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-Cc--EEEeecccccccCC
Q 039371 77 YFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DT--IKIADFGLAWEVDS 152 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~--vkl~Dfg~a~~~~~ 152 (346)
++|||+++|++.+.+.... ..+++..++.++.||+.||+|||++||+||||||+||+++. +. +||+|||++.....
T Consensus 175 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 175 CMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred EEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 9999999999998887654 35999999999999999999999999999999999999964 34 99999999976554
Q ss_pred CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
......+|+.|+|||++. ...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.|+...+........
T Consensus 255 --~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~ 331 (429)
T 3kvw_A 255 --RVYTYIQSRFYRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331 (429)
T ss_dssp --CCCSSCSCGGGCCHHHHH-TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred --cccccCCCCCccChHHHh-CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence 334567899999999987 55689999999999999999999999999999999999999999988876654322221
Q ss_pred hcCC-CCCCc----------------------------CCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 039371 233 AHGY-KFPKL----------------------------QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283 (346)
Q Consensus 233 ~~~~-~~~~~----------------------------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~ 283 (346)
.... ..+.. .......+....++++.+||++||+.||++|||++|+|+|||
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw 411 (429)
T 3kvw_A 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW 411 (429)
T ss_dssp HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence 1110 00000 000001112244778999999999999999999999999999
Q ss_pred CCCCCC
Q 039371 284 FQGCLQ 289 (346)
Q Consensus 284 ~~~~~~ 289 (346)
|+....
T Consensus 412 ~~~~~~ 417 (429)
T 3kvw_A 412 LRRRLP 417 (429)
T ss_dssp TC----
T ss_pred hccCCC
Confidence 997543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=371.05 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=208.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|+++++||+|+||+||+|.+..+|+.||+|++....... .......|+..+.++.+||||+++++++.+++.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999986654443 33445677777777778999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEY 159 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~ 159 (346)
|+++|++.+.+...+..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++............
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 216 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CC
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCccc
Confidence 9999999998888777799999999999999999999999999999999999995 569999999999887766566667
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (346)
.||+.|+|||++. +.++.++||||+||++|+|++|..||.+... ...+... ..+
T Consensus 217 ~gt~~y~aPE~~~--~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~--~~~------------------- 270 (311)
T 3p1a_A 217 EGDPRYMAPELLQ--GSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQG--YLP------------------- 270 (311)
T ss_dssp CCCGGGCCGGGGG--TCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTT--CCC-------------------
T ss_pred CCCccccCHhHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhcc--CCC-------------------
Confidence 7999999999886 3689999999999999999999776644321 1111111 000
Q ss_pred CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
....+.+++++.++|++||+.||++|||++|+++||||++
T Consensus 271 -------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 -------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1112467899999999999999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=377.01 Aligned_cols=286 Identities=30% Similarity=0.509 Sum_probs=227.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH----------HhhhHHHHHHHHhhcCCCCeeeeeeeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE----------ECLNLKEVKCLRKINNHPNIVKLQELAS 71 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~e~~~l~~l~~hp~iv~~~~~~~ 71 (346)
++|++.+.||+|+||+||+|.+.. |+.||+|++........ .....+|+.+++++ +||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFV 99 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeEE
Confidence 689999999999999999998865 89999999865433221 24557899999999 7999999999983
Q ss_pred -----cCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecc
Q 039371 72 -----ENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFG 145 (346)
Q Consensus 72 -----~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg 145 (346)
....+|+|||+++|++.+.+...+..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 3457899999999999999988777899999999999999999999999999999999999996 5699999999
Q ss_pred cccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHH
Q 039371 146 LAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 146 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (346)
++.............+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....+.+..+.+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (362)
T 3pg1_A 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV 259 (362)
T ss_dssp C---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhh
Confidence 99876655556667899999999998765779999999999999999999999999999999999999999888776543
Q ss_pred HHHH--HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 226 EGLE--LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 226 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.... .....................+..++.+.+||++||+.||.+|||++|+++||||++...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 2111 111111222222333344455678899999999999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=377.09 Aligned_cols=255 Identities=28% Similarity=0.425 Sum_probs=211.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.++.+++.||+|+++..... ..+|+.++.++.+||||+++++++++++.+|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 5799999999999999999999999999999999765432 34688888888789999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--C---cEEEeecccccccCCC-C
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--D---TIKIADFGLAWEVDSC-P 154 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--~---~vkl~Dfg~a~~~~~~-~ 154 (346)
|+.| +|.+.+... +.+++.++..++.||+.||+|||++||+||||||+||++.+ + .+||+|||++...... .
T Consensus 97 ~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 97 LMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 9985 777777654 45999999999999999999999999999999999999832 2 5999999999865432 3
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGT---CEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....++|+.|+|||++. ...++.++|||||||++|+|++|..||.+. +..+....+.......+.
T Consensus 176 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~---------- 244 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG---------- 244 (342)
T ss_dssp CBCCSSCCSSCCCHHHHH-HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS----------
T ss_pred ceeccCCCccccCHHHhc-CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc----------
Confidence 445568899999999887 445789999999999999999999999763 333444444332211111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
...+.+++++++||++||+.||++|||++++++||||+....
T Consensus 245 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 245 ----------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp ----------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred ----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 112467899999999999999999999999999999976544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-52 Score=376.42 Aligned_cols=279 Identities=26% Similarity=0.403 Sum_probs=224.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc----CCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN----NHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~----~hp~iv~~~~~~~~~~~~~ 77 (346)
++|+++++||+|+||+||+|++..+++.||+|+++... ........|..+++.+. +||||+++++++...+..+
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 68999999999999999999999999999999996432 22333456888888885 4999999999999999999
Q ss_pred EEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe---------------------
Q 039371 78 FVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS--------------------- 135 (346)
Q Consensus 78 iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~--------------------- 135 (346)
+|||+++|+|.+.+.... ..+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 113 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp EEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 999999889988887654 3599999999999999999999999999999999999995
Q ss_pred -----CCcEEEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 039371 136 -----NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLY 210 (346)
Q Consensus 136 -----~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 210 (346)
++.+||+|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...+..+.+.
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 269 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHc-CCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 46899999999976554 234567899999999987 5668999999999999999999999999999999999
Q ss_pred HHHHHhCCCChhhHHHHHHHHHhcCCC-------CCCcCC---------CCcccccCCCCchHHHHHHHhcccCCCCCCC
Q 039371 211 KICNAIGSPTEESWAEGLELAKAHGYK-------FPKLQG---------NNLSLLIPSANDDEMSLIELLCSWDPCKRPT 274 (346)
Q Consensus 211 ~i~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps 274 (346)
.+....+.++...+............. .+.... ..........++.+.+||++||+.||++|||
T Consensus 270 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 349 (360)
T 3llt_A 270 MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349 (360)
T ss_dssp HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC
Confidence 988888877766554322111100000 000000 0000011133477889999999999999999
Q ss_pred HHHHhcCCCCC
Q 039371 275 AAEALQHPLFQ 285 (346)
Q Consensus 275 ~~ell~hp~~~ 285 (346)
++|+|+||||+
T Consensus 350 a~elL~hp~f~ 360 (360)
T 3llt_A 350 PAELLKHKFLE 360 (360)
T ss_dssp HHHHTTSGGGC
T ss_pred HHHHhcCcccC
Confidence 99999999996
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=374.45 Aligned_cols=252 Identities=29% Similarity=0.413 Sum_probs=216.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|+++.+|+.||+|+++..... .......+|..+++.+ +||||+++++++.+++.+|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 47899999999999999999999999999999999654321 1223456799999888 89999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
||||++| +|.+.+... +.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++...... .
T Consensus 119 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence 9999975 777766654 4599999999999999999999999999999999999995 569999999999876543 3
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 196 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~------------------ 256 (350)
T 1rdq_E 196 WTLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------------------ 256 (350)
T ss_dssp CCCEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------------
T ss_pred ccccCCccccCHHHhc-CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 4568999999999987 566899999999999999999999999998887777777553211
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
+ .+.+++++.++|++||+.||.+||+ ++++++||||++.
T Consensus 257 -~-----------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 257 -F-----------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp -C-----------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred -C-----------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 1 1357899999999999999999998 9999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=361.59 Aligned_cols=259 Identities=29% Similarity=0.466 Sum_probs=222.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH-hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-CLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++......... ....+|+.+++++ +||||+++++++.+++..+++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999999776655433 3446899999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C---cEEEeecccccccCCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D---TIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~---~vkl~Dfg~a~~~~~~~~ 155 (346)
|++.| ++.+.+... ..+++..+..++.|++.||.|||++|++||||||+||+++. + .+||+|||++........
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 99986 666666554 45999999999999999999999999999999999999953 2 499999999988776666
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+|+.|+|||++. ...++.++||||+||++|+|++|..||.+.+.......+.......+...
T Consensus 164 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------ 230 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------------ 230 (284)
T ss_dssp CCCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT------------
T ss_pred ccCCCCCcCCcCchhhc-CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchh------------
Confidence 66678999999999887 56689999999999999999999999998888777776655433222211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
...+++++.++|++||+.||++|||++|+++||||++...
T Consensus 231 --------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 231 --------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp --------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred --------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 1357889999999999999999999999999999987644
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=367.78 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=220.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----EECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||+||+|++..+|+.||+|++....... ......+|+.+++++ +||||+++++++.+++..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEE
Confidence 47999999999999999999999999999999997654332 233456899999999 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C----cEEEeeccccccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D----TIKIADFGLAWEV 150 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~----~vkl~Dfg~a~~~ 150 (346)
++|||+++| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||++++ + .+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999975 67666654 455999999999999999999999999999999999999954 3 6999999999887
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
..........||+.|+|||++. ...++.++|||||||++|+|++|..||.+....+....+.......+...
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------- 241 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF------- 241 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH-------
T ss_pred CccccccccCCCCCccCccccc-CCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh-------
Confidence 7665566678999999999886 56789999999999999999999999999888777776655433322221
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.+.++..+.++|++||+.||++|||++|+++||||+...
T Consensus 242 -------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 242 -------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp -------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred -------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 236788999999999999999999999999999998653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=377.02 Aligned_cols=255 Identities=22% Similarity=0.375 Sum_probs=213.3
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|.+..+++.||+|++..... ........+|+.+++.+ +||||+++++++.+.+.+|+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEE
Confidence 4789999999999999999999999999999999865432 11233456899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
||||+.| +|...+.. ...+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.........
T Consensus 93 v~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 171 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171 (384)
T ss_dssp EECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence 9999986 55555554 45699999999999999999999999999999999999995 569999999999887766667
Q ss_pred ccccccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 157 TEYITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTCED---DQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
...+||+.|+|||++.. ...++.++|||||||++|+|++|..||...... +....+...
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---------------- 235 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---------------- 235 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC----------------
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc----------------
Confidence 77899999999999864 235899999999999999999999999754332 222222111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-HHHHhcCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-AAEALQHPLFQGC 287 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-~~ell~hp~~~~~ 287 (346)
...+ ...+++++.+||++||+.||.+||+ ++++++||||++.
T Consensus 236 ---~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 236 ---VVTY-----------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp ---CCCC-----------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred ---ccCC-----------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 1111 1357899999999999999999998 9999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=376.17 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=213.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc----CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY----SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++.+.||+|+||+||+|.++.+++.||+|++..... ........+|+.+++.+ +||||+++++++.+++.+|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEE
Confidence 479999999999999999999999999999999864321 11233456899999999 7999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C---cEEEeecccccc
Q 039371 78 FVFEYMDC-NLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D---TIKIADFGLAWE 149 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~---~vkl~Dfg~a~~ 149 (346)
+||||++| +|.+.+... +..+++..+..++.||+.||+|||++||+||||||+||+++. + .+||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999984 776666543 235899999999999999999999999999999999999953 2 499999999987
Q ss_pred cCCCCC-CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHH
Q 039371 150 VDSCPP-YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL 228 (346)
Q Consensus 150 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 228 (346)
...... .....||+.|+|||++. ...++.++|||||||++|+|++|..||.+. ..+....+...........|
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~---- 256 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVK-REPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW---- 256 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH----
T ss_pred ecCCCeeecCCcCCcCccCHHHHc-CCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc----
Confidence 665432 44567999999999987 566899999999999999999999999875 33444555444333332222
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+.+++++++||++||+.||++|||+.|+++||||++.
T Consensus 257 ----------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 ----------------------SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ----------------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 3578999999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=373.22 Aligned_cols=255 Identities=29% Similarity=0.433 Sum_probs=198.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|++..+++.||+|+++... ......+|+.+++++ +||||+++++++.+++..++|||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEEEEEE
Confidence 46999999999999999999999999999999997543 223345799999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CCcEEEeecccccccCCCCCC
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|+.| +|.+.+... +.+++.++..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++.........
T Consensus 129 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 207 (349)
T 2w4o_A 129 LVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207 (349)
T ss_dssp CCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred eCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence 9985 676666554 4599999999999999999999999999999999999996 569999999999877655555
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD-QLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....||+.|+|||++. ...++.++|||||||++|+|++|..||......+ ....+.........
T Consensus 208 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~-------------- 272 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILR-GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS-------------- 272 (349)
T ss_dssp -----CGGGSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT--------------
T ss_pred ccccCCCCccCHHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC--------------
Confidence 6678999999999887 5568999999999999999999999998776554 33333322111111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
...+.++.++.+||++||+.||++|||++|+++||||++..
T Consensus 273 ------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 273 ------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 11246789999999999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=370.55 Aligned_cols=257 Identities=30% Similarity=0.477 Sum_probs=194.5
Q ss_pred Cceeee---eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLM---KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++. +.||+|+||+||+|.++.+++.||+|++... ......+|+.+++.+.+||||+++++++.+++..|+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 467775 7899999999999999999999999999654 223445799999999779999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC----cEEEeecccccccCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSC 153 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~----~vkl~Dfg~a~~~~~~ 153 (346)
|||+++| +|.+.+... ..+++.++..++.|++.||+|||++||+||||||+||+++++ .+||+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 84 VMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999986 677766654 559999999999999999999999999999999999999543 7999999999765432
Q ss_pred -CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHHhCCCChhhHH
Q 039371 154 -PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE-------DDQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 154 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~ 225 (346)
.......+|+.|+|||++. ...++.++||||+||++|+|++|..||.+.+. .+....+.......+.+.|
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~- 240 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW- 240 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHH-
T ss_pred CCcccccCCCcCccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccc-
Confidence 3345567899999999886 56689999999999999999999999976543 2333333322222222222
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
+.+++++++||++||+.||.+|||++|+++||||++..+.
T Consensus 241 -------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 241 -------------------------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp -------------------------HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred -------------------------cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 2578999999999999999999999999999999976544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=375.73 Aligned_cols=285 Identities=29% Similarity=0.448 Sum_probs=220.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC------
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY------ 74 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~------ 74 (346)
+++|++.+.||+|+||+||+|++..+|+.||+|++...... .....+++..+..+ +||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccc
Confidence 47899999999999999999999999999999988554322 22334667777777 7999999999986533
Q ss_pred -EEEEEEEcCCCCHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCCEEEe--CCcEEEeeccc
Q 039371 75 -RLYFVFEYMDCNLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMH--RQGYFHRDLISKNLLVS--NDTIKIADFGL 146 (346)
Q Consensus 75 -~~~iv~e~~~g~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dikp~NIli~--~~~vkl~Dfg~ 146 (346)
.+++||||++|++...+. .....+++..+..++.|++.||.||| ++||+||||||+||+++ ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 389999999998876554 34556999999999999999999999 99999999999999996 56999999999
Q ss_pred ccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHH
Q 039371 147 AWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 147 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (346)
+.............+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++.+.+..
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 98877666666678899999999987666789999999999999999999999999999999999999999988776653
Q ss_pred HHHHHHhcCCCCCCcCCCCccc----ccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSL----LIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
....... ............. .....++++.+||.+||+.||.+|||++|+++||||++....
T Consensus 259 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 259 LNPSHTD--VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HCTTCCC--GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred cccchhh--ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 2111000 0001111111111 122357789999999999999999999999999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=375.47 Aligned_cols=259 Identities=27% Similarity=0.369 Sum_probs=198.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|++..+++.||+|++....... ....+|+..++++ +||||+++++++.+++.+++|||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID--ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC--HHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc--HHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEEEE
Confidence 68999999999999999999999999999999997554332 3355899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC---cEEEeecccccccCCCCCCc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND---TIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~---~vkl~Dfg~a~~~~~~~~~~ 157 (346)
|+.| +|.+.+... +.+++..++.++.|++.||+|||++||+||||||+||+++.+ .+||+|||++..........
T Consensus 97 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 97 YASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred eCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 9975 676666554 459999999999999999999999999999999999999643 49999999997655444555
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...||+.|+|||++.+....+.++||||+||++|+|++|..||.+.........+.... ......
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~---------------~~~~~~ 240 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI---------------LSVKYS 240 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH---------------HTTCCC
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH---------------hcCCCC
Confidence 67899999999998755544556999999999999999999998755432222222211 111111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
++. ...+++++++||++||+.||++|||++|+++||||+...
T Consensus 241 ~~~---------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 241 IPD---------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp CCT---------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred CCC---------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 111 125789999999999999999999999999999997643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=361.85 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=210.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+..++..+|+|++.............+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEEEEEE
Confidence 57999999999999999999999999999999997765544455567899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC----CcEEEeecccccccCCC
Q 039371 82 YMDC-NLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN----DTIKIADFGLAWEVDSC 153 (346)
Q Consensus 82 ~~~g-~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~----~~vkl~Dfg~a~~~~~~ 153 (346)
+++| +|.+.+... +..+++..+..++.|++.||+|||++||+||||||+||++++ +.+||+|||++......
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 9985 777776433 356999999999999999999999999999999999999942 47999999999876665
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.......+|+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+........
T Consensus 181 ~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 245 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA------------- 245 (285)
T ss_dssp ------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred ccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-------------
Confidence 5556678999999999874 5689999999999999999999999998876665554433211110
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.....+++++.++|++||+.||++|||++|+++||||++
T Consensus 246 --------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 --------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred --------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011346889999999999999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=391.38 Aligned_cols=258 Identities=31% Similarity=0.494 Sum_probs=221.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH------------HHhhhHHHHHHHHhhcCCCCeeeeeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW------------EECLNLKEVKCLRKINNHPNIVKLQEL 69 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~e~~~l~~l~~hp~iv~~~~~ 69 (346)
++|++++.||+|+||+||+|.++.+++.||+|++....... ......+|+.+++++ +||||++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~ 114 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDV 114 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEEE
Confidence 68999999999999999999999999999999997654321 123456899999999 79999999999
Q ss_pred eecCCEEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC----cEEEeec
Q 039371 70 ASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND----TIKIADF 144 (346)
Q Consensus 70 ~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~----~vkl~Df 144 (346)
+.+++.+|+||||++| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++.+ .+||+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999985 677776654 459999999999999999999999999999999999999643 6999999
Q ss_pred ccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhH
Q 039371 145 GLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 145 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (346)
|++.............||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+....+.......+.+.|
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 9998877666666778999999999875 46899999999999999999999999999988888888766544444433
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
+.+++++++||++||+.||.+|||++|+|+||||+....
T Consensus 272 --------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 272 --------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp --------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred --------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 367899999999999999999999999999999987543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=361.55 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=222.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+..++..||+|++....... .....+|+.+++++ +||||+++++++.+++..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-HHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999999999999999997654432 33456899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE---e-CCcEEEeecccccccCCCCCC
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV---S-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli---~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|++| ++.+.+... ..+++..+..++.|++.||.|||++|++|+||||+||++ + ++.++|+|||++.........
T Consensus 87 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 87 LCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred ccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 9986 666666554 459999999999999999999999999999999999999 3 458999999999887766666
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+|+.|+|||++. +.++.++|||||||++|+|++|..||......+....+......++...+
T Consensus 166 ~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------ 231 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW------------ 231 (277)
T ss_dssp CCCCSCTTTCCHHHHT--TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH------------
T ss_pred hccCCCCCccChHHhc--ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh------------
Confidence 6778999999999885 44899999999999999999999999998888887777766554444333
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..+++.+.++|++||+.||++|||+.++++||||++...
T Consensus 232 --------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 232 --------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp --------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred --------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 257899999999999999999999999999999986433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=367.11 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=205.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-------------------------HHhhhHHHHHHHH
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-------------------------EECLNLKEVKCLR 55 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------------------~~~~~~~e~~~l~ 55 (346)
+++|++.+.||+|+||+||+|++..+++.||+|++....... ......+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999999999999999996543211 1234568999999
Q ss_pred hhcCCCCeeeeeeeeec--CCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEE
Q 039371 56 KINNHPNIVKLQELASE--NYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLL 133 (346)
Q Consensus 56 ~l~~hp~iv~~~~~~~~--~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIl 133 (346)
++ +||||+++++++.+ ++.+++|||+++|+.+..+.. ...+++.++..++.|++.||+|||++||+||||||+||+
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99 79999999999986 578999999998643333332 345999999999999999999999999999999999999
Q ss_pred Ee-CCcEEEeecccccccCCCC-CCccccccCcccCcccccccCC--CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 039371 134 VS-NDTIKIADFGLAWEVDSCP-PYTEYITTLQYRAPEMLLMSGQ--YNSKVDMWALGLIMAELITFHPLFPGTCEDDQL 209 (346)
Q Consensus 134 i~-~~~vkl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 209 (346)
++ ++.+||+|||++....... ......||+.|+|||++.+... ++.++|||||||++|+|++|..||.........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 95 5699999999997765432 2345679999999998864332 478899999999999999999999887765554
Q ss_pred HHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 210 YKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 210 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
..+..... .++. .+.+++++.++|.+||+.||++|||++|+++||||+
T Consensus 250 ~~~~~~~~-------------------~~~~---------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQAL-------------------EFPD---------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCC-------------------CCCS---------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccC-------------------CCCC---------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 44433211 1111 136789999999999999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=367.24 Aligned_cols=259 Identities=28% Similarity=0.445 Sum_probs=203.4
Q ss_pred Cceeee-eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLM-KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++. +.||+|+||+||+|.+..+++.||+|++...... ......+|+.++.++.+||||+++++++.+++.+++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC-CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch-hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 579996 7899999999999999999999999999765432 33456789999999768999999999999999999999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC----cEEEeecccccccCCC--
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLAWEVDSC-- 153 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~----~vkl~Dfg~a~~~~~~-- 153 (346)
|+++ |+|.+.+... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ .+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 9998 5777776654 459999999999999999999999999999999999999643 3999999998754321
Q ss_pred ------CCCccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---------------HH
Q 039371 154 ------PPYTEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCED---------------DQ 208 (346)
Q Consensus 154 ------~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------------~~ 208 (346)
.......||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.... ..
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 12234568999999998863 245789999999999999999999999775432 12
Q ss_pred HHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 209 LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 209 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
...+.......+.. ..+.+++++++||++||+.||.+|||++|+++||||++..
T Consensus 250 ~~~i~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 250 FESIQEGKYEFPDK--------------------------DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHCCCCCCHH--------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHhccCcccCch--------------------------hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 22222211111111 1135788999999999999999999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=389.97 Aligned_cols=258 Identities=32% Similarity=0.524 Sum_probs=220.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc-CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++++.||+|+||+||+|.+..+++.||+|++..... ........+|+.+++++ +||||+++++++.+.+.+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999864332 22334557899999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CCcEEEeecccccccCCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~~vkl~Dfg~a~~~~~~~~ 155 (346)
|++.| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 99985 676766554 4599999999999999999999999999999999999994 23799999999987776666
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....||+.|+|||++. +.++.++||||+||++|+|++|.+||.+.+..+.+..+......++.+.|
T Consensus 180 ~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------- 246 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW----------- 246 (486)
T ss_dssp --CCTTGGGGCCGGGGG--SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG-----------
T ss_pred cCCCcCCCCCCCHHHhC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc-----------
Confidence 66778999999999886 35899999999999999999999999999888888877665443333322
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
+.+++++++||++||+.||.+|||+.|+|+||||+....
T Consensus 247 ---------------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 247 ---------------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp ---------------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred ---------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 357899999999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=381.48 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=215.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|+++.+++.||+|+++...... ......+|..++..+ +||||+++++++.+++.+|+|
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEE
Confidence 68999999999999999999999999999999986532211 122345788888888 899999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--C
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--P 155 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~ 155 (346)
|||++| +|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|....... .
T Consensus 148 ~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp ECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred EeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 999975 77776654 3499999999999999999999999999999999999995 5699999999998765433 2
Q ss_pred CccccccCcccCcccccccC---CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLMSG---QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
..+.+||+.|+|||++.... .++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 291 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS-------------- 291 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--------------
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc--------------
Confidence 34678999999999987433 2789999999999999999999999999888888877653211
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK--RPTAAEALQHPLFQGCL 288 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~--Rps~~ell~hp~~~~~~ 288 (346)
..++. .+.+++++++||++||+.+|.+ ||+++|+++||||++..
T Consensus 292 ---~~~p~---------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 292 ---LTFPD---------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp ---CCCCT---------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ---ccCCC---------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 01111 1357899999999999999988 99999999999999854
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=374.81 Aligned_cols=255 Identities=30% Similarity=0.444 Sum_probs=209.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|+++.+++.||+|+++...... .......|..++.+..+||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999999999999999997665432 223345566654443489999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc-CCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV-DSCPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~-~~~~~ 155 (346)
||||++| +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++... .....
T Consensus 117 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence 9999986 66666654 44599999999999999999999999999999999999995 569999999999763 33345
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 196 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~------------------ 256 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL------------------ 256 (373)
T ss_dssp CCSBSCCCCCCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC------------------
T ss_pred cccccCCccccCHHHhC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc------------------
Confidence 56678999999999987 56689999999999999999999999999888777777754311
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH----HHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA----AEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~----~ell~hp~~~~~ 287 (346)
. ..+.++.++++||++||+.||.+||++ +++++||||++.
T Consensus 257 -~-----------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 257 -Q-----------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp -C-----------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred -C-----------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 1 113578999999999999999999996 699999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-52 Score=387.16 Aligned_cols=255 Identities=28% Similarity=0.414 Sum_probs=218.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|++..+|+.||+|+++...... ......+|+.+++.+ +||||+++++++.+.+.+|+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 368999999999999999999999999999999996543211 223456899999888 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
||||++| +|.+.+.. .+.+++.+++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++.........
T Consensus 94 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~ 172 (476)
T 2y94_A 94 VMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172 (476)
T ss_dssp EEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence 9999975 66666654 45699999999999999999999999999999999999996 569999999999887766666
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+.......
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------- 235 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT----------------- 235 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC-----------------
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC-----------------
Confidence 677899999999999755556889999999999999999999999888777766665432111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
...+++++.+||++||+.||.+|||++|+++||||+..
T Consensus 236 -------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 236 -------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 12468899999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=365.96 Aligned_cols=285 Identities=34% Similarity=0.601 Sum_probs=232.5
Q ss_pred CceeeeeeecccCceEEEEEEEc-cCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhc--CCCCeeeeeeeee-----c
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-QSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKIN--NHPNIVKLQELAS-----E 72 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~--~hp~iv~~~~~~~-----~ 72 (346)
++|++++.||+|+||+||+|.+. .+++.||+|++........ .....+|+.+++.+. +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 68999999999999999999995 6789999999975543221 223346777666654 7999999999987 5
Q ss_pred CCEEEEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc
Q 039371 73 NYRLYFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV 150 (346)
Q Consensus 73 ~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~ 150 (346)
....++|||+++|+|.+.+.... ..+++..+..++.|++.||.|||++||+|+||||+||+++ ++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 91 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence 67889999999999998887653 3499999999999999999999999999999999999995 569999999999776
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
..........+|+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....|......
T Consensus 171 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (326)
T 1blx_A 171 SFQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249 (326)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cCCCCccccccccceeCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence 6544455567899999999887 566899999999999999999999999999999999999998888877666432111
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
.. ..+............+.++..+++||.+||+.||++|||++|+++||||+.....
T Consensus 250 ~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 250 PR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp CG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ch---hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 00 1111112223344556789999999999999999999999999999999976543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=376.54 Aligned_cols=289 Identities=21% Similarity=0.298 Sum_probs=212.3
Q ss_pred Cceeeeeeeccc--CceEEEEEEEccCCcEEEEEEccccccCHHH-hhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEG--SFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-CLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++++.||+| +||+||+|+++.+|+.||+|+++........ ....+|+.+++++ +||||+++++++.+++.+|+
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEEE
Confidence 689999999999 9999999999999999999999876655443 3445799999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC--
Q 039371 79 VFEYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-- 153 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-- 153 (346)
||||++| +|.+.+... ...+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||.+......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 9999985 676666543 35599999999999999999999999999999999999996 669999999987543211
Q ss_pred ------CCCccccccCcccCccccccc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC------
Q 039371 154 ------PPYTEYITTLQYRAPEMLLMS-GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPT------ 220 (346)
Q Consensus 154 ------~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 220 (346)
.......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence 122234788999999998743 5689999999999999999999999988776665554433221100
Q ss_pred --hhhHHHHHHHHH--------hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 221 --EESWAEGLELAK--------AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 221 --~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
............ ......+.............+++++.+||++||+.||++|||++|+|+||||++....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 343 (389)
T ss_dssp ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence 000000000000 0000000000001111234678899999999999999999999999999999987654
Q ss_pred C
Q 039371 291 P 291 (346)
Q Consensus 291 ~ 291 (346)
.
T Consensus 344 ~ 344 (389)
T 3gni_B 344 A 344 (389)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=383.60 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=218.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|+++.+++.||+|+++...... ......+|..++..+ +||||+++++++.+++.+|+|
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEE
Confidence 68999999999999999999999999999999996532211 122245788888888 899999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
|||+. |+|.+.+....+.+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||+|........
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 99996 578888777566799999999999999999999999999999999999996 56999999999976554332
Q ss_pred CccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
....+||+.|+|||++.. ...++.++||||+||++|+|++|..||.+.+..+....+......
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~------------- 299 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER------------- 299 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-------------
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc-------------
Confidence 334689999999999862 456899999999999999999999999999888888777643210
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCK--RPTAAEALQHPLFQGCL 288 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~--Rps~~ell~hp~~~~~~ 288 (346)
..+|. ..+.+++++++||++||+.+|++ |++++|+++||||++..
T Consensus 300 ----~~~p~--------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 300 ----FQFPT--------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp ----CCCCS--------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred ----ccCCc--------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 11111 11357899999999999988888 99999999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=370.85 Aligned_cols=282 Identities=35% Similarity=0.547 Sum_probs=227.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE-----
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYR----- 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~----- 75 (346)
++|++.+.||+|+||+||+|.+..+|+.||+|++........ .....+|+.+++.+ +||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccce
Confidence 589999999999999999999999999999999976554433 34556899999999 79999999999987653
Q ss_pred -EEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 -LYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 -~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
.|++||+++|++.+.+.. .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 499999999987766532 499999999999999999999999999999999999996 569999999999765432
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH-
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK- 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 232 (346)
.....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++.+.+........
T Consensus 180 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred --ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 34457899999999987657789999999999999999999999999999999999999888887655432111100
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..-...+...........+.+++++.+||++||+.||++|||++|+++||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 000011222222334445678999999999999999999999999999999997654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=363.13 Aligned_cols=257 Identities=22% Similarity=0.332 Sum_probs=199.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+..+|+.||+|++..............|...+.+..+||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 68999999999999999999999999999999997665554454555566554555589999999999999999999999
Q ss_pred cCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEeC-CcEEEeecccccccCCCCCC
Q 039371 82 YMDCNLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 82 ~~~g~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~~ 156 (346)
+++|++.+.+.. .+..+++..+..++.|++.||.|||++ |++||||||+||++++ +.+||+|||++.........
T Consensus 87 ~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 87 LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred hhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 999988766543 456699999999999999999999998 9999999999999965 69999999999877665555
Q ss_pred ccccccCcccCcccc---cccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 157 TEYITTLQYRAPEML---LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE-DDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
....+|+.|+|||++ .....++.++||||+||++|+|++|..||..... ..............
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 233 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ------------- 233 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-------------
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-------------
Confidence 556799999999997 3356689999999999999999999999986433 33333332211100
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.....+++++.+++.+||+.||++|||++|+++||||+.
T Consensus 234 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 234 ---------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ---------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ---------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 011357889999999999999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=384.59 Aligned_cols=254 Identities=31% Similarity=0.472 Sum_probs=207.6
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|.+..+|+.||+|++..... ........+|+.+++.+ +||||+++++++.+++.+|+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEE
Confidence 3689999999999999999999999999999999975432 22233446788888888 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-CCcEEEeecccccccC-CCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCP 154 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~ 154 (346)
||||++| +|.+.+.. ...+++..+..++.||+.||+|||+ +||+||||||+||+++ ++.+||+|||+|.... ...
T Consensus 226 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp EECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 9999986 56555544 4469999999999999999999998 9999999999999995 5699999999997633 233
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 305 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---------------- 367 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR---------------- 367 (446)
T ss_dssp --CCSSSCGGGCCHHHHH-TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred ccccccCCccccCHhhcC-CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence 455678999999999886 567899999999999999999999999988877776666543211
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
+ ...+++++.+||.+||+.||.+|| |++|+++||||++.
T Consensus 368 ---~-----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 368 ---F-----------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp ---C-----------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---C-----------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 1 135688999999999999999999 99999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=367.49 Aligned_cols=261 Identities=30% Similarity=0.435 Sum_probs=216.8
Q ss_pred Cceeee-eeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLM-KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|.+. +.||+|+||+||+|.+..+++.||+|++....... ......+|+.++..+.+||||+++++++.+++..++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 368887 89999999999999999999999999997654432 2345578999999998889999999999999999999
Q ss_pred EEcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC----CcEEEeecccccccCCC
Q 039371 80 FEYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN----DTIKIADFGLAWEVDSC 153 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~----~~vkl~Dfg~a~~~~~~ 153 (346)
|||+.| +|.+.+... ...+++..+..++.|++.||+|||++||+||||||+||+++. +.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 999986 666665433 356999999999999999999999999999999999999964 69999999999887766
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.......+|+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+.......+.+
T Consensus 188 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------- 255 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILN-YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE----------- 255 (327)
T ss_dssp ------CCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT-----------
T ss_pred cccccccCCcCccCCeeec-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch-----------
Confidence 5566678999999999886 5678999999999999999999999999988877777765543332221
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..+.+++.+.++|++||+.||.+|||++++++||||++...
T Consensus 256 ---------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 256 ---------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp ---------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred ---------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 12367889999999999999999999999999999997644
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=370.69 Aligned_cols=286 Identities=33% Similarity=0.563 Sum_probs=229.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-----CEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN-----YRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-----~~~ 76 (346)
++|++.+.||+|+||+||+|.+..+|+.||+|++.............+|+.+++++ +||||+++++++..+ ...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCCE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccceE
Confidence 68999999999999999999999999999999997554444445567899999999 799999999987654 678
Q ss_pred EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
+++||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 90 ~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 90 YIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 99999999998888765 3499999999999999999999999999999999999995 56999999999976543221
Q ss_pred -----------CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhH
Q 039371 156 -----------YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 156 -----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (346)
.....||+.|+|||++.....++.++|||||||++|+|++|..||.+.+..+.+..+....+.|.....
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 223468999999999876677999999999999999999999999999998888888887777653221
Q ss_pred HHHHH--HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 225 AEGLE--LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 225 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
..... .........+...........+.+++++.+||++||+.||++|||++|+++||||+.....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 11000 0000000112222223344456789999999999999999999999999999999986543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=378.82 Aligned_cols=260 Identities=25% Similarity=0.372 Sum_probs=216.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|+++.+|+.||+|++++...... .....+|..++..+ +||||+++++++.+++.+|+|
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEE
Confidence 689999999999999999999999999999999965432111 22345788888888 799999999999999999999
Q ss_pred EEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 80 FEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
|||+. |+|.+.+...+..+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence 99996 578888776655799999999999999999999999999999999999996 47999999999987654332
Q ss_pred CccccccCcccCcccccc------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 156 YTEYITTLQYRAPEMLLM------SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
....+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+...++......
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----------- 288 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH----------- 288 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-----------
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----------
Confidence 234689999999999863 346899999999999999999999999999888887777643110
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR---PTAAEALQHPLFQGCL 288 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R---ps~~ell~hp~~~~~~ 288 (346)
..++. ....+++++++||++||+ +|.+| |+++|+++||||++..
T Consensus 289 ------~~~p~--------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 289 ------LSLPL--------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp ------CCCC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred ------cCCCc--------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 01110 113678999999999999 99998 5999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=375.41 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=214.6
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
...+.||+|+||+||+|.+..+|+.||+|+++.... .......+|+.+++++ +||||+++++++.+.+..++||||++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 336789999999999999999999999999976543 2334556899999999 79999999999999999999999997
Q ss_pred C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe---CCcEEEeecccccccCCCCCCcccc
Q 039371 85 C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS---NDTIKIADFGLAWEVDSCPPYTEYI 160 (346)
Q Consensus 85 g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~---~~~vkl~Dfg~a~~~~~~~~~~~~~ 160 (346)
| +|.+.+......+++..+..++.||+.||+|||++||+||||||+||++. ++.+||+|||++.............
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 249 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccccc
Confidence 5 78787776666799999999999999999999999999999999999993 3489999999998877665566678
Q ss_pred ccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCC
Q 039371 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPK 240 (346)
Q Consensus 161 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (346)
||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+.+..+......++...
T Consensus 250 gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~----------------- 311 (373)
T 2x4f_A 250 GTPEFLAPEVVN-YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE----------------- 311 (373)
T ss_dssp SSCTTCCHHHHT-TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG-----------------
T ss_pred CCCcEeChhhcc-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh-----------------
Confidence 999999999886 56689999999999999999999999999988888887766543322211
Q ss_pred cCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 241 LQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.+.+++++++||.+||+.||.+|||++|+++||||++.
T Consensus 312 ---------~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 312 ---------FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ---------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ---------hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 24678999999999999999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=390.31 Aligned_cols=257 Identities=32% Similarity=0.518 Sum_probs=222.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||+||+|.+..+|+.||+|++...... .......+|+.+++++ +||||+++++++.+.+..++|
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999655332 2344567899999999 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CCcEEEeecccccccCCCC
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~~vkl~Dfg~a~~~~~~~ 154 (346)
||++.| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 999985 676666654 4599999999999999999999999999999999999993 4589999999998877666
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
......||+.|+|||++. +.++.++||||+||++|+|++|.+||.+.+..+.+..+......++.+.|
T Consensus 184 ~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---------- 251 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLH--GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW---------- 251 (484)
T ss_dssp SHHHHTTGGGTCCHHHHH--TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG----------
T ss_pred ccccCCCCccccCceeec--CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc----------
Confidence 666678999999999886 36899999999999999999999999999888888877665443333222
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
+.+++++++||++||+.||.+|||++|+|+||||+...
T Consensus 252 ----------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 252 ----------------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp ----------------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred ----------------ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 25789999999999999999999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=388.53 Aligned_cols=256 Identities=30% Similarity=0.505 Sum_probs=217.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++++.||+|+||+||+|+++.++..||+|++....... ......+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999997654322 233456899999998 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC----CcEEEeecccccccCCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN----DTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~----~~vkl~Dfg~a~~~~~~~~ 155 (346)
||+.| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++. +.+||+|||++........
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 99985 676766554 45999999999999999999999999999999999999953 3599999999988776666
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+....+......++.+.|
T Consensus 195 ~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------- 261 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW----------- 261 (494)
T ss_dssp BCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGG-----------
T ss_pred ccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhc-----------
Confidence 66778999999999875 56899999999999999999999999999888888887766544443332
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+.+++.+++||++||+.||.+|||++|+|+||||+..
T Consensus 262 ---------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 262 ---------------KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ---------------ccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 3678999999999999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=379.30 Aligned_cols=285 Identities=29% Similarity=0.535 Sum_probs=211.8
Q ss_pred Cceee-eeeecccCceEEEEEEEc--cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee--cCCEE
Q 039371 2 EKYTL-MKQIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS--ENYRL 76 (346)
Q Consensus 2 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~--~~~~~ 76 (346)
+.|++ .++||+|+||+||+|+++ .+++.||+|++....... ...+|+.+++++ +||||+++++++. .+..+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM---SACREIALLREL-KHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH---HHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH---HHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeE
Confidence 35777 458999999999999966 568899999997654432 346899999999 7999999999994 57789
Q ss_pred EEEEEcCCCCHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-----CCcEEEee
Q 039371 77 YFVFEYMDCNLHQLMSNRK--------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-----NDTIKIAD 143 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-----~~~vkl~D 143 (346)
|+||||++|++.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||++. ++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999999999988775321 2499999999999999999999999999999999999992 35899999
Q ss_pred cccccccCCC----CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 039371 144 FGLAWEVDSC----PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE---------DDQLY 210 (346)
Q Consensus 144 fg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~ 210 (346)
||++...... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+... .+.+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999766532 2334567899999999998666799999999999999999999999977654 47888
Q ss_pred HHHHHhCCCChhhHHHHHHHHHh----cCCCCCCcCCCC----cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCC
Q 039371 211 KICNAIGSPTEESWAEGLELAKA----HGYKFPKLQGNN----LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282 (346)
Q Consensus 211 ~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp 282 (346)
.+....+.|+...|......... ............ ........++.+.+||++||+.||.+|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 99999999888777543211000 000000000000 0111123478899999999999999999999999999
Q ss_pred CCCCCCCC
Q 039371 283 LFQGCLQV 290 (346)
Q Consensus 283 ~~~~~~~~ 290 (346)
||++....
T Consensus 336 ~f~~~~~~ 343 (405)
T 3rgf_A 336 YFLEDPLP 343 (405)
T ss_dssp GGTSSSCC
T ss_pred hhccCCCC
Confidence 99976543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=364.39 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=206.3
Q ss_pred CceeeeeeecccCceEEEEEEEc---cCCcEEEEEEccccccC---HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYS---WEECLNLKEVKCLRKINNHPNIVKLQELASENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~ 75 (346)
++|++++.||+|+||+||+|++. .+++.||+|+++..... .......+|+.+++++ +||||+++++++.+++.
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSSC
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCCE
Confidence 68999999999999999999985 68999999999765432 1223446799999999 79999999999999999
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS- 152 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~- 152 (346)
+|+||||++| +|.+.+... +.+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 9999999985 666666543 4599999999999999999999999999999999999995 56999999999875432
Q ss_pred CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
........||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~------------- 240 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL------------- 240 (327)
T ss_dssp ----CTTSSCCTTSCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-------------
T ss_pred CccccccCCCcCccCHhhCc-CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-------------
Confidence 22344567999999999887 5668999999999999999999999999988877777665532111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
.+.+++++.++|++||+.||.+|| +++|+++||||+..
T Consensus 241 -----------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 241 -----------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp -----------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred -----------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 135688999999999999999999 89999999999865
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=368.39 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=219.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--H-----HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--W-----EECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~-----~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... . ......+|+.+++++.+||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4799999999999999999999999999999998654321 1 12344679999999878999999999999999
Q ss_pred EEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
..++||||++| +|.+.+.. ...+++..+..++.||+.||.|||+.|++|+||||+||+++ ++.++|+|||++.....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999986 66666654 44599999999999999999999999999999999999995 56999999999988776
Q ss_pred CCCCccccccCcccCcccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLM-----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
........||+.|+|||++.+ ...++.++|||||||++|+|++|..||...........+......++...|
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--- 329 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW--- 329 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH---
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc---
Confidence 666667789999999998863 235788999999999999999999999988877777776655444333322
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
..++..+.++|++||+.||++|||++|+++||||+
T Consensus 330 -----------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 330 -----------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp -----------------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred -----------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 25688999999999999999999999999999997
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=368.37 Aligned_cols=265 Identities=25% Similarity=0.296 Sum_probs=184.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC----EEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY----RLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~----~~~ 77 (346)
++|.+.++||+|+||+||+|++ +|+.||||+++... ........|+..+.++ +||||+++++++.+++ .+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEE
Confidence 5799999999999999999987 58999999996542 2222222455555566 7999999999987653 689
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCEEEe-CCcEEEeecccc
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ--------GYFHRDLISKNLLVS-NDTIKIADFGLA 147 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------~ivH~dikp~NIli~-~~~vkl~Dfg~a 147 (346)
||||||+ |+|.+.+... .++++.+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+|
T Consensus 78 lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999998 5777777543 489999999999999999999987 999999999999996 569999999999
Q ss_pred cccCCCC-----CCccccccCcccCcccccccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 039371 148 WEVDSCP-----PYTEYITTLQYRAPEMLLMSG-----QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG 217 (346)
Q Consensus 148 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 217 (346)
+...... .....+||+.|||||++.+.. .++.++|||||||++|||+||.+||........... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~----~~ 231 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY----DL 231 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT----TT
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch----hc
Confidence 7654432 223457999999999986432 367799999999999999999887744321100000 00
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 218 SPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+.................+ |.... .. .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~r-p~~p~-~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVCEQKLR-PNIPN-RW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCC-CCCCG-GG--GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHhcccCC-CCCCc-cc--cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00000000000111111111 10000 00 001223467899999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=376.93 Aligned_cols=255 Identities=29% Similarity=0.425 Sum_probs=202.0
Q ss_pred Cceeee-eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec----CCEE
Q 039371 2 EKYTLM-KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE----NYRL 76 (346)
Q Consensus 2 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~----~~~~ 76 (346)
++|.+. +.||+|+||+||+|.++.+++.||+|++... ....+|+.++.++.+||||+++++++.. .+.+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 578887 6899999999999999999999999999632 1244788888777789999999999875 6789
Q ss_pred EEEEEcCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CCcEEEeeccccccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEV 150 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~~vkl~Dfg~a~~~ 150 (346)
|+||||++| +|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 999999985 7888877653 3599999999999999999999999999999999999996 468999999999877
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhhHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD----QLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~ 226 (346)
.........+||+.|+|||++. ...++.++|||||||++|+|++|..||.+..... ....+...
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~----------- 282 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG----------- 282 (400)
T ss_dssp C-----------CTTCCGGGSC-CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-----------
T ss_pred CCCCccccCCCCCCccCHhhcC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-----------
Confidence 6655566778999999999886 5678999999999999999999999997754321 22222221
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
...++.. ....++.++.+||++||+.||++|||++|+++||||+....
T Consensus 283 --------~~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 283 --------QYEFPNP-------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp --------CCCCCTT-------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred --------cccCCCc-------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 1111111 12367899999999999999999999999999999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=363.62 Aligned_cols=273 Identities=25% Similarity=0.476 Sum_probs=216.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--NYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~~~iv 79 (346)
++|++++.||+|+||+||+|++..+++.||+|+++... .....+|+.+++++.+||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 68999999999999999999999999999999987432 23456899999999779999999999987 6788999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC-cEEEeecccccccCCCCCC
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND-TIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~-~vkl~Dfg~a~~~~~~~~~ 156 (346)
||+++| ++.+.+. .+++..+..++.|++.||+|||++||+||||||+||+++ ++ .+||+|||++.........
T Consensus 112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 999986 5554443 289999999999999999999999999999999999997 44 8999999999877766666
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFP-GTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+++.|+|||++.+...++.++|||||||++|+|++|..||. +....+.+..+....+.+....+. ....
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~------~~~~ 261 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI------DKYN 261 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH------HHTT
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH------HHhc
Confidence 677899999999998765779999999999999999999999984 445556666665554432211111 0100
Q ss_pred CCCC-------------CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 236 YKFP-------------KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
...+ .............+++++++||++||+.||++|||++|+|+||||++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0000 0000000111123789999999999999999999999999999999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=367.37 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=217.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|++..+++.||+|++........ .....+|+.+++++ +||||+++++++.+++..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEE
Confidence 359999999999999999999999999999999976543332 24457899999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCCCcc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|||+.|++.+.+......+++..+..++.|++.||.|||++||+||||||+||++++ +.+||+|||++..... ...
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~ 209 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS 209 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence 999999999888776677999999999999999999999999999999999999964 6999999999976553 234
Q ss_pred ccccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 159 YITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
..||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 272 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA----------------- 272 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------------
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------------
Confidence 579999999998852 4668999999999999999999999998887766665554431110
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.....+++.+.++|.+||+.||++|||++++++||||...
T Consensus 273 -----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 -----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0113568899999999999999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=359.32 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=211.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||+||+|.+..+++.||+|++........ .....+|+.+++++ +||||+++++++.+++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEE
Confidence 5799999999999999999999999999999999865432221 23346788989888 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
||||++| ++.+.+... ..+++..+..++.|++.||.|||++||+|+||||+||+++ ++.++|+|||++...... ..
T Consensus 87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~ 164 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RR 164 (279)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cc
Confidence 9999985 666666544 4599999999999999999999999999999999999995 569999999998655442 23
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+++.|+|||.+. ...++.++||||+|+++|+|++|..||...+..+....+.......
T Consensus 165 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 226 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----------------- 226 (279)
T ss_dssp ---CCCCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-----------------
T ss_pred cccCCCCCccCHhHhc-cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC-----------------
Confidence 4457899999999886 5668999999999999999999999999888777666654432111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
...+++++.+||++||+.||.+|||++|+++||||+....
T Consensus 227 -------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 227 -------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp -------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred -------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 1246788999999999999999999999999999987544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=357.62 Aligned_cols=261 Identities=30% Similarity=0.406 Sum_probs=221.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc---C-----HHHhhhHHHHHHHHhhcCCCCeeeeeeeeec
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY---S-----WEECLNLKEVKCLRKINNHPNIVKLQELASE 72 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~-----~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~ 72 (346)
.++|++.+.||+|+||.||+|.++.+|+.||+|+++.... . .......+|+.+++++.+||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4789999999999999999999999999999999965431 1 1223456899999999779999999999999
Q ss_pred CCEEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc
Q 039371 73 NYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV 150 (346)
Q Consensus 73 ~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~ 150 (346)
++..++|||+++| +|.+.+... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999985 777766553 4599999999999999999999999999999999999995 569999999999887
Q ss_pred CCCCCCccccccCcccCccccc-----ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLL-----MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (346)
..........+++.|+|||++. ....++.++|||||||++|+|++|..||...+..+....+.......+...
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 252 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE-- 252 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT--
T ss_pred CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc--
Confidence 7666666678999999999885 245678999999999999999999999998887776666655433222211
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.+.++..+.++|.+||+.||.+|||++|+++||||++..
T Consensus 253 ------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 253 ------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp ------------------------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ------------------------ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 135688999999999999999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=364.30 Aligned_cols=281 Identities=32% Similarity=0.514 Sum_probs=222.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee----------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS---------- 71 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~---------- 71 (346)
++|++++.||+|+||+||+|.+..+++.||+|++.... ........+|+.+++++ +||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccc
Confidence 68999999999999999999999999999999987543 22334556899999999 7999999999873
Q ss_pred ----cCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe--CCcEEEeecc
Q 039371 72 ----ENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS--NDTIKIADFG 145 (346)
Q Consensus 72 ----~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~--~~~vkl~Dfg 145 (346)
+.+..++|||+++|+|.+.+.. +.+++..++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||
T Consensus 89 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp --CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred ccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 4478899999999998887754 4589999999999999999999999999999999999996 3489999999
Q ss_pred cccccCCC----CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 146 LAWEVDSC----PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 146 ~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
++...... .......+|+.|+|||.+.....++.++|||||||++|+|++|..||.+.+..+....+......+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 99765432 22344567899999999876677999999999999999999999999999998988888888777766
Q ss_pred hhHHHHHHHHH---hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 222 ESWAEGLELAK---AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 222 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
+.+.+...... ...... .........+.++.+++++|++||+.||++|||++|+++||||+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTE---PHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTS---CCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred hhhhhhhhcCcccccccccC---CCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 65543322110 000000 111223334578999999999999999999999999999999986543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=362.79 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=215.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|++..+|+.||+|+++..... ......+|+.+++++ +||||+++++++.+++..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEE
Confidence 5799999999999999999999999999999999754332 233456899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE---e-CCcEEEeecccccccCCCCCC
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV---S-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli---~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
+++| +|.+.+... +.+++..+..++.|++.||.|||++|++|+||||+||++ + ++.++|+|||++..... ...
T Consensus 87 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~ 164 (304)
T 2jam_A 87 LVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIM 164 (304)
T ss_dssp CCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTT
T ss_pred cCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Ccc
Confidence 9985 777766554 459999999999999999999999999999999999999 3 45899999999876543 234
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+|+.|+|||++. ...++.++|||||||++|+|++|..||......+....+.......+.
T Consensus 165 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--------------- 228 (304)
T 2jam_A 165 STACGTPGYVAPEVLA-QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES--------------- 228 (304)
T ss_dssp HHHHSCCCBCCTTTBS-SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT---------------
T ss_pred ccccCCCCccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---------------
Confidence 4567899999999886 566899999999999999999999999988877776666554322111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
...+.+++++.++|.+||+.||++|||++|+++||||++...
T Consensus 229 -----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 229 -----------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp -----------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred -----------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 112367899999999999999999999999999999987543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=369.62 Aligned_cols=282 Identities=30% Similarity=0.452 Sum_probs=222.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCC-----eeeeeeeeecCCE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN-----IVKLQELASENYR 75 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~-----iv~~~~~~~~~~~ 75 (346)
+++|++.+.||+|+||+||+|.+..+++.||+|+++... ........|+.++..+..|++ |+++++++...+.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 478999999999999999999999999999999997432 122334567788877755664 9999999999999
Q ss_pred EEEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCCEEEe---CCcEEEeecccccc
Q 039371 76 LYFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMH--RQGYFHRDLISKNLLVS---NDTIKIADFGLAWE 149 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dikp~NIli~---~~~vkl~Dfg~a~~ 149 (346)
.|+|||+++|+|.+.+.... ..+++..++.++.|++.||.||| +.||+||||||+||+++ ++.+||+|||++..
T Consensus 131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 99999999999999887654 45999999999999999999999 57999999999999994 35799999999987
Q ss_pred cCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 150 VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 150 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.+. ......+|+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+.+..+....+.++...+.....
T Consensus 211 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (382)
T 2vx3_A 211 LGQ--RIYQYIQSRFYRSPEVLL-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287 (382)
T ss_dssp TTC--CCCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred ccc--ccccccCCccccChHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence 654 234567899999999987 55689999999999999999999999999999999999999988887765532211
Q ss_pred HHHhcCCC----------------CCCcCCCCccccc-----------CC-------CCchHHHHHHHhcccCCCCCCCH
Q 039371 230 LAKAHGYK----------------FPKLQGNNLSLLI-----------PS-------ANDDEMSLIELLCSWDPCKRPTA 275 (346)
Q Consensus 230 ~~~~~~~~----------------~~~~~~~~~~~~~-----------~~-------~~~~~~~li~~~l~~dP~~Rps~ 275 (346)
........ +.......+.... .. .++++++||++||+.||++|||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta 367 (382)
T 2vx3_A 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP 367 (382)
T ss_dssp HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence 11100000 0000000000000 00 01368899999999999999999
Q ss_pred HHHhcCCCCCCC
Q 039371 276 AEALQHPLFQGC 287 (346)
Q Consensus 276 ~ell~hp~~~~~ 287 (346)
+|+|+||||++.
T Consensus 368 ~e~L~hp~f~~~ 379 (382)
T 2vx3_A 368 YYALQHSFFKKT 379 (382)
T ss_dssp HHHTTSGGGCC-
T ss_pred HHHhcCcccccC
Confidence 999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=376.74 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=200.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-------HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-------WEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++...... .......+|+.+++++ +||||+++++++..+
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE- 212 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEESS-
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-
Confidence 5899999999999999999999999999999998654321 1122346899999999 899999999998654
Q ss_pred EEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C---cEEEeecccccc
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D---TIKIADFGLAWE 149 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~---~vkl~Dfg~a~~ 149 (346)
..++||||+.| +|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+||+++. + .+||+|||++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 57999999986 56555544 456999999999999999999999999999999999999953 2 599999999988
Q ss_pred cCCCCCCccccccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCChhhHHH
Q 039371 150 VDSCPPYTEYITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICN-AIGSPTEESWAE 226 (346)
Q Consensus 150 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~ 226 (346)
.+.........||+.|+|||++.. ...++.++|||||||++|+|++|..||........+..... ......++
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~---- 367 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE---- 367 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHH----
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCch----
Confidence 776666667789999999998853 35678899999999999999999999987654333322222 22122221
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
..+.+++.+.+||++||+.||++|||++|+++||||++
T Consensus 368 ----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 368 ----------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ----------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----------------------hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 12467899999999999999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=394.08 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=218.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++++.||+|+||+||+|+++.+++.||+|+++.... .........|..++..+.+||+|+++++++++.+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 4789999999999999999999999999999999975432 22233456788888888789999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC-CCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD-SCPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~-~~~~ 155 (346)
||||++| +|...+... +.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|.... ....
T Consensus 420 V~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred EEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence 9999985 666666544 4599999999999999999999999999999999999995 5699999999997633 3344
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||+.|+|||++. ...++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 499 ~~~~~GT~~Y~APE~l~-~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----------------- 560 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA----------------- 560 (674)
T ss_dssp BCCCCSCSSSCCHHHHT-CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC-----------------
T ss_pred cccccCCCcccCHhhhc-CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 55678999999999886 567899999999999999999999999999888887777543211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA-----AEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~-----~ell~hp~~~~~ 287 (346)
+ ...+++++++||++||+.||++||++ +|+++||||++.
T Consensus 561 --~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 561 --Y-----------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp --C-----------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred --C-----------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 1 13578999999999999999999997 999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=353.12 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=212.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+..+++.||+|+++............+|+.+++.+ +||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEEE
Confidence 68999999999999999999999999999999997665554555667899999988 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC---CCC
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC---PPY 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~---~~~ 156 (346)
+++| +|.+.+.. ...+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||.+...... ...
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9986 66655543 44599999999999999999999999999999999999996 469999999999754322 223
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ-LYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+++.|+|||++.+...++.++|||||||++|+|++|..||........ ...+.....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 226 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------------ 226 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT------------------
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc------------------
Confidence 4567899999999987555457899999999999999999999987654322 222111000
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.. .....+++.+.++|.+||+.||++|||++|+++||||+....
T Consensus 227 -~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 227 -YL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp -TS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred -cc---------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 00 011357889999999999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=354.45 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=213.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----EECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||+||+|.+..+++.||+|+++...... ......+|+.+++++ +||||+++++++.+.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeE
Confidence 57999999999999999999999999999999987654322 134456899999999 799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C----cEEEeeccccccc
Q 039371 77 YFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D----TIKIADFGLAWEV 150 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~----~vkl~Dfg~a~~~ 150 (346)
++|||+++ ++|.+.+.. ...+++..+..++.|++.||.|||++|++|+||||+||++++ + .+||+|||++...
T Consensus 84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 99999997 467666654 345999999999999999999999999999999999999954 3 7999999999877
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
..........+++.|+|||++. ...++.++||||||+++|+|++|..||.+....+....+.......+..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 233 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE-------- 233 (283)
T ss_dssp C--------CCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH--------
T ss_pred cCCCcccccCCCcCccCcceec-CCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch--------
Confidence 6655555667999999999886 5668999999999999999999999999888777666654433222221
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
..+.++..+.+++++||+.||++|||++|+++||||+..
T Consensus 234 ------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 234 ------------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp ------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ------------------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 123678899999999999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=370.77 Aligned_cols=280 Identities=27% Similarity=0.402 Sum_probs=220.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc-------CCCCeeeeeeeee---
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN-------NHPNIVKLQELAS--- 71 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-------~hp~iv~~~~~~~--- 71 (346)
++|++++.||+|+||+||+|++..+++.||+|++.... .......+|+.+++++. +||||+++++.+.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 68999999999999999999999999999999997442 23344568898888885 2888999999987
Q ss_pred -cCCEEEEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEeCC-----------
Q 039371 72 -ENYRLYFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVSND----------- 137 (346)
Q Consensus 72 -~~~~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~~~----------- 137 (346)
++..+++|||+++|++++.+.... ..+++..++.++.||+.||.|||++ ||+||||||+||+++.+
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 567899999999999998887654 5699999999999999999999998 99999999999999643
Q ss_pred ---------------------------------------cEEEeecccccccCCCCCCccccccCcccCcccccccCCCC
Q 039371 138 ---------------------------------------TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYN 178 (346)
Q Consensus 138 ---------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 178 (346)
.+||+|||++...... .....||+.|+|||++. ...++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~ 271 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI-GSGYN 271 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH-TSCCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc-CCCCC
Confidence 6999999999876542 34457899999999987 55689
Q ss_pred ChhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC--CCCCcCCCCc----
Q 039371 179 SKVDMWALGLIMAELITFHPLFPGTC------EDDQLYKICNAIGSPTEESWAEGLELAKAHGY--KFPKLQGNNL---- 246 (346)
Q Consensus 179 ~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---- 246 (346)
.++|||||||++|+|++|..||...+ ..+.+..+....+.++...+............ ..........
T Consensus 272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (397)
T 1wak_A 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351 (397)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence 99999999999999999999998755 45667778888888776655322111110000 0000000000
Q ss_pred ------ccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 247 ------SLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 247 ------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.......++.+.+||++||+.||++|||++|+|+||||++
T Consensus 352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0001223457889999999999999999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=364.03 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=210.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-------HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-------EECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|++++.||+|+||+||+|.+..+++.||+|+++...... ......+|+.+++++ +||||+++++++.+++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQG 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCC
Confidence 57999999999999999999999999999999997654321 223456799999999 7999999999999999
Q ss_pred EEEEEEEcCC-C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC
Q 039371 75 RLYFVFEYMD-C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD 151 (346)
Q Consensus 75 ~~~iv~e~~~-g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~ 151 (346)
..++|||++. | ++.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++....
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999986 4 666666544 4599999999999999999999999999999999999996 5599999999998877
Q ss_pred CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.........||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~----------------- 238 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE----------------- 238 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-----------------
T ss_pred CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-----------------
Confidence 7666667789999999999875555588999999999999999999999652210 00
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
........+++++.+||++||+.||++|||++++++||||+....
T Consensus 239 -------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 283 (335)
T 3dls_A 239 -------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283 (335)
T ss_dssp -------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred -------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence 000111347889999999999999999999999999999987443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=362.25 Aligned_cols=258 Identities=23% Similarity=0.367 Sum_probs=205.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH-hhhHHHHHHHHhhcCC-CCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-CLNLKEVKCLRKINNH-PNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~~h-p~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|.+. +++.||+|++......... ....+|+.++.++.+| |||+++++++.+++.+++|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 57999999999999999999874 6889999999766554433 4456899999999533 9999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccccCCCC---CC
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCP---PY 156 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~---~~ 156 (346)
||+.+|+|.+.+... ..+++.++..++.|++.||.|||++||+||||||+||+++++.+||+|||++....... ..
T Consensus 88 ~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 88 MECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp ECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC---------
T ss_pred EeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccccC
Confidence 998778888888765 45999999999999999999999999999999999999999999999999997665432 23
Q ss_pred ccccccCcccCcccccc----------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhHH
Q 039371 157 TEYITTLQYRAPEMLLM----------SGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 225 (346)
....||+.|+|||++.+ ...++.++|||||||++|+|++|..||...... .....+.....
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------- 238 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-------- 238 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS--------
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc--------
Confidence 35679999999999863 256889999999999999999999999765432 22222211100
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
. .......+.++.++|.+||+.||.+|||++|+++||||+....
T Consensus 239 -----------~---------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 239 -----------E---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp -----------C---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred -----------c---------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 0 0111245678999999999999999999999999999986543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=365.66 Aligned_cols=260 Identities=29% Similarity=0.394 Sum_probs=212.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccc----cCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRI----YSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++.... .........+|+.+++++ +||||+++++++.+++..+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCeEE
Confidence 57999999999999999999999999999999986542 122334567899999999 7999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcc---------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 039371 78 FVFEYMDC-NLHQLMSNR---------------------------------------KQCFSEAEVKNWCFQILQGLNYM 117 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~---------------------------------------~~~l~~~~~~~i~~ql~~~l~~L 117 (346)
+||||++| +|.+.+... ...+++..++.++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999975 676666311 11246788999999999999999
Q ss_pred HHCCccccCCCCCCEEEeC-C--cEEEeecccccccCCCC-----CCccccccCcccCcccccc-cCCCCChhhHHHHHH
Q 039371 118 HRQGYFHRDLISKNLLVSN-D--TIKIADFGLAWEVDSCP-----PYTEYITTLQYRAPEMLLM-SGQYNSKVDMWALGL 188 (346)
Q Consensus 118 H~~~ivH~dikp~NIli~~-~--~vkl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~ 188 (346)
|++||+||||||+||+++. + .+||+|||++....... ......||+.|+|||++.. ...++.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 9999999999999999963 3 79999999997543211 2345678999999999863 267899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccC
Q 039371 189 IMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWD 268 (346)
Q Consensus 189 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 268 (346)
++|+|++|..||.+....+....+...........+ ..+++++.++|.+||+.|
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY--------------------------NVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGG--------------------------GGSCHHHHHHHHHHSCSC
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCccc--------------------------ccCCHHHHHHHHHHcCCC
Confidence 999999999999999888877777664433222211 246889999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 039371 269 PCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 269 P~~Rps~~ell~hp~~~~~~ 288 (346)
|.+|||+.++++||||++..
T Consensus 319 p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 319 VDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp TTTSCCHHHHHHSHHHHTTS
T ss_pred hhHCCCHHHHhcChhhccCh
Confidence 99999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=369.62 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=207.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcC-CCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINN-HPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~-hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|.+.. ++.||+|++........ .....+|+.++.++.+ ||||+++++++..++.+|+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 359999999999999999998765 88999999976654433 3455789999999964 69999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccccCCCC---CC
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCP---PY 156 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~---~~ 156 (346)
||+.+|+|.+.+.... .+++.++..++.||+.||.|||++||+||||||+||+++++.+||+|||++....... ..
T Consensus 135 ~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 135 MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp EECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------
T ss_pred EecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccC
Confidence 9977778888877654 5999999999999999999999999999999999999998999999999997664332 23
Q ss_pred ccccccCcccCcccccc----------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhHH
Q 039371 157 TEYITTLQYRAPEMLLM----------SGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 225 (346)
....||+.|+|||++.+ ...++.++|||||||++|+|++|..||...... ..+..+.....
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~-------- 285 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-------- 285 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS--------
T ss_pred CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc--------
Confidence 45679999999999863 236889999999999999999999999765432 22322221100
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.. ......+.++.+||++||+.||.+|||++|+++||||+...
T Consensus 286 -----------~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 286 -----------EI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp -----------CC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -----------cC---------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 00 01123467899999999999999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=355.76 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=211.6
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
.|+..+.||+|+||+||+|++..+|+.||+|++...... ......+|+.+++++ +||||+++++++..++..++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEec
Confidence 378889999999999999999999999999999755433 233456899999999 799999999999999999999999
Q ss_pred CCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCccc
Q 039371 83 MDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTEY 159 (346)
Q Consensus 83 ~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~~ 159 (346)
++| +|.+.+. . ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++....... .....
T Consensus 124 ~~~~~L~~~l~-~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 124 LQGGALTDIVS-Q-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCSCBHHHHHT-T-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCHHHHHH-h-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 986 5555544 3 3499999999999999999999999999999999999996 5699999999987665432 34456
Q ss_pred cccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCC
Q 039371 160 ITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239 (346)
Q Consensus 160 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (346)
.||+.|+|||++. ...++.++|||||||++|+|++|..||......+....+.........
T Consensus 202 ~gt~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------ 262 (321)
T 2c30_A 202 VGTPYWMAPEVIS-RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK------------------ 262 (321)
T ss_dssp CSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT------------------
T ss_pred cCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC------------------
Confidence 7999999999886 567899999999999999999999999888776666555432111000
Q ss_pred CcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
....+++.+.++|.+||+.||++|||++|+++||||+..
T Consensus 263 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 263 ---------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp ---------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ---------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 012467889999999999999999999999999999853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=351.62 Aligned_cols=254 Identities=27% Similarity=0.372 Sum_probs=204.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||+||+|.+..+|+.||+|++...... .......+|+..++.+ +||||+++++++.+++..++|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEEE
Confidence 6899999999999999999999999999999998654321 1223456789999998 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||++.| +|.+.+... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++..........
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCccee
Confidence 999975 777766554 4599999999999999999999999999999999999996 5699999999998776655555
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+++.|+|||.+.+....+.++||||||+++|+|++|..||...........+......
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------- 229 (276)
T 2h6d_A 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY------------------- 229 (276)
T ss_dssp --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------------------
T ss_pred cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc-------------------
Confidence 6678999999999875444578999999999999999999999887766655554332111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
....++..+.++|.+||+.||.+|||++|+++||||++.
T Consensus 230 -----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 230 -----------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 113467889999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=357.90 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=216.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++...... .......+|+.+++.+ +||||+++++++.+++..++|
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEE
Confidence 5899999999999999999999999999999998765432 2334456899999998 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCC
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPY 156 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~ 156 (346)
|||++| +|.+.+.. ...+++.++..++.|++.||.|||++||+|+||||+||+++ ++.+||+|||++...... ...
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 999985 56555544 45699999999999999999999999999999999999996 459999999999876532 234
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+|+.|+|||++. ...++.++|||||||++|+|++|..||......+....+.....
T Consensus 199 ~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------- 258 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY------------------- 258 (335)
T ss_dssp CCCCSCCSSCCHHHHH-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-------------------
T ss_pred cccCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-------------------
Confidence 4567899999999887 56689999999999999999999999988877666555433211
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~~ 291 (346)
.. ...+++.+.++|++||+.||++|||++|+++||||++.....
T Consensus 259 ~~-----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 259 SI-----------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp CC-----------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred CC-----------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 11 135678899999999999999999999999999998765433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=353.58 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=190.2
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||+||+|.+..+|+.||+|++....... ......+|+.++.++ +||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEE
Confidence 478999999999999999999999999999999996543211 123456799999888 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~ 155 (346)
|||+++| ++.+.+......+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++...... ..
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 9999975 77777776667799999999999999999999999999999999999995 569999999999776532 22
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+|+.|+|||.+. ...++.++||||+||++|+|++|..||......+....+..
T Consensus 169 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 226 (278)
T 3cok_A 169 HYTLCGTPNYISPEIAT-RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL--------------------- 226 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS---------------------
T ss_pred ceeccCCCCcCCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh---------------------
Confidence 33457899999999886 56689999999999999999999999987654333222100
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.. ......++.++.++|.+||+.||++|||++++++||||+...
T Consensus 227 ---~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 227 ---AD------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ---SC------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ---cc------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 00 011235688999999999999999999999999999998643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=380.10 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=213.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|+++.+|+.||+|++...... .......+|..++..+ +||||+++++++.+.+.+|+|
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEE
Confidence 5799999999999999999999999999999999654321 1233456899999999 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 80 FEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|||++| +|.+.+...+ ..+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++.........
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence 999975 7776665543 3499999999999999999999999999999999999996 569999999999887665555
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE----DDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
...+||+.|+|||++. ...++.++|||||||++|+|++|..||.+... ......+...
T Consensus 343 ~~~~GT~~Y~APEvl~-~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----------------- 404 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------------- 404 (576)
T ss_dssp ECCCSCGGGCCHHHHT-TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----------------
T ss_pred cccCCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----------------
Confidence 6678999999999987 45689999999999999999999999987643 2222222111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
... ....+++++++||++||+.||.+|| +++|+++||||++.
T Consensus 405 --~~~-----------~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 405 --PEE-----------YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp --CCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred --ccc-----------CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 011 1135789999999999999999999 89999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=358.40 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=201.2
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC------
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY------ 74 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~------ 74 (346)
+++|++++.||+|+||+||+|+++.+|+.||+|+++............+|+.+++++ +||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhh
Confidence 368999999999999999999999999999999998665555556677999999999 7999999999875432
Q ss_pred ---------------------------------------------------EEEEEEEcCCC-CHHHHHhccc--CCCCH
Q 039371 75 ---------------------------------------------------RLYFVFEYMDC-NLHQLMSNRK--QCFSE 100 (346)
Q Consensus 75 ---------------------------------------------------~~~iv~e~~~g-~l~~~~~~~~--~~l~~ 100 (346)
..+++|||++| +|.+.+.... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999986 7777666543 23567
Q ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-------------CCccccccCccc
Q 039371 101 AEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-------------PYTEYITTLQYR 166 (346)
Q Consensus 101 ~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~t~~y~ 166 (346)
..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++....... ......||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 78999999999999999999999999999999996 6699999999998765432 233457999999
Q ss_pred CcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCc
Q 039371 167 APEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNL 246 (346)
Q Consensus 167 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
|||++. ...++.++|||||||++|+|++|..|+. +....+........+..
T Consensus 244 aPE~~~-~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~~----------------------- 294 (332)
T 3qd2_B 244 SPEQIH-GNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPLL----------------------- 294 (332)
T ss_dssp CHHHHH-CCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCHH-----------------------
T ss_pred ChHHhc-CCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCcc-----------------------
Confidence 999987 5678999999999999999999877642 11111111111111111
Q ss_pred ccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 247 SLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 247 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.+..++++.++|++||+.||++|||++|+++||||++
T Consensus 295 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 295 ---FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp ---HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ---cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 1234677899999999999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=349.68 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=214.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++...... .......+|+.+++.+ +||||+++++++.+++..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEE
Confidence 5899999999999999999999999999999998765432 2334456799999999 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCC
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPY 156 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~ 156 (346)
||+++| ++.+.+.. ...+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||++...... ...
T Consensus 94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 999985 55555544 45699999999999999999999999999999999999996 559999999999776532 234
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+|+.|+|||++. ...++.++||||+|+++|+|++|..||......+....+.....
T Consensus 173 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------- 232 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY------------------- 232 (294)
T ss_dssp CCCCSCCSSCCHHHHT-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------------
T ss_pred ccccCCCCcCCcchhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC-------------------
Confidence 4567899999999886 56689999999999999999999999988876665544432110
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
. ....+++.+.+++++||+.||++|||++|+++||||++....
T Consensus 233 ~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 233 S-----------IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp C-----------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred C-----------CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 1 113567889999999999999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=347.57 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=208.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeec----CCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASE----NYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~----~~~~ 76 (346)
+.|++.+.||+|+||+||+|.+..++..||+|++........ .....+|+.+++++ +||||+++++++.. ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceE
Confidence 358999999999999999999999999999999976655443 34456899999999 79999999998865 4678
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEe--CCcEEEeecccccccC
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG--YFHRDLISKNLLVS--NDTIKIADFGLAWEVD 151 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dikp~NIli~--~~~vkl~Dfg~a~~~~ 151 (346)
++||||++| +|.+.+... ..+++..+..++.|++.||.|||++| ++|+||||+||+++ ++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999976 666666543 45999999999999999999999999 99999999999996 5699999999997654
Q ss_pred CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
. .......+|+.|+|||++. ..++.++||||+||++|+|++|..||..................+
T Consensus 184 ~-~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 248 (290)
T 1t4h_A 184 A-SFAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------------ 248 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------------
T ss_pred c-cccccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc------------
Confidence 4 3344567899999999875 458999999999999999999999998866554443332211111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.......++++.++|++||+.||.+|||++|+++||||++
T Consensus 249 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 249 ---------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ---------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ---------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 1112356788999999999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=348.59 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=206.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc-CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++++.||+|+||+||+|.+..+++.||+|++..... ........+|+..+..+.+||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 579999999999999999999999999999999976533 3345566789999998878999999999999999999999
Q ss_pred EcCCC-CHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--------------------
Q 039371 81 EYMDC-NLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-------------------- 136 (346)
Q Consensus 81 e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-------------------- 136 (346)
||++| +|.+.+... ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99975 787777654 255899999999999999999999999999999999999952
Q ss_pred CcEEEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 039371 137 DTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI 216 (346)
Q Consensus 137 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 216 (346)
..+||+|||.+....... ...+|+.|+|||++.+...++.++|||||||++|+|++|.+|+..... ...+...
T Consensus 171 ~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~- 243 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQG- 243 (289)
T ss_dssp CCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTT-
T ss_pred eEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcC-
Confidence 269999999998765432 345899999999997655677899999999999999999987754321 2222111
Q ss_pred CCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 217 GSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
. .....+.+++++.++|++||+.||++|||++|+++||||++.
T Consensus 244 --------------------~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 244 --------------------R--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp --------------------C--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred --------------------C--------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 0 111224678999999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=357.50 Aligned_cols=257 Identities=30% Similarity=0.478 Sum_probs=207.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-------HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-------WEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++...... .......+|+.+++++ +||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESSS
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCCc
Confidence 5799999999999999999999999999999998654321 1123346899999999 7999999999998766
Q ss_pred EEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C---cEEEeecccccc
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D---TIKIADFGLAWE 149 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~---~vkl~Dfg~a~~ 149 (346)
.++|||++.| +|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++. + .+||+|||++..
T Consensus 89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 8999999986 77766654 445999999999999999999999999999999999999953 2 499999999987
Q ss_pred cCCCCCCccccccCcccCccccc--ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhhHHH
Q 039371 150 VDSCPPYTEYITTLQYRAPEMLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQL-YKICNAIGSPTEESWAE 226 (346)
Q Consensus 150 ~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~ 226 (346)
...........+|+.|+|||++. ....++.++|||||||++|+|++|..||........+ ..+........+.
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 242 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPE---- 242 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHH----
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCch----
Confidence 76544444567899999999874 2466899999999999999999999999776543222 2222222111111
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
....+++++.++|++||+.||++|||++++++||||+..
T Consensus 243 ----------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 243 ----------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp ----------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred ----------------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 123678999999999999999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=351.51 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=213.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||+||+|.+..+++.||+|++....... ......+|+.+++++ +||||+++++++.+++..++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEE
Confidence 478999999999999999999999999999999986543211 123456799999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|||+++| +|.+.+... +.+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++...... ..
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 169 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RR 169 (284)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CB
T ss_pred EEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-cc
Confidence 9999985 777777654 4599999999999999999999999999999999999995 569999999998765542 33
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+++.|+|||++. ...++.++||||||+++|+|++|..||......+....+.....
T Consensus 170 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------- 229 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL------------------- 229 (284)
T ss_dssp CCCCSCGGGCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------------
T ss_pred ccccCCCCcCCHHHhc-cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-------------------
Confidence 4567899999999887 56689999999999999999999999988877666555433211
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
. ..+.++.+++++|.+||+.||.+|||++++++||||+..
T Consensus 230 ~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 K-----------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp C-----------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred C-----------CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1 113568899999999999999999999999999999854
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=349.65 Aligned_cols=256 Identities=32% Similarity=0.507 Sum_probs=217.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++++.||+|+||+||+|.+..+++.||+|++...... .......+|+.+++++ +||||+++++++.+.+..++||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEEE
Confidence 5899999999999999999999999999999999655433 2334556899999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC----CcEEEeecccccccCCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN----DTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~----~~vkl~Dfg~a~~~~~~~~ 155 (346)
|++.| ++.+.+... ..+++..+..++.|++.||.|||++|++|+||||+||+++. +.+||+|||++........
T Consensus 101 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 99975 676666554 35999999999999999999999999999999999999953 2699999999987766555
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....+++.|+|||++. +.++.++||||||+++|+|++|..||.+.+..+....+.......+...
T Consensus 180 ~~~~~~~~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 245 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ------------ 245 (287)
T ss_dssp CSCHHHHHTTCCHHHHT--TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG------------
T ss_pred cccccCcccccChHHhc--CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchh------------
Confidence 56667899999999885 3589999999999999999999999998887776666654322211111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
...+++++.++|++||+.||++|||++|+++||||++.
T Consensus 246 --------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 246 --------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp --------------GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred --------------hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 13578899999999999999999999999999999853
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=354.41 Aligned_cols=281 Identities=26% Similarity=0.408 Sum_probs=220.2
Q ss_pred CceeeeeeecccCceEEEEEEE-ccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc-----CCCCeeeeeeeeecCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIK-KQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN-----NHPNIVKLQELASENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-----~hp~iv~~~~~~~~~~~ 75 (346)
++|++++.||+|+||+||+|.+ ..+++.||+|+++... .......+|+.+++.+. .|++++++++++.+++.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 6899999999999999999998 5688999999996432 22334457888877773 23459999999999999
Q ss_pred EEEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-------------------
Q 039371 76 LYFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS------------------- 135 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~------------------- 135 (346)
.++|||++++++.+.+...+ ..+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 92 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 92 ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 99999999889998887654 3589999999999999999999999999999999999995
Q ss_pred -CCcEEEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 039371 136 -NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 136 -~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 214 (346)
++.+||+|||++...... .....+|+.|+|||++. ...++.++|||||||++|+|++|..||...+..+....+..
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 248 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248 (339)
T ss_dssp SCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHH
T ss_pred cCCCceEeeCcccccCccc--cccccCCccccChHHhh-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 347999999999775542 34557899999999987 56689999999999999999999999999998888888888
Q ss_pred HhCCCChhhHHHHHHHHHhcCC--CCCCc------------CCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 215 AIGSPTEESWAEGLELAKAHGY--KFPKL------------QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~------------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+.++...+............ ..+.. ............++++.+||++||+.||.+|||++|+++
T Consensus 249 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 7777766544321110000000 00000 000000011233567889999999999999999999999
Q ss_pred CCCCCCC
Q 039371 281 HPLFQGC 287 (346)
Q Consensus 281 hp~~~~~ 287 (346)
||||+..
T Consensus 329 hp~f~~~ 335 (339)
T 1z57_A 329 HPFFDLL 335 (339)
T ss_dssp SGGGGGG
T ss_pred CHHHHHH
Confidence 9999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=374.33 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=211.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|+++.+|+.||+|++....... ......+|..++.++ +||||+++++++.+.+.+|+|
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEE
Confidence 68999999999999999999999999999999996543221 223456899999999 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 80 FEYMDC-NLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
|||++| +|...+... ...+++..++.++.||+.||.|||++||+||||||+||+++ +|.+||+|||++.......
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 999985 676666543 34599999999999999999999999999999999999995 5699999999998765543
Q ss_pred C-CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCChhhHHHHHH
Q 039371 155 P-YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE----DDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 155 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
. ....+||+.|+|||++. ...++.++|||||||++|+|++|.+||.+... .+....+....
T Consensus 344 ~~~~~~~GT~~Y~APE~l~-~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~------------- 409 (543)
T 3c4z_A 344 TKTKGYAGTPGFMAPELLL-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA------------- 409 (543)
T ss_dssp CCBCCCCSCTTTSCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-------------
T ss_pred cccccccCCccccChhhhc-CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-------------
Confidence 3 34458999999999987 56789999999999999999999999987542 23333332211
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
..+ .+.+++++++||++||+.||++||+ ++++++||||++.
T Consensus 410 ------~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 410 ------VTY-----------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp ------CCC-----------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ------cCC-----------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 111 1357899999999999999999996 5899999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=361.19 Aligned_cols=274 Identities=20% Similarity=0.306 Sum_probs=212.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+..+++.||+|++.............+|+.+++++ +||||+++++++.+++..++|||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEE
Confidence 68999999999999999999999999999999998765444455667899999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|++| +|.+.+... +.+++..+..++.|++.||.|||++ ||+|+||||+||+++ ++.+||+|||++...... ....
T Consensus 112 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 189 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 189 (360)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C---
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccC
Confidence 9986 676666554 4599999999999999999999996 999999999999995 569999999998654321 2334
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-Chhh--------------
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSP-TEES-------------- 223 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~-------------- 223 (346)
..||+.|+|||++. ...++.++|||||||++|+|++|..||...+..+....+....... ....
T Consensus 190 ~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 190 FVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp -CCCCTTCCHHHHT-TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCeECHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 57899999999887 5678999999999999999999999998877655433321111100 0000
Q ss_pred --------HHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 224 --------WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 224 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
..+..+...... ........++.++.+||++||+.||++|||++|+++||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEP---------PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -----CCCHHHHHHHHHHSC---------CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cCCCCcccchhhhhHHhccC---------CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 000011110000 00111234688999999999999999999999999999998643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=352.74 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=195.1
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+++|++++.||+|+||+||+|.+..+|+.||+|++..............|+..+.+..+||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 47899999999999999999999999999999999766554444445555554444448999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|++++.+..........+++..+..++.|++.||.|||++ |++|+||||+||+++ ++.+||+|||++...........
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR 183 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccc
Confidence 9996666555555566799999999999999999999996 999999999999995 56999999999977665555556
Q ss_pred ccccCcccCccccc----ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 159 YITTLQYRAPEMLL----MSGQYNSKVDMWALGLIMAELITFHPLFPGTC-EDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 159 ~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
..+|+.|+|||++. ....++.++||||+||++|+|++|..||.... ..+....+.......
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 249 (318)
T 2dyl_A 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-------------- 249 (318)
T ss_dssp ---CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC--------------
T ss_pred cCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC--------------
Confidence 67999999999985 24568899999999999999999999998743 334444443321100
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.+ ....+++++.++|.+||+.||.+|||++++++||||+..
T Consensus 250 ----~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 250 ----LP---------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp ----CC---------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ----CC---------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 00 012578899999999999999999999999999999854
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=358.68 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=207.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCC----E
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENY----R 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~----~ 75 (346)
++|++.+.||+|+||+||+|++..+++.||+|++........ .....+|+.++.++ +||||+++++++.... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCcc
Confidence 689999999999999999999999999999999976543322 23456788888888 7999999999986543 4
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
.|+||||++| +|.+.+... +.+++.++..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 5999999985 666666544 4599999999999999999999999999999999999995 569999999999765432
Q ss_pred C----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 P----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
. ......||+.|+|||++. ...++.++|||||||++|+|++|..||.+....+....+......++..
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------- 241 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA------- 241 (311)
T ss_dssp ------------CCTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH-------
T ss_pred ccccccccccCcCcccCCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc-------
Confidence 2 223356899999999987 5678999999999999999999999999988877766665543322211
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..+.+++++.++|.+||+.||.+||++.+++.|+|++....
T Consensus 242 -------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 242 -------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp -------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred -------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 12367899999999999999999999999999999985443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=353.68 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=193.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++.............+|+.++.++ +||||+++++++...+..++|||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEEeh
Confidence 68999999999999999999999999999999997654443444556888888888 79999999999999999999999
Q ss_pred cCCC-CHHHHHhc-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 82 YMDC-NLHQLMSN-------RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 82 ~~~g-~l~~~~~~-------~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
+++| +|.+.+.. ....+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++.....
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 9975 77776653 244589999999999999999999999999999999999995 56999999999876543
Q ss_pred CC------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHH
Q 039371 153 CP------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 153 ~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (346)
.. ......+|+.|+|||++.....++.++|||||||++|+|++|..||.....................
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 248 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE----- 248 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT-----
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc-----
Confidence 21 2234578999999999875466899999999999999999999999887765544433222111100
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
...........++.++.++|.+||+.||.+|||++++++||||+...
T Consensus 249 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 249 ---------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp ---------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred ---------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 00011122356788999999999999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=349.51 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=208.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+..+++.||+|++...... ......+|+.++..+ +||||+++++++.+++..++|||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-CHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-HHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEEE
Confidence 5899999999999999999999999999999998655332 233456899999998 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~~~~ 158 (346)
+++| ++.+.+......+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++..... ......
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 9986 56666665566699999999999999999999999999999999999996 56999999998753221 112234
Q ss_pred ccccCcccCccccc----ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 159 YITTLQYRAPEMLL----MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 159 ~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
..+|+.|+|||++. ....++.++|||||||++|+|++|..||...+.......+........
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 242 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-------------- 242 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--------------
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc--------------
Confidence 57899999999884 356688999999999999999999999998877666555543221100
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.....++..+.++|.+||+.||.+|||++++++||||++..
T Consensus 243 -------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 243 -------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp -------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred -------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 01135678899999999999999999999999999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=357.69 Aligned_cols=275 Identities=20% Similarity=0.287 Sum_probs=210.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC--EEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY--RLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~--~~~iv 79 (346)
++|++.+.||+|+||+||+|.+..+++.||+|+++............+|+.+++++ +||||+++++++...+ ..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEEE
Confidence 57999999999999999999999999999999997654433344556899999999 7999999999987654 78999
Q ss_pred EEcCC-CCHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE----eC-CcEEEeecccccccC
Q 039371 80 FEYMD-CNLHQLMSNRKQ--CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV----SN-DTIKIADFGLAWEVD 151 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli----~~-~~vkl~Dfg~a~~~~ 151 (346)
|||++ |+|.+.+..... .+++..+..++.|++.||+|||++||+||||||+||++ +. +.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 99997 577777765433 38999999999999999999999999999999999998 32 369999999998877
Q ss_pred CCCCCccccccCcccCcccccc-------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCC
Q 039371 152 SCPPYTEYITTLQYRAPEMLLM-------SGQYNSKVDMWALGLIMAELITFHPLFPGTCE----DDQLYKICNAIGSPT 220 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~ 220 (346)
.........+|+.|+|||++.. ...++.++|||||||++|+|++|..||..... .+.+..+........
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 6666667789999999998853 36689999999999999999999999975433 344444444322111
Q ss_pred hhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCC
Q 039371 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHP 282 (346)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp 282 (346)
....... .......... ...........++.+.++|++||+.||++|||++|+++||
T Consensus 248 ~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 248 ISGVQKA----ENGPIDWSGD-MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CEEEECS----TTCCEEEESS-CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred chhhhcc----cCCccccCcc-CCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 1100000 0000000000 0000111234456788999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=353.36 Aligned_cols=281 Identities=24% Similarity=0.388 Sum_probs=220.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCC-cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCC------eeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG-EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN------IVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~------iv~~~~~~~~~~ 74 (346)
++|++++.||+|+||+||+|.+..++ +.||+|+++... .......+|+.+++++. |++ ++.+++++...+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIK-EKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHH-HHCTTSCSCBCCEEEEEEETT
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHh-hcCCCCceeEEEeeeeeeeCC
Confidence 68999999999999999999998777 689999996432 22334457888888873 444 899999999999
Q ss_pred EEEEEEEcCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe------------------
Q 039371 75 RLYFVFEYMDCNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS------------------ 135 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~------------------ 135 (346)
..++|||+++|++.+.+.... ..+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus 96 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 96 HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred eEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 999999999999998887654 4699999999999999999999999999999999999992
Q ss_pred --CCcEEEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 039371 136 --NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 136 --~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 213 (346)
++.+||+|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...+..+....+.
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252 (355)
T ss_dssp ESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCcEEEeecCccccccc--cccCCcCCCcccCCeeee-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45899999999976544 234457899999999987 5668999999999999999999999999999888888888
Q ss_pred HHhCCCChhhHHHHHHHHHhcC--CCCCCcC----------C--CCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHh
Q 039371 214 NAIGSPTEESWAEGLELAKAHG--YKFPKLQ----------G--NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL 279 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell 279 (346)
...+.++...+........... ...+... . ..........+.++.+||++||+.||++|||++|++
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 8887777655432111000000 0000000 0 000000112245788999999999999999999999
Q ss_pred cCCCCCCCC
Q 039371 280 QHPLFQGCL 288 (346)
Q Consensus 280 ~hp~~~~~~ 288 (346)
+||||++..
T Consensus 333 ~hp~f~~~~ 341 (355)
T 2eu9_A 333 LHPFFAGLT 341 (355)
T ss_dssp TSGGGGGCC
T ss_pred cChhhcCCC
Confidence 999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=357.04 Aligned_cols=286 Identities=27% Similarity=0.403 Sum_probs=220.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc----------CCCCeeeeeeeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN----------NHPNIVKLQELAS 71 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~----------~hp~iv~~~~~~~ 71 (346)
++|++++.||+|+||+||+|.+..+++.||+|++..... ......+|+.+++++. +||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 689999999999999999999999999999999974322 2334457888887774 2899999999987
Q ss_pred cCC----EEEEEEEcCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEeC-------Cc
Q 039371 72 ENY----RLYFVFEYMDCNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVSN-------DT 138 (346)
Q Consensus 72 ~~~----~~~iv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~~-------~~ 138 (346)
..+ .++++||+++++|.+.+... ...+++..+..++.||+.||+|||++ ||+||||||+||+++. +.
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 654 78999999988999888764 34599999999999999999999998 9999999999999941 17
Q ss_pred EEEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHH
Q 039371 139 IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTC------EDDQLYKI 212 (346)
Q Consensus 139 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i 212 (346)
+||+|||++...... .....+|+.|+|||++. ...++.++|||||||++|+|++|..||.+.. ..+.+..+
T Consensus 177 ~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 177 IKIADLGNACWYDEH--YTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp EEECCCTTCEETTBC--CCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred EEEcccccccccCCC--CCCCCCCccccCcHHHh-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 999999999776542 33457899999999987 5668999999999999999999999998654 45677788
Q ss_pred HHHhCCCChhhHHHHHHHHHhcCC--CCCCcCCCC----------cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 213 CNAIGSPTEESWAEGLELAKAHGY--KFPKLQGNN----------LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+.++...+............ ......... .....+.++.++.+||++||+.||.+|||++|+++
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 888888777655433222111110 000000000 00011234568889999999999999999999999
Q ss_pred CCCCCCCCCCCC
Q 039371 281 HPLFQGCLQVPS 292 (346)
Q Consensus 281 hp~~~~~~~~~~ 292 (346)
||||++......
T Consensus 334 hp~f~~~~~~~~ 345 (373)
T 1q8y_A 334 HPWLKDTLGMEE 345 (373)
T ss_dssp CGGGTTCTTCTT
T ss_pred ChhhhcccCccc
Confidence 999998765443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=349.74 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=211.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc---CHHHhhhHHHHHHHHhhcCCCCeeeeeeee--ecCCE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY---SWEECLNLKEVKCLRKINNHPNIVKLQELA--SENYR 75 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~--~~~~~ 75 (346)
+++|++.+.||+|+||.||+|.+..+++.||+|+++.... ........+|+.+++++ +||||+++++++ .+.+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence 4799999999999999999999999999999999965432 22344567899999999 799999999998 45568
Q ss_pred EEEEEEcCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDCNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
.++|||++++++.+.+... ...+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++......
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 8999999998887776553 44699999999999999999999999999999999999995 569999999999766432
Q ss_pred C---CCccccccCcccCcccccccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 P---PYTEYITTLQYRAPEMLLMSG-QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
. ......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------------ 230 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------------ 230 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC------------
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC------------
Confidence 2 223456899999999886432 347799999999999999999999998876666555533211
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
. ....+++.+.++|++||+.||.+|||++|+++||||+....
T Consensus 231 -------~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 231 -------A-----------IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -------C-----------CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -------C-----------CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 1 11356889999999999999999999999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=346.45 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=214.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+..+++.||+|++.............+|+.++.++ +||||+++++++.+++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEE
Confidence 57999999999999999999999999999999997665554455667899999998 89999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
+++| ++.+.+.. +.+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++....... ....
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 9986 66666543 4599999999999999999999999999999999999995 5699999999997655432 3345
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+++.|+|||++. ...++.++|||||||++|+|++|..||...........+.....
T Consensus 179 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------- 236 (303)
T 3a7i_A 179 FVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--------------------- 236 (303)
T ss_dssp CCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---------------------
T ss_pred cCCCcCccCHHHHh-cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC---------------------
Confidence 67899999999886 56689999999999999999999999988776655544432110
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
......++..+.++|.+||+.||.+|||++++++||||..
T Consensus 237 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 237 --------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp --------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred --------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 1112467889999999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=361.05 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=206.2
Q ss_pred CCceeeeeeecccCceEEEEEEEc---cCCcEEEEEEcccccc---CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIY---SWEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
+++|++++.||+|+||+||+|++. .+++.||+|+++.... ........+|+.++.++.+||||+++++++.+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999984 5889999999865432 1122334578999999978999999999999999
Q ss_pred EEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
.+++||||++| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999985 676666554 4599999999999999999999999999999999999995 56999999999976543
Q ss_pred CC--CCccccccCcccCccccccc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 153 CP--PYTEYITTLQYRAPEMLLMS-GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 153 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.. ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+....
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------------- 278 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI------------- 278 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-------------
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH-------------
Confidence 22 23345799999999998742 457899999999999999999999997544322222221110
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
.... ....+.++..+.+||++||+.||.+|| |++|+++||||+..
T Consensus 279 --~~~~-----------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 279 --LKSE-----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp --HHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred --hccC-----------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 0000 001135788899999999999999999 99999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=345.64 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=204.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|.+..+++.||+|++....... ......+|+..+.++ +||||+++++++.+++..|+|
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEEE
Confidence 58999999999999999999999999999999986543332 234456899999999 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--C
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--P 155 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~ 155 (346)
|||++| +|.+.+... +.+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++....... .
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 999986 666666544 4699999999999999999999999999999999999995 5699999999997665432 2
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+.............
T Consensus 169 ~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 232 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV--------------- 232 (294)
T ss_dssp ------CCSSCCHHHHH-TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCH---------------
T ss_pred cCccccCccccCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCc---------------
Confidence 33457899999999987 56689999999999999999999999998877665444432211110
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
.....+.+++.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus 233 ----------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 233 ----------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp ----------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred ----------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 0112346789999999999999999999666666665544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=348.54 Aligned_cols=257 Identities=24% Similarity=0.421 Sum_probs=206.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec------CCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE------NYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------~~~ 75 (346)
++|++++.||+|+||+||+|++..+++.||+|++...... .....+|+.+++++.+||||+++++++.. .+.
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 6899999999999999999999999999999999755433 23456899999998789999999999876 568
Q ss_pred EEEEEEcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
.++|||+++| +|.+.+... ...+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++.....
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 9999999986 787777654 34699999999999999999999999999999999999996 56999999999876553
Q ss_pred CC-CCccccccCcccCcccccc----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHH
Q 039371 153 CP-PYTEYITTLQYRAPEMLLM----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 153 ~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
.. ......+|+.|+|||++.. ...++.++|||||||++|+|++|..||...........+......
T Consensus 182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 252 (326)
T 2x7f_A 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP--------- 252 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------
T ss_pred CccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc---------
Confidence 22 3345578999999998853 355889999999999999999999999887766555444322110
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
......++..+.++|++||+.||.+|||++++++||||+...
T Consensus 253 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 253 -------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp -------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred -------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 001245788999999999999999999999999999998754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=346.28 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=209.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+|+.++.++ +||||+++++++.+++..++|||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEee
Confidence 589999999999999999999999999999999976432 23356799999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~~ 158 (346)
+++| +|.+.+......+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++....... ....
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence 9986 77777765566799999999999999999999999999999999999995 5699999999997654432 3345
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
..+++.|+|||++. ...++.++|||||||++|+|++|..||...........+....... +
T Consensus 185 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~ 245 (314)
T 3com_A 185 VIGTPFWMAPEVIQ-EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT------------------F 245 (314)
T ss_dssp CCSCGGGCCHHHHS-SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC------------------C
T ss_pred cCCCCCccChhhcC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc------------------c
Confidence 57899999999886 5568999999999999999999999998877655444332211100 0
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.....++..+.++|.+||+.||.+|||++++++||||++..
T Consensus 246 ---------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 246 ---------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp ---------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 00124678999999999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=350.88 Aligned_cols=262 Identities=22% Similarity=0.339 Sum_probs=190.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.++|++++.||+|+||+||+|.++.+|+.||+|++..............|+..+.+..+||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 37899999999999999999999999999999999866554455555677775555558999999999999999999999
Q ss_pred EcCCCCHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 81 EYMDCNLHQLMSN----RKQCFSEAEVKNWCFQILQGLNYMHRQ-GYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 81 e~~~g~l~~~~~~----~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
|+++|++.+.+.. ....+++..+..++.|++.||.|||++ |++||||||+||+++ ++.+||+|||++.......
T Consensus 101 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp CCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred eecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 9999988776653 245699999999999999999999999 999999999999995 5699999999998766554
Q ss_pred CCccccccCcccCccccc---ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhHHHHHHH
Q 039371 155 PYTEYITTLQYRAPEMLL---MSGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
......||+.|+|||++. ....++.++|||||||++|+|++|..||...... +....+.
T Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----------------- 243 (327)
T 3aln_A 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV----------------- 243 (327)
T ss_dssp -------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-----------------
T ss_pred ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-----------------
Confidence 455557999999999884 2456899999999999999999999999764321 1100000
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
....+. ........+++++.++|++||+.||.+|||++++++||||+..
T Consensus 244 ----~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 244 ----KGDPPQ----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ----CSCCCC----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----cCCCCC----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 000000 0111124678899999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=369.65 Aligned_cols=248 Identities=15% Similarity=0.154 Sum_probs=195.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhc--CCCCeeeee-------eee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKIN--NHPNIVKLQ-------ELA 70 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~--~hp~iv~~~-------~~~ 70 (346)
++|++.+.||+|+||+||+|++..+|+.||+|++..... ........+|+.+++.+. +||||++++ +++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 579999999999999999999999999999999975422 223344567885444443 799999998 666
Q ss_pred ecCC-----------------EEEEEEEcCCCCHHHHHhcccCCCC-------HHHHHHHHHHHHHHHHHHHHCCccccC
Q 039371 71 SENY-----------------RLYFVFEYMDCNLHQLMSNRKQCFS-------EAEVKNWCFQILQGLNYMHRQGYFHRD 126 (346)
Q Consensus 71 ~~~~-----------------~~~iv~e~~~g~l~~~~~~~~~~l~-------~~~~~~i~~ql~~~l~~LH~~~ivH~d 126 (346)
++++ ..|++|||++|+|.+.+...+. ++ +..+..++.||+.||+|||++||+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHH-TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccc-cccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 5543 2799999999999988876432 44 488889999999999999999999999
Q ss_pred CCCCCEEEe-CCcEEEeecccccccCCCCCCccccccCcccCccccccc----------CCCCChhhHHHHHHHHHHHHh
Q 039371 127 LISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMS----------GQYNSKVDMWALGLIMAELIT 195 (346)
Q Consensus 127 ikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~ 195 (346)
|||+||+++ ++.+||+|||++...+. ......| +.|+|||++.+. ..++.++|||||||++|+|++
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt 308 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence 999999996 56999999999986543 3334567 999999998744 268999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCH
Q 039371 196 FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTA 275 (346)
Q Consensus 196 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~ 275 (346)
|..||.+....+....+ ....+.+++++.+||.+||+.||++|||+
T Consensus 309 g~~Pf~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 309 ADLPITKDAALGGSEWI----------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp SSCCC------CCSGGG----------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred CCCCCcccccccchhhh----------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCCH
Confidence 99999654322111110 01124678999999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 039371 276 AEALQHPLFQGC 287 (346)
Q Consensus 276 ~ell~hp~~~~~ 287 (346)
.|+++||||++.
T Consensus 355 ~e~l~hp~f~~~ 366 (377)
T 3byv_A 355 LQAMETPEYEQL 366 (377)
T ss_dssp HHHHTSHHHHHH
T ss_pred HHHhhChHHHHH
Confidence 999999999853
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=361.44 Aligned_cols=261 Identities=15% Similarity=0.177 Sum_probs=191.2
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhc-CCCCeeeee-------eeeec
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKIN-NHPNIVKLQ-------ELASE 72 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~-~hp~iv~~~-------~~~~~ 72 (346)
+|++.+.||+|+||+||+|++..+|+.||+|++....... ......+|+.++..+. +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 5999999999999999999999999999999998765432 2223345655455553 599988855 33332
Q ss_pred C-----------------CEEEEEEEcCCCCHHHHHhcccCCCCHHHH------HHHHHHHHHHHHHHHHCCccccCCCC
Q 039371 73 N-----------------YRLYFVFEYMDCNLHQLMSNRKQCFSEAEV------KNWCFQILQGLNYMHRQGYFHRDLIS 129 (346)
Q Consensus 73 ~-----------------~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~------~~i~~ql~~~l~~LH~~~ivH~dikp 129 (346)
. ..+|+||||++|+|.+.+...+..+++..+ ..++.||+.||+|||++||+||||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp 222 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCH
Confidence 2 348999999999999998876555666666 67789999999999999999999999
Q ss_pred CCEEEe-CCcEEEeecccccccCCCCCCccccccCcccCcccccc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 039371 130 KNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM-SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD 207 (346)
Q Consensus 130 ~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 207 (346)
+||+++ ++.+||+|||+|...+... ....+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.....
T Consensus 223 ~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 223 DNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp GGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred HHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 999996 5699999999998765422 14567799999999863 2568999999999999999999999997764320
Q ss_pred HHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCC-CCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 208 QLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQG-NNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 208 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
. ..+. ......... .......+.+++.+.+||.+||+.||++|||++++++||||++
T Consensus 301 ~-------------~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 301 K-------------GSWK---------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp T-------------TCCC---------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred c-------------cchh---------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 0 0000 000000000 0001112477899999999999999999999999999999986
Q ss_pred C
Q 039371 287 C 287 (346)
Q Consensus 287 ~ 287 (346)
.
T Consensus 359 ~ 359 (371)
T 3q60_A 359 L 359 (371)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=339.65 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=211.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeee--ecCCEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELA--SENYRLY 77 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~--~~~~~~~ 77 (346)
+++|++++.||+|+||+||+|.+..+++.||+|++........ .....+|+.+++++ +||||+++++++ ..++..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence 4789999999999999999999999999999999976654433 34456899999999 799999999987 4467899
Q ss_pred EEEEcCCC-CHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCCEEEe-CCcEEEeecccc
Q 039371 78 FVFEYMDC-NLHQLMSNR---KQCFSEAEVKNWCFQILQGLNYMHRQG-----YFHRDLISKNLLVS-NDTIKIADFGLA 147 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~-----ivH~dikp~NIli~-~~~vkl~Dfg~a 147 (346)
+||||++| +|.+.+... ...+++..+..++.|++.||+|||++| ++|+||||+||+++ ++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999985 787777543 234999999999999999999999999 99999999999996 568999999999
Q ss_pred cccCCCCC-CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHH
Q 039371 148 WEVDSCPP-YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 148 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (346)
........ .....+++.|+|||++. ...++.++|||||||++|+|++|..||...+..+....+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-------- 234 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-------- 234 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHH-CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred eeeccccccccccCCCccccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc--------
Confidence 77654321 23457899999999887 556899999999999999999999999988776665555433211
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.....++.++.++|.+||+.||++|||++|+++|+|+.+-
T Consensus 235 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 235 ---------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ---------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 1113578899999999999999999999999999999863
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=347.46 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=207.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc---EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++.+.||+|+||+||+|.+..+++ .||+|+++............+|+.+++++ +||||+++++++.+++..++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEE
Confidence 589999999999999999999986555 59999998665555556677899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~- 155 (346)
||||++| +|.+.+......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 9999975 77777776666799999999999999999999999999999999999995 55999999999987654321
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+......+.
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 275 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIA-FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA----------- 275 (325)
T ss_dssp CEECC---CCGGGSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-----------
T ss_pred eeeccCCCCcccccCHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC-----------
Confidence 22234567899999986 5668999999999999999999 9999998887776666544321111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+++.+.++|.+||+.||.+|||++++++
T Consensus 276 ------------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 276 ------------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1357889999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=342.46 Aligned_cols=254 Identities=31% Similarity=0.451 Sum_probs=198.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec---------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--------- 72 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--------- 72 (346)
++|++++.||+|+||+||+|++..+++.||+|++.... .......+|+.+++++ +||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhc
Confidence 57999999999999999999999999999999996432 2334556899999999 79999999998754
Q ss_pred ----CCEEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccc
Q 039371 73 ----NYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGL 146 (346)
Q Consensus 73 ----~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~ 146 (346)
.+..++|||+++| +|.+.+...+..+++..+..++.|++.||+|||++|++|+||||+||+++ ++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 4678999999975 88888876666689999999999999999999999999999999999995 56999999999
Q ss_pred ccccCCC---------------CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHH
Q 039371 147 AWEVDSC---------------PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLY 210 (346)
Q Consensus 147 a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~ 210 (346)
+...... .......+|+.|+|||++.+...++.++|||||||++|+|++ ||...... +...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 9765421 123345789999999998766679999999999999999998 55432221 2222
Q ss_pred HHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 211 KICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 211 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.+... ...++ .......+..+.++|++||+.||.+|||++++++||||+..
T Consensus 240 ~~~~~-------------------~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 240 KLRSV-------------------SIEFP-------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHST-------------------TCCCC-------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred hcccc-------------------ccccC-------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 21111 11111 11224566789999999999999999999999999999853
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=339.15 Aligned_cols=251 Identities=18% Similarity=0.195 Sum_probs=208.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+|+..+..+.+|||++++++++.++...++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 589999999999999999999999999999999865432 22345789999999889999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C-----cEEEeecccccccCCCC-
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D-----TIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~-----~vkl~Dfg~a~~~~~~~- 154 (346)
+++|+|.+.+...+..+++..+..++.|++.||+|||++||+||||||+||+++. + .+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 87 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred ecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9988999988877667999999999999999999999999999999999999953 3 39999999997655432
Q ss_pred -------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCChhhH
Q 039371 155 -------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTC---EDDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 155 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~ 224 (346)
......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.. ..+....+......++..
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR-- 243 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH--
T ss_pred cccccccCccCCCCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH--
Confidence 234567899999999886 5668999999999999999999999998753 333344443322211111
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+.+++++.+++.+||+.||++|||++++++.
T Consensus 244 -----------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 244 -----------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp -----------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred -----------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1124678999999999999999999999999873
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=351.69 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=207.8
Q ss_pred CceeeeeeecccCceEEEEEEEc-------cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-------QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|++.+.||+|+||+||+|.+. .++..||+|+++............+|+.+++++.+||||+++++++.+++
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 58999999999999999999875 34567999999766554455567789999999978999999999999999
Q ss_pred EEEEEEEcCCC-CHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND 137 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~ 137 (346)
.+|+||||+.| +|.+.+.... ..+++.++..++.||+.||+|||++||+||||||+||+++ ++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence 99999999985 7877776543 2489999999999999999999999999999999999995 56
Q ss_pred cEEEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.+||+|||++....... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 319 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 99999999998655432 223345678999999887 5678999999999999999999 999998877666555443
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..... .....++.++.++|++||+.||.+|||+.|++++
T Consensus 320 ~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 320 EGHRM-----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22110 1113578899999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=342.82 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=204.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcC-CCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINN-HPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~-hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|.+. +++.||+|++........ .....+|+.++.++.+ ||||+++++++.+++..+++
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 57999999999999999999875 488999999976554433 3445689999999964 69999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccccCCCC---CC
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCP---PY 156 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~---~~ 156 (346)
||+.+|+|.+.+.... .+++..+..++.|++.||.|||++||+||||||+||+++++.+||+|||++....... ..
T Consensus 107 ~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~ 185 (313)
T 3cek_A 107 MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVK 185 (313)
T ss_dssp ECCCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC----------
T ss_pred EecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccccccc
Confidence 9977788888887654 5999999999999999999999999999999999999999999999999997654332 22
Q ss_pred ccccccCcccCcccccc----------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhHH
Q 039371 157 TEYITTLQYRAPEMLLM----------SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDD-QLYKICNAIGSPTEESWA 225 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 225 (346)
....+|+.|+|||++.. ...++.++|||||||++|+|++|..||....... ....+....
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--------- 256 (313)
T 3cek_A 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN--------- 256 (313)
T ss_dssp ----CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT---------
T ss_pred cCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc---------
Confidence 34578999999998863 1468889999999999999999999997654332 222221110
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.. .......+.++.++|++||+.||.+|||++|+++||||+....
T Consensus 257 ----------~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 257 ----------HE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp ----------SC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred ----------cc---------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 00 0011245778999999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=344.92 Aligned_cols=249 Identities=20% Similarity=0.242 Sum_probs=204.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+|+.+++++.+||||+++++++.+++..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 589999999999999999999999999999999865432 22356899999999789999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-c-----EEEeecccccccCCCCC
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-T-----IKIADFGLAWEVDSCPP 155 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~-~-----vkl~Dfg~a~~~~~~~~ 155 (346)
+++|+|.+.+...+..+++..+..++.|++.||+|||++||+||||||+||+++.+ . +||+|||++........
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 86 LLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred eCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 99888988888766679999999999999999999999999999999999999643 3 99999999976543221
Q ss_pred --------CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhhH
Q 039371 156 --------YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED---DQLYKICNAIGSPTEESW 224 (346)
Q Consensus 156 --------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 224 (346)
.....||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+.. +....+.......+.+.
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 243 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHL-GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV- 243 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH-
T ss_pred CccccccccCCcCCCccccChHHHc-CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH-
Confidence 24568999999999987 566899999999999999999999999875433 33333332221111111
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+ ++.+++..||+.||.+||+++++.+
T Consensus 244 ------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 244 ------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 012334 8999999999999999999998876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=351.36 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=181.5
Q ss_pred Cceeeee-eecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec----CCEE
Q 039371 2 EKYTLMK-QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE----NYRL 76 (346)
Q Consensus 2 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~----~~~~ 76 (346)
++|++.+ .||+|+||+||+|.++.+++.||+|++.... ...+|+..+.+..+||||+++++++.. +..+
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 6899966 5999999999999999999999999986431 122445554555589999999999876 5568
Q ss_pred EEEEEcCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC----CcEEEeeccccccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN----DTIKIADFGLAWEV 150 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~----~~vkl~Dfg~a~~~ 150 (346)
++||||++| +|.+.+.... ..+++.+++.++.|++.||.|||++||+||||||+||+++. +.+||+|||++...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999986 8888777653 36999999999999999999999999999999999999953 36999999999766
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
.. .......+|+.|+|||++. ...++.++|||||||++|+|++|..||................
T Consensus 182 ~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------- 245 (336)
T 3fhr_A 182 TQ-NALQTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI-------------- 245 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred cc-cccccCCCCcCccChhhhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh--------------
Confidence 54 2334567899999999885 5668899999999999999999999997665443221111100
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......++. .....+++++.+||++||+.||.+|||++|+++||||++...
T Consensus 246 -~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 246 -RLGQYGFPN-------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp ------CCCT-------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred -hccccccCc-------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 000001111 112467899999999999999999999999999999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=345.65 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=208.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----HHhhhHHHHHHHHhhc-CCCCeeeeeeeeecCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----EECLNLKEVKCLRKIN-NHPNIVKLQELASENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~-~hp~iv~~~~~~~~~~~ 75 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++....... ......+|+.+++++. +||||+++++++.+++.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 58999999999999999999999999999999997654332 2234467999999996 37999999999999999
Q ss_pred EEEEEEcCC--CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe--CCcEEEeecccccccC
Q 039371 76 LYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS--NDTIKIADFGLAWEVD 151 (346)
Q Consensus 76 ~~iv~e~~~--g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~--~~~vkl~Dfg~a~~~~ 151 (346)
.+++||++. ++|.+.+... +.+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++....
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence 999999997 5777777654 4599999999999999999999999999999999999997 4699999999998766
Q ss_pred CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.. ......+|+.|+|||++.+....+.++|||||||++|+|++|..||..... +...
T Consensus 202 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~---------------- 258 (320)
T 3a99_A 202 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG---------------- 258 (320)
T ss_dssp SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC----------------
T ss_pred cc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc----------------
Confidence 43 344567899999999987555567899999999999999999999965311 1110
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
... ....+++++.++|++||+.||++|||++|+++||||++..
T Consensus 259 ---~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 259 ---QVF-----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ---CCC-----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---ccc-----------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 000 1136789999999999999999999999999999999754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=352.01 Aligned_cols=253 Identities=21% Similarity=0.368 Sum_probs=210.1
Q ss_pred CceeeeeeecccCceEEEEEE-----EccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|+ +..+++.||+|+++............+|+.++.++ +||||+++++++.+++..
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSC
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCC
Confidence 579999999999999999999 45677899999997665555556677899999999 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C---cEEEeecc
Q 039371 77 YFVFEYMDC-NLHQLMSNRK------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D---TIKIADFG 145 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~---~vkl~Dfg 145 (346)
++||||+.| +|.+.+.... ..+++.++..++.||+.||+|||++||+||||||+||+++. + .+||+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 999999975 8887776543 35899999999999999999999999999999999999962 2 59999999
Q ss_pred cccccC---CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 146 LAWEVD---SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 146 ~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
++.... .........+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+......+.
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~- 307 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP- 307 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-
T ss_pred cccccccccccccCCCcCCcccEECHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence 997432 122334456789999999887 5668999999999999999998 9999999887776666544321111
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
...+++.+.+++++||+.||.+|||++++++|.++-
T Consensus 308 ----------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 308 ----------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp ----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 135788899999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=334.01 Aligned_cols=246 Identities=24% Similarity=0.428 Sum_probs=207.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+. +++.||+|++........ ...+|+.+++++ +||||+++++++.+++..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEE--DFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHH--HHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHH--HHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEEEE
Confidence 68999999999999999999987 467799999986655433 356899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CCc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PYT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~~ 157 (346)
|++| ++.+.+......+++..+..++.|++.||+|||++|++||||||+||+++ ++.+||+|||++....... ...
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 9985 77777777777799999999999999999999999999999999999995 5699999999997654322 233
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+|+.|+|||++. ...++.++||||+||++|+|++ |..||......+....+........
T Consensus 166 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 228 (269)
T 4hcu_A 166 GTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---------------- 228 (269)
T ss_dssp STTCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------------
T ss_pred CcccccccCCHHHhc-CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC----------------
Confidence 345677899999886 5668999999999999999999 9999998887776666543321111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....++.+.+++++||+.||++|||++++++|
T Consensus 229 -------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 229 -------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 13467889999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=353.47 Aligned_cols=271 Identities=18% Similarity=0.324 Sum_probs=211.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH----------------hhhHHHHHHHHhhcCCCCeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE----------------CLNLKEVKCLRKINNHPNIVK 65 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----------------~~~~~e~~~l~~l~~hp~iv~ 65 (346)
++|++++.||+|+||+||+|.+ +++.||+|++......... ....+|+.++.++ +||||++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~ 107 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLT 107 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcce
Confidence 6899999999999999999998 8999999999654332211 4556899999999 7999999
Q ss_pred eeeeeecCCEEEEEEEcCCC-CHHHH------Hhcc-cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-
Q 039371 66 LQELASENYRLYFVFEYMDC-NLHQL------MSNR-KQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS- 135 (346)
Q Consensus 66 ~~~~~~~~~~~~iv~e~~~g-~l~~~------~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~- 135 (346)
+++++.+++..++||||++| +|.+. +... ...+++..+..++.|++.||.|||+ +|++|+||||+||+++
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999986 66655 3332 4569999999999999999999999 9999999999999995
Q ss_pred CCcEEEeecccccccCCCCCCccccccCcccCcccccccCCCCC-hhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHH
Q 039371 136 NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS-KVDMWALGLIMAELITFHPLFPGTCE-DDQLYKIC 213 (346)
Q Consensus 136 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~ 213 (346)
++.+||+|||++...... ......+++.|+|||++.+...++. ++||||+||++|+|++|..||..... .+....+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~ 266 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHT
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 569999999999775443 3445678999999999875545665 99999999999999999999988776 45544443
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
......+... . ...............+.++.++.+||++||+.||.+|||++|+++||||++.
T Consensus 267 ~~~~~~~~~~-~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 267 TKNIEYPLDR-N----------HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SCCCCCCCSS-S----------SSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccCcCCccch-h----------hhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 3221111100 0 0000000001111225678999999999999999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=352.43 Aligned_cols=248 Identities=24% Similarity=0.417 Sum_probs=208.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+..+++.||+|+++............+|+.+++++ +||||+++++++.+++..++|||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEE
Confidence 58999999999999999999999999999999997654444445667899999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC---C
Q 039371 82 YMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP---Y 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~---~ 156 (346)
|++ |+|.+.+...+..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++........ .
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 997 588888877666799999999999999999999999999999999999996 56999999999976543211 1
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+++.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 273 ~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------ 333 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------------------ 333 (377)
T ss_dssp SCCEEEGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC------------------
T ss_pred CCCCCCcCcCCHhHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 1234577899999887 5568999999999999999998 9999988876655544432211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.+ ....+++++.+++.+||+.||++|||++++++
T Consensus 334 --~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 334 --LP---------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11 11356789999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=338.51 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=199.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++.+.||+|+||+||+|++ +|+.||+|++........ .....+|+.+++++ +||||+++++++.+.+..++||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTCCEEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCceEEEE
Confidence 6899999999999999999976 588899999976655443 34456899999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEeC-CcEEEeecccccccCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQ--CFSEAEVKNWCFQILQGLNYMHRQG--YFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~ 154 (346)
||++| +|.+.+..... .+++..+..++.|++.||+|||++| |+||||||+||++++ +.+||+|||++.......
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 193 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence 99985 77777665432 3899999999999999999999999 999999999999965 599999999997554332
Q ss_pred -CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 155 -PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 155 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 194 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-------------- 258 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLR-DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-------------- 258 (309)
T ss_dssp --------CCTTSCHHHHT-TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--------------
T ss_pred cccccCCCCccccChhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 234567899999999987 5668999999999999999999999999887766555543221111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ--HPLFQG 286 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~--hp~~~~ 286 (346)
.....+++++.++|++||+.||.+|||++++++ +++++.
T Consensus 259 --------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 --------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 112467889999999999999999999999998 455543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=336.48 Aligned_cols=257 Identities=24% Similarity=0.311 Sum_probs=203.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
+|.....||+|+||+||+|.+..+++.||+|++..... .......+|+.+++.+ +||||+++++++.+.+..++|||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEe
Confidence 34455599999999999999999999999999976543 2334456899999998 799999999999999999999999
Q ss_pred CC-CCHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe--CCcEEEeecccccccCCCC-CC
Q 039371 83 MD-CNLHQLMSNRK--QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS--NDTIKIADFGLAWEVDSCP-PY 156 (346)
Q Consensus 83 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~--~~~vkl~Dfg~a~~~~~~~-~~ 156 (346)
++ |+|.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++....... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 97 47777776543 2467999999999999999999999999999999999996 5699999999997665422 23
Q ss_pred ccccccCcccCccccccc-CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMS-GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+++.|+|||++... ..++.++|||||||++|+|++|..||..................
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------------- 243 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV----------------- 243 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-----------------
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-----------------
Confidence 456789999999998643 23789999999999999999999999764433221111100000
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.......+++++.++|.+||+.||++|||++++++||||+...
T Consensus 244 ----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 244 ----------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred ----------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 0011246788999999999999999999999999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=350.03 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=207.2
Q ss_pred CceeeeeeecccCceEEEEEE-----EccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC-E
Q 039371 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY-R 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~-~ 75 (346)
++|++.+.||+|+||.||+|. +..+++.||+|+++............+|+.++.++.+||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 689999999999999999998 5567789999999876555555667899999999988999999999987754 5
Q ss_pred EEEEEEcCCC-CHHHHHhcccC----------------------------------------------------------
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQ---------------------------------------------------------- 96 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~---------------------------------------------------------- 96 (346)
+++||||+.| +|.+.+.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 8999999985 77777765432
Q ss_pred -------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---CCccccccCcc
Q 039371 97 -------CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP---PYTEYITTLQY 165 (346)
Q Consensus 97 -------~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y 165 (346)
.+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++....... ......+|+.|
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 289999999999999999999999999999999999995 5699999999997654332 23345678899
Q ss_pred cCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCC
Q 039371 166 RAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGN 244 (346)
Q Consensus 166 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
+|||++. ...++.++|||||||++|+|++ |..||.+....+...........+.
T Consensus 262 ~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------ 316 (359)
T 3vhe_A 262 MAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------------------------ 316 (359)
T ss_dssp CCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC------------------------
T ss_pred EChhhhc-CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC------------------------
Confidence 9999887 5678999999999999999998 9999988776555444443322111
Q ss_pred CcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 245 NLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 245 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....+++++.+++.+||+.||.+|||++|+++|
T Consensus 317 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 ----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 113568899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=348.39 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=210.0
Q ss_pred CceeeeeeecccCceEEEEEEEccC-------CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS-------GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|++.+.||+|+||+||+|.+..+ +..||+|+++............+|+.+++++.+||||+++++++.+++
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 5899999999999999999997543 357999999876555555667799999999988999999999999999
Q ss_pred EEEEEEEcCCC-CHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND 137 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~ 137 (346)
..++|||+++| +|.+.+.... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 228 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 228 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence 99999999975 7877776543 3599999999999999999999999999999999999996 56
Q ss_pred cEEEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.+||+|||++....... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 307 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999998665432 233445688999999887 5678999999999999999999 999999887766655553
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..... .....+++++.+++++||+.||++|||++|++++
T Consensus 308 ~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 308 EGHRM-----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTCCC-----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC-----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32111 0113578899999999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=343.77 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=189.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc---EEEEEEcccccc-CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE-
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIY-SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL- 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~- 76 (346)
++|++.+.||+|+||+||+|.+..++. .||+|+++.... ........+|+.+++++ +||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeecccccc
Confidence 579999999999999999999887765 899999976543 33445567899999999 899999999999877655
Q ss_pred -----EEEEEcCCC-CHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeec
Q 039371 77 -----YFVFEYMDC-NLHQLMSNRK-----QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADF 144 (346)
Q Consensus 77 -----~iv~e~~~g-~l~~~~~~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Df 144 (346)
+++|||+.| +|.+.+.... ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 999999986 7777665432 2589999999999999999999999999999999999996 459999999
Q ss_pred ccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 039371 145 GLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPT 220 (346)
Q Consensus 145 g~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 220 (346)
|++........ .....+++.|+|||.+. ...++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~- 259 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLA-DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK- 259 (323)
T ss_dssp CC-----------------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-
T ss_pred cccccccccccccccccccCcccccCchhhc-CCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC-
Confidence 99976544322 22345677899999887 5668999999999999999999 999999887776666554332111
Q ss_pred hhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCCCCCC
Q 039371 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-------AAEALQHPLFQGCLQV 290 (346)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-------~~ell~hp~~~~~~~~ 290 (346)
..+.+++++.+++++||+.||++||| ++++++|||+....+.
T Consensus 260 ----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 260 ----------------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred ----------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 12467889999999999999999999 8899999999876543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=334.96 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=196.4
Q ss_pred CceeeeeeecccCceEEEEEEEccC---CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS---GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++.+.||+|+||+||+|.+..+ +..||+|++.............+|+..++++ +||||+++++++.+ +..++
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~l 92 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE-NPVWI 92 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS-SSCEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc-CccEE
Confidence 6899999999999999999998754 4579999987655444555667899999999 79999999999854 56789
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~- 155 (346)
|||+++| +|.+.+......+++..+..++.|++.||.|||++|++||||||+||+++ ++.+||+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence 9999985 78888876666799999999999999999999999999999999999996 67999999999977654332
Q ss_pred -CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 -YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.....+++.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 173 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~--------------- 236 (281)
T 1mp8_A 173 KASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--------------- 236 (281)
T ss_dssp ------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---------------
T ss_pred ccccCCCcccccChhhcc-cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---------------
Confidence 22345677899999886 5668999999999999999996 99999988776665555332111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+.+++++.+++.+||+.||++|||+++++++
T Consensus 237 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 --------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1124678999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=330.98 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=206.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+. ++..||+|++....... ....+|+.++.++ +||||+++++++.+++..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE--DEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH--HHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEE
T ss_pred hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH--HHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEEEE
Confidence 68999999999999999999776 56779999997665543 3356899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--Cc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP--YT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~--~~ 157 (346)
+++| ++.+.+...+..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++........ ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 9975 68777777666699999999999999999999999999999999999995 56999999999976654321 22
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+|+.|+|||++. ...++.++||||+|+++|+|++ |..||......+....+......+.
T Consensus 164 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 226 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFH-YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---------------- 226 (268)
T ss_dssp SCCCCGGGCCHHHHH-HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----------------
T ss_pred CCCcCcccCCHHHHh-ccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC----------------
Confidence 344567899999886 5568999999999999999998 9999988887766655543221111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....++.+.+++++||+.||.+|||+++++++
T Consensus 227 -------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 227 -------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12457889999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=335.84 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=202.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++... .........+|+.+++++ +||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEEE
Confidence 6899999999999999999999999999999988543 223444567899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC---
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY--- 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~--- 156 (346)
|++| +|.+.+......+++.++..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++.........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 9985 77788777667799999999999999999999999999999999999996 458999999999765432221
Q ss_pred ------------ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhH
Q 039371 157 ------------TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 157 ------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (346)
....||+.|+|||++. ...++.++||||+||++|+|++|..||........... ...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----------~~~ 236 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------LNV 236 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------BCH
T ss_pred cccccccccccccccCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------hhh
Confidence 1457899999999987 56789999999999999999999999865432110000 000
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
... . .....+.+++.+.+++.+||+.||++|||++++++
T Consensus 237 ~~~---~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 237 RGF---L--------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHH---H--------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcc---c--------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 0 00012467889999999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=342.47 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=202.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcE----EEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEY----VAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++++.||+|+||+||+|.+..+++. ||+|++.............+|+.++.++ +||||+++++++.+ +..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB-SSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC-CccE
Confidence 6899999999999999999999888876 7777765444333334556899999998 79999999999874 5588
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~- 154 (346)
+||||+. |+|.+.+...++.+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 9999998 588888877666799999999999999999999999999999999999995 5699999999998764432
Q ss_pred --CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 155 --PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 155 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
......++..|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 237 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA------------ 237 (325)
T ss_dssp CCC-----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC------------
T ss_pred cccccCCCCcccccChHHhc-cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC------------
Confidence 234456788999999987 5668999999999999999999 999998877666555443221110
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....++.++.+++.+||+.||.+|||+.++++|
T Consensus 238 -----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 238 -----------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -----------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -----------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112467788999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=337.71 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=209.3
Q ss_pred CceeeeeeecccCceEEEEEEE-----ccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIK-----KQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||+||+|.+ ..+++.||+|++.............+|+.++.++.+||||+++++++.+++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5899999999999999999985 45678999999976654445556678999999997899999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcccC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQ-----------------CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND 137 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~-----------------~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~ 137 (346)
++|||+++| +|.+.+..... .+++..+..++.|++.||.|||++|++||||||+||+++ ++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 182 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence 999999985 88887765432 489999999999999999999999999999999999996 45
Q ss_pred cEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.+||+|||++........ .....+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+...........
T Consensus 183 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 261 (313)
T 1t46_A 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (313)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred CEEEccccccccccccccceeccCCCCcceeeChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence 899999999987655432 23345678899999887 5678999999999999999998 999998877655555444
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.....+. ....++.++.+++.+||+.||.+|||++|++++
T Consensus 262 ~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 262 KEGFRML----------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCCCC----------------------------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3321111 113568899999999999999999999999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=356.45 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=197.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
+|++.+.||+|+||+|+. ....+++.||+|++...... ...+|+.+++++.+||||+++++++.+++..|+|||+
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 689999999999999764 34567899999998654322 3457999999987899999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CC--cEEEeecccccccCCCC--
Q 039371 83 MDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----ND--TIKIADFGLAWEVDSCP-- 154 (346)
Q Consensus 83 ~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~--~vkl~Dfg~a~~~~~~~-- 154 (346)
++|+|.+.+......+++..+..++.||+.||.|||++||+||||||+||+++ ++ .+||+|||+|.......
T Consensus 100 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 100 CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp CSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 99999999988776677778889999999999999999999999999999994 22 68899999997765432
Q ss_pred --CCccccccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 155 --PYTEYITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 155 --~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
......||+.|+|||++.. ...++.++||||+||++|+|++ |..||...........+ . ...
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~-~---~~~--------- 246 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-G---ACS--------- 246 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT-T---CCC---------
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh-c---cCC---------
Confidence 2344679999999999864 3457889999999999999999 89999665443321111 0 000
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.+... .....+..+.+||.+||+.||.+|||++|+++||||.+.
T Consensus 247 --------~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 247 --------LDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp --------CTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred --------ccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 00000 001224557899999999999999999999999999763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=332.85 Aligned_cols=250 Identities=21% Similarity=0.254 Sum_probs=201.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|++..+++.||+|++...... ....+|+.+++.+.+|+++..+..+..+++..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 6899999999999999999999999999999998654432 2356799999999544445555555577788999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE----eCCcEEEeecccccccCCCCC--
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV----SNDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli----~~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
+++|+|.+.+......+++..+..++.|++.||+|||++||+||||||+||++ +++.+||+|||++........
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred ecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 99889999887666679999999999999999999999999999999999999 456899999999976554322
Q ss_pred ------CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhhHHH
Q 039371 156 ------YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE---DDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 156 ------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~ 226 (346)
.....||+.|+|||++. ...++.++|||||||++|+|++|..||.+... .+....+......++.+
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 240 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE---- 240 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH----
T ss_pred ccccccccccccccccCChhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH----
Confidence 24567899999999987 56689999999999999999999999987432 22333333221111111
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+.+++++.+++++||+.||++|||++++++
T Consensus 241 ---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 241 ---------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 112467899999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=332.40 Aligned_cols=246 Identities=22% Similarity=0.377 Sum_probs=204.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+. ++..||+|++....... ....+|+.++.++ +||||+++++++.+++..++|||
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE--DEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH--HHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH--HHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeEEEEe
Confidence 68999999999999999999876 56789999998665543 3356899999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CCc
Q 039371 82 YMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PYT 157 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~~ 157 (346)
+++ |+|.+.+......+++..+..++.|++.||.|||++||+|+||||+||+++ ++.+||+|||++....... ...
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 997 578888877566799999999999999999999999999999999999996 4599999999997654321 223
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+|+.|+|||++. ...++.++||||+||++|+|++ |..||......+....+........
T Consensus 180 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 242 (283)
T 3gen_A 180 GSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---------------- 242 (283)
T ss_dssp STTSCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----------------
T ss_pred CCccCcccCCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC----------------
Confidence 345677899999987 5568999999999999999998 9999998887776666644321111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....++.+.+++++||+.||.+|||++++++|
T Consensus 243 -------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 -------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 13457889999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=340.04 Aligned_cols=250 Identities=23% Similarity=0.370 Sum_probs=199.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----HHhhhHHHHHHHHhhc---CCCCeeeeeeeeecC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----EECLNLKEVKCLRKIN---NHPNIVKLQELASEN 73 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~---~hp~iv~~~~~~~~~ 73 (346)
++|++.+.||+|+||+||+|.+..+++.||+|++....... ......+|+.++.++. +||||+++++++.+.
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 58999999999999999999999999999999997554322 2233457888888875 699999999999999
Q ss_pred CEEEEEEEc-CC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe--CCcEEEeecccccc
Q 039371 74 YRLYFVFEY-MD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS--NDTIKIADFGLAWE 149 (346)
Q Consensus 74 ~~~~iv~e~-~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~--~~~vkl~Dfg~a~~ 149 (346)
+..++|||+ +. ++|.+.+... +.+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++..
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred CeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 999999998 55 5777777654 4599999999999999999999999999999999999997 56899999999987
Q ss_pred cCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 150 VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 150 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.... ......+++.|+|||++......+.++|||||||++|+|++|..||.... .+...
T Consensus 190 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~-------------- 248 (312)
T 2iwi_A 190 LHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA-------------- 248 (312)
T ss_dssp CCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT--------------
T ss_pred cccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh--------------
Confidence 6643 34456789999999998755545669999999999999999999996431 11111
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
... ....++.++.++|.+||+.||++|||++|+++||||+...+
T Consensus 249 -----~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 249 -----ELH-----------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp -----CCC-----------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred -----ccC-----------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 001 11357889999999999999999999999999999997544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=342.82 Aligned_cols=251 Identities=26% Similarity=0.443 Sum_probs=204.5
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||+||+|.+. .++..||+|++.............+|+.++.++.+||||+++++++..++..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 58999999999999999999973 4567899999976554444556678999999997899999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcccC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEE
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQ----------------------CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLL 133 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~----------------------~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIl 133 (346)
++||||++| +|.+.+..... .+++..+..++.||+.||+|||++||+||||||+||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 999999975 88888765542 3789999999999999999999999999999999999
Q ss_pred Ee-CCcEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 039371 134 VS-NDTIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQ 208 (346)
Q Consensus 134 i~-~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 208 (346)
++ ++.+||+|||++........ .....+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+......
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 283 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-cCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence 96 55899999999976543322 23345678899999887 5668999999999999999998 9999988776555
Q ss_pred HHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 209 LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 209 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+......+. ....+++++.+++.+||+.||.+|||++++++|
T Consensus 284 ~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 284 FYKLIQNGFKMD----------------------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 554443221111 113568899999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=341.92 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=204.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEE--EEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYV--AIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||+||+|++..++..+ |+|.+.............+|+.+++++.+||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 368999999999999999999999888865 999987654444455567899999999789999999999999999999
Q ss_pred EEEcCCC-CHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEE
Q 039371 79 VFEYMDC-NLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKI 141 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl 141 (346)
|||+++| +|.+.+.... ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence 9999975 8888776543 3699999999999999999999999999999999999995 459999
Q ss_pred eecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 039371 142 ADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPT 220 (346)
Q Consensus 142 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 220 (346)
+|||++.............+++.|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 184 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~--- 259 (327)
T 1fvr_A 184 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 259 (327)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC---
T ss_pred cccCcCccccccccccCCCCCccccChhhhc-cccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC---
Confidence 9999997554433444456788999999886 5568999999999999999998 9999988876655544422110
Q ss_pred hhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. .....+++++.++|.+||+.||.+|||+++++++
T Consensus 260 -----------------~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 -----------------L---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp -----------------C---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------C---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 0113568899999999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=342.43 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=207.0
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|++. .+++.||+|+++............+|+.+++++ +||||+++++++.+++..
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSC
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCCce
Confidence 68999999999999999999987 345899999998665444455667899999999 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhccc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCE
Q 039371 77 YFVFEYMDC-NLHQLMSNRK-----------------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNL 132 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~-----------------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NI 132 (346)
++||||++| +|.+.+.... ..+++.++..++.||+.||.|||++||+||||||+||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 205 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence 999999985 7877776532 4699999999999999999999999999999999999
Q ss_pred EEe-CCcEEEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 039371 133 LVS-NDTIKIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDD 207 (346)
Q Consensus 133 li~-~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 207 (346)
+++ ++.+||+|||++....... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 284 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc-cCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence 995 5599999999997654321 223456788999999887 5568999999999999999999 999999887766
Q ss_pred HHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 208 QLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 208 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....+...... .....+++++.+++++||+.||.+|||+++++++
T Consensus 285 ~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 285 VIYYVRDGNIL-----------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCcC-----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 65555332110 1123578899999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=339.31 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=197.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcE----EEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEY----VAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++++.||+|+||+||+|++..+++. ||+|.+.............+|+.++.++ +||||+++++++.++. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC-eE
Confidence 5899999999999999999999888775 4778776554444455667899999999 7999999999998876 67
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
+++|++. |++.+.+......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 7888887 688888887777799999999999999999999999999999999999995 57999999999976544332
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------ 239 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------------ 239 (327)
T ss_dssp -------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC------------
T ss_pred cccccCCCccccccChHHhc-cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC------------
Confidence 22345677999999987 5678999999999999999999 999998877665544443221111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..+.++.++.+++.+||+.||.+|||+.+++++
T Consensus 240 -----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 -----------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -----------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 113567889999999999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=328.93 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=190.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH---HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW---EECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
+++|++.+.||+|+||+||+|.+. ++.||+|++....... ......+|+.+++.+ +||||+++++++.+++..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceE
Confidence 478999999999999999999875 8899999986543322 123456789999998 7999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCCEEEe---------CCcEEEeec
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG---YFHRDLISKNLLVS---------NDTIKIADF 144 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dikp~NIli~---------~~~vkl~Df 144 (346)
+||||++| ++.+.+. ...+++..+..++.|++.||.|||++| ++||||||+||+++ ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999986 5555443 335999999999999999999999999 89999999999995 457999999
Q ss_pred ccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhH
Q 039371 145 GLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 145 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (346)
|++....... .....+|+.|+|||.+. ...++.++||||+||++|+|++|..||.+.+.......+......+
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 233 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL----- 233 (271)
T ss_dssp CC--------------CCGGGSCHHHHH-HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC-----
T ss_pred Cccccccccc-ccCCCCccceeCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC-----
Confidence 9997665433 23457899999999887 5668999999999999999999999998877665554443221110
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.....+++.+.+++.+||+.||.+|||++|++++
T Consensus 234 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 234 -----------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 1123678899999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=337.79 Aligned_cols=249 Identities=26% Similarity=0.424 Sum_probs=206.2
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||+||+|.+. .+++.||+|++.............+|+.+++++ +||||+++++++.+++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSC
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCce
Confidence 58999999999999999999883 455899999998665444455667899999999 799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCE
Q 039371 77 YFVFEYMD-CNLHQLMSNRK-----------------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNL 132 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~-----------------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NI 132 (346)
++||||++ |+|.+.+.... ..+++.++..++.|++.||.|||++||+||||||+||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI 181 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence 99999998 57777776532 2389999999999999999999999999999999999
Q ss_pred EEeC-CcEEEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 039371 133 LVSN-DTIKIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDD 207 (346)
Q Consensus 133 li~~-~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 207 (346)
+++. +.+||+|||++....... ......+++.|+|||++. ...++.++|||||||++|+|++ |..||.+.....
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc-CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9964 589999999997664432 223345678899999887 5668999999999999999999 999998877665
Q ss_pred HHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 208 QLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 208 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....+...... .....+++++.++|.+||+.||++|||+++++++
T Consensus 261 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 261 LFNLLKTGHRM-----------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhhcCCcC-----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55444322110 1123678999999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=330.88 Aligned_cols=250 Identities=21% Similarity=0.248 Sum_probs=198.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|++..+++.||+|++...... ....+|+.+++.+.+|+++..+..++.+++..+++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 5899999999999999999999999999999987544322 2356789999999544455555556678889999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE----eCCcEEEeecccccccCCCC---
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV----SNDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli----~~~~vkl~Dfg~a~~~~~~~--- 154 (346)
+++|+|.+.+......+++..+..++.|++.||.|||++||+||||||+||++ +++.+||+|||++.......
T Consensus 86 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~ 165 (296)
T 4hgt_A 86 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp CCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCc
Confidence 99889999888666679999999999999999999999999999999999999 35689999999997655432
Q ss_pred -----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhhHHH
Q 039371 155 -----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED---DQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 155 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~ 226 (346)
......+|+.|+|||++. ...++.++||||+||++|+|++|..||.+.... .....+.......+.
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----- 239 (296)
T 4hgt_A 166 HIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI----- 239 (296)
T ss_dssp BCCCCCSCCCCSCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----
T ss_pred cCCCCcccccCCCccccchHHhc-CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-----
Confidence 223567899999999887 556899999999999999999999999775432 222222222111111
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+.+++++.+++.+||+.||++|||++++++
T Consensus 240 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 --------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1112457889999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=331.68 Aligned_cols=244 Identities=17% Similarity=0.293 Sum_probs=200.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCC-------cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG-------EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|++.+.||+|+||+||+|.+..++ ..||+|++...... ......+|+.+++++ +||||+++++++.+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN-YSESFFEAASMMSKL-SHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG-GHHHHHHHHHHHHTS-CCTTBCCEEEEECCTT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH-HHHHHHHHHHHHHhC-CCCCEeEEEEEEEeCC
Confidence 68999999999999999999999877 46999998654332 334456899999999 7999999999999999
Q ss_pred EEEEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-Cc--------EEEeec
Q 039371 75 RLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DT--------IKIADF 144 (346)
Q Consensus 75 ~~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~--------vkl~Df 144 (346)
..++||||++ |+|.+.+......+++..+..++.|++.||.|||++||+||||||+||+++. +. +||+||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 9999999998 5888888776666999999999999999999999999999999999999954 33 999999
Q ss_pred ccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCChhh
Q 039371 145 GLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFH-PLFPGTCEDDQLYKICNAIGSPTEES 223 (346)
Q Consensus 145 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~ 223 (346)
|++..... .....+|+.|+|||++.+...++.++||||+||++|+|++|. +||.......... ......
T Consensus 166 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~~------ 235 (289)
T 4fvq_A 166 GISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRH------ 235 (289)
T ss_dssp CSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTTC------
T ss_pred cccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-HhhccC------
Confidence 99865433 234568899999999985577999999999999999999955 5555544433222 221110
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. .....++++.+++++||+.||.+|||++++++|
T Consensus 236 -------------~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 236 -------------Q-----------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp -------------C-----------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -------------C-----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 113457889999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=328.78 Aligned_cols=246 Identities=27% Similarity=0.336 Sum_probs=201.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH------hhhHHHHHHHHhhcCCCCeeeeeeeeecCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE------CLNLKEVKCLRKINNHPNIVKLQELASENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~ 75 (346)
++|++.+.||+|+||+||+|++..+++.||+|++......... ....+|+.+++++ +||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTT-
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCC-
Confidence 6899999999999999999999999999999998654433211 3456899999999 7999999999998776
Q ss_pred EEEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEeC-Cc-----EEEeeccc
Q 039371 76 LYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG--YFHRDLISKNLLVSN-DT-----IKIADFGL 146 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dikp~NIli~~-~~-----vkl~Dfg~ 146 (346)
++||||++ |++.+.+......+++..+..++.|++.||+|||++| |+|+||||+||+++. +. +||+|||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 69999998 6888888877778999999999999999999999999 999999999999953 33 99999999
Q ss_pred ccccCCCCCCccccccCcccCcccccc-cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChhh
Q 039371 147 AWEVDSCPPYTEYITTLQYRAPEMLLM-SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQ--LYKICNAIGSPTEES 223 (346)
Q Consensus 147 a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 223 (346)
+..... ......+|+.|+|||++.. ...++.++||||+||++|+|++|..||........ ...+......
T Consensus 176 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 248 (287)
T 4f0f_A 176 SQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR----- 248 (287)
T ss_dssp CBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC-----
T ss_pred cccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC-----
Confidence 975443 3445678999999998842 34578899999999999999999999987654433 2222111100
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 224 WAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
......+++++.++|.+||+.||.+|||++|+++
T Consensus 249 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 -----------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112467889999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=344.35 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=196.2
Q ss_pred CceeeeeeecccCceEEEEEEEc---cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++.+.||+|+||+||+|++. .++..||+|+++............+|+.++.++ +||||+++++++.+++..++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEE
Confidence 57999999999999999999877 467789999997665444555677899999999 79999999999999999999
Q ss_pred EEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-
Q 039371 79 VFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 79 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~- 155 (346)
||||++ |+|.+.+...+..+++.++..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 999997 588888877666799999999999999999999999999999999999995 56999999999976654321
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....+++.|+|||++. ...++.++|||||||++|+|++ |..||......+....+......+.
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~----------- 271 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIA-YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP----------- 271 (373)
T ss_dssp ----------CTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC-----------
T ss_pred ceeccCCCcCCCccChhhhc-cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 11223467899999887 5678999999999999999998 9999988877666555433211111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...++..+.+++.+||+.||.+|||++++++
T Consensus 272 ------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 272 ------------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ------------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 1256788999999999999999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=327.73 Aligned_cols=248 Identities=21% Similarity=0.345 Sum_probs=202.4
Q ss_pred CceeeeeeecccCceEEEEEEEcc---CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ---SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++.+.||+|+||+||+|.+.. ++..||+|++.............+|+.+++++ +||||+++++++.++. .++
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~ 89 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEEEP-TWI 89 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECSSS-CEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCC-CEE
Confidence 689999999999999999998654 34469999998665444555667899999999 7999999999987654 689
Q ss_pred EEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--
Q 039371 79 VFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-- 154 (346)
Q Consensus 79 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-- 154 (346)
|||++. |+|.+.+...+..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++.......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 999998 478787777666799999999999999999999999999999999999995 6799999999997665432
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......+++.|+|||++. ...++.++|||||||++|+|++ |..||......+....+......+.
T Consensus 170 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 235 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESIN-FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK------------- 235 (281)
T ss_dssp ---CCCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC-------------
T ss_pred ccccCCCCcceeCchhhc-cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC-------------
Confidence 223345678899999886 5668999999999999999998 9999987776665554433221111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+++.+.+++.+||+.||.+|||++|++++
T Consensus 236 ----------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 ----------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 13567889999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=336.22 Aligned_cols=250 Identities=27% Similarity=0.445 Sum_probs=207.1
Q ss_pred CceeeeeeecccCceEEEEEEEc-------cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-------QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|++.+.||+|+||+||+|.+. .++..||+|+++............+|+.+++++.+||||+++++++.+++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 68999999999999999999976 45678999999866544455566789999999978999999999999999
Q ss_pred EEEEEEEcCCC-CHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND 137 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~ 137 (346)
..++|||+++| +|.+.+.... ..+++.++..++.||+.||.|||++||+|+||||+||+++ ++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 194 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 194 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence 99999999985 7877776543 2389999999999999999999999999999999999995 56
Q ss_pred cEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.+||+|||++........ .....+++.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 273 (334)
T 2pvf_A 195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273 (334)
T ss_dssp CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CEEEccccccccccccccccccCCCCcccceeChHHhc-CCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence 999999999976654321 23345678899999887 4568999999999999999999 999999887766655554
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.....+ ....++.++.++|++||+.||.+|||++|++++
T Consensus 274 ~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 274 EGHRMD-----------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 322111 113578899999999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=327.90 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=205.6
Q ss_pred Cceeeee-eecccCceEEEEEEEc--cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMK-QIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|.+.+ .||+|+||+||+|.+. .++..||+|+++............+|+.+++++ +||||+++++++. .+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQ-AEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEec-CCCcEE
Confidence 5788887 9999999999999854 467889999998765444555667899999999 7999999999995 456899
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~- 155 (346)
|||+++| +|.+.+......+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++........
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999986 77777776666799999999999999999999999999999999999995 66999999999987654322
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....+|+.|+|||++. ...++.++|||||||++|+|++ |..||......+....+.....
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~-------------- 231 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------------- 231 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------------
T ss_pred eeccccccccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc--------------
Confidence 22334678999999886 4568999999999999999998 9999988877666555433211
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....+.+++++.++|.+||+.||.+|||+.++++|
T Consensus 232 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 232 ---------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01124678999999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=337.36 Aligned_cols=253 Identities=21% Similarity=0.369 Sum_probs=205.4
Q ss_pred CceeeeeeecccCceEEEEEE-----EccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|+ +..+++.||+|++.............+|+.+++++ +||||+++++++.+.+..
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSC
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCc
Confidence 689999999999999999998 56678899999997655555555677899999999 899999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC----CcEEEeecc
Q 039371 77 YFVFEYMD-CNLHQLMSNRK------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN----DTIKIADFG 145 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~----~~vkl~Dfg 145 (346)
++|||+++ |+|.+.+.... ..+++.++..++.|++.||.|||++||+||||||+||+++. ..+||+|||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 99999996 58888776543 34899999999999999999999999999999999999962 269999999
Q ss_pred cccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 146 LAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 146 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
++....... ......+++.|+|||++. ...++.++|||||||++|+|++ |..||......+....+......+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-- 265 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD-- 265 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC--
T ss_pred cccccccccccccCCCcCCCcceeCHhHhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC--
Confidence 987543222 233456788999999887 5668999999999999999998 999998887766555543321110
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
....++..+.++|.+||+.||.+|||++++++|.|+-
T Consensus 266 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 266 ---------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1135788999999999999999999999999997764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=334.45 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=201.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCC----cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG----EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++.+.||+|+||+||+|.+..++ ..||+|++.............+|+.++.++ +||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCCcE
Confidence 57999999999999999999887553 359999997665444555667899999999 7999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
+|||+++| +|.+.+......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 99999986 78777776666799999999999999999999999999999999999996 45999999999976654321
Q ss_pred ----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 156 ----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 156 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
.....+|+.|+|||++. ...++.++|||||||++|+|++ |..||......+....+......+.
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 271 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---------- 271 (333)
T ss_dssp --------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----------
T ss_pred cccccCCCCccccccCchhcc-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC----------
Confidence 12234577899999886 5668999999999999999998 9999988877666555533211111
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...++..+.+++++||+.||++|||+++++++
T Consensus 272 -------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 272 -------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 13567899999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=331.90 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=194.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||+||+|.+..+++.||+|++....... ......+|+.++.++ +||||+++++++.+++..++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEE
Confidence 478999999999999999999999999999999997654322 224456899999998 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-- 154 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-- 154 (346)
+||+++| +|.+.+... +.+++..+..++.|++.||.|||++||+|+||||+||+++ ++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 9999986 777666544 4599999999999999999999999999999999999995 5699999999987655432
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
......+++.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+ .....
T Consensus 191 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~---------------- 252 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFS-ESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIP---------------- 252 (309)
T ss_dssp ------CCGGGCCGGGTC-C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCC----------------
T ss_pred cccccCCCcCccCHHHHc-CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCC----------------
Confidence 233457899999999887 567899999999999999999999999876554222222 11110
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-CHHHHhc
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-TAAEALQ 280 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-s~~ell~ 280 (346)
......+.++.++.++|.+||+.||++|| |++++++
T Consensus 253 ----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 ----------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 01122357889999999999999999999 7888876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=324.36 Aligned_cols=246 Identities=24% Similarity=0.404 Sum_probs=206.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+. +++.||+|++....... ....+|+.+++++ +||||+++++++.+++..+++||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--EDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH--HHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH--HHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEEe
Confidence 68999999999999999999986 57789999998665543 3456899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CCc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PYT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~~ 157 (346)
+++| +|.+.+......+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++....... ...
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 9975 78888877666799999999999999999999999999999999999995 5699999999997654321 223
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+++.|+|||++. ...++.++||||+|+++|+|++ |..||...+..+....+.......
T Consensus 164 ~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~----------------- 225 (267)
T 3t9t_A 164 GTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY----------------- 225 (267)
T ss_dssp STTCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-----------------
T ss_pred cccccccccChhhhc-CCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC-----------------
Confidence 345678899999886 5668999999999999999999 899999887776665554321110
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.....+..+.+++.+||+.||++|||+++++++
T Consensus 226 ------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 226 ------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 113467889999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=330.97 Aligned_cols=262 Identities=23% Similarity=0.381 Sum_probs=198.8
Q ss_pred CceeeeeeecccCceEEEEEE----EccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--NYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~ 75 (346)
++|++++.||+|+||+||+|+ +..+++.||+|++.... ........+|+.+++++ +||||+++++++.. ...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTS
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCc
Confidence 689999999999999999998 56789999999987543 22334556899999999 79999999999854 356
Q ss_pred EEEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
+++||||++ |+|.+.+......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++......
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 899999997 588888877766799999999999999999999999999999999999995 669999999999766443
Q ss_pred C----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-hhhHHHHH
Q 039371 154 P----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPT-EESWAEGL 228 (346)
Q Consensus 154 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~ 228 (346)
. ......++..|+|||++. ...++.++||||+||++|+|++|..||...... . ....+... ........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp --------CTTCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTCCTHHHHHHH
T ss_pred cceeeeccCCCCccceeCcHHhc-CCCCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCccccchhHHHH
Confidence 2 122345677899999887 566899999999999999999999998654221 1 11111111 11111111
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..........+ ....+++++.+++++||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 242 IELLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhccCcCC---------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11111111111 12467899999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=336.59 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=207.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc-----EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE-----YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||+||+|.+..++. .||+|++.............+|+.+++++.+||||+++++++.+++..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 589999999999999999999887664 799999976655445556678999999997799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcc-------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEE
Q 039371 77 YFVFEYMDC-NLHQLMSNR-------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKI 141 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~-------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl 141 (346)
++|||+++| +|.+.+... ...+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEE
Confidence 999999985 887777543 23589999999999999999999999999999999999996 458999
Q ss_pred eecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 039371 142 ADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIG 217 (346)
Q Consensus 142 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 217 (346)
+|||++........ .....+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+.........+.....
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 284 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTC
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhc-cCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCC
Confidence 99999976543222 23345678899999887 5668999999999999999998 9999988776555555444321
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 218 SPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+. .....++.+.+++.+||+.||.+|||++|++++
T Consensus 285 ~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 285 QMA----------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC----------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 111 012467889999999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=334.39 Aligned_cols=251 Identities=25% Similarity=0.428 Sum_probs=205.8
Q ss_pred CceeeeeeecccCceEEEEEEE-----ccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-CE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIK-----KQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN-YR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-~~ 75 (346)
++|++.+.||+|+||+||+|.+ ..+++.||+|++.............+|+.++.++.+||||+++++++... +.
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 5899999999999999999985 45678999999987655445556678999999998899999999998765 45
Q ss_pred EEEEEEcCCC-CHHHHHhcccCC---------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCc
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQC---------------FSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDT 138 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~---------------l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~ 138 (346)
+++|||+++| +|.+.+...... +++..+..++.|++.||.|||++||+||||||+||+++ ++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence 8999999985 777777654332 89999999999999999999999999999999999995 569
Q ss_pred EEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 039371 139 IKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 139 vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 214 (346)
+||+|||++........ .....+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+.......
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 265 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhc-cccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhc
Confidence 99999999976654332 23356788999999887 5668999999999999999998 9999988765544433333
Q ss_pred HhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....+. ....+++.+.+++.+||+.||.+|||++++++|
T Consensus 266 ~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 266 EGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCccCC----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 211110 113467899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=338.06 Aligned_cols=247 Identities=28% Similarity=0.377 Sum_probs=185.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeee--------ecC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELA--------SEN 73 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~--------~~~ 73 (346)
.+|++.+.||+|+||+||+|.+..+++.||+|++.... ........+|+.++.++.+||||+++++++ ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 37999999999999999999999999999999985443 233445578999999996799999999998 445
Q ss_pred CEEEEEEEcCCCCHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEeC-CcEEEeeccccc
Q 039371 74 YRLYFVFEYMDCNLHQLMSN--RKQCFSEAEVKNWCFQILQGLNYMHRQG--YFHRDLISKNLLVSN-DTIKIADFGLAW 148 (346)
Q Consensus 74 ~~~~iv~e~~~g~l~~~~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dikp~NIli~~-~~vkl~Dfg~a~ 148 (346)
..++++||+++|+|.+.+.. ..+.+++..+..++.||+.||.|||++| |+|+||||+||++++ +.+||+|||++.
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 66899999999999888764 3456999999999999999999999999 999999999999964 699999999997
Q ss_pred ccCCCCCC-------------ccccccCcccCccccc--ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 039371 149 EVDSCPPY-------------TEYITTLQYRAPEMLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 149 ~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 213 (346)
........ ....+|+.|+|||++. ....++.++|||||||++|+|++|..||............
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~- 265 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK- 265 (337)
T ss_dssp CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc-
Confidence 76543221 1446899999999884 3556889999999999999999999999654432211110
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+ .....+..+.++|++||+.||.+|||++|+++|
T Consensus 266 ----------------------~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 266 ----------------------YSIP---------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ----------------------CCCC---------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----------------------ccCC---------cccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0000 113456789999999999999999999999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=350.91 Aligned_cols=254 Identities=28% Similarity=0.380 Sum_probs=193.1
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEc
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEY 82 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~ 82 (346)
.|.+.+.||+|+||+||.+ ...+|+.||+|++.... .....+|+.+++++.+||||+++++++.+++.+|+|||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4667789999999999875 45679999999986542 223467999998877899999999999999999999999
Q ss_pred CCCCHHHHHhcccCC------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC--------------CcEEEe
Q 039371 83 MDCNLHQLMSNRKQC------FSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN--------------DTIKIA 142 (346)
Q Consensus 83 ~~g~l~~~~~~~~~~------l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~--------------~~vkl~ 142 (346)
++|+|.+.+...... .++..+..++.||+.||+|||++||+||||||+||+++. ..+||+
T Consensus 91 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 91 CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp CSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999998888765321 133356789999999999999999999999999999953 279999
Q ss_pred ecccccccCCCC-----CCccccccCcccCcccccc------cCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 039371 143 DFGLAWEVDSCP-----PYTEYITTLQYRAPEMLLM------SGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLY 210 (346)
Q Consensus 143 Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 210 (346)
|||++....... ......||+.|+|||++.+ ...++.++|||||||++|+|++ |..||......+ .
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~ 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--S 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--H
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--H
Confidence 999998765432 1234579999999999864 2568999999999999999999 999997665433 2
Q ss_pred HHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 211 KICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 211 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.+...... .+.... ...+.+++++.++|.+||+.||.+|||+.++++||||..
T Consensus 249 ~i~~~~~~-------------------~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 249 NIIRGIFS-------------------LDEMKC----LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHTCCC-------------------CCCCTT----CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHhcCCCC-------------------cccccc----cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 23222111 111000 000124578999999999999999999999999999975
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=328.89 Aligned_cols=263 Identities=25% Similarity=0.438 Sum_probs=202.3
Q ss_pred CceeeeeeecccCceEEEEEE----EccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN--YR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~ 75 (346)
++|++++.||+|+||+||+|+ +..+++.||+|++.............+|+.+++++ +||||+++++++.+. ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCce
Confidence 469999999999999999998 57789999999997655443445567899999999 799999999999876 67
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~ 153 (346)
+++|||+++| +|.+.+......+++..+..++.|++.||+|||++||+|+||||+||++ .++.+||+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 8999999975 8888876666779999999999999999999999999999999999999 5679999999999876543
Q ss_pred C----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 P----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
. ......+|..|+|||++. ...++.++||||+||++|+|++|..|+.... ....................
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGGGHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeec-CCCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccccCHHHHH
Confidence 3 233456788899999887 5568899999999999999999999864321 11222222222221111111
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+...+ ..+.+++++.++|++||+.||.+|||++++++
T Consensus 254 ~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 NTLKEGKRLP---------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCC---------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 1111111111 12467899999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=335.64 Aligned_cols=249 Identities=23% Similarity=0.399 Sum_probs=206.8
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||+||+|.+. .+++.||+|++.............+|+.+++++ +||||+++++++.+++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSC
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccCCcc
Confidence 58999999999999999999877 467889999997655444555667899999999 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecc
Q 039371 77 YFVFEYMDC-NLHQLMSNRK---------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFG 145 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg 145 (346)
++|||+++| +|.+.+.... ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCc
Confidence 999999985 7877765432 3479999999999999999999999999999999999996 4599999999
Q ss_pred cccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 146 LAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 146 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
++....... ......+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--- 259 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL--- 259 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC---
T ss_pred cccccccccccccccCCCCCCCccChhhhc-cCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC---
Confidence 997554322 122345688899999887 5668999999999999999999 89999888776665554332110
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.....++..+.++|.+||+.||.+|||+.|+++|
T Consensus 260 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 --------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1123678899999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=351.80 Aligned_cols=273 Identities=20% Similarity=0.308 Sum_probs=205.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC--EEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY--RLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~--~~~iv 79 (346)
++|++.+.||+|+||+||+|++..+|+.||+|++.............+|+.+++++ +||||+++++++.+.+ ..++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEEE
Confidence 57999999999999999999999999999999997654433344556899999999 7999999999987654 78999
Q ss_pred EEcCCC-CHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE----eC-CcEEEeecccccccC
Q 039371 80 FEYMDC-NLHQLMSNRKQ--CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV----SN-DTIKIADFGLAWEVD 151 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli----~~-~~vkl~Dfg~a~~~~ 151 (346)
|||++| +|.+.+..... .+++..+..++.|++.||+|||++||+||||||+||++ +. +.+||+|||++....
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999975 77777665432 39999999999999999999999999999999999998 32 269999999998876
Q ss_pred CCCCCccccccCcccCccccccc-------CCCCChhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCC
Q 039371 152 SCPPYTEYITTLQYRAPEMLLMS-------GQYNSKVDMWALGLIMAELITFHPLFPGTC----EDDQLYKICNAIGSPT 220 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~ 220 (346)
.........||+.|+|||++... ..++.++|||||||++|+|++|..||.... ..+.+..+........
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 65556667899999999988631 457789999999999999999999996533 3344455444322111
Q ss_pred hhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+... .......... ......+...++..+.++|++||+.||++|||++|+++
T Consensus 248 ~~~~~~~----~~~~~~~~~~-~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 248 ISGVQKA----ENGPIDWSGD-MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CEEEECS----TTCCEEEESS-CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred chhheec----cCCCcccCcc-CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 1000000 0000000000 00001112334567889999999999999999999855
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=333.60 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=198.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEE----EEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYV----AIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++++.||+|+||+||+|.+..+++.+ ++|.+.............+|+.+++++ +||||+++++++.++. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-ce
Confidence 68999999999999999999998888765 666665444444455667899999999 7999999999998876 67
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
+++|++. |++.+.+......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 7888887 588888887777799999999999999999999999999999999999995 57999999999976543322
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 239 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------------ 239 (327)
T ss_dssp -------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC------------
T ss_pred cccccCCCccccccCHHHHc-CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 22345677899999987 5678999999999999999999 999998887766555443321111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..+.++.++.++|++||+.||.+|||++|+++.
T Consensus 240 -----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 240 -----------------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 113567899999999999999999999999873
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=340.34 Aligned_cols=258 Identities=18% Similarity=0.233 Sum_probs=194.8
Q ss_pred CceeeeeeecccCceEEEEEEEccC-----CcEEEEEEccccccCHHH----------hhhHHHHHHHHhhcCCCCeeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS-----GEYVAIKALKQRIYSWEE----------CLNLKEVKCLRKINNHPNIVKL 66 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~----------~~~~~e~~~l~~l~~hp~iv~~ 66 (346)
++|++.+.||+|+||+||+|.+..+ ++.||+|++......... .....|+..+..+ +||||+++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~ 113 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVPKY 113 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSCCE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCCeE
Confidence 4899999999999999999998765 578999998654321100 0112344445555 69999999
Q ss_pred eeeeecC----CEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe---CCcE
Q 039371 67 QELASEN----YRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS---NDTI 139 (346)
Q Consensus 67 ~~~~~~~----~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~---~~~v 139 (346)
++++... ...++||||++|+|.+.+......+++..+..++.||+.||+|||++||+||||||+||+++ ++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 9998664 56899999997788888877767799999999999999999999999999999999999996 4599
Q ss_pred EEeecccccccCCCC--------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 039371 140 KIADFGLAWEVDSCP--------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYK 211 (346)
Q Consensus 140 kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 211 (346)
||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.........
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-GVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 999999997654321 123445999999999887 55689999999999999999999999986443333222
Q ss_pred HHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 212 ICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 212 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.......+....+. .. .++ ...+++++.+++..|++.||.+||+++++++
T Consensus 273 ~~~~~~~~~~~~~~---~~------~~~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLM---DK------CFP----------AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHH---HH------HSC----------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHH---HH------hcc----------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 22111000000000 00 000 1357889999999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=327.55 Aligned_cols=246 Identities=27% Similarity=0.448 Sum_probs=206.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+..++..||+|++..... ......+|+.+++++ +||||+++++++.+++..++|||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEE
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCEEEEEE
Confidence 589999999999999999999999999999999975432 334566899999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CC
Q 039371 82 YMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~ 156 (346)
+++ |+|.+.+... ...+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++....... ..
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 998 5788777653 34599999999999999999999999999999999999995 5689999999998765433 22
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+|+.|+|||++. ...++.++||||||+++|+|++ |..||.+.+.......+......
T Consensus 170 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 231 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM----------------- 231 (288)
T ss_dssp TTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-----------------
T ss_pred cCCccccCcCChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC-----------------
Confidence 3345678899999887 5668999999999999999999 99999887766554444322111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+++.+.+++++||+.||.+|||++++++
T Consensus 232 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 232 ------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 111357889999999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=325.18 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=192.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++.+.||+|+||+||+|++. ..||+|+++....... .....+|+.+++++ +||||++++++. .....++||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEEE
Confidence 58999999999999999999764 3599999976655443 34456899999998 799999999965 445689999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC---CCC
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS---CPP 155 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~---~~~ 155 (346)
|+++ ++|.+.+......+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++..... ...
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 9998 577777776677799999999999999999999999999999999999996 56999999999975543 223
Q ss_pred CccccccCcccCccccc--ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 YTEYITTLQYRAPEMLL--MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.....||+.|+|||++. ....++.++|||||||++|+|++|..||......+...........++
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 245 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP------------- 245 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-------------
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-------------
Confidence 34567899999999885 245578899999999999999999999988776665555443321111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
........+++.+.+++.+||+.||.+|||++++++
T Consensus 246 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 -----------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -----------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112223467899999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=326.26 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=200.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCC---cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeee-ecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG---EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELA-SENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~-~~~~~~~ 77 (346)
.+|++.+.||+|+||+||+|.+..++ ..+|+|.+.............+|+.+++++ +||||+++++++ ..++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCceE
Confidence 36999999999999999999875433 368999987655545555667899999999 799999999984 5667889
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCC-
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~- 154 (346)
++||+++| +|.+.+......+++..+..++.|++.||+|||++|++||||||+||++++ +.+||+|||++.......
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999986 888888776777999999999999999999999999999999999999964 599999999997654322
Q ss_pred ----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 155 ----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 155 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
......+|+.|+|||.+. ...++.++||||+||++|+|++ |.+||...+..+....+......+.
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 253 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ--------- 253 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC---------
T ss_pred hccccccCCCCCccccChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC---------
Confidence 223345678899999886 5668999999999999999999 6678877766555554433221111
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+++.+.+++++||+.||.+|||++|+++
T Consensus 254 --------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 254 --------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp --------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1356788999999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=324.82 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=197.6
Q ss_pred Cceeeee-eecccCceEEEEEE--EccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMK-QIGEGSFGKVWQAI--KKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++.+ .||+|+||+||+|. +..+++.||+|+++...... ......+|+.+++.+ +||||+++++++ ..+..+
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcE
Confidence 5799999 99999999999994 45678899999997654332 244567899999999 799999999999 456689
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
+|||++.| +|.+.+... ..+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++........
T Consensus 94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 99999985 676666554 4599999999999999999999999999999999999994 66899999999977654332
Q ss_pred ----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 156 ----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 156 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
.....+++.|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------ 239 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------ 239 (291)
T ss_dssp EEEC----CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------------
T ss_pred cccccccCCCCceeeChHHhc-cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 12234568899999886 4558899999999999999999 99999988776655544322110
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+.+++.+.++|++||+.||.+|||+.++++
T Consensus 240 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 -----------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112367899999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=333.42 Aligned_cols=256 Identities=16% Similarity=0.188 Sum_probs=192.1
Q ss_pred CceeeeeeecccCceEEEEEEEcc---CCcEEEEEEccccccCHH----------HhhhHHHHHHHHhhcCCCCeeeeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ---SGEYVAIKALKQRIYSWE----------ECLNLKEVKCLRKINNHPNIVKLQE 68 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~----------~~~~~~e~~~l~~l~~hp~iv~~~~ 68 (346)
++|++.+.||+|+||+||+|.+.. ++..+|+|+......... .....+|+..+..+ +||||+++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~~ 115 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFYG 115 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceeec
Confidence 579999999999999999999987 788999999875532211 11234566777777 7999999999
Q ss_pred eeec----CCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C--cEEE
Q 039371 69 LASE----NYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D--TIKI 141 (346)
Q Consensus 69 ~~~~----~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~--~vkl 141 (346)
++.+ +...|+|||+++|+|.+.+...+ .+++..+..++.||+.||+|||++||+||||||+||+++. + .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9877 78899999999667777766554 6999999999999999999999999999999999999963 4 8999
Q ss_pred eecccccccCCCC--------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q 039371 142 ADFGLAWEVDSCP--------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCE-DDQLYKI 212 (346)
Q Consensus 142 ~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i 212 (346)
+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.+... .......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 9999997653221 124457899999999887 56789999999999999999999999965322 2222222
Q ss_pred H-HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 213 C-NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 213 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. ......+...... . ....+++++.++|.+||+.||++|||++++++.
T Consensus 274 ~~~~~~~~~~~~~~~-----------~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQSVLKW-----------A----------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHHHHHH-----------S----------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHHHHhh-----------c----------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1 1111111111000 0 002578899999999999999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=338.72 Aligned_cols=265 Identities=26% Similarity=0.309 Sum_probs=195.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC----CEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN----YRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~----~~~~ 77 (346)
++|++.+.||+|+||+||+|++. ++.||+|++.... ........|+.++.++ +||||+++++++.++ ..++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEE
Confidence 68999999999999999999875 7899999996543 2233344688888888 799999999998764 3579
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCCEEEeC-CcEEEeecc
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ----------GYFHRDLISKNLLVSN-DTIKIADFG 145 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~----------~ivH~dikp~NIli~~-~~vkl~Dfg 145 (346)
+||||++| +|.+.+... .+++..+..++.|++.||.|||+. ||+||||||+||++++ +.+||+|||
T Consensus 99 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999985 777777553 389999999999999999999999 9999999999999964 599999999
Q ss_pred cccccCCCC---CCccccccCcccCccccccc----CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 039371 146 LAWEVDSCP---PYTEYITTLQYRAPEMLLMS----GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGS 218 (346)
Q Consensus 146 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 218 (346)
++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+................
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 997654432 23345789999999998743 23566889999999999999999999875543222222222222
Q ss_pred CChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 219 PTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
+....+.... . .....+..... . .....++++.++|++||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~---~-~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 257 PSLEDMQEVV---V-HKKKRPVLRDY-W--QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCHHHHHHHH---T-TSCCCCCCCGG-G--GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cchhhhhhhh---h-cccCCCCcccc-c--cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2222222111 0 01111110000 0 00112345899999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=323.34 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=200.4
Q ss_pred ceeeeeeecccCceEEEEEEEccCCc---EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE-EE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL-YF 78 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~-~i 78 (346)
+|++.+.||+|+||+||+|.+..++. .||+|++.............+|+.+++++ +||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCcEE
Confidence 46778999999999999999765554 79999997655444555667899999999 799999999999766554 99
Q ss_pred EEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCC---
Q 039371 79 VFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSC--- 153 (346)
Q Consensus 79 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~--- 153 (346)
+||++. |+|.+.+......+++..+..++.|++.||+|||++|++||||||+||++++ +.+||+|||++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 999996 6888888776777999999999999999999999999999999999999965 59999999999755332
Q ss_pred --CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 154 --PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 154 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
.......+++.|+|||.+. ...++.++||||+||++|+|++| .+||...+..+....+......+
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~----------- 248 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQ-TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP----------- 248 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHT-TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC-----------
T ss_pred ccccCcCCCCCccccChhhhc-cCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC-----------
Confidence 2233456788999999886 56689999999999999999995 55566655555444443221111
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+++.+.+++++||+.||.+|||++++++
T Consensus 249 ------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 249 ------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11356789999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=320.00 Aligned_cols=245 Identities=18% Similarity=0.322 Sum_probs=201.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecC--CEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASEN--YRLY 77 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~--~~~~ 77 (346)
+++|++.+.||+|+||+||+|++. ++.||+|++........ .....+|+.+++++ +||||+++++++.+. +..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeE
Confidence 378999999999999999999875 88899999987654443 34456888888888 799999999999877 7889
Q ss_pred EEEEcCCC-CHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEeC-CcEEEeecccccccCC
Q 039371 78 FVFEYMDC-NLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQG--YFHRDLISKNLLVSN-DTIKIADFGLAWEVDS 152 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~ 152 (346)
+|||+++| +|.+.+..... .+++..+..++.|++.||.|||++| ++|+||||+||++++ +.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999985 88887776543 5899999999999999999999999 999999999999964 5889998887754332
Q ss_pred CCCCccccccCcccCcccccccCC--CCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQ--YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
....+|+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+..+....+......+.
T Consensus 166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 231 (271)
T 3kmu_A 166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT---------- 231 (271)
T ss_dssp ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC----------
T ss_pred ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC----------
Confidence 33568999999999874322 33489999999999999999999998877766555543322111
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+.+++++.+++.+||+.||++|||++++++
T Consensus 232 ------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 ------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12467889999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=341.91 Aligned_cols=250 Identities=20% Similarity=0.255 Sum_probs=205.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+..+++.||+|++...... ....+|..+++.+.+++++..+..++...+..++|||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 6899999999999999999999999999999988654332 2356799999999766888888888888899999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE----eCCcEEEeecccccccCCCCC--
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV----SNDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli----~~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
|++|+|.+.+......+++..+..++.||+.||+|||++||+||||||+|||+ .++.+||+|||++........
T Consensus 84 ~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 99889999888766779999999999999999999999999999999999999 356899999999976554322
Q ss_pred ------CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhhHHH
Q 039371 156 ------YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED---DQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 156 ------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~ 226 (346)
.....||+.|+|||++. ...++.++|||||||++|+|++|..||.+.... +.+..+.........
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----- 237 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI----- 237 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH-----
T ss_pred ccccccccccCCCccccCHHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH-----
Confidence 22567999999999987 566899999999999999999999999875542 333333222111111
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+...++.++.++|..||+.||++||++++|++
T Consensus 238 --------------------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 --------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp --------------------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --------------------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1112367889999999999999999999988765
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=364.08 Aligned_cols=279 Identities=25% Similarity=0.359 Sum_probs=208.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec------CC
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE------NY 74 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------~~ 74 (346)
+++|++.+.||+|+||+||+|.+..+|+.||+|++.............+|+.+++++ +||||+++++++.. ++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCC
Confidence 368999999999999999999999999999999997665444555667899999999 79999999998765 67
Q ss_pred EEEEEEEcCCC-CHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC----cEEEeecccc
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRK--QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND----TIKIADFGLA 147 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~----~vkl~Dfg~a 147 (346)
..++||||++| +|.+.+.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ .+||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 78999999964 7777776543 258999999999999999999999999999999999999643 3899999999
Q ss_pred cccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHH
Q 039371 148 WEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 148 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
.............+|+.|+|||++. ...++.++||||+||++|+|++|..||.+.......................
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~-- 248 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLE-QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD-- 248 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSC-CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC--
T ss_pred cccccccccccccCCcccCChHHhc-cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh--
Confidence 8877666666778999999999886 5678999999999999999999999997764432211100000000000000
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.......+.. .........+.+++.+.++|++||+.||++|||++++++||||+..
T Consensus 249 ---~l~g~~~~~~-~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 249 ---DLTGAVKFSS-VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp ---CCSSSCCCCS-SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred ---hhcccccccc-ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 0000000000 0011122334567889999999999999999999999999999753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=347.64 Aligned_cols=246 Identities=26% Similarity=0.452 Sum_probs=206.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.++.++..||+|+++..... .....+|+.+++++ +||||+++++++.+++.+++|||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEEEEE
Confidence 4799999999999999999999999999999999765443 34467899999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CC
Q 039371 82 YMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~ 156 (346)
|+. |+|.+.+... ...+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++....... ..
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 998 5888887653 34589999999999999999999999999999999999995 5699999999998764322 22
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 377 ~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------------- 436 (495)
T 1opk_A 377 AGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------------- 436 (495)
T ss_dssp TTCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-------------------
T ss_pred CCCcCCcceeCHhHHh-cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence 2344567899999987 5668999999999999999999 999998877665544442211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+ ....+++.+.+||.+||+.||.+|||++++++
T Consensus 437 -~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 437 -RME---------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCC---------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 111 11357889999999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=324.43 Aligned_cols=243 Identities=28% Similarity=0.418 Sum_probs=201.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec---------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--------- 72 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--------- 72 (346)
++|++++.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++++ +||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCccccc
Confidence 47999999999999999999999999999999997543 2345799999999 79999999998854
Q ss_pred -------CCEEEEEEEcCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEe
Q 039371 73 -------NYRLYFVFEYMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIA 142 (346)
Q Consensus 73 -------~~~~~iv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~ 142 (346)
...+++||||++| +|.+.+... ...+++..+..++.|++.||.|||++||+|+||||+||+++ ++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 4568999999996 787777644 35699999999999999999999999999999999999995 6699999
Q ss_pred ecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Q 039371 143 DFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEE 222 (346)
Q Consensus 143 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 222 (346)
|||++.............+|+.|+|||++. ...++.++|||||||++|+|++|..||... ......+
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~---------- 231 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQIS-SQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL---------- 231 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHH-CSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH----------
T ss_pred cchhheeccccccccccCCcccccChhhhc-cCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh----------
Confidence 999998776655555667999999999887 566899999999999999999999887321 0111111
Q ss_pred hHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 223 SWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
.. .. ..+.++..+.++|.+||+.||.+|||+.|+++|.+.-
T Consensus 232 ---------~~--~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 232 ---------RD--GI-----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp ---------HT--TC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------hc--cc-----------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 00 1135678899999999999999999999999997654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=326.89 Aligned_cols=239 Identities=27% Similarity=0.383 Sum_probs=188.3
Q ss_pred CCceeee-eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec----CCE
Q 039371 1 MEKYTLM-KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE----NYR 75 (346)
Q Consensus 1 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~----~~~ 75 (346)
+++|.+. +.||+|+||+||+|.+..+++.||+|++... ....+|+.++.++.+||||+++++++.. +..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 3688888 7799999999999999999999999999642 2345788888777799999999999876 778
Q ss_pred EEEEEEcCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CCcEEEeecccccc
Q 039371 76 LYFVFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWE 149 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~~vkl~Dfg~a~~ 149 (346)
+++||||++| +|.+.+.... ..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999999985 8888776653 3699999999999999999999999999999999999996 46899999998854
Q ss_pred cCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 150 VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 150 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.. ...++.++||||+||++|+|++|..||.+............
T Consensus 170 ~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--------------- 212 (299)
T 3m2w_A 170 TT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------------- 212 (299)
T ss_dssp CT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC---------------
T ss_pred cc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH---------------
Confidence 33 23467899999999999999999999976543321111000
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
................+++++.++|++||+.||.+|||++|+++||||++...
T Consensus 213 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 213 -------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp -------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred -------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 00000000011112467899999999999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=341.80 Aligned_cols=241 Identities=24% Similarity=0.432 Sum_probs=199.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-CEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN-YRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-~~~~iv~ 80 (346)
++|++.+.||+|+||+||+|.+. ++.||+|+++... ......+|+.+++++ +||||+++++++.+. +.+++||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEEE
Confidence 68999999999999999999875 7799999997653 233467899999999 799999999997655 4799999
Q ss_pred EcCCC-CHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 81 EYMDC-NLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||+.| +|.+.+...+. .+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++....... .
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~ 344 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--D 344 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--c
Confidence 99985 88888776543 379999999999999999999999999999999999996 5699999999997654322 2
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...++..|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+..+..
T Consensus 345 ~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------- 404 (450)
T 1k9a_A 345 TGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------------- 404 (450)
T ss_dssp --CCCTTTSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-------------------
T ss_pred CCCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence 336788999999987 5678999999999999999998 9999988776665555433211
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.+ ..+.+++++.++|.+||+.||.+|||+.++++
T Consensus 405 -~~---------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 -MD---------APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CC---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 11367899999999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=330.32 Aligned_cols=263 Identities=24% Similarity=0.353 Sum_probs=202.2
Q ss_pred CceeeeeeecccCceEEEEEE----EccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee--cCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS--ENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~--~~~~ 75 (346)
++|++++.||+|+||+||+|+ +..+++.||+|++..... .......+|+.+++++ +||||+++++++. +.+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCce
Confidence 689999999999999999998 567899999999975432 2334457899999999 8999999999875 5577
Q ss_pred EEEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEE-eCCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~ 153 (346)
.++||||++ |+|.+.+......+++..+..++.|++.||+|||++||+|+||||+||++ .++.+||+|||++......
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 999999996 57777777656669999999999999999999999999999999999999 5679999999999876543
Q ss_pred C----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 P----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
. ......+|+.|+|||++. ...++.++|||||||++|+|++|..||............ .............
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG----CERDVPALSRLLE 255 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--------CCHHHHHHH
T ss_pred CccceeeccCCccccccCHHHhc-cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc----cccccccHHHHHH
Confidence 3 223346788899999887 556899999999999999999999998654332111000 0000000011111
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. ...+...+ ..+.+++++.++|++||+.||.+|||++|++++
T Consensus 256 ~-~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 L-LEEGQRLP---------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp H-HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H-hhcccCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 11111111 124678999999999999999999999999654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=324.15 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=190.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc-C-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY-S-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.+.||+|+||+||+|.+..+|+.||+|++..... . .......+|+.+++++ +||||+++++++.+++..++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEE
Confidence 3689999999999999999999999999999999975332 2 2334556899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 79 VFEYMDC-NLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
|||+++| +|.+.+.. ....+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++......
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999986 77666643 345689999999999999999999999999999999999996 569999999998765443
Q ss_pred C-CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhhHHHHHHH
Q 039371 154 P-PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED--DQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 154 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
. ......+++.|+|||++. ...++.++|||||||++|+|++|..||.+.... .....+...
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 253 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--------------- 253 (310)
T ss_dssp ---------CCSSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT---------------
T ss_pred CccccccCCCeeEeChHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc---------------
Confidence 2 233457899999999887 566899999999999999999999999764322 111111110
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.++. .....+++++.+++.+||+.||.+|||+++++++
T Consensus 254 ------~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 254 ------DYPP-------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ------CSCC-------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------cCCC-------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1111 0113578899999999999999999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=325.15 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=193.7
Q ss_pred CceeeeeeecccCceEEEEEEEcc---CCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCC---
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ---SGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENY--- 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~--- 74 (346)
++|++.+.||+|+||+||+|.+.. ++..||+|+++....... .....+|+.+++++ +||||+++++++.+.+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC-----
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccccC
Confidence 589999999999999999998765 456899999976655443 34456899999999 7999999999987654
Q ss_pred --EEEEEEEcCCC-CHHHHHhc-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecc
Q 039371 75 --RLYFVFEYMDC-NLHQLMSN-----RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFG 145 (346)
Q Consensus 75 --~~~iv~e~~~g-~l~~~~~~-----~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg 145 (346)
..++|||++.| +|.+.+.. ....+++..+..++.|++.||.|||++||+||||||+||++++ +.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 35999999985 77776632 3356999999999999999999999999999999999999964 599999999
Q ss_pred cccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 146 LAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 146 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
++....... ......+++.|+|||.+. ...++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--- 268 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL--- 268 (313)
T ss_dssp CC----------------CCGGGSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---
T ss_pred cceecccccccCcccccCCCccccCchhhc-CCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC---
Confidence 997654332 223345678999999887 5678999999999999999999 89999888776655554332111
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+.+++++.++|.+||+.||.+|||+++++++
T Consensus 269 --------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 --------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp --------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1113578899999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=331.93 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=200.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+. +++.||+|++...... ......+|+.+++.+ +||||+++++++.+++..++|||
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQ-GIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSS-HHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTCCEEEEE
T ss_pred hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChH-HHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEE
Confidence 68999999999999999999864 6889999998765433 334456899999888 79999999999999999999999
Q ss_pred cCCC-CHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC---
Q 039371 82 YMDC-NLHQLMSNRK---QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC--- 153 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~--- 153 (346)
|++| +|.+.+.... ..+++..+..++.|++.||.|||++|++||||||+||+++ ++.+||+|||++......
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9985 6666664432 2489999999999999999999999999999999999996 459999999999764332
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.......||+.|+|||++. ...++.++|||||||++|+|++|..||......+...... |. .. ..
T Consensus 196 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~----------~~--~~--~~ 260 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE----------WA--VE--SH 260 (321)
T ss_dssp CCBCCCEEETTTCCHHHHH-HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH----------HT--HH--HH
T ss_pred ccccccCCCccccCHHHhc-CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH----------Hh--hh--cc
Confidence 2233456899999999887 4568999999999999999999999997654322111100 00 00 00
Q ss_pred cCCCCCCcCCCC-cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 234 HGYKFPKLQGNN-LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
............ .....+..+..+.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 001111111111 111223445678899999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=333.40 Aligned_cols=250 Identities=13% Similarity=0.217 Sum_probs=196.3
Q ss_pred CceeeeeeecccCceEEEEEEEccC--------CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeee--------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS--------GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVK-------- 65 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~-------- 65 (346)
++|++.+.||+|+||+||+|++..+ ++.||+|++... ....+|+.+++++ +||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRA-AKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHH-CCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHh-cccchhhhhhhhccC
Confidence 6899999999999999999999874 889999998754 2456799999999 6998887
Q ss_pred -------eeeeeec-CCEEEEEEEcCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC
Q 039371 66 -------LQELASE-NYRLYFVFEYMDCNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN 136 (346)
Q Consensus 66 -------~~~~~~~-~~~~~iv~e~~~g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~ 136 (346)
+++++.. ++..++||||++|+|.+.+... ...+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred CccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 5666655 6889999999977888888765 356999999999999999999999999999999999999976
Q ss_pred C---cEEEeecccccccCCCC--------CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-
Q 039371 137 D---TIKIADFGLAWEVDSCP--------PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTC- 204 (346)
Q Consensus 137 ~---~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~- 204 (346)
+ .+||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 5 79999999997654321 223457899999999887 5568999999999999999999999998764
Q ss_pred hHHHHHHHHHH-hCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 205 EDDQLYKICNA-IGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 205 ~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+........ ...+. .+.. .......+++++.++|.+||+.||++|||++++++
T Consensus 274 ~~~~~~~~~~~~~~~~~----------------~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPG----------------PFVG-----PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CHHHHHHHHHHHHHSCC----------------CEEC-----TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHhccCChh----------------hhhh-----hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 22222222111 11000 0000 00011356899999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=335.71 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=194.4
Q ss_pred ceeeeeeecccCceEEEEEEEccCC---cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeee-ecCCEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSG---EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELA-SENYRLYF 78 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~-~~~~~~~i 78 (346)
+|++.+.||+|+||+||+|++..++ ..||+|.++............+|+.+++++ +||||+++++++ ..++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeEE
Confidence 4788999999999999999876433 468999997665555666678899999999 799999999985 45568899
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-- 154 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-- 154 (346)
||||++| +|.+.+......+++.++..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 9999985 88888877767799999999999999999999999999999999999996 4599999999997654322
Q ss_pred ---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 155 ---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 155 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
......+|+.|+|||++. ...++.++|||||||++|+|++ |.+||...+..+....+......+
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~----------- 316 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL----------- 316 (373)
T ss_dssp ---------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC-----------
T ss_pred cccccCCCCCcccccChHHhc-CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 122345678899999887 5678999999999999999999 788888776555444443221100
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....+++.+.+++.+||+.||++|||++|++++
T Consensus 317 ------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 ------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 113578899999999999999999999999884
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=341.15 Aligned_cols=244 Identities=25% Similarity=0.455 Sum_probs=202.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+.. +..||+|+++..... .....+|+.+++++ +||||+++++++. .+..++|||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS--VEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBC--HHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCcc--HHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCccEEEEe
Confidence 579999999999999999998864 678999999765443 34567899999999 7999999999987 556899999
Q ss_pred cCC-CCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CC
Q 039371 82 YMD-CNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~ 156 (346)
|+. |+|.+.+.... ..+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++....... ..
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 997 57888776543 3589999999999999999999999999999999999996 4599999999998764321 12
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+......+.
T Consensus 343 ~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~--------------- 406 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR--------------- 406 (454)
T ss_dssp CSSSSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---------------
T ss_pred CCCcccccccCHHHhc-cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 2334677899999987 5668999999999999999999 9999998887777666544322111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
...+++++.++|.+||+.||++|||++++++
T Consensus 407 --------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 --------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1357889999999999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=332.86 Aligned_cols=263 Identities=23% Similarity=0.320 Sum_probs=197.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+ .+++.||+|++.............+|+.+++.+ +||||+++++++.+++..++|||
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 107 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYP 107 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECCSSCCEEEEE
T ss_pred hccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEecCCceEEEEE
Confidence 6899999999999999999974 468899999997665444444567899999888 79999999999999999999999
Q ss_pred cCCC-CHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCCEEEeC-CcEEEeecccccccCCC
Q 039371 82 YMDC-NLHQLMSNRK---QCFSEAEVKNWCFQILQGLNYMHRQ---GYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSC 153 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~ 153 (346)
|+.| +|.+.+.... ..+++..+..++.|++.||+|||++ ||+||||||+||++++ +.+||+|||++......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence 9985 7777776543 3489999999999999999999999 9999999999999965 49999999999866433
Q ss_pred C--CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCCChhhHHHH
Q 039371 154 P--PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTC----EDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 154 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
. ......||+.|+|||++. ...++.++||||+||++|+|++|..||.... ..............
T Consensus 188 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 257 (326)
T 3uim_A 188 DTHVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK--------- 257 (326)
T ss_dssp SSCEECCCCSCGGGCCHHHHH-HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS---------
T ss_pred cccccccccCCcCccCHHHhc-cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh---------
Confidence 2 233445899999999886 4568999999999999999999999995211 00001111100000
Q ss_pred HHHHHhcCCCCCCcCCCC-cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCC
Q 039371 228 LELAKAHGYKFPKLQGNN-LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPL 283 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~ 283 (346)
........... .....+..+..+.+++.+||+.||.+|||++|+++|-.
T Consensus 258 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 258 -------EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp -------SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred -------chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00000000000 01111233467899999999999999999999999743
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=327.23 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=200.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
.++|++.+.||+|+||+||+|.+.. .+|+|+++....... .....+|+.+++++ +||||+++++++.+++..+++
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEE
Confidence 3789999999999999999998763 489999875543222 23345788888888 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccccCC------
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDS------ 152 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~------ 152 (346)
||+++| +|.+.+...+..+++..+..++.|++.||+|||++|++||||||+||+++++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC----------
T ss_pred eecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCcccccccccccc
Confidence 999985 7777777666679999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccCcccCcccccc--------cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhH
Q 039371 153 CPPYTEYITTLQYRAPEMLLM--------SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESW 224 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 224 (346)
........|++.|+|||++.. ...++.++|||||||++|+|++|..||...........+.......
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----- 262 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN----- 262 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC-----
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC-----
Confidence 122334568999999998864 2457889999999999999999999998887766655543221110
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....++.++.+++.+||+.||.+|||++++++
T Consensus 263 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 -----------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -----------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -----------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011257889999999999999999999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=316.53 Aligned_cols=244 Identities=26% Similarity=0.468 Sum_probs=200.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|.+. ++..||+|++...... .....+|+.+++++ +||||+++++++.++ ..++|||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~v~e 87 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQL-QHQRLVRLYAVVTQE-PIYIITE 87 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHC-CCTTBCCEEEEECSS-SCEEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc--HHHHHHHHHHHHhC-CCcCcceEEEEEcCC-CcEEEEe
Confidence 68999999999999999999875 5678999999765444 23456899999999 799999999998754 5799999
Q ss_pred cCC-CCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCC--CC
Q 039371 82 YMD-CNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~--~~ 156 (346)
++. |+|.+.+.... ..+++..+..++.|++.||+|||++|++|+||||+||++++ +.+||+|||++....... ..
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 997 57777765443 25999999999999999999999999999999999999964 599999999997765432 22
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 168 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 229 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM----------------- 229 (279)
T ss_dssp TTCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----------------
T ss_pred cCCCCccCccChhhhc-cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC-----------------
Confidence 3345678899999886 5668999999999999999999 99999988776665554332110
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+++++.+++.+||+.||++|||++++++
T Consensus 230 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 230 ------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011357889999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=321.91 Aligned_cols=249 Identities=23% Similarity=0.371 Sum_probs=195.4
Q ss_pred CceeeeeeecccCceEEEEEEEcc-CCc--EEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-SGE--YVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|.+.. +++ .||+|+++.... ........+|+.+++++ +||||+++++++.++. .
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-C
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-c
Confidence 589999999999999999998643 333 689999875532 23445567899999999 7999999999998766 7
Q ss_pred EEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 77 YFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
++|||++. |+|.+.+......+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++.......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 89999998 588888877666799999999999999999999999999999999999994 6799999999997765433
Q ss_pred C----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 155 P----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 155 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
. .....+|..|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+......++
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 245 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--------- 245 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---------
T ss_pred cchhhhccCCCCceeeCchhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC---------
Confidence 2 22345677899999886 4567899999999999999999 9999998887766655533211111
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....++.++.++|.+||+.||.+|||+++++++
T Consensus 246 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 246 -------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 113578899999999999999999999999983
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=320.02 Aligned_cols=242 Identities=24% Similarity=0.424 Sum_probs=191.6
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec-CCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE-NYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-~~~~~iv 79 (346)
+++|++.+.||+|+||+||+|.+. |+.||+|+++... ......+|+.+++++ +||||+++++++.+ ++..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEE
Confidence 368999999999999999999764 8899999997543 233456899999999 79999999998654 4578999
Q ss_pred EEcCCC-CHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 80 FEYMDC-NLHQLMSNRKQ-CFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
||+++| +|.+.+...+. .+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999986 88877765432 389999999999999999999999999999999999996 5699999999987655432
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+++.|+|||++. ...++.++|||||||++|+|++ |..||......+....+.....
T Consensus 172 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------------ 232 (278)
T 1byg_A 172 DTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------------ 232 (278)
T ss_dssp ----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC------------------
T ss_pred cCCCccccccCHHHhC-CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------------------
Confidence 2346788999999886 5668999999999999999998 9999988766555444422110
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
......+++.+.++|++||+.||.+|||+.++++
T Consensus 233 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 233 -----------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0112467889999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=327.33 Aligned_cols=250 Identities=21% Similarity=0.377 Sum_probs=194.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee----cCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS----ENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~----~~~~~~ 77 (346)
++|++++.||+|+||.||+|.+..+++.||+|++..... .......+|+.+++.+ +||||+++++++. .....+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-QDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH-HHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeE
Confidence 579999999999999999999999999999999865322 2344556899999998 7999999999986 345789
Q ss_pred EEEEcCCC-CHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 78 FVFEYMDC-NLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
+|||++.| +|.+.+.. .+..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999986 77776654 355699999999999999999999999999999999999995 56999999998865432
Q ss_pred CCC----------CccccccCcccCcccccccC--CCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Q 039371 153 CPP----------YTEYITTLQYRAPEMLLMSG--QYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSP 219 (346)
Q Consensus 153 ~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~ 219 (346)
... .....||+.|+|||++.... .++.++|||||||++|+|++|..||...... +......
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------ 260 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV------ 260 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH------
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh------
Confidence 111 12235689999999886332 3688999999999999999999999431100 0000000
Q ss_pred ChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 220 TEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
......+. .+.++.++.++|.+||+.||.+|||+++++++
T Consensus 261 -------------~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 261 -------------QNQLSIPQ---------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -------------HCC--CCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------hccCCCCc---------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00111111 13578899999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=338.67 Aligned_cols=250 Identities=29% Similarity=0.473 Sum_probs=200.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+.. +..||+|+++...... ....+|+.+++++ +||||+++++++.+ +..++|||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSP--EAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCH--HHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEC
T ss_pred hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCH--HHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceEEEeh
Confidence 579999999999999999999875 4669999998655442 3467899999999 79999999999876 56899999
Q ss_pred cCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CC
Q 039371 82 YMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~ 156 (346)
|+. |+|.+.+... +..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||++....... ..
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 997 4788877643 34599999999999999999999999999999999999995 4599999999997654322 22
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+......+
T Consensus 339 ~~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~---------------- 401 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------------- 401 (452)
T ss_dssp ----CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------
T ss_pred cCCcccccccCHhHHh-cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 2345678899999887 5678999999999999999999 999999888777666554321111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc--CCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ--HPLFQG 286 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~--hp~~~~ 286 (346)
..+.+++.+.++|.+||+.||++|||++++++ ..++..
T Consensus 402 -------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 -------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 11357889999999999999999999999987 355543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=346.45 Aligned_cols=246 Identities=22% Similarity=0.345 Sum_probs=199.6
Q ss_pred ceeeee-eecccCceEEEEEEEc--cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 3 KYTLMK-QIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 3 ~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++.+.+ .||+|+||+||+|.++ .++..||+|+++............+|+.+++++ +||||+++++++.+ +.+++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEE
Confidence 455555 8999999999999876 345679999998765444555677899999999 79999999999987 458999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP-- 155 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~-- 155 (346)
|||+.| +|.+.+......+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999985 67777776666799999999999999999999999999999999999995 66999999999977643221
Q ss_pred --CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 156 --YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 156 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
.....+++.|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+..+...+
T Consensus 494 ~~~~~~~~~~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------------- 559 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME------------- 559 (613)
T ss_dssp --------CCTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC-------------
T ss_pred eeccCCCCccceeCHhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 12234567899999987 5678999999999999999998 999999988877666654321111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+.+++++.++|.+||+.||++|||++++++
T Consensus 560 ----------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 560 ----------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ----------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ----------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11357899999999999999999999999854
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=316.84 Aligned_cols=241 Identities=29% Similarity=0.473 Sum_probs=187.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+. ++.||+|++... .......+|+..++++ +||||+++++++.+. .++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRV-NHPNIVKLYGACLNP--VCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHC-CCTTBCCEEEBCTTT--TEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCC--cEEEEE
Confidence 68999999999999999999875 788999998643 2344567899999999 799999999998754 689999
Q ss_pred cCCC-CHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCCEEEeC-Cc-EEEeecccccccCCC
Q 039371 82 YMDC-NLHQLMSNRKQ--CFSEAEVKNWCFQILQGLNYMHR---QGYFHRDLISKNLLVSN-DT-IKIADFGLAWEVDSC 153 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~--~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dikp~NIli~~-~~-vkl~Dfg~a~~~~~~ 153 (346)
|++| +|.+.+..... .+++..+..++.|++.||+|||+ +||+||||||+||+++. +. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9975 77777765432 47899999999999999999999 89999999999999964 44 899999999765432
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.....||+.|+|||++. ...++.++|||||||++|+|++|..||................+
T Consensus 160 --~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------------- 220 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG---------------- 220 (307)
T ss_dssp -------CCTTSSCHHHHT-CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT----------------
T ss_pred --cccCCCCCceEChhhhC-CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC----------------
Confidence 23456899999999887 56789999999999999999999999976543221111000000
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.. ....+.+++.+.+++.+||+.||++|||++++++
T Consensus 221 --~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 221 --TR---------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp --CC---------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CC---------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 1112467889999999999999999999999988
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=320.43 Aligned_cols=260 Identities=27% Similarity=0.387 Sum_probs=197.2
Q ss_pred ce-eeeeeecccCceEEEEEE----EccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCE
Q 039371 3 KY-TLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--NYR 75 (346)
Q Consensus 3 ~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~ 75 (346)
+| ++++.||+|+||+||++. +..+++.||+|+++............+|+.+++++ +||||+++++++.+ ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCce
Confidence 45 999999999999998775 44578999999998765444555667899999999 69999999999987 468
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~ 153 (346)
+++|||+++| +|.+.+... .+++..+..++.|++.||.|||++||+|+||||+||++++ +.+||+|||++......
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 8999999985 676666543 3999999999999999999999999999999999999964 58999999999876553
Q ss_pred CC----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 PP----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.. .....+|..|+|||++. ...++.++|||||||++|+|++|..||....... .................
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQMTVLRLT 261 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHHHHHHHH
T ss_pred ccccccccCCCCCceeeChHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccchhHHHHH
Confidence 32 23345788899999887 5568899999999999999999999996542211 01111111111011111
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.........+ ....+++++.++|++||+.||.+|||++|+++
T Consensus 262 ~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGERLP---------RPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcccCCC---------CCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1111111111 12467899999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=345.71 Aligned_cols=247 Identities=29% Similarity=0.454 Sum_probs=204.0
Q ss_pred CceeeeeeecccCceEEEEEEEccC---CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS---GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++.+.||+|+||+||+|.+..+ +..||+|++.............+|+.+++++ +||||+++++++.+ +..++
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec-CceEE
Confidence 5799999999999999999998654 4579999987655444455677899999999 79999999999865 55899
Q ss_pred EEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-
Q 039371 79 VFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 79 v~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~- 155 (346)
||||++ |+|.+.+...+..+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++........
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence 999998 578887776666799999999999999999999999999999999999995 67999999999987654332
Q ss_pred -CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 -YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.....+|+.|+|||++. ...++.++||||+||++|+|++ |..||.+....+....+......+
T Consensus 548 ~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 612 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------------- 612 (656)
T ss_dssp ------CCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC--------------
T ss_pred eccCCCCCcceeCHHHhc-CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 22345678899999887 5678999999999999999997 999999988877766665432111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+.+++.+.++|.+||+.||.+|||+.++++
T Consensus 613 ---------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 ---------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11357889999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=318.04 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=186.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhh-cCCCCeeeeeeeeec----CCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKI-NNHPNIVKLQELASE----NYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~hp~iv~~~~~~~~----~~~~ 76 (346)
++|++++.||+|+||+||+|++ +++.||+|++.... ......|..++... .+||||+++++++.+ ....
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 6899999999999999999977 58999999986542 22334566666552 289999999998543 4568
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCCEEEe-CCcEEEeeccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH--------RQGYFHRDLISKNLLVS-NDTIKIADFGL 146 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH--------~~~ivH~dikp~NIli~-~~~vkl~Dfg~ 146 (346)
++||||++| +|.+.+.. ..+++..+..++.|++.||+||| ++||+||||||+||+++ ++.+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 999999985 77777743 35999999999999999999999 99999999999999996 56999999999
Q ss_pred ccccCCCCC-----CccccccCcccCcccccccC-----CCCChhhHHHHHHHHHHHHhC----------CCCCCCCChH
Q 039371 147 AWEVDSCPP-----YTEYITTLQYRAPEMLLMSG-----QYNSKVDMWALGLIMAELITF----------HPLFPGTCED 206 (346)
Q Consensus 147 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g----------~~pf~~~~~~ 206 (346)
+........ .....||+.|+|||++.+.. .++.++||||+||++|+|++| ..||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 975543222 23347899999999987443 234689999999999999999 8888553221
Q ss_pred ----HHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 207 ----DQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 207 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
........... ..+... ........++++.+++++||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~-------------------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQ-------------------QRPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCCHHHHHHHHTTSC-------------------CCCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcchhhhhHHHhccC-------------------CCCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 11222111100 000000 00011234567999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=315.65 Aligned_cols=262 Identities=23% Similarity=0.381 Sum_probs=201.2
Q ss_pred CceeeeeeecccCceEEEEEE----EccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC--E
Q 039371 2 EKYTLMKQIGEGSFGKVWQAI----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY--R 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~--~ 75 (346)
++|++++.||+|+||+||+|+ +..+++.||+|++.... ........+|+.+++++ +||||+++++++...+ .
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----C
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCc
Confidence 479999999999999999998 46789999999997543 33444567899999999 7999999999886543 7
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
+++|||+++| +|.+.+......+++..+..++.|++.||.|||++||+|+||||+||+++ ++.+||+|||++......
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 8999999975 88888877766799999999999999999999999999999999999995 679999999999876543
Q ss_pred CC----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-hhHHHHH
Q 039371 154 PP----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTE-ESWAEGL 228 (346)
Q Consensus 154 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~ 228 (346)
.. .....++..|+|||++. ...++.++|||||||++|+|++|..||..... ...+..+.... .......
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCTHHHHHHH
T ss_pred ccccccccCCCCceeEECchhhc-CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccchhhhHHHH
Confidence 32 22345677899999887 45688999999999999999999999854311 11111121111 1111111
Q ss_pred HHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 229 ELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
......+...+ ..+.+++++.++|++||+.||++|||+.|+++
T Consensus 273 ~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 273 IELLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhcCCCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111111111 12467899999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=343.28 Aligned_cols=240 Identities=22% Similarity=0.357 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEE--ccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 8 KQIGEGSFGKVWQAIK--KQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
+.||+|+||+||+|.+ +.+++.||+|+++...... ......+|+.++.++ +||||++++++++++ ..++||||+.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-CEEEEEEccC
Confidence 4899999999999954 4567899999997654443 234567899999999 799999999999755 5789999998
Q ss_pred C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC----Ccc
Q 039371 85 C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP----YTE 158 (346)
Q Consensus 85 g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~----~~~ 158 (346)
| +|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||++........ ...
T Consensus 453 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 453 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 5 66666654 45599999999999999999999999999999999999995 56899999999976644321 223
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..+|+.|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 532 ~~~t~~y~APE~~~-~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~------------------ 592 (635)
T 4fl3_A 532 GKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------------ 592 (635)
T ss_dssp ---CGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------------
T ss_pred CCCceeeeChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 34678899999986 5678999999999999999998 999999988877666654332111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+++++.++|.+||+.||++|||++++++
T Consensus 593 -----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 -----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp -----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11357899999999999999999999999976
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=339.73 Aligned_cols=247 Identities=14% Similarity=0.137 Sum_probs=188.5
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCC-CCeee--------------
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNH-PNIVK-------------- 65 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~h-p~iv~-------------- 65 (346)
+|.+.+.||+|+||+||+|++..+|+.||+|++........ .....+|+.++..+ +| +|...
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhhc
Confidence 48889999999999999999999999999999874333222 23345777777777 34 32211
Q ss_pred -------eeeeeec-----CCEEEEEEEcCCCCHHHHHh------cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 039371 66 -------LQELASE-----NYRLYFVFEYMDCNLHQLMS------NRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDL 127 (346)
Q Consensus 66 -------~~~~~~~-----~~~~~iv~e~~~g~l~~~~~------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~di 127 (346)
+..++.. ...++++|+.+.|+|.+.+. ..+..+++..+..++.|++.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 1111111 23468899999999988874 22445788899999999999999999999999999
Q ss_pred CCCCEEEe-CCcEEEeecccccccCCCCCCccccccCcccCccccc---------ccCCCCChhhHHHHHHHHHHHHhCC
Q 039371 128 ISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLL---------MSGQYNSKVDMWALGLIMAELITFH 197 (346)
Q Consensus 128 kp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll~g~ 197 (346)
||+|||++ ++.+||+|||++...+.. .....| +.|+|||++. ....++.++|||||||++|+|++|.
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 99999996 569999999998776543 344567 9999999984 3445788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHH
Q 039371 198 PLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAE 277 (346)
Q Consensus 198 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e 277 (346)
.||...+..+....+ + ...+.+++++.+||.+||+.||++|||+.+
T Consensus 315 ~Pf~~~~~~~~~~~~-------------------------~---------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 315 LPNTDDAALGGSEWI-------------------------F---------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQ 360 (413)
T ss_dssp CCCCTTGGGSCSGGG-------------------------G---------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCcchhhhHHHH-------------------------H---------hhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999765432211100 0 011357899999999999999999999999
Q ss_pred HhcCCCCCCC
Q 039371 278 ALQHPLFQGC 287 (346)
Q Consensus 278 ll~hp~~~~~ 287 (346)
+++||||+..
T Consensus 361 ~l~~~~~~~~ 370 (413)
T 3dzo_A 361 AMETPEYEQL 370 (413)
T ss_dssp HTTSHHHHHH
T ss_pred HHhCHHHHHH
Confidence 9999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=320.00 Aligned_cols=258 Identities=25% Similarity=0.323 Sum_probs=197.0
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc---CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY---SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
|...+.||+|+||+||+|.+ +++.||+|++..... ........+|+.+++++ +||||+++++++.+++..+++|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEEE
Confidence 45568999999999999975 588999999865432 22344566899999999 7999999999999999999999
Q ss_pred EcCC-CCHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCCC-
Q 039371 81 EYMD-CNLHQLMSNR--KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 81 e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~~- 155 (346)
|+++ |+|.+.+... ...+++..+..++.|++.||.|||++|++|+||||+||++++ +.+||+|||++........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 9997 5777776543 345899999999999999999999999999999999999964 5999999999976554221
Q ss_pred --CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 --YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.....||+.|+|||++. +.++.++|||||||++|+|++|..||...........+.........
T Consensus 190 ~~~~~~~g~~~y~aPE~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 255 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK------------ 255 (307)
T ss_dssp EECSSCCSCGGGCCHHHHT--TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC------------
T ss_pred ccccccCCCcCcCChHHhc--CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh------------
Confidence 23457899999999875 35799999999999999999999999876544333333222111000
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..+..............+..+.+++.+||+.||.+|||+++++++
T Consensus 256 ---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 256 ---TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ---CHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---hhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000000001111112345678899999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=339.83 Aligned_cols=249 Identities=29% Similarity=0.482 Sum_probs=204.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|.+.. +..||+|+++..... .....+|+.+++++ +||||+++++++.+ +..|||||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC--HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC--HHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccceEeee
Confidence 579999999999999999999875 466999999765543 23467899999999 79999999999876 56899999
Q ss_pred cCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CC
Q 039371 82 YMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~ 156 (346)
|+.| +|.+.+... +..+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....... ..
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 9985 788877643 34599999999999999999999999999999999999995 4599999999997654321 12
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....++..|+|||++. ...++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 422 ~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------ 482 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------------ 482 (535)
T ss_dssp CSTTSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC------------------
T ss_pred cCCcCcccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 2334677899999887 5678999999999999999999 9999998887766665533211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC--CCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH--PLFQ 285 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h--p~~~ 285 (346)
.+ ....++..+.+||.+||+.||++|||++++++. .++.
T Consensus 483 --~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 --MP---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --CC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 11 113578899999999999999999999999873 4444
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=324.87 Aligned_cols=241 Identities=13% Similarity=0.180 Sum_probs=187.2
Q ss_pred CceeeeeeecccCceEEEEE-----EEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc--CCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN--NHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~--~hp~iv~~~~~~~~~~ 74 (346)
++|++.+.||+|+||+||+| .+..+++.||+|+++... ......|..++.++. .|+||+.+++++..++
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 57999999999999999999 467789999999997542 223345666666663 3899999999999999
Q ss_pred EEEEEEEcCC-CCHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC------------C
Q 039371 75 RLYFVFEYMD-CNLHQLMSN----RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN------------D 137 (346)
Q Consensus 75 ~~~iv~e~~~-g~l~~~~~~----~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~------------~ 137 (346)
..|+||||++ |+|.+.+.. ....+++..+..++.||+.||+|||++||+||||||+||+++. +
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 9999999998 577777754 3456999999999999999999999999999999999999954 6
Q ss_pred cEEEeecccccccC---CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 039371 138 TIKIADFGLAWEVD---SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 214 (346)
.+||+|||+|.... .........||+.|+|||++. ...++.++|||||||++|+|++|..||........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------ 293 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS-NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------ 293 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc-CCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence 99999999996543 223345567999999999987 45689999999999999999999999954321100
Q ss_pred HhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. ....++. ...++.+.+++..||+.+|.+|++..+.+.+
T Consensus 294 ----------~--------~~~~~~~----------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 294 ----------K--------PEGLFRR----------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ----------E--------ECSCCTT----------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ----------e--------echhccc----------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 0 0000000 1235678899999999999999765555443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=324.76 Aligned_cols=274 Identities=25% Similarity=0.297 Sum_probs=186.6
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee-----cCCE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS-----ENYR 75 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~-----~~~~ 75 (346)
+++|++++.||+|+||+||+|++ +++.||+|++..... .......|+..+..+ +||||+++++.+. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHHHhc-cCcchhhheecccccccCCCce
Confidence 57999999999999999999966 589999999964422 111111233323334 8999999997542 3447
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCCEEEeC-CcEEEeec
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ---------GYFHRDLISKNLLVSN-DTIKIADF 144 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---------~ivH~dikp~NIli~~-~~vkl~Df 144 (346)
+++||||++| +|.+.+.... .++..+..++.|++.||.|||++ ||+||||||+||++++ +.+||+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 7999999975 7777775543 58999999999999999999999 9999999999999964 69999999
Q ss_pred ccccccCCCC---------CCccccccCcccCccccccc------CCCCChhhHHHHHHHHHHHHhCCCCC-CCCChHHH
Q 039371 145 GLAWEVDSCP---------PYTEYITTLQYRAPEMLLMS------GQYNSKVDMWALGLIMAELITFHPLF-PGTCEDDQ 208 (346)
Q Consensus 145 g~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~ 208 (346)
|++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..|| .+....+.
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9997654321 22345689999999988642 34567899999999999999997655 33322111
Q ss_pred HHHHHHHh-CCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHh------cC
Q 039371 209 LYKICNAI-GSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEAL------QH 281 (346)
Q Consensus 209 ~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell------~h 281 (346)
...+.... ..+....+. ..... ....+...... .....+++++.++|.+||+.||++|||++|++ -+
T Consensus 245 ~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQ---VLVSR-EKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCTTHHHHCSSCCHHHHH---HHHTT-SCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhhcccCCCchHHHHH---hhhcc-cccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11111111 112211111 11111 11111110000 00012344799999999999999999999994 46
Q ss_pred CCCCCC
Q 039371 282 PLFQGC 287 (346)
Q Consensus 282 p~~~~~ 287 (346)
+|-++.
T Consensus 319 ~~~~~~ 324 (336)
T 3g2f_A 319 IWERNK 324 (336)
T ss_dssp CCCC--
T ss_pred HHHhcc
Confidence 777654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.39 Aligned_cols=246 Identities=19% Similarity=0.174 Sum_probs=184.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC-------HHHhhhHHHHHHHHhhc--------CCCCeeee
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS-------WEECLNLKEVKCLRKIN--------NHPNIVKL 66 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~--------~hp~iv~~ 66 (346)
++|++++.||+|+||+||+|++ +|+.||+|++...... .......+|+.+++.+. +||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5799999999999999999987 6899999999765321 11234567888888874 35555555
Q ss_pred ee-----------------eeec-------------CCEEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Q 039371 67 QE-----------------LASE-------------NYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLN 115 (346)
Q Consensus 67 ~~-----------------~~~~-------------~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~ 115 (346)
.+ ++.+ ++.+|+||||+.| ++++.+.. ..+++..++.++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 54 4443 6789999999975 46666644 45899999999999999999
Q ss_pred HHH-HCCccccCCCCCCEEEeC-C--------------------cEEEeecccccccCCCCCCccccccCcccCcccccc
Q 039371 116 YMH-RQGYFHRDLISKNLLVSN-D--------------------TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173 (346)
Q Consensus 116 ~LH-~~~ivH~dikp~NIli~~-~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 173 (346)
||| ++||+||||||+|||++. + .+||+|||+|+..... ...||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 999999999999999954 3 8999999999876542 4579999999999874
Q ss_pred cCCCCChhhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccC
Q 039371 174 SGQYNSKVDMWALGLI-MAELITFHPLFPGTCE-DDQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIP 251 (346)
Q Consensus 174 ~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
.. +.++||||+|++ .++++.|..||..... ......+...... +. .......+
T Consensus 252 ~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------~~---~~~~~~~~ 306 (336)
T 2vuw_A 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF--------------------KT---KCNTPAMK 306 (336)
T ss_dssp CS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC--------------------SS---CCCSHHHH
T ss_pred CC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc--------------------Cc---ccchhhhh
Confidence 33 889999998777 7788899999843211 1111222211110 00 00011123
Q ss_pred CCCchHHHHHHHhcccCCCCCCCHHHHh-cCCCCC
Q 039371 252 SANDDEMSLIELLCSWDPCKRPTAAEAL-QHPLFQ 285 (346)
Q Consensus 252 ~~~~~~~~li~~~l~~dP~~Rps~~ell-~hp~~~ 285 (346)
.+++++++||++||+.| |++|+| +||||+
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 46788999999999977 999999 999995
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=316.93 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=184.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhh-cCCCCeeeeeeeeecC----CEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKI-NNHPNIVKLQELASEN----YRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~hp~iv~~~~~~~~~----~~~ 76 (346)
++|++.+.||+|+||+||+|++. ++.||+|++.... ......|..++... .+||||+++++++... ...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 57999999999999999999875 8999999986432 22233455544443 2799999999998776 789
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCCEEEe-CCcEEEeeccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ--------GYFHRDLISKNLLVS-NDTIKIADFGL 146 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------~ivH~dikp~NIli~-~~~vkl~Dfg~ 146 (346)
++||||++| +|.+.+... .+++..+..++.|++.||.|||++ ||+||||||+||+++ ++.+||+|||+
T Consensus 111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 999999985 777777543 489999999999999999999999 999999999999995 56999999999
Q ss_pred ccccCCCCC-----CccccccCcccCcccccccCCCCC------hhhHHHHHHHHHHHHhC----------CCCCCCCCh
Q 039371 147 AWEVDSCPP-----YTEYITTLQYRAPEMLLMSGQYNS------KVDMWALGLIMAELITF----------HPLFPGTCE 205 (346)
Q Consensus 147 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~------~~DiwslG~il~~ll~g----------~~pf~~~~~ 205 (346)
+........ .....||+.|+|||++.+. ..+. ++|||||||++|+|++| ..||.....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 976543322 2345799999999998743 3333 49999999999999999 666644321
Q ss_pred H----HHHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 206 D----DQLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 206 ~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. ......... .. ..+... .......+++++.+++.+||+.||.+|||++++++|
T Consensus 268 ~~~~~~~~~~~~~~------------------~~-~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 268 SDPSYEDMREIVCI------------------KK-LRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SSCCHHHHHHHHTT------------------SC-CCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCchhhhHHHHhh------------------hc-cCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1 111111110 00 000000 000012345678999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=314.08 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=190.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhh-cCCCCeeeeeeeeecCC----EE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKI-NNHPNIVKLQELASENY----RL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~hp~iv~~~~~~~~~~----~~ 76 (346)
++|++.+.||+|+||+||+|.+ +++.||+|++.... .....+|..++..+ .+||||+++++++.... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 5799999999999999999987 48999999986432 23345777777763 38999999999998775 89
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCCEEEe-CCcEEEeeccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH--------RQGYFHRDLISKNLLVS-NDTIKIADFGL 146 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH--------~~~ivH~dikp~NIli~-~~~vkl~Dfg~ 146 (346)
++||||++| +|.+.+... .+++..+..++.|++.||.||| ++||+||||||+||+++ ++.+||+|||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 999999986 787777653 4899999999999999999999 89999999999999995 56999999999
Q ss_pred ccccCCCC-----CCccccccCcccCcccccccCC-----CCChhhHHHHHHHHHHHHhC----------CCCCCCCCh-
Q 039371 147 AWEVDSCP-----PYTEYITTLQYRAPEMLLMSGQ-----YNSKVDMWALGLIMAELITF----------HPLFPGTCE- 205 (346)
Q Consensus 147 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g----------~~pf~~~~~- 205 (346)
+....... ......+|+.|+|||++.+... ++.++|||||||++|+|++| ..||.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 97655433 2344578999999999864322 23689999999999999999 778865422
Q ss_pred ---HHHHHHHH-HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 206 ---DDQLYKIC-NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 206 ---~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+...... .....+ .... . ......++.+.+++.+||+.||++|||++++++|
T Consensus 274 ~~~~~~~~~~~~~~~~~~--------------------~~~~-~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRP--------------------NIPN-R--WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTSCCCC--------------------CCCG-G--GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCC--------------------CCcc-c--ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 11111111 100000 0000 0 0011234578899999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.23 Aligned_cols=239 Identities=24% Similarity=0.392 Sum_probs=195.5
Q ss_pred CceeeeeeecccCceEEEEEEEcc-CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCE-----
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYR----- 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~----- 75 (346)
++|++.+.||+|+||+||+|.+.. +++.||+|++.............+|+.++.++ +||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCce
Confidence 689999999999999999999986 78999999987654444445567899999999 79999999999987654
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccccCCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~ 154 (346)
.|+||||++| +|.+.+.. .+++.++..++.||+.||.|||++||+||||||+||+++++.+||+|||++......
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCC-
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccC-
Confidence 7999999986 55444332 599999999999999999999999999999999999999899999999999876543
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
....||+.|+|||++.. . ++.++|||||||++|+|++|.+||.+..... .+...
T Consensus 235 --~~~~gt~~y~aPE~~~~-~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~~------------ 288 (681)
T 2pzi_A 235 --GYLYGTPGFQAPEIVRT-G-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPEDD------------ 288 (681)
T ss_dssp --SCCCCCTTTSCTTHHHH-C-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTTC------------
T ss_pred --CccCCCccccCHHHHcC-C-CCCceehhhhHHHHHHHHhCCCCCccccccc----------ccccc------------
Confidence 44579999999998863 3 4889999999999999999999886431110 00000
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
.....++.+.++|.+||+.||.+||+..+.+.|+|+.
T Consensus 289 --------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 289 --------------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --------------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0012357788999999999999999999999988874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=301.13 Aligned_cols=225 Identities=15% Similarity=0.072 Sum_probs=178.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++.+.||+|+||+||+|++..+++.||+|++....... ......+|+..+.++ +||||+++++++.+++..|+|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEE
Confidence 58999999999999999999999999999999997664432 234557899999888 899999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
|||++| +|.+.+.. + ..+.++..++.|++.||+|||++||+||||||+||+++ ++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 999985 66666643 2 46678899999999999999999999999999999996 5688887443
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
|++ .++.++|||||||++|+|++|..||.+.+..+.+.... .
T Consensus 175 -------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-----------------------~ 216 (286)
T 3uqc_A 175 -------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-----------------------R 216 (286)
T ss_dssp -------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-----------------------B
T ss_pred -------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-----------------------H
Confidence 333 26889999999999999999999998764421110000 0
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.............+.+++++.++|.+||+.||++| |++|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 00000011122335788999999999999999999 99999883
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=280.24 Aligned_cols=185 Identities=14% Similarity=0.062 Sum_probs=129.0
Q ss_pred eecccCceEEEEEEEccCCcEEEEEEccccccC---------HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 9 QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS---------WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 9 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
..+.|+.|.+..++....|+.|++|++...... .......+|+.+|+++..|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456788888888888888999999999654221 12234568999999998999999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCC
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPY 156 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~ 156 (346)
|||++| +|.+.+. .++++++. .|+.||+.||+|||++||+||||||+|||++ +|.+||+|||+|+..... ...
T Consensus 321 MEyv~G~~L~d~i~-~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 321 MEKLPGRLLSDMLA-AGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EECCCSEEHHHHHH-TTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred EecCCCCcHHHHHH-hCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 999997 5555555 45567765 4789999999999999999999999999995 569999999999876543 345
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPL 199 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 199 (346)
.+.+||+.|+|||++. +.+..++|+||+|++++++.++..+
T Consensus 397 ~t~vGTp~YmAPE~l~--g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 397 TNLVQSFFVFVNELFA--ENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred cCceechhhccHHHhC--CCCCCcccccccccchhhhccccch
Confidence 5678999999999985 4567889999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=233.48 Aligned_cols=183 Identities=16% Similarity=0.192 Sum_probs=138.2
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-------HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-------EECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
...+.||+|+||+||+| ...++.+++|......... ......+|+.+++++ +||||+++..++...+..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccE
Confidence 34568999999999999 4457888998864433221 123357899999999 7999996555555666679
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecccccccCCCCC-
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~~- 155 (346)
+||||++ |+|.+.+.. +..++.|+++||+|||++||+||||||+||++++ .+||+|||+|+.......
T Consensus 416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCHHHH
T ss_pred EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCcccc
Confidence 9999998 577766654 5689999999999999999999999999999988 999999999987765321
Q ss_pred -------CccccccCcccCcccccc-cCCCCChhhHHHHHHHHHHHHhCCCCC
Q 039371 156 -------YTEYITTLQYRAPEMLLM-SGQYNSKVDMWALGLIMAELITFHPLF 200 (346)
Q Consensus 156 -------~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf 200 (346)
.....||+.|+|||++.. ...|+..+|+||...-..+.+.++.+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 135689999999999863 134677889999998888888777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=195.76 Aligned_cols=143 Identities=22% Similarity=0.201 Sum_probs=111.6
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----------------HHhhhHHHHHHHHhhcCCCCeeee
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----------------EECLNLKEVKCLRKINNHPNIVKL 66 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~~e~~~l~~l~~hp~iv~~ 66 (346)
|++.+.||+|+||.||+|.+ .+|+.||+|+++...... ......+|+.+++++. | +++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~---~-~~v 166 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---G-LAV 166 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---T-SSS
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc---C-CCc
Confidence 45669999999999999999 889999999996433211 2344568999999995 4 555
Q ss_pred eeeeecCCEEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeecc
Q 039371 67 QELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFG 145 (346)
Q Consensus 67 ~~~~~~~~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg 145 (346)
.+++.. +..|+||||++| +|.+ +. ......++.|++.||.|||++||+||||||+||+++++.+||+|||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl~DFG 237 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFP 237 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEEEECC
Confidence 555544 446999999986 6655 31 1234579999999999999999999999999999997899999999
Q ss_pred cccccCCCCCCccccccCcccCccccc
Q 039371 146 LAWEVDSCPPYTEYITTLQYRAPEMLL 172 (346)
Q Consensus 146 ~a~~~~~~~~~~~~~~t~~y~aPE~~~ 172 (346)
+|.. +..+.|||.+.
T Consensus 238 ~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE------------VGEEGWREILE 252 (282)
T ss_dssp TCEE------------TTSTTHHHHHH
T ss_pred CCeE------------CCCCCHHHHHH
Confidence 9853 34578899774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=175.76 Aligned_cols=137 Identities=16% Similarity=0.221 Sum_probs=105.0
Q ss_pred eeeeeeecccCceEEEEEEEccCCcE--EEEEEccccccCH-----------------------HHhhhHHHHHHHHhhc
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEY--VAIKALKQRIYSW-----------------------EECLNLKEVKCLRKIN 58 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~ 58 (346)
|++.+.||+|+||.||+|.+..+|+. ||+|+++...... ......+|...+.++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA- 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-
Confidence 78899999999999999998778999 9999975432111 112356789999888
Q ss_pred CCCCe--eeeeeeeecCCEEEEEEEcCC--C----CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCC
Q 039371 59 NHPNI--VKLQELASENYRLYFVFEYMD--C----NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH-RQGYFHRDLIS 129 (346)
Q Consensus 59 ~hp~i--v~~~~~~~~~~~~~iv~e~~~--g----~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~ivH~dikp 129 (346)
.|+++ +.+++. +..++||||++ | .+.+.... .++..+..++.|++.||.+|| +.||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 46653 333332 24589999995 2 44444322 345678899999999999999 99999999999
Q ss_pred CCEEEeCCcEEEeeccccccc
Q 039371 130 KNLLVSNDTIKIADFGLAWEV 150 (346)
Q Consensus 130 ~NIli~~~~vkl~Dfg~a~~~ 150 (346)
+|||+++ .++|+|||+|...
T Consensus 200 ~NILl~~-~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID-KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS-SEEECCCTTCEET
T ss_pred HHEEEcC-cEEEEECcccccC
Confidence 9999988 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.6e-19 Score=158.66 Aligned_cols=138 Identities=16% Similarity=0.224 Sum_probs=94.2
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH---------------HH------hhhHHHHHHHHhhcCCCC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW---------------EE------CLNLKEVKCLRKINNHPN 62 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------~~------~~~~~e~~~l~~l~~hp~ 62 (346)
|++.++||+|++|.||+|.+. +|+.||+|+++...... .. ....+|...+.++ .+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence 899999999999999999875 68999999975332110 00 0112355556665 2333
Q ss_pred eeeeeeeeecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCC-----
Q 039371 63 IVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND----- 137 (346)
Q Consensus 63 iv~~~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~----- 137 (346)
+....-+.... .+|||||++|..+..+ ...+....++.|++.+|.+||+.|||||||||.|||++++
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQV------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGC------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhh------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 32211111122 2799999997443222 1223456789999999999999999999999999999543
Q ss_pred ------cEEEeecccccccC
Q 039371 138 ------TIKIADFGLAWEVD 151 (346)
Q Consensus 138 ------~vkl~Dfg~a~~~~ 151 (346)
.+.|+||+-+....
T Consensus 247 ~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECCCTTCEETT
T ss_pred ccccccceEEEEeCCcccCC
Confidence 38999999775543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-13 Score=119.39 Aligned_cols=138 Identities=17% Similarity=0.157 Sum_probs=108.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+.|++...++.|+.+.||++... +..+++|+....... ......+|..+++.+.++..+++++++..+.+..|+|||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 57889999999999999999643 678999998653211 122456799999998667888899999998899999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR------------------------------------------ 119 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~------------------------------------------ 119 (346)
+++|..+.... .+......++.++.++|..||+
T Consensus 91 ~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 91 EADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred ecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 99985443331 1223345788999999999998
Q ss_pred -----------------CCccccCCCCCCEEEeCCcE-EEeecccc
Q 039371 120 -----------------QGYFHRDLISKNLLVSNDTI-KIADFGLA 147 (346)
Q Consensus 120 -----------------~~ivH~dikp~NIli~~~~v-kl~Dfg~a 147 (346)
..++|+|++|.||+++++.+ .|+||+.+
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 44899999999999988765 59999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=5.1e-12 Score=108.52 Aligned_cols=132 Identities=14% Similarity=0.073 Sum_probs=94.0
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCC-eeeeeeeeecCCEEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN-IVKLQELASENYRLYFVFE 81 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~-iv~~~~~~~~~~~~~iv~e 81 (346)
.|.+....+.|..+.||++.. .+|+.+++|+..... .....+|...++.+..+.- +++++.+..+++..++|||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 455544444666799999964 456779999976431 1234578888888865522 6678888888888999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------------
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG---------------------------------------- 121 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---------------------------------------- 121 (346)
+++|..+. ... .+ ...++.+++..|..||+..
T Consensus 96 ~i~G~~l~-~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 96 EVPGQDLL-SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CCSSEETT-TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred ecCCcccC-cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 99984433 111 12 2356677777777777643
Q ss_pred ------------------ccccCCCCCCEEEeCCcE-EEeecccc
Q 039371 122 ------------------YFHRDLISKNLLVSNDTI-KIADFGLA 147 (346)
Q Consensus 122 ------------------ivH~dikp~NIli~~~~v-kl~Dfg~a 147 (346)
++|+|++|.||+++++.+ .|+||+.+
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 999999999999988765 59999976
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=4.1e-11 Score=108.03 Aligned_cols=141 Identities=14% Similarity=0.193 Sum_probs=101.3
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEcc--ccccCHHHhhhHHHHHHHHhhcC-CCCeeeeeeeeecC---CEEEE
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK--QRIYSWEECLNLKEVKCLRKINN-HPNIVKLQELASEN---YRLYF 78 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~e~~~l~~l~~-hp~iv~~~~~~~~~---~~~~i 78 (346)
.-++.++.|.++.||++... +..+++|+.. ............+|..+++.+.. +..+++++.++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678999999999999754 4678888876 33222223345678888888853 34578888887766 45799
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR--------------------------------------- 119 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~--------------------------------------- 119 (346)
|||+++|..... .....+++.+...++.+++..|..||+
T Consensus 119 vme~v~G~~l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999999843311 111237788899999999999999997
Q ss_pred -------------------CCccccCCCCCCEEEeCC--c-EEEeecccccc
Q 039371 120 -------------------QGYFHRDLISKNLLVSND--T-IKIADFGLAWE 149 (346)
Q Consensus 120 -------------------~~ivH~dikp~NIli~~~--~-vkl~Dfg~a~~ 149 (346)
..++|+|++|.||+++++ . +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 358999999999999754 3 68999998854
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.5e-10 Score=101.82 Aligned_cols=180 Identities=18% Similarity=0.168 Sum_probs=116.6
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCC--eeeeeeeeecCC---EEEEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN--IVKLQELASENY---RLYFVFE 81 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~--iv~~~~~~~~~~---~~~iv~e 81 (346)
++.++.|..+.||++. ..+++|+.... .......+|...++.+..+.. +++++.....++ ..|+||+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4668999999999973 45888986533 233445678888888754433 344444433332 3488999
Q ss_pred cCCCC-HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 039371 82 YMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR----------------------------------------- 119 (346)
Q Consensus 82 ~~~g~-l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~----------------------------------------- 119 (346)
+++|. +..... ..++..+...++.|++..+..||+
T Consensus 97 ~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 97 KIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred ccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99984 322222 127788888888999988888886
Q ss_pred -----------------CCccccCCCCCCEEEeC--C-cEEEeecccccccCCCCCCccccccCcc---cCccccc----
Q 039371 120 -----------------QGYFHRDLISKNLLVSN--D-TIKIADFGLAWEVDSCPPYTEYITTLQY---RAPEMLL---- 172 (346)
Q Consensus 120 -----------------~~ivH~dikp~NIli~~--~-~vkl~Dfg~a~~~~~~~~~~~~~~t~~y---~aPE~~~---- 172 (346)
..++|+|++|.||++++ + .+.++||+.+...+.... ....... ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHHH
Confidence 13699999999999976 4 578999998865432111 0011111 2232211
Q ss_pred ccCC---------CCChhhHHHHHHHHHHHHhCCCCC
Q 039371 173 MSGQ---------YNSKVDMWALGLIMAELITFHPLF 200 (346)
Q Consensus 173 ~~~~---------~~~~~DiwslG~il~~ll~g~~pf 200 (346)
.-+. ...-.+.|++|.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000 112368999999999999998766
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=9.6e-08 Score=82.24 Aligned_cols=131 Identities=12% Similarity=0.071 Sum_probs=89.5
Q ss_pred eecccCce-EEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCCCH
Q 039371 9 QIGEGSFG-KVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDCNL 87 (346)
Q Consensus 9 ~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g~l 87 (346)
.+..|..+ .||+.....++..+++|+-... ......+|...++.+..+-.+.+++.+.++++..++|||+++|..
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34445544 6999887777888999986533 223345788888888665557888888888899999999999843
Q ss_pred HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q 039371 88 HQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ----------------------------------------------- 120 (346)
Q Consensus 88 ~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~----------------------------------------------- 120 (346)
....... .......+..++...|..||+.
T Consensus 107 ~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 107 AFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 3322211 1112233444555555555531
Q ss_pred -----------CccccCCCCCCEEEeCCcE-EEeecccc
Q 039371 121 -----------GYFHRDLISKNLLVSNDTI-KIADFGLA 147 (346)
Q Consensus 121 -----------~ivH~dikp~NIli~~~~v-kl~Dfg~a 147 (346)
.++|+|+.+.||+++++.+ -|+||+.+
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a 221 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence 1689999999999988765 59999877
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=2.9e-07 Score=80.82 Aligned_cols=134 Identities=16% Similarity=0.133 Sum_probs=89.4
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC-C-Ceeeeeeeee-cCCEEEEEEEcC
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH-P-NIVKLQELAS-ENYRLYFVFEYM 83 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h-p-~iv~~~~~~~-~~~~~~iv~e~~ 83 (346)
++.++.|....||+. +..+++|+.... .......+|..+++.+..+ + .+.+++.+.. ..+..+++||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 467888888899998 466888885321 2234456899999998644 2 3555665553 456678999999
Q ss_pred CCCHHHH-HhcccCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 039371 84 DCNLHQL-MSNRKQCFSEAEVKNWCFQILQGLNYMHRQ------------------------------------------ 120 (346)
Q Consensus 84 ~g~l~~~-~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~------------------------------------------ 120 (346)
+|..... ... .++..+...+..++...|..||+.
T Consensus 96 ~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 96 QGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 9843322 111 145555555555555555555542
Q ss_pred ------------------CccccCCCCCCEEEeC----CcE-EEeecccccccC
Q 039371 121 ------------------GYFHRDLISKNLLVSN----DTI-KIADFGLAWEVD 151 (346)
Q Consensus 121 ------------------~ivH~dikp~NIli~~----~~v-kl~Dfg~a~~~~ 151 (346)
.++|+|++|.||++++ +.+ .|+||+.+...+
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3589999999999976 565 899999875543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=3.9e-07 Score=83.07 Aligned_cols=78 Identities=15% Similarity=0.142 Sum_probs=47.8
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEcccccc--C----HHHhhhHHHHHHHHhhcCC-C-CeeeeeeeeecCCEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--S----WEECLNLKEVKCLRKINNH-P-NIVKLQELASENYRLY 77 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~----~~~~~~~~e~~~l~~l~~h-p-~iv~~~~~~~~~~~~~ 77 (346)
-.+.+|.|..+.||++....+++.+++|....... . ....+...|..++..+... | .+++++.+. .+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccE
Confidence 36789999999999997666678899998643211 0 0112335688888777443 3 344555442 33357
Q ss_pred EEEEcCCC
Q 039371 78 FVFEYMDC 85 (346)
Q Consensus 78 iv~e~~~g 85 (346)
+|||+++|
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999986
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=8.6e-07 Score=79.47 Aligned_cols=80 Identities=6% Similarity=0.123 Sum_probs=51.9
Q ss_pred eeeee-cccCceEEEEEEEc--c----CCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCC--CCeeeeeeeeecC-
Q 039371 6 LMKQI-GEGSFGKVWQAIKK--Q----SGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNH--PNIVKLQELASEN- 73 (346)
Q Consensus 6 ~~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h--p~iv~~~~~~~~~- 73 (346)
..+.| +.|....+|+.... . ++..+++|+...... ........+|..+++.+..+ -.+.+++.+..++
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 45677 88888999998653 1 156788998754320 00012345677777777544 3567777776554
Q ss_pred --CEEEEEEEcCCC
Q 039371 74 --YRLYFVFEYMDC 85 (346)
Q Consensus 74 --~~~~iv~e~~~g 85 (346)
+..++|||+++|
T Consensus 104 ~~g~~~~v~e~l~G 117 (357)
T 3ats_A 104 VLGTPFFLMDYVEG 117 (357)
T ss_dssp TTSSCEEEEECCCC
T ss_pred ccCCceEEEEecCC
Confidence 356899999987
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.15 E-value=1e-05 Score=70.71 Aligned_cols=136 Identities=13% Similarity=0.117 Sum_probs=74.5
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcC
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
+.-++.|+.|....+|++ ..+++|+...... ......+|...++.+..+.-..+++....+. -++++|++
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~--~~~v~e~i 89 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHVDPAT--GVMVTRYI 89 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEECTTT--CCEEEECC
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEEECCC--CEEEEeec
Confidence 334788999999999999 4478898754311 1112235776666664333235555554333 36899999
Q ss_pred -CCCHH---HH----------------HhcccCCC----C-HHHHHHHHHH--------------HHHHHHHH----HH-
Q 039371 84 -DCNLH---QL----------------MSNRKQCF----S-EAEVKNWCFQ--------------ILQGLNYM----HR- 119 (346)
Q Consensus 84 -~g~l~---~~----------------~~~~~~~l----~-~~~~~~i~~q--------------l~~~l~~L----H~- 119 (346)
+|... +. +......+ . ...+..+..+ +...+..+ ..
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 66211 00 01111001 0 1111111111 11111111 11
Q ss_pred ---CCccccCCCCCCEEEeCCcEEEeecccccc
Q 039371 120 ---QGYFHRDLISKNLLVSNDTIKIADFGLAWE 149 (346)
Q Consensus 120 ---~~ivH~dikp~NIli~~~~vkl~Dfg~a~~ 149 (346)
..++|+|+.|.||+.+++.+.++||..+..
T Consensus 170 ~~~~~l~HgDl~~~Nil~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFLDTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCCEEECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred CCCceeeccCCCcCCEEECCCCEEEEecccccC
Confidence 138999999999998778999999987754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=2e-05 Score=69.89 Aligned_cols=28 Identities=25% Similarity=0.372 Sum_probs=24.9
Q ss_pred CCccccCCCCCCEEEe-CCcEEEeecccc
Q 039371 120 QGYFHRDLISKNLLVS-NDTIKIADFGLA 147 (346)
Q Consensus 120 ~~ivH~dikp~NIli~-~~~vkl~Dfg~a 147 (346)
.+++|+|+++.||+++ ++.+.++||+.+
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 5799999999999995 568999999876
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.03 E-value=1.5e-05 Score=73.05 Aligned_cols=77 Identities=16% Similarity=0.111 Sum_probs=44.5
Q ss_pred HCCccccCCCCCCEEEeCCcEEEeecccccccCCCCCCccccc--cCcccCcccccccCC--CCChhhHHHHHHHHHHHH
Q 039371 119 RQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYIT--TLQYRAPEMLLMSGQ--YNSKVDMWALGLIMAELI 194 (346)
Q Consensus 119 ~~~ivH~dikp~NIli~~~~vkl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll 194 (346)
...++|||++|.||+++++.+.++||+.+.............. ...|++|+....... -....++.+....+|+.+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDSTQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CCEEECSCCSGGGEEECSSCEEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCCCEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 4579999999999999877799999998855432111111111 123555553321110 111244456677777666
Q ss_pred h
Q 039371 195 T 195 (346)
Q Consensus 195 ~ 195 (346)
.
T Consensus 311 ~ 311 (420)
T 2pyw_A 311 N 311 (420)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.03 E-value=6.7e-05 Score=61.13 Aligned_cols=99 Identities=16% Similarity=0.156 Sum_probs=64.2
Q ss_pred CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEE-eCCcEEEeecccccccCCCCCCccccccC
Q 039371 86 NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTL 163 (346)
Q Consensus 86 ~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli-~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~ 163 (346)
+|.+.+...+.+++|++++.++.|.+.+|.-+-. +.-..+=+.|..|++ .+|.|.+.+ +.+. ....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP 101 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence 6888898889999999999999999999877632 221233345678888 456776653 1110 1223
Q ss_pred cccCcccccccCCCCChhhHHHHHHHHHHHHhCCC
Q 039371 164 QYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHP 198 (346)
Q Consensus 164 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 198 (346)
.+.|||... ...+.+.=|||||+++|.-+-...
T Consensus 102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----CCSS--SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCC
Confidence 566888652 345678899999999999886443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.91 E-value=8.8e-05 Score=64.94 Aligned_cols=75 Identities=11% Similarity=0.178 Sum_probs=56.2
Q ss_pred eeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC--CCeeeeeeeeecCCEEEEEEEcC
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH--PNIVKLQELASENYRLYFVFEYM 83 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h--p~iv~~~~~~~~~~~~~iv~e~~ 83 (346)
-.+.|+.|....+|+... ++..+++|+.... .......|...++.+... ..+++++......+..++|||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 457889999999999964 4667888987643 133345787778777533 56888888887778899999999
Q ss_pred CCC
Q 039371 84 DCN 86 (346)
Q Consensus 84 ~g~ 86 (346)
+|.
T Consensus 114 ~G~ 116 (312)
T 3jr1_A 114 NKS 116 (312)
T ss_dssp CCC
T ss_pred cCC
Confidence 873
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00019 Score=64.62 Aligned_cols=136 Identities=11% Similarity=0.111 Sum_probs=79.6
Q ss_pred eeeecccCceEEEEEEEcc-------CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQ-------SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++.+..|-...+|++.... +++.+++|+....... .....+|..+++.+..+.-.+++++.+.++ +|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~--~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG--VDSLVLESVMFAILAERSLGPQLYGVFPEG----RL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC--HHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch--HHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cE
Confidence 4567778888899997642 3578999986332111 223347888888776555456777766542 89
Q ss_pred EEcCCCCHH-----------HHH-------hccc----CCC--CHHHHHHHHHHHHH-------------------HHHH
Q 039371 80 FEYMDCNLH-----------QLM-------SNRK----QCF--SEAEVKNWCFQILQ-------------------GLNY 116 (346)
Q Consensus 80 ~e~~~g~l~-----------~~~-------~~~~----~~l--~~~~~~~i~~ql~~-------------------~l~~ 116 (346)
||+++|..+ ..+ .... ... -..++.++..++.. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 999987211 011 1111 111 23566666655432 2233
Q ss_pred HH----HC----CccccCCCCCCEEEeC-----CcEEEeeccccc
Q 039371 117 MH----RQ----GYFHRDLISKNLLVSN-----DTIKIADFGLAW 148 (346)
Q Consensus 117 LH----~~----~ivH~dikp~NIli~~-----~~vkl~Dfg~a~ 148 (346)
|. +. .++|+|+.+.||++++ +.+.++||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 32 22 4899999999999965 489999998773
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00025 Score=63.68 Aligned_cols=73 Identities=12% Similarity=0.082 Sum_probs=42.7
Q ss_pred eeeecccCceEEEEEEEccC--------CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQS--------GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++.++.|....+|++....+ ++.+++|+....... ......|..+++.+..+.-.+++++.+. + ++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~--~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTFN--G--GR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEET--T--EE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEecC--C--cE
Confidence 56778888889999976531 367889987543211 1112467777777754433446665442 2 68
Q ss_pred EEEcCCC
Q 039371 79 VFEYMDC 85 (346)
Q Consensus 79 v~e~~~g 85 (346)
|||+++|
T Consensus 112 v~e~i~G 118 (369)
T 3c5i_A 112 IEEWLYG 118 (369)
T ss_dssp EEECCCS
T ss_pred EEEEecC
Confidence 9999987
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00048 Score=63.16 Aligned_cols=73 Identities=14% Similarity=0.060 Sum_probs=48.9
Q ss_pred eeeeecccCceEEEEEEEcc-------CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQ-------SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
-++.|+.|....+|++.... +++.+++|+..... . ......|..++..+..+.-.+++++.+.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 35678888889999997653 25788999884321 1 12234688888877655444667766553 28
Q ss_pred EEEcCCC
Q 039371 79 VFEYMDC 85 (346)
Q Consensus 79 v~e~~~g 85 (346)
|+|+++|
T Consensus 150 v~e~l~G 156 (429)
T 1nw1_A 150 LEEYIPS 156 (429)
T ss_dssp EECCCCE
T ss_pred EEEEeCC
Confidence 9999986
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.0022 Score=56.18 Aligned_cols=137 Identities=15% Similarity=0.110 Sum_probs=72.8
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCC-Ceeeeeee------eecCCEEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP-NIVKLQEL------ASENYRLYFV 79 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp-~iv~~~~~------~~~~~~~~iv 79 (346)
++.|+.|....+|++... +| .+++|+....... .....|..++..+..+. .+++++.. ...++..+++
T Consensus 27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 566778888999999654 33 5889988653111 12234666666554321 13333321 1234567899
Q ss_pred EEcCCCCHH-----H----------HHhcc--c--CC----CCHHHHHH---------------HHHHHHHHHHHHHH--
Q 039371 80 FEYMDCNLH-----Q----------LMSNR--K--QC----FSEAEVKN---------------WCFQILQGLNYMHR-- 119 (346)
Q Consensus 80 ~e~~~g~l~-----~----------~~~~~--~--~~----l~~~~~~~---------------i~~ql~~~l~~LH~-- 119 (346)
+++++|... . .+... . .+ .....-.. +...+...++.+.+
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999987310 0 01110 0 00 01000000 00113344555552
Q ss_pred -----CCccccCCCCCCEEEeCCcE-EEeeccccc
Q 039371 120 -----QGYFHRDLISKNLLVSNDTI-KIADFGLAW 148 (346)
Q Consensus 120 -----~~ivH~dikp~NIli~~~~v-kl~Dfg~a~ 148 (346)
.+++|+|+.+.||+++++.+ .++||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 36999999999999988766 799998763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0028 Score=54.57 Aligned_cols=76 Identities=13% Similarity=0.126 Sum_probs=49.8
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCC--CeeeeeeeeecCCEEEEEEE
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP--NIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp--~iv~~~~~~~~~~~~~iv~e 81 (346)
..-++.+|.|..+.||+.+. .+|+.|.+|+....... .......|...|+.+.... .+++++.. ++ -+++||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e 90 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAME 90 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEE
Confidence 45578899999999999975 46788999987543322 1122346888888775432 24444443 22 268999
Q ss_pred cCCC
Q 039371 82 YMDC 85 (346)
Q Consensus 82 ~~~g 85 (346)
++.+
T Consensus 91 ~l~~ 94 (288)
T 3f7w_A 91 WVDE 94 (288)
T ss_dssp CCCC
T ss_pred eecc
Confidence 9874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0007 Score=59.73 Aligned_cols=31 Identities=29% Similarity=0.305 Sum_probs=26.3
Q ss_pred CCccccCCCCCCEEEeC-----CcEEEeeccccccc
Q 039371 120 QGYFHRDLISKNLLVSN-----DTIKIADFGLAWEV 150 (346)
Q Consensus 120 ~~ivH~dikp~NIli~~-----~~vkl~Dfg~a~~~ 150 (346)
..++|||+.+.||+++. +.+.++||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 46999999999999965 57999999987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0035 Score=54.94 Aligned_cols=74 Identities=11% Similarity=0.120 Sum_probs=44.1
Q ss_pred eeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCC-Ceeeeeee-----eecCCEEEEEEE
Q 039371 8 KQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP-NIVKLQEL-----ASENYRLYFVFE 81 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp-~iv~~~~~-----~~~~~~~~iv~e 81 (346)
..++ |....||++.. .+|+.+++|+......... ....|..++..+..+. .+++++.. ...++..+++|+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~--~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTAD--QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHH--HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHH--HHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 4566 77789998854 3466789999864322222 2334666666664321 23444432 223456789999
Q ss_pred cCCC
Q 039371 82 YMDC 85 (346)
Q Consensus 82 ~~~g 85 (346)
+++|
T Consensus 108 ~i~G 111 (328)
T 1zyl_A 108 SVGG 111 (328)
T ss_dssp CCCC
T ss_pred ecCC
Confidence 9987
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0046 Score=57.00 Aligned_cols=73 Identities=14% Similarity=0.028 Sum_probs=47.4
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
++.|+.|-...+|++....++..+++|+....... .....+|..++..+..+.-.+++++.+.. ..|+||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 56788888899999987644578889987432211 11124788888888655445677777642 259999987
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0079 Score=53.14 Aligned_cols=30 Identities=30% Similarity=0.398 Sum_probs=25.6
Q ss_pred CccccCCCCCCEEEeC-CcEEEeeccccccc
Q 039371 121 GYFHRDLISKNLLVSN-DTIKIADFGLAWEV 150 (346)
Q Consensus 121 ~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~ 150 (346)
.++|+|+.+.||++++ +.+.++||+.+...
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5899999999999974 58999999877543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.22 E-value=0.033 Score=50.68 Aligned_cols=74 Identities=12% Similarity=0.033 Sum_probs=47.6
Q ss_pred eeeeecccCceEEEEEEEccC-------CcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQS-------GEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
-++.+..|-...+|++..... ++.+++|+..... .......+|..+++.+..+.-.+++++.+. + +.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CE
Confidence 356777788889999976521 5778999874322 111122467777777765544556665443 2 68
Q ss_pred EEEcCCC
Q 039371 79 VFEYMDC 85 (346)
Q Consensus 79 v~e~~~g 85 (346)
|+|+++|
T Consensus 148 I~efI~G 154 (424)
T 3mes_A 148 IEEFIDG 154 (424)
T ss_dssp EEECCCS
T ss_pred EEEEeCC
Confidence 9999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.37 E-value=0.073 Score=48.06 Aligned_cols=27 Identities=22% Similarity=0.435 Sum_probs=22.8
Q ss_pred ccccCCCCCCEEEe-------CCcEEEeeccccc
Q 039371 122 YFHRDLISKNLLVS-------NDTIKIADFGLAW 148 (346)
Q Consensus 122 ivH~dikp~NIli~-------~~~vkl~Dfg~a~ 148 (346)
++|+|+.+.||++. ++.+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 68999999999993 2379999998874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 346 | ||||
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-71 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-71 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-70 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-70 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-70 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-69 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-66 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-66 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-66 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-66 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-65 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-65 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-65 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-65 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-65 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-62 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-59 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-56 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-54 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-54 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-53 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-21 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 2e-71
Identities = 99/286 (34%), Positives = 152/286 (53%), Gaps = 9/286 (3%)
Query: 6 LMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE----CLNLKEVKCLRKINNHP 61
+ +GEG F V++A K + + VAIK +K S + L+E+K L++++ HP
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HP 60
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
NI+ L + + VF++M+ +L ++ + + + +K + LQGL Y+H+
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 122 YFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSGQYNS 179
HRDL NLL+ + +K+ADFGLA S YT + T YRAPE+L + Y
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
VDMWA+G I+AEL+ P PG + DQL +I +G+PTEE W + L F
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV--TFK 238
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
G L + +A DD + LI+ L ++PC R TA +AL+ F
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 223 bits (569), Expect = 3e-71
Identities = 63/290 (21%), Positives = 125/290 (43%), Gaps = 33/290 (11%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
++ Y + +++G G+FG V + ++ +G A K + S +E + KE++ + + H
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVLR-H 82
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
P +V L + ++ + ++E+M L + +++ SE E + Q+ +GL +MH
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 120 QGYFHRDLISKNLLVSND---TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
Y H DL +N++ + +K+ DFGL +D T ++ APE+
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEGKP 201
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
DMW++G++ L++ F G +D+ L + + + + ++
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF------------ 249
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
++D I L DP R T +AL+HP
Sbjct: 250 --------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 2e-70
Identities = 98/304 (32%), Positives = 158/304 (51%), Gaps = 21/304 (6%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNI 63
YT K IG GSFG V+QA SGE VAIK + Q ++ +E++ +RK++ H NI
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLD-HCNI 75
Query: 64 VKLQEL------ASENYRLYFVFEYMDCNLHQLM---SNRKQCFSEAEVKNWCFQILQGL 114
V+L+ + L V +Y+ ++++ S KQ VK + +Q+ + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 115 NYMHRQGYFHRDLISKNLLVSNDT--IKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLL 172
Y+H G HRD+ +NLL+ DT +K+ DFG A ++ P YI + YRAPE++
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
+ Y S +D+W+ G ++AEL+ P+FPG DQL +I +G+PT E E
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM--NPN 253
Query: 233 AHGYKFPKLQGNNLS-LLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291
+KFP+++ + + + P + ++L L + P R T EA H F L+ P
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE-LRDP 312
Query: 292 SMSI 295
++ +
Sbjct: 313 NVKL 316
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 3e-70
Identities = 108/290 (37%), Positives = 169/290 (58%), Gaps = 6/290 (2%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINN 59
ME + +++IGEG++G V++A K +GE VA+K ++ + ++E+ L+++ N
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-N 59
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQILQGLNYMH 118
HPNIVKL ++ +LY VFE++ +L + M ++ +K++ FQ+LQGL + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSGQ 176
HRDL +NLL++ + IK+ADFGLA YT + TL YRAPE+LL
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
Y++ VD+W+LG I AE++T LFPG E DQL++I +G+P E W + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD-YKP 238
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
FPK + S ++P ++D SL+ + +DP KR +A AL HP FQ
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 220 bits (561), Expect = 5e-70
Identities = 65/317 (20%), Positives = 134/317 (42%), Gaps = 38/317 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ Y +++++G G+FG V + ++K +G K + + + E+ + +++ HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQLH-HP 86
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
++ L + + Y + + E++ L ++ SEAEV N+ Q +GL +MH
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 121 GYFHRDLISKNLLVSND---TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
H D+ +N++ ++KI DFGLA +++ T ++ APE+ +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI-VDREPV 205
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
DMWA+G++ L++ F G + + L + E+++
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------- 252
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL-----QVPS 292
S + + I+ L +P KR T +AL+HP +G ++PS
Sbjct: 253 -------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299
Query: 293 MSIDSCKMRLTPSAKKS 309
+ + ++
Sbjct: 300 SRYNKIRQKIKEKYADW 316
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-69
Identities = 94/302 (31%), Positives = 148/302 (49%), Gaps = 18/302 (5%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINN 59
+ KY + +IG+G+FG+V++A +++G+ VA+K + + L+E+K L+ +
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK- 67
Query: 60 HPNIVKLQELASE--------NYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQIL 111
H N+V L E+ +Y VF++ + +L L+SN F+ +E+K +L
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-----CPPYTEYITTLQY 165
GL Y+HR HRD+ + N+L++ D +K+ADFGLA YT + TL Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 166 RAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225
R PE+LL Y +D+W G IMAE+ T P+ G E QL I GS T E W
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 226 EGLELAKAHGYKFPKLQGNNLSLLIPSANDDE--MSLIELLCSWDPCKRPTAAEALQHPL 283
+ K Q + + + D + LI+ L DP +R + +AL H
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 284 FQ 285
F
Sbjct: 308 FW 309
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 8e-69
Identities = 58/302 (19%), Positives = 117/302 (38%), Gaps = 19/302 (6%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + + ++G G+ G V++ K SG +A K + I ++E++ L + N P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH-RQ 120
IV + + E+MD + + E + +++GL Y+ +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNS 179
HRD+ N+LV++ IK+ DFG++ ++ + ++ T Y +PE L Y+
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPER-LQGTHYSV 182
Query: 180 KVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
+ D+W++GL + E+ +P+ P ++ +L C G E Y
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 239 PKLQGNNLSLLI--------PSANDDEMS-----LIELLCSWDPCKRPTAAEALQHPLFQ 285
+ L+ P S + +P +R + + H +
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 286 GC 287
Sbjct: 303 RS 304
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 214 bits (545), Expect = 2e-68
Identities = 97/288 (33%), Positives = 162/288 (56%), Gaps = 6/288 (2%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINN 59
MEKY +++IGEG++G V++A GE A+K ++ ++ ++E+ L+++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK- 58
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
H NIVKL ++ RL VFE++D +L +L+ + K++ Q+L G+ Y H
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS-CPPYTEYITTLQYRAPEMLLMSGQY 177
+ HRDL +NLL++ + +KIADFGLA YT I TL YRAP++L+ S +Y
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
++ +D+W++G I AE++ PLFPG E DQL +I +G+P ++W EL K +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPN 237
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
F + + ++ + L+ + DP +R TA +AL+H F+
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 3e-68
Identities = 67/298 (22%), Positives = 127/298 (42%), Gaps = 34/298 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
EKY + + +G G FG V + ++ S + K +K + ++ L KE+ L H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR-HR 61
Query: 62 NIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NI+ L E L +FE++ ++ + ++ +E E+ ++ Q+ + L ++H
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 121 GYFHRDLISKNLLVSND---TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
H D+ +N++ TIKI +FG A ++ + T +Y APE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH-QHDVV 180
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
++ DMW+LG ++ L++ F + I NA + EE++
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF------------- 227
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSI 295
+ + M ++ L + R TA+EALQHP + ++ S +
Sbjct: 228 -------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (535), Expect = 1e-66
Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 37/289 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINN 59
+ ++ +++IG GSFG V+ A ++ E VAIK + E +KEV+ L+K+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR- 73
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
HPN ++ + + + V EY + L+ K+ E E+ LQGL Y+H
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMS--GQ 176
HRD+ + N+L+S +K+ DFG A P ++ T + APE++L GQ
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
Y+ KVD+W+LG+ EL P LY I
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------------------- 229
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ P LQ + S + + ++ P RPT+ L+H
Sbjct: 230 ESPALQSGHWS-------EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 208 bits (529), Expect = 3e-66
Identities = 82/299 (27%), Positives = 125/299 (41%), Gaps = 42/299 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--------LKEVKC 53
E Y + +G G V + I K + + A+K + LKEV
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 54 LRKINNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQ 112
LRK++ HPNI++L++ N + VF+ M L + K SE E + +L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLE 121
Query: 113 GLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEML 171
+ +H+ HRDL +N+L+ +D IK+ DFG + ++D E T Y APE++
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 172 LMS-----GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226
S Y +VDMW+ G+IM L+ P F + L I +
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG----------- 230
Query: 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
Y+F + ++ S D L+ P KR TA EAL HP FQ
Sbjct: 231 --------NYQFGSPEWDDYS-------DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (532), Expect = 3e-66
Identities = 83/319 (26%), Positives = 127/319 (39%), Gaps = 34/319 (10%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ Y +G G+F +V A K++ + VAIK + ++ +E E+ L KI HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHP 67
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIV L ++ LY + + + L + K ++E + FQ+L + Y+H
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 121 GYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
G HRDL +NLL + I I+DFGL+ D + T Y AP +L
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP-EVLAQKP 185
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
Y+ VD W++G+I L+ +P F + +I A W
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW------------ 233
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSID 296
+D I L DP KR T +ALQHP G +
Sbjct: 234 --------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQ 279
Query: 297 SCKMRLTPSAKKSGWKAKL 315
S ++ + KS WK
Sbjct: 280 SVSEQIKKNFAKSKWKQAF 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 4e-66
Identities = 99/309 (32%), Positives = 160/309 (51%), Gaps = 23/309 (7%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-KKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKIN- 58
++Y + +IGEG++GKV++A K G +VA+K ++ + L+ ++EV LR +
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 59 -NHPNIVKLQELAS-----ENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQIL 111
HPN+V+L ++ + +L VFE++D L + +K+ FQ+L
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 112 QGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170
+GL+++H HRDL +N+LV S+ IK+ADFGLA T + TL YRAP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP-E 185
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
+L+ Y + VD+W++G I AE+ PLF G+ + DQL KI + IG P EE W + L
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290
+ F + + ++ L+ +++P KR +A AL HP FQ
Sbjct: 246 PR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ----- 297
Query: 291 PSMSIDSCK 299
++ CK
Sbjct: 298 ---DLERCK 303
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-65
Identities = 92/295 (31%), Positives = 149/295 (50%), Gaps = 14/295 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+YT + IGEG++G V A + VAIK + + L+E+K L + H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HE 66
Query: 62 NIVKLQELASENY-----RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
NI+ + ++ +Y V M +L++L+ + Q S + + +QIL+GL Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRGLKY 124
Query: 117 MHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS----CPPYTEYITTLQYRAPEML 171
+H HRDL NLL++ +KI DFGLA D TEY+ T YRAPE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
L S Y +D+W++G I+AE+++ P+FPG DQL I +GSP++E + L
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 232 KAHG-YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ P + L P+A+ + L++ + +++P KR +AL HP +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-65
Identities = 70/298 (23%), Positives = 126/298 (42%), Gaps = 38/298 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ + ++ ++G+G+FGKV++A K++ A K + + E + E+ L + HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY-MVEIDILASCD-HP 69
Query: 62 NIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
NIVKL + L+ + E+ + +M ++ +E++++ C Q L LNY+H
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLA-WEVDSCPPYTEYITTLQYRAPEMLL----MS 174
HRDL + N+L + D IK+ADFG++ + +I T + APE+++
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
Y+ K D+W+LG+ + E+ P L KI
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---------------------- 227
Query: 235 GYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291
+ +L PS ++ + R T ++ LQHP P
Sbjct: 228 ------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-65
Identities = 71/289 (24%), Positives = 118/289 (40%), Gaps = 36/289 (12%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKIN 58
+E + + + +G+G FG V+ A +KQS +A+K L + + +EV+ +
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
HPNI++L + R+Y + EY + F E + ++ L+Y H
Sbjct: 65 -HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
+ HRD+ +NLL+ + +KIADFG + S T TL Y PEM+ +
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMI-EGRMH 181
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
+ KVD+W+LG++ E + P F + +I +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------------EFT 222
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
FP + LI L +P +RP E L+HP
Sbjct: 223 FP-----------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-65
Identities = 70/295 (23%), Positives = 127/295 (43%), Gaps = 33/295 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+KYT ++IG+G+ G V+ A+ +G+ VAI+ + + +E + + E+ +R+ +P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENK-NP 77
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
NIV + L+ V EY+ + C E ++ C + LQ L ++H
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 122 YFHRDLISKNLLVSND-TIKIADFGLAWEVDSC-PPYTEYITTLQYRAPEMLLMSGQYNS 179
HRD+ S N+L+ D ++K+ DFG ++ + + T + APE++ Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGP 195
Query: 180 KVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKFP 239
KVD+W+LG++ E+I P + LY I G+P ++
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNP--------------- 239
Query: 240 KLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMS 294
+ + D KR +A E LQH + + S++
Sbjct: 240 -----------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-65
Identities = 98/294 (33%), Positives = 155/294 (52%), Gaps = 14/294 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNH 60
Y ++ +G G++G V A+ ++G VAIK L + S +E++ L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RH 76
Query: 61 PNIVKL------QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
N++ L E + Y V +M +L +LM + K E ++ +Q+L+GL
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGL 134
Query: 115 NYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
Y+H G HRDL NL V+ D +KI DFGLA + DS T Y+ T YRAPE++L
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILN 192
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE-GLELAK 232
+Y VD+W++G IMAE+IT LF G+ DQL +I G+P E + AK
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
+ P+L+ + + ++ +A+ ++L+E + D +R TA EAL HP F+
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 206 bits (524), Expect = 7e-65
Identities = 72/300 (24%), Positives = 143/300 (47%), Gaps = 21/300 (7%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
+ Y L++++G G + +V++AI + E V +K LK ++ +E+K L +
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGG 89
Query: 61 PNIVKLQEL--ASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
PNI+ L ++ + VFE+++ + QL Q ++ +++ + ++IL+ L+Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYC 145
Query: 118 HRQGYFHRDLISKNLLVSND--TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSG 175
H G HRD+ N+++ ++ +++ D+GLA Y + + ++ PE+L+
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 176 QYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
Y+ +DMW+LG ++A +I P F G DQL +I +G+ + + +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 235 GYK--FPKLQGNNLSLLIPSANDDEMS-----LIELLCSWDPCKRPTAAEALQHPLFQGC 287
+ + + S N +S ++ L +D R TA EA++HP F
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (518), Expect = 2e-64
Identities = 99/289 (34%), Positives = 159/289 (55%), Gaps = 6/289 (2%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALK-QRIYSWEECLNLKEVKCLRKINN 59
M+KY +++IGEG++G V++A +++ E VA+K ++ L+E+ L+++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-K 59
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
H NIV+L ++ + +L VFE+ D +L + + VK++ FQ+L+GL + H
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 120 QGYFHRDLISKNLLV-SNDTIKIADFGLAWEVD-SCPPYTEYITTLQYRAPEMLLMSGQY 177
+ HRDL +NLL+ N +K+A+FGLA Y+ + TL YR P++L + Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 178 NSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
++ +DMW+ G I AEL PLFPG DDQL +I +G+PTEE W +L Y
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+L ++P N L++ L +P +R +A EALQHP F
Sbjct: 240 PMYPAT-TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-63
Identities = 80/308 (25%), Positives = 130/308 (42%), Gaps = 40/308 (12%)
Query: 1 MEKYTLMKQ-IGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINN 59
++ Y + Q +G G GKV Q K++ E A+K L+ + +EV+ + +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA------RREVELHWRASQ 63
Query: 60 HPNIVKL----QELASENYRLYFVFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQG 113
P+IV++ + L + L V E +D L + +R Q F+E E I +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 114 LNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPE 169
+ Y+H HRD+ +NLL + N +K+ DFG A E S T T Y APE
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183
Query: 170 MLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
+ L +Y+ DMW+LG+IM L+ +P F + I
Sbjct: 184 V-LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--------- 233
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289
Y+FP + + +S ++ LI L +P +R T E + HP +
Sbjct: 234 ------YEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
Query: 290 VPSMSIDS 297
VP + +
Sbjct: 281 VPQTPLHT 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-62
Identities = 60/288 (20%), Positives = 111/288 (38%), Gaps = 32/288 (11%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E + L++ +GEG++G+V A+ + + E VA+K + + KE+ + +N H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 63
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
N+VK E Y EY E + + + Q++ G+ Y+H G
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 122 YFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQY 177
HRD+ +NLL+ D +KI+DFGLA + TL Y APE+L +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
VD+W+ G+++ ++ + + Q Y +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--------------- 228
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ ++L+ + +P R T + + +
Sbjct: 229 ------------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-61
Identities = 98/293 (33%), Positives = 150/293 (51%), Gaps = 14/293 (4%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNH 60
E+Y + +G G++G V A ++G VA+K L + S +E++ L+ + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KH 76
Query: 61 PNIVKLQEL------ASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
N++ L ++ E +Y V M +L+ ++ + Q ++ V+ +QIL+GL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGL 134
Query: 115 NYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
Y+H HRDL NL V+ D +KI DFGLA D T Y+ T YRAPE++L
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLN 192
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGL-ELAK 232
YN VD+W++G IMAEL+T LFPGT DQL I +G+P E + E A+
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ ++ N + + AN + L+E + D KR TAA+AL H F
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-60
Identities = 68/291 (23%), Positives = 116/291 (39%), Gaps = 40/291 (13%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINNHPN 62
+IG GSF V++ + ++ VA L+ R + E K E + L+ + HPN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPN 69
Query: 63 IVKL----QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
IV+ + + V E M + R + +++WC QIL+GL ++H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 119 RQGY--FHRDLISKNLLVS--NDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMS 174
+ HRDL N+ ++ ++KI D GLA + I T ++ APEM
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMY--E 186
Query: 175 GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234
+Y+ VD++A G+ M E+ T + Q+Y+ + P
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD----------- 235
Query: 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ IP + +IE + +R + + L H FQ
Sbjct: 236 ------------KVAIPEVKE----IIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-59
Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 38/295 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-----LKEVKCLRK 56
+ Y +++G G F V + +K +G A K +K+R +EV L++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
I HPN++ L E+ + + E + K+ +E E + QIL G+ Y
Sbjct: 70 IQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 117 MHRQGYFHRDLISKNLLVSND-----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEML 171
+H H DL +N+++ + IKI DFGLA ++D + T ++ APE+
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI- 187
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
+ + DMW++G+I L++ F G + + L + +E ++ LA
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
K I L DP KR T ++LQHP +
Sbjct: 248 K--------------------------DFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-59
Identities = 75/296 (25%), Positives = 125/296 (42%), Gaps = 47/296 (15%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLNLKEVKCLRKINNH 60
E Y ++ IG GS+G+ + +K G+ + K L + E+ + + EV LR++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62
Query: 61 PNIVKLQE--LASENYRLYFVFEYMDC-NLHQLMSN---RKQCFSEAEVKNWCFQILQGL 114
PNIV+ + + N LY V EY + +L +++ +Q E V Q+ L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 115 NYMHRQGY-----FHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPY-TEYITTLQYRA 167
HR+ HRDL N+ + +K+ DFGLA ++ + ++ T Y +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227
PE + YN K D+W+LG ++ EL P F + + KI
Sbjct: 183 PEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG------------ 229
Query: 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQHP 282
KF + IP DE+ +I + + RP+ E L++P
Sbjct: 230 ---------KFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 7e-59
Identities = 74/297 (24%), Positives = 115/297 (38%), Gaps = 44/297 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINN 59
E + K +GEGSF V A + + AIK L++R E + +E + +++
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 66
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
HP VKL ++ +LYF Y + F E + + +I+ L Y+H
Sbjct: 67 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLA---WEVDSCPPYTEYITTLQYRAPEMLLMSG 175
+G HRDL +N+L++ D I+I DFG A ++ T QY +PE+L
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL-TEK 185
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
D+WALG I+ +L+ P F E KI E+ + + +L
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL----- 240
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEA------LQHPLFQG 286
+E L D KR E HP F+
Sbjct: 241 -------------------------VEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-58
Identities = 90/305 (29%), Positives = 139/305 (45%), Gaps = 25/305 (8%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINN 59
+++Y +K IG G+ G V A VAIK L + + +E+ ++ + N
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-N 74
Query: 60 HPNIVKL------QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQG 113
H NI+ L Q+ E +Y V E MD NL Q++ + + +Q+L G
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131
Query: 114 LNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLL 172
+ ++H G HRDL N++V +D T+KI DFGLA + T Y+ T YRAPE+ +
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-I 190
Query: 173 MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232
+ Y VD+W++G IM E++ LFPG DQ K+ +G+P E + +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 233 AHGYKFPKLQGNNLSLLIPSA------------NDDEMSLIELLCSWDPCKRPTAAEALQ 280
+ PK G L P + L+ + DP KR + +ALQ
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
Query: 281 HPLFQ 285
HP
Sbjct: 311 HPYIN 315
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-56
Identities = 67/288 (23%), Positives = 120/288 (41%), Gaps = 37/288 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLK-EVKCLRKINNH 60
+ T+ ++IG GSFG V++ VA+K L + ++ K EV LRK H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-H 63
Query: 61 PNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
NI+ ++ L V ++ + +L+ + + F ++ + Q QG++Y+H
Sbjct: 64 VNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT---TLQYRAPEMLLM-- 173
+ HRDL S N+ + D T+KI DFGLA ++ ++ + APE++ M
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
Y+ + D++A G+++ EL+T + DQ+ +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------------------- 223
Query: 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
GY P LS + + L+ +RP + L
Sbjct: 224 RGYLSPD-----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 181 bits (460), Expect = 7e-55
Identities = 68/296 (22%), Positives = 126/296 (42%), Gaps = 38/296 (12%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE----CLNLKEVKCLRK 56
M +++ + IG G FG+V+ K +G+ A+K L ++ ++ LN + + L
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
+ P IV + +L F+ + M+ ++ FSEA+++ + +I+ GL +
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 117 MHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSG 175
MH + +RDL N+L+ + ++I+D GLA + P+ + T Y APE+L
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGV 181
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
Y+S D ++LG ++ +L+ H F D+ +
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA---------------- 225
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQG 286
+ P S + + SL+E L D +R A E + P F+
Sbjct: 226 VELP-----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-54
Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 36/291 (12%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKIN 58
+E + L K +G+GSFGKV+ A K++ ++ AIKALK+ + ++ + + E + L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
HP + + L+FV EY++ F + + +I+ GL ++H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSC-PPYTEYITTLQYRAPEMLLMSGQ 176
+G +RDL N+L+ D IKIADFG+ E + T Y APE+LL +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL-GQK 179
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
YN VD W+ G+++ E++ F G E++ + I
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------------DNP 220
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA-EALQHPLFQG 286
+P+ L A D L+ L +P KR + QHPLF+
Sbjct: 221 FYPR----WLE---KEAKD----LLVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 5e-54
Identities = 59/293 (20%), Positives = 107/293 (36%), Gaps = 46/293 (15%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKAL-KQRIYSWEECLN----LKEVKCLRKI 57
+Y + +G G FG V+ I+ VAIK + K RI W E N EV L+K+
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 58 N-NHPNIVKLQELASENYRLYFVFEYMDCN-LHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
+ +++L + + E + + E +++ +Q+L+ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 116 YMHRQGYFHRDLISKNLLVSND--TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLM 173
+ H G HRD+ +N+L+ + +K+ DFG + YT++ T Y PE +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 174 SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
+ +W+LG+++ +++ F E +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ----------------------- 220
Query: 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286
F + + LI + P RPT E HP Q
Sbjct: 221 --VFFR-----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 177 bits (450), Expect = 7e-54
Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 42/294 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKIN 58
++ + +++ +G GSFG+V + +G Y A+K LK+ I + + E L +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
HP I+++ + +++ + +Y++ + + Q F K + ++ L Y+H
Sbjct: 63 -HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 119 RQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
+ +RDL +N+L+ N IKI DFG A V T Y APE+ + + Y
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEV-VSTKPY 178
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
N +D W+ G+++ E++ + F + KI NA +
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-------------------LR 219
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR-----PTAAEALQHPLFQG 286
FP P N+D L+ L + D +R + HP F+
Sbjct: 220 FP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-53
Identities = 72/294 (24%), Positives = 121/294 (41%), Gaps = 39/294 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKIN 58
M + +K +G+G+FGKV +K +G Y A+K L++ + ++ + + E + L+
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
HP + L+ + RL FV EY + +R++ F+E + + +I+ L Y+H
Sbjct: 64 -HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
+ +RD+ +NL++ D IKI DFGL E S + +L Y
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
VD W LG++M E++ F + I +
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------------------EEIR 223
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQG 286
FP+ LS P A L+ L DP +R A E ++H F
Sbjct: 224 FPR----TLS---PEAKS----LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 173 bits (440), Expect = 7e-53
Identities = 54/295 (18%), Positives = 103/295 (34%), Gaps = 39/295 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKINN 59
++Y L + +G G +V A + VA+K L+ + +E + +N
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN- 65
Query: 60 HPNIVKL----QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
HP IV + + Y V EY+D + + + + + Q LN
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 116 YMHRQGYFHRDLISKNLLVSND-----TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEM 170
+ H+ G HRD+ N+++S +A +S I T QY +PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
+++ D+++LG ++ E++T P F G Y+ P
Sbjct: 186 -ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285
+ D +++ + +P R A ++ L +
Sbjct: 239 --------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-50
Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 41/301 (13%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIK---KQSGEYVAIKALKQRIYSWEECLN---LKEVKCL 54
+E + L+K +G G++GKV+ K +G+ A+K LK+ + E + L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGL 114
I P +V L +L+ + +Y++ ++++ F+E EV+ + +I+ L
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 115 NYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCP--PYTEYITTLQYRAPEML 171
++H+ G +RD+ +N+L+ ++ + + DFGL+ E + ++ T++Y AP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 172 LMSGQ-YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
++ VD W+LG++M EL+T F E + +I I E L
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQ 285
AK LI+ L DP KR A E +H FQ
Sbjct: 263 AK--------------------------DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
Query: 286 G 286
Sbjct: 297 K 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-50
Identities = 64/287 (22%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH 60
M++ L++ IG+G FG V + G VA+K +K + L E + ++ H
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA---FLAEASVMTQLR-H 59
Query: 61 PNIVKLQE-LASENYRLYFVFEYMDCN--LHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
N+V+L + E LY V EYM + L S + + + + + + Y+
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 118 HRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
+ HRDL ++N+LVS D K++DFGL E S +++ APE L +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEA-LREKK 176
Query: 177 YNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
+++K D+W+ G+++ E+ +F +P D + ++ G
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--------------------G 216
Query: 236 YKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQH 281
YK P + +++ D RP+ + +
Sbjct: 217 YKMD----------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-50
Identities = 72/314 (22%), Positives = 133/314 (42%), Gaps = 64/314 (20%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE-----YVAIKALKQRIYSWEECLNLKEVKCLRK 56
E K +G G+FGKV A + VA+K LK++ S E + E+K + +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSE--------------- 100
+ +H NIV L + + +Y +FEY +L + ++++ FSE
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 101 -------AEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDS 152
++ + +Q+ +G+ ++ + HRDL ++N+LV++ +KI DFGLA ++ S
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 153 CPPYTEYIT---TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQ 208
Y +++ APE L G Y K D+W+ G+++ E+ + +PG D
Sbjct: 217 DSNYVVRGNARLPVKWMAPES-LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 209 LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSW 267
YK+ N + P +E+ +++ ++
Sbjct: 276 FYKLIQ-----------------------------NGFKMDQPFYATEEIYIIMQSCWAF 306
Query: 268 DPCKRPTAAEALQH 281
D KRP+
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (417), Expect = 3e-49
Identities = 51/298 (17%), Positives = 101/298 (33%), Gaps = 41/298 (13%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
+Y L ++IG GSFG ++ +GE VAIK + + E K + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMMQGGVG 64
Query: 63 IVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
I ++ +E V E + +L L + + FS V Q++ + Y+H + +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 123 FHRDLISKNLLVSND----TIKIADFGLAWEVDS--------CPPYTEYITTLQYRAPEM 170
HRD+ N L+ + I DFGLA + T +Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 171 LLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
+ + + + D+ +LG ++ + G + K E
Sbjct: 185 -HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----------------ER 227
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA---EALQHPLFQ 285
P + +L + + + S +P + + ++ +
Sbjct: 228 ISEKKMSTP------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-49
Identities = 57/285 (20%), Positives = 117/285 (41%), Gaps = 39/285 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ T +K++G G FG V + VAIK +K+ S +E + E K + ++ H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIE--EAKVMMNLS-HE 59
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
+V+L + ++ ++ + EYM L + + F ++ C + + + Y+ +
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPY--TEYITTLQYRAPEMLLMSGQY 177
+ HRDL ++N LV++ +K++DFGL+ V +++ PE+ LM ++
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV-LMYSKF 178
Query: 178 NSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
+SK D+WA G++M E+ + + + I + +E +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV-------- 230
Query: 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
+++ +RPT L +
Sbjct: 231 ---------------------YTIMYSCWHEKADERPTFKILLSN 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (411), Expect = 2e-48
Identities = 70/299 (23%), Positives = 132/299 (44%), Gaps = 41/299 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
T+ ++G G +G+V++ + K+ VA+K LK+ EE L E +++I HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK--EAAVMKEI-KHP 73
Query: 62 NIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
N+V+L + + Y + E+M L L +Q S + QI + Y+ +
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEV--DSCPPYTEYITTLQYRAPEMLLMSGQ 176
+ + HRDL ++N LV + +K+ADFGL+ + D+ + +++ AP L +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP-ESLAYNK 192
Query: 177 YNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236
++ K D+WA G+++ E+ T+ + Q+Y++
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------------- 230
Query: 237 KFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQHPLFQGCLQVPSMS 294
+ + P +++ L+ W+P RP+ AE Q F+ Q S+S
Sbjct: 231 -------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSIS 280
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 8e-48
Identities = 59/285 (20%), Positives = 118/285 (41%), Gaps = 39/285 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
+ T +++IG G FG V + + VAIK +++ S E+ + E + + K++ HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIE--EAEVMMKLS-HP 60
Query: 62 NIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQ 120
+V+L + E + VFE+M+ L + ++ F+ + C + +G+ Y+
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 121 GYFHRDLISKNLLVSND-TIKIADFGL--AWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
HRDL ++N LV + IK++DFG+ D T +++ +PE+ +Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV-FSFSRY 179
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
+SK D+W+ G++M E+ + + + ++
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--------------------------- 212
Query: 238 FPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQH 281
+ L P + ++ P RP + L+
Sbjct: 213 --EDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (411), Expect = 1e-47
Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 42/294 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLN--LKEVKCLRKIN 58
++++ +K +G GSFG+V K+SG + A+K L ++ + + L E + L+ +N
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMH 118
P +VKL+ +N LY V EY+ R FSE + + QI+ Y+H
Sbjct: 100 -FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 119 RQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQY 177
+RDL +NLL+ I++ DFG A V T + APE++ +S Y
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEII-LSKGY 215
Query: 178 NSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237
N VD WALG+++ E+ +P F KI + +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-------------------GKVR 256
Query: 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKR-----PTAAEALQHPLFQG 286
FP + D L+ L D KR + H F
Sbjct: 257 FP-----------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-47
Identities = 73/292 (25%), Positives = 116/292 (39%), Gaps = 43/292 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L ++G+G FG+VW + VAIK LK S E L E + ++K+ H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ--EAQVMKKLR-HE 72
Query: 62 NIVKLQELASENYRLYFVFEYMD--CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+V+L + SE +Y V EYM L L + ++ + QI G+ Y+ R
Sbjct: 73 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPY--TEYITTLQYRAPEMLLMSGQ 176
Y HRDL + N+LV + K+ADFGLA ++ +++ AP + G+
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP-EAALYGR 190
Query: 177 YNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
+ K D+W+ G+++ EL T +PG + L ++ P E L
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH------ 244
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ--HPLFQ 285
L+ +P +RPT F
Sbjct: 245 -----------------------DLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-47
Identities = 56/290 (19%), Positives = 117/290 (40%), Gaps = 44/290 (15%)
Query: 8 KQIGEGSFGKVWQAIKKQSGE--YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVK 65
++G G+FG V Q + + + VAIK LKQ + ++E + + +++ +P IV+
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVR 73
Query: 66 LQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
L + L V E LH+ + +++ + V Q+ G+ Y+ + + H
Sbjct: 74 LIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 125 RDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYIT----TLQYRAPEMLLMSGQYNS 179
RDL ++N+L+ N KI+DFGL+ + + Y + L++ AP + +++S
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP-ECINFRKFSS 191
Query: 180 KVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
+ D+W+ G+ M E +++ + + + I G +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------------------GKRM 231
Query: 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAE---ALQHPLFQ 285
P + +L+ + RP ++ +
Sbjct: 232 E---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (406), Expect = 2e-47
Identities = 58/303 (19%), Positives = 117/303 (38%), Gaps = 43/303 (14%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKI 57
+ + + IG G FG+V K G+ +VAIK LK + L E + +
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
+ HPN++ L+ + +++ + + E+M+ +L + F+ ++ I G+ Y
Sbjct: 85 D-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 117 MHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYTEYITTLQYRAPEMLL--- 172
+ Y HRDL ++N+LV+++ K++DFGL+ ++ Y + L + P
Sbjct: 144 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 173 --MSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229
++ S D+W+ G++M E++++ + D + I P L
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSAL- 262
Query: 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289
L+ D RP + + ++
Sbjct: 263 ----------------------------HQLMLDCWQKDRNHRPKFGQIVNT--LDKMIR 292
Query: 290 VPS 292
P+
Sbjct: 293 NPN 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 4e-47
Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 41/285 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
E L++++G G FG+VW VA+K+LKQ S + L E ++++ H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLA--EANLMKQLQ-HQ 68
Query: 62 NIVKLQELASENYRLYFVFEYMDCNL--HQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+V+L + ++ +Y + EYM+ L + + ++ + QI +G+ ++
Sbjct: 69 RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 120 QGYFHRDLISKNLLVSND-TIKIADFGLAWEV--DSCPPYTEYITTLQYRAPEMLLMSGQ 176
+ Y HRDL + N+LVS+ + KIADFGLA + + +++ AP + G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP-EAINYGT 186
Query: 177 YNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
+ K D+W+ G+++ E++T +PG + + + ++ E L
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL------- 239
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280
L+ L P RPT
Sbjct: 240 ----------------------YQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (404), Expect = 9e-47
Identities = 73/333 (21%), Positives = 128/333 (38%), Gaps = 44/333 (13%)
Query: 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPN 62
+Y L++++G G F VW A + +VA+K ++ E + E+K L+++ N +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED--EIKLLQRV-NDAD 70
Query: 63 IVKLQELASEN-YRLYFVFEYMDCN---------------LHQLMSNRKQCFSEAEVKNW 106
K + + + +L F + N L + + VK
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 107 CFQILQGLNYM-HRQGYFHRDLISKNLLVSND-----TIKIADFGLAWEVDSCPPYTEYI 160
Q+L GL+YM R G H D+ +N+L+ I+I L YT I
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 161 TTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPG------TCEDDQLYKICN 214
T +YR+PE+LL + D+W+ ++ ELIT LF T +DD + +I
Sbjct: 191 QTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 215 AIGSPTEESWAEGLEL-----AKAHGYKFPKLQGNNLSLLIPS-------ANDDEMSLIE 262
+G G ++ KL+ L ++ + +
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 263 LLCSWDPCKRPTAAEALQHPLFQGCLQVPSMSI 295
+ DP KR A + HP + L + + +
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-46
Identities = 68/308 (22%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 2 EKYTLMKQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
+ + K +G G+FGKV +A IK + VA+K LK + E + E+K L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQC-----------------F 98
+ NH NIV L + + EY +L + ++
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 99 SEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPY- 156
++ ++ +Q+ +G+ ++ + HRDL ++N+L+ KI DFGLA ++ + Y
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 157 --TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKIC 213
+++ AP + + Y + D+W+ G+ + EL + +PG D + YK+
Sbjct: 203 VKGNARLPVKWMAP-ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKR 272
+L P EM +++ DP KR
Sbjct: 262 K-----------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 273 PTAAEALQ 280
PT + +Q
Sbjct: 293 PTFKQIVQ 300
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-46
Identities = 60/286 (20%), Positives = 109/286 (38%), Gaps = 38/286 (13%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEY----VAIKALKQRIYSWEECLNLKEVKCLRKINN 59
+ +K +G G+FG V++ + GE VAIK L++ L E + ++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69
Query: 60 HPNIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR 119
+P++ +L + + L + K + NWC QI +G+NY+
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 120 QGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPY---TEYITTLQYRAPEMLLMSG 175
+ HRDL ++N+LV + +KI DFGLA + + +++ A E ++
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES-ILHR 188
Query: 176 QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
Y + D+W+ G+ + EL+TF ++ I G
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------------------KG 229
Query: 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
+ P+ P D ++ D RP E +
Sbjct: 230 ERLPQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-46
Identities = 58/291 (19%), Positives = 112/291 (38%), Gaps = 41/291 (14%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQS---GEYVAIKALKQRIYSWEECLN--LKEVKCLRK 56
+ L++++G+GSFG V + VA+K LK + S E ++ ++EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLN 115
++ H N+++L + V E +L + + F + + Q+ +G+
Sbjct: 68 LD-HRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 116 YMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY---TEYITTLQYRAPEML 171
Y+ + + HRDL ++NLL++ D +KI DFGL + + E+
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 172 LMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230
L + ++ D W G+ + E+ T+ + G L+KI
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK---------------- 229
Query: 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
G + P+ D +++ + P RPT
Sbjct: 230 ---EGERLPR---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-46
Identities = 61/291 (20%), Positives = 116/291 (39%), Gaps = 46/291 (15%)
Query: 8 KQIGEGSFGKVWQAI--KKQSGEYVAIKALKQRIYSWEECLN-LKEVKCLRKINNHPNIV 64
K++G G+FG V + K+ + VA+K LK L E +++++ +P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 71
Query: 65 KLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFH 124
++ E V E + + + + + Q+ G+ Y+ + H
Sbjct: 72 RMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 125 RDLISKN-LLVSNDTIKIADFGLAWEVDSCPPY----TEYITTLQYRAPEMLLMSGQYNS 179
RDL ++N LLV+ KI+DFGL+ + + Y T +++ APE + +++S
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSS 189
Query: 180 KVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238
K D+W+ G++M E ++ + G + + G +
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--------------------GERM 229
Query: 239 PKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAE---ALQHPLFQ 285
P+ EM L+ L ++D RP A L++ +
Sbjct: 230 G----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-46
Identities = 70/318 (22%), Positives = 125/318 (39%), Gaps = 54/318 (16%)
Query: 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEY--VAIKALKQRIYSWEECLNLKEVKCLRKIN 58
IGEG+FG+V +A K+ G AIK +K+ + E++ L K+
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 59 NHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNR---------------KQCFSEAE 102
+HPNI+ L LY EY NL + S +
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 103 VKNWCFQILQGLNYMHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYIT 161
+ ++ + +G++Y+ ++ + HRDL ++N+LV N KIADFGL+ + T
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188
Query: 162 TLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPT 220
+++ A E L Y + D+W+ G+++ E+++ + G + K+
Sbjct: 189 PVRWMAIES-LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------ 241
Query: 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEAL 279
GY+ P DDE+ L+ P +RP+ A+ L
Sbjct: 242 --------------GYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277
Query: 280 QHPLFQGCLQVPSMSIDS 297
L+ +++
Sbjct: 278 VS--LNRMLEERKTYVNT 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-46
Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 40/288 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI---KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN 58
E+ L + IGEG FG V Q I + VAIK K L+E +R+ +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 59 NHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYM 117
HP+IVKL + +EN ++ + E L + RK A + + +Q+ L Y+
Sbjct: 67 -HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 118 HRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPY--TEYITTLQYRAPEMLLMS 174
+ + HRD+ ++N+LV SND +K+ DFGL+ ++ Y ++ +++ APE +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NF 183
Query: 175 GQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233
++ S D+W G+ M E++ F G +D + +I N
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------------------- 224
Query: 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
G + P + P+ SL+ ++DP +RP E
Sbjct: 225 -GERLP---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-45
Identities = 67/301 (22%), Positives = 125/301 (41%), Gaps = 42/301 (13%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYSWEECLNLKEVKCLRKI 57
T K IG G FG+V++ + K S VAIK LK + L E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 58 NNHPNIVKLQELASENYRLYFVFEYMDCNLH-QLMSNRKQCFSEAEVKNWCFQILQGLNY 116
+ H NI++L+ + S+ + + EYM+ + + + FS ++ I G+ Y
Sbjct: 67 S-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 117 MHRQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYIT----TLQYRAPEML 171
+ Y HRDL ++N+LV SN K++DFGL+ ++ P T + +++ APE
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA- 184
Query: 172 LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231
+ ++ S D+W+ G++M E++T+ + ++ K N
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN----------------- 227
Query: 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQVP 291
G++ P L+ + +RP A+ + + ++ P
Sbjct: 228 --DGFRLP---------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS--ILDKLIRAP 274
Query: 292 S 292
Sbjct: 275 D 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 8e-45
Identities = 41/225 (18%), Positives = 80/225 (35%), Gaps = 18/225 (8%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
Y + ++IGEGSFG +++ + + VAIK +R + + E + + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL---RDEYRTYKLLAGCT 61
Query: 62 NIVKLQELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG 121
I + E V + + +L L+ + FS V Q+L + +H +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 122 YFHRDLISKNLLVSNDT------IKIADFGLAWEVDS--------CPPYTEYITTLQYRA 167
+RD+ N L+ I + DFG+ T +Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 168 PEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKI 212
+ + + + D+ ALG + + + G K
Sbjct: 182 INT-HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-44
Identities = 69/303 (22%), Positives = 113/303 (37%), Gaps = 39/303 (12%)
Query: 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP 61
L + IG+G FG+VW+ K GE VA+K R E+ + H
Sbjct: 3 RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSR--EERSWFREAEIYQTVML-RHE 57
Query: 62 NIVKLQELASEN----YRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNY 116
NI+ +++ +L+ V +Y + +L + + + + GL +
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAH 115
Query: 117 MH--------RQGYFHRDLISKNLLV-SNDTIKIADFGLAWEVDSCPPYTEYIT-----T 162
+H + HRDL SKN+LV N T IAD GLA DS + T
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 163 LQYRAPEML-----LMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG 217
+Y APE+L + + + D++A+GL+ E+ + G ED QL
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPS 234
Query: 218 SPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAE 277
P+ E + + P + S A ++ + R TA
Sbjct: 235 DPSVEEMRKVV----CEQKLRPNIPNRWQS---CEALRVMAKIMRECWYANGAARLTALR 287
Query: 278 ALQ 280
+
Sbjct: 288 IKK 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 6e-43
Identities = 66/313 (21%), Positives = 127/313 (40%), Gaps = 65/313 (20%)
Query: 2 EKYTLMKQIGEGSFGKVWQA-----IKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
++ IGEG+FG+V+QA + + VA+K LK+ + + +E + +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMDC-NLHQLMSNR--------------------- 94
+ +PNIVKL + + + +FEYM +L++ + +
Sbjct: 73 FD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 95 --KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVD 151
S AE Q+ G+ Y+ + + HRDL ++N LV + +KIADFGL+ +
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 152 SCPPY---TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFH-PLFPGTCEDD 207
S Y +++ PE + +Y ++ D+WA G+++ E+ ++ + G ++
Sbjct: 192 SADYYKADGNDAIPIRWMPPES-IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 208 QLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSW 267
+Y + + E+ L +L+ L S
Sbjct: 251 VIYYVRDGNILACPENCPLEL-----------------------------YNLMRLCWSK 281
Query: 268 DPCKRPTAAEALQ 280
P RP+ +
Sbjct: 282 LPADRPSFCSIHR 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-42
Identities = 69/319 (21%), Positives = 129/319 (40%), Gaps = 60/319 (18%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
++ L K +G G+FG+V +A K + VA+K LK+ E + E+K L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 57 INNHPNIVKLQELASE-NYRLYFVFEYMD-CNLHQLMSNR---------------KQCFS 99
I +H N+V L ++ L + E+ NL + ++ K +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 100 EAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPY-- 156
+ + FQ+ +G+ ++ + HRDL ++N+L+S +KI DFGLA ++ P Y
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 157 -TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFH-PLFPGTCEDDQLYKICN 214
+ L++ AP + Y + D+W+ G+++ E+ + +PG D++ +
Sbjct: 193 KGDARLPLKWMAP-ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRP 273
+ P EM + +P +RP
Sbjct: 252 -----------------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 282
Query: 274 TAAEALQHPLFQGCLQVPS 292
T +E ++H LQ +
Sbjct: 283 TFSELVEH--LGNLLQANA 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-42
Identities = 69/309 (22%), Positives = 130/309 (42%), Gaps = 60/309 (19%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-------KKQSGEYVAIKALKQRIYSWEECLNLKEVKCL 54
++ L K +GEG+FG+V A K VA+K LK + + E++ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 55 RKINNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQC---------------F 98
+ I H NI+ L +++ LY + EY NL + + R+
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 99 SEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPYT 157
S ++ + +Q+ +G+ Y+ + HRDL ++N+LV+ D +KIADFGLA ++ Y
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 158 E---YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKIC 213
+ +++ APE L Y + D+W+ G+++ E+ T +PG ++ +
Sbjct: 193 KTTNGRLPVKWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKR 272
G++ PS +E+ ++ P +R
Sbjct: 252 E--------------------GHRMD----------KPSNCTNELYMMMRDCWHAVPSQR 281
Query: 273 PTAAEALQH 281
PT + ++
Sbjct: 282 PTFKQLVED 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-41
Identities = 60/287 (20%), Positives = 112/287 (39%), Gaps = 45/287 (15%)
Query: 8 KQIGEGSFGKVWQAI---KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIV 64
+ IG G FG V+ + A+K+L + E L E ++ + HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVL 91
Query: 65 KLQELASE-NYRLYFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGY 122
L + V YM +L + N + ++ + Q+ +G+ ++ + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 123 FHRDLISKNLLVSND-TIKIADFGLAW-----EVDSCPPYTEYITTLQYRAPEMLLMSGQ 176
HRDL ++N ++ T+K+ADFGLA E DS T +++ A E L + +
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES-LQTQK 210
Query: 177 YNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235
+ +K D+W+ G+++ EL+T P +P D +
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---------------------- 248
Query: 236 YKFPKLQGNNLSLLIPSANDDEM-SLIELLCSWDPCKRPTAAEALQH 281
LL P D + ++ RP+ +E +
Sbjct: 249 --------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-38
Identities = 59/300 (19%), Positives = 125/300 (41%), Gaps = 51/300 (17%)
Query: 2 EKYTLMKQIGEGSFGKVWQAI-----KKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRK 56
EK T+ +++G+GSFG V++ + K + VAIK + + E L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 57 INNHPNIVKLQELASENYRLYFVFEYMD-CNLHQLMSNRKQC---------FSEAEVKNW 106
N ++V+L + S+ + E M +L + + + S +++
Sbjct: 80 F-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 107 CFQILQGLNYMHRQGYFHRDLISKNLLVSND-TIKIADFGLAWEVDSCPPY---TEYITT 162
+I G+ Y++ + HRDL ++N +V+ D T+KI DFG+ ++ Y + +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 163 LQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTE 221
+++ +PE L G + + D+W+ G+++ E+ T + G + L +
Sbjct: 199 VRWMSPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281
++ + L L+ + ++P RP+ E +
Sbjct: 258 DNCPDML-----------------------------FELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 3e-21
Identities = 38/203 (18%), Positives = 68/203 (33%), Gaps = 27/203 (13%)
Query: 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEEC--------LNLKEVKCLR 55
+ K +GEG V+ + +K K S+++ L+ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 56 KINNHPNIVKLQELAS----ENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQIL 111
N + KLQ LA + E +D IL
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELY-------RVRVENPDEVLDMIL 113
Query: 112 QGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGLAWEVDSCPPYTEYITTLQYRAPEML 171
+ + + +G H DL N+LVS + I I DF + EV + E + R +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGE-EGWREIL----ERDVRNI 168
Query: 172 L--MSGQYNSKVDMWALGLIMAE 192
+ S Y ++ D+ + + +
Sbjct: 169 ITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 346 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.02 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.67 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-64 Score=436.55 Aligned_cols=257 Identities=24% Similarity=0.361 Sum_probs=212.6
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+++|++++.||+|+||+||+|+++.+|+.||+|+++............+|+.+++++ +||||+++++++.+++.+|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEE
Confidence 589999999999999999999999999999999997665544455667899999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC---CC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC---PP 155 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~---~~ 155 (346)
||++| +|.+.+. ..+.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|...... ..
T Consensus 83 Ey~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 83 EYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp ECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred eccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99986 6766664 445699999999999999999999999999999999999995 569999999999865432 23
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||+.|+|||++.+...++.++||||+||++|+|++|++||....................
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~--------------- 226 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--------------- 226 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS---------------
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC---------------
Confidence 45578999999999998555567899999999999999999999987665433333322211110
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
...+.+++++++||++||+.||++|||++|+++||||+.
T Consensus 227 ------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 227 ------------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 112357899999999999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-64 Score=444.36 Aligned_cols=260 Identities=30% Similarity=0.450 Sum_probs=206.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|+++.+|+.||+|++.............+|+.+++++ +||||+++++++.+++.+|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEe
Confidence 46999999999999999999999999999999998766555555667899999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CCcEEEeecccccccCCCCCC
Q 039371 82 YMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|++ |+|.+.+... +.+++.++..++.||+.||+|||++||+||||||+||++. ++.+||+|||+|...+.....
T Consensus 88 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred ccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 998 5777777654 4599999999999999999999999999999999999993 468999999999887766666
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
.+.+||+.|+|||++. ...++.++||||+||++|+|++|.+||.+....+....+......++.+
T Consensus 167 ~~~~GT~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------- 231 (307)
T d1a06a_ 167 STACGTPGYVAPEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-------------- 231 (307)
T ss_dssp ------CTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT--------------
T ss_pred eeeeeCccccCcHHHc-CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc--------------
Confidence 7788999999999987 5678999999999999999999999999988888777776543322221
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
..+.+|+++++||++||+.||++|||++|+++||||++....
T Consensus 232 ------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 273 (307)
T d1a06a_ 232 ------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL 273 (307)
T ss_dssp ------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCC
T ss_pred ------------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCcc
Confidence 124678999999999999999999999999999999875443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-63 Score=429.96 Aligned_cols=252 Identities=28% Similarity=0.470 Sum_probs=217.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
|++|++++.||+|+||+||+|+++.+++.||+|++...... .......+|+.+++++ +||||+++++++.+++.+|+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEE
Confidence 58999999999999999999999999999999998654322 2233456899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
||||++| +|.+.+.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|...... ..
T Consensus 84 vmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~ 161 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RR 161 (263)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CC
T ss_pred EEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cc
Confidence 9999985 66666654 44599999999999999999999999999999999999996 569999999999776543 34
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+....+.+....
T Consensus 162 ~~~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------------------ 222 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------------------ 222 (263)
T ss_dssp EETTEEGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC------------------
T ss_pred cccCCCCcccCHHHHc-CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 5568999999999997 566899999999999999999999999998887777766443211
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
+ .+.+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 223 -~-----------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 -F-----------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -C-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -C-----------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 1 1357899999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-62 Score=430.40 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=217.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|+++++||+|+||+||+|+++.+|+.||+|+++...... .....+|+.+++++ +||||+++++++.+++.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-HHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEE
Confidence 47999999999999999999999999999999997654432 34567899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~ 158 (346)
|++| +|.+.+.. ..+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|...... .....
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9986 55554433 3499999999999999999999999999999999999995 569999999999876543 34556
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
.+||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+.+..+......+..
T Consensus 176 ~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~----------------- 237 (293)
T d1yhwa1 176 MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ----------------- 237 (293)
T ss_dssp CCSCGGGCCHHHHS-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-----------------
T ss_pred cccCCCccChhhhc-CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCC-----------------
Confidence 78999999999987 567899999999999999999999999998887777766554221110
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
..+.+++++++||++||+.||++|||++|+|+||||+..
T Consensus 238 ----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 238 ----------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp ----------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 113578999999999999999999999999999999853
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-62 Score=438.50 Aligned_cols=259 Identities=24% Similarity=0.425 Sum_probs=229.0
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
|++|++++.||+|+||+||+|+++.+|+.||+|++...... ......+|+.+++++ +||||+++++++.+++.+|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH-HHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh-hHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999999765432 334556899999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe---CCcEEEeecccccccCCCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS---NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~---~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|||+| +|.+.+....+.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|...+.....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 99985 77788877777799999999999999999999999999999999999994 358999999999988776677
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+.+..+......++...
T Consensus 183 ~~~~gT~~Y~aPEv~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------- 248 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA------------- 248 (350)
T ss_dssp EEECSCTTTCCHHHHH-TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG-------------
T ss_pred ceecCcccccCHHHHc-CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc-------------
Confidence 7789999999999987 56689999999999999999999999999988888888876544333222
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.+.+|+++++||++||+.||++|||++|+|+||||+...
T Consensus 249 -------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 249 -------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp -------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred -------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 235789999999999999999999999999999998754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-62 Score=429.29 Aligned_cols=287 Identities=38% Similarity=0.668 Sum_probs=242.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
||+|+++++||+|+||+||+|++..+|+.||+|+++...... ......+|+.+++++ +||||+++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEE
Confidence 799999999999999999999999999999999996554332 234557899999998 799999999999999999999
Q ss_pred EEcCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCC
Q 039371 80 FEYMDCNLHQLMSN-RKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPY 156 (346)
Q Consensus 80 ~e~~~g~l~~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~ 156 (346)
|||++|++...+.. ....+++.+++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||.|...... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 99999987776644 355699999999999999999999999999999999999995 559999999999776543 345
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.+..+....+.+....|..... ......
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~ 238 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS-MPDYKP 238 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-STTCCT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc-cccccc
Confidence 5668999999999988777789999999999999999999999999999999999999988888777654322 222333
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
..+...........+.+++++++||++||+.||++|||++|+++||||++..+
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 34444444455566788999999999999999999999999999999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.8e-62 Score=437.47 Aligned_cols=258 Identities=24% Similarity=0.431 Sum_probs=227.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|+++.+|+.||+|+++..... ......+|+.+++++ +||||+++++++++++.+|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEE
Confidence 6799999999999999999999999999999999765432 334556899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe---CCcEEEeecccccccCCCCCCc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS---NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~---~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||+| +|.+.+...+.++++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|..........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 9985 77777777766799999999999999999999999999999999999995 4689999999999888766677
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+.+..+......++..
T Consensus 187 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------- 250 (352)
T d1koba_ 187 VTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED--------------- 250 (352)
T ss_dssp EECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS---------------
T ss_pred eccCcccccCHHHHc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc---------------
Confidence 788999999999887 5678999999999999999999999999999888888887654333221
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
..+.+++++++||++||+.||++|||++|+|+||||++..
T Consensus 251 -----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 251 -----------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp -----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -----------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 1246889999999999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-62 Score=426.52 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=222.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----EECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|+++.+|+.||+|+++...... ......+|+.+++++ +||||+++++++++++.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence 57999999999999999999999999999999996554332 234456899999999 799999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C----cEEEeeccccccc
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D----TIKIADFGLAWEV 150 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~----~vkl~Dfg~a~~~ 150 (346)
|||||||+| +|.+.+... +.+++..++.++.|++.||+|||++||+||||||+||+++. + .+||+|||+|...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999985 666666554 45999999999999999999999999999999999999953 2 5999999999888
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
..........+|+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+.+..+......++...
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------- 239 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY------- 239 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH-------
T ss_pred CCCccccccCCCCcccCHHHHc-CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh-------
Confidence 7666666778999999999987 56789999999999999999999999999988888887766544333322
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.+.+|+++++||++||+.||++|||++|+++||||+...
T Consensus 240 -------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 240 -------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp -------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred -------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 246789999999999999999999999999999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-62 Score=426.67 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=218.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
|.|++++.||+|+||+||+|+++.+|+.||+|+++.... .......+|+.+++++ +||||+++++++.+++.+|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEe
Confidence 469999999999999999999999999999999976533 3345567899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~ 158 (346)
|++| +|.+.+....+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|...... .....
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 9985 66666666666799999999999999999999999999999999999996 569999999998654322 12335
Q ss_pred ccccCcccCccccc----ccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 159 YITTLQYRAPEMLL----MSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 159 ~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
..||+.|+|||++. ....|+.++||||+||++|+|++|..||.+.+..+.+..+.........
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------- 236 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA------------- 236 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS-------------
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC-------------
Confidence 67999999999884 2455899999999999999999999999998888877777654211110
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
..+.+|+++++||++||+.||++|||++|+++||||+.
T Consensus 237 --------------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 237 --------------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 11357899999999999999999999999999999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-62 Score=429.57 Aligned_cols=282 Identities=35% Similarity=0.608 Sum_probs=234.5
Q ss_pred eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH----HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 5 TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE----ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+.++.||+|+||+||+|+++.+|+.||+|+++....... .....+|+.+++++ +||||+++++++.+++.+|+||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehh
Confidence 467899999999999999999999999999975543322 23457899999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CCCcc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PPYTE 158 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~~~~ 158 (346)
||+.|++...+...+..+++.+++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|...... .....
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccc
Confidence 9999988888877777899999999999999999999999999999999999995 469999999999776543 34455
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYKF 238 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (346)
.+||+.|+|||++.....++.++||||+||++|+|++|.+||.+.+..+++..+.+..+.|..+.|.+....... ..+
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~--~~~ 237 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY--VTF 237 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC--CCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh--hhh
Confidence 689999999999876777899999999999999999999999999999999999999998887766532221111 111
Q ss_pred CCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 239 PKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
............+..++++++||++||+.||++|||++|+|+||||++...
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 122222334445678999999999999999999999999999999997543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-61 Score=426.03 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=218.9
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
+|+++++||+|+||+||+|++..+|+.||+|+++....... .....+|+.+++++ +||||+++++++.+++.+|+||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEE
Confidence 49999999999999999999999999999999976654433 23467899999999 7999999999999999999999
Q ss_pred EcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCccc
Q 039371 81 EYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTEY 159 (346)
Q Consensus 81 e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~~ 159 (346)
|||.|++++.+...++++++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|..... ....
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~ 171 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSF 171 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCcc
Confidence 9999877776666667799999999999999999999999999999999999996 56999999999976554 3356
Q ss_pred cccCcccCcccccc--cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 160 ITTLQYRAPEMLLM--SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 160 ~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
.||+.|+|||++.+ ...|+.++||||+||++|+|++|..||.+.+..+.+..+......+..
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------------- 235 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---------------- 235 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS----------------
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----------------
Confidence 79999999999863 346899999999999999999999999988887777776553221111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
...+|+++++||++||+.||++|||++|+|+||||+..
T Consensus 236 ------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 236 ------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 13578999999999999999999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-61 Score=422.69 Aligned_cols=254 Identities=29% Similarity=0.414 Sum_probs=214.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++|++++.||+|+||+||+|+++.+|+.||+|+++.... ........+|+.+++++ +||||+++++++++++.+|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEE
Confidence 689999999999999999999999999999999965432 22234457899999999 799999999999999999999
Q ss_pred EEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC---
Q 039371 80 FEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 80 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--- 154 (346)
|||++| +|.+.+... +.+++..++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||+|.......
T Consensus 87 mEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999986 666665554 4599999999999999999999999999999999999995 5699999999998765322
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhc
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAH 234 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 234 (346)
.....+||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+...++......
T Consensus 166 ~~~~~~GT~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---------------- 228 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD---------------- 228 (288)
T ss_dssp ----CCCCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC----------------
T ss_pred ccccccCCccccCceeec-cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC----------------
Confidence 334567999999999987 567899999999999999999999999998888877777543211
Q ss_pred CCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHH------HhcCCCCCCCC
Q 039371 235 GYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAE------ALQHPLFQGCL 288 (346)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e------ll~hp~~~~~~ 288 (346)
+ ...+++++++||++||+.||++|||++| +++||||++..
T Consensus 229 ---~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 229 ---F-----------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp ---C-----------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ---C-----------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 1 1357899999999999999999999998 58899998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.9e-61 Score=415.50 Aligned_cols=258 Identities=30% Similarity=0.410 Sum_probs=224.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--------HHhhhHHHHHHHHhhcCCCCeeeeeeeeecC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--------EECLNLKEVKCLRKINNHPNIVKLQELASEN 73 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~ 73 (346)
++|++.+.||+|+||+||+|+++.+|+.||+|+++...... ......+|+.+++++..||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 79999999999999999999999999999999996654321 1234578999999996799999999999999
Q ss_pred CEEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccC
Q 039371 74 YRLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVD 151 (346)
Q Consensus 74 ~~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~ 151 (346)
+.+||||||++| +|.+.+.. ++++++.+++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||++...+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999985 77777765 45699999999999999999999999999999999999995 5699999999999887
Q ss_pred CCCCCccccccCcccCcccccc-----cCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHH
Q 039371 152 SCPPYTEYITTLQYRAPEMLLM-----SGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAE 226 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 226 (346)
.........||+.|+|||.+.. ...++.++||||+||++|+|++|+.||.+.+..+....+......++...
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--- 238 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE--- 238 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT---
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc---
Confidence 7666677789999999998863 34578899999999999999999999999988888877776543322211
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.+.+|+++++||.+||+.||++|||++|+++||||++
T Consensus 239 -----------------------~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 -----------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -----------------------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -----------------------cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 2367899999999999999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.7e-61 Score=420.67 Aligned_cols=283 Identities=34% Similarity=0.603 Sum_probs=238.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
||||+++++||+|+||+||+|+++ +|+.||+|+++...... ......+|+.+++++ +||||+++++.+.+++..+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEE
Confidence 799999999999999999999986 78999999996654322 234567899999999 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~ 157 (346)
||++.|+++..+....+.+++..++.++.||+.||+|||++||+||||||+||+++ ++.+|++|||.|....... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 99999999988888778899999999999999999999999999999999999995 5699999999997765432 344
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
...+++.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+.++....+.+....|....... .....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~ 237 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP-KYDPN 237 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST-TCCTT
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh-hcccc
Confidence 55789999999999877788999999999999999999999999999999999999999998887776443322 22223
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQG 286 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~ 286 (346)
.............+..++++++||++||+.||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 3333333445556788999999999999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-61 Score=426.32 Aligned_cols=254 Identities=29% Similarity=0.443 Sum_probs=219.5
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
|++|++++.||+|+||+||+|+++.+|+.||+|++++... ........+|+.+++++ +||||+++++++++++.+|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecccccccc
Confidence 6899999999999999999999999999999999975532 22234457899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC-CCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS-CPP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~-~~~ 155 (346)
||||++| +|.+.+.. .+.++|..++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|..... ...
T Consensus 83 v~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred ceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 9999996 55555544 45699999999999999999999999999999999999996 57999999999986543 345
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+||+.|+|||++. ...|+.++||||+||++|+|++|.+||.+.+..+....+.......
T Consensus 162 ~~~~~GT~~Y~aPE~~~-~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~---------------- 224 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---------------- 224 (337)
T ss_dssp BCCCEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------------
T ss_pred cccceeCHHHhhhhhcc-CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC----------------
Confidence 56678999999999887 5668999999999999999999999999998887777765532211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
.+.+|+++++||++||+.||++|++ ++|+++||||++.
T Consensus 225 --------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 225 --------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp --------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 1357899999999999999999994 9999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-62 Score=432.58 Aligned_cols=282 Identities=20% Similarity=0.318 Sum_probs=211.5
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
|+|++++.||+|+||+||+|+++.+|+.||+|+++............+|+.+++++ +||||+++++++.+++.+|+|||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEE
Confidence 68999999999999999999999999999999998765555556677899999999 79999999999999999999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCcc
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYTE 158 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~~ 158 (346)
|+.| +|.+.+.+ .+.+++..++.++.|++.||.|||+ +||+||||||+|||++ ++.+||+|||+|...... ...+
T Consensus 85 y~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~ 162 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 162 (322)
T ss_dssp CCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC--
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-cccc
Confidence 9996 66666654 4559999999999999999999997 4999999999999995 669999999999765432 3345
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCChhhHHHHHHHHHhcCC-
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYK-ICNAIGSPTEESWAEGLELAKAHGY- 236 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~- 236 (346)
.+||+.|+|||++. ...|+.++||||+||++|+|++|+.||.+.+..+.... +....+.+.................
T Consensus 163 ~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp -CCSSCCCCHHHHH-CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred ccCCccccCchHHc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 78999999999997 56799999999999999999999999987665433221 1111111110000000000000000
Q ss_pred --CCCCc----------CCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 237 --KFPKL----------QGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 237 --~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
..+.. ............|.++++||++||+.||++|||++|+|+||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000 0000001112467899999999999999999999999999999853
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-61 Score=416.11 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=204.4
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASE--NYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~~~i 78 (346)
|+|++++.||+|+||+||+|+++.+|+.||+|+++....... .....+|+.+++++ +||||+++++++.+ ++.+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEE
Confidence 799999999999999999999999999999999977665543 34456899999999 79999999998854 567899
Q ss_pred EEEcCCC-CHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCCEEEe-CCcEEEeeccccc
Q 039371 79 VFEYMDC-NLHQLMSN---RKQCFSEAEVKNWCFQILQGLNYMHRQG-----YFHRDLISKNLLVS-NDTIKIADFGLAW 148 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~-----ivH~dikp~NIli~-~~~vkl~Dfg~a~ 148 (346)
||||++| +|.+.+.+ .+..+++..++.++.||+.||+|||++| |+||||||+|||++ ++.+||+|||+|.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999985 77776643 3456999999999999999999999976 99999999999996 5699999999998
Q ss_pred ccCCCC-CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHH
Q 039371 149 EVDSCP-PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEG 227 (346)
Q Consensus 149 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 227 (346)
...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~-------- 233 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-------- 233 (269)
T ss_dssp HC-----------CCCSCCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------
T ss_pred ecccCCCccccCCCCcccCCHHHHc-CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 765433 345578999999999986 5678999999999999999999999999988877777765432111
Q ss_pred HHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 039371 228 LELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLF 284 (346)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~ 284 (346)
....+|+++.+||++||+.||++|||++|+++|||+
T Consensus 234 ---------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 ---------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 123578999999999999999999999999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-60 Score=412.50 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=207.3
Q ss_pred ce-eeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeec----CCEE
Q 039371 3 KY-TLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASE----NYRL 76 (346)
Q Consensus 3 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~----~~~~ 76 (346)
|| ++.++||+|+||+||+|+++.+++.||+|++........ .....+|+.+++++ +||||+++++++++ +..+
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEE
Confidence 45 677899999999999999999999999999976655443 34456899999999 79999999999864 4578
Q ss_pred EEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCCEEEe--CCcEEEeecccccccC
Q 039371 77 YFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQG--YFHRDLISKNLLVS--NDTIKIADFGLAWEVD 151 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dikp~NIli~--~~~vkl~Dfg~a~~~~ 151 (346)
|+||||++| +|.+.+.+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+|....
T Consensus 88 ~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999986 66666654 455999999999999999999999998 99999999999994 4699999999997654
Q ss_pred CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
. .......||+.|+|||++. +.++.++||||+||++|+|++|+.||.+......+.+.+.....|.
T Consensus 167 ~-~~~~~~~GT~~Y~aPE~~~--~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~----------- 232 (270)
T d1t4ha_ 167 A-SFAKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----------- 232 (270)
T ss_dssp T-TSBEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG-----------
T ss_pred C-CccCCcccCccccCHHHhC--CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc-----------
Confidence 3 3445678999999999885 4599999999999999999999999987665544433322211111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQ 285 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~ 285 (346)
......++++++||.+||+.||++|||++|+|+|||||
T Consensus 233 ----------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 ----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 11235688999999999999999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-61 Score=426.65 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=228.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
.|+|++++.||+|+||+||+|.++.+|+.||+|+++... .......+|+.+++.+ +||||+++++++++++.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEE
Confidence 489999999999999999999999999999999997653 3344466899999999 7999999999999999999999
Q ss_pred EcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC---CcEEEeecccccccCCCCCC
Q 039371 81 EYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN---DTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 81 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~---~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|||+| +|.+.+...+..+++.+++.++.||+.||+|||++||+||||||+||+++. ..+||+|||++.........
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 99985 788888777667999999999999999999999999999999999999953 38999999999887766666
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....+|+.|+|||... ...++.++||||+||++|+|++|..||.+.+..+.+..+.+....++...|
T Consensus 161 ~~~~~t~~y~ape~~~-~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------ 227 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF------------ 227 (321)
T ss_dssp EEEESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH------------
T ss_pred cccccccccccchhcc-CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc------------
Confidence 6778999999999886 566899999999999999999999999999999998888876655554433
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
+.+|+++++||++||+.||++|||++|+++||||++.
T Consensus 228 --------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 228 --------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp --------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred --------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 3678999999999999999999999999999999754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-60 Score=422.64 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=219.9
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
|++|++++.||+|+||+||+|+++.+|+.||+|+++..... .......+|+.+++++ +||||+++++++.+++.+|+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeee
Confidence 68999999999999999999999999999999999654322 2234456899999999 79999999999999999999
Q ss_pred EEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCCc
Q 039371 79 VFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 79 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~~ 157 (346)
||||+.|+.+..+......+++..++.++.||+.||+|||++||+||||||+|||++ +|.+||+|||+|..... ...
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~~~ 159 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTY 159 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBC
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--ccc
Confidence 999999766655555566699999999999999999999999999999999999996 56999999999987654 334
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..+||+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+...++.......
T Consensus 160 ~~~Gt~~Y~APE~l~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~------------------ 220 (316)
T d1fota_ 160 TLCGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF------------------ 220 (316)
T ss_dssp CCCSCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC------------------
T ss_pred cccCcccccCHHHHc-CCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC------------------
Confidence 568999999999886 5668999999999999999999999999998888887776542211
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
.+.++++++++|++||+.||.+|+ |++++++||||++.
T Consensus 221 ------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 221 ------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 135789999999999999999996 99999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-60 Score=419.26 Aligned_cols=285 Identities=34% Similarity=0.602 Sum_probs=233.2
Q ss_pred CceeeeeeecccCceEEEEEEEccC-CcEEEEEEccccccCHH-HhhhHHHHHHHHhhc--CCCCeeeeeeeee-----c
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS-GEYVAIKALKQRIYSWE-ECLNLKEVKCLRKIN--NHPNIVKLQELAS-----E 72 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~--~hp~iv~~~~~~~-----~ 72 (346)
++|+++++||+|+||+||+|++..+ ++.||+|+++....... .....+|+.+++.+. +||||+++++++. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999999765 67799999976544322 223456777776653 7999999999985 3
Q ss_pred CCEEEEEEEcCCCCHHHHH-hcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc
Q 039371 73 NYRLYFVFEYMDCNLHQLM-SNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV 150 (346)
Q Consensus 73 ~~~~~iv~e~~~g~l~~~~-~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~ 150 (346)
...++++||+++|++.... ......+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 4578999999998766544 44455699999999999999999999999999999999999995 579999999999877
Q ss_pred CCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 151 DSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 151 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
..........||+.|+|||++. ...++.++||||+||++|+|++|++||.+.+..+.+..+....+.+....|......
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~-~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 245 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred cccccCCCcccChhhcCcchhc-CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence 6656667788999999999987 567999999999999999999999999999999999999999998887766532111
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
.. ..+............+..++++++||++||+.||++|||++|+|+||||++..+.
T Consensus 246 ~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 246 PR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 302 (305)
T ss_dssp CG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred hh---hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence 11 1111222233344556788999999999999999999999999999999986543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-60 Score=423.20 Aligned_cols=252 Identities=29% Similarity=0.404 Sum_probs=218.2
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccC--HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYS--WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
|++|++++.||+|+||+||+|+++.+|+.||+|+++..... .......+|+.+++.+ +||||+++++++.+.+.+++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccccc
Confidence 58999999999999999999999999999999998654321 2233457899999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|||++.| ++...+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ +|.+||+|||+|..... ..
T Consensus 119 v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~~ 195 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RT 195 (350)
T ss_dssp EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CB
T ss_pred ccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--cc
Confidence 9999986 55555544 44599999999999999999999999999999999999995 66999999999987764 33
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+.......+......++
T Consensus 196 ~~~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p---------------- 258 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP---------------- 258 (350)
T ss_dssp CCCEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------------
T ss_pred ccccCccccCCHHHHc-CCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----------------
Confidence 4578999999999987 56689999999999999999999999999888887777765432211
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
+.+++++.+||++||+.||.+|+ |++++++||||++.
T Consensus 259 --------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 259 --------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp --------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred --------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 35789999999999999999995 99999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-60 Score=417.76 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=216.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
||+|++++.||+|+||+||+|+++.+|+.||+|++++... .........|..++.+..+||||+++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 7899999999999999999999999999999999975432 22223445677777655589999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC-CC
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-PP 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-~~ 155 (346)
||||++| +|.+.+.. ...+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|...... ..
T Consensus 81 vmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence 9999986 66666654 45599999999999999999999999999999999999996 469999999999765543 34
Q ss_pred CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 156 YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
.....||+.|+|||++. ...++.++||||+||++|+|++|+.||.+.+..+....+......
T Consensus 160 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~----------------- 221 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF----------------- 221 (320)
T ss_dssp BCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred ccccCCCCCcCCHHHHc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 45568999999999997 567899999999999999999999999999888877777543211
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHH-HHhcCCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA-EALQHPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~-ell~hp~~~~~ 287 (346)
+ .+.+|+++++||++||+.||.+|||+. ++++||||++.
T Consensus 222 --~-----------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 222 --Y-----------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp --C-----------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred --C-----------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 1 135789999999999999999999995 89999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-59 Score=422.20 Aligned_cols=257 Identities=28% Similarity=0.402 Sum_probs=209.6
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH--HhhhHHH---HHHHHhhcCCCCeeeeeeeeecCCE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE--ECLNLKE---VKCLRKINNHPNIVKLQELASENYR 75 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e---~~~l~~l~~hp~iv~~~~~~~~~~~ 75 (346)
|++|++++.||+|+||+||+|+++.+|+.||+|++........ .....+| +.+++.+ +||||+++++++.+++.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCE
Confidence 7899999999999999999999999999999999865432211 1122333 4555555 79999999999999999
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
+|+||||++| +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|......
T Consensus 82 ~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999985 66666654 45599999999999999999999999999999999999995 579999999999876653
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+...........+
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-------------- 225 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-------------- 225 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC--------------
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC--------------
Confidence 34456899999999999766679999999999999999999999998765443322221111100
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCCC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPT-----AAEALQHPLFQGC 287 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps-----~~ell~hp~~~~~ 287 (346)
....+.+|+++++||.+||+.||++||| ++|+++||||++.
T Consensus 226 -------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 226 -------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp -------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred -------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 1112367899999999999999999999 7999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-59 Score=420.26 Aligned_cols=283 Identities=34% Similarity=0.538 Sum_probs=231.7
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeecCC------
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASENY------ 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~------ 74 (346)
++|+++++||+|+||+||+|+++.+|+.||+|+++....... .....+|+.+++++ +||||+++++++...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccc
Confidence 689999999999999999999999999999999976554433 34557899999999 7999999999997654
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
.+|+||||+++++...... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+|++|||+|.....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~- 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC-
Confidence 5799999997666665543 3499999999999999999999999999999999999995 56999999999987665
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH-HH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL-AK 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~ 232 (346)
......+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....+.++.+.+...... ..
T Consensus 174 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 174 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 3345689999999999986677899999999999999999999999999999999999999999887766432111 11
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
......+......+....+..++++++||++||+.||++|||++|+|+||||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 111123344444555666788999999999999999999999999999999998653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=415.17 Aligned_cols=279 Identities=33% Similarity=0.558 Sum_probs=234.0
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec------CCEE
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE------NYRL 76 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------~~~~ 76 (346)
+|+.++.||+|+||+||+|+++.+|+.||+|++..... ...+|+.+++++ +||||+++++++.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999975432 234799999999 89999999999843 3468
Q ss_pred EEEEEcCCCCHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC-cEEEeecccccccC
Q 039371 77 YFVFEYMDCNLHQLMS---NRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND-TIKIADFGLAWEVD 151 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~-~vkl~Dfg~a~~~~ 151 (346)
|+||||++|++...+. .....+++.+++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||++....
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 9999999988766553 3455699999999999999999999999999999999999996 33 89999999998877
Q ss_pred CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
......+..||+.|+|||.+.+...++.++||||+||++|+|++|.+||...+..+.+..+.+..+.+..+.+.......
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 76667778899999999998877789999999999999999999999999999999999999999999988776543322
Q ss_pred HhcCCCCCCcCCCC-cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 232 KAHGYKFPKLQGNN-LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
.. ..++...... .....+..++++.+||++||+.||++|||++|+|+||||++...
T Consensus 255 ~~--~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 255 TE--FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp -C--CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hh--ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 22 2222222221 12234567899999999999999999999999999999987654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-58 Score=403.22 Aligned_cols=285 Identities=34% Similarity=0.590 Sum_probs=238.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
|+||+++++||+|+||+||+|++..+|+.||+|+++...... ......+|+.+++.+ +||||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEE
Confidence 799999999999999999999999999999999997655433 345567899999998 799999999999999999999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-CCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-PYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-~~~ 157 (346)
+|++.|+.+..+....+.+++..++.++.|++.||+|||++||+||||||+||+++ ++.+||+|||.|....... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 99999887777777777899999999999999999999999999999999999995 5699999999998765433 344
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPL-FPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+++.|+|||.+.....++.++||||+||++|+|++|+.| |.+.+..+.+..+....+.+....|............
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 456788999999988667789999999999999999999877 5667777888888888888887776654333222222
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
.... .........+..++.+.+||++||+.||++|||++|+|+||||++.
T Consensus 240 ~~~~-~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 240 PMYP-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCC-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccc-ccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 1111 1223344456788999999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-59 Score=416.72 Aligned_cols=260 Identities=28% Similarity=0.406 Sum_probs=211.4
Q ss_pred CCceeeee-eecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec----CCE
Q 039371 1 MEKYTLMK-QIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE----NYR 75 (346)
Q Consensus 1 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~----~~~ 75 (346)
+++|++++ .||+|+||+||+|+++.+++.||+|+++.. ....+|+.++.++.+||||++++++|++ +..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 47899986 599999999999999999999999998642 2345788888777789999999999875 467
Q ss_pred EEEEEEcCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC----CcEEEeecccccc
Q 039371 76 LYFVFEYMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN----DTIKIADFGLAWE 149 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~----~~vkl~Dfg~a~~ 149 (346)
+|+|||||+| +|.+.+...+ ..+++.+++.++.||+.||+|||++||+||||||+||++++ +.+||+|||+|..
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 8999999985 8888887653 46999999999999999999999999999999999999953 4799999999988
Q ss_pred cCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 150 VDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 150 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
...........||+.|+|||++. ...|+.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~-~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~---------- 232 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---------- 232 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCC-GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC----------
T ss_pred ccCCCccccccCCcccCCcHHHc-CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC----------
Confidence 77766677788999999999887 5668999999999999999999999998776555444433221110
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQ 289 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~ 289 (346)
...++ ....+.+|+++++||++||+.||++|||++|+++||||++...
T Consensus 233 -----~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 233 -----QYEFP-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp -----SSSCC-------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred -----CCCCC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 00111 0111357899999999999999999999999999999976543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=401.95 Aligned_cols=248 Identities=22% Similarity=0.390 Sum_probs=208.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----HHhhhHHHHHHHHhhc-CCCCeeeeeeeeecCCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----EECLNLKEVKCLRKIN-NHPNIVKLQELASENYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~e~~~l~~l~-~hp~iv~~~~~~~~~~~ 75 (346)
++|++.+.||+|+||+||+|++..+|+.||+|+++...... ......+|+.+++++. .||||+++++++++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 58999999999999999999999999999999997554322 1223468999999985 48999999999999999
Q ss_pred EEEEEEcCCC--CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-C-CcEEEeecccccccC
Q 039371 76 LYFVFEYMDC--NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-N-DTIKIADFGLAWEVD 151 (346)
Q Consensus 76 ~~iv~e~~~g--~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~-~~vkl~Dfg~a~~~~ 151 (346)
.|+|||++.| ++.+.+.. +..+++.+++.++.||+.||+|||++||+||||||+||+++ + +.+||+|||+|....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 9999999975 45555544 45699999999999999999999999999999999999996 3 589999999997655
Q ss_pred CCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 152 SCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 152 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
. ....+..||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+ .+...
T Consensus 163 ~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~---------------- 219 (273)
T d1xwsa_ 163 D-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG---------------- 219 (273)
T ss_dssp S-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC----------------
T ss_pred c-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc----------------
Confidence 4 344567899999999999866666788999999999999999999996531 12111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
... ..+.+|+++++||++||+.||++|||++|+++||||++.
T Consensus 220 ---~~~-----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 220 ---QVF-----------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ---CCC-----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ---ccC-----------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 111 124678999999999999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-58 Score=412.85 Aligned_cols=283 Identities=31% Similarity=0.466 Sum_probs=221.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHH-hhhHHHHHHHHhhcCCCCeeeeeeeee------cC
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEE-CLNLKEVKCLRKINNHPNIVKLQELAS------EN 73 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~l~~l~~hp~iv~~~~~~~------~~ 73 (346)
+++|+++++||+|+||+||+|+++.+|+.||+|+++....+... ....+|+.+++++ +||||++++++|. +.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccC
Confidence 47899999999999999999999999999999999876655433 3457899999998 7999999999985 34
Q ss_pred CEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 74 YRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 74 ~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
..+|+||||+.|+++..+.. .+++..++.++.||+.||+|||++||+||||||+||+++ ++.++++|||++.....
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchHHHHhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 78999999999998887753 489999999999999999999999999999999999996 56999999999988777
Q ss_pred CCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHH
Q 039371 153 CPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAK 232 (346)
Q Consensus 153 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 232 (346)
........+|+.|+|||++. +..++.++||||+||++|+|++|++||.+.+.......+......+..+.|........
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~-~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred ccccccccccccccChhhhc-CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 66777778999999999987 46789999999999999999999999999999999999999999888877754333322
Q ss_pred hcCCCCCCcCCCCcc------------cccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLS------------LLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
......+........ ......++++.+||++||+.||++|||++|+|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 111111111111110 01112466789999999999999999999999999998743
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-58 Score=407.43 Aligned_cols=286 Identities=32% Similarity=0.519 Sum_probs=225.7
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeec-------
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASE------- 72 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------- 72 (346)
++||+++++||+|+||+||+|+++.+|+.||||++..+.... ......+|+.+++++ +||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence 479999999999999999999999999999999986554432 233456899999999 79999999998754
Q ss_pred -CCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeeccccccc
Q 039371 73 -NYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEV 150 (346)
Q Consensus 73 -~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~ 150 (346)
++.+|++||++.+++..........+++..++.++.|++.||.|||++||+||||||+||+++ ++.+||+|||++...
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 456899999999988888877777899999999999999999999999999999999999995 569999999999765
Q ss_pred CCC-----CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHH
Q 039371 151 DSC-----PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWA 225 (346)
Q Consensus 151 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 225 (346)
... ......+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+....+....+.++++.+.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 432 233445799999999999877789999999999999999999999999999999999999988887765543
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccc--cCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 039371 226 EGLELAKAHGYKFPKLQGNNLSLL--IPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGC 287 (346)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~ 287 (346)
........................ ....++++++||.+||+.||++|||++|+|+||||++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 211111100000000000000000 01236788899999999999999999999999999964
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=408.34 Aligned_cols=286 Identities=32% Similarity=0.533 Sum_probs=232.3
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecC-----CEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASEN-----YRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~-----~~~ 76 (346)
+||++++.||+|+||+||+|+++.+|+.||||+++............+|+.+++++ +||||+++++++... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceE
Confidence 58999999999999999999999999999999997655444455667899999999 899999999998654 346
Q ss_pred EEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC--
Q 039371 77 YFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC-- 153 (346)
Q Consensus 77 ~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~-- 153 (346)
|+++++++|+|.+.+... .+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||+|......
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 788887778998887653 499999999999999999999999999999999999996 469999999999765432
Q ss_pred --CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH-H
Q 039371 154 --PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE-L 230 (346)
Q Consensus 154 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~ 230 (346)
.......||+.|+|||++.....++.++||||+||++|+|++|.+||.+.+..+...........+.......... .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 2345567999999999987677789999999999999999999999999998888888888877777654432111 1
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
........+...........+..++++++||++||+.||++|||++|+|+||||+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 111112233333344455567889999999999999999999999999999999976553
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.5e-57 Score=404.14 Aligned_cols=280 Identities=24% Similarity=0.441 Sum_probs=219.8
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec--CCEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE--NYRLYFV 79 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~--~~~~~iv 79 (346)
++|+++++||+|+||+||+|+++.+|+.||+|+++... .....+|+.+++++.+||||+++++++.. ...+++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 68999999999999999999999999999999986532 23456899999999779999999999874 4579999
Q ss_pred EEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-C-cEEEeecccccccCCCCCCc
Q 039371 80 FEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-D-TIKIADFGLAWEVDSCPPYT 157 (346)
Q Consensus 80 ~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~-~vkl~Dfg~a~~~~~~~~~~ 157 (346)
|||++++.+..+ ...+++.+++.++.||+.||+|||++||+||||||+|||++. + .+||+|||+|..........
T Consensus 111 ~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~ 187 (328)
T d3bqca1 111 FEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187 (328)
T ss_dssp EECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred EeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence 999997554333 235999999999999999999999999999999999999963 4 69999999998887766777
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCChhhHHHHHHHHHhc--
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTC-EDDQLYKICNAIGSPTEESWAEGLELAKAH-- 234 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-- 234 (346)
...+|+.|+|||.+.+...++.++||||+||++|+|++|..||.... ..+....+....+.+....+..........
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 267 (328)
T d3bqca1 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267 (328)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence 78899999999998877778999999999999999999999997654 445566666655544333322111000000
Q ss_pred CCCCCCcCCC-----CcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 039371 235 GYKFPKLQGN-----NLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCL 288 (346)
Q Consensus 235 ~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~ 288 (346)
.......... ........+++++++||++||+.||++|||++|+|+||||++..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0000000000 01112235788999999999999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=404.16 Aligned_cols=284 Identities=33% Similarity=0.508 Sum_probs=228.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHH-HhhhHHHHHHHHhhcCCCCeeeeeeeeec------CC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWE-ECLNLKEVKCLRKINNHPNIVKLQELASE------NY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~l~~l~~hp~iv~~~~~~~~------~~ 74 (346)
+||+++++||+|+||+||+|++..+|+.||+|+++....+.. .....+|+.+++++ +||||+++++++.. .+
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccCc
Confidence 689999999999999999999999999999999986655443 34567899999999 79999999999853 33
Q ss_pred EEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 75 RLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 75 ~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
..++++++.+|+|.+.+.. ..+++.+++.++.||+.||+|||++||+||||||+||+++ ++.+|++|||.+.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 4566666555677776644 3499999999999999999999999999999999999995 56999999999976543
Q ss_pred CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH-HHH
Q 039371 154 PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE-LAK 232 (346)
Q Consensus 154 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~ 232 (346)
...+..||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+.......+....+.+..+.+..... ...
T Consensus 174 -~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 174 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp -GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred -ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 344567899999999988777789999999999999999999999999999999999999888877665432111 111
Q ss_pred hcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q 039371 233 AHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQHPLFQGCLQV 290 (346)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~hp~~~~~~~~ 290 (346)
.............+.......++++++||++||+.||++|||++|+|+||||++....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 1112233333444455566889999999999999999999999999999999976543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=395.91 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=207.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc-----EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE-----YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|++..+++ .||+|.+.............+|+.++.++.+||||+++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 589999999999999999999876554 699999876655555556678999999997899999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEE
Q 039371 77 YFVFEYMD-CNLHQLMSNRK----------------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLL 133 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~----------------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIl 133 (346)
|+||||++ |+|.+.+.... ..+++..+..++.|++.||+|||++||+||||||+||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 99999998 57887776543 24899999999999999999999999999999999999
Q ss_pred Ee-CCcEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 039371 134 VS-NDTIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQ 208 (346)
Q Consensus 134 i~-~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 208 (346)
++ ++.+||+|||+|+....... ..+..||+.|+|||++. ...++.++||||+||++|||++ |.+||.+.+..+.
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-CCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 96 56999999999976554332 23456799999999887 5679999999999999999997 8999998877776
Q ss_pred HHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 209 LYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 209 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
+.+++.....++. .+.+++++++||.+||+.||++|||++||++|
T Consensus 276 ~~~~~~~~~~~~~----------------------------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 276 FYKLIQNGFKMDQ----------------------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHTTCCCCC----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCC----------------------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6666554322111 13578899999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-55 Score=388.40 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=199.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc---EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE---YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++.+.||+|+||+||+|+++.+++ .||+|.+...........+.+|+.+++++ +||||+++++++.+++.+++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEE
Confidence 579999999999999999999887665 58899887665555556678999999999 79999999999999999999
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~- 155 (346)
||||++| +|.+.+....+.+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+.......
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 9999985 66666766666799999999999999999999999999999999999996 45999999999986654322
Q ss_pred -----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 156 -----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 156 -----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.....+|+.|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+......+.
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~--------- 254 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP--------- 254 (299)
T ss_dssp -----------CGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---------
T ss_pred ceeeecccccCCccccCHHHHh-cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---------
Confidence 11245788999999887 5679999999999999999998 8999998888777666644321111
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+++++.+|+.+||+.||++|||++|++++
T Consensus 255 --------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 --------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 13578899999999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=383.38 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=203.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-EECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVF 80 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~ 80 (346)
++|++.+.||+|+||+||+|+.+ ..||+|+++....+. ....+.+|+.+++++ +||||++++++..+ +.+++||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec-cEEEEEE
Confidence 58999999999999999999754 359999997554433 344556899999999 79999999998765 4579999
Q ss_pred EcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCC---CC
Q 039371 81 EYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSC---PP 155 (346)
Q Consensus 81 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~---~~ 155 (346)
||++ |+|.+.+...+..+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||+|...... ..
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 9998 5888888777777999999999999999999999999999999999999964 59999999999765432 23
Q ss_pred CccccccCcccCccccccc--CCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 156 YTEYITTLQYRAPEMLLMS--GQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 156 ~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
.....||+.|+|||++... ..++.++||||+||++|||++|+.||.+.+..............++
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p------------- 229 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP------------- 229 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC-------------
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-------------
Confidence 3456799999999998642 4589999999999999999999999998877666555544322111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
......+.+++++.+|+.+||+.||++|||++|++++
T Consensus 230 -----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 -----------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -----------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1122235678999999999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.4e-56 Score=388.18 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=202.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH--HHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC----E
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW--EECLNLKEVKCLRKINNHPNIVKLQELASENY----R 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~----~ 75 (346)
+||++.+.||+|+||+||+|++..+|+.||+|+++...... ......+|+.+++++ +||||+++++++...+ .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCce
Confidence 68999999999999999999999999999999997654432 234567899999998 8999999999987543 4
Q ss_pred EEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCC
Q 039371 76 LYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSC 153 (346)
Q Consensus 76 ~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~ 153 (346)
+|+||||++| +|.+.+. ..+.+++.+++.++.||+.||+|||++||+||||||+||+++ ++..+++|||.+......
T Consensus 86 ~~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 8999999996 5555544 445699999999999999999999999999999999999995 569999999988654332
Q ss_pred C----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 154 P----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 154 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
. ......||+.|+|||++. ...++.++||||+||++|+|++|.+||.+.+..+...++......++.
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 235 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-------- 235 (277)
T ss_dssp --------------TTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG--------
T ss_pred cccccccccccCcccccCHHHHc-CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc--------
Confidence 2 344567999999999986 567899999999999999999999999998888877777654333222
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-CHHHHhcCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-TAAEALQHPLF 284 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-s~~ell~hp~~ 284 (346)
...+.+|+++.++|++||+.||.+|| |++++ .|+|.
T Consensus 236 ------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 236 ------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp ------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred ------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence 12246889999999999999999999 55555 45553
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=377.91 Aligned_cols=246 Identities=22% Similarity=0.382 Sum_probs=211.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|+++++||+|+||+||+|+++ +++.||+|+++...... ....+|+.+++++ +||||+++++++.+++.+++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~--~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE--DEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH--HHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH--HHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEE
Confidence 68999999999999999999975 67889999998765553 3467899999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCC--CCc
Q 039371 82 YMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP--PYT 157 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~--~~~ 157 (346)
|+. |++...+......+++..+.+++.|+++||+|||++||+||||||+||++++ +.+||+|||++....... ...
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 998 5677777777777999999999999999999999999999999999999965 599999999997654432 233
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...+|+.|+|||.+. ...++.++||||+||++|||++ |+.||.+.+..+....+.+....+.+
T Consensus 160 ~~~~t~~y~aPE~~~-~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p--------------- 223 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP--------------- 223 (258)
T ss_dssp CSCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---------------
T ss_pred ccCCCCCcCCcHHhc-CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc---------------
Confidence 467899999999887 5668999999999999999998 89999999888877776543221111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...++++.+||++||+.||++|||++++++|
T Consensus 224 --------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 224 --------------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 2467889999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=379.28 Aligned_cols=246 Identities=24% Similarity=0.419 Sum_probs=198.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|+++++||+|+||+||+|.++ +++.||+|+++...... ....+|+.+++++ +||||+++++++.+++.+++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~--~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE--EDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH--HHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH--HHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEE
Confidence 58999999999999999999876 46789999997655443 3467899999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CCc
Q 039371 82 YMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PYT 157 (346)
Q Consensus 82 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~~ 157 (346)
|++ |+|.+.+......+++..+..++.|++.||+|||+++|+||||||+||+++ ++.+||+|||+|+...... ...
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 998 577777777777799999999999999999999999999999999999996 4599999999997665433 223
Q ss_pred cccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 158 EYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 158 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
...||+.|+|||++. ...++.++||||+||++|||++ |.+||...+..+....+..+...+.
T Consensus 161 ~~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---------------- 223 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---------------- 223 (263)
T ss_dssp ----CTTSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC----------------
T ss_pred ceecCcccCChHHhc-CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC----------------
Confidence 457899999999987 5668999999999999999999 5677777777666666654322111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+++++.+++.+||+.||++|||++|+++|
T Consensus 224 -------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 224 -------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 12467899999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-55 Score=384.62 Aligned_cols=247 Identities=26% Similarity=0.434 Sum_probs=203.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|+++.+++.||+|+++...... ....+|+.+++++ +||||+++++++.+++.+++|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH--HHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchH--HHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEEee
Confidence 57999999999999999999999999999999997655443 3467899999999 79999999999999999999999
Q ss_pred cCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC--C
Q 039371 82 YMD-CNLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP--Y 156 (346)
Q Consensus 82 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~--~ 156 (346)
|++ |++.+.+... ...+++..+..++.|++.||+|||++||+||||||+|||++ ++.+||+|||+|+....... .
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 998 5777776543 45699999999999999999999999999999999999995 56999999999987654322 2
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGY 236 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 236 (346)
....|++.|+|||++. ...++.++||||+||++|+|++|..||...........++.....++
T Consensus 174 ~~~~g~~~y~aPE~~~-~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~---------------- 236 (287)
T d1opja_ 174 AGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME---------------- 236 (287)
T ss_dssp TTEEECGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC----------------
T ss_pred ccccccccccChHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC----------------
Confidence 3345788999999887 56789999999999999999997666544444333333332211111
Q ss_pred CCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 237 KFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+.+++++.+|+.+||+.||++|||++|+++
T Consensus 237 ------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 237 ------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 12367899999999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=384.13 Aligned_cols=252 Identities=21% Similarity=0.349 Sum_probs=209.2
Q ss_pred Cceeeee-eecccCceEEEEEEEcc--CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMK-QIGEGSFGKVWQAIKKQ--SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|.+.+ +||+|+||+||+|.++. ++..||||+++..........+.+|+.+++++ +||||+++++++.++ .+|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC-eEEE
Confidence 4688888 49999999999998764 34579999997665555556678999999999 799999999998765 5799
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC-
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP- 155 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~- 155 (346)
||||++| +|.+.+...+..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||+|+.......
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 9999995 77777766667799999999999999999999999999999999999995 66999999999987654332
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....||+.|+|||++. ...++.++||||+||++|||++ |..||.+.+..+....+.++...
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~------------- 231 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------------- 231 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-------------
T ss_pred cccccccccCccccChHHHh-CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 23456889999999987 5678999999999999999998 89999988877766665432211
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHH---hcCCCCC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEA---LQHPLFQ 285 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~el---l~hp~~~ 285 (346)
...+.+++++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 232 ----------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 ----------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1124678999999999999999999999888 6677764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-55 Score=378.75 Aligned_cols=249 Identities=26% Similarity=0.467 Sum_probs=203.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|+++ +++.||||+++...... ..+.+|+.+++++ +||||+++++++.++ .+++|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~--~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~iv~E 87 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP--DAFLAEANLMKQL-QHQRLVRLYAVVTQE-PIYIITE 87 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH--HHHHHHHHHHHHC-CCTTBCCEEEEECSS-SCEEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH--HHHHHHHHHHHhC-CCCCEeEEEeeeccC-CeEEEEE
Confidence 68999999999999999999976 57789999997655443 3467899999999 799999999987654 5789999
Q ss_pred cCCC-CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCC--CC
Q 039371 82 YMDC-NLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~--~~ 156 (346)
|+++ +|.+.+.... ..+++.++..++.||+.||.|||++||+||||||+||++++ +.+||+|||+|+...... ..
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 9985 6666554332 35999999999999999999999999999999999999965 599999999998765432 33
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+|+.|+|||++. ...++.++|||||||++|||++| .+||...+..+....+......+
T Consensus 168 ~~~~gt~~y~APE~~~-~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---------------- 230 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---------------- 230 (272)
T ss_dssp TTCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------
T ss_pred cccCCcccccChHHHh-CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------
Confidence 4457899999999887 56689999999999999999995 56666666666655553321111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ--HPLFQ 285 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~--hp~~~ 285 (346)
..+.+++++.+|+++||+.||++|||++|+++ |+||.
T Consensus 231 -------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 231 -------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11357889999999999999999999999998 77775
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-55 Score=378.25 Aligned_cols=248 Identities=29% Similarity=0.456 Sum_probs=199.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCC---cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG---EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
++|++++.||+|+||+||+|++..++ ..||+|.++............+|+.+++++ +||||+++++++.+ +.+|+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS-SSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CeEEE
Confidence 68999999999999999999987543 468999987665555556678999999999 79999999999965 56899
Q ss_pred EEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--
Q 039371 79 VFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP-- 154 (346)
Q Consensus 79 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~-- 154 (346)
||||+.| ++.+.+......+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||+|.......
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 9999985 67676666677799999999999999999999999999999999999995 5799999999998765432
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......||+.|+|||++. ...++.++|||||||++|||++ |.+||.+.+..+....+.++...+
T Consensus 165 ~~~~~~gt~~y~apE~l~-~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~-------------- 229 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------------- 229 (273)
T ss_dssp ------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC--------------
T ss_pred eccceecCcccchhhHhc-cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--------------
Confidence 233456789999999987 5678999999999999999998 899999988877777665432111
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..+.+++++.+||.+||+.||++|||++|+++|
T Consensus 230 ---------------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 230 ---------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 124678999999999999999999999999885
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=389.53 Aligned_cols=260 Identities=28% Similarity=0.417 Sum_probs=211.7
Q ss_pred CCceeeeeeecccCceEEEEEEEc---cCCcEEEEEEccccccC---HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKK---QSGEYVAIKALKQRIYS---WEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
|++|++++.||+|+||+||+|++. .+|+.||+|+++..... .......+|+.+++++.+||||+++++++++..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 578999999999999999999874 46899999998654321 223445689999999976699999999999999
Q ss_pred EEEEEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCC
Q 039371 75 RLYFVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDS 152 (346)
Q Consensus 75 ~~~iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~ 152 (346)
.++++|||+.| +|.+.+... +.+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|.....
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999985 666666554 4589999999999999999999999999999999999996 56999999999976543
Q ss_pred CC--CCccccccCcccCcccccccC-CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 153 CP--PYTEYITTLQYRAPEMLLMSG-QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 153 ~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
.. ......|++.|+|||.+.... .++.++||||+||++|+|++|..||.+.+..+....+......+..
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~-------- 253 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-------- 253 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--------
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC--------
Confidence 22 344568999999999987443 5788999999999999999999999887665555554433211100
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCCC
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRP-----TAAEALQHPLFQGC 287 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~ell~hp~~~~~ 287 (346)
. ..+.+++++++||++||+.||++|| |++|+++||||++.
T Consensus 254 -------~-----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 254 -------P-----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp -------C-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred -------C-----------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 0 1135789999999999999999999 58999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=376.73 Aligned_cols=244 Identities=22% Similarity=0.369 Sum_probs=195.3
Q ss_pred eeecccCceEEEEEEEc--cCCcEEEEEEccccccC-HHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEEcCC
Q 039371 8 KQIGEGSFGKVWQAIKK--QSGEYVAIKALKQRIYS-WEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFEYMD 84 (346)
Q Consensus 8 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e~~~ 84 (346)
++||+|+||+||+|.++ .+++.||+|+++....+ .......+|+.+++++ +||||++++++++++ ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC-CEEEEEEcCC
Confidence 46999999999999865 45678999999654433 3345567999999999 799999999999765 4689999998
Q ss_pred C-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC----Ccc
Q 039371 85 C-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP----YTE 158 (346)
Q Consensus 85 g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~----~~~ 158 (346)
| +|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|+....... ...
T Consensus 91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 6 56665554 45599999999999999999999999999999999999995 67999999999986654322 233
Q ss_pred ccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcCCC
Q 039371 159 YITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHGYK 237 (346)
Q Consensus 159 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (346)
..||+.|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+.++...+
T Consensus 170 ~~gt~~y~APE~l~-~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~------------------ 230 (277)
T d1xbba_ 170 GKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------------ 230 (277)
T ss_dssp -CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC------------------
T ss_pred cCCCceecCchhhc-CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC------------------
Confidence 56889999999987 5668999999999999999997 899999888776666554321111
Q ss_pred CCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHH---hcCCCC
Q 039371 238 FPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEA---LQHPLF 284 (346)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~el---l~hp~~ 284 (346)
..+.+++++.+|+.+||+.||++|||++++ |+|+|+
T Consensus 231 -----------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 -----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 113678999999999999999999999998 466654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-54 Score=380.55 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=200.6
Q ss_pred CceeeeeeecccCceEEEEEEEccCCc----EEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGE----YVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
++|++++.||+|+||+||+|.+..+|+ .||+|.++............+|+.+++++ +||||+++++++.+++. +
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~-~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTSTV-Q 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESSSE-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCe-e
Confidence 579999999999999999999988876 57888886554444455678999999999 79999999999988765 5
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCC
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPP 155 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~ 155 (346)
+++|++. |++.+.+......+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+|........
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 5566665 788888888777899999999999999999999999999999999999995 56999999999987654332
Q ss_pred ---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHH
Q 039371 156 ---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELA 231 (346)
Q Consensus 156 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 231 (346)
.....||+.|+|||++. .+.++.++|||||||++|||+| |.+||.+.+..+....+..+...+.
T Consensus 167 ~~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~----------- 234 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ----------- 234 (317)
T ss_dssp --------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC-----------
T ss_pred cccccccccCccccChHHHh-cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 23346899999999887 5679999999999999999998 7899988877666555543321111
Q ss_pred HhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 232 KAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+.+++++.+|+.+||+.||++|||+.|+++|
T Consensus 235 ------------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 235 ------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 13578899999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=372.35 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=197.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCC----cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG----EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~ 77 (346)
+.|++.+.||+|+||+||+|.++.++ ..||+|+++............+|+.+++++ +||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceE
Confidence 57999999999999999999887654 479999997665555555677999999999 7999999999999999999
Q ss_pred EEEEcCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC-
Q 039371 78 FVFEYMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP- 154 (346)
Q Consensus 78 iv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~- 154 (346)
+|||++.+ ++.+.+......+++.++..++.|++.||+|||+++|+||||||+|||++ ++.+||+|||+|+......
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 99999986 55666666667799999999999999999999999999999999999996 4599999999997654432
Q ss_pred ---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCChhhHHHHHHH
Q 039371 155 ---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFH-PLFPGTCEDDQLYKICNAIGSPTEESWAEGLEL 230 (346)
Q Consensus 155 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 230 (346)
......||+.|+|||++. ...++.++|||||||++|||++|. +||...+..+.+..+......+
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~-~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~----------- 233 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP----------- 233 (283)
T ss_dssp --------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-----------
T ss_pred cceEeccCCCCccccCHHHHc-cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-----------
Confidence 223356789999999887 667999999999999999999965 5555555555544443221111
Q ss_pred HHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 231 AKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+++++.+||.+||+.||++|||+.|+++
T Consensus 234 ------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 ------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 11356788999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=371.11 Aligned_cols=251 Identities=29% Similarity=0.477 Sum_probs=200.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++.+.||+|+||+||+|+++.+ +.||+|+++...... ..+.+|+.+++++ +||||+++++++.++ ..++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~--~~~~~E~~~l~~l-~h~nIv~~~g~~~~~-~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP--EAFLQEAQVMKKL-RHEKLVQLYAVVSEE-PIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH--HHHHHHHHHHHHC-CCTTBCCEEEEECSS-SCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH--HHHHHHHHHHHhc-ccCCEeEEEEEEecC-CeEEEEE
Confidence 7899999999999999999998765 569999997665543 3467899999999 799999999998654 5789999
Q ss_pred cCCC-CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC--CC
Q 039371 82 YMDC-NLHQLMSNR-KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP--PY 156 (346)
Q Consensus 82 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~--~~ 156 (346)
|+.+ ++...+... ...+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...... ..
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9985 566555433 34699999999999999999999999999999999999996 4699999999997664332 33
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFH-PLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+|+.|+|||++. .+.++.++||||+||++|||++|. +|+......+.+..+......+
T Consensus 172 ~~~~gt~~y~aPE~~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~---------------- 234 (285)
T d1fmka3 172 QGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------------- 234 (285)
T ss_dssp ----CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC----------------
T ss_pred ccccccccccChHHHh-CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC----------------
Confidence 3457899999999987 667899999999999999999965 5556666655655554322111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc--CCCCCCC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ--HPLFQGC 287 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~--hp~~~~~ 287 (346)
..+.++++++++|.+||+.||++|||++++++ ++||++.
T Consensus 235 -------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 -------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 12467899999999999999999999999998 8899764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-53 Score=373.62 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=198.1
Q ss_pred CceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec-CCE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE-NYR 75 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-~~~ 75 (346)
++|+++++||+|+||+||+|++.. +++.||+|+++............+|...+.++.+||||+.+++++.+ ++.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 689999999999999999999764 34689999998766655666677888999999889999999998754 457
Q ss_pred EEEEEEcCC-CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCc
Q 039371 76 LYFVFEYMD-CNLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDT 138 (346)
Q Consensus 76 ~~iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~ 138 (346)
+++|||||+ |+|.+.+.... ..+++.++..++.||+.||+|||++||+||||||+|||++ ++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence 899999998 57777765432 2489999999999999999999999999999999999995 569
Q ss_pred EEEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 039371 139 IKIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICN 214 (346)
Q Consensus 139 vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~ 214 (346)
+||+|||+|+...... ......||+.|+|||++. ...++.++||||+||++|||++| .+||.+....+.+..++.
T Consensus 173 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~ 251 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251 (299)
T ss_dssp EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred EEEccCcchhhccccccccccCceeeCccccchhHhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999997654332 234467999999999987 56789999999999999999986 578988766655555444
Q ss_pred HhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 215 AIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
....+. ..+.++++++++|.+||+.||++|||++|+++|
T Consensus 252 ~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 252 EGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 322111 113578899999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=374.45 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=205.8
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcE--EEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEY--VAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYF 78 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~i 78 (346)
+++|++.++||+|+||+||+|+++.+|.. ||+|.++............+|+.++.++.+||||+++++++.+++.+++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 36899999999999999999999988874 6777776554444555678999999998779999999999999999999
Q ss_pred EEEcCC-CCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEE
Q 039371 79 VFEYMD-CNLHQLMSNR---------------KQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKI 141 (346)
Q Consensus 79 v~e~~~-g~l~~~~~~~---------------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl 141 (346)
||||++ |+|.+.+... ...+++.++..++.||+.||.|||+++|+||||||+|||++ ++.+||
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence 999998 5777776533 35699999999999999999999999999999999999995 459999
Q ss_pred eecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCC
Q 039371 142 ADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFH-PLFPGTCEDDQLYKICNAIGSPT 220 (346)
Q Consensus 142 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~ 220 (346)
+|||+|.............+|..|+|||.+. ...++.++|||||||++|+|++|. +||.+.+..+....+.++..
T Consensus 169 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~--- 244 (309)
T d1fvra_ 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--- 244 (309)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC---
T ss_pred ccccccccccccccccceecCCcccchHHhc-cCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---
Confidence 9999998776655555667899999999987 566899999999999999999965 67888777776655533211
Q ss_pred hhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 221 EESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
. .....+++++.+||.+||+.||++|||++|+++|
T Consensus 245 -----------------~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 -----------------L---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -----------------C---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------C---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 0113578899999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=369.33 Aligned_cols=249 Identities=25% Similarity=0.442 Sum_probs=203.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCC-------cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSG-------EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY 74 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~ 74 (346)
++|++++.||+|+||+||+|++..++ ..||+|+++............+|...+.++.+||||+++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 78999999999999999999876554 47999999876665555667889999999988999999999999999
Q ss_pred EEEEEEEcCC-CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC
Q 039371 75 RLYFVFEYMD-CNLHQLMSNRK---------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND 137 (346)
Q Consensus 75 ~~~iv~e~~~-g~l~~~~~~~~---------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~ 137 (346)
.+++||||++ |++.+.+.... ..+++.++..++.||+.||+|||++||+||||||+|||++ ++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence 9999999998 57777775443 3489999999999999999999999999999999999996 45
Q ss_pred cEEEeecccccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.+||+|||++....... ......+|+.|+|||.+. .+.|+.++|||||||++|+|++ |.+||.+.+..+....+.
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~ 251 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhc-CCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 99999999997654432 334467899999999887 5779999999999999999998 789998887766555443
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
... .++ ..+.+++++.+||.+||+.||++|||++|+++
T Consensus 252 ~~~-~~~----------------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 252 EGH-RMD----------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TTC-CCC----------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCC-CCC----------------------------CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 221 111 11357899999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=366.22 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=197.2
Q ss_pred CceeeeeeecccCceEEEEEEEccC-C--cEEEEEEcccccc--CHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQS-G--EYVAIKALKQRIY--SWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|+...+ + ..||+|+++.... ......+.+|+.+++++ +||||+++++++.++ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-SC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeec-ch
Confidence 5899999999999999999986533 3 3689999876543 23344567999999999 899999999999765 56
Q ss_pred EEEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCC
Q 039371 77 YFVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCP 154 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~ 154 (346)
++||||++ |++.+.+....+.+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 89999998 577777777777799999999999999999999999999999999999995 5699999999998765443
Q ss_pred C----CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHH
Q 039371 155 P----YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLE 229 (346)
Q Consensus 155 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 229 (346)
. .....++..|+|||++. ...++.++|||||||++|||++ |..||.+.+..+....+.+....++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--------- 235 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--------- 235 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---------
T ss_pred CcceecCccccCcccCCHHHHh-CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC---------
Confidence 2 23345788999999987 5678999999999999999998 8999999988888777754322211
Q ss_pred HHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 230 LAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+.+++++.+||.+||+.||++|||++|+++
T Consensus 236 -------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 -------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 12467899999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-52 Score=366.32 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=206.5
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++++.||+|+||+||+|+.+ .+++.||||+++............+|+.+++++ +||||+++++++.+.+..
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSC
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCCce
Confidence 58999999999999999999875 356789999998665555556678999999999 899999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCE
Q 039371 77 YFVFEYMD-CNLHQLMSNRK-----------------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNL 132 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~-----------------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NI 132 (346)
+++||++. |+|.+.+.... ..+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 99999998 57777664321 2388999999999999999999999999999999999
Q ss_pred EEeC-CcEEEeecccccccCCC---CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCC-CCCCCCChHH
Q 039371 133 LVSN-DTIKIADFGLAWEVDSC---PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFH-PLFPGTCEDD 207 (346)
Q Consensus 133 li~~-~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~ 207 (346)
++++ +.+||+|||+|...... .......+++.|+|||.+. ...++.++|||||||++|||++|. +||.+.+..+
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e 250 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-cCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence 9965 59999999999755332 2333467889999999987 667999999999999999999985 7898888887
Q ss_pred HHHHHHHHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 208 QLYKICNAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 208 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
....+.+....+ ....+++++.+||.+||+.||++|||+.||++
T Consensus 251 ~~~~v~~~~~~~-----------------------------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 251 VIYYVRDGNILA-----------------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCC-----------------------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 777664432111 12367889999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=359.65 Aligned_cols=243 Identities=24% Similarity=0.419 Sum_probs=194.4
Q ss_pred CCceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeee-cCCEEEEE
Q 039371 1 MEKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELAS-ENYRLYFV 79 (346)
Q Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~-~~~~~~iv 79 (346)
+++|++++.||+|+||+||+|+++ |+.||+|+++.+.. .....+|+.+++++ +||||+++++++. +.+.+|+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT---AQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHH---HHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEE
Confidence 579999999999999999999874 78899999975432 23456899999999 7999999999885 45668999
Q ss_pred EEcCC-CCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CCcEEEeecccccccCCCCCC
Q 039371 80 FEYMD-CNLHQLMSNRK-QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-NDTIKIADFGLAWEVDSCPPY 156 (346)
Q Consensus 80 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~~vkl~Dfg~a~~~~~~~~~ 156 (346)
|||++ |+|.+.+...+ ..+++..+..++.||+.||.|||+++|+||||||+||+++ ++.+||+|||++...... .
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~ 157 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--Q 157 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--C
Confidence 99998 57777775443 3589999999999999999999999999999999999996 569999999999775543 3
Q ss_pred ccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhhHHHHHHHHHhcC
Q 039371 157 TEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKICNAIGSPTEESWAEGLELAKAHG 235 (346)
Q Consensus 157 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 235 (346)
....+|..|+|||++. ...++.++|||||||++|||++ |.+||...+..+....+.++...
T Consensus 158 ~~~~~~~~y~aPE~l~-~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~----------------- 219 (262)
T d1byga_ 158 DTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM----------------- 219 (262)
T ss_dssp ----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-----------------
T ss_pred ccccccccCCChHHHh-CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 3456889999999987 5678999999999999999998 78999888777666665332111
Q ss_pred CCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 236 YKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
...+.+++++.+||++||+.||++|||+.+++++
T Consensus 220 ------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 220 ------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1124578899999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=363.64 Aligned_cols=250 Identities=25% Similarity=0.413 Sum_probs=209.2
Q ss_pred CceeeeeeecccCceEEEEEEEc-----cCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKK-----QSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|++.+.||+|+||+||+|++. .+++.||+|+++............+|+.++.++.+||||+++++++.+++.+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 68999999999999999999863 4567899999987665555566779999999997899999999999999999
Q ss_pred EEEEEcCCC-CHHHHHhccc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe-CC
Q 039371 77 YFVFEYMDC-NLHQLMSNRK-----------------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS-ND 137 (346)
Q Consensus 77 ~iv~e~~~g-~l~~~~~~~~-----------------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~-~~ 137 (346)
+++|||++| ++.+.+.... ..+++..+..++.||+.||+|||++|++||||||+||+++ ++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence 999999985 6666665432 2589999999999999999999999999999999999996 56
Q ss_pred cEEEeecccccccCCCCC---CccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 039371 138 TIKIADFGLAWEVDSCPP---YTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELIT-FHPLFPGTCEDDQLYKIC 213 (346)
Q Consensus 138 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 213 (346)
.+|++|||.+........ .....||+.|+|||++. ...++.++|||||||++|+|++ |.+||.+.+..+.+.++.
T Consensus 183 ~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i 261 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261 (311)
T ss_dssp EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred cccccccchheeccCCCcceEeeecccChHHcCHHHhc-CCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999987654332 23457899999999887 6778999999999999999998 677787777766666665
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
.....+.. ....++++.+||.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~----------------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 262 KEGFRMLS----------------------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHTCCCCC----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCCC----------------------------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 54322211 1356889999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-51 Score=359.10 Aligned_cols=256 Identities=20% Similarity=0.249 Sum_probs=205.1
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|++..+|+.||+|++..... ......|..+++.+.+|++|+.+..++.+++..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 589999999999999999999999999999999865432 22356799999999656667777778888899999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe----CCcEEEeecccccccCCCC---
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS----NDTIKIADFGLAWEVDSCP--- 154 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~----~~~vkl~Dfg~a~~~~~~~--- 154 (346)
+++|++...+......+++..+..++.|++.||+|||++||+||||||+||+++ +..++|+|||+|.......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 999999988887777899999999999999999999999999999999999984 2379999999998654322
Q ss_pred -----CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh---CCCChhhHHH
Q 039371 155 -----PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAI---GSPTEESWAE 226 (346)
Q Consensus 155 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~ 226 (346)
......||+.|+|||++. +..++.++|||||||++|+|++|..||...........+.... ..++
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~------ 236 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------ 236 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHT-TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC------
T ss_pred ceeccccCCcCCCccccCHHHHh-CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC------
Confidence 223457999999999887 5668999999999999999999999998876554443332211 0011
Q ss_pred HHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHH---HHhcCCCCCC
Q 039371 227 GLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAA---EALQHPLFQG 286 (346)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~---ell~hp~~~~ 286 (346)
.....+.+++++.+++..|++.||++||+++ ++|+|+|.+.
T Consensus 237 -------------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 237 -------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -------------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 1112246789999999999999999999987 4577776543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=362.09 Aligned_cols=248 Identities=23% Similarity=0.406 Sum_probs=207.4
Q ss_pred CceeeeeeecccCceEEEEEEEcc-----CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQ-----SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRL 76 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~ 76 (346)
++|+++++||+|+||+||+|.++. +++.||||+++............+|+.+++++ +||||+++++++..++..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCCce
Confidence 689999999999999999998763 35789999998665555555678999999999 799999999999999999
Q ss_pred EEEEEcCC-CCHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecc
Q 039371 77 YFVFEYMD-CNLHQLMSNRK---------QCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFG 145 (346)
Q Consensus 77 ~iv~e~~~-g~l~~~~~~~~---------~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg 145 (346)
++||||+. |++.+.+.... ..+++..+..++.|++.||.|||+++|+||||||+|||+++ +.+||+|||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecc
Confidence 99999998 56766654321 24789999999999999999999999999999999999965 489999999
Q ss_pred cccccCCCC---CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCh
Q 039371 146 LAWEVDSCP---PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITF-HPLFPGTCEDDQLYKICNAIGSPTE 221 (346)
Q Consensus 146 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~ 221 (346)
+|+...... ......+|+.|+|||.+. ...++.++||||+||++|||++| .+||.+.+..+.+..+.+....+
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~-~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~-- 255 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD-- 255 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC--
T ss_pred cceeccCCcceeeccceecccccCCHHHHc-cCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC--
Confidence 997654332 233446899999999987 56789999999999999999998 58898888887777665432111
Q ss_pred hhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 222 ESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+.+++.+.++|.+||+.||++|||++++++
T Consensus 256 ---------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 256 ---------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11357889999999999999999999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.5e-50 Score=351.23 Aligned_cols=250 Identities=18% Similarity=0.198 Sum_probs=205.9
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
++|++++.||+|+||+||+|++..+|+.||+|+++..... ....+|+..+..+.+|+|++.+++++.++...++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 5899999999999999999999999999999998654322 2345788888888777999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEe------CCcEEEeecccccccCCC--
Q 039371 82 YMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVS------NDTIKIADFGLAWEVDSC-- 153 (346)
Q Consensus 82 ~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~------~~~vkl~Dfg~a~~~~~~-- 153 (346)
+++|++.+.+...+..+++..+..++.|++.||+|||++||+||||||+||+++ ++.+||+|||+|+.....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 999999998887777799999999999999999999999999999999999995 358999999999765432
Q ss_pred ------CCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhhH
Q 039371 154 ------PPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED---DQLYKICNAIGSPTEESW 224 (346)
Q Consensus 154 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 224 (346)
.......||+.|+|||++. ...++.++|||||||++|+|++|..||.+.... .....+......++.
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~--- 237 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL--- 237 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH---
T ss_pred ccceeecccCceEEchhhcCHHHhc-CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh---
Confidence 1233467999999999987 567999999999999999999999999865433 223333222111111
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhc
Q 039371 225 AEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQ 280 (346)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~ 280 (346)
..+.+.+++++.+++..|++.+|++||+.+.+.+
T Consensus 238 ----------------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 238 ----------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp ----------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1122467889999999999999999999777654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=353.10 Aligned_cols=245 Identities=21% Similarity=0.309 Sum_probs=195.2
Q ss_pred eeeeecccCceEEEEEEEccCC---cEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeec-CCEEEEEEE
Q 039371 6 LMKQIGEGSFGKVWQAIKKQSG---EYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASE-NYRLYFVFE 81 (346)
Q Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~-~~~~~iv~e 81 (346)
..+.||+|+||+||+|++..++ ..||+|+++..........+.+|+.++.++ +||||+++++++.+ ++..++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEE
Confidence 3678999999999999986543 368999997655555556678999999999 79999999999754 568999999
Q ss_pred cCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeC-CcEEEeecccccccCCCC-----
Q 039371 82 YMDC-NLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSN-DTIKIADFGLAWEVDSCP----- 154 (346)
Q Consensus 82 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~-~~vkl~Dfg~a~~~~~~~----- 154 (346)
|+++ ++.+.+......+++..+..++.|++.||.|||+.+|+||||||+|||+++ +.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence 9995 666667766667889999999999999999999999999999999999965 599999999997654332
Q ss_pred CCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhhHHHHHHHHHh
Q 039371 155 PYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTCED-DQLYKICNAIGSPTEESWAEGLELAKA 233 (346)
Q Consensus 155 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~ 233 (346)
......||+.|+|||.+. ...++.++||||||+++|||++|+.||...... +....+..+. .+.
T Consensus 190 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-~~~------------- 254 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLL------------- 254 (311)
T ss_dssp CTTCSSCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-CCC-------------
T ss_pred ecccccccccccChHHHh-cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CCC-------------
Confidence 223356889999999887 567899999999999999999987777554333 2223222211 110
Q ss_pred cCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 234 HGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..+.+++++.+||.+||+.||++|||+.|+++|
T Consensus 255 ---------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 255 ---------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 113567899999999999999999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-48 Score=353.80 Aligned_cols=284 Identities=27% Similarity=0.381 Sum_probs=211.3
Q ss_pred ceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhc----------CCCCeeeeeeeeec
Q 039371 3 KYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKIN----------NHPNIVKLQELASE 72 (346)
Q Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~----------~hp~iv~~~~~~~~ 72 (346)
||+++++||+|+||+||+|+++.+|+.||||+++.+.. ......+|+.+++.+. .||||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 69999999999999999999999999999999975532 2233456777777663 36899999998754
Q ss_pred --CCEEEEEEEcCC--CCHH-HHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCCEEEeC-C------cE
Q 039371 73 --NYRLYFVFEYMD--CNLH-QLMSNRKQCFSEAEVKNWCFQILQGLNYMHR-QGYFHRDLISKNLLVSN-D------TI 139 (346)
Q Consensus 73 --~~~~~iv~e~~~--g~l~-~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dikp~NIli~~-~------~v 139 (346)
....+.+++++. ++.. .........+++..++.++.||+.||+|||+ .||+||||||+|||++. + .+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 356666666664 3333 3334445569999999999999999999998 89999999999999952 2 59
Q ss_pred EEeecccccccCCCCCCccccccCcccCcccccccCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHH
Q 039371 140 KIADFGLAWEVDSCPPYTEYITTLQYRAPEMLLMSGQYNSKVDMWALGLIMAELITFHPLFPGTC------EDDQLYKIC 213 (346)
Q Consensus 140 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~ 213 (346)
+++|||.|..... ......||+.|+|||++. ...++.++||||+||++++|++|+.||.... ..+.+....
T Consensus 172 kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 172 KIADLGNACWYDE--HYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EECCCTTCEETTB--CCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eEeeccccccccc--ccccccccccccChhhcc-ccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 9999999976554 334568999999999887 5668999999999999999999999997543 345667777
Q ss_pred HHhCCCChhhHHHHHHHHHhcCCCCC--CcCCCC----------cccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 214 NAIGSPTEESWAEGLELAKAHGYKFP--KLQGNN----------LSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
..++.++...+............... ...... .....+..++++++||.+||+.||.+|||++|+|+|
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 78888777666543333222221100 000000 001112346789999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 039371 282 PLFQGCLQVP 291 (346)
Q Consensus 282 p~~~~~~~~~ 291 (346)
|||++.....
T Consensus 329 p~f~~~~~~~ 338 (362)
T d1q8ya_ 329 PWLKDTLGME 338 (362)
T ss_dssp GGGTTCTTCT
T ss_pred cccCCCCCcc
Confidence 9999765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=340.54 Aligned_cols=265 Identities=24% Similarity=0.287 Sum_probs=183.0
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCC----EEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENY----RLY 77 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~----~~~ 77 (346)
++|.+.+.||+|+||+||+|+. +|+.||+|+++.+.. .......|+..+.++ +||||+++++++.+.+ .+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEE
Confidence 5799999999999999999975 588999999865422 222222344444455 7999999999986543 689
Q ss_pred EEEEcCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCCEEEe-CCcEEEeecccc
Q 039371 78 FVFEYMD-CNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHR--------QGYFHRDLISKNLLVS-NDTIKIADFGLA 147 (346)
Q Consensus 78 iv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~--------~~ivH~dikp~NIli~-~~~vkl~Dfg~a 147 (346)
+||||++ |+|.+.+.+. .+++.++..++.|++.||+|||+ +||+||||||+|||++ ++.+||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999998 4777777653 48999999999999999999996 5999999999999995 569999999999
Q ss_pred cccCCCC-----CCccccccCcccCcccccccC-----CCCChhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 039371 148 WEVDSCP-----PYTEYITTLQYRAPEMLLMSG-----QYNSKVDMWALGLIMAELITFHPLFPGTCEDDQLYKICNAIG 217 (346)
Q Consensus 148 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 217 (346)
....... ......||+.|+|||++.... .++.++|||||||++|||++|.+||............. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-~~~ 234 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-VPS 234 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-SCS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-ccc
Confidence 7654332 234467999999999886432 25678999999999999999998874432211000000 000
Q ss_pred CCChhhHHHHHHHHHhcCCCCCCcCCCCcccccCCCCchHHHHHHHhcccCCCCCCCHHHHhcC
Q 039371 218 SPTEESWAEGLELAKAHGYKFPKLQGNNLSLLIPSANDDEMSLIELLCSWDPCKRPTAAEALQH 281 (346)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~ell~h 281 (346)
.+.. ............ .|.... .. ........+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~---~~~~~~~~~~~~-~p~~~~-~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSV---EEMRKVVCEQKL-RPNIPN-RW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCH---HHHHHHHTTSCC-CCCCCG-GG--GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchH---HHHHHHHhcccc-CCCCCc-cc--CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0000 000000001011 010000 00 001123458899999999999999999999873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=4.7e-27 Score=191.83 Aligned_cols=163 Identities=20% Similarity=0.153 Sum_probs=119.6
Q ss_pred eeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCH-----------------HHhhhHHHHHHHHhhcCCCCeeee
Q 039371 4 YTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSW-----------------EECLNLKEVKCLRKINNHPNIVKL 66 (346)
Q Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~~e~~~l~~l~~hp~iv~~ 66 (346)
|.+.++||+|+||+||+|++. +|+.||+|+++...... .......|...+.++ .|++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 568999999999999999875 68899999875322110 011223577778888 68999888
Q ss_pred eeeeecCCEEEEEEEcCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCCEEEeCCcEEEeeccc
Q 039371 67 QELASENYRLYFVFEYMDCNLHQLMSNRKQCFSEAEVKNWCFQILQGLNYMHRQGYFHRDLISKNLLVSNDTIKIADFGL 146 (346)
Q Consensus 67 ~~~~~~~~~~~iv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dikp~NIli~~~~vkl~Dfg~ 146 (346)
++... .+++||++++.... .+++..+..++.|++.++.|||++||+||||||+|||++++.++|+|||.
T Consensus 80 ~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDFG~ 148 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQ 148 (191)
T ss_dssp EEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTT
T ss_pred EEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEECCC
Confidence 76543 27999999974321 25666678899999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCccccccCcccC------cccccccCCCCChhhHHHHHH
Q 039371 147 AWEVDSCPPYTEYITTLQYRA------PEMLLMSGQYNSKVDMWALGL 188 (346)
Q Consensus 147 a~~~~~~~~~~~~~~t~~y~a------PE~~~~~~~~~~~~DiwslG~ 188 (346)
|...+..... .|.. .+.+ ...|+.++|+||+.-
T Consensus 149 a~~~~~~~~~-------~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 149 SVEVGEEGWR-------EILERDVRNIITYF--SRTYRTEKDINSAID 187 (191)
T ss_dssp CEETTSTTHH-------HHHHHHHHHHHHHH--HHHHCCCCCHHHHHH
T ss_pred cccCCCCCcH-------HHHHHHHHHHHHHH--cCCCCCcccHHHHHH
Confidence 8765432110 1111 1212 355788999999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=2.8e-08 Score=83.13 Aligned_cols=84 Identities=17% Similarity=0.134 Sum_probs=58.2
Q ss_pred CceeeeeeecccCceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEEEE
Q 039371 2 EKYTLMKQIGEGSFGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFVFE 81 (346)
Q Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv~e 81 (346)
+.|+..+..+.++.+.||+.. .++..+++|+....... ......+|...+..+..+--+.+++.+.++++..++||+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 567777776666667999985 34566778877543322 122335678888777555456778888888889999999
Q ss_pred cCCCCHH
Q 039371 82 YMDCNLH 88 (346)
Q Consensus 82 ~~~g~l~ 88 (346)
+++|...
T Consensus 91 ~l~G~~~ 97 (263)
T d1j7la_ 91 EADGVLC 97 (263)
T ss_dssp CCSSEEH
T ss_pred ecccccc
Confidence 9998443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.35 E-value=3.3e-07 Score=81.20 Aligned_cols=77 Identities=16% Similarity=0.166 Sum_probs=46.8
Q ss_pred eeeecccCceEEEEEEEccCCcEEEEEEcccc------ccCHHHhhhHHHHHHHHhhcCC--CCeeeeeeeeecCCEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQSGEYVAIKALKQR------IYSWEECLNLKEVKCLRKINNH--PNIVKLQELASENYRLYF 78 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~e~~~l~~l~~h--p~iv~~~~~~~~~~~~~i 78 (346)
.+.||.|....||++.+..+++.+++|.-... .......+...|...+..+..+ ..+++++.+..+ ..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--MAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--TTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC--CCEE
Confidence 56789999999999988888888999965321 0111112234577777776544 235556554333 3478
Q ss_pred EEEcCCC
Q 039371 79 VFEYMDC 85 (346)
Q Consensus 79 v~e~~~g 85 (346)
|||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999976
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.02 E-value=2.2e-05 Score=64.54 Aligned_cols=72 Identities=11% Similarity=0.039 Sum_probs=47.8
Q ss_pred eecccC-ceEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCC-CCeeeeeeeeecCCEEEEEEEcCCC
Q 039371 9 QIGEGS-FGKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNH-PNIVKLQELASENYRLYFVFEYMDC 85 (346)
Q Consensus 9 ~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~h-p~iv~~~~~~~~~~~~~iv~e~~~g 85 (346)
.+..|. .+.||+.... ++..+++|........ ....|...++.+..+ -.+.+++.+..+++..+++|++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 445554 3679999753 4666888976544322 234566666666433 2366777777888889999999987
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.28 E-value=0.00041 Score=60.69 Aligned_cols=72 Identities=14% Similarity=0.063 Sum_probs=49.9
Q ss_pred eeeecccCceEEEEEEEcc-------CCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCCCeeeeeeeeecCCEEEEE
Q 039371 7 MKQIGEGSFGKVWQAIKKQ-------SGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHPNIVKLQELASENYRLYFV 79 (346)
Q Consensus 7 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp~iv~~~~~~~~~~~~~iv 79 (346)
++.|+.|-.-.+|++.... .++.|.+++.-. ... .....+|..+++.+..+.-.+++++++.+ .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 4678888888999998653 235677777652 222 22344788888888766556678877764 578
Q ss_pred EEcCCC
Q 039371 80 FEYMDC 85 (346)
Q Consensus 80 ~e~~~g 85 (346)
+|+++|
T Consensus 120 ~efi~g 125 (395)
T d1nw1a_ 120 EEYIPS 125 (395)
T ss_dssp ECCCCE
T ss_pred EEEecc
Confidence 999987
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.03 E-value=0.0027 Score=53.69 Aligned_cols=129 Identities=12% Similarity=0.110 Sum_probs=71.0
Q ss_pred eEEEEEEEccCCcEEEEEEccccccCHHHhhhHHHHHHHHhhcCCC-Ceeeeee-----eeecCCEEEEEEEcCCCCH--
Q 039371 16 GKVWQAIKKQSGEYVAIKALKQRIYSWEECLNLKEVKCLRKINNHP-NIVKLQE-----LASENYRLYFVFEYMDCNL-- 87 (346)
Q Consensus 16 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~hp-~iv~~~~-----~~~~~~~~~iv~e~~~g~l-- 87 (346)
-.||+++. .+|+.|++|+......+... ...|...+..|..+. .++.... .+..++..+.++++++|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~--i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQ--ILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHH--HHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHH--HHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 47999965 46788999998654333222 345666666664221 1111111 2345667889999987621
Q ss_pred ---HHHH----------hc----cc----CC-------------------CCHH---HHHHHHHHHHHHHHHHH----HC
Q 039371 88 ---HQLM----------SN----RK----QC-------------------FSEA---EVKNWCFQILQGLNYMH----RQ 120 (346)
Q Consensus 88 ---~~~~----------~~----~~----~~-------------------l~~~---~~~~i~~ql~~~l~~LH----~~ 120 (346)
.+.. .. .. .. ++.. .....+.++...+.-.- ..
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1111 00 00 00 1111 12223333333333221 12
Q ss_pred CccccCCCCCCEEEeCCcEEEeeccccc
Q 039371 121 GYFHRDLISKNLLVSNDTIKIADFGLAW 148 (346)
Q Consensus 121 ~ivH~dikp~NIli~~~~vkl~Dfg~a~ 148 (346)
+++|+|+.|.||+++++ ..++||+.+.
T Consensus 193 ~liHgDlh~~NvL~~~~-~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG-PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS-EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC-ceEEechhcc
Confidence 68999999999999766 4589999774
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.67 E-value=0.0092 Score=49.88 Aligned_cols=27 Identities=33% Similarity=0.602 Sum_probs=24.4
Q ss_pred CccccCCCCCCEEEeCCcE-EEeecccc
Q 039371 121 GYFHRDLISKNLLVSNDTI-KIADFGLA 147 (346)
Q Consensus 121 ~ivH~dikp~NIli~~~~v-kl~Dfg~a 147 (346)
|++|+|+.++||+++++.+ -++||+.+
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred ccccCCcchhhhhcccccceeEeccccc
Confidence 7999999999999988865 79999977
|